data_6mie_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6mie _Structure_validation_residue.Date_analyzed 2020-02-28 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.4 t -114.68 -43.78 3.12 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 127.23 2.212 . . . . 0.0 110.144 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -73.27 56.23 0.47 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.008 1.723 . . . . 0.0 112.274 167.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.3 p -169.89 -36.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 130.491 3.516 . . . . 0.0 109.581 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -83.6 -49.89 8.75 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.632 1.173 . . . . 0.0 109.661 170.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -55.45 -24.26 37.74 Favored Glycine 0 CA--C 1.537 1.433 0 O-C-N 120.722 -1.236 . . . . 0.0 113.006 164.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . 0.275 0.3 OUTLIER -77.22 -42.57 36.88 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.29 1.036 . . . . 0.0 112.391 174.141 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 t -53.39 -52.05 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.68 1.192 . . . . 0.0 110.336 165.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -72.29 -9.64 58.75 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -84.96 -46.22 11.44 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 119.464 1.029 . . . . 0.0 110.527 162.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -66.65 -46.1 76.84 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.344 1.058 . . . . 0.0 111.434 -169.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pp -71.37 -14.29 62.13 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -109.11 -32.54 7.19 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.722 0.809 . . . . 0.0 113.178 -172.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -80.63 111.5 23.59 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.6 1.16 . . . . 0.0 111.621 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -69.1 119.99 6.91 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.928 1.752 . . . . 0.0 110.066 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.0 p -145.43 178.68 7.93 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.855 1.262 . . . . 0.0 108.84 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -53.84 -42.29 68.83 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.222 -0.766 . . . . 0.0 111.518 164.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -66.59 -47.02 74.04 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -59.08 -50.54 73.68 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.933 0.788 . . . . 0.0 109.795 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 13.0 t -56.75 -50.41 72.32 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.27 0.628 . . . . 0.0 111.752 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -60.55 -52.13 66.5 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 121.774 -0.579 . . . . 0.0 112.25 -174.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.8 t -87.31 -39.52 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.343 -0.848 . . . . 0.0 113.172 -170.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -69.59 -41.5 75.7 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.351 0.66 . . . . 0.0 111.016 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -81.39 -25.59 36.14 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -176.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -57.61 -51.63 68.74 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.498 1.044 . . . . 0.0 110.857 161.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.16 -43.13 73.97 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 173.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . 0.289 1.2 m -63.85 -42.26 95.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-N 121.55 1.977 . . . . 0.0 112.114 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -66.5 -42.72 86.95 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.093 1.315 . . . . 0.0 111.593 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.77 -48.38 81.91 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.905 0.482 . . . . 0.0 109.913 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.04 -43.68 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 117.933 -1.032 . . . . 0.0 111.018 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.95 -39.49 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 120.592 1.542 . . . . 0.0 113.158 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 63.3 tp -63.53 -45.49 90.37 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.955 1.302 . . . . 0.0 111.032 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.69 -53.25 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.504 0.722 . . . . 0.0 110.781 174.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 63.7 m -61.42 -35.58 77.95 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.479 1.512 . . . . 0.0 113.09 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.4 mt -81.08 -37.53 28.83 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.166 1.348 . . . . 0.0 113.552 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.57 -44.44 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 119.258 0.935 . . . . 0.0 109.511 168.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -64.34 -31.71 73.03 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-O 117.614 -1.184 . . . . 0.0 112.409 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.4 t -63.45 -43.59 96.94 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 121.103 1.774 . . . . 0.0 112.394 176.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 90.2 t -59.7 -39.53 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.764 1.226 . . . . 0.0 111.612 174.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 30.6 tp -71.72 -47.31 54.78 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.367 1.067 . . . . 0.0 112.358 174.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.9 t -59.53 -37.59 78.77 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.744 2.418 . . . . 0.0 112.929 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.8 t -76.77 1.7 16.51 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.0 -1.062 . . . . 0.0 113.027 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.0 mm -113.26 -35.65 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 127.225 2.21 . . . . 0.0 112.165 165.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.51 ' CD ' ' HG1' ' A' ' 155' ' ' THR . 7.0 mm-40 -55.55 -31.53 62.22 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.282 1.033 . . . . 0.0 113.174 168.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -61.52 -22.09 64.82 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -93.42 -28.53 16.08 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.207 1.003 . . . . 0.0 111.702 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.36 -35.09 79.76 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.087 0.955 . . . . 0.0 111.067 168.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.91 -6.55 3.92 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.145 1.378 . . . . 0.0 114.396 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.4 mt -84.46 -15.3 46.55 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.382 1.473 . . . . 0.0 113.414 170.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.25 -38.87 1.06 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -163.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.8 t -157.45 177.26 11.63 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.429 -0.794 . . . . 0.0 111.984 -148.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -72.01 156.24 52.3 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 121.519 0.51 . . . . 0.0 113.042 173.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.51 ' HG1' ' CD ' ' A' ' 146' ' ' GLU . 4.7 t -164.26 151.58 11.88 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.548 -0.972 . . . . 0.0 112.337 -166.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 33.9 mt -73.04 -0.12 13.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.388 1.475 . . . . 0.0 113.584 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -54.34 -26.32 29.1 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.605 1.562 . . . . 0.0 114.449 -173.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -52.59 -32.3 40.62 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.743 1.217 . . . . 0.0 114.071 171.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 17.8 tpt -71.06 -18.63 62.55 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.248 0.619 . . . . 0.0 112.562 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -67.42 -38.45 84.62 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.674 -1.266 . . . . 0.0 111.664 169.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.6 mp -66.87 -37.49 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 122.845 0.458 . . . . 0.0 110.384 174.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.65 -49.95 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.568 0.747 . . . . 0.0 111.698 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.8 mt -71.86 -28.99 63.91 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 20.5 t -61.36 -40.06 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 120.338 1.426 . . . . 0.0 111.951 165.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.9 t -68.71 -37.01 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 119.205 0.911 . . . . 0.0 111.047 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -57.89 -56.72 18.35 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.812 0.733 . . . . 0.0 111.272 168.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -67.03 -38.88 86.68 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.464 1.029 . . . . 0.0 113.392 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -61.72 -45.61 95.91 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.877 0.751 . . . . 0.0 111.61 172.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 89.2 m -63.14 -43.39 98.49 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 117.617 0.709 . . . . 0.0 111.382 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -62.18 -33.01 73.71 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.076 1.75 . . . . 0.0 112.864 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -66.38 -45.77 78.94 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.39 -0.819 . . . . 0.0 111.757 170.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.8 t -70.97 -32.22 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.964 0.906 . . . . 0.0 112.25 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.6 t -60.62 -37.79 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.344 1.458 . . . . 0.0 111.919 174.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 37.0 mtm180 -62.65 -43.18 99.47 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.531 0.605 . . . . 0.0 111.998 167.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 48.6 mt -62.89 -32.23 73.45 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.996 -1.065 . . . . 0.0 113.447 175.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 29.4 m0 -70.66 -35.78 73.04 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.277 -0.889 . . . . 0.0 113.241 170.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 94.2 p -78.59 13.53 1.59 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 121.153 1.797 . . . . 0.0 114.863 165.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -47.9 -44.52 29.73 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.58 1.082 . . . . 0.0 111.43 160.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -162.72 23.49 0.2 Allowed Glycine 0 CA--C 1.531 1.087 0 CA-C-O 118.372 -1.238 . . . . 0.0 115.336 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 62.5 m 69.13 -39.95 0.44 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.004 2.122 . . . . 0.0 116.574 168.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.31 -9.32 15.5 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.735 1.614 . . . . 0.0 113.837 164.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.483 ' HB2' ' H ' ' A' ' 186' ' ' GLY . 86.9 p -72.08 25.73 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.689 2.396 . . . . 0.0 115.465 -169.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.31 -0.52 17.33 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 -158.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -109.94 -43.37 4.01 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.916 1.287 . . . . 0.0 111.112 153.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.62 -73.42 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.867 1.267 . . . . 0.0 112.832 -170.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.483 ' H ' ' HB2' ' A' ' 182' ' ' SER . . . -78.68 -9.42 87.08 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.212 1.387 . . . . 0.0 113.946 175.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.56 -44.41 76.79 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.927 0.863 . . . . 0.0 109.913 167.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 34.6 t-105 -76.3 -50.31 14.69 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.671 -0.643 . . . . 0.0 112.289 161.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -56.58 -33.8 63.13 Favored Glycine 0 CA--C 1.535 1.307 0 N-CA-C 116.513 1.365 . . . . 0.0 116.513 -167.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -83.88 -21.52 31.92 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.328 1.564 . . . . 0.0 113.841 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 2.5 tt -73.02 -45.18 59.2 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -55.24 -39.09 69.33 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.235 166.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -70.27 -15.15 62.86 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -80.71 57.93 3.13 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 120.849 -1.157 . . . . 0.0 113.36 -171.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 43.3 mtt-85 -93.69 -14.37 26.44 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.221 1.808 . . . . 0.0 115.295 -161.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -77.57 164.7 56.39 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 124.695 1.198 . . . . 0.0 111.087 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -60.25 -46.3 19.07 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.704 1.602 . . . . 0.0 114.274 -160.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 50.9 mm -66.67 -34.78 72.31 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 CA-C-N 117.975 0.352 . . . . 0.0 111.281 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 15.9 m -69.07 -37.14 78.34 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.282 1.433 . . . . 0.0 112.507 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 30.1 mm -66.8 -42.99 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.561 0.744 . . . . 0.0 110.718 170.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.1 mt -62.56 -41.58 92.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 O-C-N 121.175 -0.953 . . . . 0.0 111.051 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -64.91 -43.05 94.11 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.426 1.89 . . . . 0.0 110.181 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 45.9 tp -59.41 -50.51 73.67 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 169.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 44.2 mt -60.03 -43.39 92.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 O-C-N 121.392 -0.817 . . . . 0.0 111.226 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.7 t -72.68 -29.23 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 117.667 -1.158 . . . . 0.0 112.471 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.48 -39.01 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 121.55 1.977 . . . . 0.0 111.174 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 28.6 m -74.44 -35.68 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 118.367 0.53 . . . . 0.0 111.189 176.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.39 -45.25 84.68 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 118.202 0.455 . . . . 0.0 111.407 168.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 36.0 t -61.71 -38.42 87.81 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.345 1.458 . . . . 0.0 112.118 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 36.3 mmt -71.67 -41.03 69.2 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 171.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 10.3 t -60.49 -38.84 79.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 118.642 0.655 . . . . 0.0 111.052 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 3.4 t -61.34 -46.32 96.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 127.624 2.369 . . . . 0.0 111.493 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 61.5 mt -58.94 -41.18 86.77 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.475 1.034 . . . . 0.0 111.568 166.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 11.4 t -74.48 -31.45 62.22 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -165.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 84.9 t -66.76 -20.25 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.203 1.001 . . . . 0.0 111.56 173.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 218' ' ' LYS . . . 106.41 156.47 21.35 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 124.295 0.95 . . . . 0.0 111.619 -166.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 41.2 p -62.01 17.86 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 128.519 2.727 . . . . 0.0 115.203 172.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 216' ' ' GLY . 15.3 mttp -166.34 174.27 9.24 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 129.714 3.206 . . . . 0.0 110.012 -176.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.564 ' C ' ' H ' ' A' ' 221' ' ' VAL . . . 69.5 104.92 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 105.269 -3.133 . . . . 0.0 105.269 -113.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -59.4 3.74 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.936 0 O-C-N 121.744 -0.857 . . . . 0.0 112.211 170.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.564 ' H ' ' C ' ' A' ' 219' ' ' GLY . 23.2 m -79.7 -35.12 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 127.296 2.238 . . . . 0.0 112.71 167.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.2 -47.37 68.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.288 1.404 . . . . 0.0 109.799 163.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -62.44 -52.49 63.35 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.08 0.552 . . . . 0.0 111.496 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.88 -35.36 74.65 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.456 1.025 . . . . 0.0 112.316 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 17.0 m -75.18 -36.72 61.45 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.489 1.041 . . . . 0.0 112.773 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.28 -46.91 76.16 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.482 -0.761 . . . . 0.0 110.308 169.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.0 mt -66.79 -82.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 125.301 1.44 . . . . 0.0 110.974 172.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.483 ' HA ' ' CD1' ' A' ' 232' ' ' PHE . 48.1 mtt180 -77.74 14.52 1.04 Allowed 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 130.854 3.661 . . . . 0.0 114.573 -170.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -124.1 -59.58 0.18 Allowed Glycine 0 N--CA 1.462 0.382 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 162.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . 0.343 0.3 OUTLIER -99.97 -2.66 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -163.577 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.42 -39.79 11.79 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 121.229 -0.919 . . . . 0.0 111.871 145.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.483 ' CD1' ' HA ' ' A' ' 228' ' ' ARG . 1.7 m-30 -57.05 -30.57 64.36 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -177.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 7.1 tp -68.88 -31.41 70.32 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.756 -0.59 . . . . 0.0 112.37 172.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -75.45 -35.72 60.86 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.052 1.341 . . . . 0.0 112.505 -168.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -26.71 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.248 1.019 . . . . 0.0 111.639 170.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 62.2 mt -70.92 -28.85 64.81 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.79 0.805 . . . . 0.0 110.44 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -75.6 -25.08 56.68 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.065 2.146 . . . . 0.0 111.914 -171.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 66.6 mtp -46.1 -29.03 1.36 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.859 2.064 . . . . 0.0 115.525 155.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 20.0 mt -112.49 -31.26 6.85 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.858 1.263 . . . . 0.0 109.908 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.43 16.59 0.1 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.931 1.692 . . . . 0.0 114.019 155.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.505 -0.756 0 CA-C-O 124.273 1.987 . . . . 0.0 110.875 -170.175 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.528 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.48 -21.72 12.02 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.037 0.935 . . . . 0.0 112.074 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -57.19 -39.76 76.01 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.501 1.5 . . . . 0.0 112.451 168.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.4 p -61.98 -21.7 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 126.606 1.962 . . . . 0.0 113.682 171.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -95.51 -31.42 13.35 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.802 -0.562 . . . . 0.0 111.379 173.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -50.96 -26.47 11.38 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.289 1.424 . . . . 0.0 112.481 162.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -63.44 -48.85 76.06 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.776 0.831 . . . . 0.0 111.714 172.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.3 -57.36 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.956 0.902 . . . . 0.0 110.47 167.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -58.93 -46.21 88.5 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.497 1.119 . . . . 0.0 112.39 -167.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -65.86 -25.99 67.45 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 171.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -77.77 -34.93 52.15 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.131 1.332 . . . . 0.0 110.718 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 mt -59.67 -49.15 78.85 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 162.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -74.28 -32.01 62.75 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.162 -162.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -104.88 92.2 4.99 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 127.069 2.148 . . . . 0.0 110.711 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -58.22 128.3 28.14 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.129 1.886 . . . . 0.0 109.678 173.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.1 p -155.69 165.75 35.59 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.414 1.886 . . . . 0.0 107.805 -163.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -49.24 -42.29 32.29 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 118.957 -0.913 . . . . 0.0 111.466 175.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -75.4 -39.07 59.47 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.621 1.71 . . . . 0.0 115.568 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.445 ' HE3' ' CZ ' ' A' ' 125' ' ' TYR . 77.5 tttt -57.06 -50.54 72.44 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.679 1.582 . . . . 0.0 108.855 172.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 46.6 t -57.33 -43.8 83.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.288 1.835 . . . . 0.0 111.867 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -59.08 -57.01 14.94 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.13 -0.981 . . . . 0.0 111.208 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.1 m -81.87 -32.06 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -166.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.445 ' CZ ' ' HE3' ' A' ' 121' ' ' LYS . 6.4 m-85 -64.04 -34.46 78.07 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.216 0.916 . . . . 0.0 111.381 176.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.1 m170 -77.48 -43.11 33.38 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.846 0.748 . . . . 0.0 110.307 -171.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -67.06 -38.51 85.92 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.255 -0.879 . . . . 0.0 112.446 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.09 -40.24 76.58 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 120.172 1.351 . . . . 0.0 113.14 168.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.84 -41.98 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 121.308 1.867 . . . . 0.0 111.412 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -63.96 -41.93 97.44 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.59 0.632 . . . . 0.0 112.081 175.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.1 tp -73.72 -44.42 56.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.841 0.456 . . . . 0.0 111.892 -173.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.3 mp -67.39 -40.81 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 O-C-N 121.031 -1.043 . . . . 0.0 111.872 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.76 -44.78 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 120.465 1.484 . . . . 0.0 112.062 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 23.7 tp -54.67 -56.36 19.91 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.723 1.609 . . . . 0.0 111.469 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 55.3 t -65.18 -44.39 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 122.715 0.406 . . . . 0.0 111.416 -174.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 73.0 m -71.53 -35.04 70.55 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 91.3 mt -76.73 -37.51 55.87 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.431 1.468 . . . . 0.0 112.521 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 87.7 mt -59.91 -42.25 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 118.852 0.751 . . . . 0.0 109.312 169.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -64.49 -40.13 95.09 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 115.805 -2.045 . . . . 0.0 111.99 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.5 m -49.44 -44.47 45.6 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 121.346 1.884 . . . . 0.0 113.123 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 70.7 t -60.16 -34.91 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.157 0.983 . . . . 0.0 111.88 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.8 tp -85.44 -44.81 12.42 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 169.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 24.2 p -67.69 -30.04 69.46 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.931 1.293 . . . . 0.0 113.252 -167.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.2 t -75.05 -11.64 60.14 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.562 -0.711 . . . . 0.0 112.769 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.5 mm -97.36 -46.89 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 126.069 1.748 . . . . 0.0 111.771 170.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -55.21 -34.1 63.64 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.663 1.185 . . . . 0.0 112.596 173.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -68.13 -21.63 64.92 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.283 -1.51 . . . . 0.0 114.991 173.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -75.38 -26.93 58.88 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 121.05 1.75 . . . . 0.0 109.916 171.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -72.99 -30.09 63.54 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.286 -0.884 . . . . 0.0 112.174 167.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -56.48 -27.41 57.0 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.764 -1.21 . . . . 0.0 114.002 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 73.1 mt -57.35 -28.41 63.12 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.651 1.18 . . . . 0.0 113.688 173.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.11 -42.28 2.02 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.648 1.579 . . . . 0.0 114.451 -165.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.8 t -155.6 -172.7 4.24 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.758 0.79 . . . . 0.0 111.751 -147.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -70.98 140.93 32.08 Favored Glycine 0 CA--C 1.533 1.159 0 O-C-N 121.167 -0.958 . . . . 0.0 114.114 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.8 t -166.21 139.18 4.02 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.367 1.067 . . . . 0.0 112.104 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.5 3.19 2.5 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 171.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -56.79 -10.49 1.06 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.005 1.722 . . . . 0.0 113.686 166.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 33.7 p-90 -62.29 -24.58 67.38 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.861 -1.15 . . . . 0.0 112.787 167.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 69.0 mtm -73.9 -16.89 61.1 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.968 -1.082 . . . . 0.0 113.789 171.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -67.59 -41.35 84.24 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.606 1.548 . . . . 0.0 109.942 165.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 7.2 mt -56.6 -38.93 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 118.419 0.554 . . . . 0.0 111.85 170.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.46 -52.27 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 121.199 -0.938 . . . . 0.0 112.209 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 13.1 mt -67.27 -26.55 66.61 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.289 0.95 . . . . 0.0 112.195 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 6.2 t -64.49 -35.39 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 119.999 -1.688 . . . . 0.0 111.397 169.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 73.1 t -76.48 -30.4 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 118.72 -0.657 . . . . 0.0 110.504 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -62.35 -48.31 80.34 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 119.638 1.108 . . . . 0.0 112.261 167.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -69.04 -39.23 79.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.364 1.438 . . . . 0.0 112.581 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -54.05 -45.85 71.22 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 119.286 0.948 . . . . 0.0 112.954 166.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.9 m -62.05 -40.58 96.26 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.462 0.705 . . . . 0.0 111.707 172.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -60.1 -39.66 86.91 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.485 1.493 . . . . 0.0 112.912 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -71.12 -43.16 68.21 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.94 0.791 . . . . 0.0 111.961 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 90.1 t -72.38 -34.57 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 118.828 -0.605 . . . . 0.0 111.708 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 15.4 t -58.84 -37.23 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.114 1.366 . . . . 0.0 111.542 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -59.72 -46.78 88.07 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.471 1.032 . . . . 0.0 112.049 170.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.03 -23.42 66.55 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 120.456 -1.403 . . . . 0.0 114.288 172.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 54.5 m0 -76.09 -13.57 60.2 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 168.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 6.6 p -61.8 -36.8 82.19 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 121.746 2.066 . . . . 0.0 111.079 164.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.44 -26.62 66.88 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 165.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -68.15 0.78 10.31 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.449 1.976 . . . . 0.0 114.954 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 9.0 t -63.14 -31.87 73.12 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.711 1.756 . . . . 0.0 112.12 165.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.22 -47.58 0.06 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.315 1.446 . . . . 0.0 113.057 164.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 24.4 m -71.74 43.18 0.09 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 128.52 2.728 . . . . 0.0 112.513 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -49.01 -36.52 17.93 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 130.592 3.557 . . . . 0.0 113.53 -170.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -120.35 -36.8 3.15 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 124.374 1.046 . . . . 0.0 112.195 175.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 40.7 t -56.44 -59.42 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.437 1.095 . . . . 0.0 110.852 176.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -74.65 -35.83 50.17 Favored Glycine 0 C--O 1.222 -0.595 0 C-N-CA 124.84 1.21 . . . . 0.0 112.258 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.59 -47.8 75.87 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.956 1.378 . . . . 0.0 112.472 172.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -75.27 -41.02 58.15 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -56.42 -54.53 35.34 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -69.8 -30.62 68.2 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.828 1.314 . . . . 0.0 113.656 -174.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 38.6 tp -62.36 -31.31 71.95 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.631 0.65 . . . . 0.0 112.208 169.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 34.2 mtp-105 -92.3 -13.66 30.0 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 172.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -82.3 -16.47 49.25 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.598 1.159 . . . . 0.0 112.68 163.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -78.5 62.01 3.01 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.305 1.842 . . . . 0.0 112.082 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -93.56 -22.51 18.78 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 128.444 2.698 . . . . 0.0 115.652 -170.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -58.57 152.46 45.59 Favored Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 125.432 1.493 . . . . 0.0 112.03 -175.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -50.37 -41.96 49.62 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.904 2.403 . . . . 0.0 114.049 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 10.9 tp -61.86 -41.12 89.52 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 118.524 0.602 . . . . 0.0 112.163 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 18.8 m -68.45 -28.85 67.41 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.812 1.245 . . . . 0.0 111.574 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 36.0 mm -75.4 -42.13 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.883 0.873 . . . . 0.0 111.116 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 94.1 mt -58.84 -50.32 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 118.862 0.755 . . . . 0.0 110.071 171.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -59.18 -39.04 81.29 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.912 2.485 . . . . 0.0 112.243 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 54.9 tp -61.99 -51.7 66.98 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.767 1.227 . . . . 0.0 112.987 169.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 71.1 mt -65.89 -41.41 89.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.374 -0.829 . . . . 0.0 109.92 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 69.6 t -74.13 -35.32 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 125.244 1.418 . . . . 0.0 113.45 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.6 p -65.24 -35.67 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 120.908 1.685 . . . . 0.0 110.859 172.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 89.3 t -72.35 -42.58 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 117.934 -1.032 . . . . 0.0 109.617 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -55.54 -41.12 72.76 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.173 0.897 . . . . 0.0 112.16 170.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.8 t -62.39 -43.09 99.65 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.432 1.093 . . . . 0.0 112.835 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 30.2 mmt -70.35 -37.89 74.71 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.612 0.765 . . . . 0.0 111.424 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.39 -48.12 89.64 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 O-C-N 121.799 -0.563 . . . . 0.0 109.994 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 30.0 m -75.52 -34.65 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 O-C-N 121.663 -0.648 . . . . 0.0 112.374 -171.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.66 -21.01 66.51 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.253 -0.905 . . . . 0.0 112.088 170.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 57.6 m -85.56 -38.62 18.29 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.697 1.599 . . . . 0.0 113.6 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 24.3 t -56.86 -37.46 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.338 1.055 . . . . 0.0 108.863 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 218' ' ' LYS . . . 134.58 146.63 5.43 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 109.014 -1.635 . . . . 0.0 109.014 175.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 98.4 p -60.2 15.54 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 216' ' ' GLY . 0.9 OUTLIER -152.14 116.17 4.92 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 127.877 2.471 . . . . 0.0 111.56 -176.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.441 ' CA ' ' H ' ' A' ' 221' ' ' VAL . . . -97.76 -88.73 1.89 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 104.908 -3.277 . . . . 0.0 104.908 92.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 78.49 -51.58 0.48 Allowed 'General case' 0 N--CA 1.466 0.34 1 C-N-CA 132.674 4.39 . . . . 0.0 120.409 -21.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.441 ' H ' ' CA ' ' A' ' 219' ' ' GLY . 54.0 t -87.02 -51.3 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 120.119 -1.613 . . . . 0.0 110.203 -164.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -56.7 -36.14 69.32 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.815 -0.553 . . . . 0.0 111.941 167.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.45 -55.14 38.86 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 118.554 -0.736 . . . . 0.0 110.81 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.94 -36.22 83.67 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 120.742 1.61 . . . . 0.0 113.061 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 13.9 t -71.48 -43.61 66.27 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.386 1.448 . . . . 0.0 110.756 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.79 -53.61 55.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.847 0.459 . . . . 0.0 110.371 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 80.9 mt -63.48 -81.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 122.726 1.251 . . . . 0.0 109.517 173.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 -75.74 -14.62 60.33 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 124.793 1.237 . . . . 0.0 113.012 -157.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -95.26 -55.79 1.34 Allowed Glycine 0 CA--C 1.534 1.256 0 CA-C-N 118.701 0.682 . . . . 0.0 114.151 160.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.95 -39.95 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 120.745 -1.444 . . . . 0.0 112.156 -166.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 2.1 tpp85 -60.71 -35.01 75.25 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 119.573 1.079 . . . . 0.0 110.417 168.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.15 -36.96 84.51 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.215 1.406 . . . . 0.0 112.42 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 29.8 tp -64.46 -23.68 67.36 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 117.915 -1.04 . . . . 0.0 111.607 168.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -80.54 -44.87 18.36 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.913 1.688 . . . . 0.0 112.923 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -20.02 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.491 -1.38 . . . . 0.0 112.461 169.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 52.1 tp -71.02 -30.53 66.76 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.194 0.521 . . . . 0.0 111.888 174.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.488 ' HA ' ' CD2' ' A' ' 240' ' ' HIS . 19.7 mtp180 -70.32 -25.43 63.3 Favored 'General case' 0 C--O 1.212 -0.9 0 C-N-CA 124.866 1.267 . . . . 0.0 112.617 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 68.0 mtp -54.03 -23.97 15.4 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 160.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 6.1 mt -115.47 -35.39 4.61 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.873 -166.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . 0.488 ' CD2' ' HA ' ' A' ' 237' ' ' ARG . 5.6 p80 -75.72 -36.61 59.92 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.631 0.65 . . . . 0.0 111.354 164.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.366 5.6 p . . . . . 0 N--CA 1.468 0.468 0 C-N-CA 129.576 3.15 . . . . 0.0 115.148 164.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 . . . . . 0 N--CA 1.466 0.327 0 CA-C-O 118.714 -0.66 . . . . 0.0 111.735 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.5 p -66.95 -20.15 65.85 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.06 0.944 . . . . 0.0 112.025 172.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -79.09 -50.52 10.91 Favored 'General case' 0 CA--C 1.507 -0.704 0 O-C-N 121.416 -0.803 . . . . 0.0 109.042 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.5 m -76.21 -38.72 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.374 0.67 . . . . 0.0 110.749 -173.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -68.17 -32.97 73.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.533 172.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.1 -30.16 70.0 Favored Glycine 0 C--N 1.34 0.766 0 O-C-N 120.831 -1.168 . . . . 0.0 112.343 170.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -68.22 -46.6 70.14 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 126.377 1.871 . . . . 0.0 111.301 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.0 t -54.71 -54.09 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.297 1.039 . . . . 0.0 109.639 167.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -55.53 -48.16 75.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.662 -0.685 . . . . 0.0 112.377 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -64.75 -25.35 67.89 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.544 1.065 . . . . 0.0 113.518 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -77.41 -40.99 41.68 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.29 1.036 . . . . 0.0 110.344 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.2 mt -60.44 -40.58 91.66 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 120.787 -1.196 . . . . 0.0 110.829 167.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -78.78 -41.09 31.39 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.499 -162.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -116.95 145.69 36.17 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 124.198 0.999 . . . . 0.0 111.299 -173.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.4 155.82 36.65 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.587 2.192 . . . . 0.0 111.899 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 46.9 p -147.95 169.56 19.6 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.143 1.777 . . . . 0.0 107.568 163.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.07 -31.28 48.23 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.013 -0.882 . . . . 0.0 113.197 170.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -79.83 -45.43 18.74 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 170.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.82 -52.7 64.59 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.141 0.882 . . . . 0.0 110.045 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 43.8 t -62.72 -38.64 91.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.106 0.562 . . . . 0.0 111.915 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -57.73 -57.97 10.4 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.608 0.64 . . . . 0.0 111.495 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.4 m -74.36 -44.99 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -172.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -87.12 -36.77 17.91 Favored 'General case' 0 C--O 1.226 -0.133 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -164.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -65.35 -30.57 71.41 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.066 1.303 . . . . 0.0 111.033 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.39 -39.28 78.07 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 167.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.23 -45.47 79.94 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 167.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.8 m -64.58 -39.17 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-N 121.423 1.92 . . . . 0.0 111.789 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -54.44 -45.79 73.13 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.868 0.867 . . . . 0.0 112.292 170.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.7 mt -67.19 -39.58 86.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 118.46 -0.781 . . . . 0.0 113.025 174.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.51 -43.69 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 119.812 1.187 . . . . 0.0 110.877 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.36 -40.92 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-N 121.197 1.817 . . . . 0.0 112.646 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.9 tp -52.51 -52.11 56.22 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.066 1.746 . . . . 0.0 111.765 168.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 37.9 t -63.27 -39.57 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.985 0.914 . . . . 0.0 111.081 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 65.7 m -60.5 -44.72 95.68 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.937 0.895 . . . . 0.0 113.379 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.65 -31.94 47.02 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 120.442 1.474 . . . . 0.0 111.93 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 59.0 mt -56.62 -47.6 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.509 0.723 . . . . 0.0 110.305 167.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -57.81 -49.35 76.94 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 117.322 -1.323 . . . . 0.0 110.999 170.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 73.6 m -49.6 -40.9 40.56 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 120.067 1.303 . . . . 0.0 114.061 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.5 -48.5 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.0 0.52 . . . . 0.0 110.797 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.2 tp -72.61 -44.23 62.24 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.862 0.865 . . . . 0.0 112.89 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 55.9 p -78.89 -30.15 44.79 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -155.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.2 t -75.27 -1.81 25.22 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.733 1.152 . . . . 0.0 111.86 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.4 mm -102.51 -34.48 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 126.18 1.792 . . . . 0.0 113.231 163.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -56.77 -27.53 59.78 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.891 -1.131 . . . . 0.0 111.892 164.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -58.88 -42.86 90.47 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 129.002 2.921 . . . . 0.0 112.066 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 17.1 m-30 -74.76 -31.1 61.68 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.876 0.762 . . . . 0.0 111.073 176.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.68 -41.22 96.22 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.58 -0.7 . . . . 0.0 111.407 169.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.25 -13.47 28.39 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.46 1.504 . . . . 0.0 114.888 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.6 mt -64.53 -23.64 67.34 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.572 1.149 . . . . 0.0 113.277 168.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.49 -49.68 0.13 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -155.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.4 p -122.15 177.84 5.17 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.518 1.927 . . . . 0.0 109.011 -163.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.35 154.39 47.88 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.448 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.8 t -156.13 158.38 37.59 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.864 1.266 . . . . 0.0 111.123 -163.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.9 mt -94.68 3.43 55.07 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.967 1.307 . . . . 0.0 113.81 166.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -65.05 -4.58 4.89 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 120.036 1.289 . . . . 0.0 114.188 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -72.73 -30.56 64.28 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.781 -1.199 . . . . 0.0 111.822 166.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 47.6 tpp -73.02 -32.17 64.93 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.268 1.027 . . . . 0.0 111.355 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.21 -51.27 69.68 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.553 -0.717 . . . . 0.0 110.341 165.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.1 mt -53.99 -40.21 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 118.787 -0.625 . . . . 0.0 112.028 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.9 t -56.34 -48.16 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 120.293 1.406 . . . . 0.0 112.127 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 11.4 mt -71.11 -33.78 70.48 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.074 1.306 . . . . 0.0 113.08 176.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 26.5 t -61.73 -39.43 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 120.596 1.543 . . . . 0.0 111.743 172.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 68.0 t -75.01 -33.1 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.834 1.254 . . . . 0.0 110.651 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -62.56 -42.68 99.7 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 117.981 -1.009 . . . . 0.0 112.296 165.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -65.01 -46.25 82.14 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.536 1.516 . . . . 0.0 111.918 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.13 -37.96 74.44 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-N 119.282 0.946 . . . . 0.0 112.779 171.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.6 m -67.2 -39.53 86.33 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -60.41 -40.64 91.7 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.934 1.294 . . . . 0.0 111.629 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -54.24 -51.94 62.93 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 172.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 26.9 m -73.64 -31.73 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 23.1 t -63.48 -33.55 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 119.337 0.971 . . . . 0.0 112.144 173.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -60.94 -41.4 96.17 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 120.951 -1.093 . . . . 0.0 111.81 167.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 41.4 mt -69.97 -25.24 63.53 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -82.03 -40.44 22.07 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.999 0.92 . . . . 0.0 112.907 173.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 79.1 p -70.32 6.13 1.47 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 116.817 2.154 . . . . 0.0 116.817 160.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.78 -37.69 52.52 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.216 0.916 . . . . 0.0 111.514 160.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 167.22 30.99 0.02 OUTLIER Glycine 0 C--N 1.341 0.847 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 175.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 18.1 t 63.1 -67.42 0.09 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.871 2.068 . . . . 0.0 115.121 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -35.8 79.47 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.721 2.008 . . . . 0.0 111.022 170.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.413 ' HB2' ' H ' ' A' ' 186' ' ' GLY . 82.4 p -72.56 25.12 0.05 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 -175.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -53.53 -23.48 10.64 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 128.107 2.563 . . . . 0.0 116.293 -171.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -118.63 -37.23 3.32 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.2 1.4 . . . . 0.0 111.826 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 85.8 t -65.81 -68.94 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.436 1.494 . . . . 0.0 111.378 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 182' ' ' SER . . . -70.69 -23.97 77.33 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.699 1.619 . . . . 0.0 112.881 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.7 tt -51.07 -52.3 44.75 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.073 1.437 . . . . 0.0 110.087 164.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 35.1 t-105 -74.03 -44.72 53.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.23 0.538 . . . . 0.0 112.432 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -59.52 -45.17 96.01 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.885 0.755 . . . . 0.0 113.07 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -68.95 -33.1 73.16 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 118.44 1.12 . . . . 0.0 112.129 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 25.5 tp -74.96 -29.52 60.95 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.973 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 36.4 mtp-105 -80.17 -31.68 38.85 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.27 1.428 . . . . 0.0 113.097 171.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -64.02 -38.21 90.23 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.882 1.273 . . . . 0.0 111.173 171.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -82.97 58.81 4.56 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.123 1.369 . . . . 0.0 112.237 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.74 -28.95 66.36 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 120.773 -1.205 . . . . 0.0 112.56 169.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -49.6 147.19 6.26 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 127.877 2.471 . . . . 0.0 116.268 -173.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -57.33 -39.61 88.3 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.821 2.347 . . . . 0.0 116.488 -163.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 93.9 mt -67.72 -30.33 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 O-C-N 120.894 -1.129 . . . . 0.0 111.329 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.7 t -68.17 -31.56 71.19 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.06 1.3 . . . . 0.0 111.652 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 34.6 mm -70.35 -43.22 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.383 1.073 . . . . 0.0 111.49 171.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.83 -37.05 77.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.031 0.532 . . . . 0.0 111.445 173.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -74.87 -38.99 61.79 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.319 1.848 . . . . 0.0 110.729 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 20.3 tp -57.71 -48.4 79.69 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.272 1.029 . . . . 0.0 111.072 166.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 76.4 mt -69.43 -37.21 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 121.839 -0.538 . . . . 0.0 111.284 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.6 t -75.3 -33.41 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-N 119.918 1.235 . . . . 0.0 112.58 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 4.4 p -67.43 -34.2 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 120.615 1.552 . . . . 0.0 110.685 170.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 78.1 t -72.76 -39.52 59.93 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-O 117.936 -1.031 . . . . 0.0 110.115 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.61 -45.47 85.3 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 119.106 0.867 . . . . 0.0 110.41 170.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 30.2 t -62.95 -48.82 77.24 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.549 1.14 . . . . 0.0 111.851 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 75.2 mtm -55.58 -51.43 67.13 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.837 1.255 . . . . 0.0 111.004 168.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 9.5 t -59.09 -47.08 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 118.972 0.806 . . . . 0.0 111.295 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 33.5 m -75.71 -41.56 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 119.403 1.001 . . . . 0.0 111.845 -172.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.6 pp -63.31 -23.81 67.58 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.719 1.145 . . . . 0.0 111.601 171.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 19.2 m -77.8 -44.89 26.08 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.83 1.252 . . . . 0.0 112.929 173.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.73 -38.04 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.157 1.783 . . . . 0.0 109.476 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 218' ' ' LYS . . . 142.31 162.33 9.17 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 125.909 1.719 . . . . 0.0 110.029 172.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 60.5 p -70.62 18.23 0.06 Allowed 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.452 ' H ' ' C ' ' A' ' 216' ' ' GLY . 5.8 mtmt -173.15 175.67 3.13 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 131.514 3.926 . . . . 0.0 108.937 -172.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.543 ' C ' ' H ' ' A' ' 221' ' ' VAL . . . 66.81 105.96 0.02 OUTLIER Glycine 0 N--CA 1.436 -1.3 0 N-CA-C 106.176 -2.77 . . . . 0.0 106.176 -115.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -56.4 -5.66 0.22 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.492 1.517 . . . . 0.0 113.276 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.543 ' H ' ' C ' ' A' ' 219' ' ' GLY . 18.1 m -68.79 -38.12 78.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 125.421 1.489 . . . . 0.0 110.507 172.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.53 -49.77 73.79 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.348 166.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.92 -54.76 43.52 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.3 t -69.05 -30.74 69.15 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 34.1 t -74.29 -41.77 60.65 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.627 -1.295 . . . . 0.0 111.076 175.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.85 -62.13 1.91 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.114 0.966 . . . . 0.0 109.083 173.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 38.6 mt -57.26 -83.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.503 1.121 . . . . 0.0 109.79 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -65.32 -50.11 66.89 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-O 116.85 -1.548 . . . . 0.0 109.606 -163.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -54.56 -56.5 21.85 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 120.247 1.385 . . . . 0.0 113.281 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.8 -34.89 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 118.024 0.912 . . . . 0.0 111.639 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -77.8 -26.96 49.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.573 -1.329 . . . . 0.0 113.78 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -60.37 -42.29 95.51 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.782 1.633 . . . . 0.0 107.666 174.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 15.5 tp -62.9 -33.85 76.18 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.413 174.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -75.47 -43.49 49.08 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 120.87 1.668 . . . . 0.0 112.815 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 45.0 pt -66.35 -6.63 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 169.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 48.2 tp -95.9 -35.3 11.51 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.485 1.514 . . . . 0.0 111.137 171.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -63.52 -35.61 81.04 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.966 1.307 . . . . 0.0 110.121 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 61.3 tpp -34.07 -33.97 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 129.342 3.057 . . . . 0.0 116.702 156.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 49.9 mt -111.64 -13.32 13.79 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.859 1.663 . . . . 0.0 111.983 -171.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.3 3.5 54.43 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.83 0.852 . . . . 0.0 113.201 160.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 CA--C 1.511 -0.521 0 C-N-CA 127.161 2.184 . . . . 0.0 111.667 -164.14 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.7 t -80.87 -26.19 37.1 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.335 -0.853 . . . . 0.0 113.268 166.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -75.13 -27.17 59.69 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 119.568 -1.957 . . . . 0.0 111.885 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 23.3 m -85.31 2.55 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 126.12 1.768 . . . . 0.0 113.435 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -111.66 -45.61 3.34 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 127.575 2.35 . . . . 0.0 108.052 170.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.09 -20.29 8.73 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.509 1.528 . . . . 0.0 115.393 161.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . 0.261 25.0 ptt180 -73.22 -37.32 66.45 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.327 1.564 . . . . 0.0 110.455 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.7 t -58.88 -47.88 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.758 1.223 . . . . 0.0 110.541 168.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -66.91 -54.64 20.15 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.413 1.085 . . . . 0.0 111.447 -174.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -62.3 -25.29 67.79 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.81 -1.181 . . . . 0.0 112.719 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -75.76 -41.76 52.24 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.317 1.417 . . . . 0.0 110.375 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 pp -75.4 -22.51 57.39 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -125.16 -9.72 7.06 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -166.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -109.55 118.63 50.07 Favored Pre-proline 0 N--CA 1.473 0.722 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 161.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -61.47 137.77 71.8 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 121.697 1.598 . . . . 0.0 113.307 -171.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -151.85 143.3 23.46 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.671 1.189 . . . . 0.0 107.973 173.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.21 -28.76 50.75 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.904 -0.387 . . . . 0.0 112.59 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -67.37 -32.92 74.17 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 172.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -61.25 -48.76 79.98 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.559 1.072 . . . . 0.0 108.203 168.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 35.6 m -64.49 -40.41 95.61 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.415 0.686 . . . . 0.0 112.147 -174.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -56.64 -67.52 0.3 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.107 0.963 . . . . 0.0 111.214 173.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.7 p -79.67 -38.26 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 121.009 -1.057 . . . . 0.0 113.627 -168.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -73.12 -42.96 62.34 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.38 -0.825 . . . . 0.0 112.067 -170.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -71.52 -26.73 62.78 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -68.19 -49.4 61.1 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.196 -0.94 . . . . 0.0 111.989 166.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -51.3 -40.15 58.37 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 117.514 -1.231 . . . . 0.0 114.232 173.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . 0.289 2.9 m -62.97 -43.38 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 121.174 1.806 . . . . 0.0 112.634 174.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -67.85 -39.25 83.81 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.737 0.699 . . . . 0.0 112.548 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 73.4 mt -56.39 -54.87 40.52 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 118.624 -0.703 . . . . 0.0 110.366 169.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -53.87 -49.89 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.456 0.703 . . . . 0.0 112.011 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.4 p -66.13 -42.97 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 119.837 1.198 . . . . 0.0 113.09 -171.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 35.6 tp -70.38 -45.4 66.12 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.051 0.94 . . . . 0.0 111.567 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 32.2 m -65.08 -38.51 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 119.86 1.209 . . . . 0.0 111.901 176.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 98.4 m -66.83 -34.15 77.18 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.66 -0.686 . . . . 0.0 112.799 174.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.7 mt -74.42 -37.59 63.3 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.651 1.569 . . . . 0.0 112.516 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 52.2 mt -61.87 -46.6 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.312 0.96 . . . . 0.0 110.72 169.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -62.34 -27.17 68.87 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 117.866 -1.064 . . . . 0.0 112.343 171.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.7 m -65.68 -31.1 71.92 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 121.019 1.736 . . . . 0.0 113.166 173.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.33 -35.84 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.113 0.565 . . . . 0.0 110.699 172.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.0 tp -74.28 -50.69 17.85 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.296 0.953 . . . . 0.0 112.391 169.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.7 p -67.19 -27.13 67.01 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 120.377 -1.452 . . . . 0.0 113.273 -166.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.0 t -68.6 -22.85 64.42 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 17.9 pt -95.32 -31.41 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.946 1.248 . . . . 0.0 113.187 169.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -59.7 -26.57 65.7 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 121.021 -1.049 . . . . 0.0 111.281 164.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -60.57 -30.21 69.65 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.929 2.092 . . . . 0.0 113.093 167.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -87.9 -26.34 22.78 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.817 -1.177 . . . . 0.0 110.856 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.08 -40.2 94.32 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.149 0.579 . . . . 0.0 111.637 166.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.31 -15.22 23.36 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.632 1.573 . . . . 0.0 114.869 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.5 mt -59.15 -31.63 69.15 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.807 -1.183 . . . . 0.0 112.69 167.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.86 -43.83 0.21 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -153.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 82.8 p -134.09 152.83 52.01 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.163 1.385 . . . . 0.0 109.976 -155.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -75.4 128.93 10.12 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 121.289 -0.882 . . . . 0.0 112.582 -170.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.3 t -144.46 148.61 34.78 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -155.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.3 mt -56.4 4.28 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.568 2.347 . . . . 0.0 114.88 166.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -62.12 -13.94 31.93 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 120.975 1.716 . . . . 0.0 112.803 163.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 18.0 p-90 -59.37 -29.8 67.95 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.092 -1.63 . . . . 0.0 112.233 163.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 10.7 tpt -76.83 -25.55 53.34 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.335 0.97 . . . . 0.0 112.804 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -61.0 -48.82 80.06 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.788 -1.195 . . . . 0.0 109.404 162.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.82 -37.62 72.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 122.993 0.517 . . . . 0.0 111.583 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 64.0 t -60.93 -51.92 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 120.948 -1.095 . . . . 0.0 112.293 173.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 11.5 mt -69.98 -30.44 67.79 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.119 -0.988 . . . . 0.0 112.355 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 22.7 t -58.17 -38.17 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.698 1.136 . . . . 0.0 109.958 169.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 64.7 t -75.22 -29.7 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 118.104 -0.951 . . . . 0.0 111.11 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -66.6 -51.03 60.83 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 121.011 1.732 . . . . 0.0 112.933 170.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -60.65 -46.46 90.24 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.198 0.908 . . . . 0.0 111.37 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.96 -40.89 93.94 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.974 0.797 . . . . 0.0 113.15 173.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 55.5 m -66.96 -40.01 87.38 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.738 -0.86 . . . . 0.0 111.453 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -62.4 -41.38 98.63 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.303 0.956 . . . . 0.0 111.738 173.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -55.65 -45.67 77.63 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.646 0.657 . . . . 0.0 111.5 170.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 69.1 t -67.31 -41.89 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.188 -0.945 . . . . 0.0 113.13 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 25.8 t -62.28 -38.16 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.452 1.501 . . . . 0.0 112.337 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -55.91 -45.14 78.78 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.487 0.715 . . . . 0.0 111.811 168.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 21.8 mt -67.0 -40.3 87.32 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 178.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -65.81 -30.8 71.49 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.5 t -69.79 -21.16 63.43 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 173.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.1 -14.58 25.24 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 170.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -158.07 51.25 0.41 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 124.972 1.272 . . . . 0.0 110.505 -161.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 35.1 t -45.2 -31.07 1.34 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.225 1.81 . . . . 0.0 112.643 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.19 -59.45 1.73 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.172 1.789 . . . . 0.0 111.656 159.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 55.1 p -70.98 -16.1 62.62 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.906 1.282 . . . . 0.0 113.776 -156.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 59.8 pttt 47.01 -59.55 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.361 1 C-N-CA 133.464 4.706 . . . . 0.0 115.868 172.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -93.84 -29.21 15.44 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 124.68 1.192 . . . . 0.0 112.011 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.19 -54.32 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 166.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.1 -70.46 0.85 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 126.973 2.225 . . . . 0.0 112.362 176.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.4 tt -52.0 -42.07 62.69 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.33 1.452 . . . . 0.0 112.584 -170.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 44.6 t-105 -75.4 -46.36 33.35 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -172.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -64.19 -36.76 93.64 Favored Glycine 0 N--CA 1.48 1.568 0 O-C-N 121.641 -0.662 . . . . 0.0 112.501 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -61.16 -44.61 97.04 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 127.178 2.191 . . . . 0.0 112.167 168.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 25.7 tp -68.31 -32.58 72.82 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.608 0.64 . . . . 0.0 112.451 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -67.1 -18.57 65.38 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.108 -0.995 . . . . 0.0 113.213 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -67.49 -3.71 9.36 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.118 1.367 . . . . 0.0 114.301 167.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.31 83.47 0.55 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.53 1.532 . . . . 0.0 110.43 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.7 ttt85 -149.92 -37.67 0.15 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -164.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -68.89 151.25 97.35 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 123.974 0.91 . . . . 0.0 109.906 168.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -51.26 -46.85 28.85 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 CA-C-N 121.534 1.583 . . . . 0.0 115.488 -170.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 17.5 tt -62.99 -36.23 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 119.422 1.01 . . . . 0.0 113.501 176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 95.5 p -82.93 -25.85 32.0 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.148 1.34 . . . . 0.0 111.231 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 15.1 mm -63.19 -49.1 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.8 0.84 . . . . 0.0 110.026 160.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 21.2 mm -59.36 -41.61 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.539 -0.726 . . . . 0.0 111.376 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -69.71 -35.24 74.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.587 1.555 . . . . 0.0 111.43 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.3 tp -64.21 -49.2 72.9 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.088 0.555 . . . . 0.0 110.696 171.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 59.5 mt -61.5 -40.95 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 121.653 -0.654 . . . . 0.0 110.154 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.5 t -78.92 -22.65 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 117.605 -1.188 . . . . 0.0 113.779 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.46 -32.21 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 122.316 2.325 . . . . 0.0 110.344 166.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 46.0 t -81.17 -29.69 11.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 O-C-N 120.951 -1.093 . . . . 0.0 109.51 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.38 -42.79 87.84 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.805 -0.559 . . . . 0.0 111.511 161.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.1 m -61.3 -36.99 81.62 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.948 0.899 . . . . 0.0 111.843 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 55.6 mtt -64.46 -54.19 36.44 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.523 1.129 . . . . 0.0 111.0 166.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 30.4 t -56.63 -38.39 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 119.771 1.168 . . . . 0.0 112.237 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 28.4 t -53.53 -52.61 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 126.293 1.837 . . . . 0.0 111.396 171.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.87 -15.46 44.57 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.078 0.951 . . . . 0.0 113.294 -175.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 93.2 m -102.68 -56.25 2.28 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.52 1.528 . . . . 0.0 114.4 -171.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 25.4 t -56.88 -38.75 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-N 119.521 1.055 . . . . 0.0 112.025 -175.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 164.21 -116.55 0.71 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.037 1.303 . . . . 0.0 110.288 168.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 77.3 p -164.17 34.64 0.08 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.436 1.094 . . . . 0.0 113.063 -174.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -169.45 168.75 9.29 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.97 2.108 . . . . 0.0 110.709 -174.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -67.36 -49.78 49.3 Favored Glycine 0 N--CA 1.473 1.139 0 C-N-CA 127.556 2.503 . . . . 0.0 112.461 -10.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -144.62 4.9 1.18 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.364 1.066 . . . . 0.0 113.775 170.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 15.2 t -73.55 -42.88 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 120.155 1.343 . . . . 0.0 111.493 -170.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -47.28 -45.91 24.45 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.933 1.293 . . . . 0.0 112.394 164.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.38 -54.68 9.9 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.833 1.253 . . . . 0.0 111.214 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.11 -35.74 81.28 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 121.113 -0.992 . . . . 0.0 111.885 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 18.0 m -69.17 -45.65 69.48 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.485 1.493 . . . . 0.0 110.884 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -52.87 -52.37 57.63 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.615 -0.678 . . . . 0.0 111.412 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.415 ' C ' ' H ' ' A' ' 229' ' ' GLY . 72.6 mt -67.08 -84.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 123.392 1.568 . . . . 0.0 110.269 175.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -76.36 10.04 2.28 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 128.145 2.578 . . . . 0.0 113.338 -167.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 227' ' ' ILE . . . -117.84 -63.64 0.31 Allowed Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 166.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 18.2 mt -79.57 -37.44 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 118.482 1.141 . . . . 0.0 111.374 -171.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.72 -41.59 87.67 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.862 1.21 . . . . 0.0 109.771 174.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -63.32 -33.25 75.12 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.057 2.143 . . . . 0.0 113.521 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 23.4 tp -63.87 -33.41 75.62 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.344 1.058 . . . . 0.0 111.654 165.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -69.08 -37.54 78.53 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.715 1.598 . . . . 0.0 114.289 -175.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -19.69 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.255 -0.903 . . . . 0.0 113.094 175.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 37.7 mt -72.99 -23.67 60.67 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.974 0.893 . . . . 0.0 110.539 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -83.12 -18.45 39.46 Favored 'General case' 0 C--O 1.216 -0.708 0 C-N-CA 124.386 1.074 . . . . 0.0 112.816 -167.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -24.76 -40.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 128.587 2.755 . . . . 0.0 114.779 143.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 16.6 mt -99.99 -28.24 13.18 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.258 1.423 . . . . 0.0 110.717 -172.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -75.58 9.78 2.06 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 158.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.303 4.2 t . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 124.779 2.228 . . . . 0.0 110.409 150.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.265 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.229 0.062 . . . . 0.0 110.97 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -58.09 -40.13 80.32 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.352 1.461 . . . . 0.0 114.634 165.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -78.25 -51.38 10.25 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 126.119 1.768 . . . . 0.0 109.743 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.0 m -81.04 -21.15 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -157.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -73.69 -29.3 62.2 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.199 0.599 . . . . 0.0 110.802 166.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.12 -32.82 60.02 Favored Glycine 0 CA--C 1.525 0.696 0 O-C-N 121.097 -1.002 . . . . 0.0 111.552 167.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -63.34 -40.19 96.62 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.117 1.367 . . . . 0.0 111.256 175.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.2 t -60.51 -55.36 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.53 1.932 . . . . 0.0 110.98 168.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -62.44 -22.54 66.28 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.407 1.083 . . . . 0.0 113.803 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -84.8 -34.18 22.8 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.824 1.25 . . . . 0.0 111.913 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -74.09 -43.34 58.01 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.136 -0.977 . . . . 0.0 112.814 -176.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.25 -20.98 64.85 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 176.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -101.88 -24.51 14.02 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 125.046 1.338 . . . . 0.0 112.676 -171.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.4 mtm105 -91.74 107.68 24.13 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 124.363 1.065 . . . . 0.0 109.928 165.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -65.29 127.13 17.59 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.904 1.736 . . . . 0.0 109.091 166.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 82.2 p -139.44 178.61 7.08 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.271 1.029 . . . . 0.0 109.091 176.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.82 -30.03 62.47 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 121.912 -0.493 . . . . 0.0 112.597 165.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -78.54 -43.42 26.77 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -60.27 -40.3 89.9 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.342 0.973 . . . . 0.0 109.746 170.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 49.7 t -61.43 -54.36 44.58 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.26 1.024 . . . . 0.0 112.294 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -53.62 -49.64 67.39 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.364 1.066 . . . . 0.0 111.89 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.0 p -85.81 -47.23 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -73.21 -39.27 65.66 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.998 0.817 . . . . 0.0 111.858 -163.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -80.3 -27.99 38.36 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 120.852 -1.155 . . . . 0.0 112.788 -173.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -70.39 -35.59 73.58 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.816 0.734 . . . . 0.0 111.122 164.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.97 -44.68 87.22 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 119.923 1.238 . . . . 0.0 113.218 168.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.43 -35.56 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 121.7 2.046 . . . . 0.0 113.235 176.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -68.02 -47.61 67.96 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.222 1.009 . . . . 0.0 112.077 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 62.9 mt -62.78 -47.84 81.72 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.459 0.704 . . . . 0.0 111.435 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 84.7 mt -61.99 -34.48 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 118.11 -0.948 . . . . 0.0 111.253 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.7 t -74.89 -34.07 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 120.781 1.628 . . . . 0.0 114.273 177.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 28.2 mt -59.44 -48.22 82.49 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.447 1.476 . . . . 0.0 110.535 167.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.5 t -55.89 -53.67 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 118.348 0.522 . . . . 0.0 110.23 172.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 60.8 m -61.62 -46.09 91.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.988 -173.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.9 mt -72.31 -40.91 67.13 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.679 1.127 . . . . 0.0 112.58 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.53 -42.35 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.366 0.666 . . . . 0.0 110.557 174.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -68.5 -33.29 73.88 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.384 -0.823 . . . . 0.0 111.99 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 t -58.08 -40.71 81.79 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.928 0.891 . . . . 0.0 111.716 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.33 -53.01 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.386 1.074 . . . . 0.0 110.299 174.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.9 tp -55.6 -50.44 70.1 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.014 0.526 . . . . 0.0 111.714 171.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 68.7 m -57.42 -23.53 50.08 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 116.172 1.915 . . . . 0.0 116.172 -174.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.4 t -109.44 -5.46 15.78 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.367 0.985 . . . . 0.0 112.845 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.7 tp -85.03 -36.08 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 O-C-N 121.554 -0.716 . . . . 0.0 111.344 149.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -71.95 -4.05 26.17 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 119.967 -1.708 . . . . 0.0 115.304 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -63.28 -34.09 76.93 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 120.72 -1.238 . . . . 0.0 112.58 169.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -74.52 -20.62 59.91 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.348 -0.845 . . . . 0.0 112.844 172.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.93 -45.22 43.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.956 0.903 . . . . 0.0 111.254 166.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -57.49 -28.67 63.63 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.747 1.219 . . . . 0.0 113.151 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.43 -35.45 73.39 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.196 1.398 . . . . 0.0 113.559 173.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -97.56 -47.91 5.47 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.993 2.117 . . . . 0.0 114.124 -168.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 69.7 p -149.52 -169.05 3.27 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.469 2.308 . . . . 0.0 109.006 -159.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -77.62 169.69 54.8 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.323 -0.861 . . . . 0.0 112.828 159.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -170.28 152.35 4.1 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.411 1.885 . . . . 0.0 110.887 -176.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.0 mt -52.59 -14.82 0.56 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.039 1.736 . . . . 0.0 114.368 172.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -49.38 -15.9 0.16 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.823 1.649 . . . . 0.0 114.428 168.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 18.5 p-90 -57.22 -27.74 62.27 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.752 -1.217 . . . . 0.0 112.713 166.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 28.4 ttp -70.71 -20.77 62.63 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.197 -1.564 . . . . 0.0 112.067 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -64.65 -26.04 68.22 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.683 -1.26 . . . . 0.0 112.184 169.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 26.9 mt -70.17 -42.36 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.044 0.538 . . . . 0.0 109.575 172.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.41 -44.12 98.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.698 0.799 . . . . 0.0 111.372 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.04 -28.38 57.66 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.127 0.876 . . . . 0.0 113.262 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.6 t -60.11 -41.83 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 120.646 1.566 . . . . 0.0 110.46 165.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.57 -35.25 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 117.759 -1.115 . . . . 0.0 110.347 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -64.42 -53.6 45.83 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.874 1.67 . . . . 0.0 112.546 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -69.1 -24.3 64.11 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.2 1.364 . . . . 0.0 112.916 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -72.05 -47.11 32.63 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.543 1.068 . . . . 0.0 111.348 168.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.9 m -66.51 -36.25 82.26 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -62.56 -49.22 76.14 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 120.537 1.517 . . . . 0.0 110.874 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -51.69 -48.62 63.42 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.151 0.581 . . . . 0.0 111.896 172.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.58 -38.65 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.19 0.996 . . . . 0.0 113.239 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 14.4 t -61.86 -33.54 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.509 1.524 . . . . 0.0 111.56 173.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -63.23 -32.82 74.32 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.219 1.008 . . . . 0.0 112.393 170.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 23.4 mt -74.28 -35.46 63.75 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 173.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -70.6 -35.76 73.18 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.097 0.959 . . . . 0.0 113.42 173.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 83.6 p -68.22 -10.4 54.15 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 168.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.98 -15.27 20.93 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 120.05 1.296 . . . . 0.0 114.329 157.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 178.97 80.77 0.06 OUTLIER Glycine 0 C--N 1.343 0.964 0 CA-C-N 120.149 1.34 . . . . 0.0 115.674 -167.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 49.5 t -49.27 -27.3 3.67 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 117.759 0.779 . . . . 0.0 112.753 153.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.86 58.69 1.72 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.599 1.19 . . . . 0.0 111.94 157.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 21.2 p -162.65 50.16 0.18 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.198 159.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.45 ' HE2' ' CD2' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -61.13 -22.12 64.38 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -167.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.45 ' CD2' ' HE2' ' A' ' 183' ' ' LYS . 25.2 m-85 -105.46 -38.91 6.3 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 118.167 -0.921 . . . . 0.0 112.587 161.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -56.36 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 119.686 1.13 . . . . 0.0 111.408 -172.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -70.35 -43.08 63.65 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.56 -38.96 64.39 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.031 1.733 . . . . 0.0 111.947 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -70.79 -44.32 66.89 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.089 0.859 . . . . 0.0 112.296 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -66.74 -35.19 89.38 Favored Glycine 0 N--CA 1.476 1.354 0 O-C-N 121.259 -0.901 . . . . 0.0 112.283 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -65.67 -39.42 91.32 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 127.804 2.442 . . . . 0.0 112.942 172.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 23.6 tp -68.58 -33.37 73.95 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.864 -0.522 . . . . 0.0 111.827 173.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -73.05 -7.39 51.05 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -74.02 59.47 0.72 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.39 1.45 . . . . 0.0 110.214 163.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -142.66 76.58 1.54 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.86 2.864 . . . . 0.0 106.857 -169.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 44.8 mtp85 -137.89 -43.99 0.53 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.398 1.079 . . . . 0.0 111.472 -169.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -64.97 152.04 91.97 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 123.752 0.821 . . . . 0.0 110.434 167.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -54.1 -46.89 30.24 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.671 2.247 . . . . 0.0 112.827 -172.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.3 tt -58.21 -39.01 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.536 1.134 . . . . 0.0 113.981 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 78.7 p -87.63 -20.11 26.8 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 120.573 1.533 . . . . 0.0 112.633 -174.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 64.0 mt -72.39 -43.38 64.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 118.383 0.538 . . . . 0.0 110.509 159.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 43.5 mt -60.1 -39.58 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.238 1.015 . . . . 0.0 110.971 174.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -70.09 -39.69 75.41 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.782 1.633 . . . . 0.0 110.684 -178.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.51 -46.85 88.23 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.483 1.113 . . . . 0.0 112.707 169.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 54.1 mt -63.68 -41.76 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 O-C-N 120.685 -1.26 . . . . 0.0 110.411 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 31.6 t -66.27 -39.79 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 116.308 -1.806 . . . . 0.0 112.559 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.08 -33.06 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 122.212 2.278 . . . . 0.0 111.485 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.28 -46.12 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 123.373 0.669 . . . . 0.0 109.694 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -53.26 -48.14 68.53 Favored 'General case' 0 C--O 1.223 -0.342 0 C-N-CA 123.732 0.813 . . . . 0.0 110.797 169.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 34.3 t -59.84 -49.69 76.73 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.636 1.175 . . . . 0.0 112.947 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 15.0 tpt -70.85 -34.03 71.25 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 118.786 -0.626 . . . . 0.0 112.027 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.7 t -60.76 -50.99 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 120.38 1.446 . . . . 0.0 111.938 171.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.18 -33.09 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 119.461 1.028 . . . . 0.0 111.117 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 5.1 tp -58.38 -45.01 89.13 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.51 0.724 . . . . 0.0 111.211 165.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 59.4 m -69.69 -25.66 63.98 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.287 1.435 . . . . 0.0 114.706 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 52.1 t -64.02 -16.01 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.008 1.323 . . . . 0.0 110.95 166.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 94.13 114.29 2.52 Favored Glycine 0 C--N 1.332 0.35 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -165.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 66.3 p -62.3 34.8 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 129.092 2.957 . . . . 0.0 116.969 -170.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.261 39.7 mmtm -171.2 -23.46 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.343 2.257 . . . . 0.0 114.162 -155.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -46.04 123.66 6.87 Favored Glycine 0 C--N 1.341 0.809 0 N-CA-C 104.014 -3.635 . . . . 0.0 104.014 138.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -75.65 50.49 0.56 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 126.345 1.858 . . . . 0.0 110.377 -162.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 11.1 m -150.76 -35.72 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.583 1.553 . . . . 0.0 109.491 -162.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -57.07 -38.31 73.1 Favored 'General case' 0 C--O 1.216 -0.667 0 O-C-N 120.743 -1.223 . . . . 0.0 111.269 151.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.53 -42.83 88.69 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.266 0.939 . . . . 0.0 111.283 173.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 23.1 p -79.04 -55.3 5.22 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.039 -173.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 15.9 t -63.47 -34.18 77.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.528 1.513 . . . . 0.0 113.197 175.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.18 -50.19 72.82 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.102 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 65.4 mt -63.52 -70.27 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-O 122.282 1.039 . . . . 0.0 110.044 173.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 72.6 mtt-85 -76.74 1.65 16.58 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.122 1.769 . . . . 0.0 113.381 -163.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -125.48 -69.45 0.19 Allowed Glycine 0 N--CA 1.461 0.354 0 C-N-CA 125.636 1.589 . . . . 0.0 109.75 175.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.26 -27.57 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 117.169 -1.396 . . . . 0.0 112.518 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -96.87 -28.83 14.05 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 120.844 1.657 . . . . 0.0 114.095 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -54.69 -34.19 61.98 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.584 1.154 . . . . 0.0 111.009 167.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 58.0 tp -56.67 -30.3 63.23 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 168.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -82.84 -37.0 25.01 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 119.387 -2.071 . . . . 0.0 115.4 -171.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -16.67 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.427 1.091 . . . . 0.0 112.577 170.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 70.4 mt -75.02 -45.02 44.59 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.65 -0.656 . . . . 0.0 111.723 168.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -68.64 -41.09 79.87 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.752 1.621 . . . . 0.0 111.451 -170.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 32.1 tpp -25.7 -22.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 131.153 3.781 . . . . 0.0 117.797 149.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 17.0 mt -131.3 -4.39 3.84 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.061 1.745 . . . . 0.0 112.701 -174.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -66.6 -53.05 38.54 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.276 141.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 52.5 t . . . . . 0 N--CA 1.47 0.551 0 C-N-CA 125.115 1.366 . . . . 0.0 109.344 -160.829 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 37.6 mmm-85 . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.25 -28.35 4.71 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.17 0.988 . . . . 0.0 110.96 162.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -65.23 -47.71 75.86 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.244 1.384 . . . . 0.0 114.039 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.07 -32.11 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.342 1.457 . . . . 0.0 111.044 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -72.12 -36.32 69.4 Favored 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 123.683 0.793 . . . . 0.0 110.859 174.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -55.12 -34.74 58.78 Favored Glycine 0 CA--C 1.541 1.701 0 O-C-N 121.144 -0.973 . . . . 0.0 111.044 165.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.8 mtm180 -66.76 -43.63 83.54 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 117.944 0.872 . . . . 0.0 111.719 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 42.6 t -56.93 -53.29 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 125.18 1.392 . . . . 0.0 110.469 173.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -62.39 -49.95 73.49 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.644 0.778 . . . . 0.0 111.593 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -62.61 -19.91 64.23 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.092 1.357 . . . . 0.0 113.919 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.41 ' CZ ' ' HA ' ' A' ' 121' ' ' LYS . 26.4 t80 -83.06 -41.44 18.62 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 126.344 1.857 . . . . 0.0 110.719 174.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.7 mt -62.41 -43.07 99.68 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.421 1.009 . . . . 0.0 110.971 169.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -77.37 -37.6 51.8 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.5 -157.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 16.1 mtp-105 -82.72 161.69 57.8 Favored Pre-proline 0 N--CA 1.47 0.544 0 C-N-CA 125.409 1.484 . . . . 0.0 113.022 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -71.18 131.26 18.93 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 121.177 1.251 . . . . 0.0 109.11 149.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.445 ' C ' ' H ' ' A' ' 120' ' ' TRP . 11.9 t -154.73 149.91 27.02 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 120.352 -1.467 . . . . 0.0 109.8 167.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.0 8.64 0.05 OUTLIER Glycine 0 CA--C 1.537 1.468 0 N-CA-C 117.114 1.606 . . . . 0.0 117.114 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . 0.445 ' H ' ' C ' ' A' ' 118' ' ' THR . 75.5 m95 -124.82 -16.11 6.26 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 166.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.41 ' HA ' ' CZ ' ' A' ' 113' ' ' PHE . 35.5 ttpt -61.24 -69.56 0.23 Allowed 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 121.114 1.779 . . . . 0.0 111.528 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 60.2 m -65.78 -34.93 79.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 118.881 -0.58 . . . . 0.0 109.926 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -58.61 -52.13 66.96 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.365 0.53 . . . . 0.0 111.705 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.7 t -82.47 -43.2 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 121.25 -0.906 . . . . 0.0 113.018 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -75.72 -33.97 60.32 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.628 -0.67 . . . . 0.0 112.343 -171.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -68.74 -33.56 74.12 Favored 'General case' 0 C--N 1.346 0.435 0 O-C-N 120.897 -1.127 . . . . 0.0 111.128 169.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -64.31 -40.9 96.84 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.253 -0.904 . . . . 0.0 112.977 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.23 -44.83 65.04 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 118.168 -0.92 . . . . 0.0 113.443 167.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.64 -36.76 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 120.95 1.704 . . . . 0.0 113.159 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -54.62 -52.32 62.6 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.019 0.827 . . . . 0.0 111.308 172.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 87.7 mt -68.17 -40.64 82.25 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.908 0.483 . . . . 0.0 112.296 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 58.9 mt -69.62 -43.12 80.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 CA-C-O 117.874 -1.06 . . . . 0.0 112.083 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 80.8 t -60.82 -45.09 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 121.25 1.841 . . . . 0.0 111.674 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.4 tp -53.85 -54.07 43.59 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.513 1.525 . . . . 0.0 111.731 171.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 53.5 t -62.6 -39.97 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.712 0.805 . . . . 0.0 112.241 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.5 m -61.21 -42.98 99.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 119.335 0.971 . . . . 0.0 111.721 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.2 mt -74.61 -38.45 62.57 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.336 0.655 . . . . 0.0 112.23 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 71.7 mt -59.31 -48.42 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.887 0.875 . . . . 0.0 110.639 170.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -69.05 -35.71 76.87 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 118.969 -0.539 . . . . 0.0 111.563 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.3 t -58.42 -44.45 89.09 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.852 1.261 . . . . 0.0 112.874 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.1 m -67.49 -28.19 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.7 mt -71.42 -46.81 59.19 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.679 0.672 . . . . 0.0 111.756 166.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 72.6 m -70.39 -33.02 70.91 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.29 1.836 . . . . 0.0 115.036 -170.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.2 t -66.57 -47.52 72.51 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 120.164 1.347 . . . . 0.0 109.895 -174.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 26.5 mm -56.0 -44.63 78.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 124.466 1.106 . . . . 0.0 111.135 175.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -80.65 -14.37 58.22 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -73.19 -37.71 66.39 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.361 1.437 . . . . 0.0 111.196 166.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -79.9 -2.83 45.44 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.163 -0.961 . . . . 0.0 112.089 170.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.65 -27.93 18.72 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.596 1.158 . . . . 0.0 112.954 157.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.58 -19.38 57.43 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.6 pp -63.88 -4.49 3.31 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 126.697 1.999 . . . . 0.0 114.557 166.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.23 -35.17 0.32 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.851 2.46 . . . . 0.0 114.24 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 72.5 m -129.22 141.53 51.11 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.7 1.2 . . . . 0.0 110.448 -151.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -72.49 140.91 30.13 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.278 -0.487 . . . . 0.0 112.101 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.2 t -147.62 143.44 27.71 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -158.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -60.93 -7.23 2.27 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 170.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -56.31 -8.67 0.54 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.89 2.476 . . . . 0.0 116.367 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -68.8 -24.04 64.35 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.472 -1.392 . . . . 0.0 112.508 171.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 76.5 mtm -74.16 -13.81 60.87 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -68.56 -44.08 75.23 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.723 1.147 . . . . 0.0 110.492 164.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 28.8 mt -58.62 -36.75 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 118.481 -0.771 . . . . 0.0 111.916 169.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.5 t -57.53 -45.58 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 120.409 1.459 . . . . 0.0 111.49 171.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 19.3 mt -62.7 -42.82 99.84 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 173.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.88 -24.17 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.24 0.927 . . . . 0.0 112.34 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 54.6 t -78.87 -38.99 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.233 1.013 . . . . 0.0 110.429 172.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -61.56 -49.75 75.4 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.394 0.997 . . . . 0.0 112.297 170.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -65.71 -46.33 79.35 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.711 0.687 . . . . 0.0 112.47 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -52.26 -40.86 53.48 Favored Glycine 0 CA--C 1.539 1.546 0 O-C-N 121.598 -0.689 . . . . 0.0 112.788 167.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 70.2 m -69.17 -37.83 78.39 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 117.775 0.787 . . . . 0.0 112.482 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -59.71 -50.2 74.75 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.981 1.312 . . . . 0.0 110.888 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -51.66 -47.41 63.8 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.362 1.065 . . . . 0.0 112.247 172.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 37.8 t -66.37 -37.97 80.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.959 0.904 . . . . 0.0 112.363 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 12.2 t -62.85 -33.51 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.146 1.379 . . . . 0.0 112.427 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 24.5 mtt180 -59.99 -44.86 94.24 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.118 -0.989 . . . . 0.0 111.221 170.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.7 mt -68.7 -35.43 77.17 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.173 0.589 . . . . 0.0 112.381 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 53.2 m0 -65.34 -26.58 68.1 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 172.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 47.8 t -70.34 -30.21 67.11 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.604 1.093 . . . . 0.0 113.534 166.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -68.89 -0.46 5.56 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.307 -1.496 . . . . 0.0 112.598 161.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -104.92 7.39 44.75 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 126.58 2.038 . . . . 0.0 116.238 172.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 7.8 t -54.49 -23.12 14.97 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.247 1.524 . . . . 0.0 112.48 173.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -122.47 -60.37 1.55 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.254 1.422 . . . . 0.0 110.988 153.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.9 p -86.35 64.5 8.58 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.473 1.509 . . . . 0.0 111.971 -163.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -44.82 -35.73 2.91 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.732 1.613 . . . . 0.0 115.05 -167.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -112.32 -33.07 6.31 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.739 1.216 . . . . 0.0 113.859 174.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -56.74 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 119.786 1.176 . . . . 0.0 111.606 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -67.63 -35.79 86.69 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 119.022 -0.877 . . . . 0.0 111.179 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 1.2 tt -51.9 -33.21 35.88 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.019 0.928 . . . . 0.0 113.062 169.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 49.8 t-105 -86.13 -36.18 19.72 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -73.88 -38.17 49.55 Favored Glycine 0 N--CA 1.466 0.638 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -64.99 -40.29 94.73 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 124.675 1.19 . . . . 0.0 111.005 169.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 19.3 tp -63.76 -40.87 97.74 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.41 1.005 . . . . 0.0 111.914 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 52.5 mtp180 -64.43 -23.81 67.41 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 171.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -74.73 0.47 15.16 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.919 1.288 . . . . 0.0 113.977 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.03 27.71 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 116.839 2.163 . . . . 0.0 116.839 -173.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -92.75 -7.16 47.4 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 117.198 2.295 . . . . 0.0 117.198 -159.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -61.03 147.23 86.48 Favored Pre-proline 0 N--CA 1.482 1.138 0 CA-C-N 120.976 1.716 . . . . 0.0 109.975 167.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -45.33 -50.18 9.39 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.93 3.087 . . . . 0.0 115.669 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 96.5 mt -71.98 -29.96 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.409 1.083 . . . . 0.0 111.784 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 50.6 m -72.79 -30.72 64.31 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.093 0.957 . . . . 0.0 112.279 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.8 mt -68.16 -42.77 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.586 0.754 . . . . 0.0 109.808 168.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 49.4 mt -61.87 -43.52 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 121.656 -0.653 . . . . 0.0 110.933 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.13 -38.78 92.29 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.501 1.52 . . . . 0.0 112.099 175.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.5 tt -63.12 -48.76 77.16 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.55 0.614 . . . . 0.0 110.716 170.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.1 -36.93 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.618 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 72.1 t -74.1 -33.93 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 120.24 1.382 . . . . 0.0 113.5 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.3 p -66.39 -36.99 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 121.052 1.751 . . . . 0.0 110.802 169.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 77.4 t -71.45 -39.56 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 120.904 -1.122 . . . . 0.0 110.777 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.5 -57.77 10.83 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.036 0.934 . . . . 0.0 110.628 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 59.8 p -56.14 -42.44 76.93 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.761 0.424 . . . . 0.0 111.261 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -64.0 -54.93 26.55 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.928 0.891 . . . . 0.0 112.526 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.15 -36.43 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 119.65 1.113 . . . . 0.0 111.855 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 27.9 m -75.17 -38.87 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 117.561 -1.209 . . . . 0.0 112.047 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.92 -22.13 65.08 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.031 1.287 . . . . 0.0 111.655 171.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 66.8 m -74.68 -36.87 62.79 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.422 1.089 . . . . 0.0 113.177 171.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 76.6 t -64.04 -31.61 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 118.933 0.788 . . . . 0.0 110.273 164.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 137.76 -107.68 0.59 Allowed Glycine 0 CA--C 1.522 0.506 0 C-N-CA 124.555 1.074 . . . . 0.0 112.908 158.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 87.1 p -139.8 2.21 1.95 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.55 1.14 . . . . 0.0 113.195 -167.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -171.92 -177.8 2.01 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.667 2.387 . . . . 0.0 110.23 -172.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 221' ' ' VAL . . . 57.69 108.25 0.01 OUTLIER Glycine 0 CA--C 1.526 0.781 0 N-CA-C 106.966 -2.454 . . . . 0.0 106.966 -107.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -57.92 -6.4 0.56 Allowed 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 120.348 2.074 . . . . 0.0 112.586 172.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.45 ' H ' ' C ' ' A' ' 219' ' ' GLY . 22.3 m -72.12 -32.17 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.528 1.531 . . . . 0.0 113.119 169.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.37 -47.68 62.76 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.929 1.241 . . . . 0.0 111.181 159.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.29 -55.31 12.56 Favored 'General case' 0 C--O 1.223 -0.341 0 O-C-N 124.217 0.948 . . . . 0.0 110.768 -168.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' THR . . . . . 0.586 ' HG1' ' NH1' ' A' ' 228' ' ' ARG . 8.1 t -52.97 -39.72 63.21 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.166 -0.959 . . . . 0.0 111.78 176.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 16.1 m -69.2 -58.29 4.25 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.163 -0.961 . . . . 0.0 111.999 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -54.79 -54.69 38.91 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 126.049 1.739 . . . . 0.0 110.914 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.53 -71.79 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.845 1.658 . . . . 0.0 107.835 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.586 ' NH1' ' HG1' ' A' ' 224' ' ' THR . 79.4 mtt180 -74.52 -43.38 56.15 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.246 -154.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -59.45 -46.33 94.09 Favored Glycine 0 N--CA 1.472 1.056 0 CA-C-O 119.616 -0.547 . . . . 0.0 112.854 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.98 -34.67 39.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 117.979 0.89 . . . . 0.0 111.623 -177.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -40.74 98.54 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.058 -1.026 . . . . 0.0 112.168 166.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -66.56 -36.53 82.9 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.34 0.656 . . . . 0.0 110.634 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.5 tp -67.29 -23.85 65.7 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 172.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.48 -48.2 20.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.51 1.124 . . . . 0.0 113.071 176.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 22.9 pt -68.08 -16.6 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 173.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 52.0 tp -70.26 -26.06 63.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.266 1.426 . . . . 0.0 111.608 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -67.44 -19.29 65.35 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.211 1.005 . . . . 0.0 112.221 -176.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.7 -24.08 2.1 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.685 1.994 . . . . 0.0 113.94 160.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.1 mt -114.36 -19.85 11.07 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.819 1.648 . . . . 0.0 111.334 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -64.66 -32.22 73.78 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 118.964 -0.541 . . . . 0.0 111.425 162.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.297 11.1 p . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 125.159 2.409 . . . . 0.0 110.618 158.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.823 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.416 HG22 ' H ' ' A' ' 105' ' ' HIS . 2.6 t -62.8 -95.07 0.0 OUTLIER 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 127.382 2.273 . . . . 0.0 113.893 143.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.416 ' H ' HG22 ' A' ' 104' ' ' THR . 49.5 m80 -58.58 -19.85 41.79 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 119.975 3.324 . . . . 0.0 119.975 -168.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.413 HG11 ' H ' ' A' ' 107' ' ' GLN . 4.6 p -61.0 -37.62 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 120.456 1.48 . . . . 0.0 111.946 172.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.413 ' H ' HG11 ' A' ' 106' ' ' VAL . 16.3 mm-40 -67.45 -41.5 84.61 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.827 0.851 . . . . 0.0 109.249 173.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -58.86 -26.72 60.94 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.091 -1.394 . . . . 0.0 113.866 167.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -67.18 -45.19 77.7 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 120.36 2.08 . . . . 0.0 111.647 174.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.2 t -57.13 -47.39 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.144 0.978 . . . . 0.0 110.038 171.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -66.32 -56.6 10.38 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 118.848 -0.596 . . . . 0.0 112.453 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -58.89 -20.44 51.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 119.376 0.989 . . . . 0.0 113.463 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -80.39 -42.73 22.27 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.65 1.114 . . . . 0.0 111.773 171.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.63 -25.68 38.2 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -178.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -108.99 -38.71 5.5 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.06 1.344 . . . . 0.0 112.513 -164.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -90.75 151.1 43.37 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 123.279 0.632 . . . . 0.0 111.885 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.65 128.37 18.91 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.991 1.794 . . . . 0.0 112.986 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.2 t -152.4 151.13 30.43 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 156.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.47 -28.86 22.34 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 119.544 1.065 . . . . 0.0 112.654 172.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -70.88 -27.54 63.9 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 175.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.7 tmmt? -56.61 -60.87 2.91 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.34 1.056 . . . . 0.0 109.165 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 25.5 p -71.69 -27.33 62.96 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.682 1.193 . . . . 0.0 112.682 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -61.67 -52.24 65.14 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.715 1.598 . . . . 0.0 110.427 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.5 t -76.54 -48.17 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.051 0.54 . . . . 0.0 111.666 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -63.99 -46.54 84.1 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -75.77 -28.95 58.63 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.571 -0.705 . . . . 0.0 111.285 -174.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -69.99 -39.24 76.04 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.469 1.031 . . . . 0.0 112.375 169.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.51 -43.99 84.66 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.477 1.035 . . . . 0.0 113.362 167.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 76.4 t -62.15 -44.42 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 120.553 1.524 . . . . 0.0 111.727 172.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -56.72 -50.47 72.11 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.05 1.295 . . . . 0.0 111.553 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 94.2 mt -65.19 -45.37 85.11 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 119.019 -0.515 . . . . 0.0 111.469 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 76.1 mt -65.36 -37.23 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.859 0.754 . . . . 0.0 112.085 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.76 -45.46 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 119.956 1.253 . . . . 0.0 110.731 174.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 45.3 tp -63.92 -47.98 78.39 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.074 0.95 . . . . 0.0 111.922 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.4 t -59.9 -47.37 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.631 0.772 . . . . 0.0 110.126 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 41.5 t -58.06 -43.71 87.09 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.713 1.205 . . . . 0.0 112.824 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 61.2 mt -76.75 -36.18 57.26 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.2 mt -61.66 -48.31 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 120.813 -1.179 . . . . 0.0 109.77 167.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -63.48 -25.78 68.42 Favored 'General case' 0 C--O 1.22 -0.485 0 O-C-N 121.431 -0.793 . . . . 0.0 111.921 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.1 t -56.94 -39.59 74.81 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 120.047 1.294 . . . . 0.0 112.068 175.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 52.1 t -66.31 -42.34 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.584 0.754 . . . . 0.0 111.652 173.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.4 mt -70.63 -55.52 8.59 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.652 1.181 . . . . 0.0 112.661 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.3 m -68.17 -29.82 68.79 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.915 2.086 . . . . 0.0 113.538 -171.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.19 -46.29 51.44 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.218 1.372 . . . . 0.0 110.382 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.7 mm -52.84 -44.0 47.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.023 0.929 . . . . 0.0 110.834 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -74.07 -33.41 63.66 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -74.26 -21.69 59.65 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 119.856 -1.778 . . . . 0.0 112.082 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -79.98 -41.88 25.03 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.556 0.616 . . . . 0.0 109.455 171.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -57.91 -28.14 63.97 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.369 1.068 . . . . 0.0 113.424 170.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -57.63 -18.11 18.35 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.8 mp -83.86 -34.88 24.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.047 0.939 . . . . 0.0 111.952 174.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -84.58 -36.7 21.89 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.005 1.722 . . . . 0.0 114.073 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.0 t -158.51 -168.13 2.35 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 126.784 2.034 . . . . 0.0 108.313 -159.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -71.91 -174.99 23.44 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 120.711 -1.243 . . . . 0.0 113.74 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 10.0 t -161.02 148.18 15.25 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 49.3 tp -68.42 -10.38 54.83 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.194 1.798 . . . . 0.0 114.314 165.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -53.52 -17.77 2.31 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 -167.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 30.0 p-90 -58.14 -29.86 65.9 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 119.978 -1.701 . . . . 0.0 112.908 169.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 61.7 ttp -65.09 -32.89 74.83 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.858 1.663 . . . . 0.0 112.108 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -69.16 -38.94 79.01 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.508 -0.745 . . . . 0.0 111.884 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 50.1 mm -56.35 -34.51 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.059 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.4 t -60.5 -46.18 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.147 0.885 . . . . 0.0 111.271 172.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 15.9 mt -72.19 -47.47 50.45 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.746 0.818 . . . . 0.0 112.871 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 69.0 t -62.14 -43.29 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.754 0.822 . . . . 0.0 111.161 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 84.6 t -72.15 -32.41 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.05 174.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -62.12 -49.16 77.0 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 120.807 1.64 . . . . 0.0 112.486 170.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -64.83 -39.71 94.02 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.52 -1.363 . . . . 0.0 111.636 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -62.56 -38.11 95.84 Favored Glycine 0 CA--C 1.538 1.475 0 O-C-N 121.989 -0.444 . . . . 0.0 112.714 169.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 59.8 m -67.53 -36.65 81.43 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 117.731 0.765 . . . . 0.0 111.706 173.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -62.33 -44.18 97.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.521 1.128 . . . . 0.0 110.784 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -58.51 -41.1 84.63 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 77.9 t -71.08 -36.65 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.217 -0.927 . . . . 0.0 113.153 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 46.8 t -67.17 -29.99 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.035 1.334 . . . . 0.0 111.746 175.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -59.43 -40.01 85.35 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.971 -1.081 . . . . 0.0 112.19 165.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 74.5 mt -74.63 -36.93 62.92 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.708 0.803 . . . . 0.0 112.928 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 54.9 m0 -62.57 -41.17 98.76 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.072 1.305 . . . . 0.0 112.708 169.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 42.8 p -71.41 0.82 7.37 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.84 -23.45 60.67 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.556 1.525 . . . . 0.0 113.579 154.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 164.27 112.54 0.27 Allowed Glycine 0 N--CA 1.433 -1.541 0 O-C-N 121.878 -0.514 . . . . 0.0 112.157 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 45.0 t -34.06 -32.51 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.14 1.776 . . . . 0.0 113.514 152.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.46 -44.64 3.85 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 161.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.7 m -74.47 24.97 0.08 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -171.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -5.66 2.89 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 118.067 2.618 . . . . 0.0 118.067 -173.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -119.2 -37.53 3.18 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 120.276 1.398 . . . . 0.0 111.822 166.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.436 ' CG1' ' H ' ' A' ' 186' ' ' GLY . 10.8 p -73.09 -62.0 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.96 0.904 . . . . 0.0 112.71 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.436 ' H ' ' CG1' ' A' ' 185' ' ' VAL . . . -61.63 -31.65 78.61 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 118.591 -1.116 . . . . 0.0 112.656 169.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.0 tt -55.79 -49.58 72.8 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.4 1.6 . . . . 0.0 110.048 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -66.99 -42.38 85.17 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 122.211 -0.305 . . . . 0.0 111.092 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -53.36 -43.95 65.62 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.238 1.399 . . . . 0.0 114.105 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . 0.326 9.9 ptp180 -80.51 -31.02 37.26 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 40.0 tp -69.0 -41.02 78.34 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.49 0.586 . . . . 0.0 112.365 171.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -76.18 -17.39 59.57 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -78.97 -13.83 59.56 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.757 1.223 . . . . 0.0 113.831 169.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -78.79 43.89 0.52 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 117.052 2.242 . . . . 0.0 117.052 -165.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -93.86 -5.57 47.72 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -165.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -61.89 141.45 95.4 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 120.199 1.363 . . . . 0.0 109.104 175.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -47.57 -43.37 27.95 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.025 2.483 . . . . 0.0 115.021 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.481 ' CG2' ' HE2' ' A' ' 240' ' ' HIS . 35.0 mm -68.43 -32.24 54.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.117 0.967 . . . . 0.0 112.419 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 14.3 m -71.61 -36.6 70.86 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.973 1.309 . . . . 0.0 111.46 175.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 63.6 mt -68.94 -39.32 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.707 1.203 . . . . 0.0 110.733 173.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 33.9 mt -62.85 -41.48 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 121.286 -0.884 . . . . 0.0 111.129 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -65.23 -36.45 84.19 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.26 1.424 . . . . 0.0 111.647 176.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 28.6 tp -60.95 -52.96 62.83 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.529 0.732 . . . . 0.0 111.48 166.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 49.5 mt -61.59 -36.32 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.496 -0.752 . . . . 0.0 111.077 -175.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.0 t -65.9 -45.84 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.962 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.02 -31.39 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 CA-C-N 120.818 1.645 . . . . 0.0 112.018 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 97.5 t -74.25 -39.38 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 120.557 1.526 . . . . 0.0 110.893 176.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.15 81.96 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.34 0.973 . . . . 0.0 110.369 170.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 47.6 m -58.62 -43.94 89.79 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.77 0.828 . . . . 0.0 112.197 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 28.3 ttm -59.66 -55.45 34.31 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.295 1.438 . . . . 0.0 111.875 171.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 23.8 t -56.01 -47.47 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.099 1.36 . . . . 0.0 112.053 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 33.4 m -75.95 -25.79 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 118.043 -0.979 . . . . 0.0 113.28 -171.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 86.3 mt -68.85 -48.32 63.75 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.829 1.195 . . . . 0.0 110.968 159.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 43.8 t -63.04 -46.79 85.85 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.169 0.987 . . . . 0.0 113.003 -165.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 8.4 p -71.13 -11.72 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.896 -1.128 . . . . 0.0 113.214 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.41 125.58 5.66 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 125.357 1.456 . . . . 0.0 112.301 -168.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.5 m -72.75 61.23 0.53 Allowed 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 128.37 2.668 . . . . 0.0 113.427 -168.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -166.73 164.72 16.64 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 127.735 2.414 . . . . 0.0 112.064 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -85.24 -106.14 0.67 Allowed Glycine 0 C--N 1.337 0.603 0 C-N-CA 126.462 1.982 . . . . 0.0 111.923 -1.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -66.32 -23.64 66.4 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.095 -1.053 . . . . 0.0 112.302 171.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.68 -44.79 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 O-C-N 121.259 -0.901 . . . . 0.0 110.486 -166.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.65 -51.58 54.69 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.482 0.713 . . . . 0.0 111.906 163.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.66 -52.36 65.46 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.58 0.752 . . . . 0.0 109.559 -171.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.49 -37.73 88.57 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-O 117.915 -1.04 . . . . 0.0 112.715 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 46.1 m -67.92 -48.26 66.48 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 121.397 1.908 . . . . 0.0 111.298 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -56.42 -46.77 80.07 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 125.072 1.349 . . . . 0.0 110.976 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 72.5 mt -59.29 -71.1 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-O 122.478 1.133 . . . . 0.0 110.184 167.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -78.38 -17.92 55.79 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.153 -150.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.43 -53.73 2.24 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.532 1.063 . . . . 0.0 114.058 162.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -30.66 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 119.512 1.656 . . . . 0.0 113.637 -170.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 4.0 mmt85 -73.49 -32.46 64.31 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.779 -1.2 . . . . 0.0 110.923 170.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -67.19 -36.5 81.89 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.479 1.111 . . . . 0.0 112.42 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 65.3 tp -58.34 -36.23 73.1 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 118.316 0.507 . . . . 0.0 112.198 165.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.21 -34.71 61.52 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 119.95 -1.719 . . . . 0.0 113.552 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 3.7 pt -73.35 -22.75 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 120.779 -1.2 . . . . 0.0 113.832 164.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.5 tp -58.7 -42.47 88.68 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.606 1.163 . . . . 0.0 110.789 164.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -56.98 -30.6 64.26 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.309 1.044 . . . . 0.0 112.893 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 18.5 mmt -49.08 -31.93 8.79 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 168.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 40.5 mt -112.65 -7.67 13.84 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.182 1.393 . . . . 0.0 109.982 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . 0.481 ' HE2' ' CG2' ' A' ' 198' ' ' ILE . 36.7 m170 -68.12 -12.93 61.77 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.661 0.664 . . . . 0.0 112.084 153.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 61.8 t . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 124.272 1.987 . . . . 0.0 108.765 138.708 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 t -43.71 -57.27 3.29 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.932 2.493 . . . . 0.0 114.027 165.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -92.22 -25.33 18.69 Favored 'General case' 0 C--N 1.335 -0.06 0 O-C-N 120.196 -1.565 . . . . 0.0 114.349 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.56 -38.93 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 119.446 1.021 . . . . 0.0 111.144 171.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -73.54 -32.35 64.16 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.137 -0.977 . . . . 0.0 111.159 171.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.02 -32.31 42.0 Favored Glycine 0 CA--C 1.536 1.348 0 O-C-N 121.755 -0.591 . . . . 0.0 112.579 163.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -37.05 84.13 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.263 1.425 . . . . 0.0 111.546 -177.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.07 -54.1 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 122.292 1.044 . . . . 0.0 109.485 170.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . 0.25 77.0 m-85 -74.78 -33.75 62.33 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.101 -168.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -62.31 -22.86 66.38 Favored 'General case' 0 CA--C 1.552 1.051 0 O-C-N 120.179 -1.576 . . . . 0.0 114.469 165.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -75.38 -28.41 59.47 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.289 1.035 . . . . 0.0 111.811 171.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.2 mt -58.92 -43.65 91.16 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.56 1.073 . . . . 0.0 109.836 165.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -74.65 -40.82 61.23 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.306 -161.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.9 ptt85 -87.43 123.0 70.41 Favored Pre-proline 0 N--CA 1.47 0.554 0 C-N-CA 124.24 1.016 . . . . 0.0 110.46 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -65.89 126.61 16.21 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.869 1.712 . . . . 0.0 110.886 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.1 p -133.32 166.84 21.56 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 167.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.01 -37.59 71.78 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-N 118.634 0.652 . . . . 0.0 112.579 171.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -73.0 -34.99 66.74 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 175.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.43 -55.99 27.73 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.785 1.175 . . . . 0.0 108.864 164.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 34.0 t -58.52 -48.5 80.62 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.488 1.115 . . . . 0.0 111.994 -171.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -59.72 -52.96 63.26 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.824 0.45 . . . . 0.0 111.428 -175.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.6 t -84.27 -42.87 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -64.77 -48.98 72.52 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.705 0.402 . . . . 0.0 112.05 -172.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -68.8 -33.96 74.74 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.9 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -68.55 -36.08 78.31 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.275 0.943 . . . . 0.0 113.047 173.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.79 -46.13 81.74 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.352 0.978 . . . . 0.0 113.628 169.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . 0.268 0.7 OUTLIER -64.69 -39.05 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 CA-C-N 120.39 1.45 . . . . 0.0 111.16 178.743 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -60.45 -48.74 80.46 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.868 -1.145 . . . . 0.0 113.173 172.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.7 mt -61.82 -38.89 89.84 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.854 -1.154 . . . . 0.0 111.895 177.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 77.2 mt -63.26 -43.49 98.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 118.716 -0.659 . . . . 0.0 111.779 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -38.11 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 119.556 1.071 . . . . 0.0 111.662 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.6 mt -59.31 -47.74 84.27 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.761 0.425 . . . . 0.0 111.859 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.4 m -70.63 -41.11 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.608 1.095 . . . . 0.0 110.944 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 95.9 m -64.51 -39.91 94.67 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 119.105 0.866 . . . . 0.0 112.834 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 78.1 mt -71.2 -41.23 70.55 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 120.091 1.314 . . . . 0.0 112.599 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.3 mm -64.31 -48.09 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 121.232 -0.917 . . . . 0.0 110.02 172.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -61.5 -35.63 78.24 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-O 116.915 -1.516 . . . . 0.0 110.663 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.4 m -49.73 -48.38 50.12 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 121.006 1.73 . . . . 0.0 113.084 173.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.43 -30.67 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 122.999 0.52 . . . . 0.0 112.212 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.3 mt -89.84 -30.92 17.6 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.49 1.516 . . . . 0.0 114.907 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.7 p -90.17 -26.11 20.31 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.014 -1.053 . . . . 0.0 113.25 -158.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.3 t -68.97 -32.51 72.14 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.307 -0.871 . . . . 0.0 112.439 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 11.8 pt -72.28 -9.13 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -62.91 -23.38 67.33 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.661 0.784 . . . . 0.0 112.099 170.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -62.85 -38.74 92.03 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.845 1.258 . . . . 0.0 111.457 168.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -74.84 -37.37 62.28 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.892 0.769 . . . . 0.0 111.36 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.75 -42.29 95.28 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.124 0.969 . . . . 0.0 113.501 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -58.23 -25.08 61.24 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -170.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -69.77 -48.14 60.36 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.488 1.115 . . . . 0.0 111.859 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.96 -51.91 11.4 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.671 1.188 . . . . 0.0 113.273 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.5 t -159.4 -179.0 7.56 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.611 -139.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -62.71 152.73 45.19 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 122.006 0.781 . . . . 0.0 112.936 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.8 t -152.9 148.28 26.96 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.843 0.83 . . . . 0.0 112.101 -166.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 11.3 tp -81.66 14.97 2.32 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.924 2.09 . . . . 0.0 112.796 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -50.24 -29.14 8.88 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.116 2.566 . . . . 0.0 114.618 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -70.99 -31.14 67.59 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.134 -0.979 . . . . 0.0 112.408 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 9.0 tpt -73.91 -35.41 64.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.433 1.015 . . . . 0.0 110.767 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -55.82 -56.35 21.56 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.516 0.726 . . . . 0.0 110.775 166.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 75.0 mt -58.45 -40.13 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.6 0.76 . . . . 0.0 112.282 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.7 t -61.95 -44.82 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 120.279 -1.513 . . . . 0.0 112.567 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.2 mt -71.2 -34.37 70.82 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.219 1.372 . . . . 0.0 112.037 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 54.9 t -59.8 -36.77 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.54 1.063 . . . . 0.0 110.881 170.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 78.8 t -76.26 -28.2 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 118.503 -0.761 . . . . 0.0 112.055 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -60.85 -48.99 79.29 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.197 1.362 . . . . 0.0 110.669 169.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -71.93 -35.79 69.75 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.53 -43.54 94.11 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 123.368 0.508 . . . . 0.0 112.361 167.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 88.9 m -68.88 -36.95 78.7 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.837 0.819 . . . . 0.0 110.739 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.4 tm-20 -60.14 -35.11 74.57 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 118.751 0.705 . . . . 0.0 112.541 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -60.69 -46.25 91.08 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.263 -0.898 . . . . 0.0 112.044 169.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.4 t -69.99 -30.82 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.494 0.717 . . . . 0.0 111.988 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.1 t -60.65 -39.51 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.305 1.442 . . . . 0.0 112.47 171.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -69.79 -20.1 63.48 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 170.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 31.8 mt -77.73 -37.7 48.73 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.311 0.959 . . . . 0.0 112.222 166.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 34.8 m0 -64.92 -45.63 85.03 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.008 -1.058 . . . . 0.0 113.355 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 95.1 p -56.02 -38.49 70.61 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.024 1.283 . . . . 0.0 113.845 169.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.09 -8.85 33.74 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 173.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -106.63 5.2 37.34 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.142 1.83 . . . . 0.0 113.815 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 20.7 p -57.35 -15.28 6.01 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -173.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.28 -33.17 2.17 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.011 1.725 . . . . 0.0 112.658 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 21.7 t -159.26 115.2 2.56 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.093 1.757 . . . . 0.0 107.347 177.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -57.7 -34.74 69.76 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -155.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -100.24 -29.32 12.53 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -169.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 99.4 t -54.42 -59.63 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 118.834 0.743 . . . . 0.0 110.695 -173.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.35 -26.76 68.33 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-O 116.101 -2.499 . . . . 0.0 114.507 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 66.4 mt -57.3 -39.47 75.83 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 121.519 2.66 . . . . 0.0 111.237 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 6.7 t-105 -70.25 -42.46 72.15 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.472 -0.768 . . . . 0.0 111.748 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -62.79 -27.1 69.5 Favored Glycine 0 CA--C 1.533 1.173 0 O-C-N 121.608 -0.682 . . . . 0.0 113.38 175.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -82.69 -31.37 28.61 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 129.901 3.28 . . . . 0.0 113.104 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 52.8 mt -81.19 -30.26 34.37 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.58 1.152 . . . . 0.0 111.906 171.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -58.94 -45.01 91.46 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 126.327 1.851 . . . . 0.0 112.291 159.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -63.13 -31.27 72.37 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.694 -0.628 . . . . 0.0 112.193 169.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.28 17.23 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 173.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 -108.01 -20.97 13.0 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.287 1.835 . . . . 0.0 112.89 172.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -70.03 153.7 95.18 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 126.025 1.73 . . . . 0.0 110.031 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.69 -57.28 1.06 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 CA-C-N 122.236 1.834 . . . . 0.0 116.019 -157.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 81.7 mt -68.34 -18.54 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 120.017 1.28 . . . . 0.0 111.834 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 37.2 m -89.44 -29.28 19.13 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 16.5 tt -79.75 -33.1 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 119.823 1.192 . . . . 0.0 110.701 168.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.09 -36.69 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 118.852 0.751 . . . . 0.0 110.213 165.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -72.02 -35.67 69.47 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.701 1.137 . . . . 0.0 111.789 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 24.1 tp -62.15 -49.31 76.34 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.729 0.412 . . . . 0.0 111.417 169.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 60.6 mt -60.78 -45.24 98.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.786 1.234 . . . . 0.0 111.084 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.2 t -68.27 -40.02 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.048 0.939 . . . . 0.0 112.002 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.1 p -69.73 -31.6 49.13 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 CA-C-N 121.331 1.878 . . . . 0.0 111.707 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 73.2 t -71.71 -45.03 68.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -54.86 -48.58 72.75 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 118.186 0.448 . . . . 0.0 111.297 171.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.0 m -57.12 -50.28 73.29 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.341 1.057 . . . . 0.0 112.847 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 21.6 ptp -69.14 -38.65 78.94 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 118.906 -0.569 . . . . 0.0 111.86 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 14.9 t -58.66 -42.12 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.336 1.054 . . . . 0.0 111.687 174.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 30.2 m -84.38 -30.84 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.32 -33.07 65.25 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.082 0.855 . . . . 0.0 111.813 160.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 48.9 t -84.56 -44.34 13.64 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.845 0.858 . . . . 0.0 112.958 -170.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 5.0 p -67.14 -21.51 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -169.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 122.61 108.22 1.94 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -159.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 97.4 p -73.37 41.21 0.11 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.84 2.056 . . . . 0.0 114.133 -173.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -157.21 166.7 32.46 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 128.621 2.769 . . . . 0.0 109.829 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -87.11 -90.61 1.0 Allowed Glycine 0 N--CA 1.468 0.775 0 C-N-CA 127.258 2.361 . . . . 0.0 107.357 -13.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -60.86 -37.15 81.13 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.648 -1.276 . . . . 0.0 112.442 169.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 24.6 t -85.89 -40.91 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 117.883 -1.527 . . . . 0.0 111.488 -148.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.1 -46.51 68.73 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.223 162.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.92 -56.06 11.9 Favored 'General case' 0 C--O 1.214 -0.765 0 O-C-N 123.815 0.697 . . . . 0.0 111.307 -171.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.1 t -54.2 -36.71 63.75 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.739 -1.226 . . . . 0.0 112.228 176.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 15.6 m -68.93 -56.71 7.0 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.243 -0.91 . . . . 0.0 112.506 174.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.33 -57.45 12.27 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 125.864 1.666 . . . . 0.0 111.953 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 59.5 mt -54.71 -79.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-O 123.413 1.578 . . . . 0.0 108.902 169.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -74.83 -34.96 62.42 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 113.946 -1.479 . . . . 0.0 108.358 -150.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -72.72 -52.87 8.94 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.025 1.298 . . . . 0.0 115.17 172.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.41 -36.94 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-N 120.747 2.273 . . . . 0.0 111.487 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -81.33 -20.94 39.64 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.4 -46.6 89.42 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.51 0.724 . . . . 0.0 109.734 164.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.79 -24.93 67.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.57 -0.728 . . . . 0.0 110.987 171.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -70.46 -46.43 63.85 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 122.015 2.189 . . . . 0.0 113.62 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 8.3 pt -72.47 -2.25 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 120.509 -1.37 . . . . 0.0 114.206 173.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 44.1 tp -87.23 -21.58 25.76 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.677 1.191 . . . . 0.0 113.213 164.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -80.53 -12.38 59.54 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.949 1.7 . . . . 0.0 111.959 175.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 16.4 tpp -35.84 -30.8 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 128.981 2.913 . . . . 0.0 114.031 147.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 10.1 mt -102.9 -9.74 19.62 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.617 1.567 . . . . 0.0 110.767 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 52.3 m170 -83.88 -15.05 49.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.179 1.392 . . . . 0.0 112.147 161.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.359 3.4 t . . . . . 0 N--CA 1.475 0.806 0 CA-C-O 125.648 2.642 . . . . 0.0 111.019 146.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 . . . . . 0 N--CA 1.444 -0.747 0 N-CA-C 111.487 0.18 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -73.4 -31.51 63.92 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.227 -0.92 . . . . 0.0 110.903 172.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -69.0 -48.46 63.03 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.928 -1.107 . . . . 0.0 111.964 172.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 5.2 p -68.47 -34.97 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 118.273 0.488 . . . . 0.0 111.832 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -67.28 -35.16 78.93 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.193 -0.942 . . . . 0.0 110.429 172.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -57.57 -31.26 63.24 Favored Glycine 0 CA--C 1.545 1.958 0 C-N-CA 124.989 1.281 . . . . 0.0 113.841 163.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -72.26 -40.88 67.34 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.355 -1.086 . . . . 0.0 112.538 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.99 -43.53 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.705 1.202 . . . . 0.0 110.707 162.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.402 ' CG ' ' HA ' ' A' ' 177' ' ' SER . 19.6 m-30 -62.52 -45.63 92.11 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 117.433 -1.27 . . . . 0.0 112.552 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -53.39 -36.86 61.9 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.983 1.265 . . . . 0.0 113.045 170.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -73.62 -31.28 63.45 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.295 -0.878 . . . . 0.0 111.777 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.4 mt -68.35 -46.7 69.43 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.133 0.879 . . . . 0.0 110.572 168.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -70.71 -42.05 71.12 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.413 -165.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 25.9 ptt85 -75.81 156.52 84.52 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 123.858 0.863 . . . . 0.0 112.338 177.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -82.07 142.13 12.13 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.907 2.405 . . . . 0.0 111.498 167.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 75.3 p -147.74 156.92 43.25 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.561 1.544 . . . . 0.0 109.624 167.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.87 -36.04 78.24 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.016 166.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -64.66 -43.66 92.91 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -63.26 -46.2 87.97 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.292 0.951 . . . . 0.0 111.122 174.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 46.5 t -65.56 -33.76 76.67 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -62.08 -56.46 18.73 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.989 -1.07 . . . . 0.0 111.349 171.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.6 p -73.49 -41.08 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 120.721 -1.237 . . . . 0.0 113.207 -173.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -67.99 -50.9 52.82 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.665 0.786 . . . . 0.0 112.491 -173.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -68.14 -27.62 66.59 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.7 0.682 . . . . 0.0 111.991 -172.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -89.4 -30.4 18.38 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.4 -38.54 74.45 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 120.183 1.356 . . . . 0.0 112.529 158.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 19.4 t -58.28 -47.98 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 120.414 1.461 . . . . 0.0 111.884 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -59.66 -50.45 73.83 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.755 0.822 . . . . 0.0 113.193 172.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.57 -42.95 99.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -176.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.3 mt -63.38 -50.81 77.16 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.035 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.56 -36.46 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 119.926 1.239 . . . . 0.0 112.544 -173.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.1 tt -62.13 -47.71 83.35 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.277 1.031 . . . . 0.0 111.616 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 32.6 m -75.9 -40.89 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.747 0.703 . . . . 0.0 111.053 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 12.5 t -49.66 -58.27 5.6 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.351 1.86 . . . . 0.0 112.834 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 69.5 mt -77.28 -32.42 55.53 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.273 -0.892 . . . . 0.0 112.987 -173.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.9 mt -68.96 -46.14 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 120.038 1.29 . . . . 0.0 110.406 171.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -61.59 -30.33 70.61 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.806 175.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.8 m -60.08 -38.42 82.84 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.445 1.475 . . . . 0.0 113.212 172.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 50.7 t -67.27 -24.04 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 123.924 0.89 . . . . 0.0 111.807 174.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 46.2 mt -87.75 -48.33 7.94 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.292 1.037 . . . . 0.0 113.208 173.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 59.4 p -71.12 -12.41 61.48 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 127.497 2.319 . . . . 0.0 113.531 -171.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.7 t -70.63 -32.67 70.07 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.663 1.185 . . . . 0.0 111.444 170.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 48.4 mm -72.6 -33.35 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.712 0.805 . . . . 0.0 110.64 168.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -66.31 -33.29 75.39 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.271 0.628 . . . . 0.0 112.187 169.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -65.2 -40.86 94.76 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.843 1.257 . . . . 0.0 111.595 170.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -69.27 -34.4 74.69 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.338 0.655 . . . . 0.0 112.379 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.03 98.14 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.852 0.861 . . . . 0.0 111.722 167.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.13 -10.27 9.89 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 76.3 mt -70.78 -12.31 61.47 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.117 1.367 . . . . 0.0 113.738 166.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -152.56 -45.73 0.1 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -163.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.6 t -156.26 175.65 13.71 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.746 0.819 . . . . 0.0 110.833 -143.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.1 139.62 48.27 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 114.628 0.611 . . . . 0.0 114.628 -166.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.1 t -156.26 143.84 19.33 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -162.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 16.7 tp -87.18 7.89 26.27 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.882 1.273 . . . . 0.0 112.624 171.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -65.59 -10.98 40.27 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 119.546 -1.972 . . . . 0.0 114.093 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 53.7 p-90 -65.3 -26.46 68.08 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.057 -1.652 . . . . 0.0 112.492 166.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 51.0 tpp -75.36 -28.75 59.66 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.652 1.581 . . . . 0.0 112.261 174.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -61.24 -43.8 98.29 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.133 -0.979 . . . . 0.0 110.453 165.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.12 -35.26 73.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 118.096 -0.954 . . . . 0.0 111.3 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.43 -53.0 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 120.66 1.573 . . . . 0.0 111.745 170.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.8 mt -68.18 -36.8 80.16 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.239 0.927 . . . . 0.0 112.411 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 38.0 t -59.29 -41.47 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 120.666 1.576 . . . . 0.0 111.092 172.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.17 -31.13 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.502 -0.761 . . . . 0.0 111.05 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -59.66 -51.94 67.65 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.601 1.092 . . . . 0.0 111.752 165.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -62.47 -36.77 83.53 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 121.226 1.83 . . . . 0.0 112.055 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -62.31 -43.87 98.47 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 172.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 56.0 m -67.27 -32.81 74.06 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.401 -1.058 . . . . 0.0 110.895 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -65.42 -41.96 93.0 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 120.738 -1.226 . . . . 0.0 112.344 173.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -58.35 -45.71 87.66 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.529 0.604 . . . . 0.0 111.832 170.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.4 t -66.04 -38.18 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.816 0.846 . . . . 0.0 111.515 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 23.1 t -65.23 -38.83 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.004 1.322 . . . . 0.0 110.967 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -62.47 -34.26 76.49 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.585 1.084 . . . . 0.0 113.335 171.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 9.7 mt -67.96 -47.34 68.87 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.915 0.779 . . . . 0.0 111.875 169.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -61.91 -43.51 98.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 118.013 -0.994 . . . . 0.0 112.858 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.402 ' HA ' ' CG ' ' A' ' 111' ' ' TYR 0.265 43.0 p -65.49 -26.98 68.16 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 176.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -57.23 -25.14 58.62 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.801 1.182 . . . . 0.0 113.247 168.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.49 -9.65 65.17 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 126.098 1.808 . . . . 0.0 114.643 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 44.1 t -53.82 -40.34 66.3 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.263 1.025 . . . . 0.0 112.382 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 3.1 ptp85 -68.51 -57.83 5.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.577 0.751 . . . . 0.0 111.803 171.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 41.7 t -162.96 137.67 6.46 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.498 1.919 . . . . 0.0 108.009 169.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -60.28 -34.02 73.15 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -153.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -103.03 -27.19 12.74 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.209 1.004 . . . . 0.0 112.765 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 61.3 t -62.21 -68.08 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.068 1.347 . . . . 0.0 111.325 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -61.0 -31.04 75.06 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 119.128 -0.818 . . . . 0.0 112.195 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 7.9 tt -66.94 -39.93 87.45 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.61 1.564 . . . . 0.0 112.449 176.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 4.7 t-105 -60.26 -40.47 90.48 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 120.804 -1.185 . . . . 0.0 110.844 166.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -64.89 -30.31 77.65 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 122.226 0.903 . . . . 0.0 113.385 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 -76.3 -32.49 58.79 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.866 2.466 . . . . 0.0 112.312 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 75.1 mt -76.0 -35.35 59.59 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.943 1.297 . . . . 0.0 112.662 167.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 65.0 mtt-85 -59.67 -36.49 76.54 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.819 -1.176 . . . . 0.0 111.456 166.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -69.49 28.5 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 126.298 1.839 . . . . 0.0 113.994 170.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.66 27.95 1.21 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.598 2.359 . . . . 0.0 112.991 164.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -105.99 -37.08 6.76 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -149.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -77.86 146.81 72.92 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 117.265 -1.35 . . . . 0.0 109.868 172.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -45.22 -44.21 15.96 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.694 3.596 . . . . 0.0 116.901 -171.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -70.27 -30.38 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 119.353 0.979 . . . . 0.0 110.93 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 66.7 m -81.68 -26.83 34.38 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.509 1.523 . . . . 0.0 112.997 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.96 -48.14 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 163.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 65.5 mt -65.01 -30.08 49.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-O 118.689 -0.672 . . . . 0.0 111.566 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -71.53 -44.52 64.46 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.496 1.498 . . . . 0.0 110.542 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 43.4 tp -61.6 -44.29 97.28 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.635 0.774 . . . . 0.0 111.403 171.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 72.2 mt -63.26 -49.1 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 121.393 -0.817 . . . . 0.0 110.804 176.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.0 t -70.39 -33.96 56.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 117.098 -1.429 . . . . 0.0 112.427 -173.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.5 p -65.38 -34.76 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 121.568 1.986 . . . . 0.0 111.394 172.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 86.9 t -75.17 -38.47 41.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 O-C-N 121.372 -0.83 . . . . 0.0 110.063 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -55.75 -47.26 77.27 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.697 0.68 . . . . 0.0 110.82 168.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 20.0 m -56.16 -43.48 78.39 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.148 0.979 . . . . 0.0 111.783 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 58.6 ttm -75.55 -50.3 16.02 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.276 0.631 . . . . 0.0 111.752 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 56.0 t -56.06 -46.74 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.066 0.946 . . . . 0.0 111.837 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.406 ' HB ' ' HA ' ' A' ' 222' ' ' PHE . 13.9 m -77.01 -39.71 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 118.974 0.806 . . . . 0.0 113.035 -173.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -56.91 -32.87 66.37 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.919 0.887 . . . . 0.0 110.746 170.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 55.2 m -75.48 -52.15 11.36 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.376 1.471 . . . . 0.0 112.97 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.7 t -58.17 -40.25 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 125.265 1.426 . . . . 0.0 112.369 -171.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 139.35 154.66 6.41 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 123.595 0.617 . . . . 0.0 112.374 173.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 55.1 p -73.56 23.21 0.07 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -160.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm -156.41 165.39 36.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.477 1.911 . . . . 0.0 111.933 -160.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -78.01 -80.31 0.7 Allowed Glycine 0 N--CA 1.478 1.434 0 C-N-CA 127.462 2.458 . . . . 0.0 109.386 -9.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -84.77 -27.17 27.06 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.927 1.291 . . . . 0.0 110.827 161.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 73.5 t -76.7 -40.91 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 121.179 -0.951 . . . . 0.0 112.42 -145.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.406 ' HA ' ' HB ' ' A' ' 212' ' ' VAL . 0.0 OUTLIER -60.01 -39.81 87.07 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 169.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -74.17 -49.8 22.02 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.764 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 8.8 t -53.77 -38.4 64.42 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 121.123 1.783 . . . . 0.0 112.219 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 19.3 m -66.05 -56.85 9.48 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.505 -0.747 . . . . 0.0 112.357 173.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.54 -48.37 77.8 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.931 1.293 . . . . 0.0 112.496 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 67.2 mt -62.72 -84.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.79 0 O-C-N 119.255 -2.153 . . . . 0.0 109.133 169.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -71.87 -38.28 70.05 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.778 -152.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -71.05 -44.21 55.19 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 125.991 1.758 . . . . 0.0 114.32 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.5 mp -78.26 -30.18 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 118.773 1.286 . . . . 0.0 109.74 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -39.91 82.34 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 120.841 -1.162 . . . . 0.0 111.57 164.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -68.01 -41.48 82.14 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 117.385 -1.293 . . . . 0.0 110.73 -174.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 31.9 tp -57.43 -45.16 84.97 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.154 0.888 . . . . 0.0 110.856 167.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -59.09 -45.94 89.57 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -170.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.4 pt -66.93 -20.8 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 35.4 mt -66.88 -22.87 65.96 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.285 -0.884 . . . . 0.0 110.756 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -74.65 -11.35 60.16 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.263 -0.898 . . . . 0.0 111.731 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 81.2 mtp -45.79 -33.72 3.26 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 126.025 1.73 . . . . 0.0 113.1 153.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.3 mt -98.56 -14.02 20.14 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.346 1.459 . . . . 0.0 111.304 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 50.0 m170 -75.31 -27.49 59.31 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.681 -0.637 . . . . 0.0 111.495 157.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.251 15.5 t . . . . . 0 N--CA 1.471 0.588 0 CA-C-O 125.557 2.599 . . . . 0.0 110.027 157.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.55 0.979 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.2 t -63.42 -33.28 75.21 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 168.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -79.85 -30.39 40.31 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.439 -1.413 . . . . 0.0 110.763 -174.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.3 m -84.1 -34.25 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-O 121.845 0.831 . . . . 0.0 112.334 -174.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -52.74 -47.83 67.12 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.321 -1.308 . . . . 0.0 110.348 156.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -56.12 -36.83 69.37 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 118.928 -0.929 . . . . 0.0 113.613 169.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -70.11 -36.07 74.59 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.942 1.371 . . . . 0.0 112.089 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 t -57.0 -57.02 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.49 0.716 . . . . 0.0 109.87 162.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -58.76 -45.79 88.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.483 0.313 . . . . 0.0 111.623 -172.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -67.68 -21.54 65.33 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -77.0 -36.45 56.4 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.349 0.977 . . . . 0.0 111.294 172.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.8 mt -62.0 -40.79 96.85 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.799 -0.563 . . . . 0.0 109.735 164.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -71.75 -44.0 64.83 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.973 -167.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -98.87 101.72 13.0 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 126.632 1.973 . . . . 0.0 110.683 -174.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -65.17 156.95 60.14 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.49 2.126 . . . . 0.0 114.97 -164.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 40.4 p -145.31 168.14 21.17 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 127.107 2.163 . . . . 0.0 107.692 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.1 -35.14 32.94 Favored Glycine 0 CA--C 1.536 1.389 0 O-C-N 121.627 -0.671 . . . . 0.0 112.282 164.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 33.9 m95 -69.13 -34.45 75.04 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -60.87 -51.18 70.38 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.66 1.118 . . . . 0.0 110.51 169.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 42.8 t -63.09 -37.19 86.23 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.265 0.626 . . . . 0.0 111.573 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -58.96 -59.26 5.75 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.023 0.44 . . . . 0.0 109.844 173.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.86 -49.37 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.012 0.525 . . . . 0.0 111.993 -168.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -68.39 -46.2 70.65 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -170.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -77.89 -27.92 49.76 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.566 -0.709 . . . . 0.0 112.113 -172.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -68.78 -44.86 72.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.997 165.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -51.78 -48.91 63.59 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 117.314 -1.327 . . . . 0.0 113.96 168.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . 0.265 0.9 OUTLIER -63.82 -41.5 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 121.76 2.073 . . . . 0.0 112.293 -179.126 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -67.27 -43.17 82.47 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.742 0.701 . . . . 0.0 111.849 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 85.4 mt -66.1 -41.85 90.05 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.612 0.365 . . . . 0.0 111.766 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 69.4 mt -64.26 -47.74 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 118.011 -0.995 . . . . 0.0 111.194 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -40.32 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 120.495 1.498 . . . . 0.0 111.378 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 33.8 tp -59.43 -43.69 93.04 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.624 1.17 . . . . 0.0 111.658 175.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.8 t -64.3 -45.79 95.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 118.694 -0.669 . . . . 0.0 111.356 171.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 90.5 m -63.7 -39.98 95.64 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.172 0.896 . . . . 0.0 112.385 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 87.5 mt -79.49 -37.27 37.17 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.419 -0.801 . . . . 0.0 112.686 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.3 mt -59.25 -48.32 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.301 0.572 . . . . 0.0 109.94 167.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -60.96 -36.3 79.03 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-O 117.726 -1.131 . . . . 0.0 110.845 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.9 m -55.41 -44.49 76.24 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 121.538 1.972 . . . . 0.0 112.444 -176.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.3 m -79.28 -16.04 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 78.4 mt -81.98 -28.41 32.66 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 120.074 1.306 . . . . 0.0 113.554 161.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 37.8 t -78.5 -38.67 40.2 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.808 1.643 . . . . 0.0 113.579 -160.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.668 ' HG1' ' NE2' ' A' ' 147' ' ' GLN 0.336 3.4 t -74.28 -17.19 60.89 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 120.295 1.407 . . . . 0.0 113.312 -175.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.1 mp -58.89 -43.13 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 120.587 -1.32 . . . . 0.0 110.959 159.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -69.52 -41.04 76.54 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.479 1.111 . . . . 0.0 110.669 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.668 ' NE2' ' HG1' ' A' ' 144' ' ' THR . 6.9 tt0 -59.04 -41.6 88.21 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.779 1.232 . . . . 0.0 111.647 171.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -67.99 -40.83 83.0 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.782 -1.199 . . . . 0.0 110.922 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.94 -33.47 73.23 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.615 0.766 . . . . 0.0 111.481 172.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.28 -8.66 8.98 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 72.3 mt -70.71 -11.93 61.25 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 120.249 -1.532 . . . . 0.0 113.482 166.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.49 -45.54 0.17 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -170.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.1 t -157.52 -178.66 7.5 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.806 0.813 . . . . 0.0 112.402 -138.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.13 134.99 52.11 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 124.609 1.099 . . . . 0.0 114.445 -170.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.5 t -155.07 137.52 15.01 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.227 1.011 . . . . 0.0 112.735 -160.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.6 tp -81.09 6.13 14.58 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.988 1.315 . . . . 0.0 113.342 166.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -64.93 -9.01 17.98 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 119.664 -1.897 . . . . 0.0 114.484 -173.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -68.73 -28.33 66.73 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.22 1.008 . . . . 0.0 112.129 167.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 50.6 tpp -66.24 -25.4 66.88 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.985 1.266 . . . . 0.0 111.862 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -63.99 -45.28 89.7 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.21 -0.931 . . . . 0.0 111.276 170.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 33.5 mt -57.48 -43.23 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.41 1.084 . . . . 0.0 111.087 172.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.3 t -61.35 -42.85 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 121.391 -0.818 . . . . 0.0 112.271 176.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 10.7 mt -71.84 -36.17 70.09 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.618 1.099 . . . . 0.0 113.233 173.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 45.2 t -59.54 -34.05 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 O-C-N 120.809 -1.182 . . . . 0.0 110.937 169.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 81.6 t -82.15 -26.75 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.315 1.046 . . . . 0.0 111.236 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -61.41 -56.72 17.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.29 1.404 . . . . 0.0 110.225 166.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -64.84 -39.09 93.01 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.221 0.919 . . . . 0.0 112.071 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -61.8 -42.85 99.8 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.638 1.113 . . . . 0.0 113.255 175.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.8 m -78.6 -30.31 46.55 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.997 1.398 . . . . 0.0 111.701 175.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.75 -41.11 97.23 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.898 -1.126 . . . . 0.0 111.851 170.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -53.09 -45.98 68.44 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.72 0.691 . . . . 0.0 110.571 169.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 92.5 t -68.22 -37.66 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.407 0.683 . . . . 0.0 112.006 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 39.3 t -63.21 -36.05 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 121.215 -0.928 . . . . 0.0 112.342 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -58.45 -38.8 78.27 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.279 0.945 . . . . 0.0 111.954 169.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 33.3 mt -72.97 -34.28 66.37 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -70.78 -39.84 72.96 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 173.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 17.6 p -62.35 -20.96 64.92 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 120.439 -1.413 . . . . 0.0 114.724 165.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -70.77 -6.63 39.1 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 120.203 1.365 . . . . 0.0 113.862 163.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -154.97 44.69 0.55 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.553 1.549 . . . . 0.0 112.986 -160.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 25.8 p -51.94 -24.53 6.55 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.028 0.931 . . . . 0.0 113.248 169.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.92 -53.41 2.28 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.76 2.024 . . . . 0.0 110.175 161.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.8 m -76.04 48.14 0.48 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 128.42 2.688 . . . . 0.0 112.563 -172.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -55.52 -19.24 9.18 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.939 2.496 . . . . 0.0 115.447 -169.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -114.18 -29.19 7.04 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 169.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 2.0 t -65.15 -61.68 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 119.907 1.231 . . . . 0.0 111.197 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -73.44 -28.45 65.73 Favored Glycine 0 C--O 1.222 -0.647 0 O-C-N 121.929 -0.482 . . . . 0.0 112.525 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 3.0 tt -53.34 -41.03 65.34 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.509 0.724 . . . . 0.0 110.773 166.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -85.93 -18.21 33.32 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.02 -37.08 16.62 Favored Glycine 0 N--CA 1.467 0.727 0 O-C-N 119.728 -1.858 . . . . 0.0 110.418 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -67.13 -25.49 66.21 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.942 1.697 . . . . 0.0 112.704 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 21.7 mt -76.0 -1.32 25.15 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 165.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 37.6 mtm105 -122.98 -8.11 8.34 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.321 1.848 . . . . 0.0 113.432 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -72.81 66.68 0.77 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.936 1.694 . . . . 0.0 108.409 149.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -148.36 82.26 1.48 Allowed 'General case' 0 C--O 1.239 0.501 0 C-N-CA 127.625 2.37 . . . . 0.0 107.432 -156.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 48.8 ttt85 -147.42 -73.69 0.2 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -154.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -72.83 154.94 91.04 Favored Pre-proline 0 N--CA 1.474 0.764 0 CA-C-N 119.28 0.945 . . . . 0.0 112.865 175.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.92 -45.61 24.23 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.893 3.062 . . . . 0.0 116.704 -168.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 69.4 mt -64.15 -35.4 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 121.525 1.966 . . . . 0.0 111.554 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 54.6 p -70.51 -31.1 68.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.8 1.182 . . . . 0.0 112.937 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.4 mm -75.39 -40.52 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.443 1.097 . . . . 0.0 111.13 172.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 56.4 mt -61.91 -41.78 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.146 0.978 . . . . 0.0 110.429 171.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.73 -43.21 97.16 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.834 1.654 . . . . 0.0 111.794 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 68.4 tp -60.98 -49.25 78.22 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.925 0.89 . . . . 0.0 112.687 170.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 61.9 mt -62.28 -44.55 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.167 -0.958 . . . . 0.0 110.53 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.0 t -69.11 -34.53 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 116.823 -1.561 . . . . 0.0 113.073 -174.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.1 p -68.22 -33.08 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 121.677 2.035 . . . . 0.0 111.6 173.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 82.4 t -77.37 -40.37 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 O-C-N 121.456 -0.777 . . . . 0.0 109.988 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -54.76 -52.03 63.84 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.118 0.967 . . . . 0.0 110.758 167.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.4 m -56.06 -47.42 77.96 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.807 0.843 . . . . 0.0 112.344 -178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 72.5 mtm -59.73 -48.72 80.57 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 174.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.57 -44.04 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 118.547 0.612 . . . . 0.0 112.323 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 27.2 m -84.67 -24.81 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 117.525 -1.226 . . . . 0.0 112.368 -167.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 38.9 mt -63.1 -30.69 71.79 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.561 1.528 . . . . 0.0 112.043 156.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 43.3 t -83.67 -45.73 13.1 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.841 0.856 . . . . 0.0 113.166 -164.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 9.5 t -50.94 -30.16 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 125.975 1.71 . . . . 0.0 114.474 -173.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 131.52 157.41 8.76 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 126.603 2.049 . . . . 0.0 109.771 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 90.3 p -81.76 34.44 0.39 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.89 -1.359 . . . . 0.0 113.663 -168.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -171.05 177.94 3.53 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 130.289 3.436 . . . . 0.0 109.092 176.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.546 ' C ' ' H ' ' A' ' 221' ' ' VAL . . . 63.36 112.48 0.01 OUTLIER Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 115.765 -3.112 . . . . 0.0 107.626 -111.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.43 -8.41 0.13 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.845 0.831 . . . . 0.0 111.89 160.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.546 ' H ' ' C ' ' A' ' 219' ' ' GLY . 0.5 OUTLIER -67.66 -44.45 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 127.35 2.26 . . . . 0.0 112.138 174.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -50.12 -52.13 37.55 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.345 1.458 . . . . 0.0 110.652 169.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.33 -59.89 3.28 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.494 1.118 . . . . 0.0 110.418 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 13.8 t -59.8 -42.12 92.73 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 21.6 m -69.13 -45.06 71.07 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.14 -0.975 . . . . 0.0 110.893 -173.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -53.36 -62.98 1.3 Allowed 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 126.073 1.749 . . . . 0.0 110.975 170.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.4 mt -56.4 -72.71 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 123.52 1.629 . . . . 0.0 111.141 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -73.7 -44.72 55.75 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 112.715 -2.039 . . . . 0.0 106.959 -152.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -65.87 -52.88 34.28 Favored Glycine 0 N--CA 1.466 0.667 0 C-N-CA 125.021 1.296 . . . . 0.0 114.41 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.72 -38.72 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.489 1.645 . . . . 0.0 111.275 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -82.82 -28.86 29.92 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -175.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -55.38 -43.4 75.12 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.051 1.341 . . . . 0.0 109.27 168.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 57.0 tp -65.07 -38.21 90.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 117.723 -1.132 . . . . 0.0 111.816 173.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -66.09 -37.94 87.02 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 121.899 2.136 . . . . 0.0 112.547 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 35.6 pt -69.52 -10.83 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 114.981 1.475 . . . . 0.0 114.981 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 11.1 mt -78.96 -20.6 48.79 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 120.918 -1.114 . . . . 0.0 110.944 167.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . 0.268 53.9 mtp180 -73.08 -19.28 61.2 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.668 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 89.2 mtp -48.63 -16.26 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 129.7 3.2 . . . . 0.0 117.059 156.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.6 pp -143.81 -19.98 0.59 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.679 1.127 . . . . 0.0 112.913 -174.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -75.63 -8.41 56.72 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.645 1.178 . . . . 0.0 111.853 157.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 CA--C 1.495 -1.152 0 CA-C-O 124.188 1.947 . . . . 0.0 107.858 171.669 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.3 m . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.1 tp -100.43 62.45 1.07 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 129.159 2.984 . . . . 0.0 111.904 -5.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -92.91 -125.55 0.09 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 125.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.31 -43.11 0.34 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 130.363 3.465 . . . . 0.0 114.269 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.4 t -114.68 -43.78 3.12 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 127.23 2.212 . . . . 0.0 110.144 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -73.27 56.23 0.47 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.008 1.723 . . . . 0.0 112.274 167.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.3 p -169.89 -36.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 130.491 3.516 . . . . 0.0 109.581 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -83.6 -49.89 8.75 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.632 1.173 . . . . 0.0 109.661 170.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -55.45 -24.26 37.74 Favored Glycine 0 CA--C 1.537 1.433 0 O-C-N 120.722 -1.236 . . . . 0.0 113.006 164.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . 0.275 0.3 OUTLIER -77.22 -42.57 36.88 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.29 1.036 . . . . 0.0 112.391 174.141 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 t -53.39 -52.05 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.68 1.192 . . . . 0.0 110.336 165.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -72.29 -9.64 58.75 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -84.96 -46.22 11.44 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 119.464 1.029 . . . . 0.0 110.527 162.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -66.65 -46.1 76.84 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.344 1.058 . . . . 0.0 111.434 -169.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pp -71.37 -14.29 62.13 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -109.11 -32.54 7.19 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.722 0.809 . . . . 0.0 113.178 -172.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -80.63 111.5 23.59 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.6 1.16 . . . . 0.0 111.621 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -69.1 119.99 6.91 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.928 1.752 . . . . 0.0 110.066 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.0 p -145.43 178.68 7.93 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.855 1.262 . . . . 0.0 108.84 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -53.84 -42.29 68.83 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.222 -0.766 . . . . 0.0 111.518 164.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -66.59 -47.02 74.04 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -59.08 -50.54 73.68 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.933 0.788 . . . . 0.0 109.795 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 13.0 t -56.75 -50.41 72.32 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.27 0.628 . . . . 0.0 111.752 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -60.55 -52.13 66.5 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 121.774 -0.579 . . . . 0.0 112.25 -174.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.8 t -87.31 -39.52 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.343 -0.848 . . . . 0.0 113.172 -170.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -69.59 -41.5 75.7 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.351 0.66 . . . . 0.0 111.016 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -81.39 -25.59 36.14 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -176.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -57.61 -51.63 68.74 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.498 1.044 . . . . 0.0 110.857 161.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.16 -43.13 73.97 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 173.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . 0.289 1.2 m -63.85 -42.26 95.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-N 121.55 1.977 . . . . 0.0 112.114 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -66.5 -42.72 86.95 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.093 1.315 . . . . 0.0 111.593 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.77 -48.38 81.91 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.905 0.482 . . . . 0.0 109.913 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.04 -43.68 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 117.933 -1.032 . . . . 0.0 111.018 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.95 -39.49 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 120.592 1.542 . . . . 0.0 113.158 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 63.3 tp -63.53 -45.49 90.37 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.955 1.302 . . . . 0.0 111.032 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.69 -53.25 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.504 0.722 . . . . 0.0 110.781 174.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 63.7 m -61.42 -35.58 77.95 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.479 1.512 . . . . 0.0 113.09 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.4 mt -81.08 -37.53 28.83 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.166 1.348 . . . . 0.0 113.552 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.57 -44.44 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 119.258 0.935 . . . . 0.0 109.511 168.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -64.34 -31.71 73.03 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-O 117.614 -1.184 . . . . 0.0 112.409 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.4 t -63.45 -43.59 96.94 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 121.103 1.774 . . . . 0.0 112.394 176.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 90.2 t -59.7 -39.53 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.764 1.226 . . . . 0.0 111.612 174.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 30.6 tp -71.72 -47.31 54.78 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.367 1.067 . . . . 0.0 112.358 174.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.9 t -59.53 -37.59 78.77 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.744 2.418 . . . . 0.0 112.929 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.8 t -76.77 1.7 16.51 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.0 -1.062 . . . . 0.0 113.027 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.0 mm -113.26 -35.65 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 127.225 2.21 . . . . 0.0 112.165 165.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.51 ' CD ' ' HG1' ' A' ' 155' ' ' THR . 7.0 mm-40 -55.55 -31.53 62.22 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.282 1.033 . . . . 0.0 113.174 168.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -61.52 -22.09 64.82 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -93.42 -28.53 16.08 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.207 1.003 . . . . 0.0 111.702 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.36 -35.09 79.76 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.087 0.955 . . . . 0.0 111.067 168.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.91 -6.55 3.92 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.145 1.378 . . . . 0.0 114.396 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.4 mt -84.46 -15.3 46.55 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.382 1.473 . . . . 0.0 113.414 170.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.25 -38.87 1.06 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -163.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.8 t -157.45 177.26 11.63 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.429 -0.794 . . . . 0.0 111.984 -148.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -72.01 156.24 52.3 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 121.519 0.51 . . . . 0.0 113.042 173.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.51 ' HG1' ' CD ' ' A' ' 146' ' ' GLU . 4.7 t -164.26 151.58 11.88 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.548 -0.972 . . . . 0.0 112.337 -166.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 33.9 mt -73.04 -0.12 13.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.388 1.475 . . . . 0.0 113.584 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -54.34 -26.32 29.1 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.605 1.562 . . . . 0.0 114.449 -173.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -52.59 -32.3 40.62 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.743 1.217 . . . . 0.0 114.071 171.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 17.8 tpt -71.06 -18.63 62.55 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.248 0.619 . . . . 0.0 112.562 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -67.42 -38.45 84.62 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.674 -1.266 . . . . 0.0 111.664 169.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.6 mp -66.87 -37.49 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 122.845 0.458 . . . . 0.0 110.384 174.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.65 -49.95 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.568 0.747 . . . . 0.0 111.698 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.8 mt -71.86 -28.99 63.91 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 20.5 t -61.36 -40.06 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 120.338 1.426 . . . . 0.0 111.951 165.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.9 t -68.71 -37.01 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 119.205 0.911 . . . . 0.0 111.047 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -57.89 -56.72 18.35 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.812 0.733 . . . . 0.0 111.272 168.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -67.03 -38.88 86.68 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.464 1.029 . . . . 0.0 113.392 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -61.72 -45.61 95.91 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.877 0.751 . . . . 0.0 111.61 172.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 89.2 m -63.14 -43.39 98.49 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 117.617 0.709 . . . . 0.0 111.382 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -62.18 -33.01 73.71 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.076 1.75 . . . . 0.0 112.864 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -66.38 -45.77 78.94 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.39 -0.819 . . . . 0.0 111.757 170.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.8 t -70.97 -32.22 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.964 0.906 . . . . 0.0 112.25 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.6 t -60.62 -37.79 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.344 1.458 . . . . 0.0 111.919 174.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 37.0 mtm180 -62.65 -43.18 99.47 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.531 0.605 . . . . 0.0 111.998 167.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 48.6 mt -62.89 -32.23 73.45 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.996 -1.065 . . . . 0.0 113.447 175.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 29.4 m0 -70.66 -35.78 73.04 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.277 -0.889 . . . . 0.0 113.241 170.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 94.2 p -78.59 13.53 1.59 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 121.153 1.797 . . . . 0.0 114.863 165.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -47.9 -44.52 29.73 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.58 1.082 . . . . 0.0 111.43 160.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -162.72 23.49 0.2 Allowed Glycine 0 CA--C 1.531 1.087 0 CA-C-O 118.372 -1.238 . . . . 0.0 115.336 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 62.5 m 69.13 -39.95 0.44 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.004 2.122 . . . . 0.0 116.574 168.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.31 -9.32 15.5 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.735 1.614 . . . . 0.0 113.837 164.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.483 ' HB2' ' H ' ' A' ' 186' ' ' GLY . 86.9 p -72.08 25.73 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.689 2.396 . . . . 0.0 115.465 -169.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.31 -0.52 17.33 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 -158.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -109.94 -43.37 4.01 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.916 1.287 . . . . 0.0 111.112 153.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.62 -73.42 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.867 1.267 . . . . 0.0 112.832 -170.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.483 ' H ' ' HB2' ' A' ' 182' ' ' SER . . . -78.68 -9.42 87.08 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.212 1.387 . . . . 0.0 113.946 175.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.56 -44.41 76.79 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.927 0.863 . . . . 0.0 109.913 167.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 34.6 t-105 -76.3 -50.31 14.69 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.671 -0.643 . . . . 0.0 112.289 161.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -56.58 -33.8 63.13 Favored Glycine 0 CA--C 1.535 1.307 0 N-CA-C 116.513 1.365 . . . . 0.0 116.513 -167.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -83.88 -21.52 31.92 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.328 1.564 . . . . 0.0 113.841 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 2.5 tt -73.02 -45.18 59.2 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -55.24 -39.09 69.33 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.235 166.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -70.27 -15.15 62.86 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -80.71 57.93 3.13 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 120.849 -1.157 . . . . 0.0 113.36 -171.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 43.3 mtt-85 -93.69 -14.37 26.44 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.221 1.808 . . . . 0.0 115.295 -161.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -77.57 164.7 56.39 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 124.695 1.198 . . . . 0.0 111.087 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -60.25 -46.3 19.07 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.704 1.602 . . . . 0.0 114.274 -160.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 50.9 mm -66.67 -34.78 72.31 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 CA-C-N 117.975 0.352 . . . . 0.0 111.281 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 15.9 m -69.07 -37.14 78.34 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.282 1.433 . . . . 0.0 112.507 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 30.1 mm -66.8 -42.99 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.561 0.744 . . . . 0.0 110.718 170.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.1 mt -62.56 -41.58 92.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 O-C-N 121.175 -0.953 . . . . 0.0 111.051 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -64.91 -43.05 94.11 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.426 1.89 . . . . 0.0 110.181 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 45.9 tp -59.41 -50.51 73.67 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 169.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 44.2 mt -60.03 -43.39 92.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 O-C-N 121.392 -0.817 . . . . 0.0 111.226 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.7 t -72.68 -29.23 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 117.667 -1.158 . . . . 0.0 112.471 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.48 -39.01 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 121.55 1.977 . . . . 0.0 111.174 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 28.6 m -74.44 -35.68 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 118.367 0.53 . . . . 0.0 111.189 176.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.39 -45.25 84.68 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 118.202 0.455 . . . . 0.0 111.407 168.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 36.0 t -61.71 -38.42 87.81 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.345 1.458 . . . . 0.0 112.118 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 36.3 mmt -71.67 -41.03 69.2 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 171.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 10.3 t -60.49 -38.84 79.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 118.642 0.655 . . . . 0.0 111.052 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 3.4 t -61.34 -46.32 96.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 127.624 2.369 . . . . 0.0 111.493 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 61.5 mt -58.94 -41.18 86.77 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.475 1.034 . . . . 0.0 111.568 166.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 11.4 t -74.48 -31.45 62.22 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -165.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 84.9 t -66.76 -20.25 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.203 1.001 . . . . 0.0 111.56 173.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 218' ' ' LYS . . . 106.41 156.47 21.35 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 124.295 0.95 . . . . 0.0 111.619 -166.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 41.2 p -62.01 17.86 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 128.519 2.727 . . . . 0.0 115.203 172.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 216' ' ' GLY . 15.3 mttp -166.34 174.27 9.24 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 129.714 3.206 . . . . 0.0 110.012 -176.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.564 ' C ' ' H ' ' A' ' 221' ' ' VAL . . . 69.5 104.92 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 105.269 -3.133 . . . . 0.0 105.269 -113.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -59.4 3.74 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.936 0 O-C-N 121.744 -0.857 . . . . 0.0 112.211 170.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.564 ' H ' ' C ' ' A' ' 219' ' ' GLY . 23.2 m -79.7 -35.12 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 127.296 2.238 . . . . 0.0 112.71 167.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.2 -47.37 68.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.288 1.404 . . . . 0.0 109.799 163.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -62.44 -52.49 63.35 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.08 0.552 . . . . 0.0 111.496 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.88 -35.36 74.65 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.456 1.025 . . . . 0.0 112.316 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 17.0 m -75.18 -36.72 61.45 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.489 1.041 . . . . 0.0 112.773 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.28 -46.91 76.16 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.482 -0.761 . . . . 0.0 110.308 169.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.0 mt -66.79 -82.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 125.301 1.44 . . . . 0.0 110.974 172.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.483 ' HA ' ' CD1' ' A' ' 232' ' ' PHE . 48.1 mtt180 -77.74 14.52 1.04 Allowed 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 130.854 3.661 . . . . 0.0 114.573 -170.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -124.1 -59.58 0.18 Allowed Glycine 0 N--CA 1.462 0.382 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 162.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . 0.343 0.3 OUTLIER -99.97 -2.66 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -163.577 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.42 -39.79 11.79 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 121.229 -0.919 . . . . 0.0 111.871 145.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.483 ' CD1' ' HA ' ' A' ' 228' ' ' ARG . 1.7 m-30 -57.05 -30.57 64.36 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -177.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 7.1 tp -68.88 -31.41 70.32 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.756 -0.59 . . . . 0.0 112.37 172.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -75.45 -35.72 60.86 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.052 1.341 . . . . 0.0 112.505 -168.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -26.71 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.248 1.019 . . . . 0.0 111.639 170.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 62.2 mt -70.92 -28.85 64.81 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.79 0.805 . . . . 0.0 110.44 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -75.6 -25.08 56.68 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.065 2.146 . . . . 0.0 111.914 -171.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 66.6 mtp -46.1 -29.03 1.36 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.859 2.064 . . . . 0.0 115.525 155.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 20.0 mt -112.49 -31.26 6.85 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.858 1.263 . . . . 0.0 109.908 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.43 16.59 0.1 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.931 1.692 . . . . 0.0 114.019 155.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 3.4 p -58.34 111.55 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 CA-C-O 124.273 1.987 . . . . 0.0 110.875 -170.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -82.67 13.95 3.46 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 111.397 -2.638 . . . . 0.0 114.024 -173.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.2 ttt-85 -77.05 17.09 0.47 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.989 2.116 . . . . 0.0 115.032 175.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 76.04 37.67 0.37 Allowed 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 146.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -106.23 -2.34 38.56 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 115.822 1.089 . . . . 0.0 115.822 172.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 71.24 54.16 9.43 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 120.049 1.924 . . . . 0.0 109.818 -161.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 45.5 p -69.36 138.03 53.35 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.931 2.093 . . . . 0.0 113.351 -152.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 85.2 m95 61.56 11.96 4.17 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 . . . . . 0 N--CA 1.477 0.897 0 C-N-CA 125.242 1.417 . . . . 0.0 113.545 -177.048 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.412 ' HA ' ' N ' ' A' ' 102' ' ' ALA . 6.3 m . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.323 27.8 tp 65.74 -95.46 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.619 1 C-N-CA 133.051 4.54 . . . . 0.0 117.962 -10.715 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.412 ' N ' ' HA ' ' A' ' 100' ' ' VAL . . . -58.06 -30.94 66.59 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -159.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -28.04 17.05 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.511 1.124 . . . . 0.0 113.664 174.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.48 -21.72 12.02 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.037 0.935 . . . . 0.0 112.074 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -57.19 -39.76 76.01 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.501 1.5 . . . . 0.0 112.451 168.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.4 p -61.98 -21.7 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 126.606 1.962 . . . . 0.0 113.682 171.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -95.51 -31.42 13.35 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.802 -0.562 . . . . 0.0 111.379 173.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -50.96 -26.47 11.38 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.289 1.424 . . . . 0.0 112.481 162.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -63.44 -48.85 76.06 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.776 0.831 . . . . 0.0 111.714 172.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.3 -57.36 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.956 0.902 . . . . 0.0 110.47 167.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -58.93 -46.21 88.5 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.497 1.119 . . . . 0.0 112.39 -167.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -65.86 -25.99 67.45 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 171.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -77.77 -34.93 52.15 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.131 1.332 . . . . 0.0 110.718 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 mt -59.67 -49.15 78.85 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 162.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -74.28 -32.01 62.75 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.162 -162.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -104.88 92.2 4.99 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 127.069 2.148 . . . . 0.0 110.711 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -58.22 128.3 28.14 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.129 1.886 . . . . 0.0 109.678 173.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.1 p -155.69 165.75 35.59 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.414 1.886 . . . . 0.0 107.805 -163.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -49.24 -42.29 32.29 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 118.957 -0.913 . . . . 0.0 111.466 175.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -75.4 -39.07 59.47 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.621 1.71 . . . . 0.0 115.568 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.445 ' HE3' ' CZ ' ' A' ' 125' ' ' TYR . 77.5 tttt -57.06 -50.54 72.44 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.679 1.582 . . . . 0.0 108.855 172.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 46.6 t -57.33 -43.8 83.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.288 1.835 . . . . 0.0 111.867 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -59.08 -57.01 14.94 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.13 -0.981 . . . . 0.0 111.208 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.1 m -81.87 -32.06 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -166.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.445 ' CZ ' ' HE3' ' A' ' 121' ' ' LYS . 6.4 m-85 -64.04 -34.46 78.07 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.216 0.916 . . . . 0.0 111.381 176.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.1 m170 -77.48 -43.11 33.38 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.846 0.748 . . . . 0.0 110.307 -171.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -67.06 -38.51 85.92 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.255 -0.879 . . . . 0.0 112.446 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.09 -40.24 76.58 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 120.172 1.351 . . . . 0.0 113.14 168.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.84 -41.98 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 121.308 1.867 . . . . 0.0 111.412 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -63.96 -41.93 97.44 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.59 0.632 . . . . 0.0 112.081 175.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.1 tp -73.72 -44.42 56.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.841 0.456 . . . . 0.0 111.892 -173.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.3 mp -67.39 -40.81 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 O-C-N 121.031 -1.043 . . . . 0.0 111.872 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.76 -44.78 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 120.465 1.484 . . . . 0.0 112.062 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 23.7 tp -54.67 -56.36 19.91 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.723 1.609 . . . . 0.0 111.469 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 55.3 t -65.18 -44.39 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 122.715 0.406 . . . . 0.0 111.416 -174.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 73.0 m -71.53 -35.04 70.55 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 91.3 mt -76.73 -37.51 55.87 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.431 1.468 . . . . 0.0 112.521 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 87.7 mt -59.91 -42.25 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 118.852 0.751 . . . . 0.0 109.312 169.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -64.49 -40.13 95.09 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 115.805 -2.045 . . . . 0.0 111.99 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.5 m -49.44 -44.47 45.6 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 121.346 1.884 . . . . 0.0 113.123 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 70.7 t -60.16 -34.91 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.157 0.983 . . . . 0.0 111.88 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.8 tp -85.44 -44.81 12.42 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 169.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 24.2 p -67.69 -30.04 69.46 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.931 1.293 . . . . 0.0 113.252 -167.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.2 t -75.05 -11.64 60.14 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.562 -0.711 . . . . 0.0 112.769 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.5 mm -97.36 -46.89 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 126.069 1.748 . . . . 0.0 111.771 170.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -55.21 -34.1 63.64 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.663 1.185 . . . . 0.0 112.596 173.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -68.13 -21.63 64.92 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.283 -1.51 . . . . 0.0 114.991 173.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -75.38 -26.93 58.88 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 121.05 1.75 . . . . 0.0 109.916 171.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -72.99 -30.09 63.54 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.286 -0.884 . . . . 0.0 112.174 167.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -56.48 -27.41 57.0 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.764 -1.21 . . . . 0.0 114.002 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 73.1 mt -57.35 -28.41 63.12 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.651 1.18 . . . . 0.0 113.688 173.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.11 -42.28 2.02 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.648 1.579 . . . . 0.0 114.451 -165.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.8 t -155.6 -172.7 4.24 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.758 0.79 . . . . 0.0 111.751 -147.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -70.98 140.93 32.08 Favored Glycine 0 CA--C 1.533 1.159 0 O-C-N 121.167 -0.958 . . . . 0.0 114.114 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.8 t -166.21 139.18 4.02 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.367 1.067 . . . . 0.0 112.104 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.5 3.19 2.5 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 171.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -56.79 -10.49 1.06 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.005 1.722 . . . . 0.0 113.686 166.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 33.7 p-90 -62.29 -24.58 67.38 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.861 -1.15 . . . . 0.0 112.787 167.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 69.0 mtm -73.9 -16.89 61.1 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.968 -1.082 . . . . 0.0 113.789 171.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -67.59 -41.35 84.24 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.606 1.548 . . . . 0.0 109.942 165.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 7.2 mt -56.6 -38.93 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 118.419 0.554 . . . . 0.0 111.85 170.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.46 -52.27 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 121.199 -0.938 . . . . 0.0 112.209 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 13.1 mt -67.27 -26.55 66.61 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.289 0.95 . . . . 0.0 112.195 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 6.2 t -64.49 -35.39 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 119.999 -1.688 . . . . 0.0 111.397 169.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 73.1 t -76.48 -30.4 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 118.72 -0.657 . . . . 0.0 110.504 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -62.35 -48.31 80.34 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 119.638 1.108 . . . . 0.0 112.261 167.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -69.04 -39.23 79.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.364 1.438 . . . . 0.0 112.581 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -54.05 -45.85 71.22 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 119.286 0.948 . . . . 0.0 112.954 166.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.9 m -62.05 -40.58 96.26 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.462 0.705 . . . . 0.0 111.707 172.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -60.1 -39.66 86.91 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.485 1.493 . . . . 0.0 112.912 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -71.12 -43.16 68.21 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.94 0.791 . . . . 0.0 111.961 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 90.1 t -72.38 -34.57 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 118.828 -0.605 . . . . 0.0 111.708 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 15.4 t -58.84 -37.23 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.114 1.366 . . . . 0.0 111.542 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -59.72 -46.78 88.07 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.471 1.032 . . . . 0.0 112.049 170.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.03 -23.42 66.55 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 120.456 -1.403 . . . . 0.0 114.288 172.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 54.5 m0 -76.09 -13.57 60.2 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 168.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 6.6 p -61.8 -36.8 82.19 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 121.746 2.066 . . . . 0.0 111.079 164.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.44 -26.62 66.88 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 165.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -68.15 0.78 10.31 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.449 1.976 . . . . 0.0 114.954 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 9.0 t -63.14 -31.87 73.12 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.711 1.756 . . . . 0.0 112.12 165.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.22 -47.58 0.06 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.315 1.446 . . . . 0.0 113.057 164.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 24.4 m -71.74 43.18 0.09 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 128.52 2.728 . . . . 0.0 112.513 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -49.01 -36.52 17.93 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 130.592 3.557 . . . . 0.0 113.53 -170.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -120.35 -36.8 3.15 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 124.374 1.046 . . . . 0.0 112.195 175.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 40.7 t -56.44 -59.42 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.437 1.095 . . . . 0.0 110.852 176.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -74.65 -35.83 50.17 Favored Glycine 0 C--O 1.222 -0.595 0 C-N-CA 124.84 1.21 . . . . 0.0 112.258 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.59 -47.8 75.87 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.956 1.378 . . . . 0.0 112.472 172.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -75.27 -41.02 58.15 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -56.42 -54.53 35.34 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -69.8 -30.62 68.2 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.828 1.314 . . . . 0.0 113.656 -174.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 38.6 tp -62.36 -31.31 71.95 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.631 0.65 . . . . 0.0 112.208 169.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 34.2 mtp-105 -92.3 -13.66 30.0 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 172.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -82.3 -16.47 49.25 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.598 1.159 . . . . 0.0 112.68 163.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -78.5 62.01 3.01 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.305 1.842 . . . . 0.0 112.082 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -93.56 -22.51 18.78 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 128.444 2.698 . . . . 0.0 115.652 -170.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -58.57 152.46 45.59 Favored Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 125.432 1.493 . . . . 0.0 112.03 -175.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -50.37 -41.96 49.62 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.904 2.403 . . . . 0.0 114.049 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 10.9 tp -61.86 -41.12 89.52 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 118.524 0.602 . . . . 0.0 112.163 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 18.8 m -68.45 -28.85 67.41 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.812 1.245 . . . . 0.0 111.574 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 36.0 mm -75.4 -42.13 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.883 0.873 . . . . 0.0 111.116 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 94.1 mt -58.84 -50.32 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 118.862 0.755 . . . . 0.0 110.071 171.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -59.18 -39.04 81.29 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.912 2.485 . . . . 0.0 112.243 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 54.9 tp -61.99 -51.7 66.98 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.767 1.227 . . . . 0.0 112.987 169.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 71.1 mt -65.89 -41.41 89.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.374 -0.829 . . . . 0.0 109.92 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 69.6 t -74.13 -35.32 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 125.244 1.418 . . . . 0.0 113.45 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.6 p -65.24 -35.67 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 120.908 1.685 . . . . 0.0 110.859 172.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 89.3 t -72.35 -42.58 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 117.934 -1.032 . . . . 0.0 109.617 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -55.54 -41.12 72.76 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.173 0.897 . . . . 0.0 112.16 170.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.8 t -62.39 -43.09 99.65 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.432 1.093 . . . . 0.0 112.835 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 30.2 mmt -70.35 -37.89 74.71 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.612 0.765 . . . . 0.0 111.424 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.39 -48.12 89.64 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 O-C-N 121.799 -0.563 . . . . 0.0 109.994 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 30.0 m -75.52 -34.65 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 O-C-N 121.663 -0.648 . . . . 0.0 112.374 -171.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.66 -21.01 66.51 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.253 -0.905 . . . . 0.0 112.088 170.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 57.6 m -85.56 -38.62 18.29 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.697 1.599 . . . . 0.0 113.6 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 24.3 t -56.86 -37.46 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.338 1.055 . . . . 0.0 108.863 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 218' ' ' LYS . . . 134.58 146.63 5.43 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 109.014 -1.635 . . . . 0.0 109.014 175.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 98.4 p -60.2 15.54 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 216' ' ' GLY . 0.9 OUTLIER -152.14 116.17 4.92 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 127.877 2.471 . . . . 0.0 111.56 -176.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.441 ' CA ' ' H ' ' A' ' 221' ' ' VAL . . . -97.76 -88.73 1.89 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 104.908 -3.277 . . . . 0.0 104.908 92.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 78.49 -51.58 0.48 Allowed 'General case' 0 N--CA 1.466 0.34 1 C-N-CA 132.674 4.39 . . . . 0.0 120.409 -21.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.441 ' H ' ' CA ' ' A' ' 219' ' ' GLY . 54.0 t -87.02 -51.3 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 120.119 -1.613 . . . . 0.0 110.203 -164.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -56.7 -36.14 69.32 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.815 -0.553 . . . . 0.0 111.941 167.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.45 -55.14 38.86 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 118.554 -0.736 . . . . 0.0 110.81 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.94 -36.22 83.67 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 120.742 1.61 . . . . 0.0 113.061 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 13.9 t -71.48 -43.61 66.27 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.386 1.448 . . . . 0.0 110.756 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.79 -53.61 55.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.847 0.459 . . . . 0.0 110.371 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 80.9 mt -63.48 -81.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 122.726 1.251 . . . . 0.0 109.517 173.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 -75.74 -14.62 60.33 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 124.793 1.237 . . . . 0.0 113.012 -157.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -95.26 -55.79 1.34 Allowed Glycine 0 CA--C 1.534 1.256 0 CA-C-N 118.701 0.682 . . . . 0.0 114.151 160.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.95 -39.95 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 120.745 -1.444 . . . . 0.0 112.156 -166.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 2.1 tpp85 -60.71 -35.01 75.25 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 119.573 1.079 . . . . 0.0 110.417 168.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.15 -36.96 84.51 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.215 1.406 . . . . 0.0 112.42 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 29.8 tp -64.46 -23.68 67.36 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 117.915 -1.04 . . . . 0.0 111.607 168.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -80.54 -44.87 18.36 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.913 1.688 . . . . 0.0 112.923 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -20.02 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.491 -1.38 . . . . 0.0 112.461 169.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 52.1 tp -71.02 -30.53 66.76 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.194 0.521 . . . . 0.0 111.888 174.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.488 ' HA ' ' CD2' ' A' ' 240' ' ' HIS . 19.7 mtp180 -70.32 -25.43 63.3 Favored 'General case' 0 C--O 1.212 -0.9 0 C-N-CA 124.866 1.267 . . . . 0.0 112.617 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 68.0 mtp -54.03 -23.97 15.4 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 160.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 6.1 mt -115.47 -35.39 4.61 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.873 -166.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . 0.488 ' CD2' ' HA ' ' A' ' 237' ' ' ARG . 5.6 p80 -75.72 -36.61 59.92 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.631 0.65 . . . . 0.0 111.354 164.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.366 5.6 p 43.46 99.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 129.576 3.15 . . . . 0.0 115.148 164.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -77.77 -4.58 47.1 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 112.18 -2.282 . . . . 0.0 113.642 173.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -9.7 57.18 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.807 1.643 . . . . 0.0 115.174 -167.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 67.05 23.26 9.75 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.574 1.55 . . . . 0.0 112.433 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -86.82 29.38 5.03 Favored Glycine 0 CA--C 1.527 0.801 0 O-C-N 120.828 -1.17 . . . . 0.0 115.637 -173.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 71.69 36.74 61.88 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-N 118.389 1.094 . . . . 0.0 112.073 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 37.1 p -65.8 107.98 1.98 Allowed 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 126.116 1.766 . . . . 0.0 111.013 -153.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 32.2 m95 62.05 12.78 5.2 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.066 1.746 . . . . 0.0 115.444 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 33.1 mtm-85 . . . . . 0 C--O 1.247 0.973 0 C-N-CA 126.243 1.817 . . . . 0.0 110.845 -171.311 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.606 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 48.2 tp -53.03 -37.12 61.26 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.921 1.237 . . . . 0.0 112.52 -177.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.81 -22.17 57.95 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -58.11 -41.58 83.86 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 120.145 -1.597 . . . . 0.0 111.735 171.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.5 p -66.95 -20.15 65.85 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.06 0.944 . . . . 0.0 112.025 172.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -79.09 -50.52 10.91 Favored 'General case' 0 CA--C 1.507 -0.704 0 O-C-N 121.416 -0.803 . . . . 0.0 109.042 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.5 m -76.21 -38.72 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.374 0.67 . . . . 0.0 110.749 -173.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -68.17 -32.97 73.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.533 172.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.1 -30.16 70.0 Favored Glycine 0 C--N 1.34 0.766 0 O-C-N 120.831 -1.168 . . . . 0.0 112.343 170.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -68.22 -46.6 70.14 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 126.377 1.871 . . . . 0.0 111.301 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.0 t -54.71 -54.09 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.297 1.039 . . . . 0.0 109.639 167.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -55.53 -48.16 75.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.662 -0.685 . . . . 0.0 112.377 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -64.75 -25.35 67.89 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.544 1.065 . . . . 0.0 113.518 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -77.41 -40.99 41.68 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.29 1.036 . . . . 0.0 110.344 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.2 mt -60.44 -40.58 91.66 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 120.787 -1.196 . . . . 0.0 110.829 167.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -78.78 -41.09 31.39 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.499 -162.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -116.95 145.69 36.17 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 124.198 0.999 . . . . 0.0 111.299 -173.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.4 155.82 36.65 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.587 2.192 . . . . 0.0 111.899 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 46.9 p -147.95 169.56 19.6 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.143 1.777 . . . . 0.0 107.568 163.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.07 -31.28 48.23 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.013 -0.882 . . . . 0.0 113.197 170.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -79.83 -45.43 18.74 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 170.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.82 -52.7 64.59 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.141 0.882 . . . . 0.0 110.045 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 43.8 t -62.72 -38.64 91.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.106 0.562 . . . . 0.0 111.915 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -57.73 -57.97 10.4 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.608 0.64 . . . . 0.0 111.495 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.4 m -74.36 -44.99 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -172.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -87.12 -36.77 17.91 Favored 'General case' 0 C--O 1.226 -0.133 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -164.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -65.35 -30.57 71.41 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.066 1.303 . . . . 0.0 111.033 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.39 -39.28 78.07 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 167.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.23 -45.47 79.94 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 167.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.8 m -64.58 -39.17 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-N 121.423 1.92 . . . . 0.0 111.789 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -54.44 -45.79 73.13 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.868 0.867 . . . . 0.0 112.292 170.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.7 mt -67.19 -39.58 86.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 118.46 -0.781 . . . . 0.0 113.025 174.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.51 -43.69 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 119.812 1.187 . . . . 0.0 110.877 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.36 -40.92 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-N 121.197 1.817 . . . . 0.0 112.646 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.9 tp -52.51 -52.11 56.22 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.066 1.746 . . . . 0.0 111.765 168.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 37.9 t -63.27 -39.57 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.985 0.914 . . . . 0.0 111.081 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 65.7 m -60.5 -44.72 95.68 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.937 0.895 . . . . 0.0 113.379 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.65 -31.94 47.02 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 120.442 1.474 . . . . 0.0 111.93 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 59.0 mt -56.62 -47.6 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.509 0.723 . . . . 0.0 110.305 167.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -57.81 -49.35 76.94 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 117.322 -1.323 . . . . 0.0 110.999 170.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 73.6 m -49.6 -40.9 40.56 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 120.067 1.303 . . . . 0.0 114.061 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.5 -48.5 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.0 0.52 . . . . 0.0 110.797 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.2 tp -72.61 -44.23 62.24 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.862 0.865 . . . . 0.0 112.89 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 55.9 p -78.89 -30.15 44.79 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -155.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.2 t -75.27 -1.81 25.22 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.733 1.152 . . . . 0.0 111.86 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.4 mm -102.51 -34.48 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 126.18 1.792 . . . . 0.0 113.231 163.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -56.77 -27.53 59.78 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.891 -1.131 . . . . 0.0 111.892 164.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -58.88 -42.86 90.47 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 129.002 2.921 . . . . 0.0 112.066 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 17.1 m-30 -74.76 -31.1 61.68 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.876 0.762 . . . . 0.0 111.073 176.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.68 -41.22 96.22 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.58 -0.7 . . . . 0.0 111.407 169.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.25 -13.47 28.39 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.46 1.504 . . . . 0.0 114.888 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.6 mt -64.53 -23.64 67.34 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.572 1.149 . . . . 0.0 113.277 168.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.49 -49.68 0.13 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -155.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.4 p -122.15 177.84 5.17 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.518 1.927 . . . . 0.0 109.011 -163.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.35 154.39 47.88 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.448 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.8 t -156.13 158.38 37.59 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.864 1.266 . . . . 0.0 111.123 -163.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.9 mt -94.68 3.43 55.07 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.967 1.307 . . . . 0.0 113.81 166.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -65.05 -4.58 4.89 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 120.036 1.289 . . . . 0.0 114.188 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -72.73 -30.56 64.28 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.781 -1.199 . . . . 0.0 111.822 166.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 47.6 tpp -73.02 -32.17 64.93 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.268 1.027 . . . . 0.0 111.355 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.21 -51.27 69.68 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.553 -0.717 . . . . 0.0 110.341 165.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.1 mt -53.99 -40.21 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 118.787 -0.625 . . . . 0.0 112.028 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.9 t -56.34 -48.16 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 120.293 1.406 . . . . 0.0 112.127 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 11.4 mt -71.11 -33.78 70.48 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.074 1.306 . . . . 0.0 113.08 176.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 26.5 t -61.73 -39.43 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 120.596 1.543 . . . . 0.0 111.743 172.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 68.0 t -75.01 -33.1 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.834 1.254 . . . . 0.0 110.651 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -62.56 -42.68 99.7 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 117.981 -1.009 . . . . 0.0 112.296 165.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -65.01 -46.25 82.14 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.536 1.516 . . . . 0.0 111.918 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.13 -37.96 74.44 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-N 119.282 0.946 . . . . 0.0 112.779 171.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.6 m -67.2 -39.53 86.33 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -60.41 -40.64 91.7 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.934 1.294 . . . . 0.0 111.629 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -54.24 -51.94 62.93 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 172.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 26.9 m -73.64 -31.73 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 23.1 t -63.48 -33.55 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 119.337 0.971 . . . . 0.0 112.144 173.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -60.94 -41.4 96.17 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 120.951 -1.093 . . . . 0.0 111.81 167.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 41.4 mt -69.97 -25.24 63.53 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -82.03 -40.44 22.07 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.999 0.92 . . . . 0.0 112.907 173.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 79.1 p -70.32 6.13 1.47 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 116.817 2.154 . . . . 0.0 116.817 160.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.78 -37.69 52.52 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.216 0.916 . . . . 0.0 111.514 160.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 167.22 30.99 0.02 OUTLIER Glycine 0 C--N 1.341 0.847 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 175.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 18.1 t 63.1 -67.42 0.09 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.871 2.068 . . . . 0.0 115.121 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -35.8 79.47 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.721 2.008 . . . . 0.0 111.022 170.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.413 ' HB2' ' H ' ' A' ' 186' ' ' GLY . 82.4 p -72.56 25.12 0.05 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 -175.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -53.53 -23.48 10.64 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 128.107 2.563 . . . . 0.0 116.293 -171.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -118.63 -37.23 3.32 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.2 1.4 . . . . 0.0 111.826 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 85.8 t -65.81 -68.94 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.436 1.494 . . . . 0.0 111.378 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 182' ' ' SER . . . -70.69 -23.97 77.33 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.699 1.619 . . . . 0.0 112.881 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.7 tt -51.07 -52.3 44.75 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.073 1.437 . . . . 0.0 110.087 164.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 35.1 t-105 -74.03 -44.72 53.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.23 0.538 . . . . 0.0 112.432 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -59.52 -45.17 96.01 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.885 0.755 . . . . 0.0 113.07 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -68.95 -33.1 73.16 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 118.44 1.12 . . . . 0.0 112.129 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 25.5 tp -74.96 -29.52 60.95 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.973 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 36.4 mtp-105 -80.17 -31.68 38.85 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.27 1.428 . . . . 0.0 113.097 171.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -64.02 -38.21 90.23 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.882 1.273 . . . . 0.0 111.173 171.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -82.97 58.81 4.56 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.123 1.369 . . . . 0.0 112.237 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.74 -28.95 66.36 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 120.773 -1.205 . . . . 0.0 112.56 169.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -49.6 147.19 6.26 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 127.877 2.471 . . . . 0.0 116.268 -173.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -57.33 -39.61 88.3 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.821 2.347 . . . . 0.0 116.488 -163.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 93.9 mt -67.72 -30.33 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 O-C-N 120.894 -1.129 . . . . 0.0 111.329 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.7 t -68.17 -31.56 71.19 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.06 1.3 . . . . 0.0 111.652 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 34.6 mm -70.35 -43.22 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.383 1.073 . . . . 0.0 111.49 171.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.83 -37.05 77.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.031 0.532 . . . . 0.0 111.445 173.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -74.87 -38.99 61.79 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.319 1.848 . . . . 0.0 110.729 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 20.3 tp -57.71 -48.4 79.69 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.272 1.029 . . . . 0.0 111.072 166.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 76.4 mt -69.43 -37.21 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 121.839 -0.538 . . . . 0.0 111.284 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.6 t -75.3 -33.41 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-N 119.918 1.235 . . . . 0.0 112.58 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 4.4 p -67.43 -34.2 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 120.615 1.552 . . . . 0.0 110.685 170.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 78.1 t -72.76 -39.52 59.93 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-O 117.936 -1.031 . . . . 0.0 110.115 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.61 -45.47 85.3 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 119.106 0.867 . . . . 0.0 110.41 170.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 30.2 t -62.95 -48.82 77.24 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.549 1.14 . . . . 0.0 111.851 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 75.2 mtm -55.58 -51.43 67.13 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.837 1.255 . . . . 0.0 111.004 168.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 9.5 t -59.09 -47.08 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 118.972 0.806 . . . . 0.0 111.295 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 33.5 m -75.71 -41.56 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 119.403 1.001 . . . . 0.0 111.845 -172.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.6 pp -63.31 -23.81 67.58 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.719 1.145 . . . . 0.0 111.601 171.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 19.2 m -77.8 -44.89 26.08 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.83 1.252 . . . . 0.0 112.929 173.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.73 -38.04 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.157 1.783 . . . . 0.0 109.476 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 218' ' ' LYS . . . 142.31 162.33 9.17 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 125.909 1.719 . . . . 0.0 110.029 172.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 60.5 p -70.62 18.23 0.06 Allowed 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.452 ' H ' ' C ' ' A' ' 216' ' ' GLY . 5.8 mtmt -173.15 175.67 3.13 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 131.514 3.926 . . . . 0.0 108.937 -172.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.543 ' C ' ' H ' ' A' ' 221' ' ' VAL . . . 66.81 105.96 0.02 OUTLIER Glycine 0 N--CA 1.436 -1.3 0 N-CA-C 106.176 -2.77 . . . . 0.0 106.176 -115.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -56.4 -5.66 0.22 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.492 1.517 . . . . 0.0 113.276 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.543 ' H ' ' C ' ' A' ' 219' ' ' GLY . 18.1 m -68.79 -38.12 78.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 125.421 1.489 . . . . 0.0 110.507 172.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.53 -49.77 73.79 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.348 166.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.92 -54.76 43.52 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.3 t -69.05 -30.74 69.15 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 34.1 t -74.29 -41.77 60.65 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.627 -1.295 . . . . 0.0 111.076 175.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.85 -62.13 1.91 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.114 0.966 . . . . 0.0 109.083 173.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 38.6 mt -57.26 -83.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.503 1.121 . . . . 0.0 109.79 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -65.32 -50.11 66.89 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-O 116.85 -1.548 . . . . 0.0 109.606 -163.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -54.56 -56.5 21.85 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 120.247 1.385 . . . . 0.0 113.281 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.8 -34.89 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 118.024 0.912 . . . . 0.0 111.639 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -77.8 -26.96 49.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.573 -1.329 . . . . 0.0 113.78 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -60.37 -42.29 95.51 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.782 1.633 . . . . 0.0 107.666 174.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 15.5 tp -62.9 -33.85 76.18 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.413 174.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -75.47 -43.49 49.08 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 120.87 1.668 . . . . 0.0 112.815 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 45.0 pt -66.35 -6.63 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 169.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 48.2 tp -95.9 -35.3 11.51 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.485 1.514 . . . . 0.0 111.137 171.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -63.52 -35.61 81.04 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.966 1.307 . . . . 0.0 110.121 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 61.3 tpp -34.07 -33.97 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 129.342 3.057 . . . . 0.0 116.702 156.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 49.9 mt -111.64 -13.32 13.79 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.859 1.663 . . . . 0.0 111.983 -171.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.3 3.5 54.43 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.83 0.852 . . . . 0.0 113.201 160.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 7.6 p -37.5 102.93 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 C-N-CA 127.161 2.184 . . . . 0.0 111.667 -164.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -76.53 11.78 1.5 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 112.731 -2.032 . . . . 0.0 114.074 -166.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -64.03 -18.72 64.61 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.032 1.733 . . . . 0.0 113.259 151.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . 0.272 22.4 pt20 60.66 30.49 19.75 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 145.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -83.35 -7.27 86.81 Favored Glycine 0 N--CA 1.468 0.774 0 O-C-N 121.237 -0.915 . . . . 0.0 114.754 173.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 117.88 78.16 0.62 Allowed Glycine 0 C--O 1.229 -0.215 0 C-N-CA 125.897 1.713 . . . . 0.0 110.192 -166.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 59.2 p -52.72 101.57 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.526 2.33 . . . . 0.0 112.655 -170.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 97.0 m95 54.99 35.05 23.75 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.587 1.955 . . . . 0.0 114.873 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 5.3 ppt_? . . . . . 0 C--O 1.253 1.275 0 C-N-CA 125.936 1.694 . . . . 0.0 112.866 173.167 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.506 -0.727 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.9 tp -103.8 157.03 17.36 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-O 122.724 1.25 . . . . 0.0 107.892 152.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.419 ' HA ' ' CD2' ' A' ' 105' ' ' HIS . . . 67.49 -18.5 0.14 Allowed 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 127.268 2.227 . . . . 0.0 116.133 173.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.03 -34.51 70.14 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.044 1.338 . . . . 0.0 111.841 176.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.7 t -80.87 -26.19 37.1 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.335 -0.853 . . . . 0.0 113.268 166.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.419 ' CD2' ' HA ' ' A' ' 102' ' ' ALA . 11.8 m-70 -75.13 -27.17 59.69 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 119.568 -1.957 . . . . 0.0 111.885 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 23.3 m -85.31 2.55 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 126.12 1.768 . . . . 0.0 113.435 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -111.66 -45.61 3.34 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 127.575 2.35 . . . . 0.0 108.052 170.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.09 -20.29 8.73 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.509 1.528 . . . . 0.0 115.393 161.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . 0.261 25.0 ptt180 -73.22 -37.32 66.45 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.327 1.564 . . . . 0.0 110.455 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.7 t -58.88 -47.88 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.758 1.223 . . . . 0.0 110.541 168.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -66.91 -54.64 20.15 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.413 1.085 . . . . 0.0 111.447 -174.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -62.3 -25.29 67.79 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.81 -1.181 . . . . 0.0 112.719 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -75.76 -41.76 52.24 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.317 1.417 . . . . 0.0 110.375 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 pp -75.4 -22.51 57.39 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -125.16 -9.72 7.06 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -166.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -109.55 118.63 50.07 Favored Pre-proline 0 N--CA 1.473 0.722 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 161.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -61.47 137.77 71.8 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 121.697 1.598 . . . . 0.0 113.307 -171.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -151.85 143.3 23.46 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.671 1.189 . . . . 0.0 107.973 173.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.21 -28.76 50.75 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.904 -0.387 . . . . 0.0 112.59 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -67.37 -32.92 74.17 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 172.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -61.25 -48.76 79.98 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.559 1.072 . . . . 0.0 108.203 168.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 35.6 m -64.49 -40.41 95.61 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.415 0.686 . . . . 0.0 112.147 -174.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -56.64 -67.52 0.3 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.107 0.963 . . . . 0.0 111.214 173.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.7 p -79.67 -38.26 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 121.009 -1.057 . . . . 0.0 113.627 -168.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -73.12 -42.96 62.34 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.38 -0.825 . . . . 0.0 112.067 -170.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -71.52 -26.73 62.78 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -68.19 -49.4 61.1 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.196 -0.94 . . . . 0.0 111.989 166.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -51.3 -40.15 58.37 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 117.514 -1.231 . . . . 0.0 114.232 173.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . 0.289 2.9 m -62.97 -43.38 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 121.174 1.806 . . . . 0.0 112.634 174.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -67.85 -39.25 83.81 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.737 0.699 . . . . 0.0 112.548 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 73.4 mt -56.39 -54.87 40.52 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 118.624 -0.703 . . . . 0.0 110.366 169.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -53.87 -49.89 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.456 0.703 . . . . 0.0 112.011 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.4 p -66.13 -42.97 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 119.837 1.198 . . . . 0.0 113.09 -171.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 35.6 tp -70.38 -45.4 66.12 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.051 0.94 . . . . 0.0 111.567 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 32.2 m -65.08 -38.51 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 119.86 1.209 . . . . 0.0 111.901 176.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 98.4 m -66.83 -34.15 77.18 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.66 -0.686 . . . . 0.0 112.799 174.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.7 mt -74.42 -37.59 63.3 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.651 1.569 . . . . 0.0 112.516 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 52.2 mt -61.87 -46.6 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.312 0.96 . . . . 0.0 110.72 169.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -62.34 -27.17 68.87 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 117.866 -1.064 . . . . 0.0 112.343 171.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.7 m -65.68 -31.1 71.92 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 121.019 1.736 . . . . 0.0 113.166 173.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.33 -35.84 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.113 0.565 . . . . 0.0 110.699 172.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.0 tp -74.28 -50.69 17.85 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.296 0.953 . . . . 0.0 112.391 169.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.7 p -67.19 -27.13 67.01 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 120.377 -1.452 . . . . 0.0 113.273 -166.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.0 t -68.6 -22.85 64.42 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 17.9 pt -95.32 -31.41 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.946 1.248 . . . . 0.0 113.187 169.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -59.7 -26.57 65.7 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 121.021 -1.049 . . . . 0.0 111.281 164.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -60.57 -30.21 69.65 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.929 2.092 . . . . 0.0 113.093 167.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -87.9 -26.34 22.78 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.817 -1.177 . . . . 0.0 110.856 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.08 -40.2 94.32 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.149 0.579 . . . . 0.0 111.637 166.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.31 -15.22 23.36 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.632 1.573 . . . . 0.0 114.869 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.5 mt -59.15 -31.63 69.15 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.807 -1.183 . . . . 0.0 112.69 167.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.86 -43.83 0.21 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -153.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 82.8 p -134.09 152.83 52.01 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.163 1.385 . . . . 0.0 109.976 -155.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -75.4 128.93 10.12 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 121.289 -0.882 . . . . 0.0 112.582 -170.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.3 t -144.46 148.61 34.78 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -155.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.3 mt -56.4 4.28 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.568 2.347 . . . . 0.0 114.88 166.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -62.12 -13.94 31.93 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 120.975 1.716 . . . . 0.0 112.803 163.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 18.0 p-90 -59.37 -29.8 67.95 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.092 -1.63 . . . . 0.0 112.233 163.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 10.7 tpt -76.83 -25.55 53.34 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.335 0.97 . . . . 0.0 112.804 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -61.0 -48.82 80.06 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.788 -1.195 . . . . 0.0 109.404 162.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.82 -37.62 72.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 122.993 0.517 . . . . 0.0 111.583 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 64.0 t -60.93 -51.92 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 120.948 -1.095 . . . . 0.0 112.293 173.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 11.5 mt -69.98 -30.44 67.79 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.119 -0.988 . . . . 0.0 112.355 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 22.7 t -58.17 -38.17 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.698 1.136 . . . . 0.0 109.958 169.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 64.7 t -75.22 -29.7 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 118.104 -0.951 . . . . 0.0 111.11 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -66.6 -51.03 60.83 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 121.011 1.732 . . . . 0.0 112.933 170.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -60.65 -46.46 90.24 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.198 0.908 . . . . 0.0 111.37 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.96 -40.89 93.94 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.974 0.797 . . . . 0.0 113.15 173.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 55.5 m -66.96 -40.01 87.38 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.738 -0.86 . . . . 0.0 111.453 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -62.4 -41.38 98.63 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.303 0.956 . . . . 0.0 111.738 173.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -55.65 -45.67 77.63 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.646 0.657 . . . . 0.0 111.5 170.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 69.1 t -67.31 -41.89 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.188 -0.945 . . . . 0.0 113.13 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 25.8 t -62.28 -38.16 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.452 1.501 . . . . 0.0 112.337 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -55.91 -45.14 78.78 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.487 0.715 . . . . 0.0 111.811 168.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 21.8 mt -67.0 -40.3 87.32 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 178.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -65.81 -30.8 71.49 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.5 t -69.79 -21.16 63.43 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 173.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.1 -14.58 25.24 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 170.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -158.07 51.25 0.41 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 124.972 1.272 . . . . 0.0 110.505 -161.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 35.1 t -45.2 -31.07 1.34 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.225 1.81 . . . . 0.0 112.643 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.19 -59.45 1.73 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.172 1.789 . . . . 0.0 111.656 159.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 55.1 p -70.98 -16.1 62.62 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.906 1.282 . . . . 0.0 113.776 -156.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 59.8 pttt 47.01 -59.55 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.361 1 C-N-CA 133.464 4.706 . . . . 0.0 115.868 172.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -93.84 -29.21 15.44 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 124.68 1.192 . . . . 0.0 112.011 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.19 -54.32 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 166.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.1 -70.46 0.85 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 126.973 2.225 . . . . 0.0 112.362 176.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.4 tt -52.0 -42.07 62.69 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.33 1.452 . . . . 0.0 112.584 -170.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 44.6 t-105 -75.4 -46.36 33.35 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -172.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -64.19 -36.76 93.64 Favored Glycine 0 N--CA 1.48 1.568 0 O-C-N 121.641 -0.662 . . . . 0.0 112.501 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -61.16 -44.61 97.04 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 127.178 2.191 . . . . 0.0 112.167 168.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 25.7 tp -68.31 -32.58 72.82 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.608 0.64 . . . . 0.0 112.451 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -67.1 -18.57 65.38 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.108 -0.995 . . . . 0.0 113.213 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -67.49 -3.71 9.36 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.118 1.367 . . . . 0.0 114.301 167.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.31 83.47 0.55 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.53 1.532 . . . . 0.0 110.43 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.7 ttt85 -149.92 -37.67 0.15 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -164.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -68.89 151.25 97.35 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 123.974 0.91 . . . . 0.0 109.906 168.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -51.26 -46.85 28.85 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 CA-C-N 121.534 1.583 . . . . 0.0 115.488 -170.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 17.5 tt -62.99 -36.23 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 119.422 1.01 . . . . 0.0 113.501 176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 95.5 p -82.93 -25.85 32.0 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.148 1.34 . . . . 0.0 111.231 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 15.1 mm -63.19 -49.1 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.8 0.84 . . . . 0.0 110.026 160.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 21.2 mm -59.36 -41.61 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.539 -0.726 . . . . 0.0 111.376 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -69.71 -35.24 74.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.587 1.555 . . . . 0.0 111.43 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.3 tp -64.21 -49.2 72.9 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.088 0.555 . . . . 0.0 110.696 171.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 59.5 mt -61.5 -40.95 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 121.653 -0.654 . . . . 0.0 110.154 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.5 t -78.92 -22.65 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 117.605 -1.188 . . . . 0.0 113.779 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.46 -32.21 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 122.316 2.325 . . . . 0.0 110.344 166.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 46.0 t -81.17 -29.69 11.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 O-C-N 120.951 -1.093 . . . . 0.0 109.51 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.38 -42.79 87.84 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.805 -0.559 . . . . 0.0 111.511 161.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.1 m -61.3 -36.99 81.62 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.948 0.899 . . . . 0.0 111.843 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 55.6 mtt -64.46 -54.19 36.44 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.523 1.129 . . . . 0.0 111.0 166.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 30.4 t -56.63 -38.39 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 119.771 1.168 . . . . 0.0 112.237 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 28.4 t -53.53 -52.61 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 126.293 1.837 . . . . 0.0 111.396 171.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.87 -15.46 44.57 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.078 0.951 . . . . 0.0 113.294 -175.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 93.2 m -102.68 -56.25 2.28 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.52 1.528 . . . . 0.0 114.4 -171.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 25.4 t -56.88 -38.75 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-N 119.521 1.055 . . . . 0.0 112.025 -175.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 164.21 -116.55 0.71 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.037 1.303 . . . . 0.0 110.288 168.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 77.3 p -164.17 34.64 0.08 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.436 1.094 . . . . 0.0 113.063 -174.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -169.45 168.75 9.29 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.97 2.108 . . . . 0.0 110.709 -174.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -67.36 -49.78 49.3 Favored Glycine 0 N--CA 1.473 1.139 0 C-N-CA 127.556 2.503 . . . . 0.0 112.461 -10.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -144.62 4.9 1.18 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.364 1.066 . . . . 0.0 113.775 170.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 15.2 t -73.55 -42.88 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 120.155 1.343 . . . . 0.0 111.493 -170.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -47.28 -45.91 24.45 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.933 1.293 . . . . 0.0 112.394 164.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.38 -54.68 9.9 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.833 1.253 . . . . 0.0 111.214 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.11 -35.74 81.28 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 121.113 -0.992 . . . . 0.0 111.885 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 18.0 m -69.17 -45.65 69.48 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.485 1.493 . . . . 0.0 110.884 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -52.87 -52.37 57.63 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.615 -0.678 . . . . 0.0 111.412 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.415 ' C ' ' H ' ' A' ' 229' ' ' GLY . 72.6 mt -67.08 -84.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 123.392 1.568 . . . . 0.0 110.269 175.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -76.36 10.04 2.28 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 128.145 2.578 . . . . 0.0 113.338 -167.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 227' ' ' ILE . . . -117.84 -63.64 0.31 Allowed Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 166.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 18.2 mt -79.57 -37.44 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 118.482 1.141 . . . . 0.0 111.374 -171.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.72 -41.59 87.67 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.862 1.21 . . . . 0.0 109.771 174.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -63.32 -33.25 75.12 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.057 2.143 . . . . 0.0 113.521 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 23.4 tp -63.87 -33.41 75.62 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.344 1.058 . . . . 0.0 111.654 165.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -69.08 -37.54 78.53 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.715 1.598 . . . . 0.0 114.289 -175.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -19.69 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.255 -0.903 . . . . 0.0 113.094 175.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 37.7 mt -72.99 -23.67 60.67 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.974 0.893 . . . . 0.0 110.539 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -83.12 -18.45 39.46 Favored 'General case' 0 C--O 1.216 -0.708 0 C-N-CA 124.386 1.074 . . . . 0.0 112.816 -167.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -24.76 -40.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 128.587 2.755 . . . . 0.0 114.779 143.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 16.6 mt -99.99 -28.24 13.18 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.258 1.423 . . . . 0.0 110.717 -172.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -75.58 9.78 2.06 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 158.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.303 4.2 t -104.0 46.79 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-O 124.779 2.228 . . . . 0.0 110.409 150.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 47.1 p-10 -59.56 61.7 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 113.283 -1.78 . . . . 0.0 111.273 137.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -45.79 -43.68 13.36 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 126.895 2.078 . . . . 0.0 114.688 -138.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -145.54 27.02 1.25 Allowed 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 127.456 2.302 . . . . 0.0 112.02 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 114.61 15.84 7.89 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.001 1.286 . . . . 0.0 115.556 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 172.5 88.16 0.07 OUTLIER Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.573 1.559 . . . . 0.0 111.655 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 4.3 t -47.01 151.43 0.64 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.389 1.476 . . . . 0.0 113.533 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 69.0 m95 46.19 43.88 11.59 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 126.853 2.061 . . . . 0.0 114.125 164.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 118.535 -0.745 . . . . 0.0 112.147 178.48 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.7 tp -69.79 102.35 1.91 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 123.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 47.18 72.89 0.21 Allowed 'General case' 0 N--CA 1.432 -1.356 0 O-C-N 124.54 1.15 . . . . 0.0 109.864 142.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.265 0.0 OUTLIER -53.18 -24.4 10.72 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 120.884 -1.135 . . . . 0.0 110.97 168.02 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -58.09 -40.13 80.32 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.352 1.461 . . . . 0.0 114.634 165.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -78.25 -51.38 10.25 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 126.119 1.768 . . . . 0.0 109.743 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.0 m -81.04 -21.15 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -157.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -73.69 -29.3 62.2 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.199 0.599 . . . . 0.0 110.802 166.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.12 -32.82 60.02 Favored Glycine 0 CA--C 1.525 0.696 0 O-C-N 121.097 -1.002 . . . . 0.0 111.552 167.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -63.34 -40.19 96.62 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.117 1.367 . . . . 0.0 111.256 175.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.2 t -60.51 -55.36 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.53 1.932 . . . . 0.0 110.98 168.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -62.44 -22.54 66.28 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.407 1.083 . . . . 0.0 113.803 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -84.8 -34.18 22.8 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.824 1.25 . . . . 0.0 111.913 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -74.09 -43.34 58.01 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.136 -0.977 . . . . 0.0 112.814 -176.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.25 -20.98 64.85 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 176.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -101.88 -24.51 14.02 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 125.046 1.338 . . . . 0.0 112.676 -171.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.4 mtm105 -91.74 107.68 24.13 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 124.363 1.065 . . . . 0.0 109.928 165.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -65.29 127.13 17.59 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.904 1.736 . . . . 0.0 109.091 166.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 82.2 p -139.44 178.61 7.08 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.271 1.029 . . . . 0.0 109.091 176.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.82 -30.03 62.47 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 121.912 -0.493 . . . . 0.0 112.597 165.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -78.54 -43.42 26.77 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -60.27 -40.3 89.9 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.342 0.973 . . . . 0.0 109.746 170.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 49.7 t -61.43 -54.36 44.58 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.26 1.024 . . . . 0.0 112.294 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -53.62 -49.64 67.39 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.364 1.066 . . . . 0.0 111.89 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.0 p -85.81 -47.23 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -73.21 -39.27 65.66 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.998 0.817 . . . . 0.0 111.858 -163.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -80.3 -27.99 38.36 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 120.852 -1.155 . . . . 0.0 112.788 -173.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -70.39 -35.59 73.58 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.816 0.734 . . . . 0.0 111.122 164.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.97 -44.68 87.22 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 119.923 1.238 . . . . 0.0 113.218 168.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.43 -35.56 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 121.7 2.046 . . . . 0.0 113.235 176.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -68.02 -47.61 67.96 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.222 1.009 . . . . 0.0 112.077 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 62.9 mt -62.78 -47.84 81.72 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.459 0.704 . . . . 0.0 111.435 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 84.7 mt -61.99 -34.48 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 118.11 -0.948 . . . . 0.0 111.253 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.7 t -74.89 -34.07 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 120.781 1.628 . . . . 0.0 114.273 177.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 28.2 mt -59.44 -48.22 82.49 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.447 1.476 . . . . 0.0 110.535 167.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.5 t -55.89 -53.67 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 118.348 0.522 . . . . 0.0 110.23 172.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 60.8 m -61.62 -46.09 91.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.988 -173.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.9 mt -72.31 -40.91 67.13 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.679 1.127 . . . . 0.0 112.58 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.53 -42.35 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.366 0.666 . . . . 0.0 110.557 174.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -68.5 -33.29 73.88 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.384 -0.823 . . . . 0.0 111.99 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 t -58.08 -40.71 81.79 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.928 0.891 . . . . 0.0 111.716 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.33 -53.01 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.386 1.074 . . . . 0.0 110.299 174.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.9 tp -55.6 -50.44 70.1 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.014 0.526 . . . . 0.0 111.714 171.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 68.7 m -57.42 -23.53 50.08 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 116.172 1.915 . . . . 0.0 116.172 -174.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.4 t -109.44 -5.46 15.78 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.367 0.985 . . . . 0.0 112.845 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.7 tp -85.03 -36.08 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 O-C-N 121.554 -0.716 . . . . 0.0 111.344 149.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -71.95 -4.05 26.17 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 119.967 -1.708 . . . . 0.0 115.304 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -63.28 -34.09 76.93 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 120.72 -1.238 . . . . 0.0 112.58 169.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -74.52 -20.62 59.91 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.348 -0.845 . . . . 0.0 112.844 172.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.93 -45.22 43.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.956 0.903 . . . . 0.0 111.254 166.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -57.49 -28.67 63.63 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.747 1.219 . . . . 0.0 113.151 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.43 -35.45 73.39 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.196 1.398 . . . . 0.0 113.559 173.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -97.56 -47.91 5.47 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.993 2.117 . . . . 0.0 114.124 -168.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 69.7 p -149.52 -169.05 3.27 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.469 2.308 . . . . 0.0 109.006 -159.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -77.62 169.69 54.8 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.323 -0.861 . . . . 0.0 112.828 159.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -170.28 152.35 4.1 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.411 1.885 . . . . 0.0 110.887 -176.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.0 mt -52.59 -14.82 0.56 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.039 1.736 . . . . 0.0 114.368 172.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -49.38 -15.9 0.16 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.823 1.649 . . . . 0.0 114.428 168.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 18.5 p-90 -57.22 -27.74 62.27 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.752 -1.217 . . . . 0.0 112.713 166.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 28.4 ttp -70.71 -20.77 62.63 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.197 -1.564 . . . . 0.0 112.067 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -64.65 -26.04 68.22 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.683 -1.26 . . . . 0.0 112.184 169.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 26.9 mt -70.17 -42.36 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.044 0.538 . . . . 0.0 109.575 172.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.41 -44.12 98.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.698 0.799 . . . . 0.0 111.372 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.04 -28.38 57.66 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.127 0.876 . . . . 0.0 113.262 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.6 t -60.11 -41.83 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 120.646 1.566 . . . . 0.0 110.46 165.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.57 -35.25 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 117.759 -1.115 . . . . 0.0 110.347 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -64.42 -53.6 45.83 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.874 1.67 . . . . 0.0 112.546 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -69.1 -24.3 64.11 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.2 1.364 . . . . 0.0 112.916 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -72.05 -47.11 32.63 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.543 1.068 . . . . 0.0 111.348 168.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.9 m -66.51 -36.25 82.26 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -62.56 -49.22 76.14 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 120.537 1.517 . . . . 0.0 110.874 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -51.69 -48.62 63.42 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.151 0.581 . . . . 0.0 111.896 172.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.58 -38.65 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.19 0.996 . . . . 0.0 113.239 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 14.4 t -61.86 -33.54 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.509 1.524 . . . . 0.0 111.56 173.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -63.23 -32.82 74.32 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.219 1.008 . . . . 0.0 112.393 170.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 23.4 mt -74.28 -35.46 63.75 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 173.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -70.6 -35.76 73.18 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.097 0.959 . . . . 0.0 113.42 173.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 83.6 p -68.22 -10.4 54.15 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 168.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.98 -15.27 20.93 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 120.05 1.296 . . . . 0.0 114.329 157.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 178.97 80.77 0.06 OUTLIER Glycine 0 C--N 1.343 0.964 0 CA-C-N 120.149 1.34 . . . . 0.0 115.674 -167.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 49.5 t -49.27 -27.3 3.67 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 117.759 0.779 . . . . 0.0 112.753 153.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.86 58.69 1.72 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.599 1.19 . . . . 0.0 111.94 157.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 21.2 p -162.65 50.16 0.18 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.198 159.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.45 ' HE2' ' CD2' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -61.13 -22.12 64.38 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -167.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.45 ' CD2' ' HE2' ' A' ' 183' ' ' LYS . 25.2 m-85 -105.46 -38.91 6.3 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 118.167 -0.921 . . . . 0.0 112.587 161.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -56.36 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 119.686 1.13 . . . . 0.0 111.408 -172.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -70.35 -43.08 63.65 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.56 -38.96 64.39 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.031 1.733 . . . . 0.0 111.947 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -70.79 -44.32 66.89 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.089 0.859 . . . . 0.0 112.296 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -66.74 -35.19 89.38 Favored Glycine 0 N--CA 1.476 1.354 0 O-C-N 121.259 -0.901 . . . . 0.0 112.283 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -65.67 -39.42 91.32 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 127.804 2.442 . . . . 0.0 112.942 172.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 23.6 tp -68.58 -33.37 73.95 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.864 -0.522 . . . . 0.0 111.827 173.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -73.05 -7.39 51.05 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -74.02 59.47 0.72 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.39 1.45 . . . . 0.0 110.214 163.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -142.66 76.58 1.54 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.86 2.864 . . . . 0.0 106.857 -169.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 44.8 mtp85 -137.89 -43.99 0.53 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.398 1.079 . . . . 0.0 111.472 -169.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -64.97 152.04 91.97 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 123.752 0.821 . . . . 0.0 110.434 167.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -54.1 -46.89 30.24 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.671 2.247 . . . . 0.0 112.827 -172.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.3 tt -58.21 -39.01 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.536 1.134 . . . . 0.0 113.981 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 78.7 p -87.63 -20.11 26.8 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 120.573 1.533 . . . . 0.0 112.633 -174.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 64.0 mt -72.39 -43.38 64.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 118.383 0.538 . . . . 0.0 110.509 159.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 43.5 mt -60.1 -39.58 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.238 1.015 . . . . 0.0 110.971 174.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -70.09 -39.69 75.41 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.782 1.633 . . . . 0.0 110.684 -178.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.51 -46.85 88.23 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.483 1.113 . . . . 0.0 112.707 169.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 54.1 mt -63.68 -41.76 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 O-C-N 120.685 -1.26 . . . . 0.0 110.411 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 31.6 t -66.27 -39.79 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 116.308 -1.806 . . . . 0.0 112.559 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.08 -33.06 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 122.212 2.278 . . . . 0.0 111.485 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.28 -46.12 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 123.373 0.669 . . . . 0.0 109.694 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -53.26 -48.14 68.53 Favored 'General case' 0 C--O 1.223 -0.342 0 C-N-CA 123.732 0.813 . . . . 0.0 110.797 169.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 34.3 t -59.84 -49.69 76.73 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.636 1.175 . . . . 0.0 112.947 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 15.0 tpt -70.85 -34.03 71.25 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 118.786 -0.626 . . . . 0.0 112.027 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.7 t -60.76 -50.99 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 120.38 1.446 . . . . 0.0 111.938 171.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.18 -33.09 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 119.461 1.028 . . . . 0.0 111.117 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 5.1 tp -58.38 -45.01 89.13 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.51 0.724 . . . . 0.0 111.211 165.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 59.4 m -69.69 -25.66 63.98 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.287 1.435 . . . . 0.0 114.706 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 52.1 t -64.02 -16.01 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.008 1.323 . . . . 0.0 110.95 166.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 94.13 114.29 2.52 Favored Glycine 0 C--N 1.332 0.35 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -165.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 66.3 p -62.3 34.8 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 129.092 2.957 . . . . 0.0 116.969 -170.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.261 39.7 mmtm -171.2 -23.46 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.343 2.257 . . . . 0.0 114.162 -155.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -46.04 123.66 6.87 Favored Glycine 0 C--N 1.341 0.809 0 N-CA-C 104.014 -3.635 . . . . 0.0 104.014 138.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -75.65 50.49 0.56 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 126.345 1.858 . . . . 0.0 110.377 -162.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 11.1 m -150.76 -35.72 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.583 1.553 . . . . 0.0 109.491 -162.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -57.07 -38.31 73.1 Favored 'General case' 0 C--O 1.216 -0.667 0 O-C-N 120.743 -1.223 . . . . 0.0 111.269 151.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.53 -42.83 88.69 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.266 0.939 . . . . 0.0 111.283 173.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 23.1 p -79.04 -55.3 5.22 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.039 -173.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 15.9 t -63.47 -34.18 77.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.528 1.513 . . . . 0.0 113.197 175.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.18 -50.19 72.82 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.102 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 65.4 mt -63.52 -70.27 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-O 122.282 1.039 . . . . 0.0 110.044 173.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 72.6 mtt-85 -76.74 1.65 16.58 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.122 1.769 . . . . 0.0 113.381 -163.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -125.48 -69.45 0.19 Allowed Glycine 0 N--CA 1.461 0.354 0 C-N-CA 125.636 1.589 . . . . 0.0 109.75 175.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.26 -27.57 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 117.169 -1.396 . . . . 0.0 112.518 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -96.87 -28.83 14.05 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 120.844 1.657 . . . . 0.0 114.095 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -54.69 -34.19 61.98 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.584 1.154 . . . . 0.0 111.009 167.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 58.0 tp -56.67 -30.3 63.23 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 168.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -82.84 -37.0 25.01 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 119.387 -2.071 . . . . 0.0 115.4 -171.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -16.67 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.427 1.091 . . . . 0.0 112.577 170.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 70.4 mt -75.02 -45.02 44.59 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.65 -0.656 . . . . 0.0 111.723 168.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -68.64 -41.09 79.87 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.752 1.621 . . . . 0.0 111.451 -170.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 32.1 tpp -25.7 -22.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 131.153 3.781 . . . . 0.0 117.797 149.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 17.0 mt -131.3 -4.39 3.84 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.061 1.745 . . . . 0.0 112.701 -174.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -66.6 -53.05 38.54 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.276 141.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 52.5 t 47.06 75.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.115 1.366 . . . . 0.0 109.344 -160.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -75.04 42.22 0.18 Allowed 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.56 -1.337 . . . . 0.0 114.537 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 20.3 ttt85 -121.3 74.92 1.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 128.377 2.671 . . . . 0.0 106.662 174.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -168.88 40.46 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.113 0 O-C-N 118.644 -2.535 . . . . 0.0 111.184 18.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 83.03 84.07 0.87 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -147.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 110.42 71.54 0.66 Allowed Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.145 1.355 . . . . 0.0 113.614 -169.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 19.9 p -58.46 142.79 47.65 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.72 1.208 . . . . 0.0 111.543 174.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 76.7 m95 53.47 38.35 27.82 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 166.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 . . . . . 0 C--O 1.253 1.243 0 CA-C-O 117.078 -1.439 . . . . 0.0 111.838 179.478 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 CA--C 1.515 -0.377 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.2 tp -82.59 172.46 12.95 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 140.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 67.83 -33.54 0.22 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 127.779 2.431 . . . . 0.0 116.828 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 37.6 mmm-85 -58.65 -18.09 27.83 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 121.213 1.824 . . . . 0.0 115.881 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.25 -28.35 4.71 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.17 0.988 . . . . 0.0 110.96 162.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -65.23 -47.71 75.86 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.244 1.384 . . . . 0.0 114.039 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.07 -32.11 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.342 1.457 . . . . 0.0 111.044 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -72.12 -36.32 69.4 Favored 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 123.683 0.793 . . . . 0.0 110.859 174.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -55.12 -34.74 58.78 Favored Glycine 0 CA--C 1.541 1.701 0 O-C-N 121.144 -0.973 . . . . 0.0 111.044 165.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.8 mtm180 -66.76 -43.63 83.54 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 117.944 0.872 . . . . 0.0 111.719 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 42.6 t -56.93 -53.29 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 125.18 1.392 . . . . 0.0 110.469 173.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -62.39 -49.95 73.49 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.644 0.778 . . . . 0.0 111.593 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -62.61 -19.91 64.23 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.092 1.357 . . . . 0.0 113.919 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.41 ' CZ ' ' HA ' ' A' ' 121' ' ' LYS . 26.4 t80 -83.06 -41.44 18.62 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 126.344 1.857 . . . . 0.0 110.719 174.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.7 mt -62.41 -43.07 99.68 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.421 1.009 . . . . 0.0 110.971 169.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -77.37 -37.6 51.8 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.5 -157.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 16.1 mtp-105 -82.72 161.69 57.8 Favored Pre-proline 0 N--CA 1.47 0.544 0 C-N-CA 125.409 1.484 . . . . 0.0 113.022 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -71.18 131.26 18.93 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 121.177 1.251 . . . . 0.0 109.11 149.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.445 ' C ' ' H ' ' A' ' 120' ' ' TRP . 11.9 t -154.73 149.91 27.02 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 120.352 -1.467 . . . . 0.0 109.8 167.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.0 8.64 0.05 OUTLIER Glycine 0 CA--C 1.537 1.468 0 N-CA-C 117.114 1.606 . . . . 0.0 117.114 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . 0.445 ' H ' ' C ' ' A' ' 118' ' ' THR . 75.5 m95 -124.82 -16.11 6.26 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 166.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.41 ' HA ' ' CZ ' ' A' ' 113' ' ' PHE . 35.5 ttpt -61.24 -69.56 0.23 Allowed 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 121.114 1.779 . . . . 0.0 111.528 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 60.2 m -65.78 -34.93 79.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 118.881 -0.58 . . . . 0.0 109.926 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -58.61 -52.13 66.96 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.365 0.53 . . . . 0.0 111.705 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.7 t -82.47 -43.2 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 121.25 -0.906 . . . . 0.0 113.018 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -75.72 -33.97 60.32 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.628 -0.67 . . . . 0.0 112.343 -171.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -68.74 -33.56 74.12 Favored 'General case' 0 C--N 1.346 0.435 0 O-C-N 120.897 -1.127 . . . . 0.0 111.128 169.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -64.31 -40.9 96.84 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.253 -0.904 . . . . 0.0 112.977 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.23 -44.83 65.04 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 118.168 -0.92 . . . . 0.0 113.443 167.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.64 -36.76 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 120.95 1.704 . . . . 0.0 113.159 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -54.62 -52.32 62.6 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.019 0.827 . . . . 0.0 111.308 172.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 87.7 mt -68.17 -40.64 82.25 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.908 0.483 . . . . 0.0 112.296 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 58.9 mt -69.62 -43.12 80.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 CA-C-O 117.874 -1.06 . . . . 0.0 112.083 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 80.8 t -60.82 -45.09 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 121.25 1.841 . . . . 0.0 111.674 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.4 tp -53.85 -54.07 43.59 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.513 1.525 . . . . 0.0 111.731 171.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 53.5 t -62.6 -39.97 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.712 0.805 . . . . 0.0 112.241 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.5 m -61.21 -42.98 99.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 119.335 0.971 . . . . 0.0 111.721 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.2 mt -74.61 -38.45 62.57 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.336 0.655 . . . . 0.0 112.23 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 71.7 mt -59.31 -48.42 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.887 0.875 . . . . 0.0 110.639 170.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -69.05 -35.71 76.87 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 118.969 -0.539 . . . . 0.0 111.563 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.3 t -58.42 -44.45 89.09 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.852 1.261 . . . . 0.0 112.874 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.1 m -67.49 -28.19 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.7 mt -71.42 -46.81 59.19 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.679 0.672 . . . . 0.0 111.756 166.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 72.6 m -70.39 -33.02 70.91 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.29 1.836 . . . . 0.0 115.036 -170.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.2 t -66.57 -47.52 72.51 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 120.164 1.347 . . . . 0.0 109.895 -174.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 26.5 mm -56.0 -44.63 78.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 124.466 1.106 . . . . 0.0 111.135 175.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -80.65 -14.37 58.22 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -73.19 -37.71 66.39 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.361 1.437 . . . . 0.0 111.196 166.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -79.9 -2.83 45.44 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.163 -0.961 . . . . 0.0 112.089 170.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.65 -27.93 18.72 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.596 1.158 . . . . 0.0 112.954 157.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.58 -19.38 57.43 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.6 pp -63.88 -4.49 3.31 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 126.697 1.999 . . . . 0.0 114.557 166.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.23 -35.17 0.32 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.851 2.46 . . . . 0.0 114.24 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 72.5 m -129.22 141.53 51.11 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.7 1.2 . . . . 0.0 110.448 -151.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -72.49 140.91 30.13 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.278 -0.487 . . . . 0.0 112.101 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.2 t -147.62 143.44 27.71 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -158.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -60.93 -7.23 2.27 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 170.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -56.31 -8.67 0.54 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.89 2.476 . . . . 0.0 116.367 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -68.8 -24.04 64.35 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.472 -1.392 . . . . 0.0 112.508 171.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 76.5 mtm -74.16 -13.81 60.87 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -68.56 -44.08 75.23 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.723 1.147 . . . . 0.0 110.492 164.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 28.8 mt -58.62 -36.75 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 118.481 -0.771 . . . . 0.0 111.916 169.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.5 t -57.53 -45.58 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 120.409 1.459 . . . . 0.0 111.49 171.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 19.3 mt -62.7 -42.82 99.84 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 173.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.88 -24.17 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.24 0.927 . . . . 0.0 112.34 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 54.6 t -78.87 -38.99 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.233 1.013 . . . . 0.0 110.429 172.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -61.56 -49.75 75.4 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.394 0.997 . . . . 0.0 112.297 170.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -65.71 -46.33 79.35 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.711 0.687 . . . . 0.0 112.47 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -52.26 -40.86 53.48 Favored Glycine 0 CA--C 1.539 1.546 0 O-C-N 121.598 -0.689 . . . . 0.0 112.788 167.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 70.2 m -69.17 -37.83 78.39 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 117.775 0.787 . . . . 0.0 112.482 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -59.71 -50.2 74.75 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.981 1.312 . . . . 0.0 110.888 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -51.66 -47.41 63.8 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.362 1.065 . . . . 0.0 112.247 172.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 37.8 t -66.37 -37.97 80.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.959 0.904 . . . . 0.0 112.363 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 12.2 t -62.85 -33.51 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.146 1.379 . . . . 0.0 112.427 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 24.5 mtt180 -59.99 -44.86 94.24 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.118 -0.989 . . . . 0.0 111.221 170.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.7 mt -68.7 -35.43 77.17 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.173 0.589 . . . . 0.0 112.381 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 53.2 m0 -65.34 -26.58 68.1 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 172.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 47.8 t -70.34 -30.21 67.11 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.604 1.093 . . . . 0.0 113.534 166.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -68.89 -0.46 5.56 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.307 -1.496 . . . . 0.0 112.598 161.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -104.92 7.39 44.75 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 126.58 2.038 . . . . 0.0 116.238 172.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 7.8 t -54.49 -23.12 14.97 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.247 1.524 . . . . 0.0 112.48 173.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -122.47 -60.37 1.55 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.254 1.422 . . . . 0.0 110.988 153.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.9 p -86.35 64.5 8.58 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.473 1.509 . . . . 0.0 111.971 -163.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -44.82 -35.73 2.91 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.732 1.613 . . . . 0.0 115.05 -167.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -112.32 -33.07 6.31 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.739 1.216 . . . . 0.0 113.859 174.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -56.74 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 119.786 1.176 . . . . 0.0 111.606 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -67.63 -35.79 86.69 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 119.022 -0.877 . . . . 0.0 111.179 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 1.2 tt -51.9 -33.21 35.88 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.019 0.928 . . . . 0.0 113.062 169.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 49.8 t-105 -86.13 -36.18 19.72 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -73.88 -38.17 49.55 Favored Glycine 0 N--CA 1.466 0.638 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -64.99 -40.29 94.73 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 124.675 1.19 . . . . 0.0 111.005 169.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 19.3 tp -63.76 -40.87 97.74 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.41 1.005 . . . . 0.0 111.914 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 52.5 mtp180 -64.43 -23.81 67.41 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 171.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -74.73 0.47 15.16 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.919 1.288 . . . . 0.0 113.977 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.03 27.71 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 116.839 2.163 . . . . 0.0 116.839 -173.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -92.75 -7.16 47.4 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 117.198 2.295 . . . . 0.0 117.198 -159.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -61.03 147.23 86.48 Favored Pre-proline 0 N--CA 1.482 1.138 0 CA-C-N 120.976 1.716 . . . . 0.0 109.975 167.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -45.33 -50.18 9.39 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.93 3.087 . . . . 0.0 115.669 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 96.5 mt -71.98 -29.96 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.409 1.083 . . . . 0.0 111.784 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 50.6 m -72.79 -30.72 64.31 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.093 0.957 . . . . 0.0 112.279 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.8 mt -68.16 -42.77 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.586 0.754 . . . . 0.0 109.808 168.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 49.4 mt -61.87 -43.52 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 121.656 -0.653 . . . . 0.0 110.933 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.13 -38.78 92.29 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.501 1.52 . . . . 0.0 112.099 175.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.5 tt -63.12 -48.76 77.16 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.55 0.614 . . . . 0.0 110.716 170.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.1 -36.93 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.618 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 72.1 t -74.1 -33.93 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 120.24 1.382 . . . . 0.0 113.5 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.3 p -66.39 -36.99 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 121.052 1.751 . . . . 0.0 110.802 169.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 77.4 t -71.45 -39.56 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 120.904 -1.122 . . . . 0.0 110.777 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.5 -57.77 10.83 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.036 0.934 . . . . 0.0 110.628 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 59.8 p -56.14 -42.44 76.93 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.761 0.424 . . . . 0.0 111.261 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -64.0 -54.93 26.55 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.928 0.891 . . . . 0.0 112.526 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.15 -36.43 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 119.65 1.113 . . . . 0.0 111.855 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 27.9 m -75.17 -38.87 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 117.561 -1.209 . . . . 0.0 112.047 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.92 -22.13 65.08 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.031 1.287 . . . . 0.0 111.655 171.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 66.8 m -74.68 -36.87 62.79 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.422 1.089 . . . . 0.0 113.177 171.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 76.6 t -64.04 -31.61 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 118.933 0.788 . . . . 0.0 110.273 164.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 137.76 -107.68 0.59 Allowed Glycine 0 CA--C 1.522 0.506 0 C-N-CA 124.555 1.074 . . . . 0.0 112.908 158.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 87.1 p -139.8 2.21 1.95 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.55 1.14 . . . . 0.0 113.195 -167.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -171.92 -177.8 2.01 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.667 2.387 . . . . 0.0 110.23 -172.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 221' ' ' VAL . . . 57.69 108.25 0.01 OUTLIER Glycine 0 CA--C 1.526 0.781 0 N-CA-C 106.966 -2.454 . . . . 0.0 106.966 -107.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -57.92 -6.4 0.56 Allowed 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 120.348 2.074 . . . . 0.0 112.586 172.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.45 ' H ' ' C ' ' A' ' 219' ' ' GLY . 22.3 m -72.12 -32.17 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.528 1.531 . . . . 0.0 113.119 169.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.37 -47.68 62.76 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.929 1.241 . . . . 0.0 111.181 159.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.29 -55.31 12.56 Favored 'General case' 0 C--O 1.223 -0.341 0 O-C-N 124.217 0.948 . . . . 0.0 110.768 -168.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' THR . . . . . 0.586 ' HG1' ' NH1' ' A' ' 228' ' ' ARG . 8.1 t -52.97 -39.72 63.21 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.166 -0.959 . . . . 0.0 111.78 176.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 16.1 m -69.2 -58.29 4.25 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.163 -0.961 . . . . 0.0 111.999 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -54.79 -54.69 38.91 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 126.049 1.739 . . . . 0.0 110.914 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.53 -71.79 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.845 1.658 . . . . 0.0 107.835 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.586 ' NH1' ' HG1' ' A' ' 224' ' ' THR . 79.4 mtt180 -74.52 -43.38 56.15 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.246 -154.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -59.45 -46.33 94.09 Favored Glycine 0 N--CA 1.472 1.056 0 CA-C-O 119.616 -0.547 . . . . 0.0 112.854 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.98 -34.67 39.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 117.979 0.89 . . . . 0.0 111.623 -177.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -40.74 98.54 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.058 -1.026 . . . . 0.0 112.168 166.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -66.56 -36.53 82.9 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.34 0.656 . . . . 0.0 110.634 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.5 tp -67.29 -23.85 65.7 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 172.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.48 -48.2 20.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.51 1.124 . . . . 0.0 113.071 176.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 22.9 pt -68.08 -16.6 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 173.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 52.0 tp -70.26 -26.06 63.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.266 1.426 . . . . 0.0 111.608 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -67.44 -19.29 65.35 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.211 1.005 . . . . 0.0 112.221 -176.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.7 -24.08 2.1 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.685 1.994 . . . . 0.0 113.94 160.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.1 mt -114.36 -19.85 11.07 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.819 1.648 . . . . 0.0 111.334 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -64.66 -32.22 73.78 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 118.964 -0.541 . . . . 0.0 111.425 162.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . 0.408 ' C ' ' H ' ' A' ' 243' ' ' ARG 0.297 11.1 p -79.02 67.37 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-O 125.159 2.409 . . . . 0.0 110.618 158.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -51.46 -4.34 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 112.412 -2.176 . . . . 0.0 114.167 152.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.408 ' H ' ' C ' ' A' ' 241' ' ' VAL . 7.0 tpt85 53.11 24.42 3.56 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 127.469 2.308 . . . . 0.0 112.104 -177.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 64.85 34.9 8.88 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 128.044 2.537 . . . . 0.0 114.325 -175.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 171.46 -3.43 0.03 OUTLIER Glycine 0 CA--C 1.537 1.468 0 N-CA-C 117.392 1.717 . . . . 0.0 117.392 169.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 157.33 104.35 0.21 Allowed Glycine 0 CA--C 1.522 0.522 0 C-N-CA 127.156 2.313 . . . . 0.0 108.196 -170.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 5.6 p -46.38 132.14 10.44 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.335 -1.097 . . . . 0.0 110.735 173.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 21.2 m95 55.96 9.71 0.49 Allowed 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 . . . . . 0 C--O 1.247 0.947 0 C-N-CA 124.866 1.266 . . . . 0.0 114.253 -165.748 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.0 m . . . . . 0 C--O 1.235 0.323 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 tp -65.44 94.27 0.17 Allowed 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 134.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 57.39 59.53 3.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 112.673 -2.058 . . . . 0.0 110.391 139.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.12 -12.55 3.58 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 120.423 -1.423 . . . . 0.0 112.534 169.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.416 HG22 ' H ' ' A' ' 105' ' ' HIS . 2.6 t -62.8 -95.07 0.0 OUTLIER 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 127.382 2.273 . . . . 0.0 113.893 143.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.416 ' H ' HG22 ' A' ' 104' ' ' THR . 49.5 m80 -58.58 -19.85 41.79 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 119.975 3.324 . . . . 0.0 119.975 -168.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.413 HG11 ' H ' ' A' ' 107' ' ' GLN . 4.6 p -61.0 -37.62 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 120.456 1.48 . . . . 0.0 111.946 172.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.413 ' H ' HG11 ' A' ' 106' ' ' VAL . 16.3 mm-40 -67.45 -41.5 84.61 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.827 0.851 . . . . 0.0 109.249 173.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -58.86 -26.72 60.94 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.091 -1.394 . . . . 0.0 113.866 167.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -67.18 -45.19 77.7 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 120.36 2.08 . . . . 0.0 111.647 174.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.2 t -57.13 -47.39 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.144 0.978 . . . . 0.0 110.038 171.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -66.32 -56.6 10.38 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 118.848 -0.596 . . . . 0.0 112.453 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -58.89 -20.44 51.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 119.376 0.989 . . . . 0.0 113.463 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -80.39 -42.73 22.27 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.65 1.114 . . . . 0.0 111.773 171.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.63 -25.68 38.2 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -178.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -108.99 -38.71 5.5 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.06 1.344 . . . . 0.0 112.513 -164.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -90.75 151.1 43.37 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 123.279 0.632 . . . . 0.0 111.885 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.65 128.37 18.91 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.991 1.794 . . . . 0.0 112.986 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.2 t -152.4 151.13 30.43 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 156.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.47 -28.86 22.34 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 119.544 1.065 . . . . 0.0 112.654 172.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -70.88 -27.54 63.9 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 175.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.7 tmmt? -56.61 -60.87 2.91 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.34 1.056 . . . . 0.0 109.165 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 25.5 p -71.69 -27.33 62.96 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.682 1.193 . . . . 0.0 112.682 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -61.67 -52.24 65.14 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.715 1.598 . . . . 0.0 110.427 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.5 t -76.54 -48.17 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.051 0.54 . . . . 0.0 111.666 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -63.99 -46.54 84.1 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -75.77 -28.95 58.63 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.571 -0.705 . . . . 0.0 111.285 -174.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -69.99 -39.24 76.04 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.469 1.031 . . . . 0.0 112.375 169.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.51 -43.99 84.66 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.477 1.035 . . . . 0.0 113.362 167.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 76.4 t -62.15 -44.42 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 120.553 1.524 . . . . 0.0 111.727 172.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -56.72 -50.47 72.11 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.05 1.295 . . . . 0.0 111.553 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 94.2 mt -65.19 -45.37 85.11 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 119.019 -0.515 . . . . 0.0 111.469 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 76.1 mt -65.36 -37.23 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.859 0.754 . . . . 0.0 112.085 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.76 -45.46 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 119.956 1.253 . . . . 0.0 110.731 174.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 45.3 tp -63.92 -47.98 78.39 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.074 0.95 . . . . 0.0 111.922 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.4 t -59.9 -47.37 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.631 0.772 . . . . 0.0 110.126 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 41.5 t -58.06 -43.71 87.09 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.713 1.205 . . . . 0.0 112.824 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 61.2 mt -76.75 -36.18 57.26 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.2 mt -61.66 -48.31 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 120.813 -1.179 . . . . 0.0 109.77 167.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -63.48 -25.78 68.42 Favored 'General case' 0 C--O 1.22 -0.485 0 O-C-N 121.431 -0.793 . . . . 0.0 111.921 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.1 t -56.94 -39.59 74.81 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 120.047 1.294 . . . . 0.0 112.068 175.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 52.1 t -66.31 -42.34 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.584 0.754 . . . . 0.0 111.652 173.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.4 mt -70.63 -55.52 8.59 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.652 1.181 . . . . 0.0 112.661 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.3 m -68.17 -29.82 68.79 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.915 2.086 . . . . 0.0 113.538 -171.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.19 -46.29 51.44 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.218 1.372 . . . . 0.0 110.382 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.7 mm -52.84 -44.0 47.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.023 0.929 . . . . 0.0 110.834 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -74.07 -33.41 63.66 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -74.26 -21.69 59.65 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 119.856 -1.778 . . . . 0.0 112.082 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -79.98 -41.88 25.03 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.556 0.616 . . . . 0.0 109.455 171.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -57.91 -28.14 63.97 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.369 1.068 . . . . 0.0 113.424 170.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -57.63 -18.11 18.35 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.8 mp -83.86 -34.88 24.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.047 0.939 . . . . 0.0 111.952 174.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -84.58 -36.7 21.89 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.005 1.722 . . . . 0.0 114.073 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.0 t -158.51 -168.13 2.35 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 126.784 2.034 . . . . 0.0 108.313 -159.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -71.91 -174.99 23.44 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 120.711 -1.243 . . . . 0.0 113.74 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 10.0 t -161.02 148.18 15.25 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 49.3 tp -68.42 -10.38 54.83 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.194 1.798 . . . . 0.0 114.314 165.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -53.52 -17.77 2.31 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 -167.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 30.0 p-90 -58.14 -29.86 65.9 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 119.978 -1.701 . . . . 0.0 112.908 169.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 61.7 ttp -65.09 -32.89 74.83 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.858 1.663 . . . . 0.0 112.108 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -69.16 -38.94 79.01 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.508 -0.745 . . . . 0.0 111.884 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 50.1 mm -56.35 -34.51 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.059 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.4 t -60.5 -46.18 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.147 0.885 . . . . 0.0 111.271 172.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 15.9 mt -72.19 -47.47 50.45 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.746 0.818 . . . . 0.0 112.871 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 69.0 t -62.14 -43.29 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.754 0.822 . . . . 0.0 111.161 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 84.6 t -72.15 -32.41 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.05 174.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -62.12 -49.16 77.0 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 120.807 1.64 . . . . 0.0 112.486 170.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -64.83 -39.71 94.02 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.52 -1.363 . . . . 0.0 111.636 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -62.56 -38.11 95.84 Favored Glycine 0 CA--C 1.538 1.475 0 O-C-N 121.989 -0.444 . . . . 0.0 112.714 169.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 59.8 m -67.53 -36.65 81.43 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 117.731 0.765 . . . . 0.0 111.706 173.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -62.33 -44.18 97.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.521 1.128 . . . . 0.0 110.784 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -58.51 -41.1 84.63 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 77.9 t -71.08 -36.65 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.217 -0.927 . . . . 0.0 113.153 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 46.8 t -67.17 -29.99 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.035 1.334 . . . . 0.0 111.746 175.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -59.43 -40.01 85.35 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.971 -1.081 . . . . 0.0 112.19 165.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 74.5 mt -74.63 -36.93 62.92 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.708 0.803 . . . . 0.0 112.928 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 54.9 m0 -62.57 -41.17 98.76 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.072 1.305 . . . . 0.0 112.708 169.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 42.8 p -71.41 0.82 7.37 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.84 -23.45 60.67 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.556 1.525 . . . . 0.0 113.579 154.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 164.27 112.54 0.27 Allowed Glycine 0 N--CA 1.433 -1.541 0 O-C-N 121.878 -0.514 . . . . 0.0 112.157 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 45.0 t -34.06 -32.51 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.14 1.776 . . . . 0.0 113.514 152.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.46 -44.64 3.85 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 161.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.7 m -74.47 24.97 0.08 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -171.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -5.66 2.89 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 118.067 2.618 . . . . 0.0 118.067 -173.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -119.2 -37.53 3.18 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 120.276 1.398 . . . . 0.0 111.822 166.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.436 ' CG1' ' H ' ' A' ' 186' ' ' GLY . 10.8 p -73.09 -62.0 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.96 0.904 . . . . 0.0 112.71 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.436 ' H ' ' CG1' ' A' ' 185' ' ' VAL . . . -61.63 -31.65 78.61 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 118.591 -1.116 . . . . 0.0 112.656 169.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.0 tt -55.79 -49.58 72.8 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.4 1.6 . . . . 0.0 110.048 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -66.99 -42.38 85.17 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 122.211 -0.305 . . . . 0.0 111.092 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -53.36 -43.95 65.62 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.238 1.399 . . . . 0.0 114.105 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . 0.326 9.9 ptp180 -80.51 -31.02 37.26 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 40.0 tp -69.0 -41.02 78.34 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.49 0.586 . . . . 0.0 112.365 171.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -76.18 -17.39 59.57 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -78.97 -13.83 59.56 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.757 1.223 . . . . 0.0 113.831 169.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -78.79 43.89 0.52 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 117.052 2.242 . . . . 0.0 117.052 -165.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -93.86 -5.57 47.72 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -165.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -61.89 141.45 95.4 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 120.199 1.363 . . . . 0.0 109.104 175.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -47.57 -43.37 27.95 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.025 2.483 . . . . 0.0 115.021 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.481 ' CG2' ' HE2' ' A' ' 240' ' ' HIS . 35.0 mm -68.43 -32.24 54.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.117 0.967 . . . . 0.0 112.419 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 14.3 m -71.61 -36.6 70.86 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.973 1.309 . . . . 0.0 111.46 175.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 63.6 mt -68.94 -39.32 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.707 1.203 . . . . 0.0 110.733 173.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 33.9 mt -62.85 -41.48 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 121.286 -0.884 . . . . 0.0 111.129 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -65.23 -36.45 84.19 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.26 1.424 . . . . 0.0 111.647 176.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 28.6 tp -60.95 -52.96 62.83 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.529 0.732 . . . . 0.0 111.48 166.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 49.5 mt -61.59 -36.32 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.496 -0.752 . . . . 0.0 111.077 -175.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.0 t -65.9 -45.84 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.962 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.02 -31.39 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 CA-C-N 120.818 1.645 . . . . 0.0 112.018 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 97.5 t -74.25 -39.38 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 120.557 1.526 . . . . 0.0 110.893 176.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.15 81.96 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.34 0.973 . . . . 0.0 110.369 170.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 47.6 m -58.62 -43.94 89.79 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.77 0.828 . . . . 0.0 112.197 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 28.3 ttm -59.66 -55.45 34.31 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.295 1.438 . . . . 0.0 111.875 171.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 23.8 t -56.01 -47.47 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.099 1.36 . . . . 0.0 112.053 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 33.4 m -75.95 -25.79 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 118.043 -0.979 . . . . 0.0 113.28 -171.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 86.3 mt -68.85 -48.32 63.75 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.829 1.195 . . . . 0.0 110.968 159.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 43.8 t -63.04 -46.79 85.85 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.169 0.987 . . . . 0.0 113.003 -165.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 8.4 p -71.13 -11.72 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.896 -1.128 . . . . 0.0 113.214 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.41 125.58 5.66 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 125.357 1.456 . . . . 0.0 112.301 -168.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.5 m -72.75 61.23 0.53 Allowed 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 128.37 2.668 . . . . 0.0 113.427 -168.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -166.73 164.72 16.64 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 127.735 2.414 . . . . 0.0 112.064 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -85.24 -106.14 0.67 Allowed Glycine 0 C--N 1.337 0.603 0 C-N-CA 126.462 1.982 . . . . 0.0 111.923 -1.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -66.32 -23.64 66.4 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.095 -1.053 . . . . 0.0 112.302 171.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.68 -44.79 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 O-C-N 121.259 -0.901 . . . . 0.0 110.486 -166.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.65 -51.58 54.69 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.482 0.713 . . . . 0.0 111.906 163.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.66 -52.36 65.46 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.58 0.752 . . . . 0.0 109.559 -171.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.49 -37.73 88.57 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-O 117.915 -1.04 . . . . 0.0 112.715 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 46.1 m -67.92 -48.26 66.48 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 121.397 1.908 . . . . 0.0 111.298 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -56.42 -46.77 80.07 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 125.072 1.349 . . . . 0.0 110.976 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 72.5 mt -59.29 -71.1 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-O 122.478 1.133 . . . . 0.0 110.184 167.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -78.38 -17.92 55.79 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.153 -150.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.43 -53.73 2.24 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.532 1.063 . . . . 0.0 114.058 162.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -30.66 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 119.512 1.656 . . . . 0.0 113.637 -170.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 4.0 mmt85 -73.49 -32.46 64.31 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.779 -1.2 . . . . 0.0 110.923 170.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -67.19 -36.5 81.89 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.479 1.111 . . . . 0.0 112.42 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 65.3 tp -58.34 -36.23 73.1 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 118.316 0.507 . . . . 0.0 112.198 165.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.21 -34.71 61.52 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 119.95 -1.719 . . . . 0.0 113.552 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 3.7 pt -73.35 -22.75 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 120.779 -1.2 . . . . 0.0 113.832 164.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.5 tp -58.7 -42.47 88.68 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.606 1.163 . . . . 0.0 110.789 164.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -56.98 -30.6 64.26 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.309 1.044 . . . . 0.0 112.893 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 18.5 mmt -49.08 -31.93 8.79 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 168.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 40.5 mt -112.65 -7.67 13.84 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.182 1.393 . . . . 0.0 109.982 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . 0.481 ' HE2' ' CG2' ' A' ' 198' ' ' ILE . 36.7 m170 -68.12 -12.93 61.77 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.661 0.664 . . . . 0.0 112.084 153.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.75 75.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-O 124.272 1.987 . . . . 0.0 108.765 138.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 52.9 p30 -105.84 29.08 6.94 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 112.379 -2.192 . . . . 0.0 111.497 144.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -55.8 -65.27 0.62 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 128.211 2.604 . . . . 0.0 112.501 -171.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -158.97 148.68 19.04 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 69.99 13.43 69.59 Favored Glycine 0 N--CA 1.466 0.649 0 CA-C-N 114.216 -1.356 . . . . 0.0 116.221 142.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 124.26 44.83 0.28 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 119.018 1.409 . . . . 0.0 113.073 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 82.1 p -59.89 116.88 4.43 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.095 -1.238 . . . . 0.0 110.33 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 78.3 m95 56.61 21.21 5.56 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.83 2.052 . . . . 0.0 115.33 -173.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 . . . . . 0 C--O 1.244 0.765 0 C-N-CA 126.594 1.958 . . . . 0.0 112.047 179.629 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.465 0.314 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.79 115.78 3.31 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 103.692 -2.707 . . . . 0.0 103.692 118.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 27.24 82.18 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 125.204 1.402 . . . . 0.0 110.744 139.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -49.91 -34.0 19.08 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 113.892 -1.504 . . . . 0.0 112.057 -170.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 t -43.71 -57.27 3.29 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.932 2.493 . . . . 0.0 114.027 165.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -92.22 -25.33 18.69 Favored 'General case' 0 C--N 1.335 -0.06 0 O-C-N 120.196 -1.565 . . . . 0.0 114.349 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.56 -38.93 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 119.446 1.021 . . . . 0.0 111.144 171.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -73.54 -32.35 64.16 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.137 -0.977 . . . . 0.0 111.159 171.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.02 -32.31 42.0 Favored Glycine 0 CA--C 1.536 1.348 0 O-C-N 121.755 -0.591 . . . . 0.0 112.579 163.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -37.05 84.13 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.263 1.425 . . . . 0.0 111.546 -177.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.07 -54.1 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 122.292 1.044 . . . . 0.0 109.485 170.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . 0.25 77.0 m-85 -74.78 -33.75 62.33 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.101 -168.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -62.31 -22.86 66.38 Favored 'General case' 0 CA--C 1.552 1.051 0 O-C-N 120.179 -1.576 . . . . 0.0 114.469 165.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -75.38 -28.41 59.47 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.289 1.035 . . . . 0.0 111.811 171.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.2 mt -58.92 -43.65 91.16 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.56 1.073 . . . . 0.0 109.836 165.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -74.65 -40.82 61.23 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.306 -161.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.9 ptt85 -87.43 123.0 70.41 Favored Pre-proline 0 N--CA 1.47 0.554 0 C-N-CA 124.24 1.016 . . . . 0.0 110.46 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -65.89 126.61 16.21 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.869 1.712 . . . . 0.0 110.886 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.1 p -133.32 166.84 21.56 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 167.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.01 -37.59 71.78 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-N 118.634 0.652 . . . . 0.0 112.579 171.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -73.0 -34.99 66.74 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 175.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.43 -55.99 27.73 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.785 1.175 . . . . 0.0 108.864 164.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 34.0 t -58.52 -48.5 80.62 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.488 1.115 . . . . 0.0 111.994 -171.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -59.72 -52.96 63.26 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.824 0.45 . . . . 0.0 111.428 -175.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.6 t -84.27 -42.87 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -64.77 -48.98 72.52 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.705 0.402 . . . . 0.0 112.05 -172.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -68.8 -33.96 74.74 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.9 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -68.55 -36.08 78.31 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.275 0.943 . . . . 0.0 113.047 173.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.79 -46.13 81.74 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.352 0.978 . . . . 0.0 113.628 169.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . 0.268 0.7 OUTLIER -64.69 -39.05 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 CA-C-N 120.39 1.45 . . . . 0.0 111.16 178.743 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -60.45 -48.74 80.46 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.868 -1.145 . . . . 0.0 113.173 172.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.7 mt -61.82 -38.89 89.84 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.854 -1.154 . . . . 0.0 111.895 177.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 77.2 mt -63.26 -43.49 98.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 118.716 -0.659 . . . . 0.0 111.779 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -38.11 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 119.556 1.071 . . . . 0.0 111.662 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.6 mt -59.31 -47.74 84.27 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.761 0.425 . . . . 0.0 111.859 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.4 m -70.63 -41.11 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.608 1.095 . . . . 0.0 110.944 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 95.9 m -64.51 -39.91 94.67 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 119.105 0.866 . . . . 0.0 112.834 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 78.1 mt -71.2 -41.23 70.55 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 120.091 1.314 . . . . 0.0 112.599 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.3 mm -64.31 -48.09 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 121.232 -0.917 . . . . 0.0 110.02 172.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -61.5 -35.63 78.24 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-O 116.915 -1.516 . . . . 0.0 110.663 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.4 m -49.73 -48.38 50.12 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 121.006 1.73 . . . . 0.0 113.084 173.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.43 -30.67 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 122.999 0.52 . . . . 0.0 112.212 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.3 mt -89.84 -30.92 17.6 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.49 1.516 . . . . 0.0 114.907 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.7 p -90.17 -26.11 20.31 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.014 -1.053 . . . . 0.0 113.25 -158.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.3 t -68.97 -32.51 72.14 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.307 -0.871 . . . . 0.0 112.439 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 11.8 pt -72.28 -9.13 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -62.91 -23.38 67.33 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.661 0.784 . . . . 0.0 112.099 170.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -62.85 -38.74 92.03 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.845 1.258 . . . . 0.0 111.457 168.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -74.84 -37.37 62.28 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.892 0.769 . . . . 0.0 111.36 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.75 -42.29 95.28 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.124 0.969 . . . . 0.0 113.501 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -58.23 -25.08 61.24 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -170.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -69.77 -48.14 60.36 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.488 1.115 . . . . 0.0 111.859 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.96 -51.91 11.4 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.671 1.188 . . . . 0.0 113.273 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.5 t -159.4 -179.0 7.56 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.611 -139.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -62.71 152.73 45.19 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 122.006 0.781 . . . . 0.0 112.936 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.8 t -152.9 148.28 26.96 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.843 0.83 . . . . 0.0 112.101 -166.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 11.3 tp -81.66 14.97 2.32 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.924 2.09 . . . . 0.0 112.796 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -50.24 -29.14 8.88 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.116 2.566 . . . . 0.0 114.618 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -70.99 -31.14 67.59 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.134 -0.979 . . . . 0.0 112.408 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 9.0 tpt -73.91 -35.41 64.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.433 1.015 . . . . 0.0 110.767 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -55.82 -56.35 21.56 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.516 0.726 . . . . 0.0 110.775 166.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 75.0 mt -58.45 -40.13 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.6 0.76 . . . . 0.0 112.282 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.7 t -61.95 -44.82 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 120.279 -1.513 . . . . 0.0 112.567 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.2 mt -71.2 -34.37 70.82 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.219 1.372 . . . . 0.0 112.037 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 54.9 t -59.8 -36.77 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.54 1.063 . . . . 0.0 110.881 170.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 78.8 t -76.26 -28.2 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 118.503 -0.761 . . . . 0.0 112.055 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -60.85 -48.99 79.29 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.197 1.362 . . . . 0.0 110.669 169.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -71.93 -35.79 69.75 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.53 -43.54 94.11 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 123.368 0.508 . . . . 0.0 112.361 167.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 88.9 m -68.88 -36.95 78.7 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.837 0.819 . . . . 0.0 110.739 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.4 tm-20 -60.14 -35.11 74.57 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 118.751 0.705 . . . . 0.0 112.541 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -60.69 -46.25 91.08 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.263 -0.898 . . . . 0.0 112.044 169.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.4 t -69.99 -30.82 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.494 0.717 . . . . 0.0 111.988 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.1 t -60.65 -39.51 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.305 1.442 . . . . 0.0 112.47 171.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -69.79 -20.1 63.48 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 170.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 31.8 mt -77.73 -37.7 48.73 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.311 0.959 . . . . 0.0 112.222 166.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 34.8 m0 -64.92 -45.63 85.03 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.008 -1.058 . . . . 0.0 113.355 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 95.1 p -56.02 -38.49 70.61 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.024 1.283 . . . . 0.0 113.845 169.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.09 -8.85 33.74 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 173.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -106.63 5.2 37.34 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.142 1.83 . . . . 0.0 113.815 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 20.7 p -57.35 -15.28 6.01 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -173.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.28 -33.17 2.17 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.011 1.725 . . . . 0.0 112.658 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 21.7 t -159.26 115.2 2.56 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.093 1.757 . . . . 0.0 107.347 177.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -57.7 -34.74 69.76 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -155.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -100.24 -29.32 12.53 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -169.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 99.4 t -54.42 -59.63 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 118.834 0.743 . . . . 0.0 110.695 -173.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.35 -26.76 68.33 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-O 116.101 -2.499 . . . . 0.0 114.507 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 66.4 mt -57.3 -39.47 75.83 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 121.519 2.66 . . . . 0.0 111.237 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 6.7 t-105 -70.25 -42.46 72.15 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.472 -0.768 . . . . 0.0 111.748 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -62.79 -27.1 69.5 Favored Glycine 0 CA--C 1.533 1.173 0 O-C-N 121.608 -0.682 . . . . 0.0 113.38 175.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -82.69 -31.37 28.61 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 129.901 3.28 . . . . 0.0 113.104 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 52.8 mt -81.19 -30.26 34.37 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.58 1.152 . . . . 0.0 111.906 171.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -58.94 -45.01 91.46 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 126.327 1.851 . . . . 0.0 112.291 159.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -63.13 -31.27 72.37 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.694 -0.628 . . . . 0.0 112.193 169.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.28 17.23 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 173.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 -108.01 -20.97 13.0 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.287 1.835 . . . . 0.0 112.89 172.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -70.03 153.7 95.18 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 126.025 1.73 . . . . 0.0 110.031 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.69 -57.28 1.06 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 CA-C-N 122.236 1.834 . . . . 0.0 116.019 -157.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 81.7 mt -68.34 -18.54 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 120.017 1.28 . . . . 0.0 111.834 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 37.2 m -89.44 -29.28 19.13 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 16.5 tt -79.75 -33.1 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 119.823 1.192 . . . . 0.0 110.701 168.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.09 -36.69 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 118.852 0.751 . . . . 0.0 110.213 165.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -72.02 -35.67 69.47 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.701 1.137 . . . . 0.0 111.789 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 24.1 tp -62.15 -49.31 76.34 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.729 0.412 . . . . 0.0 111.417 169.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 60.6 mt -60.78 -45.24 98.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.786 1.234 . . . . 0.0 111.084 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.2 t -68.27 -40.02 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.048 0.939 . . . . 0.0 112.002 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.1 p -69.73 -31.6 49.13 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 CA-C-N 121.331 1.878 . . . . 0.0 111.707 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 73.2 t -71.71 -45.03 68.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -54.86 -48.58 72.75 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 118.186 0.448 . . . . 0.0 111.297 171.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.0 m -57.12 -50.28 73.29 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.341 1.057 . . . . 0.0 112.847 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 21.6 ptp -69.14 -38.65 78.94 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 118.906 -0.569 . . . . 0.0 111.86 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 14.9 t -58.66 -42.12 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.336 1.054 . . . . 0.0 111.687 174.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 30.2 m -84.38 -30.84 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.32 -33.07 65.25 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.082 0.855 . . . . 0.0 111.813 160.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 48.9 t -84.56 -44.34 13.64 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.845 0.858 . . . . 0.0 112.958 -170.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 5.0 p -67.14 -21.51 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -169.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 122.61 108.22 1.94 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -159.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 97.4 p -73.37 41.21 0.11 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.84 2.056 . . . . 0.0 114.133 -173.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -157.21 166.7 32.46 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 128.621 2.769 . . . . 0.0 109.829 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -87.11 -90.61 1.0 Allowed Glycine 0 N--CA 1.468 0.775 0 C-N-CA 127.258 2.361 . . . . 0.0 107.357 -13.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -60.86 -37.15 81.13 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.648 -1.276 . . . . 0.0 112.442 169.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 24.6 t -85.89 -40.91 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 117.883 -1.527 . . . . 0.0 111.488 -148.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.1 -46.51 68.73 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.223 162.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.92 -56.06 11.9 Favored 'General case' 0 C--O 1.214 -0.765 0 O-C-N 123.815 0.697 . . . . 0.0 111.307 -171.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.1 t -54.2 -36.71 63.75 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.739 -1.226 . . . . 0.0 112.228 176.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 15.6 m -68.93 -56.71 7.0 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.243 -0.91 . . . . 0.0 112.506 174.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.33 -57.45 12.27 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 125.864 1.666 . . . . 0.0 111.953 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 59.5 mt -54.71 -79.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-O 123.413 1.578 . . . . 0.0 108.902 169.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -74.83 -34.96 62.42 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 113.946 -1.479 . . . . 0.0 108.358 -150.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -72.72 -52.87 8.94 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.025 1.298 . . . . 0.0 115.17 172.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.41 -36.94 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-N 120.747 2.273 . . . . 0.0 111.487 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -81.33 -20.94 39.64 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.4 -46.6 89.42 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.51 0.724 . . . . 0.0 109.734 164.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.79 -24.93 67.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.57 -0.728 . . . . 0.0 110.987 171.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -70.46 -46.43 63.85 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 122.015 2.189 . . . . 0.0 113.62 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 8.3 pt -72.47 -2.25 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 120.509 -1.37 . . . . 0.0 114.206 173.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 44.1 tp -87.23 -21.58 25.76 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.677 1.191 . . . . 0.0 113.213 164.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -80.53 -12.38 59.54 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.949 1.7 . . . . 0.0 111.959 175.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 16.4 tpp -35.84 -30.8 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 128.981 2.913 . . . . 0.0 114.031 147.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 10.1 mt -102.9 -9.74 19.62 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.617 1.567 . . . . 0.0 110.767 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 52.3 m170 -83.88 -15.05 49.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.179 1.392 . . . . 0.0 112.147 161.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.359 3.4 t -88.78 46.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 125.648 2.642 . . . . 0.0 111.019 146.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . 0.592 ' C ' ' H ' ' A' ' 244' ' ' GLN . 38.3 t0 -46.4 90.44 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 112.306 -2.224 . . . . 0.0 109.92 104.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -68.2 37.0 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 128.73 2.812 . . . . 0.0 111.947 171.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.592 ' H ' ' C ' ' A' ' 242' ' ' ASP . 6.9 mt-30 69.31 41.03 1.4 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 129.466 3.106 . . . . 0.0 114.424 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -170.86 19.88 0.07 OUTLIER Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.069 -1.406 . . . . 0.0 116.523 172.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 95.25 107.16 2.15 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 119.565 1.682 . . . . 0.0 109.989 -171.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 15.0 t -44.44 130.41 6.6 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.974 1.31 . . . . 0.0 113.684 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 69.1 m95 58.55 18.91 6.13 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.1 2.16 . . . . 0.0 116.643 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.235 1.414 . . . . 0.0 113.575 176.361 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.425 HG13 ' H ' ' A' ' 103' ' ' ARG . 12.0 m . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 119.543 -0.265 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 tp -45.9 127.49 8.22 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 130.587 3.555 . . . . 0.0 111.935 -12.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.442 ' HB1' ' H ' ' A' ' 105' ' ' HIS . . . -156.76 125.7 5.93 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 118.837 -2.414 . . . . 0.0 109.605 -11.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.425 ' H ' HG13 ' A' ' 100' ' ' VAL . 2.5 ptt180 -59.26 -28.06 66.37 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.833 -1.53 . . . . 0.0 111.487 155.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -73.4 -31.51 63.92 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.227 -0.92 . . . . 0.0 110.903 172.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.442 ' H ' ' HB1' ' A' ' 102' ' ' ALA . 83.6 t60 -69.0 -48.46 63.03 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.928 -1.107 . . . . 0.0 111.964 172.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 5.2 p -68.47 -34.97 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 118.273 0.488 . . . . 0.0 111.832 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -67.28 -35.16 78.93 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.193 -0.942 . . . . 0.0 110.429 172.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -57.57 -31.26 63.24 Favored Glycine 0 CA--C 1.545 1.958 0 C-N-CA 124.989 1.281 . . . . 0.0 113.841 163.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -72.26 -40.88 67.34 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.355 -1.086 . . . . 0.0 112.538 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.99 -43.53 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.705 1.202 . . . . 0.0 110.707 162.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.402 ' CG ' ' HA ' ' A' ' 177' ' ' SER . 19.6 m-30 -62.52 -45.63 92.11 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 117.433 -1.27 . . . . 0.0 112.552 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -53.39 -36.86 61.9 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.983 1.265 . . . . 0.0 113.045 170.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -73.62 -31.28 63.45 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.295 -0.878 . . . . 0.0 111.777 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.4 mt -68.35 -46.7 69.43 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.133 0.879 . . . . 0.0 110.572 168.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -70.71 -42.05 71.12 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.413 -165.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 25.9 ptt85 -75.81 156.52 84.52 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 123.858 0.863 . . . . 0.0 112.338 177.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -82.07 142.13 12.13 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.907 2.405 . . . . 0.0 111.498 167.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 75.3 p -147.74 156.92 43.25 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.561 1.544 . . . . 0.0 109.624 167.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.87 -36.04 78.24 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.016 166.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -64.66 -43.66 92.91 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -63.26 -46.2 87.97 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.292 0.951 . . . . 0.0 111.122 174.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 46.5 t -65.56 -33.76 76.67 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -62.08 -56.46 18.73 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.989 -1.07 . . . . 0.0 111.349 171.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.6 p -73.49 -41.08 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 120.721 -1.237 . . . . 0.0 113.207 -173.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -67.99 -50.9 52.82 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.665 0.786 . . . . 0.0 112.491 -173.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -68.14 -27.62 66.59 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.7 0.682 . . . . 0.0 111.991 -172.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -89.4 -30.4 18.38 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.4 -38.54 74.45 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 120.183 1.356 . . . . 0.0 112.529 158.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 19.4 t -58.28 -47.98 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 120.414 1.461 . . . . 0.0 111.884 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -59.66 -50.45 73.83 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.755 0.822 . . . . 0.0 113.193 172.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.57 -42.95 99.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -176.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.3 mt -63.38 -50.81 77.16 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.035 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.56 -36.46 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 119.926 1.239 . . . . 0.0 112.544 -173.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.1 tt -62.13 -47.71 83.35 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.277 1.031 . . . . 0.0 111.616 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 32.6 m -75.9 -40.89 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.747 0.703 . . . . 0.0 111.053 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 12.5 t -49.66 -58.27 5.6 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.351 1.86 . . . . 0.0 112.834 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 69.5 mt -77.28 -32.42 55.53 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.273 -0.892 . . . . 0.0 112.987 -173.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.9 mt -68.96 -46.14 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 120.038 1.29 . . . . 0.0 110.406 171.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -61.59 -30.33 70.61 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.806 175.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.8 m -60.08 -38.42 82.84 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.445 1.475 . . . . 0.0 113.212 172.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 50.7 t -67.27 -24.04 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 123.924 0.89 . . . . 0.0 111.807 174.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 46.2 mt -87.75 -48.33 7.94 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.292 1.037 . . . . 0.0 113.208 173.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 59.4 p -71.12 -12.41 61.48 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 127.497 2.319 . . . . 0.0 113.531 -171.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.7 t -70.63 -32.67 70.07 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.663 1.185 . . . . 0.0 111.444 170.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 48.4 mm -72.6 -33.35 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.712 0.805 . . . . 0.0 110.64 168.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -66.31 -33.29 75.39 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.271 0.628 . . . . 0.0 112.187 169.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -65.2 -40.86 94.76 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.843 1.257 . . . . 0.0 111.595 170.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -69.27 -34.4 74.69 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.338 0.655 . . . . 0.0 112.379 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.03 98.14 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.852 0.861 . . . . 0.0 111.722 167.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.13 -10.27 9.89 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 76.3 mt -70.78 -12.31 61.47 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.117 1.367 . . . . 0.0 113.738 166.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -152.56 -45.73 0.1 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -163.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.6 t -156.26 175.65 13.71 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.746 0.819 . . . . 0.0 110.833 -143.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.1 139.62 48.27 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 114.628 0.611 . . . . 0.0 114.628 -166.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.1 t -156.26 143.84 19.33 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -162.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 16.7 tp -87.18 7.89 26.27 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.882 1.273 . . . . 0.0 112.624 171.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -65.59 -10.98 40.27 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 119.546 -1.972 . . . . 0.0 114.093 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 53.7 p-90 -65.3 -26.46 68.08 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.057 -1.652 . . . . 0.0 112.492 166.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 51.0 tpp -75.36 -28.75 59.66 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.652 1.581 . . . . 0.0 112.261 174.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -61.24 -43.8 98.29 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.133 -0.979 . . . . 0.0 110.453 165.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.12 -35.26 73.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 118.096 -0.954 . . . . 0.0 111.3 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.43 -53.0 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 120.66 1.573 . . . . 0.0 111.745 170.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.8 mt -68.18 -36.8 80.16 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.239 0.927 . . . . 0.0 112.411 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 38.0 t -59.29 -41.47 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 120.666 1.576 . . . . 0.0 111.092 172.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.17 -31.13 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.502 -0.761 . . . . 0.0 111.05 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -59.66 -51.94 67.65 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.601 1.092 . . . . 0.0 111.752 165.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -62.47 -36.77 83.53 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 121.226 1.83 . . . . 0.0 112.055 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -62.31 -43.87 98.47 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 172.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 56.0 m -67.27 -32.81 74.06 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.401 -1.058 . . . . 0.0 110.895 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -65.42 -41.96 93.0 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 120.738 -1.226 . . . . 0.0 112.344 173.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -58.35 -45.71 87.66 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.529 0.604 . . . . 0.0 111.832 170.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.4 t -66.04 -38.18 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.816 0.846 . . . . 0.0 111.515 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 23.1 t -65.23 -38.83 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.004 1.322 . . . . 0.0 110.967 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -62.47 -34.26 76.49 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.585 1.084 . . . . 0.0 113.335 171.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 9.7 mt -67.96 -47.34 68.87 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.915 0.779 . . . . 0.0 111.875 169.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -61.91 -43.51 98.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 118.013 -0.994 . . . . 0.0 112.858 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.402 ' HA ' ' CG ' ' A' ' 111' ' ' TYR 0.265 43.0 p -65.49 -26.98 68.16 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 176.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -57.23 -25.14 58.62 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.801 1.182 . . . . 0.0 113.247 168.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.49 -9.65 65.17 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 126.098 1.808 . . . . 0.0 114.643 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 44.1 t -53.82 -40.34 66.3 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.263 1.025 . . . . 0.0 112.382 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 3.1 ptp85 -68.51 -57.83 5.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.577 0.751 . . . . 0.0 111.803 171.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 41.7 t -162.96 137.67 6.46 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.498 1.919 . . . . 0.0 108.009 169.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -60.28 -34.02 73.15 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -153.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -103.03 -27.19 12.74 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.209 1.004 . . . . 0.0 112.765 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 61.3 t -62.21 -68.08 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.068 1.347 . . . . 0.0 111.325 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -61.0 -31.04 75.06 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 119.128 -0.818 . . . . 0.0 112.195 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 7.9 tt -66.94 -39.93 87.45 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.61 1.564 . . . . 0.0 112.449 176.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 4.7 t-105 -60.26 -40.47 90.48 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 120.804 -1.185 . . . . 0.0 110.844 166.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -64.89 -30.31 77.65 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 122.226 0.903 . . . . 0.0 113.385 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 -76.3 -32.49 58.79 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.866 2.466 . . . . 0.0 112.312 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 75.1 mt -76.0 -35.35 59.59 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.943 1.297 . . . . 0.0 112.662 167.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 65.0 mtt-85 -59.67 -36.49 76.54 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.819 -1.176 . . . . 0.0 111.456 166.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -69.49 28.5 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 126.298 1.839 . . . . 0.0 113.994 170.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.66 27.95 1.21 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.598 2.359 . . . . 0.0 112.991 164.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -105.99 -37.08 6.76 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -149.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -77.86 146.81 72.92 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 117.265 -1.35 . . . . 0.0 109.868 172.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -45.22 -44.21 15.96 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.694 3.596 . . . . 0.0 116.901 -171.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -70.27 -30.38 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 119.353 0.979 . . . . 0.0 110.93 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 66.7 m -81.68 -26.83 34.38 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.509 1.523 . . . . 0.0 112.997 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.96 -48.14 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 163.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 65.5 mt -65.01 -30.08 49.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-O 118.689 -0.672 . . . . 0.0 111.566 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -71.53 -44.52 64.46 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.496 1.498 . . . . 0.0 110.542 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 43.4 tp -61.6 -44.29 97.28 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.635 0.774 . . . . 0.0 111.403 171.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 72.2 mt -63.26 -49.1 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 121.393 -0.817 . . . . 0.0 110.804 176.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.0 t -70.39 -33.96 56.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 117.098 -1.429 . . . . 0.0 112.427 -173.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.5 p -65.38 -34.76 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 121.568 1.986 . . . . 0.0 111.394 172.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 86.9 t -75.17 -38.47 41.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 O-C-N 121.372 -0.83 . . . . 0.0 110.063 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -55.75 -47.26 77.27 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.697 0.68 . . . . 0.0 110.82 168.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 20.0 m -56.16 -43.48 78.39 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.148 0.979 . . . . 0.0 111.783 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 58.6 ttm -75.55 -50.3 16.02 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.276 0.631 . . . . 0.0 111.752 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 56.0 t -56.06 -46.74 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.066 0.946 . . . . 0.0 111.837 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.406 ' HB ' ' HA ' ' A' ' 222' ' ' PHE . 13.9 m -77.01 -39.71 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 118.974 0.806 . . . . 0.0 113.035 -173.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -56.91 -32.87 66.37 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.919 0.887 . . . . 0.0 110.746 170.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 55.2 m -75.48 -52.15 11.36 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.376 1.471 . . . . 0.0 112.97 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.7 t -58.17 -40.25 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 125.265 1.426 . . . . 0.0 112.369 -171.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 139.35 154.66 6.41 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 123.595 0.617 . . . . 0.0 112.374 173.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 55.1 p -73.56 23.21 0.07 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -160.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm -156.41 165.39 36.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.477 1.911 . . . . 0.0 111.933 -160.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -78.01 -80.31 0.7 Allowed Glycine 0 N--CA 1.478 1.434 0 C-N-CA 127.462 2.458 . . . . 0.0 109.386 -9.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -84.77 -27.17 27.06 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.927 1.291 . . . . 0.0 110.827 161.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 73.5 t -76.7 -40.91 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 121.179 -0.951 . . . . 0.0 112.42 -145.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.406 ' HA ' ' HB ' ' A' ' 212' ' ' VAL . 0.0 OUTLIER -60.01 -39.81 87.07 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 169.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -74.17 -49.8 22.02 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.764 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 8.8 t -53.77 -38.4 64.42 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 121.123 1.783 . . . . 0.0 112.219 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 19.3 m -66.05 -56.85 9.48 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.505 -0.747 . . . . 0.0 112.357 173.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.54 -48.37 77.8 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.931 1.293 . . . . 0.0 112.496 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 67.2 mt -62.72 -84.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.79 0 O-C-N 119.255 -2.153 . . . . 0.0 109.133 169.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -71.87 -38.28 70.05 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.778 -152.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -71.05 -44.21 55.19 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 125.991 1.758 . . . . 0.0 114.32 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.5 mp -78.26 -30.18 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 118.773 1.286 . . . . 0.0 109.74 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -39.91 82.34 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 120.841 -1.162 . . . . 0.0 111.57 164.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -68.01 -41.48 82.14 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 117.385 -1.293 . . . . 0.0 110.73 -174.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 31.9 tp -57.43 -45.16 84.97 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.154 0.888 . . . . 0.0 110.856 167.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -59.09 -45.94 89.57 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -170.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.4 pt -66.93 -20.8 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 35.4 mt -66.88 -22.87 65.96 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.285 -0.884 . . . . 0.0 110.756 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -74.65 -11.35 60.16 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.263 -0.898 . . . . 0.0 111.731 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 81.2 mtp -45.79 -33.72 3.26 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 126.025 1.73 . . . . 0.0 113.1 153.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.3 mt -98.56 -14.02 20.14 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.346 1.459 . . . . 0.0 111.304 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . 0.426 ' C ' ' H ' ' A' ' 242' ' ' ASP . 50.0 m170 -75.31 -27.49 59.31 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.681 -0.637 . . . . 0.0 111.495 157.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.251 15.5 t -79.01 60.62 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 125.557 2.599 . . . . 0.0 110.027 157.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 244' ' ' GLN . 40.9 t0 -61.18 100.01 0.11 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 112.397 -2.183 . . . . 0.0 108.422 107.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -64.51 30.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 130.127 3.371 . . . . 0.0 113.526 171.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 242' ' ' ASP . 49.6 mt-30 74.66 38.5 0.48 Allowed 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 128.812 2.845 . . . . 0.0 113.837 170.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -166.46 12.22 0.07 OUTLIER Glycine 0 CA--C 1.537 1.433 0 CA-C-O 118.113 -1.382 . . . . 0.0 116.309 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 78.89 67.49 1.59 Allowed Glycine 0 N--CA 1.468 0.801 0 CA-C-N 120.083 1.942 . . . . 0.0 112.638 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 15.6 p -106.38 -177.68 3.43 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -156.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 9.3 m95 60.81 32.02 20.1 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 126.318 1.847 . . . . 0.0 112.826 -140.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 . . . . . 0 N--CA 1.479 0.98 0 O-C-N 119.338 -2.101 . . . . 0.0 111.996 -173.187 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.1 tp -89.44 92.16 9.01 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 116.658 -2.017 . . . . 0.0 105.56 124.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . 0.278 . . 61.79 57.85 2.1 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 110.785 -2.916 . . . . 0.0 115.738 142.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -49.47 -29.38 6.54 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.178 142.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.2 t -63.42 -33.28 75.21 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 168.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -79.85 -30.39 40.31 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.439 -1.413 . . . . 0.0 110.763 -174.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.3 m -84.1 -34.25 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-O 121.845 0.831 . . . . 0.0 112.334 -174.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -52.74 -47.83 67.12 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.321 -1.308 . . . . 0.0 110.348 156.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -56.12 -36.83 69.37 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 118.928 -0.929 . . . . 0.0 113.613 169.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -70.11 -36.07 74.59 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.942 1.371 . . . . 0.0 112.089 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 t -57.0 -57.02 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.49 0.716 . . . . 0.0 109.87 162.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -58.76 -45.79 88.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.483 0.313 . . . . 0.0 111.623 -172.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -67.68 -21.54 65.33 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -77.0 -36.45 56.4 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.349 0.977 . . . . 0.0 111.294 172.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.8 mt -62.0 -40.79 96.85 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.799 -0.563 . . . . 0.0 109.735 164.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -71.75 -44.0 64.83 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.973 -167.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -98.87 101.72 13.0 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 126.632 1.973 . . . . 0.0 110.683 -174.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -65.17 156.95 60.14 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.49 2.126 . . . . 0.0 114.97 -164.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 40.4 p -145.31 168.14 21.17 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 127.107 2.163 . . . . 0.0 107.692 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.1 -35.14 32.94 Favored Glycine 0 CA--C 1.536 1.389 0 O-C-N 121.627 -0.671 . . . . 0.0 112.282 164.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 33.9 m95 -69.13 -34.45 75.04 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -60.87 -51.18 70.38 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.66 1.118 . . . . 0.0 110.51 169.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 42.8 t -63.09 -37.19 86.23 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.265 0.626 . . . . 0.0 111.573 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -58.96 -59.26 5.75 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.023 0.44 . . . . 0.0 109.844 173.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.86 -49.37 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.012 0.525 . . . . 0.0 111.993 -168.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -68.39 -46.2 70.65 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -170.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -77.89 -27.92 49.76 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.566 -0.709 . . . . 0.0 112.113 -172.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -68.78 -44.86 72.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.997 165.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -51.78 -48.91 63.59 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 117.314 -1.327 . . . . 0.0 113.96 168.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . 0.265 0.9 OUTLIER -63.82 -41.5 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 121.76 2.073 . . . . 0.0 112.293 -179.126 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -67.27 -43.17 82.47 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.742 0.701 . . . . 0.0 111.849 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 85.4 mt -66.1 -41.85 90.05 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.612 0.365 . . . . 0.0 111.766 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 69.4 mt -64.26 -47.74 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 118.011 -0.995 . . . . 0.0 111.194 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -40.32 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 120.495 1.498 . . . . 0.0 111.378 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 33.8 tp -59.43 -43.69 93.04 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.624 1.17 . . . . 0.0 111.658 175.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.8 t -64.3 -45.79 95.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 118.694 -0.669 . . . . 0.0 111.356 171.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 90.5 m -63.7 -39.98 95.64 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.172 0.896 . . . . 0.0 112.385 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 87.5 mt -79.49 -37.27 37.17 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.419 -0.801 . . . . 0.0 112.686 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.3 mt -59.25 -48.32 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.301 0.572 . . . . 0.0 109.94 167.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -60.96 -36.3 79.03 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-O 117.726 -1.131 . . . . 0.0 110.845 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.9 m -55.41 -44.49 76.24 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 121.538 1.972 . . . . 0.0 112.444 -176.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.3 m -79.28 -16.04 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 78.4 mt -81.98 -28.41 32.66 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 120.074 1.306 . . . . 0.0 113.554 161.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 37.8 t -78.5 -38.67 40.2 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.808 1.643 . . . . 0.0 113.579 -160.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.668 ' HG1' ' NE2' ' A' ' 147' ' ' GLN 0.336 3.4 t -74.28 -17.19 60.89 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 120.295 1.407 . . . . 0.0 113.312 -175.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.1 mp -58.89 -43.13 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 120.587 -1.32 . . . . 0.0 110.959 159.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -69.52 -41.04 76.54 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.479 1.111 . . . . 0.0 110.669 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.668 ' NE2' ' HG1' ' A' ' 144' ' ' THR . 6.9 tt0 -59.04 -41.6 88.21 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.779 1.232 . . . . 0.0 111.647 171.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -67.99 -40.83 83.0 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.782 -1.199 . . . . 0.0 110.922 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.94 -33.47 73.23 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.615 0.766 . . . . 0.0 111.481 172.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.28 -8.66 8.98 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 72.3 mt -70.71 -11.93 61.25 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 120.249 -1.532 . . . . 0.0 113.482 166.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.49 -45.54 0.17 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -170.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.1 t -157.52 -178.66 7.5 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.806 0.813 . . . . 0.0 112.402 -138.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.13 134.99 52.11 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 124.609 1.099 . . . . 0.0 114.445 -170.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.5 t -155.07 137.52 15.01 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.227 1.011 . . . . 0.0 112.735 -160.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.6 tp -81.09 6.13 14.58 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.988 1.315 . . . . 0.0 113.342 166.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -64.93 -9.01 17.98 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 119.664 -1.897 . . . . 0.0 114.484 -173.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -68.73 -28.33 66.73 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.22 1.008 . . . . 0.0 112.129 167.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 50.6 tpp -66.24 -25.4 66.88 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.985 1.266 . . . . 0.0 111.862 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -63.99 -45.28 89.7 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.21 -0.931 . . . . 0.0 111.276 170.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 33.5 mt -57.48 -43.23 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.41 1.084 . . . . 0.0 111.087 172.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.3 t -61.35 -42.85 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 121.391 -0.818 . . . . 0.0 112.271 176.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 10.7 mt -71.84 -36.17 70.09 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.618 1.099 . . . . 0.0 113.233 173.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 45.2 t -59.54 -34.05 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 O-C-N 120.809 -1.182 . . . . 0.0 110.937 169.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 81.6 t -82.15 -26.75 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.315 1.046 . . . . 0.0 111.236 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -61.41 -56.72 17.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.29 1.404 . . . . 0.0 110.225 166.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -64.84 -39.09 93.01 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.221 0.919 . . . . 0.0 112.071 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -61.8 -42.85 99.8 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.638 1.113 . . . . 0.0 113.255 175.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.8 m -78.6 -30.31 46.55 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.997 1.398 . . . . 0.0 111.701 175.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.75 -41.11 97.23 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.898 -1.126 . . . . 0.0 111.851 170.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -53.09 -45.98 68.44 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.72 0.691 . . . . 0.0 110.571 169.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 92.5 t -68.22 -37.66 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.407 0.683 . . . . 0.0 112.006 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 39.3 t -63.21 -36.05 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 121.215 -0.928 . . . . 0.0 112.342 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -58.45 -38.8 78.27 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.279 0.945 . . . . 0.0 111.954 169.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 33.3 mt -72.97 -34.28 66.37 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -70.78 -39.84 72.96 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 173.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 17.6 p -62.35 -20.96 64.92 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 120.439 -1.413 . . . . 0.0 114.724 165.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -70.77 -6.63 39.1 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 120.203 1.365 . . . . 0.0 113.862 163.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -154.97 44.69 0.55 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.553 1.549 . . . . 0.0 112.986 -160.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 25.8 p -51.94 -24.53 6.55 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.028 0.931 . . . . 0.0 113.248 169.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.92 -53.41 2.28 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.76 2.024 . . . . 0.0 110.175 161.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.8 m -76.04 48.14 0.48 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 128.42 2.688 . . . . 0.0 112.563 -172.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -55.52 -19.24 9.18 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.939 2.496 . . . . 0.0 115.447 -169.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -114.18 -29.19 7.04 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 169.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 2.0 t -65.15 -61.68 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 119.907 1.231 . . . . 0.0 111.197 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -73.44 -28.45 65.73 Favored Glycine 0 C--O 1.222 -0.647 0 O-C-N 121.929 -0.482 . . . . 0.0 112.525 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 3.0 tt -53.34 -41.03 65.34 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.509 0.724 . . . . 0.0 110.773 166.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -85.93 -18.21 33.32 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.02 -37.08 16.62 Favored Glycine 0 N--CA 1.467 0.727 0 O-C-N 119.728 -1.858 . . . . 0.0 110.418 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -67.13 -25.49 66.21 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.942 1.697 . . . . 0.0 112.704 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 21.7 mt -76.0 -1.32 25.15 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 165.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 37.6 mtm105 -122.98 -8.11 8.34 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.321 1.848 . . . . 0.0 113.432 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -72.81 66.68 0.77 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.936 1.694 . . . . 0.0 108.409 149.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -148.36 82.26 1.48 Allowed 'General case' 0 C--O 1.239 0.501 0 C-N-CA 127.625 2.37 . . . . 0.0 107.432 -156.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 48.8 ttt85 -147.42 -73.69 0.2 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -154.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -72.83 154.94 91.04 Favored Pre-proline 0 N--CA 1.474 0.764 0 CA-C-N 119.28 0.945 . . . . 0.0 112.865 175.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.92 -45.61 24.23 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.893 3.062 . . . . 0.0 116.704 -168.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 69.4 mt -64.15 -35.4 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 121.525 1.966 . . . . 0.0 111.554 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 54.6 p -70.51 -31.1 68.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.8 1.182 . . . . 0.0 112.937 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.4 mm -75.39 -40.52 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.443 1.097 . . . . 0.0 111.13 172.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 56.4 mt -61.91 -41.78 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.146 0.978 . . . . 0.0 110.429 171.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.73 -43.21 97.16 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.834 1.654 . . . . 0.0 111.794 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 68.4 tp -60.98 -49.25 78.22 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.925 0.89 . . . . 0.0 112.687 170.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 61.9 mt -62.28 -44.55 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.167 -0.958 . . . . 0.0 110.53 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.0 t -69.11 -34.53 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 116.823 -1.561 . . . . 0.0 113.073 -174.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.1 p -68.22 -33.08 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 121.677 2.035 . . . . 0.0 111.6 173.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 82.4 t -77.37 -40.37 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 O-C-N 121.456 -0.777 . . . . 0.0 109.988 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -54.76 -52.03 63.84 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.118 0.967 . . . . 0.0 110.758 167.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.4 m -56.06 -47.42 77.96 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.807 0.843 . . . . 0.0 112.344 -178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 72.5 mtm -59.73 -48.72 80.57 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 174.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.57 -44.04 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 118.547 0.612 . . . . 0.0 112.323 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 27.2 m -84.67 -24.81 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 117.525 -1.226 . . . . 0.0 112.368 -167.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 38.9 mt -63.1 -30.69 71.79 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.561 1.528 . . . . 0.0 112.043 156.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 43.3 t -83.67 -45.73 13.1 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.841 0.856 . . . . 0.0 113.166 -164.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 9.5 t -50.94 -30.16 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 125.975 1.71 . . . . 0.0 114.474 -173.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 131.52 157.41 8.76 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 126.603 2.049 . . . . 0.0 109.771 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 90.3 p -81.76 34.44 0.39 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.89 -1.359 . . . . 0.0 113.663 -168.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -171.05 177.94 3.53 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 130.289 3.436 . . . . 0.0 109.092 176.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.546 ' C ' ' H ' ' A' ' 221' ' ' VAL . . . 63.36 112.48 0.01 OUTLIER Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 115.765 -3.112 . . . . 0.0 107.626 -111.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.43 -8.41 0.13 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.845 0.831 . . . . 0.0 111.89 160.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.546 ' H ' ' C ' ' A' ' 219' ' ' GLY . 0.5 OUTLIER -67.66 -44.45 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 127.35 2.26 . . . . 0.0 112.138 174.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -50.12 -52.13 37.55 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.345 1.458 . . . . 0.0 110.652 169.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.33 -59.89 3.28 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.494 1.118 . . . . 0.0 110.418 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 13.8 t -59.8 -42.12 92.73 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 21.6 m -69.13 -45.06 71.07 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.14 -0.975 . . . . 0.0 110.893 -173.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -53.36 -62.98 1.3 Allowed 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 126.073 1.749 . . . . 0.0 110.975 170.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.4 mt -56.4 -72.71 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 123.52 1.629 . . . . 0.0 111.141 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -73.7 -44.72 55.75 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 112.715 -2.039 . . . . 0.0 106.959 -152.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -65.87 -52.88 34.28 Favored Glycine 0 N--CA 1.466 0.667 0 C-N-CA 125.021 1.296 . . . . 0.0 114.41 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.72 -38.72 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.489 1.645 . . . . 0.0 111.275 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -82.82 -28.86 29.92 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -175.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -55.38 -43.4 75.12 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.051 1.341 . . . . 0.0 109.27 168.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 57.0 tp -65.07 -38.21 90.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 117.723 -1.132 . . . . 0.0 111.816 173.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -66.09 -37.94 87.02 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 121.899 2.136 . . . . 0.0 112.547 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 35.6 pt -69.52 -10.83 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 114.981 1.475 . . . . 0.0 114.981 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 11.1 mt -78.96 -20.6 48.79 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 120.918 -1.114 . . . . 0.0 110.944 167.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . 0.268 53.9 mtp180 -73.08 -19.28 61.2 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.668 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 89.2 mtp -48.63 -16.26 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 129.7 3.2 . . . . 0.0 117.059 156.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.6 pp -143.81 -19.98 0.59 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.679 1.127 . . . . 0.0 112.913 -174.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -75.63 -8.41 56.72 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.645 1.178 . . . . 0.0 111.853 157.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 3.2 p -56.31 125.12 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.152 0 CA-C-O 124.188 1.947 . . . . 0.0 107.858 171.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . 0.588 ' C ' ' H ' ' A' ' 244' ' ' GLN . 27.5 t0 -119.84 97.23 5.52 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 110.592 -3.004 . . . . 0.0 109.653 150.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 27.1 ttt-85 -64.56 18.33 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.176 1.39 . . . . 0.0 113.113 157.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.588 ' H ' ' C ' ' A' ' 242' ' ' ASP 0.415 8.2 pt20 74.82 51.77 0.08 Allowed 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 131.634 3.974 . . . . 0.0 114.096 159.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -157.78 3.96 0.14 Allowed Glycine 0 CA--C 1.541 1.686 0 CA-C-N 114.211 -1.359 . . . . 0.0 114.23 164.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 87.46 75.58 1.27 Allowed Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.061 1.43 . . . . 0.0 110.911 -163.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 4.5 m -59.01 155.51 13.41 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.081 1.752 . . . . 0.0 112.466 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 99.0 m95 55.1 38.74 30.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.61 1.964 . . . . 0.0 115.302 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 45.1 ttm-85 . . . . . 0 C--O 1.25 1.129 0 C-N-CA 124.958 1.303 . . . . 0.0 112.81 179.465 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.4 t -114.68 -43.78 3.12 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 127.23 2.212 . . . . 0.0 110.144 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -73.27 56.23 0.47 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.008 1.723 . . . . 0.0 112.274 167.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.3 p -169.89 -36.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 130.491 3.516 . . . . 0.0 109.581 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -83.6 -49.89 8.75 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.632 1.173 . . . . 0.0 109.661 170.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -55.45 -24.26 37.74 Favored Glycine 0 CA--C 1.537 1.433 0 O-C-N 120.722 -1.236 . . . . 0.0 113.006 164.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . 0.275 0.3 OUTLIER -77.22 -42.57 36.88 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.29 1.036 . . . . 0.0 112.391 174.141 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 t -53.39 -52.05 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.68 1.192 . . . . 0.0 110.336 165.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -72.29 -9.64 58.75 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -84.96 -46.22 11.44 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 119.464 1.029 . . . . 0.0 110.527 162.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -66.65 -46.1 76.84 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.344 1.058 . . . . 0.0 111.434 -169.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pp -71.37 -14.29 62.13 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -109.11 -32.54 7.19 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.722 0.809 . . . . 0.0 113.178 -172.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -80.63 111.5 23.59 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.6 1.16 . . . . 0.0 111.621 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -69.1 119.99 6.91 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.928 1.752 . . . . 0.0 110.066 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.0 p -145.43 178.68 7.93 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.855 1.262 . . . . 0.0 108.84 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -53.84 -42.29 68.83 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.222 -0.766 . . . . 0.0 111.518 164.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -66.59 -47.02 74.04 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -59.08 -50.54 73.68 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.933 0.788 . . . . 0.0 109.795 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 13.0 t -56.75 -50.41 72.32 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.27 0.628 . . . . 0.0 111.752 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -60.55 -52.13 66.5 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 121.774 -0.579 . . . . 0.0 112.25 -174.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.8 t -87.31 -39.52 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.343 -0.848 . . . . 0.0 113.172 -170.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -69.59 -41.5 75.7 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.351 0.66 . . . . 0.0 111.016 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -81.39 -25.59 36.14 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -176.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -57.61 -51.63 68.74 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.498 1.044 . . . . 0.0 110.857 161.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.16 -43.13 73.97 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 173.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . 0.289 1.2 m -63.85 -42.26 95.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-N 121.55 1.977 . . . . 0.0 112.114 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -66.5 -42.72 86.95 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.093 1.315 . . . . 0.0 111.593 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.77 -48.38 81.91 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.905 0.482 . . . . 0.0 109.913 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.04 -43.68 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 117.933 -1.032 . . . . 0.0 111.018 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.95 -39.49 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 120.592 1.542 . . . . 0.0 113.158 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 63.3 tp -63.53 -45.49 90.37 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.955 1.302 . . . . 0.0 111.032 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.69 -53.25 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.504 0.722 . . . . 0.0 110.781 174.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 63.7 m -61.42 -35.58 77.95 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.479 1.512 . . . . 0.0 113.09 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.4 mt -81.08 -37.53 28.83 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.166 1.348 . . . . 0.0 113.552 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.57 -44.44 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 119.258 0.935 . . . . 0.0 109.511 168.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -64.34 -31.71 73.03 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-O 117.614 -1.184 . . . . 0.0 112.409 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.4 t -63.45 -43.59 96.94 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 121.103 1.774 . . . . 0.0 112.394 176.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 90.2 t -59.7 -39.53 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.764 1.226 . . . . 0.0 111.612 174.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 30.6 tp -71.72 -47.31 54.78 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.367 1.067 . . . . 0.0 112.358 174.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.9 t -59.53 -37.59 78.77 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.744 2.418 . . . . 0.0 112.929 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.8 t -76.77 1.7 16.51 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.0 -1.062 . . . . 0.0 113.027 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.0 mm -113.26 -35.65 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 127.225 2.21 . . . . 0.0 112.165 165.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -55.55 -31.53 62.22 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.282 1.033 . . . . 0.0 113.174 168.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -61.52 -22.09 64.82 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -93.42 -28.53 16.08 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.207 1.003 . . . . 0.0 111.702 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.36 -35.09 79.76 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.087 0.955 . . . . 0.0 111.067 168.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.91 -6.55 3.92 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.145 1.378 . . . . 0.0 114.396 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.4 mt -84.46 -15.3 46.55 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.382 1.473 . . . . 0.0 113.414 170.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.25 -38.87 1.06 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -163.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.8 t -157.45 177.26 11.63 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.429 -0.794 . . . . 0.0 111.984 -148.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -72.01 156.24 52.3 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 121.519 0.51 . . . . 0.0 113.042 173.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.7 t -164.26 151.58 11.88 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.548 -0.972 . . . . 0.0 112.337 -166.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 33.9 mt -73.04 -0.12 13.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.388 1.475 . . . . 0.0 113.584 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -54.34 -26.32 29.1 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.605 1.562 . . . . 0.0 114.449 -173.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -52.59 -32.3 40.62 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.743 1.217 . . . . 0.0 114.071 171.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 17.8 tpt -71.06 -18.63 62.55 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.248 0.619 . . . . 0.0 112.562 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -67.42 -38.45 84.62 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.674 -1.266 . . . . 0.0 111.664 169.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.6 mp -66.87 -37.49 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 122.845 0.458 . . . . 0.0 110.384 174.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.65 -49.95 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.568 0.747 . . . . 0.0 111.698 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.8 mt -71.86 -28.99 63.91 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 20.5 t -61.36 -40.06 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 120.338 1.426 . . . . 0.0 111.951 165.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.9 t -68.71 -37.01 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 119.205 0.911 . . . . 0.0 111.047 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -57.89 -56.72 18.35 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.812 0.733 . . . . 0.0 111.272 168.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -67.03 -38.88 86.68 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.464 1.029 . . . . 0.0 113.392 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -61.72 -45.61 95.91 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.877 0.751 . . . . 0.0 111.61 172.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 89.2 m -63.14 -43.39 98.49 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 117.617 0.709 . . . . 0.0 111.382 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -62.18 -33.01 73.71 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.076 1.75 . . . . 0.0 112.864 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -66.38 -45.77 78.94 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.39 -0.819 . . . . 0.0 111.757 170.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.8 t -70.97 -32.22 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.964 0.906 . . . . 0.0 112.25 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.6 t -60.62 -37.79 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.344 1.458 . . . . 0.0 111.919 174.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 37.0 mtm180 -62.65 -43.18 99.47 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.531 0.605 . . . . 0.0 111.998 167.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 48.6 mt -62.89 -32.23 73.45 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.996 -1.065 . . . . 0.0 113.447 175.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 29.4 m0 -70.66 -35.78 73.04 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.277 -0.889 . . . . 0.0 113.241 170.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 94.2 p -78.59 13.53 1.59 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 121.153 1.797 . . . . 0.0 114.863 165.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -47.9 -44.52 29.73 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.58 1.082 . . . . 0.0 111.43 160.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -162.72 23.49 0.2 Allowed Glycine 0 CA--C 1.531 1.087 0 CA-C-O 118.372 -1.238 . . . . 0.0 115.336 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 62.5 m 69.13 -39.95 0.44 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.004 2.122 . . . . 0.0 116.574 168.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.31 -9.32 15.5 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.735 1.614 . . . . 0.0 113.837 164.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.495 ' HB2' ' H ' ' A' ' 186' ' ' GLY . 86.9 p -72.08 25.73 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.689 2.396 . . . . 0.0 115.465 -169.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.31 -0.52 17.33 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 -158.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -109.94 -43.37 4.01 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.916 1.287 . . . . 0.0 111.112 153.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.62 -73.42 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.867 1.267 . . . . 0.0 112.832 -170.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.495 ' H ' ' HB2' ' A' ' 182' ' ' SER . . . -78.68 -9.42 87.08 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.212 1.387 . . . . 0.0 113.946 175.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.451 HD13 ' C ' ' A' ' 187' ' ' LEU . 0.4 OUTLIER -55.56 -44.41 76.79 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.927 0.863 . . . . 0.0 109.913 167.701 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 34.6 t-105 -76.3 -50.31 14.69 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.671 -0.643 . . . . 0.0 112.289 161.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -56.58 -33.8 63.13 Favored Glycine 0 CA--C 1.535 1.307 0 N-CA-C 116.513 1.365 . . . . 0.0 116.513 -167.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -83.88 -21.52 31.92 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.328 1.564 . . . . 0.0 113.841 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.423 HD21 HD13 ' A' ' 203' ' ' LEU . 2.5 tt -73.02 -45.18 59.2 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -55.24 -39.09 69.33 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.235 166.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -70.27 -15.15 62.86 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -80.71 57.93 3.13 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 120.849 -1.157 . . . . 0.0 113.36 -171.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 43.3 mtt-85 -93.69 -14.37 26.44 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.221 1.808 . . . . 0.0 115.295 -161.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -77.57 164.7 56.39 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 124.695 1.198 . . . . 0.0 111.087 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -60.25 -46.3 19.07 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.704 1.602 . . . . 0.0 114.274 -160.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 50.9 mm -66.67 -34.78 72.31 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 CA-C-N 117.975 0.352 . . . . 0.0 111.281 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 15.9 m -69.07 -37.14 78.34 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.282 1.433 . . . . 0.0 112.507 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 30.1 mm -66.8 -42.99 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.561 0.744 . . . . 0.0 110.718 170.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.1 mt -62.56 -41.58 92.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 O-C-N 121.175 -0.953 . . . . 0.0 111.051 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -64.91 -43.05 94.11 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.426 1.89 . . . . 0.0 110.181 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.423 HD13 HD21 ' A' ' 191' ' ' LEU . 45.9 tp -59.41 -50.51 73.67 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 169.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 44.2 mt -60.03 -43.39 92.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 O-C-N 121.392 -0.817 . . . . 0.0 111.226 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.7 t -72.68 -29.23 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 117.667 -1.158 . . . . 0.0 112.471 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.48 -39.01 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 121.55 1.977 . . . . 0.0 111.174 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 28.6 m -74.44 -35.68 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 118.367 0.53 . . . . 0.0 111.189 176.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.39 -45.25 84.68 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 118.202 0.455 . . . . 0.0 111.407 168.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 36.0 t -61.71 -38.42 87.81 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.345 1.458 . . . . 0.0 112.118 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 36.3 mmt -71.67 -41.03 69.2 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 171.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 10.3 t -60.49 -38.84 79.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 118.642 0.655 . . . . 0.0 111.052 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.415 HG21 ' CB ' ' A' ' 225' ' ' SER . 3.4 t -61.34 -46.32 96.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 127.624 2.369 . . . . 0.0 111.493 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 61.5 mt -58.94 -41.18 86.77 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.475 1.034 . . . . 0.0 111.568 166.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 11.4 t -74.48 -31.45 62.22 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -165.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 84.9 t -66.76 -20.25 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.203 1.001 . . . . 0.0 111.56 173.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.41 156.47 21.35 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 124.295 0.95 . . . . 0.0 111.619 -166.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 41.2 p -62.01 17.86 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 128.519 2.727 . . . . 0.0 115.203 172.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 15.3 mttp -166.34 174.27 9.24 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 129.714 3.206 . . . . 0.0 110.012 -176.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 69.5 104.92 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 105.269 -3.133 . . . . 0.0 105.269 -113.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -59.4 3.74 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.936 0 O-C-N 121.744 -0.857 . . . . 0.0 112.211 170.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 23.2 m -79.7 -35.12 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 127.296 2.238 . . . . 0.0 112.71 167.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.2 -47.37 68.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.288 1.404 . . . . 0.0 109.799 163.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -62.44 -52.49 63.35 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.08 0.552 . . . . 0.0 111.496 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.88 -35.36 74.65 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.456 1.025 . . . . 0.0 112.316 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.415 ' CB ' HG21 ' A' ' 212' ' ' VAL . 17.0 m -75.18 -36.72 61.45 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.489 1.041 . . . . 0.0 112.773 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.28 -46.91 76.16 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.482 -0.761 . . . . 0.0 110.308 169.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.0 mt -66.79 -82.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 125.301 1.44 . . . . 0.0 110.974 172.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.49 ' HA ' ' CD1' ' A' ' 232' ' ' PHE . 48.1 mtt180 -77.74 14.52 1.04 Allowed 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 130.854 3.661 . . . . 0.0 114.573 -170.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -124.1 -59.58 0.18 Allowed Glycine 0 N--CA 1.462 0.382 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 162.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . 0.343 0.3 OUTLIER -99.97 -2.66 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -163.577 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.42 -39.79 11.79 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 121.229 -0.919 . . . . 0.0 111.871 145.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.49 ' CD1' ' HA ' ' A' ' 228' ' ' ARG . 1.7 m-30 -57.05 -30.57 64.36 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -177.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 7.1 tp -68.88 -31.41 70.32 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.756 -0.59 . . . . 0.0 112.37 172.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -75.45 -35.72 60.86 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.052 1.341 . . . . 0.0 112.505 -168.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -26.71 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.248 1.019 . . . . 0.0 111.639 170.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 62.2 mt -70.92 -28.85 64.81 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.79 0.805 . . . . 0.0 110.44 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -75.6 -25.08 56.68 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.065 2.146 . . . . 0.0 111.914 -171.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 66.6 mtp -46.1 -29.03 1.36 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.859 2.064 . . . . 0.0 115.525 155.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 20.0 mt -112.49 -31.26 6.85 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.858 1.263 . . . . 0.0 109.908 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.43 16.59 0.1 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.931 1.692 . . . . 0.0 114.019 155.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.505 -0.756 0 CA-C-O 124.273 1.987 . . . . 0.0 110.875 -170.175 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.528 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.48 -21.72 12.02 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.037 0.935 . . . . 0.0 112.074 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -57.19 -39.76 76.01 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.501 1.5 . . . . 0.0 112.451 168.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.4 p -61.98 -21.7 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 126.606 1.962 . . . . 0.0 113.682 171.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -95.51 -31.42 13.35 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.802 -0.562 . . . . 0.0 111.379 173.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -50.96 -26.47 11.38 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.289 1.424 . . . . 0.0 112.481 162.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -63.44 -48.85 76.06 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.776 0.831 . . . . 0.0 111.714 172.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.3 -57.36 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.956 0.902 . . . . 0.0 110.47 167.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -58.93 -46.21 88.5 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.497 1.119 . . . . 0.0 112.39 -167.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -65.86 -25.99 67.45 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 171.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -77.77 -34.93 52.15 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.131 1.332 . . . . 0.0 110.718 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 mt -59.67 -49.15 78.85 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 162.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -74.28 -32.01 62.75 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.162 -162.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -104.88 92.2 4.99 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 127.069 2.148 . . . . 0.0 110.711 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -58.22 128.3 28.14 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.129 1.886 . . . . 0.0 109.678 173.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.1 p -155.69 165.75 35.59 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.414 1.886 . . . . 0.0 107.805 -163.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -49.24 -42.29 32.29 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 118.957 -0.913 . . . . 0.0 111.466 175.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -75.4 -39.07 59.47 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.621 1.71 . . . . 0.0 115.568 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.463 ' HE3' ' CZ ' ' A' ' 125' ' ' TYR . 77.5 tttt -57.06 -50.54 72.44 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.679 1.582 . . . . 0.0 108.855 172.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 46.6 t -57.33 -43.8 83.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.288 1.835 . . . . 0.0 111.867 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -59.08 -57.01 14.94 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.13 -0.981 . . . . 0.0 111.208 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.1 m -81.87 -32.06 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -166.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.463 ' CZ ' ' HE3' ' A' ' 121' ' ' LYS . 6.4 m-85 -64.04 -34.46 78.07 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.216 0.916 . . . . 0.0 111.381 176.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -77.48 -43.11 33.38 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.846 0.748 . . . . 0.0 110.307 -171.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -67.06 -38.51 85.92 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.255 -0.879 . . . . 0.0 112.446 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.09 -40.24 76.58 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 120.172 1.351 . . . . 0.0 113.14 168.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.84 -41.98 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 121.308 1.867 . . . . 0.0 111.412 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -63.96 -41.93 97.44 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.59 0.632 . . . . 0.0 112.081 175.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.1 tp -73.72 -44.42 56.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.841 0.456 . . . . 0.0 111.892 -173.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.3 mp -67.39 -40.81 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 O-C-N 121.031 -1.043 . . . . 0.0 111.872 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.76 -44.78 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 120.465 1.484 . . . . 0.0 112.062 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 23.7 tp -54.67 -56.36 19.91 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.723 1.609 . . . . 0.0 111.469 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 55.3 t -65.18 -44.39 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 122.715 0.406 . . . . 0.0 111.416 -174.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 73.0 m -71.53 -35.04 70.55 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 91.3 mt -76.73 -37.51 55.87 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.431 1.468 . . . . 0.0 112.521 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 87.7 mt -59.91 -42.25 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 118.852 0.751 . . . . 0.0 109.312 169.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -64.49 -40.13 95.09 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 115.805 -2.045 . . . . 0.0 111.99 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.5 m -49.44 -44.47 45.6 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 121.346 1.884 . . . . 0.0 113.123 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 70.7 t -60.16 -34.91 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.157 0.983 . . . . 0.0 111.88 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.8 tp -85.44 -44.81 12.42 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 169.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 24.2 p -67.69 -30.04 69.46 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.931 1.293 . . . . 0.0 113.252 -167.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.2 t -75.05 -11.64 60.14 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.562 -0.711 . . . . 0.0 112.769 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' A' ' 145' ' ' ILE . 4.5 mm -97.36 -46.89 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 126.069 1.748 . . . . 0.0 111.771 170.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -55.21 -34.1 63.64 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.663 1.185 . . . . 0.0 112.596 173.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -68.13 -21.63 64.92 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.283 -1.51 . . . . 0.0 114.991 173.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -75.38 -26.93 58.88 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 121.05 1.75 . . . . 0.0 109.916 171.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -72.99 -30.09 63.54 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.286 -0.884 . . . . 0.0 112.174 167.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -56.48 -27.41 57.0 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.764 -1.21 . . . . 0.0 114.002 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 73.1 mt -57.35 -28.41 63.12 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.651 1.18 . . . . 0.0 113.688 173.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.11 -42.28 2.02 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.648 1.579 . . . . 0.0 114.451 -165.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.8 t -155.6 -172.7 4.24 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.758 0.79 . . . . 0.0 111.751 -147.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -70.98 140.93 32.08 Favored Glycine 0 CA--C 1.533 1.159 0 O-C-N 121.167 -0.958 . . . . 0.0 114.114 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.8 t -166.21 139.18 4.02 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.367 1.067 . . . . 0.0 112.104 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.5 3.19 2.5 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 171.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -56.79 -10.49 1.06 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.005 1.722 . . . . 0.0 113.686 166.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 33.7 p-90 -62.29 -24.58 67.38 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.861 -1.15 . . . . 0.0 112.787 167.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 69.0 mtm -73.9 -16.89 61.1 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.968 -1.082 . . . . 0.0 113.789 171.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -67.59 -41.35 84.24 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.606 1.548 . . . . 0.0 109.942 165.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 7.2 mt -56.6 -38.93 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 118.419 0.554 . . . . 0.0 111.85 170.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.46 -52.27 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 121.199 -0.938 . . . . 0.0 112.209 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 13.1 mt -67.27 -26.55 66.61 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.289 0.95 . . . . 0.0 112.195 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 6.2 t -64.49 -35.39 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 119.999 -1.688 . . . . 0.0 111.397 169.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 73.1 t -76.48 -30.4 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 118.72 -0.657 . . . . 0.0 110.504 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -62.35 -48.31 80.34 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 119.638 1.108 . . . . 0.0 112.261 167.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -69.04 -39.23 79.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.364 1.438 . . . . 0.0 112.581 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -54.05 -45.85 71.22 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 119.286 0.948 . . . . 0.0 112.954 166.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.9 m -62.05 -40.58 96.26 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.462 0.705 . . . . 0.0 111.707 172.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -60.1 -39.66 86.91 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.485 1.493 . . . . 0.0 112.912 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -71.12 -43.16 68.21 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.94 0.791 . . . . 0.0 111.961 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 90.1 t -72.38 -34.57 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 118.828 -0.605 . . . . 0.0 111.708 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 15.4 t -58.84 -37.23 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.114 1.366 . . . . 0.0 111.542 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -59.72 -46.78 88.07 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.471 1.032 . . . . 0.0 112.049 170.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.03 -23.42 66.55 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 120.456 -1.403 . . . . 0.0 114.288 172.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 54.5 m0 -76.09 -13.57 60.2 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 168.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 6.6 p -61.8 -36.8 82.19 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 121.746 2.066 . . . . 0.0 111.079 164.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.44 -26.62 66.88 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 165.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -68.15 0.78 10.31 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.449 1.976 . . . . 0.0 114.954 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 9.0 t -63.14 -31.87 73.12 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.711 1.756 . . . . 0.0 112.12 165.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.22 -47.58 0.06 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.315 1.446 . . . . 0.0 113.057 164.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 24.4 m -71.74 43.18 0.09 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 128.52 2.728 . . . . 0.0 112.513 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -49.01 -36.52 17.93 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 130.592 3.557 . . . . 0.0 113.53 -170.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -120.35 -36.8 3.15 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 124.374 1.046 . . . . 0.0 112.195 175.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 40.7 t -56.44 -59.42 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.437 1.095 . . . . 0.0 110.852 176.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -74.65 -35.83 50.17 Favored Glycine 0 C--O 1.222 -0.595 0 C-N-CA 124.84 1.21 . . . . 0.0 112.258 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.59 -47.8 75.87 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.956 1.378 . . . . 0.0 112.472 172.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' TRP . . . . . 0.42 ' CZ2' ' HD2' ' A' ' 192' ' ' ARG . 67.2 t-105 -75.27 -41.02 58.15 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -56.42 -54.53 35.34 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -69.8 -30.62 68.2 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.828 1.314 . . . . 0.0 113.656 -174.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 38.6 tp -62.36 -31.31 71.95 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.631 0.65 . . . . 0.0 112.208 169.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ARG . . . . . 0.42 ' HD2' ' CZ2' ' A' ' 188' ' ' TRP . 34.2 mtp-105 -92.3 -13.66 30.0 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 172.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -82.3 -16.47 49.25 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.598 1.159 . . . . 0.0 112.68 163.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -78.5 62.01 3.01 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.305 1.842 . . . . 0.0 112.082 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -93.56 -22.51 18.78 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 128.444 2.698 . . . . 0.0 115.652 -170.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -58.57 152.46 45.59 Favored Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 125.432 1.493 . . . . 0.0 112.03 -175.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -50.37 -41.96 49.62 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.904 2.403 . . . . 0.0 114.049 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 10.9 tp -61.86 -41.12 89.52 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 118.524 0.602 . . . . 0.0 112.163 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 18.8 m -68.45 -28.85 67.41 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.812 1.245 . . . . 0.0 111.574 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 36.0 mm -75.4 -42.13 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.883 0.873 . . . . 0.0 111.116 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 94.1 mt -58.84 -50.32 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 118.862 0.755 . . . . 0.0 110.071 171.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -59.18 -39.04 81.29 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.912 2.485 . . . . 0.0 112.243 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 54.9 tp -61.99 -51.7 66.98 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.767 1.227 . . . . 0.0 112.987 169.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 71.1 mt -65.89 -41.41 89.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.374 -0.829 . . . . 0.0 109.92 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 69.6 t -74.13 -35.32 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 125.244 1.418 . . . . 0.0 113.45 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.6 p -65.24 -35.67 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 120.908 1.685 . . . . 0.0 110.859 172.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 89.3 t -72.35 -42.58 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 117.934 -1.032 . . . . 0.0 109.617 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -55.54 -41.12 72.76 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.173 0.897 . . . . 0.0 112.16 170.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.8 t -62.39 -43.09 99.65 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.432 1.093 . . . . 0.0 112.835 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 30.2 mmt -70.35 -37.89 74.71 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.612 0.765 . . . . 0.0 111.424 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.39 -48.12 89.64 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 O-C-N 121.799 -0.563 . . . . 0.0 109.994 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.517 HG21 ' HB3' ' A' ' 225' ' ' SER . 30.0 m -75.52 -34.65 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 O-C-N 121.663 -0.648 . . . . 0.0 112.374 -171.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.66 -21.01 66.51 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.253 -0.905 . . . . 0.0 112.088 170.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 57.6 m -85.56 -38.62 18.29 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.697 1.599 . . . . 0.0 113.6 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 24.3 t -56.86 -37.46 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.338 1.055 . . . . 0.0 108.863 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 134.58 146.63 5.43 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 109.014 -1.635 . . . . 0.0 109.014 175.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 98.4 p -60.2 15.54 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.14 116.17 4.92 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 127.877 2.471 . . . . 0.0 111.56 -176.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.641 ' H ' ' H ' ' A' ' 221' ' ' VAL . . . -97.76 -88.73 1.89 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 104.908 -3.277 . . . . 0.0 104.908 92.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 78.49 -51.58 0.48 Allowed 'General case' 0 N--CA 1.466 0.34 1 C-N-CA 132.674 4.39 . . . . 0.0 120.409 -21.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.641 ' H ' ' H ' ' A' ' 219' ' ' GLY . 54.0 t -87.02 -51.3 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 120.119 -1.613 . . . . 0.0 110.203 -164.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -56.7 -36.14 69.32 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.815 -0.553 . . . . 0.0 111.941 167.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.45 -55.14 38.86 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 118.554 -0.736 . . . . 0.0 110.81 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.94 -36.22 83.67 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 120.742 1.61 . . . . 0.0 113.061 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.517 ' HB3' HG21 ' A' ' 212' ' ' VAL . 13.9 t -71.48 -43.61 66.27 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.386 1.448 . . . . 0.0 110.756 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.79 -53.61 55.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.847 0.459 . . . . 0.0 110.371 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 80.9 mt -63.48 -81.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 122.726 1.251 . . . . 0.0 109.517 173.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 -75.74 -14.62 60.33 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 124.793 1.237 . . . . 0.0 113.012 -157.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -95.26 -55.79 1.34 Allowed Glycine 0 CA--C 1.534 1.256 0 CA-C-N 118.701 0.682 . . . . 0.0 114.151 160.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.95 -39.95 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 120.745 -1.444 . . . . 0.0 112.156 -166.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 2.1 tpp85 -60.71 -35.01 75.25 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 119.573 1.079 . . . . 0.0 110.417 168.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.15 -36.96 84.51 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.215 1.406 . . . . 0.0 112.42 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 29.8 tp -64.46 -23.68 67.36 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 117.915 -1.04 . . . . 0.0 111.607 168.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -80.54 -44.87 18.36 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.913 1.688 . . . . 0.0 112.923 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -20.02 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.491 -1.38 . . . . 0.0 112.461 169.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 52.1 tp -71.02 -30.53 66.76 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.194 0.521 . . . . 0.0 111.888 174.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.5 ' HA ' ' CD2' ' A' ' 240' ' ' HIS . 19.7 mtp180 -70.32 -25.43 63.3 Favored 'General case' 0 C--O 1.212 -0.9 0 C-N-CA 124.866 1.267 . . . . 0.0 112.617 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 68.0 mtp -54.03 -23.97 15.4 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 160.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 6.1 mt -115.47 -35.39 4.61 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.873 -166.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' HIS . . . . . 0.5 ' CD2' ' HA ' ' A' ' 237' ' ' ARG . 5.6 p80 -75.72 -36.61 59.92 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.631 0.65 . . . . 0.0 111.354 164.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.366 5.6 p . . . . . 0 N--CA 1.468 0.468 0 C-N-CA 129.576 3.15 . . . . 0.0 115.148 164.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 . . . . . 0 N--CA 1.466 0.327 0 CA-C-O 118.714 -0.66 . . . . 0.0 111.735 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.5 p -66.95 -20.15 65.85 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.06 0.944 . . . . 0.0 112.025 172.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -79.09 -50.52 10.91 Favored 'General case' 0 CA--C 1.507 -0.704 0 O-C-N 121.416 -0.803 . . . . 0.0 109.042 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.5 m -76.21 -38.72 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.374 0.67 . . . . 0.0 110.749 -173.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -68.17 -32.97 73.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.533 172.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.1 -30.16 70.0 Favored Glycine 0 C--N 1.34 0.766 0 O-C-N 120.831 -1.168 . . . . 0.0 112.343 170.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -68.22 -46.6 70.14 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 126.377 1.871 . . . . 0.0 111.301 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.0 t -54.71 -54.09 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.297 1.039 . . . . 0.0 109.639 167.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -55.53 -48.16 75.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.662 -0.685 . . . . 0.0 112.377 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -64.75 -25.35 67.89 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.544 1.065 . . . . 0.0 113.518 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -77.41 -40.99 41.68 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.29 1.036 . . . . 0.0 110.344 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.2 mt -60.44 -40.58 91.66 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 120.787 -1.196 . . . . 0.0 110.829 167.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -78.78 -41.09 31.39 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.499 -162.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -116.95 145.69 36.17 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 124.198 0.999 . . . . 0.0 111.299 -173.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.4 155.82 36.65 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.587 2.192 . . . . 0.0 111.899 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.445 ' H ' ' HB3' ' A' ' 121' ' ' LYS . 46.9 p -147.95 169.56 19.6 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.143 1.777 . . . . 0.0 107.568 163.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.07 -31.28 48.23 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.013 -0.882 . . . . 0.0 113.197 170.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -79.83 -45.43 18.74 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 170.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.445 ' HB3' ' H ' ' A' ' 118' ' ' THR . 0.9 OUTLIER -58.82 -52.7 64.59 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.141 0.882 . . . . 0.0 110.045 -178.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 43.8 t -62.72 -38.64 91.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.106 0.562 . . . . 0.0 111.915 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -57.73 -57.97 10.4 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.608 0.64 . . . . 0.0 111.495 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.4 m -74.36 -44.99 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -172.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -87.12 -36.77 17.91 Favored 'General case' 0 C--O 1.226 -0.133 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -164.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -65.35 -30.57 71.41 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.066 1.303 . . . . 0.0 111.033 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.39 -39.28 78.07 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 167.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.23 -45.47 79.94 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 167.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.8 m -64.58 -39.17 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-N 121.423 1.92 . . . . 0.0 111.789 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -54.44 -45.79 73.13 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.868 0.867 . . . . 0.0 112.292 170.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.7 mt -67.19 -39.58 86.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 118.46 -0.781 . . . . 0.0 113.025 174.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.51 -43.69 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 119.812 1.187 . . . . 0.0 110.877 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.36 -40.92 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-N 121.197 1.817 . . . . 0.0 112.646 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.9 tp -52.51 -52.11 56.22 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.066 1.746 . . . . 0.0 111.765 168.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 37.9 t -63.27 -39.57 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.985 0.914 . . . . 0.0 111.081 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 65.7 m -60.5 -44.72 95.68 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.937 0.895 . . . . 0.0 113.379 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.65 -31.94 47.02 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 120.442 1.474 . . . . 0.0 111.93 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 59.0 mt -56.62 -47.6 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.509 0.723 . . . . 0.0 110.305 167.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -57.81 -49.35 76.94 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 117.322 -1.323 . . . . 0.0 110.999 170.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 73.6 m -49.6 -40.9 40.56 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 120.067 1.303 . . . . 0.0 114.061 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.5 -48.5 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.0 0.52 . . . . 0.0 110.797 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.2 tp -72.61 -44.23 62.24 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.862 0.865 . . . . 0.0 112.89 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 55.9 p -78.89 -30.15 44.79 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -155.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.2 t -75.27 -1.81 25.22 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.733 1.152 . . . . 0.0 111.86 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.4 mm -102.51 -34.48 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 126.18 1.792 . . . . 0.0 113.231 163.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -56.77 -27.53 59.78 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.891 -1.131 . . . . 0.0 111.892 164.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -58.88 -42.86 90.47 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 129.002 2.921 . . . . 0.0 112.066 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 17.1 m-30 -74.76 -31.1 61.68 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.876 0.762 . . . . 0.0 111.073 176.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.68 -41.22 96.22 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.58 -0.7 . . . . 0.0 111.407 169.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.25 -13.47 28.39 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.46 1.504 . . . . 0.0 114.888 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.6 mt -64.53 -23.64 67.34 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.572 1.149 . . . . 0.0 113.277 168.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.49 -49.68 0.13 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -155.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.4 p -122.15 177.84 5.17 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.518 1.927 . . . . 0.0 109.011 -163.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.35 154.39 47.88 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.448 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.8 t -156.13 158.38 37.59 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.864 1.266 . . . . 0.0 111.123 -163.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.9 mt -94.68 3.43 55.07 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.967 1.307 . . . . 0.0 113.81 166.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -65.05 -4.58 4.89 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 120.036 1.289 . . . . 0.0 114.188 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -72.73 -30.56 64.28 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.781 -1.199 . . . . 0.0 111.822 166.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 47.6 tpp -73.02 -32.17 64.93 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.268 1.027 . . . . 0.0 111.355 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.21 -51.27 69.68 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.553 -0.717 . . . . 0.0 110.341 165.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.1 mt -53.99 -40.21 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 118.787 -0.625 . . . . 0.0 112.028 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.9 t -56.34 -48.16 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 120.293 1.406 . . . . 0.0 112.127 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 11.4 mt -71.11 -33.78 70.48 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.074 1.306 . . . . 0.0 113.08 176.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 26.5 t -61.73 -39.43 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 120.596 1.543 . . . . 0.0 111.743 172.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 68.0 t -75.01 -33.1 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.834 1.254 . . . . 0.0 110.651 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -62.56 -42.68 99.7 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 117.981 -1.009 . . . . 0.0 112.296 165.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -65.01 -46.25 82.14 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.536 1.516 . . . . 0.0 111.918 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.13 -37.96 74.44 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-N 119.282 0.946 . . . . 0.0 112.779 171.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.6 m -67.2 -39.53 86.33 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -60.41 -40.64 91.7 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.934 1.294 . . . . 0.0 111.629 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -54.24 -51.94 62.93 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 172.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 26.9 m -73.64 -31.73 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 23.1 t -63.48 -33.55 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 119.337 0.971 . . . . 0.0 112.144 173.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -60.94 -41.4 96.17 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 120.951 -1.093 . . . . 0.0 111.81 167.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 41.4 mt -69.97 -25.24 63.53 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -82.03 -40.44 22.07 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.999 0.92 . . . . 0.0 112.907 173.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 79.1 p -70.32 6.13 1.47 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 116.817 2.154 . . . . 0.0 116.817 160.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.526 ' HB2' ' HD2' ' A' ' 190' ' ' ARG . . . -51.78 -37.69 52.52 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.216 0.916 . . . . 0.0 111.514 160.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 167.22 30.99 0.02 OUTLIER Glycine 0 C--N 1.341 0.847 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 175.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 18.1 t 63.1 -67.42 0.09 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.871 2.068 . . . . 0.0 115.121 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -35.8 79.47 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.721 2.008 . . . . 0.0 111.022 170.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.46 ' HB2' ' H ' ' A' ' 186' ' ' GLY . 82.4 p -72.56 25.12 0.05 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 -175.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -53.53 -23.48 10.64 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 128.107 2.563 . . . . 0.0 116.293 -171.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -118.63 -37.23 3.32 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.2 1.4 . . . . 0.0 111.826 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 85.8 t -65.81 -68.94 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.436 1.494 . . . . 0.0 111.378 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.46 ' H ' ' HB2' ' A' ' 182' ' ' SER . . . -70.69 -23.97 77.33 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.699 1.619 . . . . 0.0 112.881 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.7 tt -51.07 -52.3 44.75 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.073 1.437 . . . . 0.0 110.087 164.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 35.1 t-105 -74.03 -44.72 53.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.23 0.538 . . . . 0.0 112.432 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -59.52 -45.17 96.01 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.885 0.755 . . . . 0.0 113.07 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.526 ' HD2' ' HB2' ' A' ' 178' ' ' ALA . 7.3 ptm180 -68.95 -33.1 73.16 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 118.44 1.12 . . . . 0.0 112.129 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 25.5 tp -74.96 -29.52 60.95 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.973 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 36.4 mtp-105 -80.17 -31.68 38.85 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.27 1.428 . . . . 0.0 113.097 171.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -64.02 -38.21 90.23 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.882 1.273 . . . . 0.0 111.173 171.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -82.97 58.81 4.56 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.123 1.369 . . . . 0.0 112.237 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.74 -28.95 66.36 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 120.773 -1.205 . . . . 0.0 112.56 169.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 197' ' ' PRO . 16.2 ptpt -49.6 147.19 6.26 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 127.877 2.471 . . . . 0.0 116.268 -173.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 196' ' ' LYS . 87.1 Cg_exo -57.33 -39.61 88.3 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.821 2.347 . . . . 0.0 116.488 -163.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 93.9 mt -67.72 -30.33 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 O-C-N 120.894 -1.129 . . . . 0.0 111.329 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.7 t -68.17 -31.56 71.19 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.06 1.3 . . . . 0.0 111.652 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 34.6 mm -70.35 -43.22 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.383 1.073 . . . . 0.0 111.49 171.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.83 -37.05 77.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.031 0.532 . . . . 0.0 111.445 173.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -74.87 -38.99 61.79 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.319 1.848 . . . . 0.0 110.729 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 20.3 tp -57.71 -48.4 79.69 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.272 1.029 . . . . 0.0 111.072 166.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 76.4 mt -69.43 -37.21 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 121.839 -0.538 . . . . 0.0 111.284 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.6 t -75.3 -33.41 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-N 119.918 1.235 . . . . 0.0 112.58 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 4.4 p -67.43 -34.2 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 120.615 1.552 . . . . 0.0 110.685 170.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 78.1 t -72.76 -39.52 59.93 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-O 117.936 -1.031 . . . . 0.0 110.115 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.61 -45.47 85.3 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 119.106 0.867 . . . . 0.0 110.41 170.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 30.2 t -62.95 -48.82 77.24 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.549 1.14 . . . . 0.0 111.851 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 75.2 mtm -55.58 -51.43 67.13 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.837 1.255 . . . . 0.0 111.004 168.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 9.5 t -59.09 -47.08 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 118.972 0.806 . . . . 0.0 111.295 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 222' ' ' PHE . 33.5 m -75.71 -41.56 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 119.403 1.001 . . . . 0.0 111.845 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.6 pp -63.31 -23.81 67.58 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.719 1.145 . . . . 0.0 111.601 171.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 19.2 m -77.8 -44.89 26.08 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.83 1.252 . . . . 0.0 112.929 173.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.73 -38.04 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.157 1.783 . . . . 0.0 109.476 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 218' ' ' LYS . . . 142.31 162.33 9.17 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 125.909 1.719 . . . . 0.0 110.029 172.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 60.5 p -70.62 18.23 0.06 Allowed 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 216' ' ' GLY . 5.8 mtmt -173.15 175.67 3.13 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 131.514 3.926 . . . . 0.0 108.937 -172.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 66.81 105.96 0.02 OUTLIER Glycine 0 N--CA 1.436 -1.3 0 N-CA-C 106.176 -2.77 . . . . 0.0 106.176 -115.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -56.4 -5.66 0.22 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.492 1.517 . . . . 0.0 113.276 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 18.1 m -68.79 -38.12 78.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 125.421 1.489 . . . . 0.0 110.507 172.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.457 ' HA ' ' HB ' ' A' ' 212' ' ' VAL . 0.8 OUTLIER -56.53 -49.77 73.79 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.348 166.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.92 -54.76 43.52 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.3 t -69.05 -30.74 69.15 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 34.1 t -74.29 -41.77 60.65 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.627 -1.295 . . . . 0.0 111.076 175.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.85 -62.13 1.91 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.114 0.966 . . . . 0.0 109.083 173.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 38.6 mt -57.26 -83.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.503 1.121 . . . . 0.0 109.79 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -65.32 -50.11 66.89 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-O 116.85 -1.548 . . . . 0.0 109.606 -163.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -54.56 -56.5 21.85 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 120.247 1.385 . . . . 0.0 113.281 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.8 -34.89 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 118.024 0.912 . . . . 0.0 111.639 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -77.8 -26.96 49.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.573 -1.329 . . . . 0.0 113.78 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -60.37 -42.29 95.51 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.782 1.633 . . . . 0.0 107.666 174.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 15.5 tp -62.9 -33.85 76.18 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.413 174.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -75.47 -43.49 49.08 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 120.87 1.668 . . . . 0.0 112.815 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 45.0 pt -66.35 -6.63 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 169.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 48.2 tp -95.9 -35.3 11.51 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.485 1.514 . . . . 0.0 111.137 171.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -63.52 -35.61 81.04 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.966 1.307 . . . . 0.0 110.121 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 61.3 tpp -34.07 -33.97 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 129.342 3.057 . . . . 0.0 116.702 156.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 49.9 mt -111.64 -13.32 13.79 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.859 1.663 . . . . 0.0 111.983 -171.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.3 3.5 54.43 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.83 0.852 . . . . 0.0 113.201 160.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 CA--C 1.511 -0.521 0 C-N-CA 127.161 2.184 . . . . 0.0 111.667 -164.14 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.7 t -80.87 -26.19 37.1 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.335 -0.853 . . . . 0.0 113.268 166.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -75.13 -27.17 59.69 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 119.568 -1.957 . . . . 0.0 111.885 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 23.3 m -85.31 2.55 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 126.12 1.768 . . . . 0.0 113.435 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -111.66 -45.61 3.34 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 127.575 2.35 . . . . 0.0 108.052 170.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.09 -20.29 8.73 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.509 1.528 . . . . 0.0 115.393 161.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . 0.261 25.0 ptt180 -73.22 -37.32 66.45 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.327 1.564 . . . . 0.0 110.455 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.7 t -58.88 -47.88 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.758 1.223 . . . . 0.0 110.541 168.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -66.91 -54.64 20.15 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.413 1.085 . . . . 0.0 111.447 -174.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -62.3 -25.29 67.79 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.81 -1.181 . . . . 0.0 112.719 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -75.76 -41.76 52.24 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.317 1.417 . . . . 0.0 110.375 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 pp -75.4 -22.51 57.39 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -125.16 -9.72 7.06 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -166.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -109.55 118.63 50.07 Favored Pre-proline 0 N--CA 1.473 0.722 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 161.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -61.47 137.77 71.8 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 121.697 1.598 . . . . 0.0 113.307 -171.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -151.85 143.3 23.46 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.671 1.189 . . . . 0.0 107.973 173.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.21 -28.76 50.75 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.904 -0.387 . . . . 0.0 112.59 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -67.37 -32.92 74.17 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 172.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -61.25 -48.76 79.98 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.559 1.072 . . . . 0.0 108.203 168.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 35.6 m -64.49 -40.41 95.61 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.415 0.686 . . . . 0.0 112.147 -174.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -56.64 -67.52 0.3 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.107 0.963 . . . . 0.0 111.214 173.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.7 p -79.67 -38.26 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 121.009 -1.057 . . . . 0.0 113.627 -168.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -73.12 -42.96 62.34 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.38 -0.825 . . . . 0.0 112.067 -170.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -71.52 -26.73 62.78 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -68.19 -49.4 61.1 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.196 -0.94 . . . . 0.0 111.989 166.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -51.3 -40.15 58.37 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 117.514 -1.231 . . . . 0.0 114.232 173.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . 0.289 2.9 m -62.97 -43.38 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 121.174 1.806 . . . . 0.0 112.634 174.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -67.85 -39.25 83.81 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.737 0.699 . . . . 0.0 112.548 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 73.4 mt -56.39 -54.87 40.52 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 118.624 -0.703 . . . . 0.0 110.366 169.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -53.87 -49.89 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.456 0.703 . . . . 0.0 112.011 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.4 p -66.13 -42.97 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 119.837 1.198 . . . . 0.0 113.09 -171.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 35.6 tp -70.38 -45.4 66.12 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.051 0.94 . . . . 0.0 111.567 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 32.2 m -65.08 -38.51 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 119.86 1.209 . . . . 0.0 111.901 176.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 98.4 m -66.83 -34.15 77.18 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.66 -0.686 . . . . 0.0 112.799 174.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.7 mt -74.42 -37.59 63.3 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.651 1.569 . . . . 0.0 112.516 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 52.2 mt -61.87 -46.6 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.312 0.96 . . . . 0.0 110.72 169.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -62.34 -27.17 68.87 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 117.866 -1.064 . . . . 0.0 112.343 171.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.7 m -65.68 -31.1 71.92 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 121.019 1.736 . . . . 0.0 113.166 173.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.33 -35.84 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.113 0.565 . . . . 0.0 110.699 172.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.0 tp -74.28 -50.69 17.85 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.296 0.953 . . . . 0.0 112.391 169.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.7 p -67.19 -27.13 67.01 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 120.377 -1.452 . . . . 0.0 113.273 -166.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.0 t -68.6 -22.85 64.42 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 176.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 17.9 pt -95.32 -31.41 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.946 1.248 . . . . 0.0 113.187 169.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -59.7 -26.57 65.7 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 121.021 -1.049 . . . . 0.0 111.281 164.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -60.57 -30.21 69.65 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.929 2.092 . . . . 0.0 113.093 167.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -87.9 -26.34 22.78 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.817 -1.177 . . . . 0.0 110.856 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.08 -40.2 94.32 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.149 0.579 . . . . 0.0 111.637 166.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.31 -15.22 23.36 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.632 1.573 . . . . 0.0 114.869 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.5 mt -59.15 -31.63 69.15 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.807 -1.183 . . . . 0.0 112.69 167.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.86 -43.83 0.21 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -153.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 82.8 p -134.09 152.83 52.01 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.163 1.385 . . . . 0.0 109.976 -155.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -75.4 128.93 10.12 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 121.289 -0.882 . . . . 0.0 112.582 -170.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.3 t -144.46 148.61 34.78 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -155.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.3 mt -56.4 4.28 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.568 2.347 . . . . 0.0 114.88 166.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -62.12 -13.94 31.93 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 120.975 1.716 . . . . 0.0 112.803 163.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 18.0 p-90 -59.37 -29.8 67.95 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.092 -1.63 . . . . 0.0 112.233 163.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 10.7 tpt -76.83 -25.55 53.34 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.335 0.97 . . . . 0.0 112.804 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -61.0 -48.82 80.06 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.788 -1.195 . . . . 0.0 109.404 162.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.82 -37.62 72.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 122.993 0.517 . . . . 0.0 111.583 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 64.0 t -60.93 -51.92 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 120.948 -1.095 . . . . 0.0 112.293 173.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 11.5 mt -69.98 -30.44 67.79 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.119 -0.988 . . . . 0.0 112.355 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 22.7 t -58.17 -38.17 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.698 1.136 . . . . 0.0 109.958 169.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 64.7 t -75.22 -29.7 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 118.104 -0.951 . . . . 0.0 111.11 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -66.6 -51.03 60.83 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 121.011 1.732 . . . . 0.0 112.933 170.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -60.65 -46.46 90.24 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.198 0.908 . . . . 0.0 111.37 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.96 -40.89 93.94 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.974 0.797 . . . . 0.0 113.15 173.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 55.5 m -66.96 -40.01 87.38 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.738 -0.86 . . . . 0.0 111.453 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -62.4 -41.38 98.63 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.303 0.956 . . . . 0.0 111.738 173.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -55.65 -45.67 77.63 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.646 0.657 . . . . 0.0 111.5 170.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 69.1 t -67.31 -41.89 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.188 -0.945 . . . . 0.0 113.13 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 25.8 t -62.28 -38.16 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.452 1.501 . . . . 0.0 112.337 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -55.91 -45.14 78.78 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.487 0.715 . . . . 0.0 111.811 168.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 21.8 mt -67.0 -40.3 87.32 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 178.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -65.81 -30.8 71.49 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.5 t -69.79 -21.16 63.43 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 173.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.1 -14.58 25.24 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 170.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -158.07 51.25 0.41 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 124.972 1.272 . . . . 0.0 110.505 -161.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 35.1 t -45.2 -31.07 1.34 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.225 1.81 . . . . 0.0 112.643 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.19 -59.45 1.73 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.172 1.789 . . . . 0.0 111.656 159.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 55.1 p -70.98 -16.1 62.62 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.906 1.282 . . . . 0.0 113.776 -156.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 59.8 pttt 47.01 -59.55 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.361 1 C-N-CA 133.464 4.706 . . . . 0.0 115.868 172.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -93.84 -29.21 15.44 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 124.68 1.192 . . . . 0.0 112.011 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.19 -54.32 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 166.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.1 -70.46 0.85 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 126.973 2.225 . . . . 0.0 112.362 176.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.4 tt -52.0 -42.07 62.69 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.33 1.452 . . . . 0.0 112.584 -170.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 44.6 t-105 -75.4 -46.36 33.35 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -172.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -64.19 -36.76 93.64 Favored Glycine 0 N--CA 1.48 1.568 0 O-C-N 121.641 -0.662 . . . . 0.0 112.501 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -61.16 -44.61 97.04 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 127.178 2.191 . . . . 0.0 112.167 168.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 25.7 tp -68.31 -32.58 72.82 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.608 0.64 . . . . 0.0 112.451 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -67.1 -18.57 65.38 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.108 -0.995 . . . . 0.0 113.213 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -67.49 -3.71 9.36 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.118 1.367 . . . . 0.0 114.301 167.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.31 83.47 0.55 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.53 1.532 . . . . 0.0 110.43 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.7 ttt85 -149.92 -37.67 0.15 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -164.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -68.89 151.25 97.35 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 123.974 0.91 . . . . 0.0 109.906 168.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -51.26 -46.85 28.85 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 CA-C-N 121.534 1.583 . . . . 0.0 115.488 -170.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 17.5 tt -62.99 -36.23 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 119.422 1.01 . . . . 0.0 113.501 176.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 95.5 p -82.93 -25.85 32.0 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.148 1.34 . . . . 0.0 111.231 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 15.1 mm -63.19 -49.1 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.8 0.84 . . . . 0.0 110.026 160.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 21.2 mm -59.36 -41.61 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.539 -0.726 . . . . 0.0 111.376 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -69.71 -35.24 74.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.587 1.555 . . . . 0.0 111.43 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.3 tp -64.21 -49.2 72.9 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.088 0.555 . . . . 0.0 110.696 171.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 59.5 mt -61.5 -40.95 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 121.653 -0.654 . . . . 0.0 110.154 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.434 ' HA ' ' HB3' ' A' ' 208' ' ' ALA . 73.5 t -78.92 -22.65 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 117.605 -1.188 . . . . 0.0 113.779 -176.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.46 -32.21 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 122.316 2.325 . . . . 0.0 110.344 166.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 46.0 t -81.17 -29.69 11.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 O-C-N 120.951 -1.093 . . . . 0.0 109.51 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.434 ' HB3' ' HA ' ' A' ' 205' ' ' VAL . . . -58.38 -42.79 87.84 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.805 -0.559 . . . . 0.0 111.511 161.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.1 m -61.3 -36.99 81.62 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.948 0.899 . . . . 0.0 111.843 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 55.6 mtt -64.46 -54.19 36.44 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.523 1.129 . . . . 0.0 111.0 166.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 30.4 t -56.63 -38.39 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 119.771 1.168 . . . . 0.0 112.237 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 28.4 t -53.53 -52.61 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 126.293 1.837 . . . . 0.0 111.396 171.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.87 -15.46 44.57 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.078 0.951 . . . . 0.0 113.294 -175.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 93.2 m -102.68 -56.25 2.28 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.52 1.528 . . . . 0.0 114.4 -171.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 25.4 t -56.88 -38.75 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-N 119.521 1.055 . . . . 0.0 112.025 -175.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 164.21 -116.55 0.71 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.037 1.303 . . . . 0.0 110.288 168.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 77.3 p -164.17 34.64 0.08 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.436 1.094 . . . . 0.0 113.063 -174.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -169.45 168.75 9.29 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.97 2.108 . . . . 0.0 110.709 -174.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -67.36 -49.78 49.3 Favored Glycine 0 N--CA 1.473 1.139 0 C-N-CA 127.556 2.503 . . . . 0.0 112.461 -10.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -144.62 4.9 1.18 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.364 1.066 . . . . 0.0 113.775 170.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 15.2 t -73.55 -42.88 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 120.155 1.343 . . . . 0.0 111.493 -170.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -47.28 -45.91 24.45 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.933 1.293 . . . . 0.0 112.394 164.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.38 -54.68 9.9 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.833 1.253 . . . . 0.0 111.214 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.11 -35.74 81.28 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 121.113 -0.992 . . . . 0.0 111.885 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 18.0 m -69.17 -45.65 69.48 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.485 1.493 . . . . 0.0 110.884 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -52.87 -52.37 57.63 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.615 -0.678 . . . . 0.0 111.412 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 227' ' ' ILE . 72.6 mt -67.08 -84.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 123.392 1.568 . . . . 0.0 110.269 175.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -76.36 10.04 2.28 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 128.145 2.578 . . . . 0.0 113.338 -167.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -117.84 -63.64 0.31 Allowed Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 166.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 18.2 mt -79.57 -37.44 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 118.482 1.141 . . . . 0.0 111.374 -171.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.72 -41.59 87.67 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.862 1.21 . . . . 0.0 109.771 174.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -63.32 -33.25 75.12 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.057 2.143 . . . . 0.0 113.521 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 23.4 tp -63.87 -33.41 75.62 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.344 1.058 . . . . 0.0 111.654 165.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -69.08 -37.54 78.53 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.715 1.598 . . . . 0.0 114.289 -175.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -19.69 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.255 -0.903 . . . . 0.0 113.094 175.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 37.7 mt -72.99 -23.67 60.67 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.974 0.893 . . . . 0.0 110.539 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -83.12 -18.45 39.46 Favored 'General case' 0 C--O 1.216 -0.708 0 C-N-CA 124.386 1.074 . . . . 0.0 112.816 -167.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -24.76 -40.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 128.587 2.755 . . . . 0.0 114.779 143.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 16.6 mt -99.99 -28.24 13.18 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.258 1.423 . . . . 0.0 110.717 -172.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -75.58 9.78 2.06 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 158.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.303 4.2 t . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 124.779 2.228 . . . . 0.0 110.409 150.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.569 ' HA ' HG22 ' A' ' 106' ' ' VAL 0.265 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.229 0.062 . . . . 0.0 110.97 . . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -58.09 -40.13 80.32 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.352 1.461 . . . . 0.0 114.634 165.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -78.25 -51.38 10.25 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 126.119 1.768 . . . . 0.0 109.743 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.569 HG22 ' HA ' ' A' ' 103' ' ' ARG . 35.0 m -81.04 -21.15 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -157.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -73.69 -29.3 62.2 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.199 0.599 . . . . 0.0 110.802 166.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.12 -32.82 60.02 Favored Glycine 0 CA--C 1.525 0.696 0 O-C-N 121.097 -1.002 . . . . 0.0 111.552 167.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -63.34 -40.19 96.62 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.117 1.367 . . . . 0.0 111.256 175.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.2 t -60.51 -55.36 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.53 1.932 . . . . 0.0 110.98 168.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -62.44 -22.54 66.28 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.407 1.083 . . . . 0.0 113.803 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -84.8 -34.18 22.8 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.824 1.25 . . . . 0.0 111.913 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -74.09 -43.34 58.01 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.136 -0.977 . . . . 0.0 112.814 -176.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.25 -20.98 64.85 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 176.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -101.88 -24.51 14.02 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 125.046 1.338 . . . . 0.0 112.676 -171.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.4 mtm105 -91.74 107.68 24.13 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 124.363 1.065 . . . . 0.0 109.928 165.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -65.29 127.13 17.59 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.904 1.736 . . . . 0.0 109.091 166.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 82.2 p -139.44 178.61 7.08 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.271 1.029 . . . . 0.0 109.091 176.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.82 -30.03 62.47 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 121.912 -0.493 . . . . 0.0 112.597 165.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -78.54 -43.42 26.77 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -60.27 -40.3 89.9 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.342 0.973 . . . . 0.0 109.746 170.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 49.7 t -61.43 -54.36 44.58 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.26 1.024 . . . . 0.0 112.294 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -53.62 -49.64 67.39 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.364 1.066 . . . . 0.0 111.89 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.0 p -85.81 -47.23 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -73.21 -39.27 65.66 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.998 0.817 . . . . 0.0 111.858 -163.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -80.3 -27.99 38.36 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 120.852 -1.155 . . . . 0.0 112.788 -173.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -70.39 -35.59 73.58 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.816 0.734 . . . . 0.0 111.122 164.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.97 -44.68 87.22 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 119.923 1.238 . . . . 0.0 113.218 168.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.43 -35.56 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 121.7 2.046 . . . . 0.0 113.235 176.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -68.02 -47.61 67.96 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.222 1.009 . . . . 0.0 112.077 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 62.9 mt -62.78 -47.84 81.72 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.459 0.704 . . . . 0.0 111.435 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 84.7 mt -61.99 -34.48 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 118.11 -0.948 . . . . 0.0 111.253 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.7 t -74.89 -34.07 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 120.781 1.628 . . . . 0.0 114.273 177.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 28.2 mt -59.44 -48.22 82.49 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.447 1.476 . . . . 0.0 110.535 167.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.5 t -55.89 -53.67 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 118.348 0.522 . . . . 0.0 110.23 172.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 60.8 m -61.62 -46.09 91.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.988 -173.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.9 mt -72.31 -40.91 67.13 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.679 1.127 . . . . 0.0 112.58 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.53 -42.35 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.366 0.666 . . . . 0.0 110.557 174.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -68.5 -33.29 73.88 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.384 -0.823 . . . . 0.0 111.99 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 t -58.08 -40.71 81.79 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.928 0.891 . . . . 0.0 111.716 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.33 -53.01 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.386 1.074 . . . . 0.0 110.299 174.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.9 tp -55.6 -50.44 70.1 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.014 0.526 . . . . 0.0 111.714 171.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 68.7 m -57.42 -23.53 50.08 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 116.172 1.915 . . . . 0.0 116.172 -174.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.4 t -109.44 -5.46 15.78 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.367 0.985 . . . . 0.0 112.845 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.7 tp -85.03 -36.08 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 O-C-N 121.554 -0.716 . . . . 0.0 111.344 149.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -71.95 -4.05 26.17 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 119.967 -1.708 . . . . 0.0 115.304 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -63.28 -34.09 76.93 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 120.72 -1.238 . . . . 0.0 112.58 169.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -74.52 -20.62 59.91 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.348 -0.845 . . . . 0.0 112.844 172.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.93 -45.22 43.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.956 0.903 . . . . 0.0 111.254 166.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -57.49 -28.67 63.63 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.747 1.219 . . . . 0.0 113.151 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.43 -35.45 73.39 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.196 1.398 . . . . 0.0 113.559 173.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -97.56 -47.91 5.47 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.993 2.117 . . . . 0.0 114.124 -168.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 69.7 p -149.52 -169.05 3.27 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.469 2.308 . . . . 0.0 109.006 -159.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -77.62 169.69 54.8 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.323 -0.861 . . . . 0.0 112.828 159.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.452 HG23 ' HB3' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -170.28 152.35 4.1 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.411 1.885 . . . . 0.0 110.887 -176.266 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.0 mt -52.59 -14.82 0.56 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.039 1.736 . . . . 0.0 114.368 172.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.452 ' HB3' HG23 ' A' ' 155' ' ' THR . 58.1 t80 -49.38 -15.9 0.16 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.823 1.649 . . . . 0.0 114.428 168.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 18.5 p-90 -57.22 -27.74 62.27 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.752 -1.217 . . . . 0.0 112.713 166.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 28.4 ttp -70.71 -20.77 62.63 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.197 -1.564 . . . . 0.0 112.067 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -64.65 -26.04 68.22 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.683 -1.26 . . . . 0.0 112.184 169.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 26.9 mt -70.17 -42.36 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.044 0.538 . . . . 0.0 109.575 172.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.41 -44.12 98.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.698 0.799 . . . . 0.0 111.372 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.04 -28.38 57.66 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.127 0.876 . . . . 0.0 113.262 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.6 t -60.11 -41.83 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 120.646 1.566 . . . . 0.0 110.46 165.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.57 -35.25 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 117.759 -1.115 . . . . 0.0 110.347 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -64.42 -53.6 45.83 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.874 1.67 . . . . 0.0 112.546 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -69.1 -24.3 64.11 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.2 1.364 . . . . 0.0 112.916 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -72.05 -47.11 32.63 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.543 1.068 . . . . 0.0 111.348 168.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.9 m -66.51 -36.25 82.26 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -62.56 -49.22 76.14 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 120.537 1.517 . . . . 0.0 110.874 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -51.69 -48.62 63.42 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.151 0.581 . . . . 0.0 111.896 172.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.58 -38.65 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.19 0.996 . . . . 0.0 113.239 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 14.4 t -61.86 -33.54 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.509 1.524 . . . . 0.0 111.56 173.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -63.23 -32.82 74.32 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.219 1.008 . . . . 0.0 112.393 170.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.405 ' HA ' ' HG2' ' A' ' 190' ' ' ARG . 23.4 mt -74.28 -35.46 63.75 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 173.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -70.6 -35.76 73.18 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.097 0.959 . . . . 0.0 113.42 173.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 83.6 p -68.22 -10.4 54.15 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 168.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.98 -15.27 20.93 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 120.05 1.296 . . . . 0.0 114.329 157.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 178.97 80.77 0.06 OUTLIER Glycine 0 C--N 1.343 0.964 0 CA-C-N 120.149 1.34 . . . . 0.0 115.674 -167.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 49.5 t -49.27 -27.3 3.67 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 117.759 0.779 . . . . 0.0 112.753 153.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.86 58.69 1.72 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.599 1.19 . . . . 0.0 111.94 157.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 21.2 p -162.65 50.16 0.18 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.198 159.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.449 ' HE2' ' CD2' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -61.13 -22.12 64.38 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -167.809 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.449 ' CD2' ' HE2' ' A' ' 183' ' ' LYS . 25.2 m-85 -105.46 -38.91 6.3 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 118.167 -0.921 . . . . 0.0 112.587 161.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -56.36 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 119.686 1.13 . . . . 0.0 111.408 -172.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -70.35 -43.08 63.65 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.56 -38.96 64.39 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.031 1.733 . . . . 0.0 111.947 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -70.79 -44.32 66.89 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.089 0.859 . . . . 0.0 112.296 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -66.74 -35.19 89.38 Favored Glycine 0 N--CA 1.476 1.354 0 O-C-N 121.259 -0.901 . . . . 0.0 112.283 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.405 ' HG2' ' HA ' ' A' ' 175' ' ' LEU . 7.5 tpp180 -65.67 -39.42 91.32 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 127.804 2.442 . . . . 0.0 112.942 172.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.498 HD11 HD13 ' A' ' 203' ' ' LEU . 23.6 tp -68.58 -33.37 73.95 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.864 -0.522 . . . . 0.0 111.827 173.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -73.05 -7.39 51.05 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -74.02 59.47 0.72 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.39 1.45 . . . . 0.0 110.214 163.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -142.66 76.58 1.54 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.86 2.864 . . . . 0.0 106.857 -169.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 44.8 mtp85 -137.89 -43.99 0.53 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.398 1.079 . . . . 0.0 111.472 -169.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -64.97 152.04 91.97 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 123.752 0.821 . . . . 0.0 110.434 167.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -54.1 -46.89 30.24 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.671 2.247 . . . . 0.0 112.827 -172.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.3 tt -58.21 -39.01 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.536 1.134 . . . . 0.0 113.981 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 78.7 p -87.63 -20.11 26.8 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 120.573 1.533 . . . . 0.0 112.633 -174.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 64.0 mt -72.39 -43.38 64.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 118.383 0.538 . . . . 0.0 110.509 159.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 43.5 mt -60.1 -39.58 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.238 1.015 . . . . 0.0 110.971 174.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -70.09 -39.69 75.41 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.782 1.633 . . . . 0.0 110.684 -178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.498 HD13 HD11 ' A' ' 191' ' ' LEU . 38.0 tp -61.51 -46.85 88.23 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.483 1.113 . . . . 0.0 112.707 169.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 54.1 mt -63.68 -41.76 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 O-C-N 120.685 -1.26 . . . . 0.0 110.411 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 31.6 t -66.27 -39.79 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 116.308 -1.806 . . . . 0.0 112.559 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.08 -33.06 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 122.212 2.278 . . . . 0.0 111.485 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.28 -46.12 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 123.373 0.669 . . . . 0.0 109.694 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -53.26 -48.14 68.53 Favored 'General case' 0 C--O 1.223 -0.342 0 C-N-CA 123.732 0.813 . . . . 0.0 110.797 169.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 34.3 t -59.84 -49.69 76.73 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.636 1.175 . . . . 0.0 112.947 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 15.0 tpt -70.85 -34.03 71.25 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 118.786 -0.626 . . . . 0.0 112.027 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.7 t -60.76 -50.99 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 120.38 1.446 . . . . 0.0 111.938 171.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.18 -33.09 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 119.461 1.028 . . . . 0.0 111.117 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 5.1 tp -58.38 -45.01 89.13 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.51 0.724 . . . . 0.0 111.211 165.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 59.4 m -69.69 -25.66 63.98 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.287 1.435 . . . . 0.0 114.706 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 52.1 t -64.02 -16.01 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.008 1.323 . . . . 0.0 110.95 166.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 94.13 114.29 2.52 Favored Glycine 0 C--N 1.332 0.35 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -165.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 66.3 p -62.3 34.8 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 129.092 2.957 . . . . 0.0 116.969 -170.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.261 39.7 mmtm -171.2 -23.46 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.343 2.257 . . . . 0.0 114.162 -155.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -46.04 123.66 6.87 Favored Glycine 0 C--N 1.341 0.809 0 N-CA-C 104.014 -3.635 . . . . 0.0 104.014 138.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -75.65 50.49 0.56 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 126.345 1.858 . . . . 0.0 110.377 -162.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 11.1 m -150.76 -35.72 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.583 1.553 . . . . 0.0 109.491 -162.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -57.07 -38.31 73.1 Favored 'General case' 0 C--O 1.216 -0.667 0 O-C-N 120.743 -1.223 . . . . 0.0 111.269 151.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.53 -42.83 88.69 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.266 0.939 . . . . 0.0 111.283 173.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 23.1 p -79.04 -55.3 5.22 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.039 -173.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 15.9 t -63.47 -34.18 77.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.528 1.513 . . . . 0.0 113.197 175.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.18 -50.19 72.82 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.102 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 65.4 mt -63.52 -70.27 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-O 122.282 1.039 . . . . 0.0 110.044 173.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 72.6 mtt-85 -76.74 1.65 16.58 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.122 1.769 . . . . 0.0 113.381 -163.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -125.48 -69.45 0.19 Allowed Glycine 0 N--CA 1.461 0.354 0 C-N-CA 125.636 1.589 . . . . 0.0 109.75 175.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.26 -27.57 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 117.169 -1.396 . . . . 0.0 112.518 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -96.87 -28.83 14.05 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 120.844 1.657 . . . . 0.0 114.095 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -54.69 -34.19 61.98 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.584 1.154 . . . . 0.0 111.009 167.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 58.0 tp -56.67 -30.3 63.23 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 168.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -82.84 -37.0 25.01 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 119.387 -2.071 . . . . 0.0 115.4 -171.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -16.67 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.427 1.091 . . . . 0.0 112.577 170.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 70.4 mt -75.02 -45.02 44.59 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.65 -0.656 . . . . 0.0 111.723 168.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -68.64 -41.09 79.87 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.752 1.621 . . . . 0.0 111.451 -170.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 32.1 tpp -25.7 -22.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 131.153 3.781 . . . . 0.0 117.797 149.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 17.0 mt -131.3 -4.39 3.84 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.061 1.745 . . . . 0.0 112.701 -174.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -66.6 -53.05 38.54 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.276 141.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 52.5 t . . . . . 0 N--CA 1.47 0.551 0 C-N-CA 125.115 1.366 . . . . 0.0 109.344 -160.829 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 37.6 mmm-85 . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.25 -28.35 4.71 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.17 0.988 . . . . 0.0 110.96 162.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -65.23 -47.71 75.86 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.244 1.384 . . . . 0.0 114.039 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.07 -32.11 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.342 1.457 . . . . 0.0 111.044 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -72.12 -36.32 69.4 Favored 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 123.683 0.793 . . . . 0.0 110.859 174.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -55.12 -34.74 58.78 Favored Glycine 0 CA--C 1.541 1.701 0 O-C-N 121.144 -0.973 . . . . 0.0 111.044 165.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.8 mtm180 -66.76 -43.63 83.54 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 117.944 0.872 . . . . 0.0 111.719 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 42.6 t -56.93 -53.29 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 125.18 1.392 . . . . 0.0 110.469 173.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -62.39 -49.95 73.49 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.644 0.778 . . . . 0.0 111.593 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -62.61 -19.91 64.23 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.092 1.357 . . . . 0.0 113.919 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.433 ' CZ ' ' HA ' ' A' ' 121' ' ' LYS . 26.4 t80 -83.06 -41.44 18.62 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 126.344 1.857 . . . . 0.0 110.719 174.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.7 mt -62.41 -43.07 99.68 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.421 1.009 . . . . 0.0 110.971 169.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -77.37 -37.6 51.8 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.5 -157.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 16.1 mtp-105 -82.72 161.69 57.8 Favored Pre-proline 0 N--CA 1.47 0.544 0 C-N-CA 125.409 1.484 . . . . 0.0 113.022 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -71.18 131.26 18.93 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 121.177 1.251 . . . . 0.0 109.11 149.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.9 t -154.73 149.91 27.02 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 120.352 -1.467 . . . . 0.0 109.8 167.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.0 8.64 0.05 OUTLIER Glycine 0 CA--C 1.537 1.468 0 N-CA-C 117.114 1.606 . . . . 0.0 117.114 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -124.82 -16.11 6.26 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 166.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 113' ' ' PHE . 35.5 ttpt -61.24 -69.56 0.23 Allowed 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 121.114 1.779 . . . . 0.0 111.528 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 60.2 m -65.78 -34.93 79.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 118.881 -0.58 . . . . 0.0 109.926 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -58.61 -52.13 66.96 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.365 0.53 . . . . 0.0 111.705 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.7 t -82.47 -43.2 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 121.25 -0.906 . . . . 0.0 113.018 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -75.72 -33.97 60.32 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.628 -0.67 . . . . 0.0 112.343 -171.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -68.74 -33.56 74.12 Favored 'General case' 0 C--N 1.346 0.435 0 O-C-N 120.897 -1.127 . . . . 0.0 111.128 169.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -64.31 -40.9 96.84 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.253 -0.904 . . . . 0.0 112.977 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.23 -44.83 65.04 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 118.168 -0.92 . . . . 0.0 113.443 167.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.64 -36.76 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 120.95 1.704 . . . . 0.0 113.159 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -54.62 -52.32 62.6 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.019 0.827 . . . . 0.0 111.308 172.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 87.7 mt -68.17 -40.64 82.25 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.908 0.483 . . . . 0.0 112.296 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 58.9 mt -69.62 -43.12 80.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 CA-C-O 117.874 -1.06 . . . . 0.0 112.083 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 80.8 t -60.82 -45.09 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 121.25 1.841 . . . . 0.0 111.674 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.4 tp -53.85 -54.07 43.59 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.513 1.525 . . . . 0.0 111.731 171.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 53.5 t -62.6 -39.97 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.712 0.805 . . . . 0.0 112.241 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.5 m -61.21 -42.98 99.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 119.335 0.971 . . . . 0.0 111.721 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.2 mt -74.61 -38.45 62.57 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.336 0.655 . . . . 0.0 112.23 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 71.7 mt -59.31 -48.42 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.887 0.875 . . . . 0.0 110.639 170.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -69.05 -35.71 76.87 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 118.969 -0.539 . . . . 0.0 111.563 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.3 t -58.42 -44.45 89.09 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.852 1.261 . . . . 0.0 112.874 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.1 m -67.49 -28.19 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.7 mt -71.42 -46.81 59.19 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.679 0.672 . . . . 0.0 111.756 166.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 72.6 m -70.39 -33.02 70.91 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.29 1.836 . . . . 0.0 115.036 -170.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.2 t -66.57 -47.52 72.51 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 120.164 1.347 . . . . 0.0 109.895 -174.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 26.5 mm -56.0 -44.63 78.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 124.466 1.106 . . . . 0.0 111.135 175.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -80.65 -14.37 58.22 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -73.19 -37.71 66.39 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.361 1.437 . . . . 0.0 111.196 166.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -79.9 -2.83 45.44 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.163 -0.961 . . . . 0.0 112.089 170.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.65 -27.93 18.72 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.596 1.158 . . . . 0.0 112.954 157.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.467 ' HB2' HG21 ' A' ' 155' ' ' THR . . . -60.58 -19.38 57.43 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -173.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.432 ' H ' ' HG ' ' A' ' 151' ' ' LEU . 1.6 pp -63.88 -4.49 3.31 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 126.697 1.999 . . . . 0.0 114.557 166.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.23 -35.17 0.32 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.851 2.46 . . . . 0.0 114.24 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 72.5 m -129.22 141.53 51.11 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.7 1.2 . . . . 0.0 110.448 -151.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -72.49 140.91 30.13 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.278 -0.487 . . . . 0.0 112.101 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.467 HG21 ' HB2' ' A' ' 150' ' ' ALA . 2.2 t -147.62 143.44 27.71 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -158.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -60.93 -7.23 2.27 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 170.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -56.31 -8.67 0.54 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.89 2.476 . . . . 0.0 116.367 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -68.8 -24.04 64.35 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.472 -1.392 . . . . 0.0 112.508 171.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 76.5 mtm -74.16 -13.81 60.87 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -68.56 -44.08 75.23 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.723 1.147 . . . . 0.0 110.492 164.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 28.8 mt -58.62 -36.75 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 118.481 -0.771 . . . . 0.0 111.916 169.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.5 t -57.53 -45.58 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 120.409 1.459 . . . . 0.0 111.49 171.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 19.3 mt -62.7 -42.82 99.84 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 173.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.88 -24.17 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.24 0.927 . . . . 0.0 112.34 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 54.6 t -78.87 -38.99 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.233 1.013 . . . . 0.0 110.429 172.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -61.56 -49.75 75.4 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.394 0.997 . . . . 0.0 112.297 170.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -65.71 -46.33 79.35 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.711 0.687 . . . . 0.0 112.47 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -52.26 -40.86 53.48 Favored Glycine 0 CA--C 1.539 1.546 0 O-C-N 121.598 -0.689 . . . . 0.0 112.788 167.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 70.2 m -69.17 -37.83 78.39 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 117.775 0.787 . . . . 0.0 112.482 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -59.71 -50.2 74.75 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.981 1.312 . . . . 0.0 110.888 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -51.66 -47.41 63.8 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.362 1.065 . . . . 0.0 112.247 172.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 37.8 t -66.37 -37.97 80.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.959 0.904 . . . . 0.0 112.363 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 12.2 t -62.85 -33.51 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.146 1.379 . . . . 0.0 112.427 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 24.5 mtt180 -59.99 -44.86 94.24 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.118 -0.989 . . . . 0.0 111.221 170.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.7 mt -68.7 -35.43 77.17 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.173 0.589 . . . . 0.0 112.381 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 53.2 m0 -65.34 -26.58 68.1 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 172.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 47.8 t -70.34 -30.21 67.11 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.604 1.093 . . . . 0.0 113.534 166.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -68.89 -0.46 5.56 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.307 -1.496 . . . . 0.0 112.598 161.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -104.92 7.39 44.75 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 126.58 2.038 . . . . 0.0 116.238 172.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 7.8 t -54.49 -23.12 14.97 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.247 1.524 . . . . 0.0 112.48 173.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -122.47 -60.37 1.55 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.254 1.422 . . . . 0.0 110.988 153.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.9 p -86.35 64.5 8.58 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.473 1.509 . . . . 0.0 111.971 -163.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -44.82 -35.73 2.91 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.732 1.613 . . . . 0.0 115.05 -167.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -112.32 -33.07 6.31 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.739 1.216 . . . . 0.0 113.859 174.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -56.74 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 119.786 1.176 . . . . 0.0 111.606 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -67.63 -35.79 86.69 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 119.022 -0.877 . . . . 0.0 111.179 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 1.2 tt -51.9 -33.21 35.88 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.019 0.928 . . . . 0.0 113.062 169.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 49.8 t-105 -86.13 -36.18 19.72 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -73.88 -38.17 49.55 Favored Glycine 0 N--CA 1.466 0.638 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -64.99 -40.29 94.73 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 124.675 1.19 . . . . 0.0 111.005 169.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 19.3 tp -63.76 -40.87 97.74 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.41 1.005 . . . . 0.0 111.914 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 52.5 mtp180 -64.43 -23.81 67.41 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 171.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -74.73 0.47 15.16 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.919 1.288 . . . . 0.0 113.977 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.03 27.71 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 116.839 2.163 . . . . 0.0 116.839 -173.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -92.75 -7.16 47.4 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 117.198 2.295 . . . . 0.0 117.198 -159.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -61.03 147.23 86.48 Favored Pre-proline 0 N--CA 1.482 1.138 0 CA-C-N 120.976 1.716 . . . . 0.0 109.975 167.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -45.33 -50.18 9.39 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.93 3.087 . . . . 0.0 115.669 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 96.5 mt -71.98 -29.96 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.409 1.083 . . . . 0.0 111.784 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 50.6 m -72.79 -30.72 64.31 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.093 0.957 . . . . 0.0 112.279 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.8 mt -68.16 -42.77 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.586 0.754 . . . . 0.0 109.808 168.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 49.4 mt -61.87 -43.52 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 121.656 -0.653 . . . . 0.0 110.933 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.13 -38.78 92.29 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.501 1.52 . . . . 0.0 112.099 175.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.5 tt -63.12 -48.76 77.16 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.55 0.614 . . . . 0.0 110.716 170.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.1 -36.93 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.618 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 72.1 t -74.1 -33.93 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 120.24 1.382 . . . . 0.0 113.5 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.3 p -66.39 -36.99 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 121.052 1.751 . . . . 0.0 110.802 169.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 77.4 t -71.45 -39.56 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 120.904 -1.122 . . . . 0.0 110.777 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.5 -57.77 10.83 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.036 0.934 . . . . 0.0 110.628 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 59.8 p -56.14 -42.44 76.93 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.761 0.424 . . . . 0.0 111.261 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -64.0 -54.93 26.55 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.928 0.891 . . . . 0.0 112.526 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.15 -36.43 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 119.65 1.113 . . . . 0.0 111.855 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 27.9 m -75.17 -38.87 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 117.561 -1.209 . . . . 0.0 112.047 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.92 -22.13 65.08 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.031 1.287 . . . . 0.0 111.655 171.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 66.8 m -74.68 -36.87 62.79 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.422 1.089 . . . . 0.0 113.177 171.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 76.6 t -64.04 -31.61 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 118.933 0.788 . . . . 0.0 110.273 164.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 137.76 -107.68 0.59 Allowed Glycine 0 CA--C 1.522 0.506 0 C-N-CA 124.555 1.074 . . . . 0.0 112.908 158.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 87.1 p -139.8 2.21 1.95 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.55 1.14 . . . . 0.0 113.195 -167.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -171.92 -177.8 2.01 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.667 2.387 . . . . 0.0 110.23 -172.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 57.69 108.25 0.01 OUTLIER Glycine 0 CA--C 1.526 0.781 0 N-CA-C 106.966 -2.454 . . . . 0.0 106.966 -107.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -57.92 -6.4 0.56 Allowed 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 120.348 2.074 . . . . 0.0 112.586 172.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.531 ' HA ' HG22 ' A' ' 224' ' ' THR . 22.3 m -72.12 -32.17 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.528 1.531 . . . . 0.0 113.119 169.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.37 -47.68 62.76 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.929 1.241 . . . . 0.0 111.181 159.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.29 -55.31 12.56 Favored 'General case' 0 C--O 1.223 -0.341 0 O-C-N 124.217 0.948 . . . . 0.0 110.768 -168.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.531 HG22 ' HA ' ' A' ' 221' ' ' VAL . 8.1 t -52.97 -39.72 63.21 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.166 -0.959 . . . . 0.0 111.78 176.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 16.1 m -69.2 -58.29 4.25 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.163 -0.961 . . . . 0.0 111.999 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -54.79 -54.69 38.91 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 126.049 1.739 . . . . 0.0 110.914 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.53 -71.79 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.845 1.658 . . . . 0.0 107.835 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -74.52 -43.38 56.15 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.246 -154.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -59.45 -46.33 94.09 Favored Glycine 0 N--CA 1.472 1.056 0 CA-C-O 119.616 -0.547 . . . . 0.0 112.854 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.98 -34.67 39.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 117.979 0.89 . . . . 0.0 111.623 -177.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -40.74 98.54 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.058 -1.026 . . . . 0.0 112.168 166.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -66.56 -36.53 82.9 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.34 0.656 . . . . 0.0 110.634 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.5 tp -67.29 -23.85 65.7 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 172.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.48 -48.2 20.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.51 1.124 . . . . 0.0 113.071 176.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 22.9 pt -68.08 -16.6 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 173.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 52.0 tp -70.26 -26.06 63.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.266 1.426 . . . . 0.0 111.608 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.443 ' HG2' ' HD1' ' A' ' 240' ' ' HIS . 10.3 mtp180 -67.44 -19.29 65.35 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.211 1.005 . . . . 0.0 112.221 -176.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.7 -24.08 2.1 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.685 1.994 . . . . 0.0 113.94 160.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.1 mt -114.36 -19.85 11.07 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.819 1.648 . . . . 0.0 111.334 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' HIS . . . . . 0.443 ' HD1' ' HG2' ' A' ' 237' ' ' ARG . 39.8 m170 -64.66 -32.22 73.78 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 118.964 -0.541 . . . . 0.0 111.425 162.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.297 11.1 p . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 125.159 2.409 . . . . 0.0 110.618 158.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.823 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.447 HG23 ' H ' ' A' ' 105' ' ' HIS . 2.6 t -62.8 -95.07 0.0 OUTLIER 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 127.382 2.273 . . . . 0.0 113.893 143.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.447 ' H ' HG23 ' A' ' 104' ' ' THR . 49.5 m80 -58.58 -19.85 41.79 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 119.975 3.324 . . . . 0.0 119.975 -168.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.6 p -61.0 -37.62 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 120.456 1.48 . . . . 0.0 111.946 172.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -67.45 -41.5 84.61 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.827 0.851 . . . . 0.0 109.249 173.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -58.86 -26.72 60.94 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.091 -1.394 . . . . 0.0 113.866 167.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -67.18 -45.19 77.7 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 120.36 2.08 . . . . 0.0 111.647 174.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.2 t -57.13 -47.39 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.144 0.978 . . . . 0.0 110.038 171.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -66.32 -56.6 10.38 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 118.848 -0.596 . . . . 0.0 112.453 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -58.89 -20.44 51.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 119.376 0.989 . . . . 0.0 113.463 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -80.39 -42.73 22.27 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.65 1.114 . . . . 0.0 111.773 171.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.63 -25.68 38.2 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -178.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -108.99 -38.71 5.5 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.06 1.344 . . . . 0.0 112.513 -164.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -90.75 151.1 43.37 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 123.279 0.632 . . . . 0.0 111.885 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.65 128.37 18.91 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.991 1.794 . . . . 0.0 112.986 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.2 t -152.4 151.13 30.43 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 156.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.47 -28.86 22.34 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 119.544 1.065 . . . . 0.0 112.654 172.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -70.88 -27.54 63.9 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 175.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.7 tmmt? -56.61 -60.87 2.91 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.34 1.056 . . . . 0.0 109.165 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 25.5 p -71.69 -27.33 62.96 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.682 1.193 . . . . 0.0 112.682 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -61.67 -52.24 65.14 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.715 1.598 . . . . 0.0 110.427 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.5 t -76.54 -48.17 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.051 0.54 . . . . 0.0 111.666 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -63.99 -46.54 84.1 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -75.77 -28.95 58.63 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.571 -0.705 . . . . 0.0 111.285 -174.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -69.99 -39.24 76.04 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.469 1.031 . . . . 0.0 112.375 169.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.51 -43.99 84.66 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.477 1.035 . . . . 0.0 113.362 167.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 76.4 t -62.15 -44.42 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 120.553 1.524 . . . . 0.0 111.727 172.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -56.72 -50.47 72.11 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.05 1.295 . . . . 0.0 111.553 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 94.2 mt -65.19 -45.37 85.11 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 119.019 -0.515 . . . . 0.0 111.469 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 76.1 mt -65.36 -37.23 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.859 0.754 . . . . 0.0 112.085 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.76 -45.46 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 119.956 1.253 . . . . 0.0 110.731 174.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 45.3 tp -63.92 -47.98 78.39 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.074 0.95 . . . . 0.0 111.922 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.4 t -59.9 -47.37 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.631 0.772 . . . . 0.0 110.126 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 41.5 t -58.06 -43.71 87.09 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.713 1.205 . . . . 0.0 112.824 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 61.2 mt -76.75 -36.18 57.26 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.2 mt -61.66 -48.31 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 120.813 -1.179 . . . . 0.0 109.77 167.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -63.48 -25.78 68.42 Favored 'General case' 0 C--O 1.22 -0.485 0 O-C-N 121.431 -0.793 . . . . 0.0 111.921 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.1 t -56.94 -39.59 74.81 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 120.047 1.294 . . . . 0.0 112.068 175.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 52.1 t -66.31 -42.34 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.584 0.754 . . . . 0.0 111.652 173.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.4 mt -70.63 -55.52 8.59 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.652 1.181 . . . . 0.0 112.661 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.3 m -68.17 -29.82 68.79 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.915 2.086 . . . . 0.0 113.538 -171.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.19 -46.29 51.44 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.218 1.372 . . . . 0.0 110.382 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.7 mm -52.84 -44.0 47.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.023 0.929 . . . . 0.0 110.834 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -74.07 -33.41 63.66 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -74.26 -21.69 59.65 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 119.856 -1.778 . . . . 0.0 112.082 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -79.98 -41.88 25.03 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.556 0.616 . . . . 0.0 109.455 171.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -57.91 -28.14 63.97 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.369 1.068 . . . . 0.0 113.424 170.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -57.63 -18.11 18.35 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.8 mp -83.86 -34.88 24.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.047 0.939 . . . . 0.0 111.952 174.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -84.58 -36.7 21.89 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.005 1.722 . . . . 0.0 114.073 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.0 t -158.51 -168.13 2.35 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 126.784 2.034 . . . . 0.0 108.313 -159.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -71.91 -174.99 23.44 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 120.711 -1.243 . . . . 0.0 113.74 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 10.0 t -161.02 148.18 15.25 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 49.3 tp -68.42 -10.38 54.83 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.194 1.798 . . . . 0.0 114.314 165.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -53.52 -17.77 2.31 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 -167.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 30.0 p-90 -58.14 -29.86 65.9 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 119.978 -1.701 . . . . 0.0 112.908 169.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 61.7 ttp -65.09 -32.89 74.83 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.858 1.663 . . . . 0.0 112.108 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -69.16 -38.94 79.01 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.508 -0.745 . . . . 0.0 111.884 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 50.1 mm -56.35 -34.51 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.059 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.4 t -60.5 -46.18 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.147 0.885 . . . . 0.0 111.271 172.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 15.9 mt -72.19 -47.47 50.45 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.746 0.818 . . . . 0.0 112.871 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 69.0 t -62.14 -43.29 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.754 0.822 . . . . 0.0 111.161 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 84.6 t -72.15 -32.41 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.05 174.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -62.12 -49.16 77.0 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 120.807 1.64 . . . . 0.0 112.486 170.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -64.83 -39.71 94.02 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.52 -1.363 . . . . 0.0 111.636 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -62.56 -38.11 95.84 Favored Glycine 0 CA--C 1.538 1.475 0 O-C-N 121.989 -0.444 . . . . 0.0 112.714 169.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 59.8 m -67.53 -36.65 81.43 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 117.731 0.765 . . . . 0.0 111.706 173.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -62.33 -44.18 97.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.521 1.128 . . . . 0.0 110.784 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -58.51 -41.1 84.63 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 77.9 t -71.08 -36.65 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.217 -0.927 . . . . 0.0 113.153 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 46.8 t -67.17 -29.99 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.035 1.334 . . . . 0.0 111.746 175.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -59.43 -40.01 85.35 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.971 -1.081 . . . . 0.0 112.19 165.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 74.5 mt -74.63 -36.93 62.92 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.708 0.803 . . . . 0.0 112.928 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 54.9 m0 -62.57 -41.17 98.76 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.072 1.305 . . . . 0.0 112.708 169.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 42.8 p -71.41 0.82 7.37 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.84 -23.45 60.67 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.556 1.525 . . . . 0.0 113.579 154.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 164.27 112.54 0.27 Allowed Glycine 0 N--CA 1.433 -1.541 0 O-C-N 121.878 -0.514 . . . . 0.0 112.157 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 45.0 t -34.06 -32.51 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.14 1.776 . . . . 0.0 113.514 152.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.46 -44.64 3.85 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 161.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.7 m -74.47 24.97 0.08 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -171.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -5.66 2.89 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 118.067 2.618 . . . . 0.0 118.067 -173.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -119.2 -37.53 3.18 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 120.276 1.398 . . . . 0.0 111.822 166.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.404 HG13 ' H ' ' A' ' 186' ' ' GLY . 10.8 p -73.09 -62.0 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.96 0.904 . . . . 0.0 112.71 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.404 ' H ' HG13 ' A' ' 185' ' ' VAL . . . -61.63 -31.65 78.61 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 118.591 -1.116 . . . . 0.0 112.656 169.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.0 tt -55.79 -49.58 72.8 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.4 1.6 . . . . 0.0 110.048 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -66.99 -42.38 85.17 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 122.211 -0.305 . . . . 0.0 111.092 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -53.36 -43.95 65.62 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.238 1.399 . . . . 0.0 114.105 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . 0.326 9.9 ptp180 -80.51 -31.02 37.26 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 40.0 tp -69.0 -41.02 78.34 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.49 0.586 . . . . 0.0 112.365 171.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -76.18 -17.39 59.57 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -78.97 -13.83 59.56 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.757 1.223 . . . . 0.0 113.831 169.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -78.79 43.89 0.52 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 117.052 2.242 . . . . 0.0 117.052 -165.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -93.86 -5.57 47.72 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -165.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -61.89 141.45 95.4 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 120.199 1.363 . . . . 0.0 109.104 175.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -47.57 -43.37 27.95 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.025 2.483 . . . . 0.0 115.021 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 35.0 mm -68.43 -32.24 54.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.117 0.967 . . . . 0.0 112.419 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 14.3 m -71.61 -36.6 70.86 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.973 1.309 . . . . 0.0 111.46 175.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 63.6 mt -68.94 -39.32 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.707 1.203 . . . . 0.0 110.733 173.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 33.9 mt -62.85 -41.48 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 121.286 -0.884 . . . . 0.0 111.129 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -65.23 -36.45 84.19 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.26 1.424 . . . . 0.0 111.647 176.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 28.6 tp -60.95 -52.96 62.83 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.529 0.732 . . . . 0.0 111.48 166.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 49.5 mt -61.59 -36.32 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.496 -0.752 . . . . 0.0 111.077 -175.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.0 t -65.9 -45.84 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.962 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.02 -31.39 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 CA-C-N 120.818 1.645 . . . . 0.0 112.018 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 97.5 t -74.25 -39.38 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 120.557 1.526 . . . . 0.0 110.893 176.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.15 81.96 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.34 0.973 . . . . 0.0 110.369 170.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 47.6 m -58.62 -43.94 89.79 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.77 0.828 . . . . 0.0 112.197 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 28.3 ttm -59.66 -55.45 34.31 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.295 1.438 . . . . 0.0 111.875 171.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 23.8 t -56.01 -47.47 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.099 1.36 . . . . 0.0 112.053 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 33.4 m -75.95 -25.79 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 118.043 -0.979 . . . . 0.0 113.28 -171.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 86.3 mt -68.85 -48.32 63.75 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.829 1.195 . . . . 0.0 110.968 159.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 43.8 t -63.04 -46.79 85.85 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.169 0.987 . . . . 0.0 113.003 -165.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 8.4 p -71.13 -11.72 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.896 -1.128 . . . . 0.0 113.214 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.41 125.58 5.66 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 125.357 1.456 . . . . 0.0 112.301 -168.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.5 m -72.75 61.23 0.53 Allowed 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 128.37 2.668 . . . . 0.0 113.427 -168.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -166.73 164.72 16.64 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 127.735 2.414 . . . . 0.0 112.064 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -85.24 -106.14 0.67 Allowed Glycine 0 C--N 1.337 0.603 0 C-N-CA 126.462 1.982 . . . . 0.0 111.923 -1.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -66.32 -23.64 66.4 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.095 -1.053 . . . . 0.0 112.302 171.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.68 -44.79 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 O-C-N 121.259 -0.901 . . . . 0.0 110.486 -166.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.65 -51.58 54.69 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.482 0.713 . . . . 0.0 111.906 163.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.66 -52.36 65.46 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.58 0.752 . . . . 0.0 109.559 -171.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.49 -37.73 88.57 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-O 117.915 -1.04 . . . . 0.0 112.715 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 46.1 m -67.92 -48.26 66.48 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 121.397 1.908 . . . . 0.0 111.298 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -56.42 -46.77 80.07 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 125.072 1.349 . . . . 0.0 110.976 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 227' ' ' ILE . 72.5 mt -59.29 -71.1 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-O 122.478 1.133 . . . . 0.0 110.184 167.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -78.38 -17.92 55.79 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.153 -150.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.43 -53.73 2.24 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.532 1.063 . . . . 0.0 114.058 162.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -30.66 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 119.512 1.656 . . . . 0.0 113.637 -170.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 4.0 mmt85 -73.49 -32.46 64.31 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.779 -1.2 . . . . 0.0 110.923 170.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -67.19 -36.5 81.89 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.479 1.111 . . . . 0.0 112.42 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 65.3 tp -58.34 -36.23 73.1 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 118.316 0.507 . . . . 0.0 112.198 165.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.21 -34.71 61.52 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 119.95 -1.719 . . . . 0.0 113.552 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 3.7 pt -73.35 -22.75 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 120.779 -1.2 . . . . 0.0 113.832 164.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.5 tp -58.7 -42.47 88.68 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.606 1.163 . . . . 0.0 110.789 164.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -56.98 -30.6 64.26 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.309 1.044 . . . . 0.0 112.893 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 18.5 mmt -49.08 -31.93 8.79 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 168.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 40.5 mt -112.65 -7.67 13.84 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.182 1.393 . . . . 0.0 109.982 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -68.12 -12.93 61.77 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.661 0.664 . . . . 0.0 112.084 153.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 61.8 t . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 124.272 1.987 . . . . 0.0 108.765 138.708 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.588 ' HA ' HG12 ' A' ' 106' ' ' VAL . 18.7 ttp180 . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 t -43.71 -57.27 3.29 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.932 2.493 . . . . 0.0 114.027 165.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -92.22 -25.33 18.69 Favored 'General case' 0 C--N 1.335 -0.06 0 O-C-N 120.196 -1.565 . . . . 0.0 114.349 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.588 HG12 ' HA ' ' A' ' 103' ' ' ARG . 1.4 p -69.56 -38.93 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 119.446 1.021 . . . . 0.0 111.144 171.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -73.54 -32.35 64.16 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.137 -0.977 . . . . 0.0 111.159 171.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.02 -32.31 42.0 Favored Glycine 0 CA--C 1.536 1.348 0 O-C-N 121.755 -0.591 . . . . 0.0 112.579 163.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -37.05 84.13 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.263 1.425 . . . . 0.0 111.546 -177.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.07 -54.1 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 122.292 1.044 . . . . 0.0 109.485 170.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . 0.25 77.0 m-85 -74.78 -33.75 62.33 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.101 -168.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -62.31 -22.86 66.38 Favored 'General case' 0 CA--C 1.552 1.051 0 O-C-N 120.179 -1.576 . . . . 0.0 114.469 165.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -75.38 -28.41 59.47 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.289 1.035 . . . . 0.0 111.811 171.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.2 mt -58.92 -43.65 91.16 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.56 1.073 . . . . 0.0 109.836 165.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -74.65 -40.82 61.23 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.306 -161.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.9 ptt85 -87.43 123.0 70.41 Favored Pre-proline 0 N--CA 1.47 0.554 0 C-N-CA 124.24 1.016 . . . . 0.0 110.46 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -65.89 126.61 16.21 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.869 1.712 . . . . 0.0 110.886 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.1 p -133.32 166.84 21.56 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 167.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.01 -37.59 71.78 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-N 118.634 0.652 . . . . 0.0 112.579 171.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -73.0 -34.99 66.74 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 175.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.43 -55.99 27.73 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.785 1.175 . . . . 0.0 108.864 164.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 34.0 t -58.52 -48.5 80.62 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.488 1.115 . . . . 0.0 111.994 -171.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -59.72 -52.96 63.26 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.824 0.45 . . . . 0.0 111.428 -175.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.6 t -84.27 -42.87 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -64.77 -48.98 72.52 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.705 0.402 . . . . 0.0 112.05 -172.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -68.8 -33.96 74.74 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.9 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -68.55 -36.08 78.31 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.275 0.943 . . . . 0.0 113.047 173.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.79 -46.13 81.74 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.352 0.978 . . . . 0.0 113.628 169.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . 0.268 0.7 OUTLIER -64.69 -39.05 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 CA-C-N 120.39 1.45 . . . . 0.0 111.16 178.743 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -60.45 -48.74 80.46 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.868 -1.145 . . . . 0.0 113.173 172.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.7 mt -61.82 -38.89 89.84 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.854 -1.154 . . . . 0.0 111.895 177.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 77.2 mt -63.26 -43.49 98.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 118.716 -0.659 . . . . 0.0 111.779 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -38.11 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 119.556 1.071 . . . . 0.0 111.662 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.6 mt -59.31 -47.74 84.27 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.761 0.425 . . . . 0.0 111.859 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.4 m -70.63 -41.11 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.608 1.095 . . . . 0.0 110.944 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 95.9 m -64.51 -39.91 94.67 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 119.105 0.866 . . . . 0.0 112.834 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 78.1 mt -71.2 -41.23 70.55 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 120.091 1.314 . . . . 0.0 112.599 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.3 mm -64.31 -48.09 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 121.232 -0.917 . . . . 0.0 110.02 172.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -61.5 -35.63 78.24 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-O 116.915 -1.516 . . . . 0.0 110.663 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.4 m -49.73 -48.38 50.12 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 121.006 1.73 . . . . 0.0 113.084 173.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.43 -30.67 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 122.999 0.52 . . . . 0.0 112.212 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.3 mt -89.84 -30.92 17.6 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.49 1.516 . . . . 0.0 114.907 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.7 p -90.17 -26.11 20.31 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.014 -1.053 . . . . 0.0 113.25 -158.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.3 t -68.97 -32.51 72.14 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.307 -0.871 . . . . 0.0 112.439 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 11.8 pt -72.28 -9.13 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -62.91 -23.38 67.33 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.661 0.784 . . . . 0.0 112.099 170.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -62.85 -38.74 92.03 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.845 1.258 . . . . 0.0 111.457 168.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -74.84 -37.37 62.28 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.892 0.769 . . . . 0.0 111.36 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.75 -42.29 95.28 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.124 0.969 . . . . 0.0 113.501 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -58.23 -25.08 61.24 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -170.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -69.77 -48.14 60.36 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.488 1.115 . . . . 0.0 111.859 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.96 -51.91 11.4 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.671 1.188 . . . . 0.0 113.273 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.5 t -159.4 -179.0 7.56 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.611 -139.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -62.71 152.73 45.19 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 122.006 0.781 . . . . 0.0 112.936 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.8 t -152.9 148.28 26.96 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.843 0.83 . . . . 0.0 112.101 -166.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 11.3 tp -81.66 14.97 2.32 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.924 2.09 . . . . 0.0 112.796 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -50.24 -29.14 8.88 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.116 2.566 . . . . 0.0 114.618 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -70.99 -31.14 67.59 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.134 -0.979 . . . . 0.0 112.408 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 9.0 tpt -73.91 -35.41 64.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.433 1.015 . . . . 0.0 110.767 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -55.82 -56.35 21.56 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.516 0.726 . . . . 0.0 110.775 166.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 75.0 mt -58.45 -40.13 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.6 0.76 . . . . 0.0 112.282 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.7 t -61.95 -44.82 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 120.279 -1.513 . . . . 0.0 112.567 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.2 mt -71.2 -34.37 70.82 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.219 1.372 . . . . 0.0 112.037 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 54.9 t -59.8 -36.77 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.54 1.063 . . . . 0.0 110.881 170.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 78.8 t -76.26 -28.2 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 118.503 -0.761 . . . . 0.0 112.055 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -60.85 -48.99 79.29 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.197 1.362 . . . . 0.0 110.669 169.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -71.93 -35.79 69.75 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.53 -43.54 94.11 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 123.368 0.508 . . . . 0.0 112.361 167.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 88.9 m -68.88 -36.95 78.7 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.837 0.819 . . . . 0.0 110.739 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.4 tm-20 -60.14 -35.11 74.57 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 118.751 0.705 . . . . 0.0 112.541 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -60.69 -46.25 91.08 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.263 -0.898 . . . . 0.0 112.044 169.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.4 t -69.99 -30.82 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.494 0.717 . . . . 0.0 111.988 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.1 t -60.65 -39.51 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.305 1.442 . . . . 0.0 112.47 171.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -69.79 -20.1 63.48 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 170.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 31.8 mt -77.73 -37.7 48.73 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.311 0.959 . . . . 0.0 112.222 166.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 34.8 m0 -64.92 -45.63 85.03 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.008 -1.058 . . . . 0.0 113.355 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 95.1 p -56.02 -38.49 70.61 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.024 1.283 . . . . 0.0 113.845 169.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.09 -8.85 33.74 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 173.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -106.63 5.2 37.34 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.142 1.83 . . . . 0.0 113.815 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 20.7 p -57.35 -15.28 6.01 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -173.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.28 -33.17 2.17 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.011 1.725 . . . . 0.0 112.658 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 21.7 t -159.26 115.2 2.56 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.093 1.757 . . . . 0.0 107.347 177.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -57.7 -34.74 69.76 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -155.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -100.24 -29.32 12.53 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -169.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 99.4 t -54.42 -59.63 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 118.834 0.743 . . . . 0.0 110.695 -173.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.35 -26.76 68.33 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-O 116.101 -2.499 . . . . 0.0 114.507 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 66.4 mt -57.3 -39.47 75.83 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 121.519 2.66 . . . . 0.0 111.237 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 6.7 t-105 -70.25 -42.46 72.15 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.472 -0.768 . . . . 0.0 111.748 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -62.79 -27.1 69.5 Favored Glycine 0 CA--C 1.533 1.173 0 O-C-N 121.608 -0.682 . . . . 0.0 113.38 175.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -82.69 -31.37 28.61 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 129.901 3.28 . . . . 0.0 113.104 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 52.8 mt -81.19 -30.26 34.37 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.58 1.152 . . . . 0.0 111.906 171.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -58.94 -45.01 91.46 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 126.327 1.851 . . . . 0.0 112.291 159.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -63.13 -31.27 72.37 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.694 -0.628 . . . . 0.0 112.193 169.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.28 17.23 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 173.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 -108.01 -20.97 13.0 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.287 1.835 . . . . 0.0 112.89 172.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -70.03 153.7 95.18 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 126.025 1.73 . . . . 0.0 110.031 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.69 -57.28 1.06 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 CA-C-N 122.236 1.834 . . . . 0.0 116.019 -157.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 81.7 mt -68.34 -18.54 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 120.017 1.28 . . . . 0.0 111.834 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 37.2 m -89.44 -29.28 19.13 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 16.5 tt -79.75 -33.1 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 119.823 1.192 . . . . 0.0 110.701 168.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.09 -36.69 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 118.852 0.751 . . . . 0.0 110.213 165.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -72.02 -35.67 69.47 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.701 1.137 . . . . 0.0 111.789 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 24.1 tp -62.15 -49.31 76.34 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.729 0.412 . . . . 0.0 111.417 169.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 60.6 mt -60.78 -45.24 98.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.786 1.234 . . . . 0.0 111.084 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.2 t -68.27 -40.02 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.048 0.939 . . . . 0.0 112.002 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.1 p -69.73 -31.6 49.13 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 CA-C-N 121.331 1.878 . . . . 0.0 111.707 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 73.2 t -71.71 -45.03 68.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -54.86 -48.58 72.75 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 118.186 0.448 . . . . 0.0 111.297 171.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.0 m -57.12 -50.28 73.29 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.341 1.057 . . . . 0.0 112.847 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 21.6 ptp -69.14 -38.65 78.94 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 118.906 -0.569 . . . . 0.0 111.86 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 14.9 t -58.66 -42.12 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.336 1.054 . . . . 0.0 111.687 174.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 30.2 m -84.38 -30.84 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.32 -33.07 65.25 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.082 0.855 . . . . 0.0 111.813 160.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 48.9 t -84.56 -44.34 13.64 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.845 0.858 . . . . 0.0 112.958 -170.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 5.0 p -67.14 -21.51 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -169.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 122.61 108.22 1.94 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -159.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' SER . . . . . 0.412 ' HA ' ' CG ' ' A' ' 222' ' ' PHE . 97.4 p -73.37 41.21 0.11 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.84 2.056 . . . . 0.0 114.133 -173.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -157.21 166.7 32.46 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 128.621 2.769 . . . . 0.0 109.829 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -87.11 -90.61 1.0 Allowed Glycine 0 N--CA 1.468 0.775 0 C-N-CA 127.258 2.361 . . . . 0.0 107.357 -13.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -60.86 -37.15 81.13 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.648 -1.276 . . . . 0.0 112.442 169.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 24.6 t -85.89 -40.91 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 117.883 -1.527 . . . . 0.0 111.488 -148.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.412 ' CG ' ' HA ' ' A' ' 217' ' ' SER . 0.1 OUTLIER -53.1 -46.51 68.73 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.223 162.596 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.92 -56.06 11.9 Favored 'General case' 0 C--O 1.214 -0.765 0 O-C-N 123.815 0.697 . . . . 0.0 111.307 -171.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.1 t -54.2 -36.71 63.75 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.739 -1.226 . . . . 0.0 112.228 176.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 15.6 m -68.93 -56.71 7.0 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.243 -0.91 . . . . 0.0 112.506 174.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.33 -57.45 12.27 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 125.864 1.666 . . . . 0.0 111.953 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.425 HD13 HG21 ' A' ' 227' ' ' ILE . 59.5 mt -54.71 -79.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-O 123.413 1.578 . . . . 0.0 108.902 169.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -74.83 -34.96 62.42 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 113.946 -1.479 . . . . 0.0 108.358 -150.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -72.72 -52.87 8.94 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.025 1.298 . . . . 0.0 115.17 172.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.41 -36.94 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-N 120.747 2.273 . . . . 0.0 111.487 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -81.33 -20.94 39.64 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.4 -46.6 89.42 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.51 0.724 . . . . 0.0 109.734 164.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.79 -24.93 67.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.57 -0.728 . . . . 0.0 110.987 171.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -70.46 -46.43 63.85 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 122.015 2.189 . . . . 0.0 113.62 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 8.3 pt -72.47 -2.25 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 120.509 -1.37 . . . . 0.0 114.206 173.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 44.1 tp -87.23 -21.58 25.76 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.677 1.191 . . . . 0.0 113.213 164.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -80.53 -12.38 59.54 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.949 1.7 . . . . 0.0 111.959 175.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 16.4 tpp -35.84 -30.8 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 128.981 2.913 . . . . 0.0 114.031 147.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 10.1 mt -102.9 -9.74 19.62 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.617 1.567 . . . . 0.0 110.767 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 52.3 m170 -83.88 -15.05 49.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.179 1.392 . . . . 0.0 112.147 161.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.359 3.4 t . . . . . 0 N--CA 1.475 0.806 0 CA-C-O 125.648 2.642 . . . . 0.0 111.019 146.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.547 ' HA ' HG12 ' A' ' 106' ' ' VAL . 2.5 ptt180 . . . . . 0 N--CA 1.444 -0.747 0 N-CA-C 111.487 0.18 . . . . 0.0 111.487 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -73.4 -31.51 63.92 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.227 -0.92 . . . . 0.0 110.903 172.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -69.0 -48.46 63.03 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.928 -1.107 . . . . 0.0 111.964 172.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 103' ' ' ARG . 5.2 p -68.47 -34.97 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 118.273 0.488 . . . . 0.0 111.832 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -67.28 -35.16 78.93 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.193 -0.942 . . . . 0.0 110.429 172.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -57.57 -31.26 63.24 Favored Glycine 0 CA--C 1.545 1.958 0 C-N-CA 124.989 1.281 . . . . 0.0 113.841 163.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -72.26 -40.88 67.34 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.355 -1.086 . . . . 0.0 112.538 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.99 -43.53 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.705 1.202 . . . . 0.0 110.707 162.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.434 ' HB3' ' HA ' ' A' ' 177' ' ' SER . 19.6 m-30 -62.52 -45.63 92.11 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 117.433 -1.27 . . . . 0.0 112.552 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -53.39 -36.86 61.9 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.983 1.265 . . . . 0.0 113.045 170.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -73.62 -31.28 63.45 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.295 -0.878 . . . . 0.0 111.777 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.4 mt -68.35 -46.7 69.43 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.133 0.879 . . . . 0.0 110.572 168.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -70.71 -42.05 71.12 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.413 -165.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 25.9 ptt85 -75.81 156.52 84.52 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 123.858 0.863 . . . . 0.0 112.338 177.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -82.07 142.13 12.13 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.907 2.405 . . . . 0.0 111.498 167.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 75.3 p -147.74 156.92 43.25 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.561 1.544 . . . . 0.0 109.624 167.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.87 -36.04 78.24 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.016 166.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -64.66 -43.66 92.91 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -63.26 -46.2 87.97 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.292 0.951 . . . . 0.0 111.122 174.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 46.5 t -65.56 -33.76 76.67 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -62.08 -56.46 18.73 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.989 -1.07 . . . . 0.0 111.349 171.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.6 p -73.49 -41.08 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 120.721 -1.237 . . . . 0.0 113.207 -173.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -67.99 -50.9 52.82 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.665 0.786 . . . . 0.0 112.491 -173.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -68.14 -27.62 66.59 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.7 0.682 . . . . 0.0 111.991 -172.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -89.4 -30.4 18.38 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.4 -38.54 74.45 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 120.183 1.356 . . . . 0.0 112.529 158.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 19.4 t -58.28 -47.98 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 120.414 1.461 . . . . 0.0 111.884 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -59.66 -50.45 73.83 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.755 0.822 . . . . 0.0 113.193 172.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.57 -42.95 99.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -176.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.3 mt -63.38 -50.81 77.16 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.035 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.56 -36.46 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 119.926 1.239 . . . . 0.0 112.544 -173.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.1 tt -62.13 -47.71 83.35 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.277 1.031 . . . . 0.0 111.616 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 32.6 m -75.9 -40.89 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.747 0.703 . . . . 0.0 111.053 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 12.5 t -49.66 -58.27 5.6 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.351 1.86 . . . . 0.0 112.834 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 69.5 mt -77.28 -32.42 55.53 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.273 -0.892 . . . . 0.0 112.987 -173.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.9 mt -68.96 -46.14 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 120.038 1.29 . . . . 0.0 110.406 171.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -61.59 -30.33 70.61 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.806 175.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.8 m -60.08 -38.42 82.84 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.445 1.475 . . . . 0.0 113.212 172.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 50.7 t -67.27 -24.04 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 123.924 0.89 . . . . 0.0 111.807 174.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 46.2 mt -87.75 -48.33 7.94 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.292 1.037 . . . . 0.0 113.208 173.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 59.4 p -71.12 -12.41 61.48 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 127.497 2.319 . . . . 0.0 113.531 -171.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.7 t -70.63 -32.67 70.07 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.663 1.185 . . . . 0.0 111.444 170.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 48.4 mm -72.6 -33.35 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.712 0.805 . . . . 0.0 110.64 168.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -66.31 -33.29 75.39 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.271 0.628 . . . . 0.0 112.187 169.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -65.2 -40.86 94.76 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.843 1.257 . . . . 0.0 111.595 170.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -69.27 -34.4 74.69 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.338 0.655 . . . . 0.0 112.379 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.03 98.14 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.852 0.861 . . . . 0.0 111.722 167.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.13 -10.27 9.89 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 76.3 mt -70.78 -12.31 61.47 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.117 1.367 . . . . 0.0 113.738 166.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -152.56 -45.73 0.1 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -163.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.6 t -156.26 175.65 13.71 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.746 0.819 . . . . 0.0 110.833 -143.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.1 139.62 48.27 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 114.628 0.611 . . . . 0.0 114.628 -166.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.1 t -156.26 143.84 19.33 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -162.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 16.7 tp -87.18 7.89 26.27 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.882 1.273 . . . . 0.0 112.624 171.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -65.59 -10.98 40.27 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 119.546 -1.972 . . . . 0.0 114.093 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 53.7 p-90 -65.3 -26.46 68.08 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.057 -1.652 . . . . 0.0 112.492 166.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 51.0 tpp -75.36 -28.75 59.66 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.652 1.581 . . . . 0.0 112.261 174.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -61.24 -43.8 98.29 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.133 -0.979 . . . . 0.0 110.453 165.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.12 -35.26 73.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 118.096 -0.954 . . . . 0.0 111.3 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.43 -53.0 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 120.66 1.573 . . . . 0.0 111.745 170.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.8 mt -68.18 -36.8 80.16 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.239 0.927 . . . . 0.0 112.411 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 38.0 t -59.29 -41.47 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 120.666 1.576 . . . . 0.0 111.092 172.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.17 -31.13 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.502 -0.761 . . . . 0.0 111.05 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -59.66 -51.94 67.65 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.601 1.092 . . . . 0.0 111.752 165.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -62.47 -36.77 83.53 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 121.226 1.83 . . . . 0.0 112.055 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -62.31 -43.87 98.47 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 172.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 56.0 m -67.27 -32.81 74.06 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.401 -1.058 . . . . 0.0 110.895 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -65.42 -41.96 93.0 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 120.738 -1.226 . . . . 0.0 112.344 173.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -58.35 -45.71 87.66 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.529 0.604 . . . . 0.0 111.832 170.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.4 t -66.04 -38.18 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.816 0.846 . . . . 0.0 111.515 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 23.1 t -65.23 -38.83 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.004 1.322 . . . . 0.0 110.967 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -62.47 -34.26 76.49 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.585 1.084 . . . . 0.0 113.335 171.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 9.7 mt -67.96 -47.34 68.87 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.915 0.779 . . . . 0.0 111.875 169.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -61.91 -43.51 98.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 118.013 -0.994 . . . . 0.0 112.858 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.434 ' HA ' ' HB3' ' A' ' 111' ' ' TYR 0.265 43.0 p -65.49 -26.98 68.16 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 176.664 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.448 ' HB1' ' C ' ' A' ' 186' ' ' GLY . . . -57.23 -25.14 58.62 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.801 1.182 . . . . 0.0 113.247 168.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.412 ' CA ' ' HA ' ' A' ' 183' ' ' LYS . . . -70.49 -9.65 65.17 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 126.098 1.808 . . . . 0.0 114.643 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 44.1 t -53.82 -40.34 66.3 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.263 1.025 . . . . 0.0 112.382 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 3.1 ptp85 -68.51 -57.83 5.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.577 0.751 . . . . 0.0 111.803 171.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 41.7 t -162.96 137.67 6.46 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.498 1.919 . . . . 0.0 108.009 169.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.412 ' HA ' ' CA ' ' A' ' 179' ' ' GLY . 18.0 ptmt -60.28 -34.02 73.15 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -153.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -103.03 -27.19 12.74 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.209 1.004 . . . . 0.0 112.765 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 61.3 t -62.21 -68.08 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.068 1.347 . . . . 0.0 111.325 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.448 ' C ' ' HB1' ' A' ' 178' ' ' ALA . . . -61.0 -31.04 75.06 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 119.128 -0.818 . . . . 0.0 112.195 -178.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 7.9 tt -66.94 -39.93 87.45 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.61 1.564 . . . . 0.0 112.449 176.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 4.7 t-105 -60.26 -40.47 90.48 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 120.804 -1.185 . . . . 0.0 110.844 166.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -64.89 -30.31 77.65 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 122.226 0.903 . . . . 0.0 113.385 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 -76.3 -32.49 58.79 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.866 2.466 . . . . 0.0 112.312 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 75.1 mt -76.0 -35.35 59.59 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.943 1.297 . . . . 0.0 112.662 167.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 65.0 mtt-85 -59.67 -36.49 76.54 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.819 -1.176 . . . . 0.0 111.456 166.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -69.49 28.5 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 126.298 1.839 . . . . 0.0 113.994 170.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.66 27.95 1.21 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.598 2.359 . . . . 0.0 112.991 164.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -105.99 -37.08 6.76 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -149.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -77.86 146.81 72.92 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 117.265 -1.35 . . . . 0.0 109.868 172.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -45.22 -44.21 15.96 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.694 3.596 . . . . 0.0 116.901 -171.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -70.27 -30.38 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 119.353 0.979 . . . . 0.0 110.93 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.446 ' HA ' ' HB3' ' A' ' 202' ' ' ASP . 66.7 m -81.68 -26.83 34.38 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.509 1.523 . . . . 0.0 112.997 176.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.96 -48.14 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 163.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 65.5 mt -65.01 -30.08 49.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-O 118.689 -0.672 . . . . 0.0 111.566 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.446 ' HB3' ' HA ' ' A' ' 199' ' ' SER . 29.1 t70 -71.53 -44.52 64.46 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.496 1.498 . . . . 0.0 110.542 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 43.4 tp -61.6 -44.29 97.28 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.635 0.774 . . . . 0.0 111.403 171.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 72.2 mt -63.26 -49.1 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 121.393 -0.817 . . . . 0.0 110.804 176.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.0 t -70.39 -33.96 56.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 117.098 -1.429 . . . . 0.0 112.427 -173.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.5 p -65.38 -34.76 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 121.568 1.986 . . . . 0.0 111.394 172.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 86.9 t -75.17 -38.47 41.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 O-C-N 121.372 -0.83 . . . . 0.0 110.063 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -55.75 -47.26 77.27 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.697 0.68 . . . . 0.0 110.82 168.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 20.0 m -56.16 -43.48 78.39 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.148 0.979 . . . . 0.0 111.783 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 58.6 ttm -75.55 -50.3 16.02 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.276 0.631 . . . . 0.0 111.752 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 56.0 t -56.06 -46.74 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.066 0.946 . . . . 0.0 111.837 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 222' ' ' PHE . 13.9 m -77.01 -39.71 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 118.974 0.806 . . . . 0.0 113.035 -173.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -56.91 -32.87 66.37 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.919 0.887 . . . . 0.0 110.746 170.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 55.2 m -75.48 -52.15 11.36 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.376 1.471 . . . . 0.0 112.97 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.7 t -58.17 -40.25 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 125.265 1.426 . . . . 0.0 112.369 -171.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 139.35 154.66 6.41 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 123.595 0.617 . . . . 0.0 112.374 173.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 55.1 p -73.56 23.21 0.07 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -160.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm -156.41 165.39 36.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.477 1.911 . . . . 0.0 111.933 -160.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -78.01 -80.31 0.7 Allowed Glycine 0 N--CA 1.478 1.434 0 C-N-CA 127.462 2.458 . . . . 0.0 109.386 -9.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -84.77 -27.17 27.06 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.927 1.291 . . . . 0.0 110.827 161.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 73.5 t -76.7 -40.91 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 121.179 -0.951 . . . . 0.0 112.42 -145.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.428 ' HA ' ' HB ' ' A' ' 212' ' ' VAL . 0.0 OUTLIER -60.01 -39.81 87.07 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 169.128 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -74.17 -49.8 22.02 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.764 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 8.8 t -53.77 -38.4 64.42 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 121.123 1.783 . . . . 0.0 112.219 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 19.3 m -66.05 -56.85 9.48 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.505 -0.747 . . . . 0.0 112.357 173.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.54 -48.37 77.8 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.931 1.293 . . . . 0.0 112.496 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 67.2 mt -62.72 -84.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.79 0 O-C-N 119.255 -2.153 . . . . 0.0 109.133 169.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -71.87 -38.28 70.05 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.778 -152.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -71.05 -44.21 55.19 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 125.991 1.758 . . . . 0.0 114.32 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.5 mp -78.26 -30.18 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 118.773 1.286 . . . . 0.0 109.74 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -39.91 82.34 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 120.841 -1.162 . . . . 0.0 111.57 164.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -68.01 -41.48 82.14 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 117.385 -1.293 . . . . 0.0 110.73 -174.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 31.9 tp -57.43 -45.16 84.97 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.154 0.888 . . . . 0.0 110.856 167.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -59.09 -45.94 89.57 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -170.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.4 pt -66.93 -20.8 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 35.4 mt -66.88 -22.87 65.96 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.285 -0.884 . . . . 0.0 110.756 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -74.65 -11.35 60.16 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.263 -0.898 . . . . 0.0 111.731 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 81.2 mtp -45.79 -33.72 3.26 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 126.025 1.73 . . . . 0.0 113.1 153.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.3 mt -98.56 -14.02 20.14 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.346 1.459 . . . . 0.0 111.304 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 50.0 m170 -75.31 -27.49 59.31 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.681 -0.637 . . . . 0.0 111.495 157.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.251 15.5 t . . . . . 0 N--CA 1.471 0.588 0 CA-C-O 125.557 2.599 . . . . 0.0 110.027 157.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.55 0.979 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.2 t -63.42 -33.28 75.21 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 168.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -79.85 -30.39 40.31 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.439 -1.413 . . . . 0.0 110.763 -174.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.3 m -84.1 -34.25 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-O 121.845 0.831 . . . . 0.0 112.334 -174.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -52.74 -47.83 67.12 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.321 -1.308 . . . . 0.0 110.348 156.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -56.12 -36.83 69.37 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 118.928 -0.929 . . . . 0.0 113.613 169.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -70.11 -36.07 74.59 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.942 1.371 . . . . 0.0 112.089 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 t -57.0 -57.02 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.49 0.716 . . . . 0.0 109.87 162.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.419 ' HB3' ' HA ' ' A' ' 177' ' ' SER . 20.5 m-85 -58.76 -45.79 88.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.483 0.313 . . . . 0.0 111.623 -172.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -67.68 -21.54 65.33 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -77.0 -36.45 56.4 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.349 0.977 . . . . 0.0 111.294 172.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.8 mt -62.0 -40.79 96.85 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.799 -0.563 . . . . 0.0 109.735 164.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -71.75 -44.0 64.83 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.973 -167.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -98.87 101.72 13.0 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 126.632 1.973 . . . . 0.0 110.683 -174.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -65.17 156.95 60.14 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.49 2.126 . . . . 0.0 114.97 -164.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 40.4 p -145.31 168.14 21.17 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 127.107 2.163 . . . . 0.0 107.692 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.1 -35.14 32.94 Favored Glycine 0 CA--C 1.536 1.389 0 O-C-N 121.627 -0.671 . . . . 0.0 112.282 164.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 33.9 m95 -69.13 -34.45 75.04 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -60.87 -51.18 70.38 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.66 1.118 . . . . 0.0 110.51 169.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 42.8 t -63.09 -37.19 86.23 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.265 0.626 . . . . 0.0 111.573 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -58.96 -59.26 5.75 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.023 0.44 . . . . 0.0 109.844 173.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.86 -49.37 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.012 0.525 . . . . 0.0 111.993 -168.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -68.39 -46.2 70.65 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -170.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -77.89 -27.92 49.76 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.566 -0.709 . . . . 0.0 112.113 -172.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -68.78 -44.86 72.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.997 165.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -51.78 -48.91 63.59 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 117.314 -1.327 . . . . 0.0 113.96 168.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . 0.265 0.9 OUTLIER -63.82 -41.5 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 121.76 2.073 . . . . 0.0 112.293 -179.126 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -67.27 -43.17 82.47 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.742 0.701 . . . . 0.0 111.849 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 85.4 mt -66.1 -41.85 90.05 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.612 0.365 . . . . 0.0 111.766 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 69.4 mt -64.26 -47.74 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 118.011 -0.995 . . . . 0.0 111.194 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -40.32 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 120.495 1.498 . . . . 0.0 111.378 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 33.8 tp -59.43 -43.69 93.04 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.624 1.17 . . . . 0.0 111.658 175.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.8 t -64.3 -45.79 95.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 118.694 -0.669 . . . . 0.0 111.356 171.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 90.5 m -63.7 -39.98 95.64 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.172 0.896 . . . . 0.0 112.385 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 87.5 mt -79.49 -37.27 37.17 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.419 -0.801 . . . . 0.0 112.686 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.3 mt -59.25 -48.32 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.301 0.572 . . . . 0.0 109.94 167.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -60.96 -36.3 79.03 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-O 117.726 -1.131 . . . . 0.0 110.845 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.9 m -55.41 -44.49 76.24 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 121.538 1.972 . . . . 0.0 112.444 -176.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.3 m -79.28 -16.04 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 78.4 mt -81.98 -28.41 32.66 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 120.074 1.306 . . . . 0.0 113.554 161.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 37.8 t -78.5 -38.67 40.2 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.808 1.643 . . . . 0.0 113.579 -160.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . 0.336 3.4 t -74.28 -17.19 60.89 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 120.295 1.407 . . . . 0.0 113.312 -175.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.1 mp -58.89 -43.13 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 120.587 -1.32 . . . . 0.0 110.959 159.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -69.52 -41.04 76.54 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.479 1.111 . . . . 0.0 110.669 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -59.04 -41.6 88.21 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.779 1.232 . . . . 0.0 111.647 171.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -67.99 -40.83 83.0 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.782 -1.199 . . . . 0.0 110.922 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.94 -33.47 73.23 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.615 0.766 . . . . 0.0 111.481 172.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.28 -8.66 8.98 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 72.3 mt -70.71 -11.93 61.25 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 120.249 -1.532 . . . . 0.0 113.482 166.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.49 -45.54 0.17 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -170.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.1 t -157.52 -178.66 7.5 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.806 0.813 . . . . 0.0 112.402 -138.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.13 134.99 52.11 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 124.609 1.099 . . . . 0.0 114.445 -170.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.5 t -155.07 137.52 15.01 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.227 1.011 . . . . 0.0 112.735 -160.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.6 tp -81.09 6.13 14.58 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.988 1.315 . . . . 0.0 113.342 166.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -64.93 -9.01 17.98 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 119.664 -1.897 . . . . 0.0 114.484 -173.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -68.73 -28.33 66.73 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.22 1.008 . . . . 0.0 112.129 167.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 50.6 tpp -66.24 -25.4 66.88 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.985 1.266 . . . . 0.0 111.862 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -63.99 -45.28 89.7 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.21 -0.931 . . . . 0.0 111.276 170.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 33.5 mt -57.48 -43.23 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.41 1.084 . . . . 0.0 111.087 172.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.3 t -61.35 -42.85 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 121.391 -0.818 . . . . 0.0 112.271 176.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 10.7 mt -71.84 -36.17 70.09 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.618 1.099 . . . . 0.0 113.233 173.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 45.2 t -59.54 -34.05 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 O-C-N 120.809 -1.182 . . . . 0.0 110.937 169.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 81.6 t -82.15 -26.75 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.315 1.046 . . . . 0.0 111.236 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -61.41 -56.72 17.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.29 1.404 . . . . 0.0 110.225 166.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -64.84 -39.09 93.01 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.221 0.919 . . . . 0.0 112.071 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -61.8 -42.85 99.8 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.638 1.113 . . . . 0.0 113.255 175.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.8 m -78.6 -30.31 46.55 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.997 1.398 . . . . 0.0 111.701 175.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.75 -41.11 97.23 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.898 -1.126 . . . . 0.0 111.851 170.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -53.09 -45.98 68.44 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.72 0.691 . . . . 0.0 110.571 169.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 92.5 t -68.22 -37.66 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.407 0.683 . . . . 0.0 112.006 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 39.3 t -63.21 -36.05 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 121.215 -0.928 . . . . 0.0 112.342 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -58.45 -38.8 78.27 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.279 0.945 . . . . 0.0 111.954 169.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 33.3 mt -72.97 -34.28 66.37 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -70.78 -39.84 72.96 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 173.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.419 ' HA ' ' HB3' ' A' ' 111' ' ' TYR . 17.6 p -62.35 -20.96 64.92 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 120.439 -1.413 . . . . 0.0 114.724 165.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -70.77 -6.63 39.1 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 120.203 1.365 . . . . 0.0 113.862 163.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -154.97 44.69 0.55 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.553 1.549 . . . . 0.0 112.986 -160.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 25.8 p -51.94 -24.53 6.55 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.028 0.931 . . . . 0.0 113.248 169.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.92 -53.41 2.28 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.76 2.024 . . . . 0.0 110.175 161.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.8 m -76.04 48.14 0.48 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 128.42 2.688 . . . . 0.0 112.563 -172.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -55.52 -19.24 9.18 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.939 2.496 . . . . 0.0 115.447 -169.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -114.18 -29.19 7.04 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 169.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 2.0 t -65.15 -61.68 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 119.907 1.231 . . . . 0.0 111.197 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -73.44 -28.45 65.73 Favored Glycine 0 C--O 1.222 -0.647 0 O-C-N 121.929 -0.482 . . . . 0.0 112.525 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 3.0 tt -53.34 -41.03 65.34 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.509 0.724 . . . . 0.0 110.773 166.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -85.93 -18.21 33.32 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.02 -37.08 16.62 Favored Glycine 0 N--CA 1.467 0.727 0 O-C-N 119.728 -1.858 . . . . 0.0 110.418 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -67.13 -25.49 66.21 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.942 1.697 . . . . 0.0 112.704 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 21.7 mt -76.0 -1.32 25.15 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 165.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 37.6 mtm105 -122.98 -8.11 8.34 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.321 1.848 . . . . 0.0 113.432 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -72.81 66.68 0.77 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.936 1.694 . . . . 0.0 108.409 149.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -148.36 82.26 1.48 Allowed 'General case' 0 C--O 1.239 0.501 0 C-N-CA 127.625 2.37 . . . . 0.0 107.432 -156.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 48.8 ttt85 -147.42 -73.69 0.2 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -154.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -72.83 154.94 91.04 Favored Pre-proline 0 N--CA 1.474 0.764 0 CA-C-N 119.28 0.945 . . . . 0.0 112.865 175.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.92 -45.61 24.23 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.893 3.062 . . . . 0.0 116.704 -168.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 69.4 mt -64.15 -35.4 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 121.525 1.966 . . . . 0.0 111.554 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 54.6 p -70.51 -31.1 68.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.8 1.182 . . . . 0.0 112.937 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.4 mm -75.39 -40.52 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.443 1.097 . . . . 0.0 111.13 172.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 56.4 mt -61.91 -41.78 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.146 0.978 . . . . 0.0 110.429 171.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.73 -43.21 97.16 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.834 1.654 . . . . 0.0 111.794 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 68.4 tp -60.98 -49.25 78.22 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.925 0.89 . . . . 0.0 112.687 170.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 61.9 mt -62.28 -44.55 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.167 -0.958 . . . . 0.0 110.53 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.0 t -69.11 -34.53 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 116.823 -1.561 . . . . 0.0 113.073 -174.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.1 p -68.22 -33.08 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 121.677 2.035 . . . . 0.0 111.6 173.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 82.4 t -77.37 -40.37 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 O-C-N 121.456 -0.777 . . . . 0.0 109.988 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.467 ' O ' HG22 ' A' ' 212' ' ' VAL . . . -54.76 -52.03 63.84 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.118 0.967 . . . . 0.0 110.758 167.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.4 m -56.06 -47.42 77.96 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.807 0.843 . . . . 0.0 112.344 -178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 72.5 mtm -59.73 -48.72 80.57 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 174.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.57 -44.04 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 118.547 0.612 . . . . 0.0 112.323 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 208' ' ' ALA . 27.2 m -84.67 -24.81 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 117.525 -1.226 . . . . 0.0 112.368 -167.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 38.9 mt -63.1 -30.69 71.79 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.561 1.528 . . . . 0.0 112.043 156.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 43.3 t -83.67 -45.73 13.1 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.841 0.856 . . . . 0.0 113.166 -164.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 9.5 t -50.94 -30.16 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 125.975 1.71 . . . . 0.0 114.474 -173.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 131.52 157.41 8.76 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 126.603 2.049 . . . . 0.0 109.771 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 90.3 p -81.76 34.44 0.39 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.89 -1.359 . . . . 0.0 113.663 -168.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -171.05 177.94 3.53 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 130.289 3.436 . . . . 0.0 109.092 176.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 63.36 112.48 0.01 OUTLIER Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 115.765 -3.112 . . . . 0.0 107.626 -111.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.43 -8.41 0.13 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.845 0.831 . . . . 0.0 111.89 160.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.452 ' HA ' HG22 ' A' ' 224' ' ' THR . 0.5 OUTLIER -67.66 -44.45 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 127.35 2.26 . . . . 0.0 112.138 174.722 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -50.12 -52.13 37.55 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.345 1.458 . . . . 0.0 110.652 169.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.33 -59.89 3.28 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.494 1.118 . . . . 0.0 110.418 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 221' ' ' VAL . 13.8 t -59.8 -42.12 92.73 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.458 ' HB2' HG21 ' A' ' 212' ' ' VAL . 21.6 m -69.13 -45.06 71.07 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.14 -0.975 . . . . 0.0 110.893 -173.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -53.36 -62.98 1.3 Allowed 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 126.073 1.749 . . . . 0.0 110.975 170.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.4 mt -56.4 -72.71 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 123.52 1.629 . . . . 0.0 111.141 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -73.7 -44.72 55.75 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 112.715 -2.039 . . . . 0.0 106.959 -152.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -65.87 -52.88 34.28 Favored Glycine 0 N--CA 1.466 0.667 0 C-N-CA 125.021 1.296 . . . . 0.0 114.41 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.72 -38.72 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.489 1.645 . . . . 0.0 111.275 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -82.82 -28.86 29.92 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -175.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -55.38 -43.4 75.12 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.051 1.341 . . . . 0.0 109.27 168.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 57.0 tp -65.07 -38.21 90.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 117.723 -1.132 . . . . 0.0 111.816 173.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -66.09 -37.94 87.02 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 121.899 2.136 . . . . 0.0 112.547 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 35.6 pt -69.52 -10.83 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 114.981 1.475 . . . . 0.0 114.981 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 11.1 mt -78.96 -20.6 48.79 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 120.918 -1.114 . . . . 0.0 110.944 167.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . 0.268 53.9 mtp180 -73.08 -19.28 61.2 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.668 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 89.2 mtp -48.63 -16.26 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 129.7 3.2 . . . . 0.0 117.059 156.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.6 pp -143.81 -19.98 0.59 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.679 1.127 . . . . 0.0 112.913 -174.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -75.63 -8.41 56.72 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.645 1.178 . . . . 0.0 111.853 157.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 CA--C 1.495 -1.152 0 CA-C-O 124.188 1.947 . . . . 0.0 107.858 171.669 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.3 m . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.1 tp -100.43 62.45 1.07 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 129.159 2.984 . . . . 0.0 111.904 -5.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -92.91 -125.55 0.09 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 125.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.31 -43.11 0.34 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 130.363 3.465 . . . . 0.0 114.269 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.4 t -114.68 -43.78 3.12 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 127.23 2.212 . . . . 0.0 110.144 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -73.27 56.23 0.47 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.008 1.723 . . . . 0.0 112.274 167.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.3 p -169.89 -36.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 130.491 3.516 . . . . 0.0 109.581 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -83.6 -49.89 8.75 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.632 1.173 . . . . 0.0 109.661 170.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -55.45 -24.26 37.74 Favored Glycine 0 CA--C 1.537 1.433 0 O-C-N 120.722 -1.236 . . . . 0.0 113.006 164.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . 0.275 0.3 OUTLIER -77.22 -42.57 36.88 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.29 1.036 . . . . 0.0 112.391 174.141 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 t -53.39 -52.05 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.68 1.192 . . . . 0.0 110.336 165.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -72.29 -9.64 58.75 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -84.96 -46.22 11.44 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 119.464 1.029 . . . . 0.0 110.527 162.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -66.65 -46.1 76.84 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.344 1.058 . . . . 0.0 111.434 -169.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pp -71.37 -14.29 62.13 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -109.11 -32.54 7.19 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.722 0.809 . . . . 0.0 113.178 -172.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -80.63 111.5 23.59 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.6 1.16 . . . . 0.0 111.621 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -69.1 119.99 6.91 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.928 1.752 . . . . 0.0 110.066 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.0 p -145.43 178.68 7.93 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.855 1.262 . . . . 0.0 108.84 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -53.84 -42.29 68.83 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.222 -0.766 . . . . 0.0 111.518 164.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -66.59 -47.02 74.04 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -59.08 -50.54 73.68 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.933 0.788 . . . . 0.0 109.795 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 13.0 t -56.75 -50.41 72.32 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.27 0.628 . . . . 0.0 111.752 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -60.55 -52.13 66.5 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 121.774 -0.579 . . . . 0.0 112.25 -174.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.8 t -87.31 -39.52 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.343 -0.848 . . . . 0.0 113.172 -170.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -69.59 -41.5 75.7 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.351 0.66 . . . . 0.0 111.016 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -81.39 -25.59 36.14 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -176.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -57.61 -51.63 68.74 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.498 1.044 . . . . 0.0 110.857 161.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.16 -43.13 73.97 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 173.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . 0.289 1.2 m -63.85 -42.26 95.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-N 121.55 1.977 . . . . 0.0 112.114 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -66.5 -42.72 86.95 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.093 1.315 . . . . 0.0 111.593 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.77 -48.38 81.91 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.905 0.482 . . . . 0.0 109.913 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.04 -43.68 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 117.933 -1.032 . . . . 0.0 111.018 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.95 -39.49 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 120.592 1.542 . . . . 0.0 113.158 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 63.3 tp -63.53 -45.49 90.37 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.955 1.302 . . . . 0.0 111.032 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.69 -53.25 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.504 0.722 . . . . 0.0 110.781 174.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 63.7 m -61.42 -35.58 77.95 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.479 1.512 . . . . 0.0 113.09 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.4 mt -81.08 -37.53 28.83 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.166 1.348 . . . . 0.0 113.552 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.57 -44.44 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 119.258 0.935 . . . . 0.0 109.511 168.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -64.34 -31.71 73.03 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-O 117.614 -1.184 . . . . 0.0 112.409 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.4 t -63.45 -43.59 96.94 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 121.103 1.774 . . . . 0.0 112.394 176.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 90.2 t -59.7 -39.53 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.764 1.226 . . . . 0.0 111.612 174.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 30.6 tp -71.72 -47.31 54.78 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.367 1.067 . . . . 0.0 112.358 174.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.9 t -59.53 -37.59 78.77 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.744 2.418 . . . . 0.0 112.929 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.8 t -76.77 1.7 16.51 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.0 -1.062 . . . . 0.0 113.027 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.0 mm -113.26 -35.65 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 127.225 2.21 . . . . 0.0 112.165 165.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -55.55 -31.53 62.22 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.282 1.033 . . . . 0.0 113.174 168.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -61.52 -22.09 64.82 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -93.42 -28.53 16.08 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.207 1.003 . . . . 0.0 111.702 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.36 -35.09 79.76 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.087 0.955 . . . . 0.0 111.067 168.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.91 -6.55 3.92 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.145 1.378 . . . . 0.0 114.396 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.4 mt -84.46 -15.3 46.55 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.382 1.473 . . . . 0.0 113.414 170.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.25 -38.87 1.06 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -163.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.8 t -157.45 177.26 11.63 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.429 -0.794 . . . . 0.0 111.984 -148.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -72.01 156.24 52.3 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 121.519 0.51 . . . . 0.0 113.042 173.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.7 t -164.26 151.58 11.88 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.548 -0.972 . . . . 0.0 112.337 -166.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 33.9 mt -73.04 -0.12 13.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.388 1.475 . . . . 0.0 113.584 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -54.34 -26.32 29.1 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.605 1.562 . . . . 0.0 114.449 -173.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -52.59 -32.3 40.62 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.743 1.217 . . . . 0.0 114.071 171.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 17.8 tpt -71.06 -18.63 62.55 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.248 0.619 . . . . 0.0 112.562 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -67.42 -38.45 84.62 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.674 -1.266 . . . . 0.0 111.664 169.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.6 mp -66.87 -37.49 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 122.845 0.458 . . . . 0.0 110.384 174.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.65 -49.95 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.568 0.747 . . . . 0.0 111.698 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.8 mt -71.86 -28.99 63.91 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 20.5 t -61.36 -40.06 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 120.338 1.426 . . . . 0.0 111.951 165.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.9 t -68.71 -37.01 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 119.205 0.911 . . . . 0.0 111.047 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -57.89 -56.72 18.35 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.812 0.733 . . . . 0.0 111.272 168.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -67.03 -38.88 86.68 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.464 1.029 . . . . 0.0 113.392 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -61.72 -45.61 95.91 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.877 0.751 . . . . 0.0 111.61 172.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 89.2 m -63.14 -43.39 98.49 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 117.617 0.709 . . . . 0.0 111.382 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -62.18 -33.01 73.71 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.076 1.75 . . . . 0.0 112.864 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -66.38 -45.77 78.94 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.39 -0.819 . . . . 0.0 111.757 170.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.8 t -70.97 -32.22 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.964 0.906 . . . . 0.0 112.25 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.6 t -60.62 -37.79 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.344 1.458 . . . . 0.0 111.919 174.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 37.0 mtm180 -62.65 -43.18 99.47 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.531 0.605 . . . . 0.0 111.998 167.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 48.6 mt -62.89 -32.23 73.45 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.996 -1.065 . . . . 0.0 113.447 175.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 29.4 m0 -70.66 -35.78 73.04 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.277 -0.889 . . . . 0.0 113.241 170.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 94.2 p -78.59 13.53 1.59 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 121.153 1.797 . . . . 0.0 114.863 165.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -47.9 -44.52 29.73 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.58 1.082 . . . . 0.0 111.43 160.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -162.72 23.49 0.2 Allowed Glycine 0 CA--C 1.531 1.087 0 CA-C-O 118.372 -1.238 . . . . 0.0 115.336 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 62.5 m 69.13 -39.95 0.44 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.004 2.122 . . . . 0.0 116.574 168.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.31 -9.32 15.5 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.735 1.614 . . . . 0.0 113.837 164.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.495 ' HB2' ' H ' ' A' ' 186' ' ' GLY . 86.9 p -72.08 25.73 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.689 2.396 . . . . 0.0 115.465 -169.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.31 -0.52 17.33 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 -158.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -109.94 -43.37 4.01 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.916 1.287 . . . . 0.0 111.112 153.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.62 -73.42 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.867 1.267 . . . . 0.0 112.832 -170.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.495 ' H ' ' HB2' ' A' ' 182' ' ' SER . . . -78.68 -9.42 87.08 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.212 1.387 . . . . 0.0 113.946 175.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.451 HD13 ' C ' ' A' ' 187' ' ' LEU . 0.4 OUTLIER -55.56 -44.41 76.79 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.927 0.863 . . . . 0.0 109.913 167.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 34.6 t-105 -76.3 -50.31 14.69 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.671 -0.643 . . . . 0.0 112.289 161.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -56.58 -33.8 63.13 Favored Glycine 0 CA--C 1.535 1.307 0 N-CA-C 116.513 1.365 . . . . 0.0 116.513 -167.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -83.88 -21.52 31.92 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.328 1.564 . . . . 0.0 113.841 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.423 HD21 HD13 ' A' ' 203' ' ' LEU . 2.5 tt -73.02 -45.18 59.2 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -55.24 -39.09 69.33 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.235 166.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -70.27 -15.15 62.86 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -80.71 57.93 3.13 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 120.849 -1.157 . . . . 0.0 113.36 -171.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 43.3 mtt-85 -93.69 -14.37 26.44 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.221 1.808 . . . . 0.0 115.295 -161.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -77.57 164.7 56.39 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 124.695 1.198 . . . . 0.0 111.087 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -60.25 -46.3 19.07 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.704 1.602 . . . . 0.0 114.274 -160.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 50.9 mm -66.67 -34.78 72.31 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 CA-C-N 117.975 0.352 . . . . 0.0 111.281 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 15.9 m -69.07 -37.14 78.34 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.282 1.433 . . . . 0.0 112.507 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 30.1 mm -66.8 -42.99 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.561 0.744 . . . . 0.0 110.718 170.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.1 mt -62.56 -41.58 92.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 O-C-N 121.175 -0.953 . . . . 0.0 111.051 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -64.91 -43.05 94.11 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.426 1.89 . . . . 0.0 110.181 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.423 HD13 HD21 ' A' ' 191' ' ' LEU . 45.9 tp -59.41 -50.51 73.67 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 169.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 44.2 mt -60.03 -43.39 92.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 O-C-N 121.392 -0.817 . . . . 0.0 111.226 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.7 t -72.68 -29.23 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 117.667 -1.158 . . . . 0.0 112.471 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.48 -39.01 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 121.55 1.977 . . . . 0.0 111.174 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 28.6 m -74.44 -35.68 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 118.367 0.53 . . . . 0.0 111.189 176.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.39 -45.25 84.68 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 118.202 0.455 . . . . 0.0 111.407 168.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 36.0 t -61.71 -38.42 87.81 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.345 1.458 . . . . 0.0 112.118 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 36.3 mmt -71.67 -41.03 69.2 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 171.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 10.3 t -60.49 -38.84 79.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 118.642 0.655 . . . . 0.0 111.052 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.415 HG21 ' CB ' ' A' ' 225' ' ' SER . 3.4 t -61.34 -46.32 96.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 127.624 2.369 . . . . 0.0 111.493 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 61.5 mt -58.94 -41.18 86.77 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.475 1.034 . . . . 0.0 111.568 166.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 11.4 t -74.48 -31.45 62.22 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -165.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 84.9 t -66.76 -20.25 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.203 1.001 . . . . 0.0 111.56 173.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.41 156.47 21.35 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 124.295 0.95 . . . . 0.0 111.619 -166.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 41.2 p -62.01 17.86 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 128.519 2.727 . . . . 0.0 115.203 172.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 15.3 mttp -166.34 174.27 9.24 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 129.714 3.206 . . . . 0.0 110.012 -176.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 69.5 104.92 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 105.269 -3.133 . . . . 0.0 105.269 -113.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -59.4 3.74 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.936 0 O-C-N 121.744 -0.857 . . . . 0.0 112.211 170.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 23.2 m -79.7 -35.12 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 127.296 2.238 . . . . 0.0 112.71 167.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.2 -47.37 68.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.288 1.404 . . . . 0.0 109.799 163.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -62.44 -52.49 63.35 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.08 0.552 . . . . 0.0 111.496 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.88 -35.36 74.65 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.456 1.025 . . . . 0.0 112.316 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.415 ' CB ' HG21 ' A' ' 212' ' ' VAL . 17.0 m -75.18 -36.72 61.45 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.489 1.041 . . . . 0.0 112.773 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.28 -46.91 76.16 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.482 -0.761 . . . . 0.0 110.308 169.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.0 mt -66.79 -82.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 125.301 1.44 . . . . 0.0 110.974 172.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.49 ' HA ' ' CD1' ' A' ' 232' ' ' PHE . 48.1 mtt180 -77.74 14.52 1.04 Allowed 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 130.854 3.661 . . . . 0.0 114.573 -170.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -124.1 -59.58 0.18 Allowed Glycine 0 N--CA 1.462 0.382 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 162.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . 0.343 0.3 OUTLIER -99.97 -2.66 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -163.577 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.42 -39.79 11.79 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 121.229 -0.919 . . . . 0.0 111.871 145.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.49 ' CD1' ' HA ' ' A' ' 228' ' ' ARG . 1.7 m-30 -57.05 -30.57 64.36 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -177.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 7.1 tp -68.88 -31.41 70.32 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.756 -0.59 . . . . 0.0 112.37 172.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -75.45 -35.72 60.86 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.052 1.341 . . . . 0.0 112.505 -168.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -26.71 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.248 1.019 . . . . 0.0 111.639 170.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 62.2 mt -70.92 -28.85 64.81 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.79 0.805 . . . . 0.0 110.44 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -75.6 -25.08 56.68 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.065 2.146 . . . . 0.0 111.914 -171.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 66.6 mtp -46.1 -29.03 1.36 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.859 2.064 . . . . 0.0 115.525 155.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 20.0 mt -112.49 -31.26 6.85 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.858 1.263 . . . . 0.0 109.908 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.43 16.59 0.1 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.931 1.692 . . . . 0.0 114.019 155.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 3.4 p -58.34 111.55 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 CA-C-O 124.273 1.987 . . . . 0.0 110.875 -170.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -82.67 13.95 3.46 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 111.397 -2.638 . . . . 0.0 114.024 -173.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.2 ttt-85 -77.05 17.09 0.47 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.989 2.116 . . . . 0.0 115.032 175.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 76.04 37.67 0.37 Allowed 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 146.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -106.23 -2.34 38.56 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 115.822 1.089 . . . . 0.0 115.822 172.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 71.24 54.16 9.43 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 120.049 1.924 . . . . 0.0 109.818 -161.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 45.5 p -69.36 138.03 53.35 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.931 2.093 . . . . 0.0 113.351 -152.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 85.2 m95 61.56 11.96 4.17 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 . . . . . 0 N--CA 1.477 0.897 0 C-N-CA 125.242 1.417 . . . . 0.0 113.545 -177.048 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.474 ' HA ' ' H ' ' A' ' 102' ' ' ALA . 6.3 m . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.323 27.8 tp 65.74 -95.46 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.619 1 C-N-CA 133.051 4.54 . . . . 0.0 117.962 -10.715 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.474 ' H ' ' HA ' ' A' ' 100' ' ' VAL . . . -58.06 -30.94 66.59 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -159.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -28.04 17.05 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.511 1.124 . . . . 0.0 113.664 174.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.48 -21.72 12.02 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.037 0.935 . . . . 0.0 112.074 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -57.19 -39.76 76.01 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.501 1.5 . . . . 0.0 112.451 168.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.4 p -61.98 -21.7 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 126.606 1.962 . . . . 0.0 113.682 171.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -95.51 -31.42 13.35 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.802 -0.562 . . . . 0.0 111.379 173.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -50.96 -26.47 11.38 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.289 1.424 . . . . 0.0 112.481 162.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -63.44 -48.85 76.06 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.776 0.831 . . . . 0.0 111.714 172.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.3 -57.36 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.956 0.902 . . . . 0.0 110.47 167.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -58.93 -46.21 88.5 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.497 1.119 . . . . 0.0 112.39 -167.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -65.86 -25.99 67.45 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 171.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -77.77 -34.93 52.15 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.131 1.332 . . . . 0.0 110.718 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 mt -59.67 -49.15 78.85 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 162.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -74.28 -32.01 62.75 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.162 -162.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -104.88 92.2 4.99 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 127.069 2.148 . . . . 0.0 110.711 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -58.22 128.3 28.14 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.129 1.886 . . . . 0.0 109.678 173.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.1 p -155.69 165.75 35.59 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.414 1.886 . . . . 0.0 107.805 -163.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -49.24 -42.29 32.29 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 118.957 -0.913 . . . . 0.0 111.466 175.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -75.4 -39.07 59.47 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.621 1.71 . . . . 0.0 115.568 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.463 ' HE3' ' CZ ' ' A' ' 125' ' ' TYR . 77.5 tttt -57.06 -50.54 72.44 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.679 1.582 . . . . 0.0 108.855 172.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 46.6 t -57.33 -43.8 83.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.288 1.835 . . . . 0.0 111.867 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -59.08 -57.01 14.94 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.13 -0.981 . . . . 0.0 111.208 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.1 m -81.87 -32.06 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -166.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.463 ' CZ ' ' HE3' ' A' ' 121' ' ' LYS . 6.4 m-85 -64.04 -34.46 78.07 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.216 0.916 . . . . 0.0 111.381 176.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.443 ' CG ' ' HE ' ' A' ' 243' ' ' ARG . 46.1 m170 -77.48 -43.11 33.38 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.846 0.748 . . . . 0.0 110.307 -171.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -67.06 -38.51 85.92 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.255 -0.879 . . . . 0.0 112.446 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.09 -40.24 76.58 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 120.172 1.351 . . . . 0.0 113.14 168.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.84 -41.98 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 121.308 1.867 . . . . 0.0 111.412 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -63.96 -41.93 97.44 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.59 0.632 . . . . 0.0 112.081 175.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.1 tp -73.72 -44.42 56.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.841 0.456 . . . . 0.0 111.892 -173.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.3 mp -67.39 -40.81 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 O-C-N 121.031 -1.043 . . . . 0.0 111.872 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.76 -44.78 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 120.465 1.484 . . . . 0.0 112.062 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 23.7 tp -54.67 -56.36 19.91 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.723 1.609 . . . . 0.0 111.469 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 55.3 t -65.18 -44.39 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 122.715 0.406 . . . . 0.0 111.416 -174.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 73.0 m -71.53 -35.04 70.55 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 91.3 mt -76.73 -37.51 55.87 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.431 1.468 . . . . 0.0 112.521 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 87.7 mt -59.91 -42.25 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 118.852 0.751 . . . . 0.0 109.312 169.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -64.49 -40.13 95.09 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 115.805 -2.045 . . . . 0.0 111.99 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.5 m -49.44 -44.47 45.6 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 121.346 1.884 . . . . 0.0 113.123 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 70.7 t -60.16 -34.91 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.157 0.983 . . . . 0.0 111.88 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.8 tp -85.44 -44.81 12.42 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 169.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 24.2 p -67.69 -30.04 69.46 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.931 1.293 . . . . 0.0 113.252 -167.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.2 t -75.05 -11.64 60.14 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.562 -0.711 . . . . 0.0 112.769 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' A' ' 145' ' ' ILE . 4.5 mm -97.36 -46.89 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 126.069 1.748 . . . . 0.0 111.771 170.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -55.21 -34.1 63.64 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.663 1.185 . . . . 0.0 112.596 173.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -68.13 -21.63 64.92 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.283 -1.51 . . . . 0.0 114.991 173.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -75.38 -26.93 58.88 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 121.05 1.75 . . . . 0.0 109.916 171.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -72.99 -30.09 63.54 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.286 -0.884 . . . . 0.0 112.174 167.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -56.48 -27.41 57.0 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.764 -1.21 . . . . 0.0 114.002 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 73.1 mt -57.35 -28.41 63.12 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.651 1.18 . . . . 0.0 113.688 173.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.11 -42.28 2.02 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.648 1.579 . . . . 0.0 114.451 -165.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.8 t -155.6 -172.7 4.24 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.758 0.79 . . . . 0.0 111.751 -147.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -70.98 140.93 32.08 Favored Glycine 0 CA--C 1.533 1.159 0 O-C-N 121.167 -0.958 . . . . 0.0 114.114 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.8 t -166.21 139.18 4.02 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.367 1.067 . . . . 0.0 112.104 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.5 3.19 2.5 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 171.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -56.79 -10.49 1.06 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.005 1.722 . . . . 0.0 113.686 166.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 33.7 p-90 -62.29 -24.58 67.38 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.861 -1.15 . . . . 0.0 112.787 167.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 69.0 mtm -73.9 -16.89 61.1 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.968 -1.082 . . . . 0.0 113.789 171.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -67.59 -41.35 84.24 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.606 1.548 . . . . 0.0 109.942 165.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 7.2 mt -56.6 -38.93 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 118.419 0.554 . . . . 0.0 111.85 170.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.46 -52.27 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 121.199 -0.938 . . . . 0.0 112.209 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 13.1 mt -67.27 -26.55 66.61 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.289 0.95 . . . . 0.0 112.195 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 6.2 t -64.49 -35.39 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 119.999 -1.688 . . . . 0.0 111.397 169.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 73.1 t -76.48 -30.4 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 118.72 -0.657 . . . . 0.0 110.504 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -62.35 -48.31 80.34 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 119.638 1.108 . . . . 0.0 112.261 167.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -69.04 -39.23 79.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.364 1.438 . . . . 0.0 112.581 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -54.05 -45.85 71.22 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 119.286 0.948 . . . . 0.0 112.954 166.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.9 m -62.05 -40.58 96.26 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.462 0.705 . . . . 0.0 111.707 172.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -60.1 -39.66 86.91 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.485 1.493 . . . . 0.0 112.912 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -71.12 -43.16 68.21 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.94 0.791 . . . . 0.0 111.961 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 90.1 t -72.38 -34.57 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 118.828 -0.605 . . . . 0.0 111.708 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 15.4 t -58.84 -37.23 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.114 1.366 . . . . 0.0 111.542 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -59.72 -46.78 88.07 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.471 1.032 . . . . 0.0 112.049 170.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.03 -23.42 66.55 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 120.456 -1.403 . . . . 0.0 114.288 172.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 54.5 m0 -76.09 -13.57 60.2 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 168.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 6.6 p -61.8 -36.8 82.19 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 121.746 2.066 . . . . 0.0 111.079 164.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.44 -26.62 66.88 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 165.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -68.15 0.78 10.31 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.449 1.976 . . . . 0.0 114.954 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 9.0 t -63.14 -31.87 73.12 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.711 1.756 . . . . 0.0 112.12 165.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.22 -47.58 0.06 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.315 1.446 . . . . 0.0 113.057 164.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 24.4 m -71.74 43.18 0.09 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 128.52 2.728 . . . . 0.0 112.513 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -49.01 -36.52 17.93 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 130.592 3.557 . . . . 0.0 113.53 -170.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -120.35 -36.8 3.15 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 124.374 1.046 . . . . 0.0 112.195 175.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 40.7 t -56.44 -59.42 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.437 1.095 . . . . 0.0 110.852 176.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -74.65 -35.83 50.17 Favored Glycine 0 C--O 1.222 -0.595 0 C-N-CA 124.84 1.21 . . . . 0.0 112.258 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.59 -47.8 75.87 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.956 1.378 . . . . 0.0 112.472 172.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' TRP . . . . . 0.42 ' CZ2' ' HD2' ' A' ' 192' ' ' ARG . 67.2 t-105 -75.27 -41.02 58.15 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -56.42 -54.53 35.34 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -69.8 -30.62 68.2 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.828 1.314 . . . . 0.0 113.656 -174.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 38.6 tp -62.36 -31.31 71.95 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.631 0.65 . . . . 0.0 112.208 169.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.42 ' HD2' ' CZ2' ' A' ' 188' ' ' TRP . 34.2 mtp-105 -92.3 -13.66 30.0 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 172.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -82.3 -16.47 49.25 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.598 1.159 . . . . 0.0 112.68 163.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -78.5 62.01 3.01 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.305 1.842 . . . . 0.0 112.082 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -93.56 -22.51 18.78 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 128.444 2.698 . . . . 0.0 115.652 -170.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -58.57 152.46 45.59 Favored Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 125.432 1.493 . . . . 0.0 112.03 -175.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -50.37 -41.96 49.62 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.904 2.403 . . . . 0.0 114.049 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 10.9 tp -61.86 -41.12 89.52 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 118.524 0.602 . . . . 0.0 112.163 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 18.8 m -68.45 -28.85 67.41 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.812 1.245 . . . . 0.0 111.574 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 36.0 mm -75.4 -42.13 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.883 0.873 . . . . 0.0 111.116 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 94.1 mt -58.84 -50.32 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 118.862 0.755 . . . . 0.0 110.071 171.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -59.18 -39.04 81.29 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.912 2.485 . . . . 0.0 112.243 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 54.9 tp -61.99 -51.7 66.98 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.767 1.227 . . . . 0.0 112.987 169.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 71.1 mt -65.89 -41.41 89.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.374 -0.829 . . . . 0.0 109.92 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 69.6 t -74.13 -35.32 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 125.244 1.418 . . . . 0.0 113.45 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.6 p -65.24 -35.67 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 120.908 1.685 . . . . 0.0 110.859 172.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 89.3 t -72.35 -42.58 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 117.934 -1.032 . . . . 0.0 109.617 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -55.54 -41.12 72.76 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.173 0.897 . . . . 0.0 112.16 170.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.8 t -62.39 -43.09 99.65 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.432 1.093 . . . . 0.0 112.835 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 30.2 mmt -70.35 -37.89 74.71 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.612 0.765 . . . . 0.0 111.424 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.39 -48.12 89.64 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 O-C-N 121.799 -0.563 . . . . 0.0 109.994 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.517 HG21 ' HB3' ' A' ' 225' ' ' SER . 30.0 m -75.52 -34.65 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 O-C-N 121.663 -0.648 . . . . 0.0 112.374 -171.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.66 -21.01 66.51 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.253 -0.905 . . . . 0.0 112.088 170.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 57.6 m -85.56 -38.62 18.29 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.697 1.599 . . . . 0.0 113.6 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 24.3 t -56.86 -37.46 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.338 1.055 . . . . 0.0 108.863 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 134.58 146.63 5.43 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 109.014 -1.635 . . . . 0.0 109.014 175.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 98.4 p -60.2 15.54 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.14 116.17 4.92 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 127.877 2.471 . . . . 0.0 111.56 -176.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.641 ' H ' ' H ' ' A' ' 221' ' ' VAL . . . -97.76 -88.73 1.89 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 104.908 -3.277 . . . . 0.0 104.908 92.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 78.49 -51.58 0.48 Allowed 'General case' 0 N--CA 1.466 0.34 1 C-N-CA 132.674 4.39 . . . . 0.0 120.409 -21.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.641 ' H ' ' H ' ' A' ' 219' ' ' GLY . 54.0 t -87.02 -51.3 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 120.119 -1.613 . . . . 0.0 110.203 -164.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -56.7 -36.14 69.32 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.815 -0.553 . . . . 0.0 111.941 167.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.45 -55.14 38.86 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 118.554 -0.736 . . . . 0.0 110.81 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.94 -36.22 83.67 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 120.742 1.61 . . . . 0.0 113.061 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.517 ' HB3' HG21 ' A' ' 212' ' ' VAL . 13.9 t -71.48 -43.61 66.27 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.386 1.448 . . . . 0.0 110.756 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.79 -53.61 55.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.847 0.459 . . . . 0.0 110.371 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 80.9 mt -63.48 -81.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 122.726 1.251 . . . . 0.0 109.517 173.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 -75.74 -14.62 60.33 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 124.793 1.237 . . . . 0.0 113.012 -157.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -95.26 -55.79 1.34 Allowed Glycine 0 CA--C 1.534 1.256 0 CA-C-N 118.701 0.682 . . . . 0.0 114.151 160.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.95 -39.95 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 120.745 -1.444 . . . . 0.0 112.156 -166.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 2.1 tpp85 -60.71 -35.01 75.25 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 119.573 1.079 . . . . 0.0 110.417 168.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.15 -36.96 84.51 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.215 1.406 . . . . 0.0 112.42 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 29.8 tp -64.46 -23.68 67.36 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 117.915 -1.04 . . . . 0.0 111.607 168.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -80.54 -44.87 18.36 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.913 1.688 . . . . 0.0 112.923 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -20.02 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.491 -1.38 . . . . 0.0 112.461 169.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 52.1 tp -71.02 -30.53 66.76 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.194 0.521 . . . . 0.0 111.888 174.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.5 ' HA ' ' CD2' ' A' ' 240' ' ' HIS . 19.7 mtp180 -70.32 -25.43 63.3 Favored 'General case' 0 C--O 1.212 -0.9 0 C-N-CA 124.866 1.267 . . . . 0.0 112.617 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 68.0 mtp -54.03 -23.97 15.4 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 160.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 6.1 mt -115.47 -35.39 4.61 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.873 -166.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' HIS . . . . . 0.5 ' CD2' ' HA ' ' A' ' 237' ' ' ARG . 5.6 p80 -75.72 -36.61 59.92 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.631 0.65 . . . . 0.0 111.354 164.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.366 5.6 p 43.46 99.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 129.576 3.15 . . . . 0.0 115.148 164.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -77.77 -4.58 47.1 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 112.18 -2.282 . . . . 0.0 113.642 173.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.443 ' HE ' ' CG ' ' A' ' 126' ' ' HIS . 0.0 OUTLIER -70.45 -9.7 57.18 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.807 1.643 . . . . 0.0 115.174 -167.33 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 67.05 23.26 9.75 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.574 1.55 . . . . 0.0 112.433 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -86.82 29.38 5.03 Favored Glycine 0 CA--C 1.527 0.801 0 O-C-N 120.828 -1.17 . . . . 0.0 115.637 -173.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 71.69 36.74 61.88 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-N 118.389 1.094 . . . . 0.0 112.073 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 37.1 p -65.8 107.98 1.98 Allowed 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 126.116 1.766 . . . . 0.0 111.013 -153.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 32.2 m95 62.05 12.78 5.2 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.066 1.746 . . . . 0.0 115.444 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 33.1 mtm-85 . . . . . 0 C--O 1.247 0.973 0 C-N-CA 126.243 1.817 . . . . 0.0 110.845 -171.311 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.606 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 48.2 tp -53.03 -37.12 61.26 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.921 1.237 . . . . 0.0 112.52 -177.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.81 -22.17 57.95 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -58.11 -41.58 83.86 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 120.145 -1.597 . . . . 0.0 111.735 171.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.5 p -66.95 -20.15 65.85 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.06 0.944 . . . . 0.0 112.025 172.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -79.09 -50.52 10.91 Favored 'General case' 0 CA--C 1.507 -0.704 0 O-C-N 121.416 -0.803 . . . . 0.0 109.042 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.5 m -76.21 -38.72 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.374 0.67 . . . . 0.0 110.749 -173.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -68.17 -32.97 73.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.533 172.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.1 -30.16 70.0 Favored Glycine 0 C--N 1.34 0.766 0 O-C-N 120.831 -1.168 . . . . 0.0 112.343 170.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -68.22 -46.6 70.14 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 126.377 1.871 . . . . 0.0 111.301 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.0 t -54.71 -54.09 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.297 1.039 . . . . 0.0 109.639 167.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -55.53 -48.16 75.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.662 -0.685 . . . . 0.0 112.377 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -64.75 -25.35 67.89 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.544 1.065 . . . . 0.0 113.518 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -77.41 -40.99 41.68 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.29 1.036 . . . . 0.0 110.344 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.2 mt -60.44 -40.58 91.66 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 120.787 -1.196 . . . . 0.0 110.829 167.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -78.78 -41.09 31.39 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.499 -162.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -116.95 145.69 36.17 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 124.198 0.999 . . . . 0.0 111.299 -173.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.4 155.82 36.65 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.587 2.192 . . . . 0.0 111.899 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.445 ' H ' ' HB3' ' A' ' 121' ' ' LYS . 46.9 p -147.95 169.56 19.6 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.143 1.777 . . . . 0.0 107.568 163.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.07 -31.28 48.23 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.013 -0.882 . . . . 0.0 113.197 170.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -79.83 -45.43 18.74 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 170.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.445 ' HB3' ' H ' ' A' ' 118' ' ' THR . 0.9 OUTLIER -58.82 -52.7 64.59 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.141 0.882 . . . . 0.0 110.045 -178.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 43.8 t -62.72 -38.64 91.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.106 0.562 . . . . 0.0 111.915 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -57.73 -57.97 10.4 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.608 0.64 . . . . 0.0 111.495 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.4 m -74.36 -44.99 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -172.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -87.12 -36.77 17.91 Favored 'General case' 0 C--O 1.226 -0.133 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -164.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -65.35 -30.57 71.41 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.066 1.303 . . . . 0.0 111.033 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.39 -39.28 78.07 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 167.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.23 -45.47 79.94 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 167.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.8 m -64.58 -39.17 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-N 121.423 1.92 . . . . 0.0 111.789 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -54.44 -45.79 73.13 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.868 0.867 . . . . 0.0 112.292 170.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.7 mt -67.19 -39.58 86.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 118.46 -0.781 . . . . 0.0 113.025 174.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.51 -43.69 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 119.812 1.187 . . . . 0.0 110.877 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.36 -40.92 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-N 121.197 1.817 . . . . 0.0 112.646 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.9 tp -52.51 -52.11 56.22 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.066 1.746 . . . . 0.0 111.765 168.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 37.9 t -63.27 -39.57 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.985 0.914 . . . . 0.0 111.081 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 65.7 m -60.5 -44.72 95.68 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.937 0.895 . . . . 0.0 113.379 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.65 -31.94 47.02 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 120.442 1.474 . . . . 0.0 111.93 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 59.0 mt -56.62 -47.6 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.509 0.723 . . . . 0.0 110.305 167.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -57.81 -49.35 76.94 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 117.322 -1.323 . . . . 0.0 110.999 170.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 73.6 m -49.6 -40.9 40.56 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 120.067 1.303 . . . . 0.0 114.061 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.5 -48.5 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.0 0.52 . . . . 0.0 110.797 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.2 tp -72.61 -44.23 62.24 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.862 0.865 . . . . 0.0 112.89 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 55.9 p -78.89 -30.15 44.79 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -155.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.2 t -75.27 -1.81 25.22 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.733 1.152 . . . . 0.0 111.86 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.4 mm -102.51 -34.48 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 126.18 1.792 . . . . 0.0 113.231 163.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -56.77 -27.53 59.78 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.891 -1.131 . . . . 0.0 111.892 164.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -58.88 -42.86 90.47 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 129.002 2.921 . . . . 0.0 112.066 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 17.1 m-30 -74.76 -31.1 61.68 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.876 0.762 . . . . 0.0 111.073 176.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.68 -41.22 96.22 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.58 -0.7 . . . . 0.0 111.407 169.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.25 -13.47 28.39 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.46 1.504 . . . . 0.0 114.888 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.6 mt -64.53 -23.64 67.34 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.572 1.149 . . . . 0.0 113.277 168.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.49 -49.68 0.13 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -155.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.4 p -122.15 177.84 5.17 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.518 1.927 . . . . 0.0 109.011 -163.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.35 154.39 47.88 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.448 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.8 t -156.13 158.38 37.59 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.864 1.266 . . . . 0.0 111.123 -163.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.9 mt -94.68 3.43 55.07 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.967 1.307 . . . . 0.0 113.81 166.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -65.05 -4.58 4.89 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 120.036 1.289 . . . . 0.0 114.188 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -72.73 -30.56 64.28 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.781 -1.199 . . . . 0.0 111.822 166.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 47.6 tpp -73.02 -32.17 64.93 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.268 1.027 . . . . 0.0 111.355 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.21 -51.27 69.68 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.553 -0.717 . . . . 0.0 110.341 165.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.1 mt -53.99 -40.21 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 118.787 -0.625 . . . . 0.0 112.028 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.9 t -56.34 -48.16 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 120.293 1.406 . . . . 0.0 112.127 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 11.4 mt -71.11 -33.78 70.48 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.074 1.306 . . . . 0.0 113.08 176.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 26.5 t -61.73 -39.43 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 120.596 1.543 . . . . 0.0 111.743 172.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 68.0 t -75.01 -33.1 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.834 1.254 . . . . 0.0 110.651 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -62.56 -42.68 99.7 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 117.981 -1.009 . . . . 0.0 112.296 165.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -65.01 -46.25 82.14 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.536 1.516 . . . . 0.0 111.918 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.13 -37.96 74.44 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-N 119.282 0.946 . . . . 0.0 112.779 171.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.6 m -67.2 -39.53 86.33 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -60.41 -40.64 91.7 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.934 1.294 . . . . 0.0 111.629 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -54.24 -51.94 62.93 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 172.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 26.9 m -73.64 -31.73 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 23.1 t -63.48 -33.55 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 119.337 0.971 . . . . 0.0 112.144 173.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -60.94 -41.4 96.17 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 120.951 -1.093 . . . . 0.0 111.81 167.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 41.4 mt -69.97 -25.24 63.53 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -82.03 -40.44 22.07 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.999 0.92 . . . . 0.0 112.907 173.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 79.1 p -70.32 6.13 1.47 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 116.817 2.154 . . . . 0.0 116.817 160.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.526 ' HB2' ' HD2' ' A' ' 190' ' ' ARG . . . -51.78 -37.69 52.52 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.216 0.916 . . . . 0.0 111.514 160.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 167.22 30.99 0.02 OUTLIER Glycine 0 C--N 1.341 0.847 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 175.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 18.1 t 63.1 -67.42 0.09 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.871 2.068 . . . . 0.0 115.121 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -35.8 79.47 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.721 2.008 . . . . 0.0 111.022 170.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.46 ' HB2' ' H ' ' A' ' 186' ' ' GLY . 82.4 p -72.56 25.12 0.05 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 -175.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -53.53 -23.48 10.64 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 128.107 2.563 . . . . 0.0 116.293 -171.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -118.63 -37.23 3.32 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.2 1.4 . . . . 0.0 111.826 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 85.8 t -65.81 -68.94 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.436 1.494 . . . . 0.0 111.378 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.46 ' H ' ' HB2' ' A' ' 182' ' ' SER . . . -70.69 -23.97 77.33 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.699 1.619 . . . . 0.0 112.881 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.7 tt -51.07 -52.3 44.75 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.073 1.437 . . . . 0.0 110.087 164.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 35.1 t-105 -74.03 -44.72 53.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.23 0.538 . . . . 0.0 112.432 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -59.52 -45.17 96.01 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.885 0.755 . . . . 0.0 113.07 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.526 ' HD2' ' HB2' ' A' ' 178' ' ' ALA . 7.3 ptm180 -68.95 -33.1 73.16 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 118.44 1.12 . . . . 0.0 112.129 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 25.5 tp -74.96 -29.52 60.95 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.973 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 36.4 mtp-105 -80.17 -31.68 38.85 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.27 1.428 . . . . 0.0 113.097 171.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -64.02 -38.21 90.23 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.882 1.273 . . . . 0.0 111.173 171.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -82.97 58.81 4.56 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.123 1.369 . . . . 0.0 112.237 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.74 -28.95 66.36 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 120.773 -1.205 . . . . 0.0 112.56 169.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 197' ' ' PRO . 16.2 ptpt -49.6 147.19 6.26 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 127.877 2.471 . . . . 0.0 116.268 -173.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 196' ' ' LYS . 87.1 Cg_exo -57.33 -39.61 88.3 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.821 2.347 . . . . 0.0 116.488 -163.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 93.9 mt -67.72 -30.33 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 O-C-N 120.894 -1.129 . . . . 0.0 111.329 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.7 t -68.17 -31.56 71.19 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.06 1.3 . . . . 0.0 111.652 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 34.6 mm -70.35 -43.22 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.383 1.073 . . . . 0.0 111.49 171.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.83 -37.05 77.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.031 0.532 . . . . 0.0 111.445 173.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -74.87 -38.99 61.79 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.319 1.848 . . . . 0.0 110.729 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 20.3 tp -57.71 -48.4 79.69 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.272 1.029 . . . . 0.0 111.072 166.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 76.4 mt -69.43 -37.21 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 121.839 -0.538 . . . . 0.0 111.284 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.6 t -75.3 -33.41 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-N 119.918 1.235 . . . . 0.0 112.58 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 4.4 p -67.43 -34.2 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 120.615 1.552 . . . . 0.0 110.685 170.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 78.1 t -72.76 -39.52 59.93 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-O 117.936 -1.031 . . . . 0.0 110.115 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.61 -45.47 85.3 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 119.106 0.867 . . . . 0.0 110.41 170.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 30.2 t -62.95 -48.82 77.24 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.549 1.14 . . . . 0.0 111.851 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 75.2 mtm -55.58 -51.43 67.13 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.837 1.255 . . . . 0.0 111.004 168.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 9.5 t -59.09 -47.08 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 118.972 0.806 . . . . 0.0 111.295 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 222' ' ' PHE . 33.5 m -75.71 -41.56 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 119.403 1.001 . . . . 0.0 111.845 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.6 pp -63.31 -23.81 67.58 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.719 1.145 . . . . 0.0 111.601 171.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 19.2 m -77.8 -44.89 26.08 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.83 1.252 . . . . 0.0 112.929 173.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.73 -38.04 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.157 1.783 . . . . 0.0 109.476 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 218' ' ' LYS . . . 142.31 162.33 9.17 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 125.909 1.719 . . . . 0.0 110.029 172.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 60.5 p -70.62 18.23 0.06 Allowed 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 216' ' ' GLY . 5.8 mtmt -173.15 175.67 3.13 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 131.514 3.926 . . . . 0.0 108.937 -172.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 66.81 105.96 0.02 OUTLIER Glycine 0 N--CA 1.436 -1.3 0 N-CA-C 106.176 -2.77 . . . . 0.0 106.176 -115.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -56.4 -5.66 0.22 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.492 1.517 . . . . 0.0 113.276 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 18.1 m -68.79 -38.12 78.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 125.421 1.489 . . . . 0.0 110.507 172.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.457 ' HA ' ' HB ' ' A' ' 212' ' ' VAL . 0.8 OUTLIER -56.53 -49.77 73.79 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.348 166.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.92 -54.76 43.52 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.3 t -69.05 -30.74 69.15 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 34.1 t -74.29 -41.77 60.65 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.627 -1.295 . . . . 0.0 111.076 175.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.85 -62.13 1.91 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.114 0.966 . . . . 0.0 109.083 173.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 38.6 mt -57.26 -83.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.503 1.121 . . . . 0.0 109.79 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -65.32 -50.11 66.89 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-O 116.85 -1.548 . . . . 0.0 109.606 -163.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -54.56 -56.5 21.85 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 120.247 1.385 . . . . 0.0 113.281 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.8 -34.89 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 118.024 0.912 . . . . 0.0 111.639 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -77.8 -26.96 49.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.573 -1.329 . . . . 0.0 113.78 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -60.37 -42.29 95.51 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.782 1.633 . . . . 0.0 107.666 174.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 15.5 tp -62.9 -33.85 76.18 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.413 174.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -75.47 -43.49 49.08 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 120.87 1.668 . . . . 0.0 112.815 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 45.0 pt -66.35 -6.63 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 169.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 48.2 tp -95.9 -35.3 11.51 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.485 1.514 . . . . 0.0 111.137 171.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -63.52 -35.61 81.04 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.966 1.307 . . . . 0.0 110.121 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 61.3 tpp -34.07 -33.97 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 129.342 3.057 . . . . 0.0 116.702 156.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 49.9 mt -111.64 -13.32 13.79 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.859 1.663 . . . . 0.0 111.983 -171.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.3 3.5 54.43 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.83 0.852 . . . . 0.0 113.201 160.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 7.6 p -37.5 102.93 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 C-N-CA 127.161 2.184 . . . . 0.0 111.667 -164.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -76.53 11.78 1.5 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 112.731 -2.032 . . . . 0.0 114.074 -166.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -64.03 -18.72 64.61 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.032 1.733 . . . . 0.0 113.259 151.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . 0.272 22.4 pt20 60.66 30.49 19.75 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 145.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -83.35 -7.27 86.81 Favored Glycine 0 N--CA 1.468 0.774 0 O-C-N 121.237 -0.915 . . . . 0.0 114.754 173.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 117.88 78.16 0.62 Allowed Glycine 0 C--O 1.229 -0.215 0 C-N-CA 125.897 1.713 . . . . 0.0 110.192 -166.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 59.2 p -52.72 101.57 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.526 2.33 . . . . 0.0 112.655 -170.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 97.0 m95 54.99 35.05 23.75 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.587 1.955 . . . . 0.0 114.873 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 5.3 ppt_? . . . . . 0 C--O 1.253 1.275 0 C-N-CA 125.936 1.694 . . . . 0.0 112.866 173.167 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.506 -0.727 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.9 tp -103.8 157.03 17.36 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-O 122.724 1.25 . . . . 0.0 107.892 152.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.402 ' HA ' ' CD2' ' A' ' 105' ' ' HIS . . . 67.49 -18.5 0.14 Allowed 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 127.268 2.227 . . . . 0.0 116.133 173.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.03 -34.51 70.14 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.044 1.338 . . . . 0.0 111.841 176.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.7 t -80.87 -26.19 37.1 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.335 -0.853 . . . . 0.0 113.268 166.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.402 ' CD2' ' HA ' ' A' ' 102' ' ' ALA . 11.8 m-70 -75.13 -27.17 59.69 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 119.568 -1.957 . . . . 0.0 111.885 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 23.3 m -85.31 2.55 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 126.12 1.768 . . . . 0.0 113.435 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -111.66 -45.61 3.34 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 127.575 2.35 . . . . 0.0 108.052 170.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.09 -20.29 8.73 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.509 1.528 . . . . 0.0 115.393 161.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . 0.261 25.0 ptt180 -73.22 -37.32 66.45 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.327 1.564 . . . . 0.0 110.455 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.7 t -58.88 -47.88 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.758 1.223 . . . . 0.0 110.541 168.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -66.91 -54.64 20.15 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.413 1.085 . . . . 0.0 111.447 -174.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -62.3 -25.29 67.79 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.81 -1.181 . . . . 0.0 112.719 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -75.76 -41.76 52.24 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.317 1.417 . . . . 0.0 110.375 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 pp -75.4 -22.51 57.39 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -125.16 -9.72 7.06 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -166.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -109.55 118.63 50.07 Favored Pre-proline 0 N--CA 1.473 0.722 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 161.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -61.47 137.77 71.8 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 121.697 1.598 . . . . 0.0 113.307 -171.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -151.85 143.3 23.46 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.671 1.189 . . . . 0.0 107.973 173.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.21 -28.76 50.75 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.904 -0.387 . . . . 0.0 112.59 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -67.37 -32.92 74.17 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 172.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -61.25 -48.76 79.98 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.559 1.072 . . . . 0.0 108.203 168.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 35.6 m -64.49 -40.41 95.61 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.415 0.686 . . . . 0.0 112.147 -174.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -56.64 -67.52 0.3 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.107 0.963 . . . . 0.0 111.214 173.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.7 p -79.67 -38.26 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 121.009 -1.057 . . . . 0.0 113.627 -168.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -73.12 -42.96 62.34 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.38 -0.825 . . . . 0.0 112.067 -170.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -71.52 -26.73 62.78 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -68.19 -49.4 61.1 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.196 -0.94 . . . . 0.0 111.989 166.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -51.3 -40.15 58.37 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 117.514 -1.231 . . . . 0.0 114.232 173.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . 0.289 2.9 m -62.97 -43.38 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 121.174 1.806 . . . . 0.0 112.634 174.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -67.85 -39.25 83.81 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.737 0.699 . . . . 0.0 112.548 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 73.4 mt -56.39 -54.87 40.52 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 118.624 -0.703 . . . . 0.0 110.366 169.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -53.87 -49.89 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.456 0.703 . . . . 0.0 112.011 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.4 p -66.13 -42.97 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 119.837 1.198 . . . . 0.0 113.09 -171.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 35.6 tp -70.38 -45.4 66.12 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.051 0.94 . . . . 0.0 111.567 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 32.2 m -65.08 -38.51 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 119.86 1.209 . . . . 0.0 111.901 176.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 98.4 m -66.83 -34.15 77.18 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.66 -0.686 . . . . 0.0 112.799 174.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.7 mt -74.42 -37.59 63.3 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.651 1.569 . . . . 0.0 112.516 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 52.2 mt -61.87 -46.6 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.312 0.96 . . . . 0.0 110.72 169.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -62.34 -27.17 68.87 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 117.866 -1.064 . . . . 0.0 112.343 171.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.7 m -65.68 -31.1 71.92 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 121.019 1.736 . . . . 0.0 113.166 173.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.33 -35.84 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.113 0.565 . . . . 0.0 110.699 172.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.0 tp -74.28 -50.69 17.85 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.296 0.953 . . . . 0.0 112.391 169.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.7 p -67.19 -27.13 67.01 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 120.377 -1.452 . . . . 0.0 113.273 -166.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.0 t -68.6 -22.85 64.42 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 176.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 17.9 pt -95.32 -31.41 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.946 1.248 . . . . 0.0 113.187 169.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -59.7 -26.57 65.7 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 121.021 -1.049 . . . . 0.0 111.281 164.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -60.57 -30.21 69.65 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.929 2.092 . . . . 0.0 113.093 167.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -87.9 -26.34 22.78 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.817 -1.177 . . . . 0.0 110.856 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.08 -40.2 94.32 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.149 0.579 . . . . 0.0 111.637 166.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.31 -15.22 23.36 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.632 1.573 . . . . 0.0 114.869 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.5 mt -59.15 -31.63 69.15 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.807 -1.183 . . . . 0.0 112.69 167.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.86 -43.83 0.21 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -153.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 82.8 p -134.09 152.83 52.01 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.163 1.385 . . . . 0.0 109.976 -155.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -75.4 128.93 10.12 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 121.289 -0.882 . . . . 0.0 112.582 -170.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.3 t -144.46 148.61 34.78 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -155.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.3 mt -56.4 4.28 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.568 2.347 . . . . 0.0 114.88 166.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -62.12 -13.94 31.93 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 120.975 1.716 . . . . 0.0 112.803 163.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 18.0 p-90 -59.37 -29.8 67.95 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.092 -1.63 . . . . 0.0 112.233 163.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 10.7 tpt -76.83 -25.55 53.34 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.335 0.97 . . . . 0.0 112.804 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -61.0 -48.82 80.06 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.788 -1.195 . . . . 0.0 109.404 162.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.82 -37.62 72.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 122.993 0.517 . . . . 0.0 111.583 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 64.0 t -60.93 -51.92 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 120.948 -1.095 . . . . 0.0 112.293 173.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 11.5 mt -69.98 -30.44 67.79 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.119 -0.988 . . . . 0.0 112.355 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 22.7 t -58.17 -38.17 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.698 1.136 . . . . 0.0 109.958 169.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 64.7 t -75.22 -29.7 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 118.104 -0.951 . . . . 0.0 111.11 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -66.6 -51.03 60.83 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 121.011 1.732 . . . . 0.0 112.933 170.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -60.65 -46.46 90.24 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.198 0.908 . . . . 0.0 111.37 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.96 -40.89 93.94 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.974 0.797 . . . . 0.0 113.15 173.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 55.5 m -66.96 -40.01 87.38 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.738 -0.86 . . . . 0.0 111.453 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -62.4 -41.38 98.63 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.303 0.956 . . . . 0.0 111.738 173.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -55.65 -45.67 77.63 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.646 0.657 . . . . 0.0 111.5 170.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 69.1 t -67.31 -41.89 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.188 -0.945 . . . . 0.0 113.13 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 25.8 t -62.28 -38.16 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.452 1.501 . . . . 0.0 112.337 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -55.91 -45.14 78.78 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.487 0.715 . . . . 0.0 111.811 168.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 21.8 mt -67.0 -40.3 87.32 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 178.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -65.81 -30.8 71.49 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.5 t -69.79 -21.16 63.43 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 173.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.1 -14.58 25.24 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 170.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -158.07 51.25 0.41 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 124.972 1.272 . . . . 0.0 110.505 -161.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 35.1 t -45.2 -31.07 1.34 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.225 1.81 . . . . 0.0 112.643 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.19 -59.45 1.73 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.172 1.789 . . . . 0.0 111.656 159.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 55.1 p -70.98 -16.1 62.62 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.906 1.282 . . . . 0.0 113.776 -156.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 59.8 pttt 47.01 -59.55 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.361 1 C-N-CA 133.464 4.706 . . . . 0.0 115.868 172.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -93.84 -29.21 15.44 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 124.68 1.192 . . . . 0.0 112.011 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.19 -54.32 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 166.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.1 -70.46 0.85 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 126.973 2.225 . . . . 0.0 112.362 176.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.4 tt -52.0 -42.07 62.69 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.33 1.452 . . . . 0.0 112.584 -170.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 44.6 t-105 -75.4 -46.36 33.35 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -172.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -64.19 -36.76 93.64 Favored Glycine 0 N--CA 1.48 1.568 0 O-C-N 121.641 -0.662 . . . . 0.0 112.501 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -61.16 -44.61 97.04 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 127.178 2.191 . . . . 0.0 112.167 168.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 25.7 tp -68.31 -32.58 72.82 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.608 0.64 . . . . 0.0 112.451 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -67.1 -18.57 65.38 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.108 -0.995 . . . . 0.0 113.213 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -67.49 -3.71 9.36 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.118 1.367 . . . . 0.0 114.301 167.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.31 83.47 0.55 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.53 1.532 . . . . 0.0 110.43 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.7 ttt85 -149.92 -37.67 0.15 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -164.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -68.89 151.25 97.35 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 123.974 0.91 . . . . 0.0 109.906 168.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -51.26 -46.85 28.85 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 CA-C-N 121.534 1.583 . . . . 0.0 115.488 -170.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 17.5 tt -62.99 -36.23 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 119.422 1.01 . . . . 0.0 113.501 176.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 95.5 p -82.93 -25.85 32.0 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.148 1.34 . . . . 0.0 111.231 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 15.1 mm -63.19 -49.1 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.8 0.84 . . . . 0.0 110.026 160.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 21.2 mm -59.36 -41.61 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.539 -0.726 . . . . 0.0 111.376 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -69.71 -35.24 74.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.587 1.555 . . . . 0.0 111.43 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.3 tp -64.21 -49.2 72.9 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.088 0.555 . . . . 0.0 110.696 171.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 59.5 mt -61.5 -40.95 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 121.653 -0.654 . . . . 0.0 110.154 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.434 ' HA ' ' HB3' ' A' ' 208' ' ' ALA . 73.5 t -78.92 -22.65 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 117.605 -1.188 . . . . 0.0 113.779 -176.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.46 -32.21 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 122.316 2.325 . . . . 0.0 110.344 166.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 46.0 t -81.17 -29.69 11.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 O-C-N 120.951 -1.093 . . . . 0.0 109.51 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.434 ' HB3' ' HA ' ' A' ' 205' ' ' VAL . . . -58.38 -42.79 87.84 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.805 -0.559 . . . . 0.0 111.511 161.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.1 m -61.3 -36.99 81.62 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.948 0.899 . . . . 0.0 111.843 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 55.6 mtt -64.46 -54.19 36.44 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.523 1.129 . . . . 0.0 111.0 166.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 30.4 t -56.63 -38.39 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 119.771 1.168 . . . . 0.0 112.237 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 28.4 t -53.53 -52.61 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 126.293 1.837 . . . . 0.0 111.396 171.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.87 -15.46 44.57 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.078 0.951 . . . . 0.0 113.294 -175.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 93.2 m -102.68 -56.25 2.28 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.52 1.528 . . . . 0.0 114.4 -171.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 25.4 t -56.88 -38.75 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-N 119.521 1.055 . . . . 0.0 112.025 -175.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 164.21 -116.55 0.71 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.037 1.303 . . . . 0.0 110.288 168.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 77.3 p -164.17 34.64 0.08 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.436 1.094 . . . . 0.0 113.063 -174.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -169.45 168.75 9.29 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.97 2.108 . . . . 0.0 110.709 -174.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -67.36 -49.78 49.3 Favored Glycine 0 N--CA 1.473 1.139 0 C-N-CA 127.556 2.503 . . . . 0.0 112.461 -10.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -144.62 4.9 1.18 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.364 1.066 . . . . 0.0 113.775 170.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 15.2 t -73.55 -42.88 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 120.155 1.343 . . . . 0.0 111.493 -170.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -47.28 -45.91 24.45 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.933 1.293 . . . . 0.0 112.394 164.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.38 -54.68 9.9 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.833 1.253 . . . . 0.0 111.214 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.11 -35.74 81.28 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 121.113 -0.992 . . . . 0.0 111.885 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 18.0 m -69.17 -45.65 69.48 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.485 1.493 . . . . 0.0 110.884 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -52.87 -52.37 57.63 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.615 -0.678 . . . . 0.0 111.412 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 227' ' ' ILE . 72.6 mt -67.08 -84.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 123.392 1.568 . . . . 0.0 110.269 175.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -76.36 10.04 2.28 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 128.145 2.578 . . . . 0.0 113.338 -167.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -117.84 -63.64 0.31 Allowed Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 166.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 18.2 mt -79.57 -37.44 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 118.482 1.141 . . . . 0.0 111.374 -171.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.72 -41.59 87.67 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.862 1.21 . . . . 0.0 109.771 174.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -63.32 -33.25 75.12 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.057 2.143 . . . . 0.0 113.521 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 23.4 tp -63.87 -33.41 75.62 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.344 1.058 . . . . 0.0 111.654 165.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -69.08 -37.54 78.53 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.715 1.598 . . . . 0.0 114.289 -175.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -19.69 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.255 -0.903 . . . . 0.0 113.094 175.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 37.7 mt -72.99 -23.67 60.67 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.974 0.893 . . . . 0.0 110.539 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -83.12 -18.45 39.46 Favored 'General case' 0 C--O 1.216 -0.708 0 C-N-CA 124.386 1.074 . . . . 0.0 112.816 -167.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -24.76 -40.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 128.587 2.755 . . . . 0.0 114.779 143.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 16.6 mt -99.99 -28.24 13.18 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.258 1.423 . . . . 0.0 110.717 -172.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -75.58 9.78 2.06 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 158.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.303 4.2 t -104.0 46.79 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-O 124.779 2.228 . . . . 0.0 110.409 150.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 47.1 p-10 -59.56 61.7 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 113.283 -1.78 . . . . 0.0 111.273 137.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -45.79 -43.68 13.36 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 126.895 2.078 . . . . 0.0 114.688 -138.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -145.54 27.02 1.25 Allowed 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 127.456 2.302 . . . . 0.0 112.02 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 114.61 15.84 7.89 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.001 1.286 . . . . 0.0 115.556 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 172.5 88.16 0.07 OUTLIER Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.573 1.559 . . . . 0.0 111.655 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 4.3 t -47.01 151.43 0.64 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.389 1.476 . . . . 0.0 113.533 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 69.0 m95 46.19 43.88 11.59 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 126.853 2.061 . . . . 0.0 114.125 164.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 118.535 -0.745 . . . . 0.0 112.147 178.48 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.7 tp -69.79 102.35 1.91 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 123.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 47.18 72.89 0.21 Allowed 'General case' 0 N--CA 1.432 -1.356 0 O-C-N 124.54 1.15 . . . . 0.0 109.864 142.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.569 ' HA ' HG22 ' A' ' 106' ' ' VAL 0.265 0.0 OUTLIER -53.18 -24.4 10.72 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 120.884 -1.135 . . . . 0.0 110.97 168.02 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -58.09 -40.13 80.32 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.352 1.461 . . . . 0.0 114.634 165.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -78.25 -51.38 10.25 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 126.119 1.768 . . . . 0.0 109.743 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.569 HG22 ' HA ' ' A' ' 103' ' ' ARG . 35.0 m -81.04 -21.15 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -157.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -73.69 -29.3 62.2 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.199 0.599 . . . . 0.0 110.802 166.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.12 -32.82 60.02 Favored Glycine 0 CA--C 1.525 0.696 0 O-C-N 121.097 -1.002 . . . . 0.0 111.552 167.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -63.34 -40.19 96.62 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.117 1.367 . . . . 0.0 111.256 175.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.2 t -60.51 -55.36 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.53 1.932 . . . . 0.0 110.98 168.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -62.44 -22.54 66.28 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.407 1.083 . . . . 0.0 113.803 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -84.8 -34.18 22.8 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.824 1.25 . . . . 0.0 111.913 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -74.09 -43.34 58.01 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.136 -0.977 . . . . 0.0 112.814 -176.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.25 -20.98 64.85 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 176.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -101.88 -24.51 14.02 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 125.046 1.338 . . . . 0.0 112.676 -171.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.4 mtm105 -91.74 107.68 24.13 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 124.363 1.065 . . . . 0.0 109.928 165.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -65.29 127.13 17.59 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.904 1.736 . . . . 0.0 109.091 166.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 82.2 p -139.44 178.61 7.08 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.271 1.029 . . . . 0.0 109.091 176.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.82 -30.03 62.47 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 121.912 -0.493 . . . . 0.0 112.597 165.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -78.54 -43.42 26.77 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -60.27 -40.3 89.9 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.342 0.973 . . . . 0.0 109.746 170.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 49.7 t -61.43 -54.36 44.58 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.26 1.024 . . . . 0.0 112.294 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -53.62 -49.64 67.39 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.364 1.066 . . . . 0.0 111.89 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.0 p -85.81 -47.23 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -73.21 -39.27 65.66 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.998 0.817 . . . . 0.0 111.858 -163.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -80.3 -27.99 38.36 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 120.852 -1.155 . . . . 0.0 112.788 -173.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -70.39 -35.59 73.58 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.816 0.734 . . . . 0.0 111.122 164.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.97 -44.68 87.22 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 119.923 1.238 . . . . 0.0 113.218 168.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.43 -35.56 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 121.7 2.046 . . . . 0.0 113.235 176.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -68.02 -47.61 67.96 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.222 1.009 . . . . 0.0 112.077 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 62.9 mt -62.78 -47.84 81.72 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.459 0.704 . . . . 0.0 111.435 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 84.7 mt -61.99 -34.48 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 118.11 -0.948 . . . . 0.0 111.253 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.7 t -74.89 -34.07 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 120.781 1.628 . . . . 0.0 114.273 177.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 28.2 mt -59.44 -48.22 82.49 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.447 1.476 . . . . 0.0 110.535 167.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.5 t -55.89 -53.67 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 118.348 0.522 . . . . 0.0 110.23 172.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 60.8 m -61.62 -46.09 91.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.988 -173.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.9 mt -72.31 -40.91 67.13 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.679 1.127 . . . . 0.0 112.58 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.53 -42.35 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.366 0.666 . . . . 0.0 110.557 174.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -68.5 -33.29 73.88 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.384 -0.823 . . . . 0.0 111.99 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 t -58.08 -40.71 81.79 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.928 0.891 . . . . 0.0 111.716 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.33 -53.01 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.386 1.074 . . . . 0.0 110.299 174.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.9 tp -55.6 -50.44 70.1 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.014 0.526 . . . . 0.0 111.714 171.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 68.7 m -57.42 -23.53 50.08 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 116.172 1.915 . . . . 0.0 116.172 -174.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.4 t -109.44 -5.46 15.78 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.367 0.985 . . . . 0.0 112.845 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.7 tp -85.03 -36.08 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 O-C-N 121.554 -0.716 . . . . 0.0 111.344 149.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -71.95 -4.05 26.17 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 119.967 -1.708 . . . . 0.0 115.304 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -63.28 -34.09 76.93 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 120.72 -1.238 . . . . 0.0 112.58 169.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -74.52 -20.62 59.91 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.348 -0.845 . . . . 0.0 112.844 172.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.93 -45.22 43.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.956 0.903 . . . . 0.0 111.254 166.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -57.49 -28.67 63.63 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.747 1.219 . . . . 0.0 113.151 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.43 -35.45 73.39 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.196 1.398 . . . . 0.0 113.559 173.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -97.56 -47.91 5.47 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.993 2.117 . . . . 0.0 114.124 -168.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 69.7 p -149.52 -169.05 3.27 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.469 2.308 . . . . 0.0 109.006 -159.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -77.62 169.69 54.8 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.323 -0.861 . . . . 0.0 112.828 159.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.452 HG23 ' HB3' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -170.28 152.35 4.1 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.411 1.885 . . . . 0.0 110.887 -176.266 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.0 mt -52.59 -14.82 0.56 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.039 1.736 . . . . 0.0 114.368 172.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.452 ' HB3' HG23 ' A' ' 155' ' ' THR . 58.1 t80 -49.38 -15.9 0.16 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.823 1.649 . . . . 0.0 114.428 168.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 18.5 p-90 -57.22 -27.74 62.27 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.752 -1.217 . . . . 0.0 112.713 166.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 28.4 ttp -70.71 -20.77 62.63 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.197 -1.564 . . . . 0.0 112.067 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -64.65 -26.04 68.22 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.683 -1.26 . . . . 0.0 112.184 169.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 26.9 mt -70.17 -42.36 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.044 0.538 . . . . 0.0 109.575 172.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.41 -44.12 98.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.698 0.799 . . . . 0.0 111.372 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.04 -28.38 57.66 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.127 0.876 . . . . 0.0 113.262 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.6 t -60.11 -41.83 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 120.646 1.566 . . . . 0.0 110.46 165.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.57 -35.25 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 117.759 -1.115 . . . . 0.0 110.347 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -64.42 -53.6 45.83 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.874 1.67 . . . . 0.0 112.546 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -69.1 -24.3 64.11 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.2 1.364 . . . . 0.0 112.916 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -72.05 -47.11 32.63 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.543 1.068 . . . . 0.0 111.348 168.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.9 m -66.51 -36.25 82.26 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -62.56 -49.22 76.14 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 120.537 1.517 . . . . 0.0 110.874 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -51.69 -48.62 63.42 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.151 0.581 . . . . 0.0 111.896 172.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.58 -38.65 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.19 0.996 . . . . 0.0 113.239 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 14.4 t -61.86 -33.54 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.509 1.524 . . . . 0.0 111.56 173.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -63.23 -32.82 74.32 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.219 1.008 . . . . 0.0 112.393 170.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.405 ' HA ' ' HG2' ' A' ' 190' ' ' ARG . 23.4 mt -74.28 -35.46 63.75 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 173.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -70.6 -35.76 73.18 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.097 0.959 . . . . 0.0 113.42 173.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 83.6 p -68.22 -10.4 54.15 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 168.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.98 -15.27 20.93 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 120.05 1.296 . . . . 0.0 114.329 157.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 178.97 80.77 0.06 OUTLIER Glycine 0 C--N 1.343 0.964 0 CA-C-N 120.149 1.34 . . . . 0.0 115.674 -167.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 49.5 t -49.27 -27.3 3.67 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 117.759 0.779 . . . . 0.0 112.753 153.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.86 58.69 1.72 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.599 1.19 . . . . 0.0 111.94 157.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 21.2 p -162.65 50.16 0.18 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.198 159.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.449 ' HE2' ' CD2' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -61.13 -22.12 64.38 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -167.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.449 ' CD2' ' HE2' ' A' ' 183' ' ' LYS . 25.2 m-85 -105.46 -38.91 6.3 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 118.167 -0.921 . . . . 0.0 112.587 161.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -56.36 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 119.686 1.13 . . . . 0.0 111.408 -172.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -70.35 -43.08 63.65 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.56 -38.96 64.39 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.031 1.733 . . . . 0.0 111.947 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -70.79 -44.32 66.89 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.089 0.859 . . . . 0.0 112.296 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -66.74 -35.19 89.38 Favored Glycine 0 N--CA 1.476 1.354 0 O-C-N 121.259 -0.901 . . . . 0.0 112.283 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.405 ' HG2' ' HA ' ' A' ' 175' ' ' LEU . 7.5 tpp180 -65.67 -39.42 91.32 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 127.804 2.442 . . . . 0.0 112.942 172.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.498 HD11 HD13 ' A' ' 203' ' ' LEU . 23.6 tp -68.58 -33.37 73.95 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.864 -0.522 . . . . 0.0 111.827 173.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -73.05 -7.39 51.05 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -74.02 59.47 0.72 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.39 1.45 . . . . 0.0 110.214 163.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -142.66 76.58 1.54 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.86 2.864 . . . . 0.0 106.857 -169.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 44.8 mtp85 -137.89 -43.99 0.53 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.398 1.079 . . . . 0.0 111.472 -169.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -64.97 152.04 91.97 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 123.752 0.821 . . . . 0.0 110.434 167.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -54.1 -46.89 30.24 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.671 2.247 . . . . 0.0 112.827 -172.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.3 tt -58.21 -39.01 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.536 1.134 . . . . 0.0 113.981 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 78.7 p -87.63 -20.11 26.8 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 120.573 1.533 . . . . 0.0 112.633 -174.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 64.0 mt -72.39 -43.38 64.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 118.383 0.538 . . . . 0.0 110.509 159.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 43.5 mt -60.1 -39.58 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.238 1.015 . . . . 0.0 110.971 174.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -70.09 -39.69 75.41 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.782 1.633 . . . . 0.0 110.684 -178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.498 HD13 HD11 ' A' ' 191' ' ' LEU . 38.0 tp -61.51 -46.85 88.23 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.483 1.113 . . . . 0.0 112.707 169.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 54.1 mt -63.68 -41.76 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 O-C-N 120.685 -1.26 . . . . 0.0 110.411 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 31.6 t -66.27 -39.79 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 116.308 -1.806 . . . . 0.0 112.559 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.08 -33.06 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 122.212 2.278 . . . . 0.0 111.485 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.28 -46.12 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 123.373 0.669 . . . . 0.0 109.694 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -53.26 -48.14 68.53 Favored 'General case' 0 C--O 1.223 -0.342 0 C-N-CA 123.732 0.813 . . . . 0.0 110.797 169.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 34.3 t -59.84 -49.69 76.73 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.636 1.175 . . . . 0.0 112.947 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 15.0 tpt -70.85 -34.03 71.25 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 118.786 -0.626 . . . . 0.0 112.027 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.7 t -60.76 -50.99 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 120.38 1.446 . . . . 0.0 111.938 171.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.18 -33.09 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 119.461 1.028 . . . . 0.0 111.117 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 5.1 tp -58.38 -45.01 89.13 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.51 0.724 . . . . 0.0 111.211 165.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 59.4 m -69.69 -25.66 63.98 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.287 1.435 . . . . 0.0 114.706 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 52.1 t -64.02 -16.01 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.008 1.323 . . . . 0.0 110.95 166.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 94.13 114.29 2.52 Favored Glycine 0 C--N 1.332 0.35 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -165.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 66.3 p -62.3 34.8 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 129.092 2.957 . . . . 0.0 116.969 -170.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.261 39.7 mmtm -171.2 -23.46 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.343 2.257 . . . . 0.0 114.162 -155.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -46.04 123.66 6.87 Favored Glycine 0 C--N 1.341 0.809 0 N-CA-C 104.014 -3.635 . . . . 0.0 104.014 138.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -75.65 50.49 0.56 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 126.345 1.858 . . . . 0.0 110.377 -162.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 11.1 m -150.76 -35.72 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.583 1.553 . . . . 0.0 109.491 -162.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -57.07 -38.31 73.1 Favored 'General case' 0 C--O 1.216 -0.667 0 O-C-N 120.743 -1.223 . . . . 0.0 111.269 151.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.53 -42.83 88.69 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.266 0.939 . . . . 0.0 111.283 173.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 23.1 p -79.04 -55.3 5.22 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.039 -173.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 15.9 t -63.47 -34.18 77.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.528 1.513 . . . . 0.0 113.197 175.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.18 -50.19 72.82 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.102 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 65.4 mt -63.52 -70.27 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-O 122.282 1.039 . . . . 0.0 110.044 173.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 72.6 mtt-85 -76.74 1.65 16.58 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.122 1.769 . . . . 0.0 113.381 -163.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -125.48 -69.45 0.19 Allowed Glycine 0 N--CA 1.461 0.354 0 C-N-CA 125.636 1.589 . . . . 0.0 109.75 175.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.26 -27.57 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 117.169 -1.396 . . . . 0.0 112.518 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -96.87 -28.83 14.05 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 120.844 1.657 . . . . 0.0 114.095 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -54.69 -34.19 61.98 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.584 1.154 . . . . 0.0 111.009 167.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 58.0 tp -56.67 -30.3 63.23 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 168.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -82.84 -37.0 25.01 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 119.387 -2.071 . . . . 0.0 115.4 -171.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -16.67 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.427 1.091 . . . . 0.0 112.577 170.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 70.4 mt -75.02 -45.02 44.59 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.65 -0.656 . . . . 0.0 111.723 168.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -68.64 -41.09 79.87 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.752 1.621 . . . . 0.0 111.451 -170.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 32.1 tpp -25.7 -22.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 131.153 3.781 . . . . 0.0 117.797 149.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 17.0 mt -131.3 -4.39 3.84 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.061 1.745 . . . . 0.0 112.701 -174.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -66.6 -53.05 38.54 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.276 141.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 52.5 t 47.06 75.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.115 1.366 . . . . 0.0 109.344 -160.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -75.04 42.22 0.18 Allowed 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.56 -1.337 . . . . 0.0 114.537 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 20.3 ttt85 -121.3 74.92 1.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 128.377 2.671 . . . . 0.0 106.662 174.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -168.88 40.46 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.113 0 O-C-N 118.644 -2.535 . . . . 0.0 111.184 18.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 83.03 84.07 0.87 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -147.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 110.42 71.54 0.66 Allowed Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.145 1.355 . . . . 0.0 113.614 -169.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 19.9 p -58.46 142.79 47.65 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.72 1.208 . . . . 0.0 111.543 174.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 76.7 m95 53.47 38.35 27.82 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 166.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 . . . . . 0 C--O 1.253 1.243 0 CA-C-O 117.078 -1.439 . . . . 0.0 111.838 179.478 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 CA--C 1.515 -0.377 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.2 tp -82.59 172.46 12.95 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 140.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 67.83 -33.54 0.22 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 127.779 2.431 . . . . 0.0 116.828 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 37.6 mmm-85 -58.65 -18.09 27.83 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 121.213 1.824 . . . . 0.0 115.881 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.25 -28.35 4.71 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.17 0.988 . . . . 0.0 110.96 162.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -65.23 -47.71 75.86 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.244 1.384 . . . . 0.0 114.039 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.07 -32.11 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.342 1.457 . . . . 0.0 111.044 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -72.12 -36.32 69.4 Favored 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 123.683 0.793 . . . . 0.0 110.859 174.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -55.12 -34.74 58.78 Favored Glycine 0 CA--C 1.541 1.701 0 O-C-N 121.144 -0.973 . . . . 0.0 111.044 165.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.8 mtm180 -66.76 -43.63 83.54 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 117.944 0.872 . . . . 0.0 111.719 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 42.6 t -56.93 -53.29 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 125.18 1.392 . . . . 0.0 110.469 173.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -62.39 -49.95 73.49 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.644 0.778 . . . . 0.0 111.593 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -62.61 -19.91 64.23 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.092 1.357 . . . . 0.0 113.919 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.433 ' CZ ' ' HA ' ' A' ' 121' ' ' LYS . 26.4 t80 -83.06 -41.44 18.62 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 126.344 1.857 . . . . 0.0 110.719 174.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.7 mt -62.41 -43.07 99.68 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.421 1.009 . . . . 0.0 110.971 169.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -77.37 -37.6 51.8 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.5 -157.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 16.1 mtp-105 -82.72 161.69 57.8 Favored Pre-proline 0 N--CA 1.47 0.544 0 C-N-CA 125.409 1.484 . . . . 0.0 113.022 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -71.18 131.26 18.93 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 121.177 1.251 . . . . 0.0 109.11 149.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.9 t -154.73 149.91 27.02 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 120.352 -1.467 . . . . 0.0 109.8 167.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.0 8.64 0.05 OUTLIER Glycine 0 CA--C 1.537 1.468 0 N-CA-C 117.114 1.606 . . . . 0.0 117.114 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -124.82 -16.11 6.26 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 166.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 113' ' ' PHE . 35.5 ttpt -61.24 -69.56 0.23 Allowed 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 121.114 1.779 . . . . 0.0 111.528 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 60.2 m -65.78 -34.93 79.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 118.881 -0.58 . . . . 0.0 109.926 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -58.61 -52.13 66.96 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.365 0.53 . . . . 0.0 111.705 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.7 t -82.47 -43.2 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 121.25 -0.906 . . . . 0.0 113.018 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -75.72 -33.97 60.32 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.628 -0.67 . . . . 0.0 112.343 -171.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -68.74 -33.56 74.12 Favored 'General case' 0 C--N 1.346 0.435 0 O-C-N 120.897 -1.127 . . . . 0.0 111.128 169.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -64.31 -40.9 96.84 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.253 -0.904 . . . . 0.0 112.977 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.23 -44.83 65.04 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 118.168 -0.92 . . . . 0.0 113.443 167.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.64 -36.76 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 120.95 1.704 . . . . 0.0 113.159 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -54.62 -52.32 62.6 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.019 0.827 . . . . 0.0 111.308 172.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 87.7 mt -68.17 -40.64 82.25 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.908 0.483 . . . . 0.0 112.296 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 58.9 mt -69.62 -43.12 80.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 CA-C-O 117.874 -1.06 . . . . 0.0 112.083 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 80.8 t -60.82 -45.09 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 121.25 1.841 . . . . 0.0 111.674 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.4 tp -53.85 -54.07 43.59 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.513 1.525 . . . . 0.0 111.731 171.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 53.5 t -62.6 -39.97 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.712 0.805 . . . . 0.0 112.241 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.5 m -61.21 -42.98 99.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 119.335 0.971 . . . . 0.0 111.721 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.2 mt -74.61 -38.45 62.57 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.336 0.655 . . . . 0.0 112.23 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 71.7 mt -59.31 -48.42 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.887 0.875 . . . . 0.0 110.639 170.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -69.05 -35.71 76.87 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 118.969 -0.539 . . . . 0.0 111.563 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.3 t -58.42 -44.45 89.09 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.852 1.261 . . . . 0.0 112.874 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.1 m -67.49 -28.19 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.7 mt -71.42 -46.81 59.19 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.679 0.672 . . . . 0.0 111.756 166.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 72.6 m -70.39 -33.02 70.91 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.29 1.836 . . . . 0.0 115.036 -170.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.2 t -66.57 -47.52 72.51 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 120.164 1.347 . . . . 0.0 109.895 -174.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 26.5 mm -56.0 -44.63 78.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 124.466 1.106 . . . . 0.0 111.135 175.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -80.65 -14.37 58.22 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -73.19 -37.71 66.39 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.361 1.437 . . . . 0.0 111.196 166.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -79.9 -2.83 45.44 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.163 -0.961 . . . . 0.0 112.089 170.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.65 -27.93 18.72 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.596 1.158 . . . . 0.0 112.954 157.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.467 ' HB2' HG21 ' A' ' 155' ' ' THR . . . -60.58 -19.38 57.43 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -173.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.432 ' H ' ' HG ' ' A' ' 151' ' ' LEU . 1.6 pp -63.88 -4.49 3.31 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 126.697 1.999 . . . . 0.0 114.557 166.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.23 -35.17 0.32 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.851 2.46 . . . . 0.0 114.24 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 72.5 m -129.22 141.53 51.11 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.7 1.2 . . . . 0.0 110.448 -151.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -72.49 140.91 30.13 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.278 -0.487 . . . . 0.0 112.101 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.467 HG21 ' HB2' ' A' ' 150' ' ' ALA . 2.2 t -147.62 143.44 27.71 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -158.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -60.93 -7.23 2.27 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 170.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -56.31 -8.67 0.54 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.89 2.476 . . . . 0.0 116.367 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -68.8 -24.04 64.35 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.472 -1.392 . . . . 0.0 112.508 171.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 76.5 mtm -74.16 -13.81 60.87 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -68.56 -44.08 75.23 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.723 1.147 . . . . 0.0 110.492 164.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 28.8 mt -58.62 -36.75 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 118.481 -0.771 . . . . 0.0 111.916 169.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.5 t -57.53 -45.58 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 120.409 1.459 . . . . 0.0 111.49 171.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 19.3 mt -62.7 -42.82 99.84 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 173.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.88 -24.17 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.24 0.927 . . . . 0.0 112.34 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 54.6 t -78.87 -38.99 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.233 1.013 . . . . 0.0 110.429 172.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -61.56 -49.75 75.4 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.394 0.997 . . . . 0.0 112.297 170.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -65.71 -46.33 79.35 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.711 0.687 . . . . 0.0 112.47 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -52.26 -40.86 53.48 Favored Glycine 0 CA--C 1.539 1.546 0 O-C-N 121.598 -0.689 . . . . 0.0 112.788 167.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 70.2 m -69.17 -37.83 78.39 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 117.775 0.787 . . . . 0.0 112.482 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -59.71 -50.2 74.75 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.981 1.312 . . . . 0.0 110.888 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -51.66 -47.41 63.8 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.362 1.065 . . . . 0.0 112.247 172.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 37.8 t -66.37 -37.97 80.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.959 0.904 . . . . 0.0 112.363 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 12.2 t -62.85 -33.51 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.146 1.379 . . . . 0.0 112.427 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 24.5 mtt180 -59.99 -44.86 94.24 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.118 -0.989 . . . . 0.0 111.221 170.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.7 mt -68.7 -35.43 77.17 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.173 0.589 . . . . 0.0 112.381 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 53.2 m0 -65.34 -26.58 68.1 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 172.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 47.8 t -70.34 -30.21 67.11 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.604 1.093 . . . . 0.0 113.534 166.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -68.89 -0.46 5.56 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.307 -1.496 . . . . 0.0 112.598 161.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -104.92 7.39 44.75 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 126.58 2.038 . . . . 0.0 116.238 172.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 7.8 t -54.49 -23.12 14.97 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.247 1.524 . . . . 0.0 112.48 173.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -122.47 -60.37 1.55 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.254 1.422 . . . . 0.0 110.988 153.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.9 p -86.35 64.5 8.58 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.473 1.509 . . . . 0.0 111.971 -163.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -44.82 -35.73 2.91 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.732 1.613 . . . . 0.0 115.05 -167.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -112.32 -33.07 6.31 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.739 1.216 . . . . 0.0 113.859 174.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -56.74 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 119.786 1.176 . . . . 0.0 111.606 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -67.63 -35.79 86.69 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 119.022 -0.877 . . . . 0.0 111.179 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 1.2 tt -51.9 -33.21 35.88 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.019 0.928 . . . . 0.0 113.062 169.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 49.8 t-105 -86.13 -36.18 19.72 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -73.88 -38.17 49.55 Favored Glycine 0 N--CA 1.466 0.638 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -64.99 -40.29 94.73 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 124.675 1.19 . . . . 0.0 111.005 169.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 19.3 tp -63.76 -40.87 97.74 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.41 1.005 . . . . 0.0 111.914 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 52.5 mtp180 -64.43 -23.81 67.41 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 171.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -74.73 0.47 15.16 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.919 1.288 . . . . 0.0 113.977 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.03 27.71 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 116.839 2.163 . . . . 0.0 116.839 -173.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -92.75 -7.16 47.4 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 117.198 2.295 . . . . 0.0 117.198 -159.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -61.03 147.23 86.48 Favored Pre-proline 0 N--CA 1.482 1.138 0 CA-C-N 120.976 1.716 . . . . 0.0 109.975 167.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -45.33 -50.18 9.39 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.93 3.087 . . . . 0.0 115.669 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 96.5 mt -71.98 -29.96 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.409 1.083 . . . . 0.0 111.784 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 50.6 m -72.79 -30.72 64.31 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.093 0.957 . . . . 0.0 112.279 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.8 mt -68.16 -42.77 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.586 0.754 . . . . 0.0 109.808 168.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 49.4 mt -61.87 -43.52 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 121.656 -0.653 . . . . 0.0 110.933 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.13 -38.78 92.29 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.501 1.52 . . . . 0.0 112.099 175.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.5 tt -63.12 -48.76 77.16 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.55 0.614 . . . . 0.0 110.716 170.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.1 -36.93 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.618 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 72.1 t -74.1 -33.93 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 120.24 1.382 . . . . 0.0 113.5 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.3 p -66.39 -36.99 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 121.052 1.751 . . . . 0.0 110.802 169.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 77.4 t -71.45 -39.56 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 120.904 -1.122 . . . . 0.0 110.777 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.5 -57.77 10.83 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.036 0.934 . . . . 0.0 110.628 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 59.8 p -56.14 -42.44 76.93 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.761 0.424 . . . . 0.0 111.261 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -64.0 -54.93 26.55 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.928 0.891 . . . . 0.0 112.526 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.15 -36.43 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 119.65 1.113 . . . . 0.0 111.855 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 27.9 m -75.17 -38.87 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 117.561 -1.209 . . . . 0.0 112.047 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.92 -22.13 65.08 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.031 1.287 . . . . 0.0 111.655 171.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 66.8 m -74.68 -36.87 62.79 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.422 1.089 . . . . 0.0 113.177 171.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 76.6 t -64.04 -31.61 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 118.933 0.788 . . . . 0.0 110.273 164.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 137.76 -107.68 0.59 Allowed Glycine 0 CA--C 1.522 0.506 0 C-N-CA 124.555 1.074 . . . . 0.0 112.908 158.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 87.1 p -139.8 2.21 1.95 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.55 1.14 . . . . 0.0 113.195 -167.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -171.92 -177.8 2.01 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.667 2.387 . . . . 0.0 110.23 -172.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 57.69 108.25 0.01 OUTLIER Glycine 0 CA--C 1.526 0.781 0 N-CA-C 106.966 -2.454 . . . . 0.0 106.966 -107.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -57.92 -6.4 0.56 Allowed 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 120.348 2.074 . . . . 0.0 112.586 172.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.531 ' HA ' HG22 ' A' ' 224' ' ' THR . 22.3 m -72.12 -32.17 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.528 1.531 . . . . 0.0 113.119 169.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.37 -47.68 62.76 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.929 1.241 . . . . 0.0 111.181 159.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.29 -55.31 12.56 Favored 'General case' 0 C--O 1.223 -0.341 0 O-C-N 124.217 0.948 . . . . 0.0 110.768 -168.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.531 HG22 ' HA ' ' A' ' 221' ' ' VAL . 8.1 t -52.97 -39.72 63.21 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.166 -0.959 . . . . 0.0 111.78 176.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 16.1 m -69.2 -58.29 4.25 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.163 -0.961 . . . . 0.0 111.999 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -54.79 -54.69 38.91 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 126.049 1.739 . . . . 0.0 110.914 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.53 -71.79 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.845 1.658 . . . . 0.0 107.835 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -74.52 -43.38 56.15 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.246 -154.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -59.45 -46.33 94.09 Favored Glycine 0 N--CA 1.472 1.056 0 CA-C-O 119.616 -0.547 . . . . 0.0 112.854 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.98 -34.67 39.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 117.979 0.89 . . . . 0.0 111.623 -177.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -40.74 98.54 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.058 -1.026 . . . . 0.0 112.168 166.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -66.56 -36.53 82.9 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.34 0.656 . . . . 0.0 110.634 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.5 tp -67.29 -23.85 65.7 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 172.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.48 -48.2 20.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.51 1.124 . . . . 0.0 113.071 176.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 22.9 pt -68.08 -16.6 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 173.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 52.0 tp -70.26 -26.06 63.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.266 1.426 . . . . 0.0 111.608 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.443 ' HG2' ' HD1' ' A' ' 240' ' ' HIS . 10.3 mtp180 -67.44 -19.29 65.35 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.211 1.005 . . . . 0.0 112.221 -176.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.7 -24.08 2.1 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.685 1.994 . . . . 0.0 113.94 160.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.491 ' HA ' HG21 ' A' ' 247' ' ' THR . 4.1 mt -114.36 -19.85 11.07 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.819 1.648 . . . . 0.0 111.334 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' HIS . . . . . 0.443 ' HD1' ' HG2' ' A' ' 237' ' ' ARG . 39.8 m170 -64.66 -32.22 73.78 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 118.964 -0.541 . . . . 0.0 111.425 162.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.297 11.1 p -79.02 67.37 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-O 125.159 2.409 . . . . 0.0 110.618 158.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.582 ' HA ' HG22 ' A' ' 247' ' ' THR . 24.2 p-10 -51.46 -4.34 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 112.412 -2.176 . . . . 0.0 114.167 152.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 7.0 tpt85 53.11 24.42 3.56 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 127.469 2.308 . . . . 0.0 112.104 -177.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 64.85 34.9 8.88 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 128.044 2.537 . . . . 0.0 114.325 -175.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 171.46 -3.43 0.03 OUTLIER Glycine 0 CA--C 1.537 1.468 0 N-CA-C 117.392 1.717 . . . . 0.0 117.392 169.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 157.33 104.35 0.21 Allowed Glycine 0 CA--C 1.522 0.522 0 C-N-CA 127.156 2.313 . . . . 0.0 108.196 -170.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.582 HG22 ' HA ' ' A' ' 242' ' ' ASP . 5.6 p -46.38 132.14 10.44 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.335 -1.097 . . . . 0.0 110.735 173.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 21.2 m95 55.96 9.71 0.49 Allowed 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 . . . . . 0 C--O 1.247 0.947 0 C-N-CA 124.866 1.266 . . . . 0.0 114.253 -165.748 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.0 m . . . . . 0 C--O 1.235 0.323 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.531 ' HG ' ' HB3' ' A' ' 102' ' ' ALA . 1.7 tp -65.44 94.27 0.17 Allowed 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 134.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.531 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . . . 57.39 59.53 3.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 112.673 -2.058 . . . . 0.0 110.391 139.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.12 -12.55 3.58 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 120.423 -1.423 . . . . 0.0 112.534 169.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.447 HG23 ' H ' ' A' ' 105' ' ' HIS . 2.6 t -62.8 -95.07 0.0 OUTLIER 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 127.382 2.273 . . . . 0.0 113.893 143.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.447 ' H ' HG23 ' A' ' 104' ' ' THR . 49.5 m80 -58.58 -19.85 41.79 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 119.975 3.324 . . . . 0.0 119.975 -168.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.6 p -61.0 -37.62 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 120.456 1.48 . . . . 0.0 111.946 172.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -67.45 -41.5 84.61 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.827 0.851 . . . . 0.0 109.249 173.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -58.86 -26.72 60.94 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.091 -1.394 . . . . 0.0 113.866 167.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -67.18 -45.19 77.7 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 120.36 2.08 . . . . 0.0 111.647 174.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.2 t -57.13 -47.39 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.144 0.978 . . . . 0.0 110.038 171.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -66.32 -56.6 10.38 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 118.848 -0.596 . . . . 0.0 112.453 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -58.89 -20.44 51.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 119.376 0.989 . . . . 0.0 113.463 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -80.39 -42.73 22.27 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.65 1.114 . . . . 0.0 111.773 171.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.63 -25.68 38.2 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -178.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -108.99 -38.71 5.5 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.06 1.344 . . . . 0.0 112.513 -164.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -90.75 151.1 43.37 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 123.279 0.632 . . . . 0.0 111.885 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.65 128.37 18.91 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.991 1.794 . . . . 0.0 112.986 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.2 t -152.4 151.13 30.43 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 156.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.47 -28.86 22.34 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 119.544 1.065 . . . . 0.0 112.654 172.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -70.88 -27.54 63.9 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 175.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.7 tmmt? -56.61 -60.87 2.91 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.34 1.056 . . . . 0.0 109.165 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 25.5 p -71.69 -27.33 62.96 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.682 1.193 . . . . 0.0 112.682 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -61.67 -52.24 65.14 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.715 1.598 . . . . 0.0 110.427 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.5 t -76.54 -48.17 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.051 0.54 . . . . 0.0 111.666 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -63.99 -46.54 84.1 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -75.77 -28.95 58.63 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.571 -0.705 . . . . 0.0 111.285 -174.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -69.99 -39.24 76.04 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.469 1.031 . . . . 0.0 112.375 169.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.51 -43.99 84.66 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.477 1.035 . . . . 0.0 113.362 167.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 76.4 t -62.15 -44.42 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 120.553 1.524 . . . . 0.0 111.727 172.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -56.72 -50.47 72.11 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.05 1.295 . . . . 0.0 111.553 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 94.2 mt -65.19 -45.37 85.11 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 119.019 -0.515 . . . . 0.0 111.469 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 76.1 mt -65.36 -37.23 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.859 0.754 . . . . 0.0 112.085 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.76 -45.46 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 119.956 1.253 . . . . 0.0 110.731 174.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 45.3 tp -63.92 -47.98 78.39 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.074 0.95 . . . . 0.0 111.922 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.4 t -59.9 -47.37 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.631 0.772 . . . . 0.0 110.126 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 41.5 t -58.06 -43.71 87.09 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.713 1.205 . . . . 0.0 112.824 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 61.2 mt -76.75 -36.18 57.26 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.2 mt -61.66 -48.31 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 120.813 -1.179 . . . . 0.0 109.77 167.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -63.48 -25.78 68.42 Favored 'General case' 0 C--O 1.22 -0.485 0 O-C-N 121.431 -0.793 . . . . 0.0 111.921 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.1 t -56.94 -39.59 74.81 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 120.047 1.294 . . . . 0.0 112.068 175.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 52.1 t -66.31 -42.34 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.584 0.754 . . . . 0.0 111.652 173.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.4 mt -70.63 -55.52 8.59 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.652 1.181 . . . . 0.0 112.661 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.3 m -68.17 -29.82 68.79 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.915 2.086 . . . . 0.0 113.538 -171.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.19 -46.29 51.44 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.218 1.372 . . . . 0.0 110.382 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.7 mm -52.84 -44.0 47.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.023 0.929 . . . . 0.0 110.834 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -74.07 -33.41 63.66 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -74.26 -21.69 59.65 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 119.856 -1.778 . . . . 0.0 112.082 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -79.98 -41.88 25.03 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.556 0.616 . . . . 0.0 109.455 171.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -57.91 -28.14 63.97 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.369 1.068 . . . . 0.0 113.424 170.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -57.63 -18.11 18.35 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.8 mp -83.86 -34.88 24.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.047 0.939 . . . . 0.0 111.952 174.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -84.58 -36.7 21.89 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.005 1.722 . . . . 0.0 114.073 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.0 t -158.51 -168.13 2.35 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 126.784 2.034 . . . . 0.0 108.313 -159.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -71.91 -174.99 23.44 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 120.711 -1.243 . . . . 0.0 113.74 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 10.0 t -161.02 148.18 15.25 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 49.3 tp -68.42 -10.38 54.83 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.194 1.798 . . . . 0.0 114.314 165.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -53.52 -17.77 2.31 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 -167.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 30.0 p-90 -58.14 -29.86 65.9 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 119.978 -1.701 . . . . 0.0 112.908 169.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 61.7 ttp -65.09 -32.89 74.83 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.858 1.663 . . . . 0.0 112.108 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -69.16 -38.94 79.01 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.508 -0.745 . . . . 0.0 111.884 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 50.1 mm -56.35 -34.51 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.059 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.4 t -60.5 -46.18 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.147 0.885 . . . . 0.0 111.271 172.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 15.9 mt -72.19 -47.47 50.45 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.746 0.818 . . . . 0.0 112.871 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 69.0 t -62.14 -43.29 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.754 0.822 . . . . 0.0 111.161 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 84.6 t -72.15 -32.41 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.05 174.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -62.12 -49.16 77.0 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 120.807 1.64 . . . . 0.0 112.486 170.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -64.83 -39.71 94.02 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.52 -1.363 . . . . 0.0 111.636 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -62.56 -38.11 95.84 Favored Glycine 0 CA--C 1.538 1.475 0 O-C-N 121.989 -0.444 . . . . 0.0 112.714 169.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 59.8 m -67.53 -36.65 81.43 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 117.731 0.765 . . . . 0.0 111.706 173.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -62.33 -44.18 97.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.521 1.128 . . . . 0.0 110.784 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -58.51 -41.1 84.63 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 77.9 t -71.08 -36.65 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.217 -0.927 . . . . 0.0 113.153 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 46.8 t -67.17 -29.99 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.035 1.334 . . . . 0.0 111.746 175.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -59.43 -40.01 85.35 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.971 -1.081 . . . . 0.0 112.19 165.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 74.5 mt -74.63 -36.93 62.92 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.708 0.803 . . . . 0.0 112.928 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 54.9 m0 -62.57 -41.17 98.76 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.072 1.305 . . . . 0.0 112.708 169.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 42.8 p -71.41 0.82 7.37 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.84 -23.45 60.67 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.556 1.525 . . . . 0.0 113.579 154.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 164.27 112.54 0.27 Allowed Glycine 0 N--CA 1.433 -1.541 0 O-C-N 121.878 -0.514 . . . . 0.0 112.157 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 45.0 t -34.06 -32.51 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.14 1.776 . . . . 0.0 113.514 152.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.46 -44.64 3.85 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 161.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.7 m -74.47 24.97 0.08 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -171.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -5.66 2.89 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 118.067 2.618 . . . . 0.0 118.067 -173.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -119.2 -37.53 3.18 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 120.276 1.398 . . . . 0.0 111.822 166.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.404 HG13 ' H ' ' A' ' 186' ' ' GLY . 10.8 p -73.09 -62.0 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.96 0.904 . . . . 0.0 112.71 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.404 ' H ' HG13 ' A' ' 185' ' ' VAL . . . -61.63 -31.65 78.61 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 118.591 -1.116 . . . . 0.0 112.656 169.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.0 tt -55.79 -49.58 72.8 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.4 1.6 . . . . 0.0 110.048 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -66.99 -42.38 85.17 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 122.211 -0.305 . . . . 0.0 111.092 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -53.36 -43.95 65.62 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.238 1.399 . . . . 0.0 114.105 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . 0.326 9.9 ptp180 -80.51 -31.02 37.26 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 40.0 tp -69.0 -41.02 78.34 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.49 0.586 . . . . 0.0 112.365 171.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -76.18 -17.39 59.57 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -78.97 -13.83 59.56 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.757 1.223 . . . . 0.0 113.831 169.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -78.79 43.89 0.52 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 117.052 2.242 . . . . 0.0 117.052 -165.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -93.86 -5.57 47.72 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -165.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -61.89 141.45 95.4 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 120.199 1.363 . . . . 0.0 109.104 175.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -47.57 -43.37 27.95 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.025 2.483 . . . . 0.0 115.021 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 35.0 mm -68.43 -32.24 54.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.117 0.967 . . . . 0.0 112.419 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 14.3 m -71.61 -36.6 70.86 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.973 1.309 . . . . 0.0 111.46 175.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 63.6 mt -68.94 -39.32 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.707 1.203 . . . . 0.0 110.733 173.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 33.9 mt -62.85 -41.48 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 121.286 -0.884 . . . . 0.0 111.129 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -65.23 -36.45 84.19 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.26 1.424 . . . . 0.0 111.647 176.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 28.6 tp -60.95 -52.96 62.83 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.529 0.732 . . . . 0.0 111.48 166.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 49.5 mt -61.59 -36.32 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.496 -0.752 . . . . 0.0 111.077 -175.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.0 t -65.9 -45.84 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.962 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.02 -31.39 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 CA-C-N 120.818 1.645 . . . . 0.0 112.018 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 97.5 t -74.25 -39.38 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 120.557 1.526 . . . . 0.0 110.893 176.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.15 81.96 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.34 0.973 . . . . 0.0 110.369 170.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 47.6 m -58.62 -43.94 89.79 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.77 0.828 . . . . 0.0 112.197 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 28.3 ttm -59.66 -55.45 34.31 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.295 1.438 . . . . 0.0 111.875 171.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 23.8 t -56.01 -47.47 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.099 1.36 . . . . 0.0 112.053 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 33.4 m -75.95 -25.79 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 118.043 -0.979 . . . . 0.0 113.28 -171.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 86.3 mt -68.85 -48.32 63.75 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.829 1.195 . . . . 0.0 110.968 159.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 43.8 t -63.04 -46.79 85.85 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.169 0.987 . . . . 0.0 113.003 -165.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 8.4 p -71.13 -11.72 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.896 -1.128 . . . . 0.0 113.214 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.41 125.58 5.66 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 125.357 1.456 . . . . 0.0 112.301 -168.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.5 m -72.75 61.23 0.53 Allowed 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 128.37 2.668 . . . . 0.0 113.427 -168.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -166.73 164.72 16.64 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 127.735 2.414 . . . . 0.0 112.064 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -85.24 -106.14 0.67 Allowed Glycine 0 C--N 1.337 0.603 0 C-N-CA 126.462 1.982 . . . . 0.0 111.923 -1.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -66.32 -23.64 66.4 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.095 -1.053 . . . . 0.0 112.302 171.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.68 -44.79 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 O-C-N 121.259 -0.901 . . . . 0.0 110.486 -166.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.65 -51.58 54.69 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.482 0.713 . . . . 0.0 111.906 163.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.66 -52.36 65.46 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.58 0.752 . . . . 0.0 109.559 -171.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.49 -37.73 88.57 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-O 117.915 -1.04 . . . . 0.0 112.715 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 46.1 m -67.92 -48.26 66.48 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 121.397 1.908 . . . . 0.0 111.298 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -56.42 -46.77 80.07 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 125.072 1.349 . . . . 0.0 110.976 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 227' ' ' ILE . 72.5 mt -59.29 -71.1 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-O 122.478 1.133 . . . . 0.0 110.184 167.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -78.38 -17.92 55.79 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.153 -150.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.43 -53.73 2.24 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.532 1.063 . . . . 0.0 114.058 162.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -30.66 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 119.512 1.656 . . . . 0.0 113.637 -170.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 4.0 mmt85 -73.49 -32.46 64.31 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.779 -1.2 . . . . 0.0 110.923 170.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -67.19 -36.5 81.89 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.479 1.111 . . . . 0.0 112.42 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 65.3 tp -58.34 -36.23 73.1 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 118.316 0.507 . . . . 0.0 112.198 165.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.21 -34.71 61.52 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 119.95 -1.719 . . . . 0.0 113.552 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 3.7 pt -73.35 -22.75 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 120.779 -1.2 . . . . 0.0 113.832 164.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.5 tp -58.7 -42.47 88.68 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.606 1.163 . . . . 0.0 110.789 164.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -56.98 -30.6 64.26 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.309 1.044 . . . . 0.0 112.893 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 18.5 mmt -49.08 -31.93 8.79 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 168.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 40.5 mt -112.65 -7.67 13.84 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.182 1.393 . . . . 0.0 109.982 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -68.12 -12.93 61.77 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.661 0.664 . . . . 0.0 112.084 153.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.75 75.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-O 124.272 1.987 . . . . 0.0 108.765 138.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 52.9 p30 -105.84 29.08 6.94 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 112.379 -2.192 . . . . 0.0 111.497 144.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -55.8 -65.27 0.62 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 128.211 2.604 . . . . 0.0 112.501 -171.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -158.97 148.68 19.04 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 69.99 13.43 69.59 Favored Glycine 0 N--CA 1.466 0.649 0 CA-C-N 114.216 -1.356 . . . . 0.0 116.221 142.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 124.26 44.83 0.28 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 119.018 1.409 . . . . 0.0 113.073 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 82.1 p -59.89 116.88 4.43 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.095 -1.238 . . . . 0.0 110.33 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 78.3 m95 56.61 21.21 5.56 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.83 2.052 . . . . 0.0 115.33 -173.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 . . . . . 0 C--O 1.244 0.765 0 C-N-CA 126.594 1.958 . . . . 0.0 112.047 179.629 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.465 0.314 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.79 115.78 3.31 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 103.692 -2.707 . . . . 0.0 103.692 118.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 27.24 82.18 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 125.204 1.402 . . . . 0.0 110.744 139.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.588 ' HA ' HG12 ' A' ' 106' ' ' VAL . 18.7 ttp180 -49.91 -34.0 19.08 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 113.892 -1.504 . . . . 0.0 112.057 -170.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 t -43.71 -57.27 3.29 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.932 2.493 . . . . 0.0 114.027 165.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -92.22 -25.33 18.69 Favored 'General case' 0 C--N 1.335 -0.06 0 O-C-N 120.196 -1.565 . . . . 0.0 114.349 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.588 HG12 ' HA ' ' A' ' 103' ' ' ARG . 1.4 p -69.56 -38.93 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 119.446 1.021 . . . . 0.0 111.144 171.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -73.54 -32.35 64.16 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.137 -0.977 . . . . 0.0 111.159 171.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.02 -32.31 42.0 Favored Glycine 0 CA--C 1.536 1.348 0 O-C-N 121.755 -0.591 . . . . 0.0 112.579 163.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -37.05 84.13 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.263 1.425 . . . . 0.0 111.546 -177.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.07 -54.1 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 122.292 1.044 . . . . 0.0 109.485 170.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . 0.25 77.0 m-85 -74.78 -33.75 62.33 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.101 -168.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -62.31 -22.86 66.38 Favored 'General case' 0 CA--C 1.552 1.051 0 O-C-N 120.179 -1.576 . . . . 0.0 114.469 165.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -75.38 -28.41 59.47 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.289 1.035 . . . . 0.0 111.811 171.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.2 mt -58.92 -43.65 91.16 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.56 1.073 . . . . 0.0 109.836 165.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -74.65 -40.82 61.23 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.306 -161.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.9 ptt85 -87.43 123.0 70.41 Favored Pre-proline 0 N--CA 1.47 0.554 0 C-N-CA 124.24 1.016 . . . . 0.0 110.46 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -65.89 126.61 16.21 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.869 1.712 . . . . 0.0 110.886 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.1 p -133.32 166.84 21.56 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 167.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.01 -37.59 71.78 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-N 118.634 0.652 . . . . 0.0 112.579 171.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -73.0 -34.99 66.74 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 175.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.43 -55.99 27.73 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.785 1.175 . . . . 0.0 108.864 164.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 34.0 t -58.52 -48.5 80.62 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.488 1.115 . . . . 0.0 111.994 -171.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -59.72 -52.96 63.26 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.824 0.45 . . . . 0.0 111.428 -175.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.6 t -84.27 -42.87 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -64.77 -48.98 72.52 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.705 0.402 . . . . 0.0 112.05 -172.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -68.8 -33.96 74.74 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.9 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -68.55 -36.08 78.31 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.275 0.943 . . . . 0.0 113.047 173.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.79 -46.13 81.74 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.352 0.978 . . . . 0.0 113.628 169.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . 0.268 0.7 OUTLIER -64.69 -39.05 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 CA-C-N 120.39 1.45 . . . . 0.0 111.16 178.743 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -60.45 -48.74 80.46 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.868 -1.145 . . . . 0.0 113.173 172.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.7 mt -61.82 -38.89 89.84 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.854 -1.154 . . . . 0.0 111.895 177.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 77.2 mt -63.26 -43.49 98.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 118.716 -0.659 . . . . 0.0 111.779 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -38.11 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 119.556 1.071 . . . . 0.0 111.662 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.6 mt -59.31 -47.74 84.27 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.761 0.425 . . . . 0.0 111.859 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.4 m -70.63 -41.11 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.608 1.095 . . . . 0.0 110.944 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 95.9 m -64.51 -39.91 94.67 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 119.105 0.866 . . . . 0.0 112.834 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 78.1 mt -71.2 -41.23 70.55 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 120.091 1.314 . . . . 0.0 112.599 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.3 mm -64.31 -48.09 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 121.232 -0.917 . . . . 0.0 110.02 172.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -61.5 -35.63 78.24 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-O 116.915 -1.516 . . . . 0.0 110.663 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.4 m -49.73 -48.38 50.12 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 121.006 1.73 . . . . 0.0 113.084 173.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.43 -30.67 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 122.999 0.52 . . . . 0.0 112.212 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.3 mt -89.84 -30.92 17.6 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.49 1.516 . . . . 0.0 114.907 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.7 p -90.17 -26.11 20.31 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.014 -1.053 . . . . 0.0 113.25 -158.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.3 t -68.97 -32.51 72.14 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.307 -0.871 . . . . 0.0 112.439 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 11.8 pt -72.28 -9.13 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -62.91 -23.38 67.33 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.661 0.784 . . . . 0.0 112.099 170.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -62.85 -38.74 92.03 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.845 1.258 . . . . 0.0 111.457 168.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -74.84 -37.37 62.28 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.892 0.769 . . . . 0.0 111.36 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.75 -42.29 95.28 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.124 0.969 . . . . 0.0 113.501 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -58.23 -25.08 61.24 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -170.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -69.77 -48.14 60.36 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.488 1.115 . . . . 0.0 111.859 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.96 -51.91 11.4 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.671 1.188 . . . . 0.0 113.273 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.5 t -159.4 -179.0 7.56 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.611 -139.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -62.71 152.73 45.19 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 122.006 0.781 . . . . 0.0 112.936 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.8 t -152.9 148.28 26.96 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.843 0.83 . . . . 0.0 112.101 -166.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 11.3 tp -81.66 14.97 2.32 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.924 2.09 . . . . 0.0 112.796 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -50.24 -29.14 8.88 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.116 2.566 . . . . 0.0 114.618 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -70.99 -31.14 67.59 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.134 -0.979 . . . . 0.0 112.408 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 9.0 tpt -73.91 -35.41 64.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.433 1.015 . . . . 0.0 110.767 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -55.82 -56.35 21.56 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.516 0.726 . . . . 0.0 110.775 166.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 75.0 mt -58.45 -40.13 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.6 0.76 . . . . 0.0 112.282 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.7 t -61.95 -44.82 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 120.279 -1.513 . . . . 0.0 112.567 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.2 mt -71.2 -34.37 70.82 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.219 1.372 . . . . 0.0 112.037 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 54.9 t -59.8 -36.77 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.54 1.063 . . . . 0.0 110.881 170.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 78.8 t -76.26 -28.2 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 118.503 -0.761 . . . . 0.0 112.055 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -60.85 -48.99 79.29 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.197 1.362 . . . . 0.0 110.669 169.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -71.93 -35.79 69.75 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.53 -43.54 94.11 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 123.368 0.508 . . . . 0.0 112.361 167.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 88.9 m -68.88 -36.95 78.7 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.837 0.819 . . . . 0.0 110.739 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.4 tm-20 -60.14 -35.11 74.57 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 118.751 0.705 . . . . 0.0 112.541 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -60.69 -46.25 91.08 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.263 -0.898 . . . . 0.0 112.044 169.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.4 t -69.99 -30.82 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.494 0.717 . . . . 0.0 111.988 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.1 t -60.65 -39.51 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.305 1.442 . . . . 0.0 112.47 171.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -69.79 -20.1 63.48 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 170.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 31.8 mt -77.73 -37.7 48.73 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.311 0.959 . . . . 0.0 112.222 166.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 34.8 m0 -64.92 -45.63 85.03 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.008 -1.058 . . . . 0.0 113.355 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 95.1 p -56.02 -38.49 70.61 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.024 1.283 . . . . 0.0 113.845 169.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.09 -8.85 33.74 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 173.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -106.63 5.2 37.34 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.142 1.83 . . . . 0.0 113.815 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 20.7 p -57.35 -15.28 6.01 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -173.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.28 -33.17 2.17 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.011 1.725 . . . . 0.0 112.658 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 21.7 t -159.26 115.2 2.56 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.093 1.757 . . . . 0.0 107.347 177.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -57.7 -34.74 69.76 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -155.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -100.24 -29.32 12.53 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -169.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 99.4 t -54.42 -59.63 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 118.834 0.743 . . . . 0.0 110.695 -173.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.35 -26.76 68.33 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-O 116.101 -2.499 . . . . 0.0 114.507 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 66.4 mt -57.3 -39.47 75.83 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 121.519 2.66 . . . . 0.0 111.237 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 6.7 t-105 -70.25 -42.46 72.15 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.472 -0.768 . . . . 0.0 111.748 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -62.79 -27.1 69.5 Favored Glycine 0 CA--C 1.533 1.173 0 O-C-N 121.608 -0.682 . . . . 0.0 113.38 175.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -82.69 -31.37 28.61 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 129.901 3.28 . . . . 0.0 113.104 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 52.8 mt -81.19 -30.26 34.37 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.58 1.152 . . . . 0.0 111.906 171.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -58.94 -45.01 91.46 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 126.327 1.851 . . . . 0.0 112.291 159.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -63.13 -31.27 72.37 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.694 -0.628 . . . . 0.0 112.193 169.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.28 17.23 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 173.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 -108.01 -20.97 13.0 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.287 1.835 . . . . 0.0 112.89 172.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -70.03 153.7 95.18 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 126.025 1.73 . . . . 0.0 110.031 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.69 -57.28 1.06 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 CA-C-N 122.236 1.834 . . . . 0.0 116.019 -157.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 81.7 mt -68.34 -18.54 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 120.017 1.28 . . . . 0.0 111.834 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 37.2 m -89.44 -29.28 19.13 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 16.5 tt -79.75 -33.1 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 119.823 1.192 . . . . 0.0 110.701 168.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.09 -36.69 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 118.852 0.751 . . . . 0.0 110.213 165.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -72.02 -35.67 69.47 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.701 1.137 . . . . 0.0 111.789 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 24.1 tp -62.15 -49.31 76.34 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.729 0.412 . . . . 0.0 111.417 169.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 60.6 mt -60.78 -45.24 98.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.786 1.234 . . . . 0.0 111.084 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.2 t -68.27 -40.02 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.048 0.939 . . . . 0.0 112.002 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.1 p -69.73 -31.6 49.13 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 CA-C-N 121.331 1.878 . . . . 0.0 111.707 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 73.2 t -71.71 -45.03 68.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -54.86 -48.58 72.75 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 118.186 0.448 . . . . 0.0 111.297 171.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.0 m -57.12 -50.28 73.29 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.341 1.057 . . . . 0.0 112.847 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 21.6 ptp -69.14 -38.65 78.94 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 118.906 -0.569 . . . . 0.0 111.86 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 14.9 t -58.66 -42.12 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.336 1.054 . . . . 0.0 111.687 174.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 30.2 m -84.38 -30.84 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.32 -33.07 65.25 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.082 0.855 . . . . 0.0 111.813 160.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 48.9 t -84.56 -44.34 13.64 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.845 0.858 . . . . 0.0 112.958 -170.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 5.0 p -67.14 -21.51 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -169.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 122.61 108.22 1.94 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -159.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' SER . . . . . 0.412 ' HA ' ' CG ' ' A' ' 222' ' ' PHE . 97.4 p -73.37 41.21 0.11 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.84 2.056 . . . . 0.0 114.133 -173.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -157.21 166.7 32.46 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 128.621 2.769 . . . . 0.0 109.829 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -87.11 -90.61 1.0 Allowed Glycine 0 N--CA 1.468 0.775 0 C-N-CA 127.258 2.361 . . . . 0.0 107.357 -13.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -60.86 -37.15 81.13 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.648 -1.276 . . . . 0.0 112.442 169.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 24.6 t -85.89 -40.91 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 117.883 -1.527 . . . . 0.0 111.488 -148.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.412 ' CG ' ' HA ' ' A' ' 217' ' ' SER . 0.1 OUTLIER -53.1 -46.51 68.73 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.223 162.596 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.92 -56.06 11.9 Favored 'General case' 0 C--O 1.214 -0.765 0 O-C-N 123.815 0.697 . . . . 0.0 111.307 -171.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.1 t -54.2 -36.71 63.75 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.739 -1.226 . . . . 0.0 112.228 176.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 15.6 m -68.93 -56.71 7.0 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.243 -0.91 . . . . 0.0 112.506 174.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.33 -57.45 12.27 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 125.864 1.666 . . . . 0.0 111.953 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.425 HD13 HG21 ' A' ' 227' ' ' ILE . 59.5 mt -54.71 -79.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-O 123.413 1.578 . . . . 0.0 108.902 169.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -74.83 -34.96 62.42 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 113.946 -1.479 . . . . 0.0 108.358 -150.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -72.72 -52.87 8.94 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.025 1.298 . . . . 0.0 115.17 172.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.41 -36.94 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-N 120.747 2.273 . . . . 0.0 111.487 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -81.33 -20.94 39.64 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.4 -46.6 89.42 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.51 0.724 . . . . 0.0 109.734 164.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.79 -24.93 67.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.57 -0.728 . . . . 0.0 110.987 171.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -70.46 -46.43 63.85 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 122.015 2.189 . . . . 0.0 113.62 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 8.3 pt -72.47 -2.25 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 120.509 -1.37 . . . . 0.0 114.206 173.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 44.1 tp -87.23 -21.58 25.76 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.677 1.191 . . . . 0.0 113.213 164.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -80.53 -12.38 59.54 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.949 1.7 . . . . 0.0 111.959 175.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 16.4 tpp -35.84 -30.8 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 128.981 2.913 . . . . 0.0 114.031 147.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 10.1 mt -102.9 -9.74 19.62 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.617 1.567 . . . . 0.0 110.767 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 52.3 m170 -83.88 -15.05 49.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.179 1.392 . . . . 0.0 112.147 161.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.359 3.4 t -88.78 46.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 125.648 2.642 . . . . 0.0 111.019 146.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 244' ' ' GLN . 38.3 t0 -46.4 90.44 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 112.306 -2.224 . . . . 0.0 109.92 104.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -68.2 37.0 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 128.73 2.812 . . . . 0.0 111.947 171.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.509 ' H ' ' C ' ' A' ' 242' ' ' ASP . 6.9 mt-30 69.31 41.03 1.4 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 129.466 3.106 . . . . 0.0 114.424 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -170.86 19.88 0.07 OUTLIER Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.069 -1.406 . . . . 0.0 116.523 172.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 95.25 107.16 2.15 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 119.565 1.682 . . . . 0.0 109.989 -171.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 15.0 t -44.44 130.41 6.6 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.974 1.31 . . . . 0.0 113.684 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 69.1 m95 58.55 18.91 6.13 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.1 2.16 . . . . 0.0 116.643 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.235 1.414 . . . . 0.0 113.575 176.361 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.485 HG12 ' H ' ' A' ' 103' ' ' ARG . 12.0 m . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 119.543 -0.265 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.494 ' HG ' ' HB2' ' A' ' 102' ' ' ALA . 3.7 tp -45.9 127.49 8.22 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 130.587 3.555 . . . . 0.0 111.935 -12.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.494 ' HB2' ' HG ' ' A' ' 101' ' ' LEU . . . -156.76 125.7 5.93 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 118.837 -2.414 . . . . 0.0 109.605 -11.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.547 ' HA ' HG12 ' A' ' 106' ' ' VAL . 2.5 ptt180 -59.26 -28.06 66.37 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.833 -1.53 . . . . 0.0 111.487 155.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -73.4 -31.51 63.92 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.227 -0.92 . . . . 0.0 110.903 172.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.466 ' H ' ' CB ' ' A' ' 102' ' ' ALA . 83.6 t60 -69.0 -48.46 63.03 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.928 -1.107 . . . . 0.0 111.964 172.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 103' ' ' ARG . 5.2 p -68.47 -34.97 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 118.273 0.488 . . . . 0.0 111.832 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -67.28 -35.16 78.93 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.193 -0.942 . . . . 0.0 110.429 172.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -57.57 -31.26 63.24 Favored Glycine 0 CA--C 1.545 1.958 0 C-N-CA 124.989 1.281 . . . . 0.0 113.841 163.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -72.26 -40.88 67.34 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.355 -1.086 . . . . 0.0 112.538 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.99 -43.53 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.705 1.202 . . . . 0.0 110.707 162.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.434 ' HB3' ' HA ' ' A' ' 177' ' ' SER . 19.6 m-30 -62.52 -45.63 92.11 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 117.433 -1.27 . . . . 0.0 112.552 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -53.39 -36.86 61.9 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.983 1.265 . . . . 0.0 113.045 170.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -73.62 -31.28 63.45 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.295 -0.878 . . . . 0.0 111.777 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.4 mt -68.35 -46.7 69.43 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.133 0.879 . . . . 0.0 110.572 168.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -70.71 -42.05 71.12 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.413 -165.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 25.9 ptt85 -75.81 156.52 84.52 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 123.858 0.863 . . . . 0.0 112.338 177.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -82.07 142.13 12.13 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.907 2.405 . . . . 0.0 111.498 167.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 75.3 p -147.74 156.92 43.25 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.561 1.544 . . . . 0.0 109.624 167.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.87 -36.04 78.24 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.016 166.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -64.66 -43.66 92.91 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -63.26 -46.2 87.97 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.292 0.951 . . . . 0.0 111.122 174.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 46.5 t -65.56 -33.76 76.67 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -62.08 -56.46 18.73 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.989 -1.07 . . . . 0.0 111.349 171.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.6 p -73.49 -41.08 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 120.721 -1.237 . . . . 0.0 113.207 -173.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -67.99 -50.9 52.82 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.665 0.786 . . . . 0.0 112.491 -173.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -68.14 -27.62 66.59 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.7 0.682 . . . . 0.0 111.991 -172.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -89.4 -30.4 18.38 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.4 -38.54 74.45 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 120.183 1.356 . . . . 0.0 112.529 158.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 19.4 t -58.28 -47.98 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 120.414 1.461 . . . . 0.0 111.884 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -59.66 -50.45 73.83 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.755 0.822 . . . . 0.0 113.193 172.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.57 -42.95 99.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -176.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.3 mt -63.38 -50.81 77.16 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.035 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.56 -36.46 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 119.926 1.239 . . . . 0.0 112.544 -173.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.1 tt -62.13 -47.71 83.35 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.277 1.031 . . . . 0.0 111.616 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 32.6 m -75.9 -40.89 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.747 0.703 . . . . 0.0 111.053 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 12.5 t -49.66 -58.27 5.6 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.351 1.86 . . . . 0.0 112.834 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 69.5 mt -77.28 -32.42 55.53 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.273 -0.892 . . . . 0.0 112.987 -173.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.9 mt -68.96 -46.14 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 120.038 1.29 . . . . 0.0 110.406 171.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -61.59 -30.33 70.61 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.806 175.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.8 m -60.08 -38.42 82.84 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.445 1.475 . . . . 0.0 113.212 172.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 50.7 t -67.27 -24.04 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 123.924 0.89 . . . . 0.0 111.807 174.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 46.2 mt -87.75 -48.33 7.94 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.292 1.037 . . . . 0.0 113.208 173.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 59.4 p -71.12 -12.41 61.48 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 127.497 2.319 . . . . 0.0 113.531 -171.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.7 t -70.63 -32.67 70.07 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.663 1.185 . . . . 0.0 111.444 170.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 48.4 mm -72.6 -33.35 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.712 0.805 . . . . 0.0 110.64 168.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -66.31 -33.29 75.39 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.271 0.628 . . . . 0.0 112.187 169.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -65.2 -40.86 94.76 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.843 1.257 . . . . 0.0 111.595 170.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -69.27 -34.4 74.69 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.338 0.655 . . . . 0.0 112.379 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.03 98.14 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.852 0.861 . . . . 0.0 111.722 167.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.13 -10.27 9.89 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 76.3 mt -70.78 -12.31 61.47 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.117 1.367 . . . . 0.0 113.738 166.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -152.56 -45.73 0.1 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -163.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.6 t -156.26 175.65 13.71 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.746 0.819 . . . . 0.0 110.833 -143.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.1 139.62 48.27 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 114.628 0.611 . . . . 0.0 114.628 -166.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.1 t -156.26 143.84 19.33 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -162.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 16.7 tp -87.18 7.89 26.27 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.882 1.273 . . . . 0.0 112.624 171.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -65.59 -10.98 40.27 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 119.546 -1.972 . . . . 0.0 114.093 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 53.7 p-90 -65.3 -26.46 68.08 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.057 -1.652 . . . . 0.0 112.492 166.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 51.0 tpp -75.36 -28.75 59.66 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.652 1.581 . . . . 0.0 112.261 174.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -61.24 -43.8 98.29 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.133 -0.979 . . . . 0.0 110.453 165.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.12 -35.26 73.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 118.096 -0.954 . . . . 0.0 111.3 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.43 -53.0 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 120.66 1.573 . . . . 0.0 111.745 170.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.8 mt -68.18 -36.8 80.16 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.239 0.927 . . . . 0.0 112.411 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 38.0 t -59.29 -41.47 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 120.666 1.576 . . . . 0.0 111.092 172.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.17 -31.13 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.502 -0.761 . . . . 0.0 111.05 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -59.66 -51.94 67.65 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.601 1.092 . . . . 0.0 111.752 165.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -62.47 -36.77 83.53 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 121.226 1.83 . . . . 0.0 112.055 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -62.31 -43.87 98.47 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 172.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 56.0 m -67.27 -32.81 74.06 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.401 -1.058 . . . . 0.0 110.895 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -65.42 -41.96 93.0 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 120.738 -1.226 . . . . 0.0 112.344 173.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -58.35 -45.71 87.66 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.529 0.604 . . . . 0.0 111.832 170.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.4 t -66.04 -38.18 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.816 0.846 . . . . 0.0 111.515 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 23.1 t -65.23 -38.83 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.004 1.322 . . . . 0.0 110.967 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -62.47 -34.26 76.49 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.585 1.084 . . . . 0.0 113.335 171.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 9.7 mt -67.96 -47.34 68.87 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.915 0.779 . . . . 0.0 111.875 169.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -61.91 -43.51 98.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 118.013 -0.994 . . . . 0.0 112.858 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.434 ' HA ' ' HB3' ' A' ' 111' ' ' TYR 0.265 43.0 p -65.49 -26.98 68.16 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 176.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.448 ' HB1' ' C ' ' A' ' 186' ' ' GLY . . . -57.23 -25.14 58.62 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.801 1.182 . . . . 0.0 113.247 168.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.412 ' CA ' ' HA ' ' A' ' 183' ' ' LYS . . . -70.49 -9.65 65.17 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 126.098 1.808 . . . . 0.0 114.643 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 44.1 t -53.82 -40.34 66.3 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.263 1.025 . . . . 0.0 112.382 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 3.1 ptp85 -68.51 -57.83 5.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.577 0.751 . . . . 0.0 111.803 171.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 41.7 t -162.96 137.67 6.46 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.498 1.919 . . . . 0.0 108.009 169.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.412 ' HA ' ' CA ' ' A' ' 179' ' ' GLY . 18.0 ptmt -60.28 -34.02 73.15 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -153.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -103.03 -27.19 12.74 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.209 1.004 . . . . 0.0 112.765 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 61.3 t -62.21 -68.08 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.068 1.347 . . . . 0.0 111.325 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.448 ' C ' ' HB1' ' A' ' 178' ' ' ALA . . . -61.0 -31.04 75.06 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 119.128 -0.818 . . . . 0.0 112.195 -178.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 7.9 tt -66.94 -39.93 87.45 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.61 1.564 . . . . 0.0 112.449 176.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 4.7 t-105 -60.26 -40.47 90.48 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 120.804 -1.185 . . . . 0.0 110.844 166.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -64.89 -30.31 77.65 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 122.226 0.903 . . . . 0.0 113.385 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 -76.3 -32.49 58.79 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.866 2.466 . . . . 0.0 112.312 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 75.1 mt -76.0 -35.35 59.59 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.943 1.297 . . . . 0.0 112.662 167.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 65.0 mtt-85 -59.67 -36.49 76.54 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.819 -1.176 . . . . 0.0 111.456 166.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -69.49 28.5 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 126.298 1.839 . . . . 0.0 113.994 170.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.66 27.95 1.21 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.598 2.359 . . . . 0.0 112.991 164.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -105.99 -37.08 6.76 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -149.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -77.86 146.81 72.92 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 117.265 -1.35 . . . . 0.0 109.868 172.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -45.22 -44.21 15.96 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.694 3.596 . . . . 0.0 116.901 -171.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -70.27 -30.38 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 119.353 0.979 . . . . 0.0 110.93 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.446 ' HA ' ' HB3' ' A' ' 202' ' ' ASP . 66.7 m -81.68 -26.83 34.38 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.509 1.523 . . . . 0.0 112.997 176.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.96 -48.14 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 163.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 65.5 mt -65.01 -30.08 49.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-O 118.689 -0.672 . . . . 0.0 111.566 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.446 ' HB3' ' HA ' ' A' ' 199' ' ' SER . 29.1 t70 -71.53 -44.52 64.46 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.496 1.498 . . . . 0.0 110.542 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 43.4 tp -61.6 -44.29 97.28 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.635 0.774 . . . . 0.0 111.403 171.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 72.2 mt -63.26 -49.1 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 121.393 -0.817 . . . . 0.0 110.804 176.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.0 t -70.39 -33.96 56.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 117.098 -1.429 . . . . 0.0 112.427 -173.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.5 p -65.38 -34.76 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 121.568 1.986 . . . . 0.0 111.394 172.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 86.9 t -75.17 -38.47 41.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 O-C-N 121.372 -0.83 . . . . 0.0 110.063 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -55.75 -47.26 77.27 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.697 0.68 . . . . 0.0 110.82 168.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 20.0 m -56.16 -43.48 78.39 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.148 0.979 . . . . 0.0 111.783 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 58.6 ttm -75.55 -50.3 16.02 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.276 0.631 . . . . 0.0 111.752 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 56.0 t -56.06 -46.74 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.066 0.946 . . . . 0.0 111.837 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 222' ' ' PHE . 13.9 m -77.01 -39.71 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 118.974 0.806 . . . . 0.0 113.035 -173.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -56.91 -32.87 66.37 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.919 0.887 . . . . 0.0 110.746 170.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 55.2 m -75.48 -52.15 11.36 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.376 1.471 . . . . 0.0 112.97 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.7 t -58.17 -40.25 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 125.265 1.426 . . . . 0.0 112.369 -171.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 139.35 154.66 6.41 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 123.595 0.617 . . . . 0.0 112.374 173.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 55.1 p -73.56 23.21 0.07 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -160.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm -156.41 165.39 36.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.477 1.911 . . . . 0.0 111.933 -160.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -78.01 -80.31 0.7 Allowed Glycine 0 N--CA 1.478 1.434 0 C-N-CA 127.462 2.458 . . . . 0.0 109.386 -9.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -84.77 -27.17 27.06 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.927 1.291 . . . . 0.0 110.827 161.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 73.5 t -76.7 -40.91 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 121.179 -0.951 . . . . 0.0 112.42 -145.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.428 ' HA ' ' HB ' ' A' ' 212' ' ' VAL . 0.0 OUTLIER -60.01 -39.81 87.07 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 169.128 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -74.17 -49.8 22.02 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.764 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 8.8 t -53.77 -38.4 64.42 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 121.123 1.783 . . . . 0.0 112.219 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 19.3 m -66.05 -56.85 9.48 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.505 -0.747 . . . . 0.0 112.357 173.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.54 -48.37 77.8 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.931 1.293 . . . . 0.0 112.496 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 67.2 mt -62.72 -84.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.79 0 O-C-N 119.255 -2.153 . . . . 0.0 109.133 169.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -71.87 -38.28 70.05 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.778 -152.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -71.05 -44.21 55.19 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 125.991 1.758 . . . . 0.0 114.32 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.5 mp -78.26 -30.18 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 118.773 1.286 . . . . 0.0 109.74 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -39.91 82.34 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 120.841 -1.162 . . . . 0.0 111.57 164.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -68.01 -41.48 82.14 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 117.385 -1.293 . . . . 0.0 110.73 -174.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 31.9 tp -57.43 -45.16 84.97 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.154 0.888 . . . . 0.0 110.856 167.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -59.09 -45.94 89.57 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -170.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.4 pt -66.93 -20.8 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 35.4 mt -66.88 -22.87 65.96 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.285 -0.884 . . . . 0.0 110.756 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -74.65 -11.35 60.16 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.263 -0.898 . . . . 0.0 111.731 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 81.2 mtp -45.79 -33.72 3.26 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 126.025 1.73 . . . . 0.0 113.1 153.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.3 mt -98.56 -14.02 20.14 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.346 1.459 . . . . 0.0 111.304 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 50.0 m170 -75.31 -27.49 59.31 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.681 -0.637 . . . . 0.0 111.495 157.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.251 15.5 t -79.01 60.62 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 125.557 2.599 . . . . 0.0 110.027 157.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' A' ' 244' ' ' GLN . 40.9 t0 -61.18 100.01 0.11 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 112.397 -2.183 . . . . 0.0 108.422 107.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.606 ' HB3' HG21 ' A' ' 247' ' ' THR . 5.4 ttt180 -64.51 30.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 130.127 3.371 . . . . 0.0 113.526 171.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.475 ' H ' ' C ' ' A' ' 242' ' ' ASP . 49.6 mt-30 74.66 38.5 0.48 Allowed 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 128.812 2.845 . . . . 0.0 113.837 170.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -166.46 12.22 0.07 OUTLIER Glycine 0 CA--C 1.537 1.433 0 CA-C-O 118.113 -1.382 . . . . 0.0 116.309 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 78.89 67.49 1.59 Allowed Glycine 0 N--CA 1.468 0.801 0 CA-C-N 120.083 1.942 . . . . 0.0 112.638 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.606 HG21 ' HB3' ' A' ' 243' ' ' ARG . 15.6 p -106.38 -177.68 3.43 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -156.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 9.3 m95 60.81 32.02 20.1 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 126.318 1.847 . . . . 0.0 112.826 -140.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 . . . . . 0 N--CA 1.479 0.98 0 O-C-N 119.338 -2.101 . . . . 0.0 111.996 -173.187 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.402 ' HB ' ' H ' ' A' ' 102' ' ' ALA . 17.5 m . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' A' ' 102' ' ' ALA . 5.1 tp -89.44 92.16 9.01 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 116.658 -2.017 . . . . 0.0 105.56 124.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.496 ' HB1' ' CB ' ' A' ' 105' ' ' HIS 0.278 . . 61.79 57.85 2.1 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 110.785 -2.916 . . . . 0.0 115.738 142.531 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -49.47 -29.38 6.54 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.178 142.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.2 t -63.42 -33.28 75.21 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 168.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.496 ' CB ' ' HB1' ' A' ' 102' ' ' ALA . 86.5 t60 -79.85 -30.39 40.31 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.439 -1.413 . . . . 0.0 110.763 -174.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.3 m -84.1 -34.25 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-O 121.845 0.831 . . . . 0.0 112.334 -174.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -52.74 -47.83 67.12 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.321 -1.308 . . . . 0.0 110.348 156.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -56.12 -36.83 69.37 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 118.928 -0.929 . . . . 0.0 113.613 169.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -70.11 -36.07 74.59 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.942 1.371 . . . . 0.0 112.089 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 t -57.0 -57.02 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.49 0.716 . . . . 0.0 109.87 162.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.419 ' HB3' ' HA ' ' A' ' 177' ' ' SER . 20.5 m-85 -58.76 -45.79 88.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.483 0.313 . . . . 0.0 111.623 -172.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -67.68 -21.54 65.33 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -77.0 -36.45 56.4 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.349 0.977 . . . . 0.0 111.294 172.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.8 mt -62.0 -40.79 96.85 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.799 -0.563 . . . . 0.0 109.735 164.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -71.75 -44.0 64.83 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.973 -167.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -98.87 101.72 13.0 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 126.632 1.973 . . . . 0.0 110.683 -174.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -65.17 156.95 60.14 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.49 2.126 . . . . 0.0 114.97 -164.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 40.4 p -145.31 168.14 21.17 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 127.107 2.163 . . . . 0.0 107.692 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.1 -35.14 32.94 Favored Glycine 0 CA--C 1.536 1.389 0 O-C-N 121.627 -0.671 . . . . 0.0 112.282 164.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 33.9 m95 -69.13 -34.45 75.04 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -60.87 -51.18 70.38 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.66 1.118 . . . . 0.0 110.51 169.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 42.8 t -63.09 -37.19 86.23 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.265 0.626 . . . . 0.0 111.573 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -58.96 -59.26 5.75 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.023 0.44 . . . . 0.0 109.844 173.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.86 -49.37 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.012 0.525 . . . . 0.0 111.993 -168.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -68.39 -46.2 70.65 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -170.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -77.89 -27.92 49.76 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.566 -0.709 . . . . 0.0 112.113 -172.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -68.78 -44.86 72.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.997 165.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -51.78 -48.91 63.59 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 117.314 -1.327 . . . . 0.0 113.96 168.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . 0.265 0.9 OUTLIER -63.82 -41.5 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 121.76 2.073 . . . . 0.0 112.293 -179.126 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -67.27 -43.17 82.47 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.742 0.701 . . . . 0.0 111.849 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 85.4 mt -66.1 -41.85 90.05 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.612 0.365 . . . . 0.0 111.766 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 69.4 mt -64.26 -47.74 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 118.011 -0.995 . . . . 0.0 111.194 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -40.32 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 120.495 1.498 . . . . 0.0 111.378 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 33.8 tp -59.43 -43.69 93.04 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.624 1.17 . . . . 0.0 111.658 175.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.8 t -64.3 -45.79 95.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 118.694 -0.669 . . . . 0.0 111.356 171.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 90.5 m -63.7 -39.98 95.64 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.172 0.896 . . . . 0.0 112.385 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 87.5 mt -79.49 -37.27 37.17 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.419 -0.801 . . . . 0.0 112.686 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.3 mt -59.25 -48.32 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.301 0.572 . . . . 0.0 109.94 167.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -60.96 -36.3 79.03 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-O 117.726 -1.131 . . . . 0.0 110.845 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.9 m -55.41 -44.49 76.24 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 121.538 1.972 . . . . 0.0 112.444 -176.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.3 m -79.28 -16.04 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 78.4 mt -81.98 -28.41 32.66 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 120.074 1.306 . . . . 0.0 113.554 161.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 37.8 t -78.5 -38.67 40.2 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.808 1.643 . . . . 0.0 113.579 -160.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . 0.336 3.4 t -74.28 -17.19 60.89 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 120.295 1.407 . . . . 0.0 113.312 -175.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.1 mp -58.89 -43.13 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 120.587 -1.32 . . . . 0.0 110.959 159.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -69.52 -41.04 76.54 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.479 1.111 . . . . 0.0 110.669 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -59.04 -41.6 88.21 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.779 1.232 . . . . 0.0 111.647 171.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -67.99 -40.83 83.0 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.782 -1.199 . . . . 0.0 110.922 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.94 -33.47 73.23 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.615 0.766 . . . . 0.0 111.481 172.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.28 -8.66 8.98 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 72.3 mt -70.71 -11.93 61.25 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 120.249 -1.532 . . . . 0.0 113.482 166.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.49 -45.54 0.17 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -170.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.1 t -157.52 -178.66 7.5 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.806 0.813 . . . . 0.0 112.402 -138.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.13 134.99 52.11 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 124.609 1.099 . . . . 0.0 114.445 -170.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.5 t -155.07 137.52 15.01 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.227 1.011 . . . . 0.0 112.735 -160.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.6 tp -81.09 6.13 14.58 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.988 1.315 . . . . 0.0 113.342 166.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -64.93 -9.01 17.98 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 119.664 -1.897 . . . . 0.0 114.484 -173.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -68.73 -28.33 66.73 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.22 1.008 . . . . 0.0 112.129 167.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 50.6 tpp -66.24 -25.4 66.88 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.985 1.266 . . . . 0.0 111.862 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -63.99 -45.28 89.7 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.21 -0.931 . . . . 0.0 111.276 170.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 33.5 mt -57.48 -43.23 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.41 1.084 . . . . 0.0 111.087 172.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.3 t -61.35 -42.85 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 121.391 -0.818 . . . . 0.0 112.271 176.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 10.7 mt -71.84 -36.17 70.09 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.618 1.099 . . . . 0.0 113.233 173.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 45.2 t -59.54 -34.05 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 O-C-N 120.809 -1.182 . . . . 0.0 110.937 169.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 81.6 t -82.15 -26.75 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.315 1.046 . . . . 0.0 111.236 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -61.41 -56.72 17.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.29 1.404 . . . . 0.0 110.225 166.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -64.84 -39.09 93.01 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.221 0.919 . . . . 0.0 112.071 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -61.8 -42.85 99.8 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.638 1.113 . . . . 0.0 113.255 175.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.8 m -78.6 -30.31 46.55 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.997 1.398 . . . . 0.0 111.701 175.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.75 -41.11 97.23 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.898 -1.126 . . . . 0.0 111.851 170.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -53.09 -45.98 68.44 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.72 0.691 . . . . 0.0 110.571 169.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 92.5 t -68.22 -37.66 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.407 0.683 . . . . 0.0 112.006 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 39.3 t -63.21 -36.05 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 121.215 -0.928 . . . . 0.0 112.342 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -58.45 -38.8 78.27 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.279 0.945 . . . . 0.0 111.954 169.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 33.3 mt -72.97 -34.28 66.37 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -70.78 -39.84 72.96 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 173.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.419 ' HA ' ' HB3' ' A' ' 111' ' ' TYR . 17.6 p -62.35 -20.96 64.92 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 120.439 -1.413 . . . . 0.0 114.724 165.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -70.77 -6.63 39.1 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 120.203 1.365 . . . . 0.0 113.862 163.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -154.97 44.69 0.55 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.553 1.549 . . . . 0.0 112.986 -160.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 25.8 p -51.94 -24.53 6.55 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.028 0.931 . . . . 0.0 113.248 169.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.92 -53.41 2.28 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.76 2.024 . . . . 0.0 110.175 161.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.8 m -76.04 48.14 0.48 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 128.42 2.688 . . . . 0.0 112.563 -172.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -55.52 -19.24 9.18 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.939 2.496 . . . . 0.0 115.447 -169.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -114.18 -29.19 7.04 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 169.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 2.0 t -65.15 -61.68 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 119.907 1.231 . . . . 0.0 111.197 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -73.44 -28.45 65.73 Favored Glycine 0 C--O 1.222 -0.647 0 O-C-N 121.929 -0.482 . . . . 0.0 112.525 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 3.0 tt -53.34 -41.03 65.34 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.509 0.724 . . . . 0.0 110.773 166.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -85.93 -18.21 33.32 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.02 -37.08 16.62 Favored Glycine 0 N--CA 1.467 0.727 0 O-C-N 119.728 -1.858 . . . . 0.0 110.418 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -67.13 -25.49 66.21 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.942 1.697 . . . . 0.0 112.704 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 21.7 mt -76.0 -1.32 25.15 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 165.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 37.6 mtm105 -122.98 -8.11 8.34 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.321 1.848 . . . . 0.0 113.432 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -72.81 66.68 0.77 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.936 1.694 . . . . 0.0 108.409 149.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -148.36 82.26 1.48 Allowed 'General case' 0 C--O 1.239 0.501 0 C-N-CA 127.625 2.37 . . . . 0.0 107.432 -156.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 48.8 ttt85 -147.42 -73.69 0.2 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -154.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -72.83 154.94 91.04 Favored Pre-proline 0 N--CA 1.474 0.764 0 CA-C-N 119.28 0.945 . . . . 0.0 112.865 175.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.92 -45.61 24.23 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.893 3.062 . . . . 0.0 116.704 -168.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 69.4 mt -64.15 -35.4 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 121.525 1.966 . . . . 0.0 111.554 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 54.6 p -70.51 -31.1 68.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.8 1.182 . . . . 0.0 112.937 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.4 mm -75.39 -40.52 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.443 1.097 . . . . 0.0 111.13 172.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 56.4 mt -61.91 -41.78 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.146 0.978 . . . . 0.0 110.429 171.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.73 -43.21 97.16 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.834 1.654 . . . . 0.0 111.794 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 68.4 tp -60.98 -49.25 78.22 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.925 0.89 . . . . 0.0 112.687 170.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 61.9 mt -62.28 -44.55 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.167 -0.958 . . . . 0.0 110.53 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.0 t -69.11 -34.53 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 116.823 -1.561 . . . . 0.0 113.073 -174.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.1 p -68.22 -33.08 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 121.677 2.035 . . . . 0.0 111.6 173.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 82.4 t -77.37 -40.37 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 O-C-N 121.456 -0.777 . . . . 0.0 109.988 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.467 ' O ' HG22 ' A' ' 212' ' ' VAL . . . -54.76 -52.03 63.84 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.118 0.967 . . . . 0.0 110.758 167.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.4 m -56.06 -47.42 77.96 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.807 0.843 . . . . 0.0 112.344 -178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 72.5 mtm -59.73 -48.72 80.57 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 174.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.57 -44.04 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 118.547 0.612 . . . . 0.0 112.323 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 208' ' ' ALA . 27.2 m -84.67 -24.81 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 117.525 -1.226 . . . . 0.0 112.368 -167.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 38.9 mt -63.1 -30.69 71.79 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.561 1.528 . . . . 0.0 112.043 156.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 43.3 t -83.67 -45.73 13.1 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.841 0.856 . . . . 0.0 113.166 -164.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 9.5 t -50.94 -30.16 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 125.975 1.71 . . . . 0.0 114.474 -173.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 131.52 157.41 8.76 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 126.603 2.049 . . . . 0.0 109.771 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 90.3 p -81.76 34.44 0.39 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.89 -1.359 . . . . 0.0 113.663 -168.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -171.05 177.94 3.53 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 130.289 3.436 . . . . 0.0 109.092 176.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 63.36 112.48 0.01 OUTLIER Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 115.765 -3.112 . . . . 0.0 107.626 -111.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.43 -8.41 0.13 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.845 0.831 . . . . 0.0 111.89 160.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.452 ' HA ' HG22 ' A' ' 224' ' ' THR . 0.5 OUTLIER -67.66 -44.45 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 127.35 2.26 . . . . 0.0 112.138 174.722 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -50.12 -52.13 37.55 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.345 1.458 . . . . 0.0 110.652 169.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.33 -59.89 3.28 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.494 1.118 . . . . 0.0 110.418 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 221' ' ' VAL . 13.8 t -59.8 -42.12 92.73 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.458 ' HB2' HG21 ' A' ' 212' ' ' VAL . 21.6 m -69.13 -45.06 71.07 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.14 -0.975 . . . . 0.0 110.893 -173.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -53.36 -62.98 1.3 Allowed 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 126.073 1.749 . . . . 0.0 110.975 170.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.4 mt -56.4 -72.71 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 123.52 1.629 . . . . 0.0 111.141 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -73.7 -44.72 55.75 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 112.715 -2.039 . . . . 0.0 106.959 -152.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -65.87 -52.88 34.28 Favored Glycine 0 N--CA 1.466 0.667 0 C-N-CA 125.021 1.296 . . . . 0.0 114.41 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.72 -38.72 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.489 1.645 . . . . 0.0 111.275 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -82.82 -28.86 29.92 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -175.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -55.38 -43.4 75.12 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.051 1.341 . . . . 0.0 109.27 168.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 57.0 tp -65.07 -38.21 90.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 117.723 -1.132 . . . . 0.0 111.816 173.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -66.09 -37.94 87.02 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 121.899 2.136 . . . . 0.0 112.547 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 35.6 pt -69.52 -10.83 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 114.981 1.475 . . . . 0.0 114.981 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 11.1 mt -78.96 -20.6 48.79 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 120.918 -1.114 . . . . 0.0 110.944 167.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . 0.268 53.9 mtp180 -73.08 -19.28 61.2 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.668 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 89.2 mtp -48.63 -16.26 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 129.7 3.2 . . . . 0.0 117.059 156.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.6 pp -143.81 -19.98 0.59 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.679 1.127 . . . . 0.0 112.913 -174.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -75.63 -8.41 56.72 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.645 1.178 . . . . 0.0 111.853 157.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 3.2 p -56.31 125.12 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.152 0 CA-C-O 124.188 1.947 . . . . 0.0 107.858 171.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 244' ' ' GLN . 27.5 t0 -119.84 97.23 5.52 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 110.592 -3.004 . . . . 0.0 109.653 150.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 27.1 ttt-85 -64.56 18.33 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.176 1.39 . . . . 0.0 113.113 157.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.494 ' H ' ' C ' ' A' ' 242' ' ' ASP 0.415 8.2 pt20 74.82 51.77 0.08 Allowed 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 131.634 3.974 . . . . 0.0 114.096 159.853 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -157.78 3.96 0.14 Allowed Glycine 0 CA--C 1.541 1.686 0 CA-C-N 114.211 -1.359 . . . . 0.0 114.23 164.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 87.46 75.58 1.27 Allowed Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.061 1.43 . . . . 0.0 110.911 -163.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 4.5 m -59.01 155.51 13.41 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.081 1.752 . . . . 0.0 112.466 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 99.0 m95 55.1 38.74 30.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.61 1.964 . . . . 0.0 115.302 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 45.1 ttm-85 . . . . . 0 C--O 1.25 1.129 0 C-N-CA 124.958 1.303 . . . . 0.0 112.81 179.465 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.4 t -114.68 -43.78 3.12 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 127.23 2.212 . . . . 0.0 110.144 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -73.27 56.23 0.47 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.008 1.723 . . . . 0.0 112.274 167.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.3 p -169.89 -36.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 130.491 3.516 . . . . 0.0 109.581 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -83.6 -49.89 8.75 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.632 1.173 . . . . 0.0 109.661 170.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -55.45 -24.26 37.74 Favored Glycine 0 CA--C 1.537 1.433 0 O-C-N 120.722 -1.236 . . . . 0.0 113.006 164.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . 0.275 0.3 OUTLIER -77.22 -42.57 36.88 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.29 1.036 . . . . 0.0 112.391 174.141 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 t -53.39 -52.05 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.68 1.192 . . . . 0.0 110.336 165.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -72.29 -9.64 58.75 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -84.96 -46.22 11.44 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 119.464 1.029 . . . . 0.0 110.527 162.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -66.65 -46.1 76.84 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.344 1.058 . . . . 0.0 111.434 -169.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pp -71.37 -14.29 62.13 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -109.11 -32.54 7.19 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.722 0.809 . . . . 0.0 113.178 -172.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -80.63 111.5 23.59 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.6 1.16 . . . . 0.0 111.621 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -69.1 119.99 6.91 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.928 1.752 . . . . 0.0 110.066 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.0 p -145.43 178.68 7.93 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.855 1.262 . . . . 0.0 108.84 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -53.84 -42.29 68.83 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.222 -0.766 . . . . 0.0 111.518 164.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -66.59 -47.02 74.04 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -59.08 -50.54 73.68 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.933 0.788 . . . . 0.0 109.795 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 13.0 t -56.75 -50.41 72.32 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.27 0.628 . . . . 0.0 111.752 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -60.55 -52.13 66.5 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 121.774 -0.579 . . . . 0.0 112.25 -174.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.8 t -87.31 -39.52 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.343 -0.848 . . . . 0.0 113.172 -170.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -69.59 -41.5 75.7 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.351 0.66 . . . . 0.0 111.016 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -81.39 -25.59 36.14 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -176.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -57.61 -51.63 68.74 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.498 1.044 . . . . 0.0 110.857 161.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.16 -43.13 73.97 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 173.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . 0.289 1.2 m -63.85 -42.26 95.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-N 121.55 1.977 . . . . 0.0 112.114 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -66.5 -42.72 86.95 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.093 1.315 . . . . 0.0 111.593 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.77 -48.38 81.91 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.905 0.482 . . . . 0.0 109.913 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.04 -43.68 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 117.933 -1.032 . . . . 0.0 111.018 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.95 -39.49 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 120.592 1.542 . . . . 0.0 113.158 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 63.3 tp -63.53 -45.49 90.37 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.955 1.302 . . . . 0.0 111.032 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.69 -53.25 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.504 0.722 . . . . 0.0 110.781 174.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 63.7 m -61.42 -35.58 77.95 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.479 1.512 . . . . 0.0 113.09 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.4 mt -81.08 -37.53 28.83 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.166 1.348 . . . . 0.0 113.552 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.57 -44.44 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 119.258 0.935 . . . . 0.0 109.511 168.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -64.34 -31.71 73.03 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-O 117.614 -1.184 . . . . 0.0 112.409 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.4 t -63.45 -43.59 96.94 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 121.103 1.774 . . . . 0.0 112.394 176.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 90.2 t -59.7 -39.53 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.764 1.226 . . . . 0.0 111.612 174.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 30.6 tp -71.72 -47.31 54.78 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.367 1.067 . . . . 0.0 112.358 174.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.9 t -59.53 -37.59 78.77 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.744 2.418 . . . . 0.0 112.929 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.8 t -76.77 1.7 16.51 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.0 -1.062 . . . . 0.0 113.027 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.0 mm -113.26 -35.65 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 127.225 2.21 . . . . 0.0 112.165 165.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -55.55 -31.53 62.22 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.282 1.033 . . . . 0.0 113.174 168.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -61.52 -22.09 64.82 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -93.42 -28.53 16.08 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.207 1.003 . . . . 0.0 111.702 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.36 -35.09 79.76 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.087 0.955 . . . . 0.0 111.067 168.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.91 -6.55 3.92 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.145 1.378 . . . . 0.0 114.396 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.4 mt -84.46 -15.3 46.55 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.382 1.473 . . . . 0.0 113.414 170.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.25 -38.87 1.06 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -163.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.8 t -157.45 177.26 11.63 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.429 -0.794 . . . . 0.0 111.984 -148.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -72.01 156.24 52.3 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 121.519 0.51 . . . . 0.0 113.042 173.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.7 t -164.26 151.58 11.88 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.548 -0.972 . . . . 0.0 112.337 -166.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 33.9 mt -73.04 -0.12 13.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.388 1.475 . . . . 0.0 113.584 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -54.34 -26.32 29.1 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.605 1.562 . . . . 0.0 114.449 -173.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -52.59 -32.3 40.62 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.743 1.217 . . . . 0.0 114.071 171.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 17.8 tpt -71.06 -18.63 62.55 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.248 0.619 . . . . 0.0 112.562 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -67.42 -38.45 84.62 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.674 -1.266 . . . . 0.0 111.664 169.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.6 mp -66.87 -37.49 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 122.845 0.458 . . . . 0.0 110.384 174.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.65 -49.95 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.568 0.747 . . . . 0.0 111.698 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.8 mt -71.86 -28.99 63.91 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 20.5 t -61.36 -40.06 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 120.338 1.426 . . . . 0.0 111.951 165.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.9 t -68.71 -37.01 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 119.205 0.911 . . . . 0.0 111.047 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -57.89 -56.72 18.35 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.812 0.733 . . . . 0.0 111.272 168.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -67.03 -38.88 86.68 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.464 1.029 . . . . 0.0 113.392 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -61.72 -45.61 95.91 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.877 0.751 . . . . 0.0 111.61 172.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 89.2 m -63.14 -43.39 98.49 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 117.617 0.709 . . . . 0.0 111.382 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -62.18 -33.01 73.71 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.076 1.75 . . . . 0.0 112.864 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -66.38 -45.77 78.94 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.39 -0.819 . . . . 0.0 111.757 170.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.8 t -70.97 -32.22 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.964 0.906 . . . . 0.0 112.25 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.6 t -60.62 -37.79 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.344 1.458 . . . . 0.0 111.919 174.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 37.0 mtm180 -62.65 -43.18 99.47 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.531 0.605 . . . . 0.0 111.998 167.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 48.6 mt -62.89 -32.23 73.45 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.996 -1.065 . . . . 0.0 113.447 175.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 29.4 m0 -70.66 -35.78 73.04 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.277 -0.889 . . . . 0.0 113.241 170.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 94.2 p -78.59 13.53 1.59 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 121.153 1.797 . . . . 0.0 114.863 165.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -47.9 -44.52 29.73 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.58 1.082 . . . . 0.0 111.43 160.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -162.72 23.49 0.2 Allowed Glycine 0 CA--C 1.531 1.087 0 CA-C-O 118.372 -1.238 . . . . 0.0 115.336 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 62.5 m 69.13 -39.95 0.44 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.004 2.122 . . . . 0.0 116.574 168.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.31 -9.32 15.5 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.735 1.614 . . . . 0.0 113.837 164.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.495 ' HB2' ' H ' ' A' ' 186' ' ' GLY . 86.9 p -72.08 25.73 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.689 2.396 . . . . 0.0 115.465 -169.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.31 -0.52 17.33 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 -158.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -109.94 -43.37 4.01 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.916 1.287 . . . . 0.0 111.112 153.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.62 -73.42 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.867 1.267 . . . . 0.0 112.832 -170.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.495 ' H ' ' HB2' ' A' ' 182' ' ' SER . . . -78.68 -9.42 87.08 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.212 1.387 . . . . 0.0 113.946 175.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.451 HD13 ' C ' ' A' ' 187' ' ' LEU . 0.4 OUTLIER -55.56 -44.41 76.79 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.927 0.863 . . . . 0.0 109.913 167.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 34.6 t-105 -76.3 -50.31 14.69 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.671 -0.643 . . . . 0.0 112.289 161.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -56.58 -33.8 63.13 Favored Glycine 0 CA--C 1.535 1.307 0 N-CA-C 116.513 1.365 . . . . 0.0 116.513 -167.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -83.88 -21.52 31.92 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.328 1.564 . . . . 0.0 113.841 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.423 HD21 HD13 ' A' ' 203' ' ' LEU . 2.5 tt -73.02 -45.18 59.2 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -55.24 -39.09 69.33 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.235 166.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -70.27 -15.15 62.86 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -80.71 57.93 3.13 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 120.849 -1.157 . . . . 0.0 113.36 -171.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 43.3 mtt-85 -93.69 -14.37 26.44 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.221 1.808 . . . . 0.0 115.295 -161.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -77.57 164.7 56.39 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 124.695 1.198 . . . . 0.0 111.087 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -60.25 -46.3 19.07 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.704 1.602 . . . . 0.0 114.274 -160.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 50.9 mm -66.67 -34.78 72.31 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 CA-C-N 117.975 0.352 . . . . 0.0 111.281 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 15.9 m -69.07 -37.14 78.34 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.282 1.433 . . . . 0.0 112.507 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 30.1 mm -66.8 -42.99 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.561 0.744 . . . . 0.0 110.718 170.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.1 mt -62.56 -41.58 92.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 O-C-N 121.175 -0.953 . . . . 0.0 111.051 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -64.91 -43.05 94.11 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.426 1.89 . . . . 0.0 110.181 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.423 HD13 HD21 ' A' ' 191' ' ' LEU . 45.9 tp -59.41 -50.51 73.67 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 169.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 44.2 mt -60.03 -43.39 92.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 O-C-N 121.392 -0.817 . . . . 0.0 111.226 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.7 t -72.68 -29.23 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 117.667 -1.158 . . . . 0.0 112.471 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.48 -39.01 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 121.55 1.977 . . . . 0.0 111.174 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 28.6 m -74.44 -35.68 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 118.367 0.53 . . . . 0.0 111.189 176.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.39 -45.25 84.68 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 118.202 0.455 . . . . 0.0 111.407 168.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 36.0 t -61.71 -38.42 87.81 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.345 1.458 . . . . 0.0 112.118 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 36.3 mmt -71.67 -41.03 69.2 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 171.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 10.3 t -60.49 -38.84 79.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 118.642 0.655 . . . . 0.0 111.052 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.415 HG21 ' CB ' ' A' ' 225' ' ' SER . 3.4 t -61.34 -46.32 96.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 127.624 2.369 . . . . 0.0 111.493 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 61.5 mt -58.94 -41.18 86.77 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.475 1.034 . . . . 0.0 111.568 166.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 11.4 t -74.48 -31.45 62.22 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -165.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 84.9 t -66.76 -20.25 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.203 1.001 . . . . 0.0 111.56 173.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.41 156.47 21.35 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 124.295 0.95 . . . . 0.0 111.619 -166.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 41.2 p -62.01 17.86 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 128.519 2.727 . . . . 0.0 115.203 172.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 15.3 mttp -166.34 174.27 9.24 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 129.714 3.206 . . . . 0.0 110.012 -176.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 69.5 104.92 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 105.269 -3.133 . . . . 0.0 105.269 -113.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -59.4 3.74 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.936 0 O-C-N 121.744 -0.857 . . . . 0.0 112.211 170.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 23.2 m -79.7 -35.12 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 127.296 2.238 . . . . 0.0 112.71 167.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.2 -47.37 68.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.288 1.404 . . . . 0.0 109.799 163.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -62.44 -52.49 63.35 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.08 0.552 . . . . 0.0 111.496 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.88 -35.36 74.65 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.456 1.025 . . . . 0.0 112.316 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.415 ' CB ' HG21 ' A' ' 212' ' ' VAL . 17.0 m -75.18 -36.72 61.45 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.489 1.041 . . . . 0.0 112.773 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.28 -46.91 76.16 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.482 -0.761 . . . . 0.0 110.308 169.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.0 mt -66.79 -82.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 125.301 1.44 . . . . 0.0 110.974 172.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.49 ' HA ' ' CD1' ' A' ' 232' ' ' PHE . 48.1 mtt180 -77.74 14.52 1.04 Allowed 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 130.854 3.661 . . . . 0.0 114.573 -170.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -124.1 -59.58 0.18 Allowed Glycine 0 N--CA 1.462 0.382 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 162.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . 0.343 0.3 OUTLIER -99.97 -2.66 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -163.577 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.42 -39.79 11.79 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 121.229 -0.919 . . . . 0.0 111.871 145.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.49 ' CD1' ' HA ' ' A' ' 228' ' ' ARG . 1.7 m-30 -57.05 -30.57 64.36 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -177.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 7.1 tp -68.88 -31.41 70.32 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.756 -0.59 . . . . 0.0 112.37 172.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -75.45 -35.72 60.86 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.052 1.341 . . . . 0.0 112.505 -168.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -26.71 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.248 1.019 . . . . 0.0 111.639 170.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 62.2 mt -70.92 -28.85 64.81 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.79 0.805 . . . . 0.0 110.44 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -75.6 -25.08 56.68 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.065 2.146 . . . . 0.0 111.914 -171.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 66.6 mtp -46.1 -29.03 1.36 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.859 2.064 . . . . 0.0 115.525 155.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 20.0 mt -112.49 -31.26 6.85 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.858 1.263 . . . . 0.0 109.908 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.43 16.59 0.1 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.931 1.692 . . . . 0.0 114.019 155.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.505 -0.756 0 CA-C-O 124.273 1.987 . . . . 0.0 110.875 -170.175 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.528 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.48 -21.72 12.02 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.037 0.935 . . . . 0.0 112.074 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -57.19 -39.76 76.01 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.501 1.5 . . . . 0.0 112.451 168.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.4 p -61.98 -21.7 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 126.606 1.962 . . . . 0.0 113.682 171.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -95.51 -31.42 13.35 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.802 -0.562 . . . . 0.0 111.379 173.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -50.96 -26.47 11.38 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.289 1.424 . . . . 0.0 112.481 162.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -63.44 -48.85 76.06 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.776 0.831 . . . . 0.0 111.714 172.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.3 -57.36 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.956 0.902 . . . . 0.0 110.47 167.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -58.93 -46.21 88.5 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.497 1.119 . . . . 0.0 112.39 -167.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -65.86 -25.99 67.45 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 171.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -77.77 -34.93 52.15 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.131 1.332 . . . . 0.0 110.718 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 mt -59.67 -49.15 78.85 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 162.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -74.28 -32.01 62.75 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.162 -162.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -104.88 92.2 4.99 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 127.069 2.148 . . . . 0.0 110.711 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -58.22 128.3 28.14 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.129 1.886 . . . . 0.0 109.678 173.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.1 p -155.69 165.75 35.59 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.414 1.886 . . . . 0.0 107.805 -163.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -49.24 -42.29 32.29 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 118.957 -0.913 . . . . 0.0 111.466 175.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -75.4 -39.07 59.47 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.621 1.71 . . . . 0.0 115.568 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.463 ' HE3' ' CZ ' ' A' ' 125' ' ' TYR . 77.5 tttt -57.06 -50.54 72.44 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.679 1.582 . . . . 0.0 108.855 172.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 46.6 t -57.33 -43.8 83.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.288 1.835 . . . . 0.0 111.867 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -59.08 -57.01 14.94 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.13 -0.981 . . . . 0.0 111.208 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.1 m -81.87 -32.06 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -166.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.463 ' CZ ' ' HE3' ' A' ' 121' ' ' LYS . 6.4 m-85 -64.04 -34.46 78.07 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.216 0.916 . . . . 0.0 111.381 176.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.1 m170 -77.48 -43.11 33.38 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.846 0.748 . . . . 0.0 110.307 -171.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -67.06 -38.51 85.92 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.255 -0.879 . . . . 0.0 112.446 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.09 -40.24 76.58 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 120.172 1.351 . . . . 0.0 113.14 168.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.84 -41.98 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 121.308 1.867 . . . . 0.0 111.412 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -63.96 -41.93 97.44 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.59 0.632 . . . . 0.0 112.081 175.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.1 tp -73.72 -44.42 56.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.841 0.456 . . . . 0.0 111.892 -173.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.3 mp -67.39 -40.81 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 O-C-N 121.031 -1.043 . . . . 0.0 111.872 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.76 -44.78 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 120.465 1.484 . . . . 0.0 112.062 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 23.7 tp -54.67 -56.36 19.91 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.723 1.609 . . . . 0.0 111.469 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 55.3 t -65.18 -44.39 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 122.715 0.406 . . . . 0.0 111.416 -174.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 73.0 m -71.53 -35.04 70.55 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 91.3 mt -76.73 -37.51 55.87 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.431 1.468 . . . . 0.0 112.521 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 87.7 mt -59.91 -42.25 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 118.852 0.751 . . . . 0.0 109.312 169.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -64.49 -40.13 95.09 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 115.805 -2.045 . . . . 0.0 111.99 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.5 m -49.44 -44.47 45.6 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 121.346 1.884 . . . . 0.0 113.123 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 70.7 t -60.16 -34.91 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.157 0.983 . . . . 0.0 111.88 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.8 tp -85.44 -44.81 12.42 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 169.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 24.2 p -67.69 -30.04 69.46 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.931 1.293 . . . . 0.0 113.252 -167.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.2 t -75.05 -11.64 60.14 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.562 -0.711 . . . . 0.0 112.769 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' A' ' 145' ' ' ILE . 4.5 mm -97.36 -46.89 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 126.069 1.748 . . . . 0.0 111.771 170.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -55.21 -34.1 63.64 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.663 1.185 . . . . 0.0 112.596 173.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -68.13 -21.63 64.92 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.283 -1.51 . . . . 0.0 114.991 173.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -75.38 -26.93 58.88 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 121.05 1.75 . . . . 0.0 109.916 171.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -72.99 -30.09 63.54 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.286 -0.884 . . . . 0.0 112.174 167.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -56.48 -27.41 57.0 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.764 -1.21 . . . . 0.0 114.002 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 73.1 mt -57.35 -28.41 63.12 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.651 1.18 . . . . 0.0 113.688 173.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.11 -42.28 2.02 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.648 1.579 . . . . 0.0 114.451 -165.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.8 t -155.6 -172.7 4.24 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.758 0.79 . . . . 0.0 111.751 -147.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -70.98 140.93 32.08 Favored Glycine 0 CA--C 1.533 1.159 0 O-C-N 121.167 -0.958 . . . . 0.0 114.114 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.8 t -166.21 139.18 4.02 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.367 1.067 . . . . 0.0 112.104 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.5 3.19 2.5 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 171.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -56.79 -10.49 1.06 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.005 1.722 . . . . 0.0 113.686 166.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 33.7 p-90 -62.29 -24.58 67.38 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.861 -1.15 . . . . 0.0 112.787 167.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 69.0 mtm -73.9 -16.89 61.1 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.968 -1.082 . . . . 0.0 113.789 171.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -67.59 -41.35 84.24 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.606 1.548 . . . . 0.0 109.942 165.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 7.2 mt -56.6 -38.93 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 118.419 0.554 . . . . 0.0 111.85 170.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.46 -52.27 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 121.199 -0.938 . . . . 0.0 112.209 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 13.1 mt -67.27 -26.55 66.61 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.289 0.95 . . . . 0.0 112.195 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 6.2 t -64.49 -35.39 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 119.999 -1.688 . . . . 0.0 111.397 169.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 73.1 t -76.48 -30.4 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 118.72 -0.657 . . . . 0.0 110.504 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -62.35 -48.31 80.34 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 119.638 1.108 . . . . 0.0 112.261 167.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -69.04 -39.23 79.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.364 1.438 . . . . 0.0 112.581 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -54.05 -45.85 71.22 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 119.286 0.948 . . . . 0.0 112.954 166.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.9 m -62.05 -40.58 96.26 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.462 0.705 . . . . 0.0 111.707 172.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -60.1 -39.66 86.91 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.485 1.493 . . . . 0.0 112.912 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -71.12 -43.16 68.21 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.94 0.791 . . . . 0.0 111.961 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 90.1 t -72.38 -34.57 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 118.828 -0.605 . . . . 0.0 111.708 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 15.4 t -58.84 -37.23 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.114 1.366 . . . . 0.0 111.542 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -59.72 -46.78 88.07 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.471 1.032 . . . . 0.0 112.049 170.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.03 -23.42 66.55 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 120.456 -1.403 . . . . 0.0 114.288 172.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 54.5 m0 -76.09 -13.57 60.2 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 168.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 6.6 p -61.8 -36.8 82.19 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 121.746 2.066 . . . . 0.0 111.079 164.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.44 -26.62 66.88 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 165.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -68.15 0.78 10.31 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.449 1.976 . . . . 0.0 114.954 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 9.0 t -63.14 -31.87 73.12 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.711 1.756 . . . . 0.0 112.12 165.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.22 -47.58 0.06 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.315 1.446 . . . . 0.0 113.057 164.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 24.4 m -71.74 43.18 0.09 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 128.52 2.728 . . . . 0.0 112.513 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -49.01 -36.52 17.93 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 130.592 3.557 . . . . 0.0 113.53 -170.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -120.35 -36.8 3.15 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 124.374 1.046 . . . . 0.0 112.195 175.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 40.7 t -56.44 -59.42 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.437 1.095 . . . . 0.0 110.852 176.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -74.65 -35.83 50.17 Favored Glycine 0 C--O 1.222 -0.595 0 C-N-CA 124.84 1.21 . . . . 0.0 112.258 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.59 -47.8 75.87 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.956 1.378 . . . . 0.0 112.472 172.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . 0.42 ' CZ2' ' HD2' ' A' ' 192' ' ' ARG . 67.2 t-105 -75.27 -41.02 58.15 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -56.42 -54.53 35.34 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -69.8 -30.62 68.2 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.828 1.314 . . . . 0.0 113.656 -174.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 38.6 tp -62.36 -31.31 71.95 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.631 0.65 . . . . 0.0 112.208 169.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . 0.42 ' HD2' ' CZ2' ' A' ' 188' ' ' TRP . 34.2 mtp-105 -92.3 -13.66 30.0 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 172.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -82.3 -16.47 49.25 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.598 1.159 . . . . 0.0 112.68 163.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -78.5 62.01 3.01 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.305 1.842 . . . . 0.0 112.082 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -93.56 -22.51 18.78 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 128.444 2.698 . . . . 0.0 115.652 -170.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -58.57 152.46 45.59 Favored Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 125.432 1.493 . . . . 0.0 112.03 -175.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -50.37 -41.96 49.62 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.904 2.403 . . . . 0.0 114.049 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 10.9 tp -61.86 -41.12 89.52 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 118.524 0.602 . . . . 0.0 112.163 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 18.8 m -68.45 -28.85 67.41 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.812 1.245 . . . . 0.0 111.574 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 36.0 mm -75.4 -42.13 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.883 0.873 . . . . 0.0 111.116 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 94.1 mt -58.84 -50.32 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 118.862 0.755 . . . . 0.0 110.071 171.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -59.18 -39.04 81.29 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.912 2.485 . . . . 0.0 112.243 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 54.9 tp -61.99 -51.7 66.98 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.767 1.227 . . . . 0.0 112.987 169.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 71.1 mt -65.89 -41.41 89.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.374 -0.829 . . . . 0.0 109.92 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 69.6 t -74.13 -35.32 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 125.244 1.418 . . . . 0.0 113.45 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.6 p -65.24 -35.67 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 120.908 1.685 . . . . 0.0 110.859 172.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 89.3 t -72.35 -42.58 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 117.934 -1.032 . . . . 0.0 109.617 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -55.54 -41.12 72.76 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.173 0.897 . . . . 0.0 112.16 170.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.8 t -62.39 -43.09 99.65 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.432 1.093 . . . . 0.0 112.835 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 30.2 mmt -70.35 -37.89 74.71 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.612 0.765 . . . . 0.0 111.424 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.39 -48.12 89.64 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 O-C-N 121.799 -0.563 . . . . 0.0 109.994 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.517 HG21 ' HB3' ' A' ' 225' ' ' SER . 30.0 m -75.52 -34.65 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 O-C-N 121.663 -0.648 . . . . 0.0 112.374 -171.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.66 -21.01 66.51 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.253 -0.905 . . . . 0.0 112.088 170.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 57.6 m -85.56 -38.62 18.29 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.697 1.599 . . . . 0.0 113.6 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 24.3 t -56.86 -37.46 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.338 1.055 . . . . 0.0 108.863 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 134.58 146.63 5.43 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 109.014 -1.635 . . . . 0.0 109.014 175.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 98.4 p -60.2 15.54 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.14 116.17 4.92 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 127.877 2.471 . . . . 0.0 111.56 -176.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.641 ' H ' ' H ' ' A' ' 221' ' ' VAL . . . -97.76 -88.73 1.89 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 104.908 -3.277 . . . . 0.0 104.908 92.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 78.49 -51.58 0.48 Allowed 'General case' 0 N--CA 1.466 0.34 1 C-N-CA 132.674 4.39 . . . . 0.0 120.409 -21.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.641 ' H ' ' H ' ' A' ' 219' ' ' GLY . 54.0 t -87.02 -51.3 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 120.119 -1.613 . . . . 0.0 110.203 -164.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -56.7 -36.14 69.32 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.815 -0.553 . . . . 0.0 111.941 167.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.45 -55.14 38.86 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 118.554 -0.736 . . . . 0.0 110.81 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.94 -36.22 83.67 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 120.742 1.61 . . . . 0.0 113.061 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.517 ' HB3' HG21 ' A' ' 212' ' ' VAL . 13.9 t -71.48 -43.61 66.27 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.386 1.448 . . . . 0.0 110.756 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.79 -53.61 55.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.847 0.459 . . . . 0.0 110.371 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 80.9 mt -63.48 -81.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 122.726 1.251 . . . . 0.0 109.517 173.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 -75.74 -14.62 60.33 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 124.793 1.237 . . . . 0.0 113.012 -157.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -95.26 -55.79 1.34 Allowed Glycine 0 CA--C 1.534 1.256 0 CA-C-N 118.701 0.682 . . . . 0.0 114.151 160.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.95 -39.95 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 120.745 -1.444 . . . . 0.0 112.156 -166.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 2.1 tpp85 -60.71 -35.01 75.25 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 119.573 1.079 . . . . 0.0 110.417 168.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.15 -36.96 84.51 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.215 1.406 . . . . 0.0 112.42 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 29.8 tp -64.46 -23.68 67.36 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 117.915 -1.04 . . . . 0.0 111.607 168.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -80.54 -44.87 18.36 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.913 1.688 . . . . 0.0 112.923 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -20.02 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.491 -1.38 . . . . 0.0 112.461 169.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 52.1 tp -71.02 -30.53 66.76 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.194 0.521 . . . . 0.0 111.888 174.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.5 ' HA ' ' CD2' ' A' ' 240' ' ' HIS . 19.7 mtp180 -70.32 -25.43 63.3 Favored 'General case' 0 C--O 1.212 -0.9 0 C-N-CA 124.866 1.267 . . . . 0.0 112.617 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 68.0 mtp -54.03 -23.97 15.4 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 160.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 6.1 mt -115.47 -35.39 4.61 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.873 -166.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . 0.5 ' CD2' ' HA ' ' A' ' 237' ' ' ARG . 5.6 p80 -75.72 -36.61 59.92 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.631 0.65 . . . . 0.0 111.354 164.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.366 5.6 p . . . . . 0 N--CA 1.468 0.468 0 C-N-CA 129.576 3.15 . . . . 0.0 115.148 164.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 . . . . . 0 N--CA 1.466 0.327 0 CA-C-O 118.714 -0.66 . . . . 0.0 111.735 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.5 p -66.95 -20.15 65.85 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.06 0.944 . . . . 0.0 112.025 172.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -79.09 -50.52 10.91 Favored 'General case' 0 CA--C 1.507 -0.704 0 O-C-N 121.416 -0.803 . . . . 0.0 109.042 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.5 m -76.21 -38.72 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.374 0.67 . . . . 0.0 110.749 -173.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -68.17 -32.97 73.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.533 172.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.1 -30.16 70.0 Favored Glycine 0 C--N 1.34 0.766 0 O-C-N 120.831 -1.168 . . . . 0.0 112.343 170.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -68.22 -46.6 70.14 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 126.377 1.871 . . . . 0.0 111.301 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.0 t -54.71 -54.09 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.297 1.039 . . . . 0.0 109.639 167.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -55.53 -48.16 75.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.662 -0.685 . . . . 0.0 112.377 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -64.75 -25.35 67.89 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.544 1.065 . . . . 0.0 113.518 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -77.41 -40.99 41.68 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.29 1.036 . . . . 0.0 110.344 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.2 mt -60.44 -40.58 91.66 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 120.787 -1.196 . . . . 0.0 110.829 167.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -78.78 -41.09 31.39 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.499 -162.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -116.95 145.69 36.17 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 124.198 0.999 . . . . 0.0 111.299 -173.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.4 155.82 36.65 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.587 2.192 . . . . 0.0 111.899 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.445 ' H ' ' HB3' ' A' ' 121' ' ' LYS . 46.9 p -147.95 169.56 19.6 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.143 1.777 . . . . 0.0 107.568 163.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.07 -31.28 48.23 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.013 -0.882 . . . . 0.0 113.197 170.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -79.83 -45.43 18.74 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 170.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.445 ' HB3' ' H ' ' A' ' 118' ' ' THR . 0.9 OUTLIER -58.82 -52.7 64.59 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.141 0.882 . . . . 0.0 110.045 -178.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 43.8 t -62.72 -38.64 91.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.106 0.562 . . . . 0.0 111.915 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -57.73 -57.97 10.4 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.608 0.64 . . . . 0.0 111.495 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.4 m -74.36 -44.99 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -172.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -87.12 -36.77 17.91 Favored 'General case' 0 C--O 1.226 -0.133 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -164.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -65.35 -30.57 71.41 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.066 1.303 . . . . 0.0 111.033 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.39 -39.28 78.07 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 167.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.23 -45.47 79.94 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 167.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.8 m -64.58 -39.17 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-N 121.423 1.92 . . . . 0.0 111.789 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -54.44 -45.79 73.13 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.868 0.867 . . . . 0.0 112.292 170.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.7 mt -67.19 -39.58 86.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 118.46 -0.781 . . . . 0.0 113.025 174.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.51 -43.69 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 119.812 1.187 . . . . 0.0 110.877 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.36 -40.92 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-N 121.197 1.817 . . . . 0.0 112.646 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.9 tp -52.51 -52.11 56.22 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.066 1.746 . . . . 0.0 111.765 168.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 37.9 t -63.27 -39.57 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.985 0.914 . . . . 0.0 111.081 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 65.7 m -60.5 -44.72 95.68 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.937 0.895 . . . . 0.0 113.379 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.65 -31.94 47.02 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 120.442 1.474 . . . . 0.0 111.93 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 59.0 mt -56.62 -47.6 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.509 0.723 . . . . 0.0 110.305 167.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -57.81 -49.35 76.94 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 117.322 -1.323 . . . . 0.0 110.999 170.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 73.6 m -49.6 -40.9 40.56 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 120.067 1.303 . . . . 0.0 114.061 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.5 -48.5 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.0 0.52 . . . . 0.0 110.797 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.2 tp -72.61 -44.23 62.24 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.862 0.865 . . . . 0.0 112.89 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 55.9 p -78.89 -30.15 44.79 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -155.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.2 t -75.27 -1.81 25.22 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.733 1.152 . . . . 0.0 111.86 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.4 mm -102.51 -34.48 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 126.18 1.792 . . . . 0.0 113.231 163.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -56.77 -27.53 59.78 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.891 -1.131 . . . . 0.0 111.892 164.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -58.88 -42.86 90.47 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 129.002 2.921 . . . . 0.0 112.066 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 17.1 m-30 -74.76 -31.1 61.68 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.876 0.762 . . . . 0.0 111.073 176.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.68 -41.22 96.22 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.58 -0.7 . . . . 0.0 111.407 169.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.25 -13.47 28.39 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.46 1.504 . . . . 0.0 114.888 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.6 mt -64.53 -23.64 67.34 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.572 1.149 . . . . 0.0 113.277 168.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.49 -49.68 0.13 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -155.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.4 p -122.15 177.84 5.17 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.518 1.927 . . . . 0.0 109.011 -163.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.35 154.39 47.88 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.448 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.8 t -156.13 158.38 37.59 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.864 1.266 . . . . 0.0 111.123 -163.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.9 mt -94.68 3.43 55.07 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.967 1.307 . . . . 0.0 113.81 166.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -65.05 -4.58 4.89 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 120.036 1.289 . . . . 0.0 114.188 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -72.73 -30.56 64.28 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.781 -1.199 . . . . 0.0 111.822 166.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 47.6 tpp -73.02 -32.17 64.93 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.268 1.027 . . . . 0.0 111.355 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.21 -51.27 69.68 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.553 -0.717 . . . . 0.0 110.341 165.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.1 mt -53.99 -40.21 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 118.787 -0.625 . . . . 0.0 112.028 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.9 t -56.34 -48.16 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 120.293 1.406 . . . . 0.0 112.127 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 11.4 mt -71.11 -33.78 70.48 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.074 1.306 . . . . 0.0 113.08 176.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 26.5 t -61.73 -39.43 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 120.596 1.543 . . . . 0.0 111.743 172.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 68.0 t -75.01 -33.1 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.834 1.254 . . . . 0.0 110.651 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -62.56 -42.68 99.7 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 117.981 -1.009 . . . . 0.0 112.296 165.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -65.01 -46.25 82.14 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.536 1.516 . . . . 0.0 111.918 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.13 -37.96 74.44 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-N 119.282 0.946 . . . . 0.0 112.779 171.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.6 m -67.2 -39.53 86.33 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -60.41 -40.64 91.7 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.934 1.294 . . . . 0.0 111.629 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -54.24 -51.94 62.93 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 172.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 26.9 m -73.64 -31.73 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 23.1 t -63.48 -33.55 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 119.337 0.971 . . . . 0.0 112.144 173.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -60.94 -41.4 96.17 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 120.951 -1.093 . . . . 0.0 111.81 167.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 41.4 mt -69.97 -25.24 63.53 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -82.03 -40.44 22.07 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.999 0.92 . . . . 0.0 112.907 173.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 79.1 p -70.32 6.13 1.47 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 116.817 2.154 . . . . 0.0 116.817 160.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.526 ' HB2' ' HD2' ' A' ' 190' ' ' ARG . . . -51.78 -37.69 52.52 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.216 0.916 . . . . 0.0 111.514 160.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 167.22 30.99 0.02 OUTLIER Glycine 0 C--N 1.341 0.847 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 175.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 18.1 t 63.1 -67.42 0.09 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.871 2.068 . . . . 0.0 115.121 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -35.8 79.47 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.721 2.008 . . . . 0.0 111.022 170.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.46 ' HB2' ' H ' ' A' ' 186' ' ' GLY . 82.4 p -72.56 25.12 0.05 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 -175.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -53.53 -23.48 10.64 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 128.107 2.563 . . . . 0.0 116.293 -171.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -118.63 -37.23 3.32 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.2 1.4 . . . . 0.0 111.826 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 85.8 t -65.81 -68.94 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.436 1.494 . . . . 0.0 111.378 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.46 ' H ' ' HB2' ' A' ' 182' ' ' SER . . . -70.69 -23.97 77.33 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.699 1.619 . . . . 0.0 112.881 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.7 tt -51.07 -52.3 44.75 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.073 1.437 . . . . 0.0 110.087 164.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 35.1 t-105 -74.03 -44.72 53.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.23 0.538 . . . . 0.0 112.432 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -59.52 -45.17 96.01 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.885 0.755 . . . . 0.0 113.07 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.526 ' HD2' ' HB2' ' A' ' 178' ' ' ALA . 7.3 ptm180 -68.95 -33.1 73.16 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 118.44 1.12 . . . . 0.0 112.129 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 25.5 tp -74.96 -29.52 60.95 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.973 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 36.4 mtp-105 -80.17 -31.68 38.85 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.27 1.428 . . . . 0.0 113.097 171.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -64.02 -38.21 90.23 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.882 1.273 . . . . 0.0 111.173 171.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -82.97 58.81 4.56 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.123 1.369 . . . . 0.0 112.237 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.74 -28.95 66.36 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 120.773 -1.205 . . . . 0.0 112.56 169.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 197' ' ' PRO . 16.2 ptpt -49.6 147.19 6.26 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 127.877 2.471 . . . . 0.0 116.268 -173.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 196' ' ' LYS . 87.1 Cg_exo -57.33 -39.61 88.3 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.821 2.347 . . . . 0.0 116.488 -163.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 93.9 mt -67.72 -30.33 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 O-C-N 120.894 -1.129 . . . . 0.0 111.329 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.7 t -68.17 -31.56 71.19 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.06 1.3 . . . . 0.0 111.652 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 34.6 mm -70.35 -43.22 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.383 1.073 . . . . 0.0 111.49 171.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.83 -37.05 77.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.031 0.532 . . . . 0.0 111.445 173.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -74.87 -38.99 61.79 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.319 1.848 . . . . 0.0 110.729 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 20.3 tp -57.71 -48.4 79.69 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.272 1.029 . . . . 0.0 111.072 166.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 76.4 mt -69.43 -37.21 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 121.839 -0.538 . . . . 0.0 111.284 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.6 t -75.3 -33.41 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-N 119.918 1.235 . . . . 0.0 112.58 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 4.4 p -67.43 -34.2 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 120.615 1.552 . . . . 0.0 110.685 170.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 78.1 t -72.76 -39.52 59.93 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-O 117.936 -1.031 . . . . 0.0 110.115 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.61 -45.47 85.3 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 119.106 0.867 . . . . 0.0 110.41 170.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 30.2 t -62.95 -48.82 77.24 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.549 1.14 . . . . 0.0 111.851 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 75.2 mtm -55.58 -51.43 67.13 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.837 1.255 . . . . 0.0 111.004 168.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 9.5 t -59.09 -47.08 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 118.972 0.806 . . . . 0.0 111.295 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 222' ' ' PHE . 33.5 m -75.71 -41.56 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 119.403 1.001 . . . . 0.0 111.845 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.6 pp -63.31 -23.81 67.58 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.719 1.145 . . . . 0.0 111.601 171.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 19.2 m -77.8 -44.89 26.08 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.83 1.252 . . . . 0.0 112.929 173.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.73 -38.04 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.157 1.783 . . . . 0.0 109.476 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 218' ' ' LYS . . . 142.31 162.33 9.17 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 125.909 1.719 . . . . 0.0 110.029 172.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 60.5 p -70.62 18.23 0.06 Allowed 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 216' ' ' GLY . 5.8 mtmt -173.15 175.67 3.13 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 131.514 3.926 . . . . 0.0 108.937 -172.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 66.81 105.96 0.02 OUTLIER Glycine 0 N--CA 1.436 -1.3 0 N-CA-C 106.176 -2.77 . . . . 0.0 106.176 -115.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -56.4 -5.66 0.22 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.492 1.517 . . . . 0.0 113.276 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 18.1 m -68.79 -38.12 78.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 125.421 1.489 . . . . 0.0 110.507 172.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.457 ' HA ' ' HB ' ' A' ' 212' ' ' VAL . 0.8 OUTLIER -56.53 -49.77 73.79 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.348 166.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.92 -54.76 43.52 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.3 t -69.05 -30.74 69.15 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 34.1 t -74.29 -41.77 60.65 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.627 -1.295 . . . . 0.0 111.076 175.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.85 -62.13 1.91 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.114 0.966 . . . . 0.0 109.083 173.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 38.6 mt -57.26 -83.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.503 1.121 . . . . 0.0 109.79 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -65.32 -50.11 66.89 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-O 116.85 -1.548 . . . . 0.0 109.606 -163.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -54.56 -56.5 21.85 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 120.247 1.385 . . . . 0.0 113.281 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.8 -34.89 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 118.024 0.912 . . . . 0.0 111.639 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -77.8 -26.96 49.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.573 -1.329 . . . . 0.0 113.78 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -60.37 -42.29 95.51 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.782 1.633 . . . . 0.0 107.666 174.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 15.5 tp -62.9 -33.85 76.18 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.413 174.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -75.47 -43.49 49.08 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 120.87 1.668 . . . . 0.0 112.815 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 45.0 pt -66.35 -6.63 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 169.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 48.2 tp -95.9 -35.3 11.51 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.485 1.514 . . . . 0.0 111.137 171.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -63.52 -35.61 81.04 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.966 1.307 . . . . 0.0 110.121 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 61.3 tpp -34.07 -33.97 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 129.342 3.057 . . . . 0.0 116.702 156.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 49.9 mt -111.64 -13.32 13.79 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.859 1.663 . . . . 0.0 111.983 -171.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.3 3.5 54.43 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.83 0.852 . . . . 0.0 113.201 160.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 CA--C 1.511 -0.521 0 C-N-CA 127.161 2.184 . . . . 0.0 111.667 -164.14 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.7 t -80.87 -26.19 37.1 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.335 -0.853 . . . . 0.0 113.268 166.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -75.13 -27.17 59.69 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 119.568 -1.957 . . . . 0.0 111.885 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 23.3 m -85.31 2.55 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 126.12 1.768 . . . . 0.0 113.435 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -111.66 -45.61 3.34 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 127.575 2.35 . . . . 0.0 108.052 170.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.09 -20.29 8.73 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.509 1.528 . . . . 0.0 115.393 161.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . 0.261 25.0 ptt180 -73.22 -37.32 66.45 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.327 1.564 . . . . 0.0 110.455 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.7 t -58.88 -47.88 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.758 1.223 . . . . 0.0 110.541 168.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -66.91 -54.64 20.15 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.413 1.085 . . . . 0.0 111.447 -174.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -62.3 -25.29 67.79 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.81 -1.181 . . . . 0.0 112.719 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -75.76 -41.76 52.24 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.317 1.417 . . . . 0.0 110.375 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 pp -75.4 -22.51 57.39 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -125.16 -9.72 7.06 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -166.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -109.55 118.63 50.07 Favored Pre-proline 0 N--CA 1.473 0.722 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 161.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -61.47 137.77 71.8 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 121.697 1.598 . . . . 0.0 113.307 -171.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -151.85 143.3 23.46 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.671 1.189 . . . . 0.0 107.973 173.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.21 -28.76 50.75 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.904 -0.387 . . . . 0.0 112.59 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -67.37 -32.92 74.17 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 172.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -61.25 -48.76 79.98 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.559 1.072 . . . . 0.0 108.203 168.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 35.6 m -64.49 -40.41 95.61 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.415 0.686 . . . . 0.0 112.147 -174.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -56.64 -67.52 0.3 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.107 0.963 . . . . 0.0 111.214 173.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.7 p -79.67 -38.26 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 121.009 -1.057 . . . . 0.0 113.627 -168.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -73.12 -42.96 62.34 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.38 -0.825 . . . . 0.0 112.067 -170.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -71.52 -26.73 62.78 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -68.19 -49.4 61.1 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.196 -0.94 . . . . 0.0 111.989 166.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -51.3 -40.15 58.37 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 117.514 -1.231 . . . . 0.0 114.232 173.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . 0.289 2.9 m -62.97 -43.38 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 121.174 1.806 . . . . 0.0 112.634 174.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -67.85 -39.25 83.81 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.737 0.699 . . . . 0.0 112.548 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 73.4 mt -56.39 -54.87 40.52 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 118.624 -0.703 . . . . 0.0 110.366 169.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -53.87 -49.89 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.456 0.703 . . . . 0.0 112.011 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.4 p -66.13 -42.97 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 119.837 1.198 . . . . 0.0 113.09 -171.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 35.6 tp -70.38 -45.4 66.12 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.051 0.94 . . . . 0.0 111.567 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 32.2 m -65.08 -38.51 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 119.86 1.209 . . . . 0.0 111.901 176.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 98.4 m -66.83 -34.15 77.18 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.66 -0.686 . . . . 0.0 112.799 174.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.7 mt -74.42 -37.59 63.3 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.651 1.569 . . . . 0.0 112.516 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 52.2 mt -61.87 -46.6 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.312 0.96 . . . . 0.0 110.72 169.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -62.34 -27.17 68.87 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 117.866 -1.064 . . . . 0.0 112.343 171.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.7 m -65.68 -31.1 71.92 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 121.019 1.736 . . . . 0.0 113.166 173.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.33 -35.84 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.113 0.565 . . . . 0.0 110.699 172.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.0 tp -74.28 -50.69 17.85 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.296 0.953 . . . . 0.0 112.391 169.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.7 p -67.19 -27.13 67.01 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 120.377 -1.452 . . . . 0.0 113.273 -166.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.0 t -68.6 -22.85 64.42 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 176.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 17.9 pt -95.32 -31.41 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.946 1.248 . . . . 0.0 113.187 169.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -59.7 -26.57 65.7 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 121.021 -1.049 . . . . 0.0 111.281 164.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -60.57 -30.21 69.65 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.929 2.092 . . . . 0.0 113.093 167.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -87.9 -26.34 22.78 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.817 -1.177 . . . . 0.0 110.856 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.08 -40.2 94.32 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.149 0.579 . . . . 0.0 111.637 166.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.31 -15.22 23.36 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.632 1.573 . . . . 0.0 114.869 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.5 mt -59.15 -31.63 69.15 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.807 -1.183 . . . . 0.0 112.69 167.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.86 -43.83 0.21 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -153.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 82.8 p -134.09 152.83 52.01 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.163 1.385 . . . . 0.0 109.976 -155.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -75.4 128.93 10.12 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 121.289 -0.882 . . . . 0.0 112.582 -170.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.3 t -144.46 148.61 34.78 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -155.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.3 mt -56.4 4.28 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.568 2.347 . . . . 0.0 114.88 166.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -62.12 -13.94 31.93 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 120.975 1.716 . . . . 0.0 112.803 163.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 18.0 p-90 -59.37 -29.8 67.95 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.092 -1.63 . . . . 0.0 112.233 163.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 10.7 tpt -76.83 -25.55 53.34 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.335 0.97 . . . . 0.0 112.804 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -61.0 -48.82 80.06 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.788 -1.195 . . . . 0.0 109.404 162.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.82 -37.62 72.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 122.993 0.517 . . . . 0.0 111.583 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 64.0 t -60.93 -51.92 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 120.948 -1.095 . . . . 0.0 112.293 173.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 11.5 mt -69.98 -30.44 67.79 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.119 -0.988 . . . . 0.0 112.355 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 22.7 t -58.17 -38.17 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.698 1.136 . . . . 0.0 109.958 169.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 64.7 t -75.22 -29.7 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 118.104 -0.951 . . . . 0.0 111.11 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -66.6 -51.03 60.83 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 121.011 1.732 . . . . 0.0 112.933 170.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -60.65 -46.46 90.24 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.198 0.908 . . . . 0.0 111.37 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.96 -40.89 93.94 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.974 0.797 . . . . 0.0 113.15 173.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 55.5 m -66.96 -40.01 87.38 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.738 -0.86 . . . . 0.0 111.453 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -62.4 -41.38 98.63 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.303 0.956 . . . . 0.0 111.738 173.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -55.65 -45.67 77.63 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.646 0.657 . . . . 0.0 111.5 170.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 69.1 t -67.31 -41.89 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.188 -0.945 . . . . 0.0 113.13 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 25.8 t -62.28 -38.16 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.452 1.501 . . . . 0.0 112.337 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -55.91 -45.14 78.78 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.487 0.715 . . . . 0.0 111.811 168.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 21.8 mt -67.0 -40.3 87.32 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 178.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -65.81 -30.8 71.49 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.5 t -69.79 -21.16 63.43 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 173.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.1 -14.58 25.24 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 170.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -158.07 51.25 0.41 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 124.972 1.272 . . . . 0.0 110.505 -161.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 35.1 t -45.2 -31.07 1.34 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.225 1.81 . . . . 0.0 112.643 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.19 -59.45 1.73 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.172 1.789 . . . . 0.0 111.656 159.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 55.1 p -70.98 -16.1 62.62 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.906 1.282 . . . . 0.0 113.776 -156.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 59.8 pttt 47.01 -59.55 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.361 1 C-N-CA 133.464 4.706 . . . . 0.0 115.868 172.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -93.84 -29.21 15.44 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 124.68 1.192 . . . . 0.0 112.011 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.19 -54.32 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 166.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.1 -70.46 0.85 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 126.973 2.225 . . . . 0.0 112.362 176.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.4 tt -52.0 -42.07 62.69 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.33 1.452 . . . . 0.0 112.584 -170.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 44.6 t-105 -75.4 -46.36 33.35 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -172.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -64.19 -36.76 93.64 Favored Glycine 0 N--CA 1.48 1.568 0 O-C-N 121.641 -0.662 . . . . 0.0 112.501 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -61.16 -44.61 97.04 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 127.178 2.191 . . . . 0.0 112.167 168.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 25.7 tp -68.31 -32.58 72.82 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.608 0.64 . . . . 0.0 112.451 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -67.1 -18.57 65.38 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.108 -0.995 . . . . 0.0 113.213 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -67.49 -3.71 9.36 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.118 1.367 . . . . 0.0 114.301 167.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.31 83.47 0.55 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.53 1.532 . . . . 0.0 110.43 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.7 ttt85 -149.92 -37.67 0.15 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -164.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -68.89 151.25 97.35 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 123.974 0.91 . . . . 0.0 109.906 168.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -51.26 -46.85 28.85 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 CA-C-N 121.534 1.583 . . . . 0.0 115.488 -170.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 17.5 tt -62.99 -36.23 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 119.422 1.01 . . . . 0.0 113.501 176.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 95.5 p -82.93 -25.85 32.0 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.148 1.34 . . . . 0.0 111.231 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 15.1 mm -63.19 -49.1 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.8 0.84 . . . . 0.0 110.026 160.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 21.2 mm -59.36 -41.61 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.539 -0.726 . . . . 0.0 111.376 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -69.71 -35.24 74.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.587 1.555 . . . . 0.0 111.43 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.3 tp -64.21 -49.2 72.9 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.088 0.555 . . . . 0.0 110.696 171.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 59.5 mt -61.5 -40.95 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 121.653 -0.654 . . . . 0.0 110.154 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.434 ' HA ' ' HB3' ' A' ' 208' ' ' ALA . 73.5 t -78.92 -22.65 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 117.605 -1.188 . . . . 0.0 113.779 -176.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.46 -32.21 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 122.316 2.325 . . . . 0.0 110.344 166.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 46.0 t -81.17 -29.69 11.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 O-C-N 120.951 -1.093 . . . . 0.0 109.51 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.434 ' HB3' ' HA ' ' A' ' 205' ' ' VAL . . . -58.38 -42.79 87.84 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.805 -0.559 . . . . 0.0 111.511 161.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.1 m -61.3 -36.99 81.62 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.948 0.899 . . . . 0.0 111.843 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 55.6 mtt -64.46 -54.19 36.44 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.523 1.129 . . . . 0.0 111.0 166.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 30.4 t -56.63 -38.39 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 119.771 1.168 . . . . 0.0 112.237 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 28.4 t -53.53 -52.61 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 126.293 1.837 . . . . 0.0 111.396 171.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.87 -15.46 44.57 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.078 0.951 . . . . 0.0 113.294 -175.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 93.2 m -102.68 -56.25 2.28 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.52 1.528 . . . . 0.0 114.4 -171.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 25.4 t -56.88 -38.75 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-N 119.521 1.055 . . . . 0.0 112.025 -175.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 164.21 -116.55 0.71 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.037 1.303 . . . . 0.0 110.288 168.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 77.3 p -164.17 34.64 0.08 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.436 1.094 . . . . 0.0 113.063 -174.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -169.45 168.75 9.29 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.97 2.108 . . . . 0.0 110.709 -174.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -67.36 -49.78 49.3 Favored Glycine 0 N--CA 1.473 1.139 0 C-N-CA 127.556 2.503 . . . . 0.0 112.461 -10.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -144.62 4.9 1.18 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.364 1.066 . . . . 0.0 113.775 170.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 15.2 t -73.55 -42.88 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 120.155 1.343 . . . . 0.0 111.493 -170.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -47.28 -45.91 24.45 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.933 1.293 . . . . 0.0 112.394 164.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.38 -54.68 9.9 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.833 1.253 . . . . 0.0 111.214 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.11 -35.74 81.28 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 121.113 -0.992 . . . . 0.0 111.885 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 18.0 m -69.17 -45.65 69.48 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.485 1.493 . . . . 0.0 110.884 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -52.87 -52.37 57.63 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.615 -0.678 . . . . 0.0 111.412 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 227' ' ' ILE . 72.6 mt -67.08 -84.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 123.392 1.568 . . . . 0.0 110.269 175.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -76.36 10.04 2.28 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 128.145 2.578 . . . . 0.0 113.338 -167.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -117.84 -63.64 0.31 Allowed Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 166.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 18.2 mt -79.57 -37.44 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 118.482 1.141 . . . . 0.0 111.374 -171.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.72 -41.59 87.67 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.862 1.21 . . . . 0.0 109.771 174.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -63.32 -33.25 75.12 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.057 2.143 . . . . 0.0 113.521 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 23.4 tp -63.87 -33.41 75.62 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.344 1.058 . . . . 0.0 111.654 165.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -69.08 -37.54 78.53 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.715 1.598 . . . . 0.0 114.289 -175.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -19.69 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.255 -0.903 . . . . 0.0 113.094 175.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 37.7 mt -72.99 -23.67 60.67 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.974 0.893 . . . . 0.0 110.539 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -83.12 -18.45 39.46 Favored 'General case' 0 C--O 1.216 -0.708 0 C-N-CA 124.386 1.074 . . . . 0.0 112.816 -167.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -24.76 -40.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 128.587 2.755 . . . . 0.0 114.779 143.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 16.6 mt -99.99 -28.24 13.18 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.258 1.423 . . . . 0.0 110.717 -172.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -75.58 9.78 2.06 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 158.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.303 4.2 t . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 124.779 2.228 . . . . 0.0 110.409 150.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.569 ' HA ' HG22 ' A' ' 106' ' ' VAL 0.265 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.229 0.062 . . . . 0.0 110.97 . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -58.09 -40.13 80.32 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.352 1.461 . . . . 0.0 114.634 165.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -78.25 -51.38 10.25 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 126.119 1.768 . . . . 0.0 109.743 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.569 HG22 ' HA ' ' A' ' 103' ' ' ARG . 35.0 m -81.04 -21.15 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -157.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -73.69 -29.3 62.2 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.199 0.599 . . . . 0.0 110.802 166.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.12 -32.82 60.02 Favored Glycine 0 CA--C 1.525 0.696 0 O-C-N 121.097 -1.002 . . . . 0.0 111.552 167.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -63.34 -40.19 96.62 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.117 1.367 . . . . 0.0 111.256 175.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.2 t -60.51 -55.36 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.53 1.932 . . . . 0.0 110.98 168.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -62.44 -22.54 66.28 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.407 1.083 . . . . 0.0 113.803 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -84.8 -34.18 22.8 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.824 1.25 . . . . 0.0 111.913 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -74.09 -43.34 58.01 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.136 -0.977 . . . . 0.0 112.814 -176.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.25 -20.98 64.85 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 176.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -101.88 -24.51 14.02 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 125.046 1.338 . . . . 0.0 112.676 -171.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.4 mtm105 -91.74 107.68 24.13 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 124.363 1.065 . . . . 0.0 109.928 165.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -65.29 127.13 17.59 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.904 1.736 . . . . 0.0 109.091 166.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 82.2 p -139.44 178.61 7.08 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.271 1.029 . . . . 0.0 109.091 176.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.82 -30.03 62.47 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 121.912 -0.493 . . . . 0.0 112.597 165.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -78.54 -43.42 26.77 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -60.27 -40.3 89.9 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.342 0.973 . . . . 0.0 109.746 170.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 49.7 t -61.43 -54.36 44.58 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.26 1.024 . . . . 0.0 112.294 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -53.62 -49.64 67.39 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.364 1.066 . . . . 0.0 111.89 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.0 p -85.81 -47.23 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -73.21 -39.27 65.66 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.998 0.817 . . . . 0.0 111.858 -163.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -80.3 -27.99 38.36 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 120.852 -1.155 . . . . 0.0 112.788 -173.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -70.39 -35.59 73.58 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.816 0.734 . . . . 0.0 111.122 164.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.97 -44.68 87.22 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 119.923 1.238 . . . . 0.0 113.218 168.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.43 -35.56 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 121.7 2.046 . . . . 0.0 113.235 176.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -68.02 -47.61 67.96 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.222 1.009 . . . . 0.0 112.077 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 62.9 mt -62.78 -47.84 81.72 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.459 0.704 . . . . 0.0 111.435 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 84.7 mt -61.99 -34.48 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 118.11 -0.948 . . . . 0.0 111.253 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.7 t -74.89 -34.07 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 120.781 1.628 . . . . 0.0 114.273 177.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 28.2 mt -59.44 -48.22 82.49 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.447 1.476 . . . . 0.0 110.535 167.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.5 t -55.89 -53.67 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 118.348 0.522 . . . . 0.0 110.23 172.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 60.8 m -61.62 -46.09 91.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.988 -173.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.9 mt -72.31 -40.91 67.13 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.679 1.127 . . . . 0.0 112.58 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.53 -42.35 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.366 0.666 . . . . 0.0 110.557 174.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -68.5 -33.29 73.88 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.384 -0.823 . . . . 0.0 111.99 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 t -58.08 -40.71 81.79 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.928 0.891 . . . . 0.0 111.716 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.33 -53.01 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.386 1.074 . . . . 0.0 110.299 174.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.9 tp -55.6 -50.44 70.1 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.014 0.526 . . . . 0.0 111.714 171.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 68.7 m -57.42 -23.53 50.08 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 116.172 1.915 . . . . 0.0 116.172 -174.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.4 t -109.44 -5.46 15.78 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.367 0.985 . . . . 0.0 112.845 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.7 tp -85.03 -36.08 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 O-C-N 121.554 -0.716 . . . . 0.0 111.344 149.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -71.95 -4.05 26.17 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 119.967 -1.708 . . . . 0.0 115.304 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -63.28 -34.09 76.93 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 120.72 -1.238 . . . . 0.0 112.58 169.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -74.52 -20.62 59.91 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.348 -0.845 . . . . 0.0 112.844 172.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.93 -45.22 43.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.956 0.903 . . . . 0.0 111.254 166.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -57.49 -28.67 63.63 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.747 1.219 . . . . 0.0 113.151 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.43 -35.45 73.39 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.196 1.398 . . . . 0.0 113.559 173.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -97.56 -47.91 5.47 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.993 2.117 . . . . 0.0 114.124 -168.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 69.7 p -149.52 -169.05 3.27 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.469 2.308 . . . . 0.0 109.006 -159.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -77.62 169.69 54.8 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.323 -0.861 . . . . 0.0 112.828 159.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.452 HG23 ' HB3' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -170.28 152.35 4.1 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.411 1.885 . . . . 0.0 110.887 -176.266 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.0 mt -52.59 -14.82 0.56 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.039 1.736 . . . . 0.0 114.368 172.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.452 ' HB3' HG23 ' A' ' 155' ' ' THR . 58.1 t80 -49.38 -15.9 0.16 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.823 1.649 . . . . 0.0 114.428 168.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 18.5 p-90 -57.22 -27.74 62.27 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.752 -1.217 . . . . 0.0 112.713 166.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 28.4 ttp -70.71 -20.77 62.63 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.197 -1.564 . . . . 0.0 112.067 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -64.65 -26.04 68.22 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.683 -1.26 . . . . 0.0 112.184 169.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 26.9 mt -70.17 -42.36 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.044 0.538 . . . . 0.0 109.575 172.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.41 -44.12 98.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.698 0.799 . . . . 0.0 111.372 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.04 -28.38 57.66 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.127 0.876 . . . . 0.0 113.262 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.6 t -60.11 -41.83 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 120.646 1.566 . . . . 0.0 110.46 165.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.57 -35.25 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 117.759 -1.115 . . . . 0.0 110.347 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -64.42 -53.6 45.83 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.874 1.67 . . . . 0.0 112.546 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -69.1 -24.3 64.11 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.2 1.364 . . . . 0.0 112.916 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -72.05 -47.11 32.63 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.543 1.068 . . . . 0.0 111.348 168.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.9 m -66.51 -36.25 82.26 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -62.56 -49.22 76.14 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 120.537 1.517 . . . . 0.0 110.874 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -51.69 -48.62 63.42 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.151 0.581 . . . . 0.0 111.896 172.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.58 -38.65 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.19 0.996 . . . . 0.0 113.239 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 14.4 t -61.86 -33.54 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.509 1.524 . . . . 0.0 111.56 173.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -63.23 -32.82 74.32 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.219 1.008 . . . . 0.0 112.393 170.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.405 ' HA ' ' HG2' ' A' ' 190' ' ' ARG . 23.4 mt -74.28 -35.46 63.75 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 173.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -70.6 -35.76 73.18 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.097 0.959 . . . . 0.0 113.42 173.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 83.6 p -68.22 -10.4 54.15 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 168.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.98 -15.27 20.93 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 120.05 1.296 . . . . 0.0 114.329 157.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 178.97 80.77 0.06 OUTLIER Glycine 0 C--N 1.343 0.964 0 CA-C-N 120.149 1.34 . . . . 0.0 115.674 -167.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 49.5 t -49.27 -27.3 3.67 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 117.759 0.779 . . . . 0.0 112.753 153.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.86 58.69 1.72 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.599 1.19 . . . . 0.0 111.94 157.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 21.2 p -162.65 50.16 0.18 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.198 159.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.449 ' HE2' ' CD2' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -61.13 -22.12 64.38 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -167.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.449 ' CD2' ' HE2' ' A' ' 183' ' ' LYS . 25.2 m-85 -105.46 -38.91 6.3 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 118.167 -0.921 . . . . 0.0 112.587 161.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -56.36 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 119.686 1.13 . . . . 0.0 111.408 -172.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -70.35 -43.08 63.65 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.56 -38.96 64.39 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.031 1.733 . . . . 0.0 111.947 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -70.79 -44.32 66.89 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.089 0.859 . . . . 0.0 112.296 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -66.74 -35.19 89.38 Favored Glycine 0 N--CA 1.476 1.354 0 O-C-N 121.259 -0.901 . . . . 0.0 112.283 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.405 ' HG2' ' HA ' ' A' ' 175' ' ' LEU . 7.5 tpp180 -65.67 -39.42 91.32 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 127.804 2.442 . . . . 0.0 112.942 172.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.498 HD11 HD13 ' A' ' 203' ' ' LEU . 23.6 tp -68.58 -33.37 73.95 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.864 -0.522 . . . . 0.0 111.827 173.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -73.05 -7.39 51.05 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -74.02 59.47 0.72 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.39 1.45 . . . . 0.0 110.214 163.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -142.66 76.58 1.54 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.86 2.864 . . . . 0.0 106.857 -169.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 44.8 mtp85 -137.89 -43.99 0.53 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.398 1.079 . . . . 0.0 111.472 -169.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -64.97 152.04 91.97 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 123.752 0.821 . . . . 0.0 110.434 167.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -54.1 -46.89 30.24 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.671 2.247 . . . . 0.0 112.827 -172.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.3 tt -58.21 -39.01 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.536 1.134 . . . . 0.0 113.981 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 78.7 p -87.63 -20.11 26.8 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 120.573 1.533 . . . . 0.0 112.633 -174.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 64.0 mt -72.39 -43.38 64.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 118.383 0.538 . . . . 0.0 110.509 159.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 43.5 mt -60.1 -39.58 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.238 1.015 . . . . 0.0 110.971 174.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -70.09 -39.69 75.41 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.782 1.633 . . . . 0.0 110.684 -178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.498 HD13 HD11 ' A' ' 191' ' ' LEU . 38.0 tp -61.51 -46.85 88.23 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.483 1.113 . . . . 0.0 112.707 169.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 54.1 mt -63.68 -41.76 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 O-C-N 120.685 -1.26 . . . . 0.0 110.411 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 31.6 t -66.27 -39.79 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 116.308 -1.806 . . . . 0.0 112.559 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.08 -33.06 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 122.212 2.278 . . . . 0.0 111.485 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.28 -46.12 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 123.373 0.669 . . . . 0.0 109.694 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -53.26 -48.14 68.53 Favored 'General case' 0 C--O 1.223 -0.342 0 C-N-CA 123.732 0.813 . . . . 0.0 110.797 169.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 34.3 t -59.84 -49.69 76.73 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.636 1.175 . . . . 0.0 112.947 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 15.0 tpt -70.85 -34.03 71.25 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 118.786 -0.626 . . . . 0.0 112.027 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.7 t -60.76 -50.99 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 120.38 1.446 . . . . 0.0 111.938 171.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.18 -33.09 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 119.461 1.028 . . . . 0.0 111.117 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 5.1 tp -58.38 -45.01 89.13 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.51 0.724 . . . . 0.0 111.211 165.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 59.4 m -69.69 -25.66 63.98 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.287 1.435 . . . . 0.0 114.706 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 52.1 t -64.02 -16.01 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.008 1.323 . . . . 0.0 110.95 166.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 94.13 114.29 2.52 Favored Glycine 0 C--N 1.332 0.35 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -165.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 66.3 p -62.3 34.8 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 129.092 2.957 . . . . 0.0 116.969 -170.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.261 39.7 mmtm -171.2 -23.46 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.343 2.257 . . . . 0.0 114.162 -155.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -46.04 123.66 6.87 Favored Glycine 0 C--N 1.341 0.809 0 N-CA-C 104.014 -3.635 . . . . 0.0 104.014 138.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -75.65 50.49 0.56 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 126.345 1.858 . . . . 0.0 110.377 -162.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 11.1 m -150.76 -35.72 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.583 1.553 . . . . 0.0 109.491 -162.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -57.07 -38.31 73.1 Favored 'General case' 0 C--O 1.216 -0.667 0 O-C-N 120.743 -1.223 . . . . 0.0 111.269 151.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.53 -42.83 88.69 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.266 0.939 . . . . 0.0 111.283 173.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 23.1 p -79.04 -55.3 5.22 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.039 -173.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 15.9 t -63.47 -34.18 77.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.528 1.513 . . . . 0.0 113.197 175.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.18 -50.19 72.82 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.102 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 65.4 mt -63.52 -70.27 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-O 122.282 1.039 . . . . 0.0 110.044 173.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 72.6 mtt-85 -76.74 1.65 16.58 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.122 1.769 . . . . 0.0 113.381 -163.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -125.48 -69.45 0.19 Allowed Glycine 0 N--CA 1.461 0.354 0 C-N-CA 125.636 1.589 . . . . 0.0 109.75 175.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.26 -27.57 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 117.169 -1.396 . . . . 0.0 112.518 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -96.87 -28.83 14.05 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 120.844 1.657 . . . . 0.0 114.095 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -54.69 -34.19 61.98 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.584 1.154 . . . . 0.0 111.009 167.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 58.0 tp -56.67 -30.3 63.23 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 168.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -82.84 -37.0 25.01 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 119.387 -2.071 . . . . 0.0 115.4 -171.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -16.67 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.427 1.091 . . . . 0.0 112.577 170.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 70.4 mt -75.02 -45.02 44.59 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.65 -0.656 . . . . 0.0 111.723 168.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -68.64 -41.09 79.87 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.752 1.621 . . . . 0.0 111.451 -170.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 32.1 tpp -25.7 -22.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 131.153 3.781 . . . . 0.0 117.797 149.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 17.0 mt -131.3 -4.39 3.84 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.061 1.745 . . . . 0.0 112.701 -174.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -66.6 -53.05 38.54 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.276 141.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 52.5 t . . . . . 0 N--CA 1.47 0.551 0 C-N-CA 125.115 1.366 . . . . 0.0 109.344 -160.829 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 37.6 mmm-85 . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.25 -28.35 4.71 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.17 0.988 . . . . 0.0 110.96 162.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -65.23 -47.71 75.86 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.244 1.384 . . . . 0.0 114.039 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.07 -32.11 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.342 1.457 . . . . 0.0 111.044 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -72.12 -36.32 69.4 Favored 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 123.683 0.793 . . . . 0.0 110.859 174.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -55.12 -34.74 58.78 Favored Glycine 0 CA--C 1.541 1.701 0 O-C-N 121.144 -0.973 . . . . 0.0 111.044 165.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.8 mtm180 -66.76 -43.63 83.54 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 117.944 0.872 . . . . 0.0 111.719 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 42.6 t -56.93 -53.29 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 125.18 1.392 . . . . 0.0 110.469 173.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -62.39 -49.95 73.49 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.644 0.778 . . . . 0.0 111.593 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -62.61 -19.91 64.23 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.092 1.357 . . . . 0.0 113.919 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.433 ' CZ ' ' HA ' ' A' ' 121' ' ' LYS . 26.4 t80 -83.06 -41.44 18.62 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 126.344 1.857 . . . . 0.0 110.719 174.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.7 mt -62.41 -43.07 99.68 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.421 1.009 . . . . 0.0 110.971 169.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -77.37 -37.6 51.8 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.5 -157.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 16.1 mtp-105 -82.72 161.69 57.8 Favored Pre-proline 0 N--CA 1.47 0.544 0 C-N-CA 125.409 1.484 . . . . 0.0 113.022 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -71.18 131.26 18.93 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 121.177 1.251 . . . . 0.0 109.11 149.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.9 t -154.73 149.91 27.02 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 120.352 -1.467 . . . . 0.0 109.8 167.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.0 8.64 0.05 OUTLIER Glycine 0 CA--C 1.537 1.468 0 N-CA-C 117.114 1.606 . . . . 0.0 117.114 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -124.82 -16.11 6.26 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 166.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 113' ' ' PHE . 35.5 ttpt -61.24 -69.56 0.23 Allowed 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 121.114 1.779 . . . . 0.0 111.528 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 60.2 m -65.78 -34.93 79.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 118.881 -0.58 . . . . 0.0 109.926 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -58.61 -52.13 66.96 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.365 0.53 . . . . 0.0 111.705 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.7 t -82.47 -43.2 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 121.25 -0.906 . . . . 0.0 113.018 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -75.72 -33.97 60.32 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.628 -0.67 . . . . 0.0 112.343 -171.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -68.74 -33.56 74.12 Favored 'General case' 0 C--N 1.346 0.435 0 O-C-N 120.897 -1.127 . . . . 0.0 111.128 169.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -64.31 -40.9 96.84 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.253 -0.904 . . . . 0.0 112.977 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.23 -44.83 65.04 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 118.168 -0.92 . . . . 0.0 113.443 167.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.64 -36.76 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 120.95 1.704 . . . . 0.0 113.159 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -54.62 -52.32 62.6 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.019 0.827 . . . . 0.0 111.308 172.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 87.7 mt -68.17 -40.64 82.25 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.908 0.483 . . . . 0.0 112.296 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 58.9 mt -69.62 -43.12 80.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 CA-C-O 117.874 -1.06 . . . . 0.0 112.083 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 80.8 t -60.82 -45.09 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 121.25 1.841 . . . . 0.0 111.674 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.4 tp -53.85 -54.07 43.59 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.513 1.525 . . . . 0.0 111.731 171.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 53.5 t -62.6 -39.97 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.712 0.805 . . . . 0.0 112.241 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.5 m -61.21 -42.98 99.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 119.335 0.971 . . . . 0.0 111.721 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.2 mt -74.61 -38.45 62.57 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.336 0.655 . . . . 0.0 112.23 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 71.7 mt -59.31 -48.42 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.887 0.875 . . . . 0.0 110.639 170.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -69.05 -35.71 76.87 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 118.969 -0.539 . . . . 0.0 111.563 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.3 t -58.42 -44.45 89.09 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.852 1.261 . . . . 0.0 112.874 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.1 m -67.49 -28.19 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.7 mt -71.42 -46.81 59.19 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.679 0.672 . . . . 0.0 111.756 166.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 72.6 m -70.39 -33.02 70.91 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.29 1.836 . . . . 0.0 115.036 -170.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.2 t -66.57 -47.52 72.51 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 120.164 1.347 . . . . 0.0 109.895 -174.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 26.5 mm -56.0 -44.63 78.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 124.466 1.106 . . . . 0.0 111.135 175.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -80.65 -14.37 58.22 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -73.19 -37.71 66.39 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.361 1.437 . . . . 0.0 111.196 166.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -79.9 -2.83 45.44 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.163 -0.961 . . . . 0.0 112.089 170.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.65 -27.93 18.72 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.596 1.158 . . . . 0.0 112.954 157.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.467 ' HB2' HG21 ' A' ' 155' ' ' THR . . . -60.58 -19.38 57.43 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -173.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.432 ' H ' ' HG ' ' A' ' 151' ' ' LEU . 1.6 pp -63.88 -4.49 3.31 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 126.697 1.999 . . . . 0.0 114.557 166.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.23 -35.17 0.32 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.851 2.46 . . . . 0.0 114.24 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 72.5 m -129.22 141.53 51.11 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.7 1.2 . . . . 0.0 110.448 -151.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -72.49 140.91 30.13 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.278 -0.487 . . . . 0.0 112.101 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.467 HG21 ' HB2' ' A' ' 150' ' ' ALA . 2.2 t -147.62 143.44 27.71 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -158.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -60.93 -7.23 2.27 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 170.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -56.31 -8.67 0.54 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.89 2.476 . . . . 0.0 116.367 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -68.8 -24.04 64.35 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.472 -1.392 . . . . 0.0 112.508 171.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 76.5 mtm -74.16 -13.81 60.87 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -68.56 -44.08 75.23 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.723 1.147 . . . . 0.0 110.492 164.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 28.8 mt -58.62 -36.75 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 118.481 -0.771 . . . . 0.0 111.916 169.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.5 t -57.53 -45.58 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 120.409 1.459 . . . . 0.0 111.49 171.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 19.3 mt -62.7 -42.82 99.84 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 173.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.88 -24.17 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.24 0.927 . . . . 0.0 112.34 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 54.6 t -78.87 -38.99 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.233 1.013 . . . . 0.0 110.429 172.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -61.56 -49.75 75.4 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.394 0.997 . . . . 0.0 112.297 170.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -65.71 -46.33 79.35 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.711 0.687 . . . . 0.0 112.47 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -52.26 -40.86 53.48 Favored Glycine 0 CA--C 1.539 1.546 0 O-C-N 121.598 -0.689 . . . . 0.0 112.788 167.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 70.2 m -69.17 -37.83 78.39 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 117.775 0.787 . . . . 0.0 112.482 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -59.71 -50.2 74.75 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.981 1.312 . . . . 0.0 110.888 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -51.66 -47.41 63.8 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.362 1.065 . . . . 0.0 112.247 172.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 37.8 t -66.37 -37.97 80.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.959 0.904 . . . . 0.0 112.363 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 12.2 t -62.85 -33.51 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.146 1.379 . . . . 0.0 112.427 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 24.5 mtt180 -59.99 -44.86 94.24 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.118 -0.989 . . . . 0.0 111.221 170.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.7 mt -68.7 -35.43 77.17 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.173 0.589 . . . . 0.0 112.381 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 53.2 m0 -65.34 -26.58 68.1 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 172.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 47.8 t -70.34 -30.21 67.11 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.604 1.093 . . . . 0.0 113.534 166.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -68.89 -0.46 5.56 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.307 -1.496 . . . . 0.0 112.598 161.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -104.92 7.39 44.75 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 126.58 2.038 . . . . 0.0 116.238 172.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 7.8 t -54.49 -23.12 14.97 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.247 1.524 . . . . 0.0 112.48 173.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -122.47 -60.37 1.55 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.254 1.422 . . . . 0.0 110.988 153.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.9 p -86.35 64.5 8.58 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.473 1.509 . . . . 0.0 111.971 -163.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -44.82 -35.73 2.91 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.732 1.613 . . . . 0.0 115.05 -167.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -112.32 -33.07 6.31 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.739 1.216 . . . . 0.0 113.859 174.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -56.74 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 119.786 1.176 . . . . 0.0 111.606 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -67.63 -35.79 86.69 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 119.022 -0.877 . . . . 0.0 111.179 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 1.2 tt -51.9 -33.21 35.88 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.019 0.928 . . . . 0.0 113.062 169.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 49.8 t-105 -86.13 -36.18 19.72 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -73.88 -38.17 49.55 Favored Glycine 0 N--CA 1.466 0.638 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -64.99 -40.29 94.73 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 124.675 1.19 . . . . 0.0 111.005 169.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 19.3 tp -63.76 -40.87 97.74 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.41 1.005 . . . . 0.0 111.914 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 52.5 mtp180 -64.43 -23.81 67.41 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 171.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -74.73 0.47 15.16 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.919 1.288 . . . . 0.0 113.977 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.03 27.71 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 116.839 2.163 . . . . 0.0 116.839 -173.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -92.75 -7.16 47.4 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 117.198 2.295 . . . . 0.0 117.198 -159.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -61.03 147.23 86.48 Favored Pre-proline 0 N--CA 1.482 1.138 0 CA-C-N 120.976 1.716 . . . . 0.0 109.975 167.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -45.33 -50.18 9.39 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.93 3.087 . . . . 0.0 115.669 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 96.5 mt -71.98 -29.96 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.409 1.083 . . . . 0.0 111.784 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 50.6 m -72.79 -30.72 64.31 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.093 0.957 . . . . 0.0 112.279 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.8 mt -68.16 -42.77 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.586 0.754 . . . . 0.0 109.808 168.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 49.4 mt -61.87 -43.52 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 121.656 -0.653 . . . . 0.0 110.933 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.13 -38.78 92.29 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.501 1.52 . . . . 0.0 112.099 175.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.5 tt -63.12 -48.76 77.16 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.55 0.614 . . . . 0.0 110.716 170.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.1 -36.93 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.618 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 72.1 t -74.1 -33.93 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 120.24 1.382 . . . . 0.0 113.5 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.3 p -66.39 -36.99 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 121.052 1.751 . . . . 0.0 110.802 169.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 77.4 t -71.45 -39.56 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 120.904 -1.122 . . . . 0.0 110.777 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.5 -57.77 10.83 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.036 0.934 . . . . 0.0 110.628 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 59.8 p -56.14 -42.44 76.93 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.761 0.424 . . . . 0.0 111.261 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -64.0 -54.93 26.55 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.928 0.891 . . . . 0.0 112.526 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.15 -36.43 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 119.65 1.113 . . . . 0.0 111.855 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 27.9 m -75.17 -38.87 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 117.561 -1.209 . . . . 0.0 112.047 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.92 -22.13 65.08 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.031 1.287 . . . . 0.0 111.655 171.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 66.8 m -74.68 -36.87 62.79 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.422 1.089 . . . . 0.0 113.177 171.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 76.6 t -64.04 -31.61 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 118.933 0.788 . . . . 0.0 110.273 164.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 137.76 -107.68 0.59 Allowed Glycine 0 CA--C 1.522 0.506 0 C-N-CA 124.555 1.074 . . . . 0.0 112.908 158.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 87.1 p -139.8 2.21 1.95 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.55 1.14 . . . . 0.0 113.195 -167.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -171.92 -177.8 2.01 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.667 2.387 . . . . 0.0 110.23 -172.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 57.69 108.25 0.01 OUTLIER Glycine 0 CA--C 1.526 0.781 0 N-CA-C 106.966 -2.454 . . . . 0.0 106.966 -107.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -57.92 -6.4 0.56 Allowed 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 120.348 2.074 . . . . 0.0 112.586 172.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.531 ' HA ' HG22 ' A' ' 224' ' ' THR . 22.3 m -72.12 -32.17 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.528 1.531 . . . . 0.0 113.119 169.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.37 -47.68 62.76 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.929 1.241 . . . . 0.0 111.181 159.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.29 -55.31 12.56 Favored 'General case' 0 C--O 1.223 -0.341 0 O-C-N 124.217 0.948 . . . . 0.0 110.768 -168.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.531 HG22 ' HA ' ' A' ' 221' ' ' VAL . 8.1 t -52.97 -39.72 63.21 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.166 -0.959 . . . . 0.0 111.78 176.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 16.1 m -69.2 -58.29 4.25 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.163 -0.961 . . . . 0.0 111.999 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -54.79 -54.69 38.91 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 126.049 1.739 . . . . 0.0 110.914 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.53 -71.79 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.845 1.658 . . . . 0.0 107.835 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -74.52 -43.38 56.15 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.246 -154.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -59.45 -46.33 94.09 Favored Glycine 0 N--CA 1.472 1.056 0 CA-C-O 119.616 -0.547 . . . . 0.0 112.854 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.98 -34.67 39.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 117.979 0.89 . . . . 0.0 111.623 -177.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -40.74 98.54 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.058 -1.026 . . . . 0.0 112.168 166.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -66.56 -36.53 82.9 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.34 0.656 . . . . 0.0 110.634 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.5 tp -67.29 -23.85 65.7 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 172.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.48 -48.2 20.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.51 1.124 . . . . 0.0 113.071 176.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 22.9 pt -68.08 -16.6 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 173.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 52.0 tp -70.26 -26.06 63.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.266 1.426 . . . . 0.0 111.608 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.443 ' HG2' ' HD1' ' A' ' 240' ' ' HIS . 10.3 mtp180 -67.44 -19.29 65.35 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.211 1.005 . . . . 0.0 112.221 -176.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.7 -24.08 2.1 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.685 1.994 . . . . 0.0 113.94 160.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.1 mt -114.36 -19.85 11.07 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.819 1.648 . . . . 0.0 111.334 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . 0.443 ' HD1' ' HG2' ' A' ' 237' ' ' ARG . 39.8 m170 -64.66 -32.22 73.78 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 118.964 -0.541 . . . . 0.0 111.425 162.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.297 11.1 p . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 125.159 2.409 . . . . 0.0 110.618 158.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.823 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.447 HG23 ' H ' ' A' ' 105' ' ' HIS . 2.6 t -62.8 -95.07 0.0 OUTLIER 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 127.382 2.273 . . . . 0.0 113.893 143.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.447 ' H ' HG23 ' A' ' 104' ' ' THR . 49.5 m80 -58.58 -19.85 41.79 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 119.975 3.324 . . . . 0.0 119.975 -168.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.6 p -61.0 -37.62 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 120.456 1.48 . . . . 0.0 111.946 172.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -67.45 -41.5 84.61 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.827 0.851 . . . . 0.0 109.249 173.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -58.86 -26.72 60.94 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.091 -1.394 . . . . 0.0 113.866 167.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -67.18 -45.19 77.7 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 120.36 2.08 . . . . 0.0 111.647 174.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.2 t -57.13 -47.39 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.144 0.978 . . . . 0.0 110.038 171.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -66.32 -56.6 10.38 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 118.848 -0.596 . . . . 0.0 112.453 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -58.89 -20.44 51.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 119.376 0.989 . . . . 0.0 113.463 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -80.39 -42.73 22.27 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.65 1.114 . . . . 0.0 111.773 171.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.63 -25.68 38.2 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -178.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -108.99 -38.71 5.5 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.06 1.344 . . . . 0.0 112.513 -164.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -90.75 151.1 43.37 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 123.279 0.632 . . . . 0.0 111.885 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.65 128.37 18.91 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.991 1.794 . . . . 0.0 112.986 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.2 t -152.4 151.13 30.43 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 156.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.47 -28.86 22.34 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 119.544 1.065 . . . . 0.0 112.654 172.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -70.88 -27.54 63.9 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 175.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.7 tmmt? -56.61 -60.87 2.91 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.34 1.056 . . . . 0.0 109.165 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 25.5 p -71.69 -27.33 62.96 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.682 1.193 . . . . 0.0 112.682 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -61.67 -52.24 65.14 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.715 1.598 . . . . 0.0 110.427 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.5 t -76.54 -48.17 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.051 0.54 . . . . 0.0 111.666 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -63.99 -46.54 84.1 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -75.77 -28.95 58.63 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.571 -0.705 . . . . 0.0 111.285 -174.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -69.99 -39.24 76.04 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.469 1.031 . . . . 0.0 112.375 169.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.51 -43.99 84.66 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.477 1.035 . . . . 0.0 113.362 167.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 76.4 t -62.15 -44.42 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 120.553 1.524 . . . . 0.0 111.727 172.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -56.72 -50.47 72.11 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.05 1.295 . . . . 0.0 111.553 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 94.2 mt -65.19 -45.37 85.11 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 119.019 -0.515 . . . . 0.0 111.469 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 76.1 mt -65.36 -37.23 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.859 0.754 . . . . 0.0 112.085 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.76 -45.46 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 119.956 1.253 . . . . 0.0 110.731 174.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 45.3 tp -63.92 -47.98 78.39 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.074 0.95 . . . . 0.0 111.922 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.4 t -59.9 -47.37 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.631 0.772 . . . . 0.0 110.126 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 41.5 t -58.06 -43.71 87.09 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.713 1.205 . . . . 0.0 112.824 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 61.2 mt -76.75 -36.18 57.26 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.2 mt -61.66 -48.31 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 120.813 -1.179 . . . . 0.0 109.77 167.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -63.48 -25.78 68.42 Favored 'General case' 0 C--O 1.22 -0.485 0 O-C-N 121.431 -0.793 . . . . 0.0 111.921 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.1 t -56.94 -39.59 74.81 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 120.047 1.294 . . . . 0.0 112.068 175.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 52.1 t -66.31 -42.34 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.584 0.754 . . . . 0.0 111.652 173.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.4 mt -70.63 -55.52 8.59 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.652 1.181 . . . . 0.0 112.661 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.3 m -68.17 -29.82 68.79 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.915 2.086 . . . . 0.0 113.538 -171.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.19 -46.29 51.44 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.218 1.372 . . . . 0.0 110.382 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.7 mm -52.84 -44.0 47.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.023 0.929 . . . . 0.0 110.834 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -74.07 -33.41 63.66 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -74.26 -21.69 59.65 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 119.856 -1.778 . . . . 0.0 112.082 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -79.98 -41.88 25.03 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.556 0.616 . . . . 0.0 109.455 171.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -57.91 -28.14 63.97 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.369 1.068 . . . . 0.0 113.424 170.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -57.63 -18.11 18.35 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.8 mp -83.86 -34.88 24.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.047 0.939 . . . . 0.0 111.952 174.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -84.58 -36.7 21.89 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.005 1.722 . . . . 0.0 114.073 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.0 t -158.51 -168.13 2.35 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 126.784 2.034 . . . . 0.0 108.313 -159.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -71.91 -174.99 23.44 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 120.711 -1.243 . . . . 0.0 113.74 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 10.0 t -161.02 148.18 15.25 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 49.3 tp -68.42 -10.38 54.83 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.194 1.798 . . . . 0.0 114.314 165.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -53.52 -17.77 2.31 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 -167.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 30.0 p-90 -58.14 -29.86 65.9 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 119.978 -1.701 . . . . 0.0 112.908 169.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 61.7 ttp -65.09 -32.89 74.83 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.858 1.663 . . . . 0.0 112.108 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -69.16 -38.94 79.01 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.508 -0.745 . . . . 0.0 111.884 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 50.1 mm -56.35 -34.51 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.059 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.4 t -60.5 -46.18 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.147 0.885 . . . . 0.0 111.271 172.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 15.9 mt -72.19 -47.47 50.45 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.746 0.818 . . . . 0.0 112.871 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 69.0 t -62.14 -43.29 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.754 0.822 . . . . 0.0 111.161 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 84.6 t -72.15 -32.41 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.05 174.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -62.12 -49.16 77.0 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 120.807 1.64 . . . . 0.0 112.486 170.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -64.83 -39.71 94.02 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.52 -1.363 . . . . 0.0 111.636 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -62.56 -38.11 95.84 Favored Glycine 0 CA--C 1.538 1.475 0 O-C-N 121.989 -0.444 . . . . 0.0 112.714 169.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 59.8 m -67.53 -36.65 81.43 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 117.731 0.765 . . . . 0.0 111.706 173.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -62.33 -44.18 97.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.521 1.128 . . . . 0.0 110.784 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -58.51 -41.1 84.63 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 77.9 t -71.08 -36.65 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.217 -0.927 . . . . 0.0 113.153 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 46.8 t -67.17 -29.99 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.035 1.334 . . . . 0.0 111.746 175.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -59.43 -40.01 85.35 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.971 -1.081 . . . . 0.0 112.19 165.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 74.5 mt -74.63 -36.93 62.92 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.708 0.803 . . . . 0.0 112.928 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 54.9 m0 -62.57 -41.17 98.76 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.072 1.305 . . . . 0.0 112.708 169.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 42.8 p -71.41 0.82 7.37 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.84 -23.45 60.67 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.556 1.525 . . . . 0.0 113.579 154.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 164.27 112.54 0.27 Allowed Glycine 0 N--CA 1.433 -1.541 0 O-C-N 121.878 -0.514 . . . . 0.0 112.157 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 45.0 t -34.06 -32.51 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.14 1.776 . . . . 0.0 113.514 152.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.46 -44.64 3.85 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 161.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.7 m -74.47 24.97 0.08 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -171.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -5.66 2.89 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 118.067 2.618 . . . . 0.0 118.067 -173.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -119.2 -37.53 3.18 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 120.276 1.398 . . . . 0.0 111.822 166.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.404 HG13 ' H ' ' A' ' 186' ' ' GLY . 10.8 p -73.09 -62.0 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.96 0.904 . . . . 0.0 112.71 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.404 ' H ' HG13 ' A' ' 185' ' ' VAL . . . -61.63 -31.65 78.61 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 118.591 -1.116 . . . . 0.0 112.656 169.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.0 tt -55.79 -49.58 72.8 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.4 1.6 . . . . 0.0 110.048 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -66.99 -42.38 85.17 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 122.211 -0.305 . . . . 0.0 111.092 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -53.36 -43.95 65.62 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.238 1.399 . . . . 0.0 114.105 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . 0.326 9.9 ptp180 -80.51 -31.02 37.26 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 40.0 tp -69.0 -41.02 78.34 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.49 0.586 . . . . 0.0 112.365 171.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -76.18 -17.39 59.57 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -78.97 -13.83 59.56 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.757 1.223 . . . . 0.0 113.831 169.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -78.79 43.89 0.52 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 117.052 2.242 . . . . 0.0 117.052 -165.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -93.86 -5.57 47.72 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -165.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -61.89 141.45 95.4 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 120.199 1.363 . . . . 0.0 109.104 175.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -47.57 -43.37 27.95 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.025 2.483 . . . . 0.0 115.021 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 35.0 mm -68.43 -32.24 54.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.117 0.967 . . . . 0.0 112.419 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 14.3 m -71.61 -36.6 70.86 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.973 1.309 . . . . 0.0 111.46 175.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 63.6 mt -68.94 -39.32 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.707 1.203 . . . . 0.0 110.733 173.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 33.9 mt -62.85 -41.48 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 121.286 -0.884 . . . . 0.0 111.129 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -65.23 -36.45 84.19 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.26 1.424 . . . . 0.0 111.647 176.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 28.6 tp -60.95 -52.96 62.83 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.529 0.732 . . . . 0.0 111.48 166.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 49.5 mt -61.59 -36.32 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.496 -0.752 . . . . 0.0 111.077 -175.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.0 t -65.9 -45.84 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.962 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.02 -31.39 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 CA-C-N 120.818 1.645 . . . . 0.0 112.018 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 97.5 t -74.25 -39.38 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 120.557 1.526 . . . . 0.0 110.893 176.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.15 81.96 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.34 0.973 . . . . 0.0 110.369 170.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 47.6 m -58.62 -43.94 89.79 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.77 0.828 . . . . 0.0 112.197 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 28.3 ttm -59.66 -55.45 34.31 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.295 1.438 . . . . 0.0 111.875 171.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 23.8 t -56.01 -47.47 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.099 1.36 . . . . 0.0 112.053 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 33.4 m -75.95 -25.79 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 118.043 -0.979 . . . . 0.0 113.28 -171.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 86.3 mt -68.85 -48.32 63.75 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.829 1.195 . . . . 0.0 110.968 159.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 43.8 t -63.04 -46.79 85.85 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.169 0.987 . . . . 0.0 113.003 -165.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 8.4 p -71.13 -11.72 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.896 -1.128 . . . . 0.0 113.214 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.41 125.58 5.66 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 125.357 1.456 . . . . 0.0 112.301 -168.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.5 m -72.75 61.23 0.53 Allowed 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 128.37 2.668 . . . . 0.0 113.427 -168.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -166.73 164.72 16.64 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 127.735 2.414 . . . . 0.0 112.064 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -85.24 -106.14 0.67 Allowed Glycine 0 C--N 1.337 0.603 0 C-N-CA 126.462 1.982 . . . . 0.0 111.923 -1.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -66.32 -23.64 66.4 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.095 -1.053 . . . . 0.0 112.302 171.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.68 -44.79 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 O-C-N 121.259 -0.901 . . . . 0.0 110.486 -166.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.65 -51.58 54.69 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.482 0.713 . . . . 0.0 111.906 163.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.66 -52.36 65.46 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.58 0.752 . . . . 0.0 109.559 -171.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.49 -37.73 88.57 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-O 117.915 -1.04 . . . . 0.0 112.715 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 46.1 m -67.92 -48.26 66.48 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 121.397 1.908 . . . . 0.0 111.298 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -56.42 -46.77 80.07 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 125.072 1.349 . . . . 0.0 110.976 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 227' ' ' ILE . 72.5 mt -59.29 -71.1 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-O 122.478 1.133 . . . . 0.0 110.184 167.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -78.38 -17.92 55.79 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.153 -150.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.43 -53.73 2.24 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.532 1.063 . . . . 0.0 114.058 162.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -30.66 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 119.512 1.656 . . . . 0.0 113.637 -170.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 4.0 mmt85 -73.49 -32.46 64.31 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.779 -1.2 . . . . 0.0 110.923 170.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -67.19 -36.5 81.89 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.479 1.111 . . . . 0.0 112.42 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 65.3 tp -58.34 -36.23 73.1 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 118.316 0.507 . . . . 0.0 112.198 165.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.21 -34.71 61.52 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 119.95 -1.719 . . . . 0.0 113.552 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 3.7 pt -73.35 -22.75 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 120.779 -1.2 . . . . 0.0 113.832 164.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.5 tp -58.7 -42.47 88.68 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.606 1.163 . . . . 0.0 110.789 164.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -56.98 -30.6 64.26 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.309 1.044 . . . . 0.0 112.893 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 18.5 mmt -49.08 -31.93 8.79 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 168.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 40.5 mt -112.65 -7.67 13.84 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.182 1.393 . . . . 0.0 109.982 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -68.12 -12.93 61.77 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.661 0.664 . . . . 0.0 112.084 153.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 61.8 t . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 124.272 1.987 . . . . 0.0 108.765 138.708 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.588 ' HA ' HG12 ' A' ' 106' ' ' VAL . 18.7 ttp180 . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 t -43.71 -57.27 3.29 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.932 2.493 . . . . 0.0 114.027 165.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -92.22 -25.33 18.69 Favored 'General case' 0 C--N 1.335 -0.06 0 O-C-N 120.196 -1.565 . . . . 0.0 114.349 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.588 HG12 ' HA ' ' A' ' 103' ' ' ARG . 1.4 p -69.56 -38.93 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 119.446 1.021 . . . . 0.0 111.144 171.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -73.54 -32.35 64.16 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.137 -0.977 . . . . 0.0 111.159 171.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.02 -32.31 42.0 Favored Glycine 0 CA--C 1.536 1.348 0 O-C-N 121.755 -0.591 . . . . 0.0 112.579 163.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -37.05 84.13 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.263 1.425 . . . . 0.0 111.546 -177.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.07 -54.1 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 122.292 1.044 . . . . 0.0 109.485 170.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . 0.25 77.0 m-85 -74.78 -33.75 62.33 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.101 -168.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -62.31 -22.86 66.38 Favored 'General case' 0 CA--C 1.552 1.051 0 O-C-N 120.179 -1.576 . . . . 0.0 114.469 165.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -75.38 -28.41 59.47 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.289 1.035 . . . . 0.0 111.811 171.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.2 mt -58.92 -43.65 91.16 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.56 1.073 . . . . 0.0 109.836 165.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -74.65 -40.82 61.23 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.306 -161.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.9 ptt85 -87.43 123.0 70.41 Favored Pre-proline 0 N--CA 1.47 0.554 0 C-N-CA 124.24 1.016 . . . . 0.0 110.46 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -65.89 126.61 16.21 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.869 1.712 . . . . 0.0 110.886 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.1 p -133.32 166.84 21.56 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 167.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.01 -37.59 71.78 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-N 118.634 0.652 . . . . 0.0 112.579 171.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -73.0 -34.99 66.74 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 175.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.43 -55.99 27.73 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.785 1.175 . . . . 0.0 108.864 164.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 34.0 t -58.52 -48.5 80.62 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.488 1.115 . . . . 0.0 111.994 -171.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -59.72 -52.96 63.26 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.824 0.45 . . . . 0.0 111.428 -175.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.6 t -84.27 -42.87 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -64.77 -48.98 72.52 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.705 0.402 . . . . 0.0 112.05 -172.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -68.8 -33.96 74.74 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.9 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -68.55 -36.08 78.31 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.275 0.943 . . . . 0.0 113.047 173.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.79 -46.13 81.74 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.352 0.978 . . . . 0.0 113.628 169.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . 0.268 0.7 OUTLIER -64.69 -39.05 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 CA-C-N 120.39 1.45 . . . . 0.0 111.16 178.743 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -60.45 -48.74 80.46 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.868 -1.145 . . . . 0.0 113.173 172.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.7 mt -61.82 -38.89 89.84 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.854 -1.154 . . . . 0.0 111.895 177.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 77.2 mt -63.26 -43.49 98.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 118.716 -0.659 . . . . 0.0 111.779 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -38.11 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 119.556 1.071 . . . . 0.0 111.662 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.6 mt -59.31 -47.74 84.27 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.761 0.425 . . . . 0.0 111.859 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.4 m -70.63 -41.11 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.608 1.095 . . . . 0.0 110.944 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 95.9 m -64.51 -39.91 94.67 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 119.105 0.866 . . . . 0.0 112.834 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 78.1 mt -71.2 -41.23 70.55 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 120.091 1.314 . . . . 0.0 112.599 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.3 mm -64.31 -48.09 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 121.232 -0.917 . . . . 0.0 110.02 172.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -61.5 -35.63 78.24 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-O 116.915 -1.516 . . . . 0.0 110.663 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.4 m -49.73 -48.38 50.12 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 121.006 1.73 . . . . 0.0 113.084 173.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.43 -30.67 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 122.999 0.52 . . . . 0.0 112.212 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.3 mt -89.84 -30.92 17.6 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.49 1.516 . . . . 0.0 114.907 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.7 p -90.17 -26.11 20.31 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.014 -1.053 . . . . 0.0 113.25 -158.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.3 t -68.97 -32.51 72.14 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.307 -0.871 . . . . 0.0 112.439 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 11.8 pt -72.28 -9.13 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -62.91 -23.38 67.33 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.661 0.784 . . . . 0.0 112.099 170.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -62.85 -38.74 92.03 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.845 1.258 . . . . 0.0 111.457 168.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -74.84 -37.37 62.28 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.892 0.769 . . . . 0.0 111.36 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.75 -42.29 95.28 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.124 0.969 . . . . 0.0 113.501 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -58.23 -25.08 61.24 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -170.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -69.77 -48.14 60.36 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.488 1.115 . . . . 0.0 111.859 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.96 -51.91 11.4 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.671 1.188 . . . . 0.0 113.273 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.5 t -159.4 -179.0 7.56 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.611 -139.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -62.71 152.73 45.19 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 122.006 0.781 . . . . 0.0 112.936 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.8 t -152.9 148.28 26.96 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.843 0.83 . . . . 0.0 112.101 -166.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 11.3 tp -81.66 14.97 2.32 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.924 2.09 . . . . 0.0 112.796 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -50.24 -29.14 8.88 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.116 2.566 . . . . 0.0 114.618 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -70.99 -31.14 67.59 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.134 -0.979 . . . . 0.0 112.408 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 9.0 tpt -73.91 -35.41 64.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.433 1.015 . . . . 0.0 110.767 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -55.82 -56.35 21.56 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.516 0.726 . . . . 0.0 110.775 166.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 75.0 mt -58.45 -40.13 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.6 0.76 . . . . 0.0 112.282 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.7 t -61.95 -44.82 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 120.279 -1.513 . . . . 0.0 112.567 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.2 mt -71.2 -34.37 70.82 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.219 1.372 . . . . 0.0 112.037 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 54.9 t -59.8 -36.77 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.54 1.063 . . . . 0.0 110.881 170.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 78.8 t -76.26 -28.2 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 118.503 -0.761 . . . . 0.0 112.055 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -60.85 -48.99 79.29 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.197 1.362 . . . . 0.0 110.669 169.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -71.93 -35.79 69.75 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.53 -43.54 94.11 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 123.368 0.508 . . . . 0.0 112.361 167.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 88.9 m -68.88 -36.95 78.7 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.837 0.819 . . . . 0.0 110.739 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.4 tm-20 -60.14 -35.11 74.57 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 118.751 0.705 . . . . 0.0 112.541 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -60.69 -46.25 91.08 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.263 -0.898 . . . . 0.0 112.044 169.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.4 t -69.99 -30.82 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.494 0.717 . . . . 0.0 111.988 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.1 t -60.65 -39.51 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.305 1.442 . . . . 0.0 112.47 171.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -69.79 -20.1 63.48 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 170.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 31.8 mt -77.73 -37.7 48.73 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.311 0.959 . . . . 0.0 112.222 166.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 34.8 m0 -64.92 -45.63 85.03 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.008 -1.058 . . . . 0.0 113.355 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 95.1 p -56.02 -38.49 70.61 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.024 1.283 . . . . 0.0 113.845 169.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.09 -8.85 33.74 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 173.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -106.63 5.2 37.34 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.142 1.83 . . . . 0.0 113.815 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 20.7 p -57.35 -15.28 6.01 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -173.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.28 -33.17 2.17 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.011 1.725 . . . . 0.0 112.658 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 21.7 t -159.26 115.2 2.56 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.093 1.757 . . . . 0.0 107.347 177.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -57.7 -34.74 69.76 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -155.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -100.24 -29.32 12.53 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -169.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 99.4 t -54.42 -59.63 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 118.834 0.743 . . . . 0.0 110.695 -173.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.35 -26.76 68.33 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-O 116.101 -2.499 . . . . 0.0 114.507 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 66.4 mt -57.3 -39.47 75.83 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 121.519 2.66 . . . . 0.0 111.237 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 6.7 t-105 -70.25 -42.46 72.15 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.472 -0.768 . . . . 0.0 111.748 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -62.79 -27.1 69.5 Favored Glycine 0 CA--C 1.533 1.173 0 O-C-N 121.608 -0.682 . . . . 0.0 113.38 175.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -82.69 -31.37 28.61 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 129.901 3.28 . . . . 0.0 113.104 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 52.8 mt -81.19 -30.26 34.37 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.58 1.152 . . . . 0.0 111.906 171.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -58.94 -45.01 91.46 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 126.327 1.851 . . . . 0.0 112.291 159.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -63.13 -31.27 72.37 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.694 -0.628 . . . . 0.0 112.193 169.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.28 17.23 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 173.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 -108.01 -20.97 13.0 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.287 1.835 . . . . 0.0 112.89 172.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -70.03 153.7 95.18 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 126.025 1.73 . . . . 0.0 110.031 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.69 -57.28 1.06 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 CA-C-N 122.236 1.834 . . . . 0.0 116.019 -157.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 81.7 mt -68.34 -18.54 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 120.017 1.28 . . . . 0.0 111.834 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 37.2 m -89.44 -29.28 19.13 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 16.5 tt -79.75 -33.1 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 119.823 1.192 . . . . 0.0 110.701 168.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.09 -36.69 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 118.852 0.751 . . . . 0.0 110.213 165.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -72.02 -35.67 69.47 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.701 1.137 . . . . 0.0 111.789 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 24.1 tp -62.15 -49.31 76.34 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.729 0.412 . . . . 0.0 111.417 169.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 60.6 mt -60.78 -45.24 98.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.786 1.234 . . . . 0.0 111.084 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.2 t -68.27 -40.02 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.048 0.939 . . . . 0.0 112.002 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.1 p -69.73 -31.6 49.13 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 CA-C-N 121.331 1.878 . . . . 0.0 111.707 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 73.2 t -71.71 -45.03 68.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -54.86 -48.58 72.75 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 118.186 0.448 . . . . 0.0 111.297 171.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.0 m -57.12 -50.28 73.29 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.341 1.057 . . . . 0.0 112.847 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 21.6 ptp -69.14 -38.65 78.94 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 118.906 -0.569 . . . . 0.0 111.86 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 14.9 t -58.66 -42.12 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.336 1.054 . . . . 0.0 111.687 174.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 30.2 m -84.38 -30.84 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.32 -33.07 65.25 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.082 0.855 . . . . 0.0 111.813 160.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 48.9 t -84.56 -44.34 13.64 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.845 0.858 . . . . 0.0 112.958 -170.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 5.0 p -67.14 -21.51 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -169.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 122.61 108.22 1.94 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -159.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . 0.412 ' HA ' ' CG ' ' A' ' 222' ' ' PHE . 97.4 p -73.37 41.21 0.11 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.84 2.056 . . . . 0.0 114.133 -173.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -157.21 166.7 32.46 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 128.621 2.769 . . . . 0.0 109.829 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -87.11 -90.61 1.0 Allowed Glycine 0 N--CA 1.468 0.775 0 C-N-CA 127.258 2.361 . . . . 0.0 107.357 -13.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -60.86 -37.15 81.13 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.648 -1.276 . . . . 0.0 112.442 169.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 24.6 t -85.89 -40.91 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 117.883 -1.527 . . . . 0.0 111.488 -148.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.412 ' CG ' ' HA ' ' A' ' 217' ' ' SER . 0.1 OUTLIER -53.1 -46.51 68.73 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.223 162.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.92 -56.06 11.9 Favored 'General case' 0 C--O 1.214 -0.765 0 O-C-N 123.815 0.697 . . . . 0.0 111.307 -171.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.1 t -54.2 -36.71 63.75 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.739 -1.226 . . . . 0.0 112.228 176.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 15.6 m -68.93 -56.71 7.0 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.243 -0.91 . . . . 0.0 112.506 174.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.33 -57.45 12.27 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 125.864 1.666 . . . . 0.0 111.953 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.425 HD13 HG21 ' A' ' 227' ' ' ILE . 59.5 mt -54.71 -79.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-O 123.413 1.578 . . . . 0.0 108.902 169.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -74.83 -34.96 62.42 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 113.946 -1.479 . . . . 0.0 108.358 -150.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -72.72 -52.87 8.94 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.025 1.298 . . . . 0.0 115.17 172.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.41 -36.94 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-N 120.747 2.273 . . . . 0.0 111.487 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -81.33 -20.94 39.64 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.4 -46.6 89.42 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.51 0.724 . . . . 0.0 109.734 164.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.79 -24.93 67.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.57 -0.728 . . . . 0.0 110.987 171.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -70.46 -46.43 63.85 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 122.015 2.189 . . . . 0.0 113.62 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 8.3 pt -72.47 -2.25 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 120.509 -1.37 . . . . 0.0 114.206 173.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 44.1 tp -87.23 -21.58 25.76 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.677 1.191 . . . . 0.0 113.213 164.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -80.53 -12.38 59.54 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.949 1.7 . . . . 0.0 111.959 175.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 16.4 tpp -35.84 -30.8 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 128.981 2.913 . . . . 0.0 114.031 147.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 10.1 mt -102.9 -9.74 19.62 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.617 1.567 . . . . 0.0 110.767 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 52.3 m170 -83.88 -15.05 49.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.179 1.392 . . . . 0.0 112.147 161.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.359 3.4 t . . . . . 0 N--CA 1.475 0.806 0 CA-C-O 125.648 2.642 . . . . 0.0 111.019 146.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.547 ' HA ' HG12 ' A' ' 106' ' ' VAL . 2.5 ptt180 . . . . . 0 N--CA 1.444 -0.747 0 N-CA-C 111.487 0.18 . . . . 0.0 111.487 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -73.4 -31.51 63.92 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.227 -0.92 . . . . 0.0 110.903 172.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -69.0 -48.46 63.03 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.928 -1.107 . . . . 0.0 111.964 172.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 103' ' ' ARG . 5.2 p -68.47 -34.97 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 118.273 0.488 . . . . 0.0 111.832 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -67.28 -35.16 78.93 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.193 -0.942 . . . . 0.0 110.429 172.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -57.57 -31.26 63.24 Favored Glycine 0 CA--C 1.545 1.958 0 C-N-CA 124.989 1.281 . . . . 0.0 113.841 163.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -72.26 -40.88 67.34 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.355 -1.086 . . . . 0.0 112.538 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.99 -43.53 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.705 1.202 . . . . 0.0 110.707 162.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.434 ' HB3' ' HA ' ' A' ' 177' ' ' SER . 19.6 m-30 -62.52 -45.63 92.11 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 117.433 -1.27 . . . . 0.0 112.552 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -53.39 -36.86 61.9 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.983 1.265 . . . . 0.0 113.045 170.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -73.62 -31.28 63.45 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.295 -0.878 . . . . 0.0 111.777 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.4 mt -68.35 -46.7 69.43 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.133 0.879 . . . . 0.0 110.572 168.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -70.71 -42.05 71.12 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.413 -165.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 25.9 ptt85 -75.81 156.52 84.52 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 123.858 0.863 . . . . 0.0 112.338 177.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -82.07 142.13 12.13 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.907 2.405 . . . . 0.0 111.498 167.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 75.3 p -147.74 156.92 43.25 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.561 1.544 . . . . 0.0 109.624 167.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.87 -36.04 78.24 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.016 166.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -64.66 -43.66 92.91 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -63.26 -46.2 87.97 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.292 0.951 . . . . 0.0 111.122 174.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 46.5 t -65.56 -33.76 76.67 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -62.08 -56.46 18.73 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.989 -1.07 . . . . 0.0 111.349 171.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.6 p -73.49 -41.08 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 120.721 -1.237 . . . . 0.0 113.207 -173.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -67.99 -50.9 52.82 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.665 0.786 . . . . 0.0 112.491 -173.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -68.14 -27.62 66.59 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.7 0.682 . . . . 0.0 111.991 -172.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -89.4 -30.4 18.38 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.4 -38.54 74.45 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 120.183 1.356 . . . . 0.0 112.529 158.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 19.4 t -58.28 -47.98 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 120.414 1.461 . . . . 0.0 111.884 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -59.66 -50.45 73.83 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.755 0.822 . . . . 0.0 113.193 172.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.57 -42.95 99.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -176.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.3 mt -63.38 -50.81 77.16 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.035 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.56 -36.46 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 119.926 1.239 . . . . 0.0 112.544 -173.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.1 tt -62.13 -47.71 83.35 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.277 1.031 . . . . 0.0 111.616 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 32.6 m -75.9 -40.89 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.747 0.703 . . . . 0.0 111.053 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 12.5 t -49.66 -58.27 5.6 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.351 1.86 . . . . 0.0 112.834 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 69.5 mt -77.28 -32.42 55.53 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.273 -0.892 . . . . 0.0 112.987 -173.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.9 mt -68.96 -46.14 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 120.038 1.29 . . . . 0.0 110.406 171.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -61.59 -30.33 70.61 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.806 175.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.8 m -60.08 -38.42 82.84 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.445 1.475 . . . . 0.0 113.212 172.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 50.7 t -67.27 -24.04 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 123.924 0.89 . . . . 0.0 111.807 174.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 46.2 mt -87.75 -48.33 7.94 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.292 1.037 . . . . 0.0 113.208 173.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 59.4 p -71.12 -12.41 61.48 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 127.497 2.319 . . . . 0.0 113.531 -171.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.7 t -70.63 -32.67 70.07 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.663 1.185 . . . . 0.0 111.444 170.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 48.4 mm -72.6 -33.35 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.712 0.805 . . . . 0.0 110.64 168.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -66.31 -33.29 75.39 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.271 0.628 . . . . 0.0 112.187 169.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -65.2 -40.86 94.76 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.843 1.257 . . . . 0.0 111.595 170.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -69.27 -34.4 74.69 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.338 0.655 . . . . 0.0 112.379 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.03 98.14 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.852 0.861 . . . . 0.0 111.722 167.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.13 -10.27 9.89 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 76.3 mt -70.78 -12.31 61.47 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.117 1.367 . . . . 0.0 113.738 166.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -152.56 -45.73 0.1 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -163.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.6 t -156.26 175.65 13.71 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.746 0.819 . . . . 0.0 110.833 -143.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.1 139.62 48.27 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 114.628 0.611 . . . . 0.0 114.628 -166.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.1 t -156.26 143.84 19.33 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -162.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 16.7 tp -87.18 7.89 26.27 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.882 1.273 . . . . 0.0 112.624 171.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -65.59 -10.98 40.27 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 119.546 -1.972 . . . . 0.0 114.093 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 53.7 p-90 -65.3 -26.46 68.08 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.057 -1.652 . . . . 0.0 112.492 166.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 51.0 tpp -75.36 -28.75 59.66 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.652 1.581 . . . . 0.0 112.261 174.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -61.24 -43.8 98.29 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.133 -0.979 . . . . 0.0 110.453 165.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.12 -35.26 73.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 118.096 -0.954 . . . . 0.0 111.3 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.43 -53.0 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 120.66 1.573 . . . . 0.0 111.745 170.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.8 mt -68.18 -36.8 80.16 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.239 0.927 . . . . 0.0 112.411 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 38.0 t -59.29 -41.47 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 120.666 1.576 . . . . 0.0 111.092 172.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.17 -31.13 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.502 -0.761 . . . . 0.0 111.05 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -59.66 -51.94 67.65 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.601 1.092 . . . . 0.0 111.752 165.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -62.47 -36.77 83.53 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 121.226 1.83 . . . . 0.0 112.055 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -62.31 -43.87 98.47 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 172.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 56.0 m -67.27 -32.81 74.06 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.401 -1.058 . . . . 0.0 110.895 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -65.42 -41.96 93.0 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 120.738 -1.226 . . . . 0.0 112.344 173.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -58.35 -45.71 87.66 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.529 0.604 . . . . 0.0 111.832 170.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.4 t -66.04 -38.18 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.816 0.846 . . . . 0.0 111.515 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 23.1 t -65.23 -38.83 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.004 1.322 . . . . 0.0 110.967 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -62.47 -34.26 76.49 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.585 1.084 . . . . 0.0 113.335 171.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 9.7 mt -67.96 -47.34 68.87 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.915 0.779 . . . . 0.0 111.875 169.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -61.91 -43.51 98.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 118.013 -0.994 . . . . 0.0 112.858 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.434 ' HA ' ' HB3' ' A' ' 111' ' ' TYR 0.265 43.0 p -65.49 -26.98 68.16 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 176.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.448 ' HB1' ' C ' ' A' ' 186' ' ' GLY . . . -57.23 -25.14 58.62 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.801 1.182 . . . . 0.0 113.247 168.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.412 ' CA ' ' HA ' ' A' ' 183' ' ' LYS . . . -70.49 -9.65 65.17 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 126.098 1.808 . . . . 0.0 114.643 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 44.1 t -53.82 -40.34 66.3 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.263 1.025 . . . . 0.0 112.382 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 3.1 ptp85 -68.51 -57.83 5.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.577 0.751 . . . . 0.0 111.803 171.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 41.7 t -162.96 137.67 6.46 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.498 1.919 . . . . 0.0 108.009 169.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.412 ' HA ' ' CA ' ' A' ' 179' ' ' GLY . 18.0 ptmt -60.28 -34.02 73.15 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -153.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -103.03 -27.19 12.74 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.209 1.004 . . . . 0.0 112.765 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 61.3 t -62.21 -68.08 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.068 1.347 . . . . 0.0 111.325 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.448 ' C ' ' HB1' ' A' ' 178' ' ' ALA . . . -61.0 -31.04 75.06 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 119.128 -0.818 . . . . 0.0 112.195 -178.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 7.9 tt -66.94 -39.93 87.45 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.61 1.564 . . . . 0.0 112.449 176.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 4.7 t-105 -60.26 -40.47 90.48 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 120.804 -1.185 . . . . 0.0 110.844 166.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -64.89 -30.31 77.65 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 122.226 0.903 . . . . 0.0 113.385 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 -76.3 -32.49 58.79 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.866 2.466 . . . . 0.0 112.312 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 75.1 mt -76.0 -35.35 59.59 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.943 1.297 . . . . 0.0 112.662 167.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 65.0 mtt-85 -59.67 -36.49 76.54 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.819 -1.176 . . . . 0.0 111.456 166.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -69.49 28.5 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 126.298 1.839 . . . . 0.0 113.994 170.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.66 27.95 1.21 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.598 2.359 . . . . 0.0 112.991 164.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -105.99 -37.08 6.76 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -149.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -77.86 146.81 72.92 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 117.265 -1.35 . . . . 0.0 109.868 172.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -45.22 -44.21 15.96 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.694 3.596 . . . . 0.0 116.901 -171.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -70.27 -30.38 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 119.353 0.979 . . . . 0.0 110.93 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.446 ' HA ' ' HB3' ' A' ' 202' ' ' ASP . 66.7 m -81.68 -26.83 34.38 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.509 1.523 . . . . 0.0 112.997 176.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.96 -48.14 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 163.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 65.5 mt -65.01 -30.08 49.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-O 118.689 -0.672 . . . . 0.0 111.566 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.446 ' HB3' ' HA ' ' A' ' 199' ' ' SER . 29.1 t70 -71.53 -44.52 64.46 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.496 1.498 . . . . 0.0 110.542 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 43.4 tp -61.6 -44.29 97.28 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.635 0.774 . . . . 0.0 111.403 171.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 72.2 mt -63.26 -49.1 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 121.393 -0.817 . . . . 0.0 110.804 176.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.0 t -70.39 -33.96 56.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 117.098 -1.429 . . . . 0.0 112.427 -173.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.5 p -65.38 -34.76 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 121.568 1.986 . . . . 0.0 111.394 172.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 86.9 t -75.17 -38.47 41.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 O-C-N 121.372 -0.83 . . . . 0.0 110.063 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -55.75 -47.26 77.27 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.697 0.68 . . . . 0.0 110.82 168.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 20.0 m -56.16 -43.48 78.39 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.148 0.979 . . . . 0.0 111.783 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 58.6 ttm -75.55 -50.3 16.02 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.276 0.631 . . . . 0.0 111.752 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 56.0 t -56.06 -46.74 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.066 0.946 . . . . 0.0 111.837 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 222' ' ' PHE . 13.9 m -77.01 -39.71 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 118.974 0.806 . . . . 0.0 113.035 -173.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -56.91 -32.87 66.37 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.919 0.887 . . . . 0.0 110.746 170.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 55.2 m -75.48 -52.15 11.36 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.376 1.471 . . . . 0.0 112.97 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.7 t -58.17 -40.25 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 125.265 1.426 . . . . 0.0 112.369 -171.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 139.35 154.66 6.41 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 123.595 0.617 . . . . 0.0 112.374 173.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 55.1 p -73.56 23.21 0.07 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -160.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm -156.41 165.39 36.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.477 1.911 . . . . 0.0 111.933 -160.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -78.01 -80.31 0.7 Allowed Glycine 0 N--CA 1.478 1.434 0 C-N-CA 127.462 2.458 . . . . 0.0 109.386 -9.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -84.77 -27.17 27.06 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.927 1.291 . . . . 0.0 110.827 161.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 73.5 t -76.7 -40.91 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 121.179 -0.951 . . . . 0.0 112.42 -145.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.428 ' HA ' ' HB ' ' A' ' 212' ' ' VAL . 0.0 OUTLIER -60.01 -39.81 87.07 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 169.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -74.17 -49.8 22.02 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.764 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 8.8 t -53.77 -38.4 64.42 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 121.123 1.783 . . . . 0.0 112.219 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 19.3 m -66.05 -56.85 9.48 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.505 -0.747 . . . . 0.0 112.357 173.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.54 -48.37 77.8 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.931 1.293 . . . . 0.0 112.496 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 67.2 mt -62.72 -84.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.79 0 O-C-N 119.255 -2.153 . . . . 0.0 109.133 169.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -71.87 -38.28 70.05 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.778 -152.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -71.05 -44.21 55.19 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 125.991 1.758 . . . . 0.0 114.32 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.5 mp -78.26 -30.18 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 118.773 1.286 . . . . 0.0 109.74 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -39.91 82.34 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 120.841 -1.162 . . . . 0.0 111.57 164.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -68.01 -41.48 82.14 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 117.385 -1.293 . . . . 0.0 110.73 -174.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 31.9 tp -57.43 -45.16 84.97 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.154 0.888 . . . . 0.0 110.856 167.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -59.09 -45.94 89.57 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -170.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.4 pt -66.93 -20.8 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 35.4 mt -66.88 -22.87 65.96 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.285 -0.884 . . . . 0.0 110.756 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -74.65 -11.35 60.16 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.263 -0.898 . . . . 0.0 111.731 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 81.2 mtp -45.79 -33.72 3.26 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 126.025 1.73 . . . . 0.0 113.1 153.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.3 mt -98.56 -14.02 20.14 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.346 1.459 . . . . 0.0 111.304 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 50.0 m170 -75.31 -27.49 59.31 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.681 -0.637 . . . . 0.0 111.495 157.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.251 15.5 t . . . . . 0 N--CA 1.471 0.588 0 CA-C-O 125.557 2.599 . . . . 0.0 110.027 157.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.55 0.979 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.2 t -63.42 -33.28 75.21 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 168.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -79.85 -30.39 40.31 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.439 -1.413 . . . . 0.0 110.763 -174.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.3 m -84.1 -34.25 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-O 121.845 0.831 . . . . 0.0 112.334 -174.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -52.74 -47.83 67.12 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.321 -1.308 . . . . 0.0 110.348 156.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -56.12 -36.83 69.37 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 118.928 -0.929 . . . . 0.0 113.613 169.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -70.11 -36.07 74.59 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.942 1.371 . . . . 0.0 112.089 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 t -57.0 -57.02 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.49 0.716 . . . . 0.0 109.87 162.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.419 ' HB3' ' HA ' ' A' ' 177' ' ' SER . 20.5 m-85 -58.76 -45.79 88.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.483 0.313 . . . . 0.0 111.623 -172.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -67.68 -21.54 65.33 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -77.0 -36.45 56.4 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.349 0.977 . . . . 0.0 111.294 172.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.8 mt -62.0 -40.79 96.85 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.799 -0.563 . . . . 0.0 109.735 164.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -71.75 -44.0 64.83 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.973 -167.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -98.87 101.72 13.0 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 126.632 1.973 . . . . 0.0 110.683 -174.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -65.17 156.95 60.14 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.49 2.126 . . . . 0.0 114.97 -164.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 40.4 p -145.31 168.14 21.17 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 127.107 2.163 . . . . 0.0 107.692 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.1 -35.14 32.94 Favored Glycine 0 CA--C 1.536 1.389 0 O-C-N 121.627 -0.671 . . . . 0.0 112.282 164.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 33.9 m95 -69.13 -34.45 75.04 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -60.87 -51.18 70.38 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.66 1.118 . . . . 0.0 110.51 169.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 42.8 t -63.09 -37.19 86.23 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.265 0.626 . . . . 0.0 111.573 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -58.96 -59.26 5.75 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.023 0.44 . . . . 0.0 109.844 173.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.86 -49.37 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.012 0.525 . . . . 0.0 111.993 -168.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -68.39 -46.2 70.65 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -170.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -77.89 -27.92 49.76 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.566 -0.709 . . . . 0.0 112.113 -172.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -68.78 -44.86 72.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.997 165.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -51.78 -48.91 63.59 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 117.314 -1.327 . . . . 0.0 113.96 168.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . 0.265 0.9 OUTLIER -63.82 -41.5 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 121.76 2.073 . . . . 0.0 112.293 -179.126 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -67.27 -43.17 82.47 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.742 0.701 . . . . 0.0 111.849 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 85.4 mt -66.1 -41.85 90.05 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.612 0.365 . . . . 0.0 111.766 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 69.4 mt -64.26 -47.74 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 118.011 -0.995 . . . . 0.0 111.194 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -40.32 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 120.495 1.498 . . . . 0.0 111.378 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 33.8 tp -59.43 -43.69 93.04 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.624 1.17 . . . . 0.0 111.658 175.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.8 t -64.3 -45.79 95.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 118.694 -0.669 . . . . 0.0 111.356 171.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 90.5 m -63.7 -39.98 95.64 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.172 0.896 . . . . 0.0 112.385 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 87.5 mt -79.49 -37.27 37.17 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.419 -0.801 . . . . 0.0 112.686 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.3 mt -59.25 -48.32 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.301 0.572 . . . . 0.0 109.94 167.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -60.96 -36.3 79.03 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-O 117.726 -1.131 . . . . 0.0 110.845 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.9 m -55.41 -44.49 76.24 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 121.538 1.972 . . . . 0.0 112.444 -176.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.3 m -79.28 -16.04 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 78.4 mt -81.98 -28.41 32.66 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 120.074 1.306 . . . . 0.0 113.554 161.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 37.8 t -78.5 -38.67 40.2 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.808 1.643 . . . . 0.0 113.579 -160.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . 0.336 3.4 t -74.28 -17.19 60.89 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 120.295 1.407 . . . . 0.0 113.312 -175.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.1 mp -58.89 -43.13 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 120.587 -1.32 . . . . 0.0 110.959 159.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -69.52 -41.04 76.54 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.479 1.111 . . . . 0.0 110.669 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -59.04 -41.6 88.21 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.779 1.232 . . . . 0.0 111.647 171.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -67.99 -40.83 83.0 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.782 -1.199 . . . . 0.0 110.922 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.94 -33.47 73.23 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.615 0.766 . . . . 0.0 111.481 172.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.28 -8.66 8.98 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 72.3 mt -70.71 -11.93 61.25 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 120.249 -1.532 . . . . 0.0 113.482 166.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.49 -45.54 0.17 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -170.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.1 t -157.52 -178.66 7.5 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.806 0.813 . . . . 0.0 112.402 -138.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.13 134.99 52.11 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 124.609 1.099 . . . . 0.0 114.445 -170.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.5 t -155.07 137.52 15.01 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.227 1.011 . . . . 0.0 112.735 -160.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.6 tp -81.09 6.13 14.58 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.988 1.315 . . . . 0.0 113.342 166.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -64.93 -9.01 17.98 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 119.664 -1.897 . . . . 0.0 114.484 -173.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -68.73 -28.33 66.73 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.22 1.008 . . . . 0.0 112.129 167.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 50.6 tpp -66.24 -25.4 66.88 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.985 1.266 . . . . 0.0 111.862 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -63.99 -45.28 89.7 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.21 -0.931 . . . . 0.0 111.276 170.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 33.5 mt -57.48 -43.23 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.41 1.084 . . . . 0.0 111.087 172.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.3 t -61.35 -42.85 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 121.391 -0.818 . . . . 0.0 112.271 176.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 10.7 mt -71.84 -36.17 70.09 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.618 1.099 . . . . 0.0 113.233 173.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 45.2 t -59.54 -34.05 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 O-C-N 120.809 -1.182 . . . . 0.0 110.937 169.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 81.6 t -82.15 -26.75 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.315 1.046 . . . . 0.0 111.236 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -61.41 -56.72 17.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.29 1.404 . . . . 0.0 110.225 166.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -64.84 -39.09 93.01 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.221 0.919 . . . . 0.0 112.071 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -61.8 -42.85 99.8 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.638 1.113 . . . . 0.0 113.255 175.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.8 m -78.6 -30.31 46.55 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.997 1.398 . . . . 0.0 111.701 175.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.75 -41.11 97.23 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.898 -1.126 . . . . 0.0 111.851 170.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -53.09 -45.98 68.44 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.72 0.691 . . . . 0.0 110.571 169.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 92.5 t -68.22 -37.66 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.407 0.683 . . . . 0.0 112.006 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 39.3 t -63.21 -36.05 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 121.215 -0.928 . . . . 0.0 112.342 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -58.45 -38.8 78.27 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.279 0.945 . . . . 0.0 111.954 169.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 33.3 mt -72.97 -34.28 66.37 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -70.78 -39.84 72.96 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 173.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.419 ' HA ' ' HB3' ' A' ' 111' ' ' TYR . 17.6 p -62.35 -20.96 64.92 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 120.439 -1.413 . . . . 0.0 114.724 165.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -70.77 -6.63 39.1 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 120.203 1.365 . . . . 0.0 113.862 163.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -154.97 44.69 0.55 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.553 1.549 . . . . 0.0 112.986 -160.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 25.8 p -51.94 -24.53 6.55 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.028 0.931 . . . . 0.0 113.248 169.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.92 -53.41 2.28 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.76 2.024 . . . . 0.0 110.175 161.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.8 m -76.04 48.14 0.48 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 128.42 2.688 . . . . 0.0 112.563 -172.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -55.52 -19.24 9.18 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.939 2.496 . . . . 0.0 115.447 -169.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -114.18 -29.19 7.04 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 169.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 2.0 t -65.15 -61.68 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 119.907 1.231 . . . . 0.0 111.197 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -73.44 -28.45 65.73 Favored Glycine 0 C--O 1.222 -0.647 0 O-C-N 121.929 -0.482 . . . . 0.0 112.525 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 3.0 tt -53.34 -41.03 65.34 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.509 0.724 . . . . 0.0 110.773 166.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -85.93 -18.21 33.32 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.02 -37.08 16.62 Favored Glycine 0 N--CA 1.467 0.727 0 O-C-N 119.728 -1.858 . . . . 0.0 110.418 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -67.13 -25.49 66.21 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.942 1.697 . . . . 0.0 112.704 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 21.7 mt -76.0 -1.32 25.15 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 165.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 37.6 mtm105 -122.98 -8.11 8.34 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.321 1.848 . . . . 0.0 113.432 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -72.81 66.68 0.77 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.936 1.694 . . . . 0.0 108.409 149.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -148.36 82.26 1.48 Allowed 'General case' 0 C--O 1.239 0.501 0 C-N-CA 127.625 2.37 . . . . 0.0 107.432 -156.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 48.8 ttt85 -147.42 -73.69 0.2 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -154.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -72.83 154.94 91.04 Favored Pre-proline 0 N--CA 1.474 0.764 0 CA-C-N 119.28 0.945 . . . . 0.0 112.865 175.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.92 -45.61 24.23 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.893 3.062 . . . . 0.0 116.704 -168.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 69.4 mt -64.15 -35.4 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 121.525 1.966 . . . . 0.0 111.554 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 54.6 p -70.51 -31.1 68.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.8 1.182 . . . . 0.0 112.937 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.4 mm -75.39 -40.52 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.443 1.097 . . . . 0.0 111.13 172.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 56.4 mt -61.91 -41.78 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.146 0.978 . . . . 0.0 110.429 171.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.73 -43.21 97.16 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.834 1.654 . . . . 0.0 111.794 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 68.4 tp -60.98 -49.25 78.22 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.925 0.89 . . . . 0.0 112.687 170.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 61.9 mt -62.28 -44.55 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.167 -0.958 . . . . 0.0 110.53 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.0 t -69.11 -34.53 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 116.823 -1.561 . . . . 0.0 113.073 -174.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.1 p -68.22 -33.08 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 121.677 2.035 . . . . 0.0 111.6 173.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 82.4 t -77.37 -40.37 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 O-C-N 121.456 -0.777 . . . . 0.0 109.988 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.467 ' O ' HG22 ' A' ' 212' ' ' VAL . . . -54.76 -52.03 63.84 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.118 0.967 . . . . 0.0 110.758 167.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.4 m -56.06 -47.42 77.96 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.807 0.843 . . . . 0.0 112.344 -178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 72.5 mtm -59.73 -48.72 80.57 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 174.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.57 -44.04 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 118.547 0.612 . . . . 0.0 112.323 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 208' ' ' ALA . 27.2 m -84.67 -24.81 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 117.525 -1.226 . . . . 0.0 112.368 -167.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 38.9 mt -63.1 -30.69 71.79 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.561 1.528 . . . . 0.0 112.043 156.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 43.3 t -83.67 -45.73 13.1 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.841 0.856 . . . . 0.0 113.166 -164.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 9.5 t -50.94 -30.16 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 125.975 1.71 . . . . 0.0 114.474 -173.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 131.52 157.41 8.76 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 126.603 2.049 . . . . 0.0 109.771 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 90.3 p -81.76 34.44 0.39 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.89 -1.359 . . . . 0.0 113.663 -168.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -171.05 177.94 3.53 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 130.289 3.436 . . . . 0.0 109.092 176.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 63.36 112.48 0.01 OUTLIER Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 115.765 -3.112 . . . . 0.0 107.626 -111.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.43 -8.41 0.13 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.845 0.831 . . . . 0.0 111.89 160.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.452 ' HA ' HG22 ' A' ' 224' ' ' THR . 0.5 OUTLIER -67.66 -44.45 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 127.35 2.26 . . . . 0.0 112.138 174.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -50.12 -52.13 37.55 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.345 1.458 . . . . 0.0 110.652 169.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.33 -59.89 3.28 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.494 1.118 . . . . 0.0 110.418 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 221' ' ' VAL . 13.8 t -59.8 -42.12 92.73 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.458 ' HB2' HG21 ' A' ' 212' ' ' VAL . 21.6 m -69.13 -45.06 71.07 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.14 -0.975 . . . . 0.0 110.893 -173.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -53.36 -62.98 1.3 Allowed 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 126.073 1.749 . . . . 0.0 110.975 170.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.4 mt -56.4 -72.71 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 123.52 1.629 . . . . 0.0 111.141 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -73.7 -44.72 55.75 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 112.715 -2.039 . . . . 0.0 106.959 -152.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -65.87 -52.88 34.28 Favored Glycine 0 N--CA 1.466 0.667 0 C-N-CA 125.021 1.296 . . . . 0.0 114.41 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.72 -38.72 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.489 1.645 . . . . 0.0 111.275 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -82.82 -28.86 29.92 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -175.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -55.38 -43.4 75.12 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.051 1.341 . . . . 0.0 109.27 168.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 57.0 tp -65.07 -38.21 90.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 117.723 -1.132 . . . . 0.0 111.816 173.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -66.09 -37.94 87.02 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 121.899 2.136 . . . . 0.0 112.547 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 35.6 pt -69.52 -10.83 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 114.981 1.475 . . . . 0.0 114.981 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 11.1 mt -78.96 -20.6 48.79 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 120.918 -1.114 . . . . 0.0 110.944 167.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . 0.268 53.9 mtp180 -73.08 -19.28 61.2 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.668 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 89.2 mtp -48.63 -16.26 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 129.7 3.2 . . . . 0.0 117.059 156.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.6 pp -143.81 -19.98 0.59 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.679 1.127 . . . . 0.0 112.913 -174.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -75.63 -8.41 56.72 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.645 1.178 . . . . 0.0 111.853 157.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 CA--C 1.495 -1.152 0 CA-C-O 124.188 1.947 . . . . 0.0 107.858 171.669 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.3 m . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.1 tp -100.43 62.45 1.07 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 129.159 2.984 . . . . 0.0 111.904 -5.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -92.91 -125.55 0.09 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 125.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.31 -43.11 0.34 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 130.363 3.465 . . . . 0.0 114.269 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.4 t -114.68 -43.78 3.12 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 127.23 2.212 . . . . 0.0 110.144 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -73.27 56.23 0.47 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.008 1.723 . . . . 0.0 112.274 167.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.3 p -169.89 -36.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 130.491 3.516 . . . . 0.0 109.581 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -83.6 -49.89 8.75 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.632 1.173 . . . . 0.0 109.661 170.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -55.45 -24.26 37.74 Favored Glycine 0 CA--C 1.537 1.433 0 O-C-N 120.722 -1.236 . . . . 0.0 113.006 164.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . 0.275 0.3 OUTLIER -77.22 -42.57 36.88 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.29 1.036 . . . . 0.0 112.391 174.141 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 t -53.39 -52.05 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.68 1.192 . . . . 0.0 110.336 165.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -72.29 -9.64 58.75 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -84.96 -46.22 11.44 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 119.464 1.029 . . . . 0.0 110.527 162.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -66.65 -46.1 76.84 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.344 1.058 . . . . 0.0 111.434 -169.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pp -71.37 -14.29 62.13 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -109.11 -32.54 7.19 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.722 0.809 . . . . 0.0 113.178 -172.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -80.63 111.5 23.59 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.6 1.16 . . . . 0.0 111.621 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -69.1 119.99 6.91 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.928 1.752 . . . . 0.0 110.066 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.0 p -145.43 178.68 7.93 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.855 1.262 . . . . 0.0 108.84 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -53.84 -42.29 68.83 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.222 -0.766 . . . . 0.0 111.518 164.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -66.59 -47.02 74.04 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -59.08 -50.54 73.68 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.933 0.788 . . . . 0.0 109.795 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 13.0 t -56.75 -50.41 72.32 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.27 0.628 . . . . 0.0 111.752 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -60.55 -52.13 66.5 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 121.774 -0.579 . . . . 0.0 112.25 -174.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.8 t -87.31 -39.52 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.343 -0.848 . . . . 0.0 113.172 -170.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -69.59 -41.5 75.7 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.351 0.66 . . . . 0.0 111.016 -171.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -81.39 -25.59 36.14 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -176.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -57.61 -51.63 68.74 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.498 1.044 . . . . 0.0 110.857 161.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.16 -43.13 73.97 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 173.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . 0.289 1.2 m -63.85 -42.26 95.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-N 121.55 1.977 . . . . 0.0 112.114 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -66.5 -42.72 86.95 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.093 1.315 . . . . 0.0 111.593 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.77 -48.38 81.91 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.905 0.482 . . . . 0.0 109.913 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.04 -43.68 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 117.933 -1.032 . . . . 0.0 111.018 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.95 -39.49 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 120.592 1.542 . . . . 0.0 113.158 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 63.3 tp -63.53 -45.49 90.37 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.955 1.302 . . . . 0.0 111.032 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.69 -53.25 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.504 0.722 . . . . 0.0 110.781 174.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 63.7 m -61.42 -35.58 77.95 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.479 1.512 . . . . 0.0 113.09 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.4 mt -81.08 -37.53 28.83 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.166 1.348 . . . . 0.0 113.552 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.57 -44.44 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 119.258 0.935 . . . . 0.0 109.511 168.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -64.34 -31.71 73.03 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-O 117.614 -1.184 . . . . 0.0 112.409 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.4 t -63.45 -43.59 96.94 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 121.103 1.774 . . . . 0.0 112.394 176.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 90.2 t -59.7 -39.53 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.764 1.226 . . . . 0.0 111.612 174.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 30.6 tp -71.72 -47.31 54.78 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.367 1.067 . . . . 0.0 112.358 174.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.9 t -59.53 -37.59 78.77 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.744 2.418 . . . . 0.0 112.929 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.8 t -76.77 1.7 16.51 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.0 -1.062 . . . . 0.0 113.027 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.0 mm -113.26 -35.65 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 127.225 2.21 . . . . 0.0 112.165 165.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -55.55 -31.53 62.22 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.282 1.033 . . . . 0.0 113.174 168.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -61.52 -22.09 64.82 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -93.42 -28.53 16.08 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.207 1.003 . . . . 0.0 111.702 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.36 -35.09 79.76 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.087 0.955 . . . . 0.0 111.067 168.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.91 -6.55 3.92 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.145 1.378 . . . . 0.0 114.396 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.4 mt -84.46 -15.3 46.55 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.382 1.473 . . . . 0.0 113.414 170.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.25 -38.87 1.06 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -163.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.8 t -157.45 177.26 11.63 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.429 -0.794 . . . . 0.0 111.984 -148.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -72.01 156.24 52.3 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 121.519 0.51 . . . . 0.0 113.042 173.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.7 t -164.26 151.58 11.88 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.548 -0.972 . . . . 0.0 112.337 -166.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 33.9 mt -73.04 -0.12 13.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.388 1.475 . . . . 0.0 113.584 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -54.34 -26.32 29.1 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.605 1.562 . . . . 0.0 114.449 -173.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -52.59 -32.3 40.62 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.743 1.217 . . . . 0.0 114.071 171.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 17.8 tpt -71.06 -18.63 62.55 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.248 0.619 . . . . 0.0 112.562 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -67.42 -38.45 84.62 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.674 -1.266 . . . . 0.0 111.664 169.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.6 mp -66.87 -37.49 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 122.845 0.458 . . . . 0.0 110.384 174.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.65 -49.95 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.568 0.747 . . . . 0.0 111.698 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.8 mt -71.86 -28.99 63.91 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 20.5 t -61.36 -40.06 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 120.338 1.426 . . . . 0.0 111.951 165.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.9 t -68.71 -37.01 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 119.205 0.911 . . . . 0.0 111.047 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -57.89 -56.72 18.35 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.812 0.733 . . . . 0.0 111.272 168.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -67.03 -38.88 86.68 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.464 1.029 . . . . 0.0 113.392 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -61.72 -45.61 95.91 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 123.877 0.751 . . . . 0.0 111.61 172.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 89.2 m -63.14 -43.39 98.49 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 117.617 0.709 . . . . 0.0 111.382 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -62.18 -33.01 73.71 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.076 1.75 . . . . 0.0 112.864 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -66.38 -45.77 78.94 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.39 -0.819 . . . . 0.0 111.757 170.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.8 t -70.97 -32.22 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.964 0.906 . . . . 0.0 112.25 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.6 t -60.62 -37.79 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.344 1.458 . . . . 0.0 111.919 174.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 37.0 mtm180 -62.65 -43.18 99.47 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.531 0.605 . . . . 0.0 111.998 167.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 48.6 mt -62.89 -32.23 73.45 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 120.996 -1.065 . . . . 0.0 113.447 175.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 29.4 m0 -70.66 -35.78 73.04 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.277 -0.889 . . . . 0.0 113.241 170.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 94.2 p -78.59 13.53 1.59 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 121.153 1.797 . . . . 0.0 114.863 165.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -47.9 -44.52 29.73 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.58 1.082 . . . . 0.0 111.43 160.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -162.72 23.49 0.2 Allowed Glycine 0 CA--C 1.531 1.087 0 CA-C-O 118.372 -1.238 . . . . 0.0 115.336 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 62.5 m 69.13 -39.95 0.44 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.004 2.122 . . . . 0.0 116.574 168.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.31 -9.32 15.5 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.735 1.614 . . . . 0.0 113.837 164.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.495 ' HB2' ' H ' ' A' ' 186' ' ' GLY . 86.9 p -72.08 25.73 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.689 2.396 . . . . 0.0 115.465 -169.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.31 -0.52 17.33 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 -158.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -109.94 -43.37 4.01 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.916 1.287 . . . . 0.0 111.112 153.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.62 -73.42 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.867 1.267 . . . . 0.0 112.832 -170.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.495 ' H ' ' HB2' ' A' ' 182' ' ' SER . . . -78.68 -9.42 87.08 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.212 1.387 . . . . 0.0 113.946 175.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.451 HD13 ' C ' ' A' ' 187' ' ' LEU . 0.4 OUTLIER -55.56 -44.41 76.79 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.927 0.863 . . . . 0.0 109.913 167.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 34.6 t-105 -76.3 -50.31 14.69 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.671 -0.643 . . . . 0.0 112.289 161.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -56.58 -33.8 63.13 Favored Glycine 0 CA--C 1.535 1.307 0 N-CA-C 116.513 1.365 . . . . 0.0 116.513 -167.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -83.88 -21.52 31.92 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.328 1.564 . . . . 0.0 113.841 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.423 HD21 HD13 ' A' ' 203' ' ' LEU . 2.5 tt -73.02 -45.18 59.2 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -55.24 -39.09 69.33 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.235 166.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -70.27 -15.15 62.86 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -80.71 57.93 3.13 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 120.849 -1.157 . . . . 0.0 113.36 -171.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 43.3 mtt-85 -93.69 -14.37 26.44 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.221 1.808 . . . . 0.0 115.295 -161.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -77.57 164.7 56.39 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 124.695 1.198 . . . . 0.0 111.087 -176.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -60.25 -46.3 19.07 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.704 1.602 . . . . 0.0 114.274 -160.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 50.9 mm -66.67 -34.78 72.31 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 CA-C-N 117.975 0.352 . . . . 0.0 111.281 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 15.9 m -69.07 -37.14 78.34 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.282 1.433 . . . . 0.0 112.507 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 30.1 mm -66.8 -42.99 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.561 0.744 . . . . 0.0 110.718 170.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.1 mt -62.56 -41.58 92.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 O-C-N 121.175 -0.953 . . . . 0.0 111.051 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -64.91 -43.05 94.11 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.426 1.89 . . . . 0.0 110.181 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.423 HD13 HD21 ' A' ' 191' ' ' LEU . 45.9 tp -59.41 -50.51 73.67 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 169.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 44.2 mt -60.03 -43.39 92.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 O-C-N 121.392 -0.817 . . . . 0.0 111.226 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.7 t -72.68 -29.23 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 117.667 -1.158 . . . . 0.0 112.471 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.48 -39.01 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 121.55 1.977 . . . . 0.0 111.174 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 28.6 m -74.44 -35.68 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 118.367 0.53 . . . . 0.0 111.189 176.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.39 -45.25 84.68 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 118.202 0.455 . . . . 0.0 111.407 168.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 36.0 t -61.71 -38.42 87.81 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.345 1.458 . . . . 0.0 112.118 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 36.3 mmt -71.67 -41.03 69.2 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 171.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 10.3 t -60.49 -38.84 79.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 118.642 0.655 . . . . 0.0 111.052 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.415 HG21 ' CB ' ' A' ' 225' ' ' SER . 3.4 t -61.34 -46.32 96.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 127.624 2.369 . . . . 0.0 111.493 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 61.5 mt -58.94 -41.18 86.77 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.475 1.034 . . . . 0.0 111.568 166.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 11.4 t -74.48 -31.45 62.22 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -165.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 84.9 t -66.76 -20.25 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.203 1.001 . . . . 0.0 111.56 173.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 106.41 156.47 21.35 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 124.295 0.95 . . . . 0.0 111.619 -166.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 41.2 p -62.01 17.86 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 128.519 2.727 . . . . 0.0 115.203 172.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 15.3 mttp -166.34 174.27 9.24 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 129.714 3.206 . . . . 0.0 110.012 -176.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 69.5 104.92 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 105.269 -3.133 . . . . 0.0 105.269 -113.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -59.4 3.74 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.936 0 O-C-N 121.744 -0.857 . . . . 0.0 112.211 170.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 23.2 m -79.7 -35.12 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 127.296 2.238 . . . . 0.0 112.71 167.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.2 -47.37 68.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.288 1.404 . . . . 0.0 109.799 163.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -62.44 -52.49 63.35 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.08 0.552 . . . . 0.0 111.496 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.88 -35.36 74.65 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.456 1.025 . . . . 0.0 112.316 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.415 ' CB ' HG21 ' A' ' 212' ' ' VAL . 17.0 m -75.18 -36.72 61.45 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.489 1.041 . . . . 0.0 112.773 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.28 -46.91 76.16 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.482 -0.761 . . . . 0.0 110.308 169.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.0 mt -66.79 -82.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 125.301 1.44 . . . . 0.0 110.974 172.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.49 ' HA ' ' CD1' ' A' ' 232' ' ' PHE . 48.1 mtt180 -77.74 14.52 1.04 Allowed 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 130.854 3.661 . . . . 0.0 114.573 -170.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -124.1 -59.58 0.18 Allowed Glycine 0 N--CA 1.462 0.382 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 162.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . 0.343 0.3 OUTLIER -99.97 -2.66 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -163.577 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.42 -39.79 11.79 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 121.229 -0.919 . . . . 0.0 111.871 145.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.49 ' CD1' ' HA ' ' A' ' 228' ' ' ARG . 1.7 m-30 -57.05 -30.57 64.36 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -177.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 7.1 tp -68.88 -31.41 70.32 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.756 -0.59 . . . . 0.0 112.37 172.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -75.45 -35.72 60.86 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.052 1.341 . . . . 0.0 112.505 -168.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -26.71 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.248 1.019 . . . . 0.0 111.639 170.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 62.2 mt -70.92 -28.85 64.81 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.79 0.805 . . . . 0.0 110.44 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -75.6 -25.08 56.68 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.065 2.146 . . . . 0.0 111.914 -171.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 66.6 mtp -46.1 -29.03 1.36 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.859 2.064 . . . . 0.0 115.525 155.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 20.0 mt -112.49 -31.26 6.85 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.858 1.263 . . . . 0.0 109.908 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.43 16.59 0.1 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.931 1.692 . . . . 0.0 114.019 155.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 3.4 p -58.34 111.55 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 CA-C-O 124.273 1.987 . . . . 0.0 110.875 -170.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -82.67 13.95 3.46 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 111.397 -2.638 . . . . 0.0 114.024 -173.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.2 ttt-85 -77.05 17.09 0.47 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.989 2.116 . . . . 0.0 115.032 175.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 76.04 37.67 0.37 Allowed 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 146.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -106.23 -2.34 38.56 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 115.822 1.089 . . . . 0.0 115.822 172.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 71.24 54.16 9.43 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 120.049 1.924 . . . . 0.0 109.818 -161.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 45.5 p -69.36 138.03 53.35 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.931 2.093 . . . . 0.0 113.351 -152.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 85.2 m95 61.56 11.96 4.17 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 . . . . . 0 N--CA 1.477 0.897 0 C-N-CA 125.242 1.417 . . . . 0.0 113.545 -177.048 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.474 ' HA ' ' H ' ' A' ' 102' ' ' ALA . 6.3 m . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.323 27.8 tp 65.74 -95.46 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.619 1 C-N-CA 133.051 4.54 . . . . 0.0 117.962 -10.715 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.474 ' H ' ' HA ' ' A' ' 100' ' ' VAL . . . -58.06 -30.94 66.59 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -159.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -28.04 17.05 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.511 1.124 . . . . 0.0 113.664 174.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.48 -21.72 12.02 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.037 0.935 . . . . 0.0 112.074 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -57.19 -39.76 76.01 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.501 1.5 . . . . 0.0 112.451 168.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.4 p -61.98 -21.7 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 126.606 1.962 . . . . 0.0 113.682 171.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -95.51 -31.42 13.35 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.802 -0.562 . . . . 0.0 111.379 173.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -50.96 -26.47 11.38 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.289 1.424 . . . . 0.0 112.481 162.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -63.44 -48.85 76.06 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.776 0.831 . . . . 0.0 111.714 172.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.3 -57.36 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 123.956 0.902 . . . . 0.0 110.47 167.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -58.93 -46.21 88.5 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.497 1.119 . . . . 0.0 112.39 -167.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -65.86 -25.99 67.45 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 171.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -77.77 -34.93 52.15 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.131 1.332 . . . . 0.0 110.718 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 mt -59.67 -49.15 78.85 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 162.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -74.28 -32.01 62.75 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.162 -162.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -104.88 92.2 4.99 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 127.069 2.148 . . . . 0.0 110.711 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -58.22 128.3 28.14 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.129 1.886 . . . . 0.0 109.678 173.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.1 p -155.69 165.75 35.59 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.414 1.886 . . . . 0.0 107.805 -163.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -49.24 -42.29 32.29 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 118.957 -0.913 . . . . 0.0 111.466 175.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -75.4 -39.07 59.47 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.621 1.71 . . . . 0.0 115.568 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.463 ' HE3' ' CZ ' ' A' ' 125' ' ' TYR . 77.5 tttt -57.06 -50.54 72.44 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.679 1.582 . . . . 0.0 108.855 172.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 46.6 t -57.33 -43.8 83.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.288 1.835 . . . . 0.0 111.867 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -59.08 -57.01 14.94 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.13 -0.981 . . . . 0.0 111.208 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.1 m -81.87 -32.06 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -166.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.463 ' CZ ' ' HE3' ' A' ' 121' ' ' LYS . 6.4 m-85 -64.04 -34.46 78.07 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.216 0.916 . . . . 0.0 111.381 176.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.443 ' CG ' ' HE ' ' A' ' 243' ' ' ARG . 46.1 m170 -77.48 -43.11 33.38 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.846 0.748 . . . . 0.0 110.307 -171.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -67.06 -38.51 85.92 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.255 -0.879 . . . . 0.0 112.446 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.09 -40.24 76.58 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 120.172 1.351 . . . . 0.0 113.14 168.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.84 -41.98 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 121.308 1.867 . . . . 0.0 111.412 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -63.96 -41.93 97.44 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.59 0.632 . . . . 0.0 112.081 175.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.1 tp -73.72 -44.42 56.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.841 0.456 . . . . 0.0 111.892 -173.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.3 mp -67.39 -40.81 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 O-C-N 121.031 -1.043 . . . . 0.0 111.872 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.76 -44.78 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 120.465 1.484 . . . . 0.0 112.062 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 23.7 tp -54.67 -56.36 19.91 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.723 1.609 . . . . 0.0 111.469 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 55.3 t -65.18 -44.39 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 122.715 0.406 . . . . 0.0 111.416 -174.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 73.0 m -71.53 -35.04 70.55 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 91.3 mt -76.73 -37.51 55.87 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.431 1.468 . . . . 0.0 112.521 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 87.7 mt -59.91 -42.25 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 118.852 0.751 . . . . 0.0 109.312 169.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -64.49 -40.13 95.09 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 115.805 -2.045 . . . . 0.0 111.99 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.5 m -49.44 -44.47 45.6 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 121.346 1.884 . . . . 0.0 113.123 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 70.7 t -60.16 -34.91 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.157 0.983 . . . . 0.0 111.88 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.8 tp -85.44 -44.81 12.42 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 169.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 24.2 p -67.69 -30.04 69.46 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.931 1.293 . . . . 0.0 113.252 -167.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.2 t -75.05 -11.64 60.14 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.562 -0.711 . . . . 0.0 112.769 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' A' ' 145' ' ' ILE . 4.5 mm -97.36 -46.89 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 126.069 1.748 . . . . 0.0 111.771 170.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -55.21 -34.1 63.64 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.663 1.185 . . . . 0.0 112.596 173.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -68.13 -21.63 64.92 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.283 -1.51 . . . . 0.0 114.991 173.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -75.38 -26.93 58.88 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 121.05 1.75 . . . . 0.0 109.916 171.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -72.99 -30.09 63.54 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.286 -0.884 . . . . 0.0 112.174 167.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -56.48 -27.41 57.0 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.764 -1.21 . . . . 0.0 114.002 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 73.1 mt -57.35 -28.41 63.12 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.651 1.18 . . . . 0.0 113.688 173.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.11 -42.28 2.02 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.648 1.579 . . . . 0.0 114.451 -165.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.8 t -155.6 -172.7 4.24 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.758 0.79 . . . . 0.0 111.751 -147.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -70.98 140.93 32.08 Favored Glycine 0 CA--C 1.533 1.159 0 O-C-N 121.167 -0.958 . . . . 0.0 114.114 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.8 t -166.21 139.18 4.02 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.367 1.067 . . . . 0.0 112.104 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.5 3.19 2.5 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 171.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -56.79 -10.49 1.06 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.005 1.722 . . . . 0.0 113.686 166.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 33.7 p-90 -62.29 -24.58 67.38 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.861 -1.15 . . . . 0.0 112.787 167.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 69.0 mtm -73.9 -16.89 61.1 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.968 -1.082 . . . . 0.0 113.789 171.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -67.59 -41.35 84.24 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.606 1.548 . . . . 0.0 109.942 165.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 7.2 mt -56.6 -38.93 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 118.419 0.554 . . . . 0.0 111.85 170.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.46 -52.27 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 121.199 -0.938 . . . . 0.0 112.209 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 13.1 mt -67.27 -26.55 66.61 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.289 0.95 . . . . 0.0 112.195 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 6.2 t -64.49 -35.39 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 119.999 -1.688 . . . . 0.0 111.397 169.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 73.1 t -76.48 -30.4 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 118.72 -0.657 . . . . 0.0 110.504 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -62.35 -48.31 80.34 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 119.638 1.108 . . . . 0.0 112.261 167.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -69.04 -39.23 79.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.364 1.438 . . . . 0.0 112.581 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -54.05 -45.85 71.22 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 119.286 0.948 . . . . 0.0 112.954 166.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.9 m -62.05 -40.58 96.26 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.462 0.705 . . . . 0.0 111.707 172.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -60.1 -39.66 86.91 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.485 1.493 . . . . 0.0 112.912 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -71.12 -43.16 68.21 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.94 0.791 . . . . 0.0 111.961 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 90.1 t -72.38 -34.57 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 118.828 -0.605 . . . . 0.0 111.708 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 15.4 t -58.84 -37.23 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.114 1.366 . . . . 0.0 111.542 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -59.72 -46.78 88.07 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.471 1.032 . . . . 0.0 112.049 170.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.03 -23.42 66.55 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 120.456 -1.403 . . . . 0.0 114.288 172.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 54.5 m0 -76.09 -13.57 60.2 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 168.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 6.6 p -61.8 -36.8 82.19 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 121.746 2.066 . . . . 0.0 111.079 164.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.44 -26.62 66.88 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 165.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -68.15 0.78 10.31 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.449 1.976 . . . . 0.0 114.954 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 9.0 t -63.14 -31.87 73.12 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.711 1.756 . . . . 0.0 112.12 165.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.22 -47.58 0.06 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.315 1.446 . . . . 0.0 113.057 164.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 24.4 m -71.74 43.18 0.09 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 128.52 2.728 . . . . 0.0 112.513 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -49.01 -36.52 17.93 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 130.592 3.557 . . . . 0.0 113.53 -170.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -120.35 -36.8 3.15 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 124.374 1.046 . . . . 0.0 112.195 175.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 40.7 t -56.44 -59.42 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.437 1.095 . . . . 0.0 110.852 176.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -74.65 -35.83 50.17 Favored Glycine 0 C--O 1.222 -0.595 0 C-N-CA 124.84 1.21 . . . . 0.0 112.258 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.59 -47.8 75.87 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.956 1.378 . . . . 0.0 112.472 172.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . 0.42 ' CZ2' ' HD2' ' A' ' 192' ' ' ARG . 67.2 t-105 -75.27 -41.02 58.15 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -56.42 -54.53 35.34 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -69.8 -30.62 68.2 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.828 1.314 . . . . 0.0 113.656 -174.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 38.6 tp -62.36 -31.31 71.95 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.631 0.65 . . . . 0.0 112.208 169.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.42 ' HD2' ' CZ2' ' A' ' 188' ' ' TRP . 34.2 mtp-105 -92.3 -13.66 30.0 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 172.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -82.3 -16.47 49.25 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.598 1.159 . . . . 0.0 112.68 163.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -78.5 62.01 3.01 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.305 1.842 . . . . 0.0 112.082 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -93.56 -22.51 18.78 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 128.444 2.698 . . . . 0.0 115.652 -170.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -58.57 152.46 45.59 Favored Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 125.432 1.493 . . . . 0.0 112.03 -175.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -50.37 -41.96 49.62 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.904 2.403 . . . . 0.0 114.049 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 10.9 tp -61.86 -41.12 89.52 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 118.524 0.602 . . . . 0.0 112.163 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 18.8 m -68.45 -28.85 67.41 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.812 1.245 . . . . 0.0 111.574 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 36.0 mm -75.4 -42.13 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.883 0.873 . . . . 0.0 111.116 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 94.1 mt -58.84 -50.32 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 118.862 0.755 . . . . 0.0 110.071 171.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -59.18 -39.04 81.29 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.912 2.485 . . . . 0.0 112.243 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 54.9 tp -61.99 -51.7 66.98 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.767 1.227 . . . . 0.0 112.987 169.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 71.1 mt -65.89 -41.41 89.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.374 -0.829 . . . . 0.0 109.92 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 69.6 t -74.13 -35.32 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 125.244 1.418 . . . . 0.0 113.45 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.6 p -65.24 -35.67 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 120.908 1.685 . . . . 0.0 110.859 172.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 89.3 t -72.35 -42.58 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 117.934 -1.032 . . . . 0.0 109.617 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -55.54 -41.12 72.76 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.173 0.897 . . . . 0.0 112.16 170.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.8 t -62.39 -43.09 99.65 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.432 1.093 . . . . 0.0 112.835 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 30.2 mmt -70.35 -37.89 74.71 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.612 0.765 . . . . 0.0 111.424 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.39 -48.12 89.64 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 O-C-N 121.799 -0.563 . . . . 0.0 109.994 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.517 HG21 ' HB3' ' A' ' 225' ' ' SER . 30.0 m -75.52 -34.65 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 O-C-N 121.663 -0.648 . . . . 0.0 112.374 -171.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.66 -21.01 66.51 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.253 -0.905 . . . . 0.0 112.088 170.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 57.6 m -85.56 -38.62 18.29 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.697 1.599 . . . . 0.0 113.6 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 24.3 t -56.86 -37.46 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.338 1.055 . . . . 0.0 108.863 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 134.58 146.63 5.43 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 109.014 -1.635 . . . . 0.0 109.014 175.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 98.4 p -60.2 15.54 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.14 116.17 4.92 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 127.877 2.471 . . . . 0.0 111.56 -176.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.641 ' H ' ' H ' ' A' ' 221' ' ' VAL . . . -97.76 -88.73 1.89 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 104.908 -3.277 . . . . 0.0 104.908 92.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 78.49 -51.58 0.48 Allowed 'General case' 0 N--CA 1.466 0.34 1 C-N-CA 132.674 4.39 . . . . 0.0 120.409 -21.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.641 ' H ' ' H ' ' A' ' 219' ' ' GLY . 54.0 t -87.02 -51.3 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 120.119 -1.613 . . . . 0.0 110.203 -164.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -56.7 -36.14 69.32 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.815 -0.553 . . . . 0.0 111.941 167.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.45 -55.14 38.86 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 118.554 -0.736 . . . . 0.0 110.81 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.94 -36.22 83.67 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 120.742 1.61 . . . . 0.0 113.061 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.517 ' HB3' HG21 ' A' ' 212' ' ' VAL . 13.9 t -71.48 -43.61 66.27 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.386 1.448 . . . . 0.0 110.756 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.79 -53.61 55.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.847 0.459 . . . . 0.0 110.371 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 80.9 mt -63.48 -81.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 122.726 1.251 . . . . 0.0 109.517 173.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 -75.74 -14.62 60.33 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 124.793 1.237 . . . . 0.0 113.012 -157.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -95.26 -55.79 1.34 Allowed Glycine 0 CA--C 1.534 1.256 0 CA-C-N 118.701 0.682 . . . . 0.0 114.151 160.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.95 -39.95 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 120.745 -1.444 . . . . 0.0 112.156 -166.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 2.1 tpp85 -60.71 -35.01 75.25 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 119.573 1.079 . . . . 0.0 110.417 168.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.15 -36.96 84.51 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.215 1.406 . . . . 0.0 112.42 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 29.8 tp -64.46 -23.68 67.36 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 117.915 -1.04 . . . . 0.0 111.607 168.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -80.54 -44.87 18.36 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.913 1.688 . . . . 0.0 112.923 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -20.02 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.491 -1.38 . . . . 0.0 112.461 169.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 52.1 tp -71.02 -30.53 66.76 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.194 0.521 . . . . 0.0 111.888 174.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.5 ' HA ' ' CD2' ' A' ' 240' ' ' HIS . 19.7 mtp180 -70.32 -25.43 63.3 Favored 'General case' 0 C--O 1.212 -0.9 0 C-N-CA 124.866 1.267 . . . . 0.0 112.617 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 68.0 mtp -54.03 -23.97 15.4 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 160.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 6.1 mt -115.47 -35.39 4.61 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.873 -166.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . 0.5 ' CD2' ' HA ' ' A' ' 237' ' ' ARG . 5.6 p80 -75.72 -36.61 59.92 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.631 0.65 . . . . 0.0 111.354 164.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.366 5.6 p 43.46 99.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 129.576 3.15 . . . . 0.0 115.148 164.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -77.77 -4.58 47.1 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 112.18 -2.282 . . . . 0.0 113.642 173.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.443 ' HE ' ' CG ' ' A' ' 126' ' ' HIS . 0.0 OUTLIER -70.45 -9.7 57.18 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.807 1.643 . . . . 0.0 115.174 -167.33 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 67.05 23.26 9.75 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.574 1.55 . . . . 0.0 112.433 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -86.82 29.38 5.03 Favored Glycine 0 CA--C 1.527 0.801 0 O-C-N 120.828 -1.17 . . . . 0.0 115.637 -173.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 71.69 36.74 61.88 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-N 118.389 1.094 . . . . 0.0 112.073 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 37.1 p -65.8 107.98 1.98 Allowed 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 126.116 1.766 . . . . 0.0 111.013 -153.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 32.2 m95 62.05 12.78 5.2 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.066 1.746 . . . . 0.0 115.444 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 33.1 mtm-85 . . . . . 0 C--O 1.247 0.973 0 C-N-CA 126.243 1.817 . . . . 0.0 110.845 -171.311 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.606 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 48.2 tp -53.03 -37.12 61.26 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.921 1.237 . . . . 0.0 112.52 -177.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.81 -22.17 57.95 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -58.11 -41.58 83.86 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 120.145 -1.597 . . . . 0.0 111.735 171.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.5 p -66.95 -20.15 65.85 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.06 0.944 . . . . 0.0 112.025 172.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -79.09 -50.52 10.91 Favored 'General case' 0 CA--C 1.507 -0.704 0 O-C-N 121.416 -0.803 . . . . 0.0 109.042 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.5 m -76.21 -38.72 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.374 0.67 . . . . 0.0 110.749 -173.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -68.17 -32.97 73.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.533 172.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.1 -30.16 70.0 Favored Glycine 0 C--N 1.34 0.766 0 O-C-N 120.831 -1.168 . . . . 0.0 112.343 170.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -68.22 -46.6 70.14 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 126.377 1.871 . . . . 0.0 111.301 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.0 t -54.71 -54.09 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.297 1.039 . . . . 0.0 109.639 167.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -55.53 -48.16 75.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.662 -0.685 . . . . 0.0 112.377 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -64.75 -25.35 67.89 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.544 1.065 . . . . 0.0 113.518 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -77.41 -40.99 41.68 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.29 1.036 . . . . 0.0 110.344 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.2 mt -60.44 -40.58 91.66 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 120.787 -1.196 . . . . 0.0 110.829 167.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -78.78 -41.09 31.39 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.499 -162.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -116.95 145.69 36.17 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 124.198 0.999 . . . . 0.0 111.299 -173.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.4 155.82 36.65 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.587 2.192 . . . . 0.0 111.899 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.445 ' H ' ' HB3' ' A' ' 121' ' ' LYS . 46.9 p -147.95 169.56 19.6 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.143 1.777 . . . . 0.0 107.568 163.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.07 -31.28 48.23 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.013 -0.882 . . . . 0.0 113.197 170.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -79.83 -45.43 18.74 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 170.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.445 ' HB3' ' H ' ' A' ' 118' ' ' THR . 0.9 OUTLIER -58.82 -52.7 64.59 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.141 0.882 . . . . 0.0 110.045 -178.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 43.8 t -62.72 -38.64 91.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.106 0.562 . . . . 0.0 111.915 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -57.73 -57.97 10.4 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.608 0.64 . . . . 0.0 111.495 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.4 m -74.36 -44.99 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -172.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -87.12 -36.77 17.91 Favored 'General case' 0 C--O 1.226 -0.133 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -164.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -65.35 -30.57 71.41 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.066 1.303 . . . . 0.0 111.033 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.39 -39.28 78.07 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 167.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.23 -45.47 79.94 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 167.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.8 m -64.58 -39.17 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-N 121.423 1.92 . . . . 0.0 111.789 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -54.44 -45.79 73.13 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.868 0.867 . . . . 0.0 112.292 170.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.7 mt -67.19 -39.58 86.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 118.46 -0.781 . . . . 0.0 113.025 174.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.51 -43.69 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 119.812 1.187 . . . . 0.0 110.877 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.36 -40.92 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-N 121.197 1.817 . . . . 0.0 112.646 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.9 tp -52.51 -52.11 56.22 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.066 1.746 . . . . 0.0 111.765 168.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 37.9 t -63.27 -39.57 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.985 0.914 . . . . 0.0 111.081 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 65.7 m -60.5 -44.72 95.68 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.937 0.895 . . . . 0.0 113.379 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.65 -31.94 47.02 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 120.442 1.474 . . . . 0.0 111.93 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 59.0 mt -56.62 -47.6 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.509 0.723 . . . . 0.0 110.305 167.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -57.81 -49.35 76.94 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 117.322 -1.323 . . . . 0.0 110.999 170.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 73.6 m -49.6 -40.9 40.56 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 120.067 1.303 . . . . 0.0 114.061 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.5 -48.5 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.0 0.52 . . . . 0.0 110.797 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.2 tp -72.61 -44.23 62.24 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.862 0.865 . . . . 0.0 112.89 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 55.9 p -78.89 -30.15 44.79 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -155.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.2 t -75.27 -1.81 25.22 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.733 1.152 . . . . 0.0 111.86 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.4 mm -102.51 -34.48 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 126.18 1.792 . . . . 0.0 113.231 163.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -56.77 -27.53 59.78 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.891 -1.131 . . . . 0.0 111.892 164.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -58.88 -42.86 90.47 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 129.002 2.921 . . . . 0.0 112.066 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 17.1 m-30 -74.76 -31.1 61.68 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.876 0.762 . . . . 0.0 111.073 176.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.68 -41.22 96.22 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.58 -0.7 . . . . 0.0 111.407 169.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.25 -13.47 28.39 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.46 1.504 . . . . 0.0 114.888 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.6 mt -64.53 -23.64 67.34 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.572 1.149 . . . . 0.0 113.277 168.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.49 -49.68 0.13 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -155.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.4 p -122.15 177.84 5.17 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.518 1.927 . . . . 0.0 109.011 -163.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.35 154.39 47.88 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.448 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.8 t -156.13 158.38 37.59 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.864 1.266 . . . . 0.0 111.123 -163.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.9 mt -94.68 3.43 55.07 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.967 1.307 . . . . 0.0 113.81 166.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -65.05 -4.58 4.89 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 120.036 1.289 . . . . 0.0 114.188 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -72.73 -30.56 64.28 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.781 -1.199 . . . . 0.0 111.822 166.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 47.6 tpp -73.02 -32.17 64.93 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.268 1.027 . . . . 0.0 111.355 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.21 -51.27 69.68 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.553 -0.717 . . . . 0.0 110.341 165.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.1 mt -53.99 -40.21 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 118.787 -0.625 . . . . 0.0 112.028 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.9 t -56.34 -48.16 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 120.293 1.406 . . . . 0.0 112.127 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 11.4 mt -71.11 -33.78 70.48 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.074 1.306 . . . . 0.0 113.08 176.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 26.5 t -61.73 -39.43 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 120.596 1.543 . . . . 0.0 111.743 172.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 68.0 t -75.01 -33.1 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.834 1.254 . . . . 0.0 110.651 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -62.56 -42.68 99.7 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 117.981 -1.009 . . . . 0.0 112.296 165.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -65.01 -46.25 82.14 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.536 1.516 . . . . 0.0 111.918 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -56.13 -37.96 74.44 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-N 119.282 0.946 . . . . 0.0 112.779 171.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 87.6 m -67.2 -39.53 86.33 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -60.41 -40.64 91.7 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.934 1.294 . . . . 0.0 111.629 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -54.24 -51.94 62.93 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 172.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 26.9 m -73.64 -31.73 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 23.1 t -63.48 -33.55 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 119.337 0.971 . . . . 0.0 112.144 173.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -60.94 -41.4 96.17 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 120.951 -1.093 . . . . 0.0 111.81 167.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 41.4 mt -69.97 -25.24 63.53 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -82.03 -40.44 22.07 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.999 0.92 . . . . 0.0 112.907 173.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 79.1 p -70.32 6.13 1.47 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 116.817 2.154 . . . . 0.0 116.817 160.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.526 ' HB2' ' HD2' ' A' ' 190' ' ' ARG . . . -51.78 -37.69 52.52 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.216 0.916 . . . . 0.0 111.514 160.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 167.22 30.99 0.02 OUTLIER Glycine 0 C--N 1.341 0.847 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 175.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 18.1 t 63.1 -67.42 0.09 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.871 2.068 . . . . 0.0 115.121 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -35.8 79.47 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.721 2.008 . . . . 0.0 111.022 170.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.46 ' HB2' ' H ' ' A' ' 186' ' ' GLY . 82.4 p -72.56 25.12 0.05 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 -175.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -53.53 -23.48 10.64 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 128.107 2.563 . . . . 0.0 116.293 -171.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -118.63 -37.23 3.32 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.2 1.4 . . . . 0.0 111.826 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 85.8 t -65.81 -68.94 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.436 1.494 . . . . 0.0 111.378 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.46 ' H ' ' HB2' ' A' ' 182' ' ' SER . . . -70.69 -23.97 77.33 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.699 1.619 . . . . 0.0 112.881 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.7 tt -51.07 -52.3 44.75 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.073 1.437 . . . . 0.0 110.087 164.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 35.1 t-105 -74.03 -44.72 53.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.23 0.538 . . . . 0.0 112.432 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -59.52 -45.17 96.01 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.885 0.755 . . . . 0.0 113.07 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.526 ' HD2' ' HB2' ' A' ' 178' ' ' ALA . 7.3 ptm180 -68.95 -33.1 73.16 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 118.44 1.12 . . . . 0.0 112.129 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 25.5 tp -74.96 -29.52 60.95 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.973 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 36.4 mtp-105 -80.17 -31.68 38.85 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.27 1.428 . . . . 0.0 113.097 171.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -64.02 -38.21 90.23 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.882 1.273 . . . . 0.0 111.173 171.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -82.97 58.81 4.56 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.123 1.369 . . . . 0.0 112.237 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.74 -28.95 66.36 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 120.773 -1.205 . . . . 0.0 112.56 169.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 197' ' ' PRO . 16.2 ptpt -49.6 147.19 6.26 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 127.877 2.471 . . . . 0.0 116.268 -173.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 196' ' ' LYS . 87.1 Cg_exo -57.33 -39.61 88.3 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.821 2.347 . . . . 0.0 116.488 -163.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 93.9 mt -67.72 -30.33 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 O-C-N 120.894 -1.129 . . . . 0.0 111.329 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.7 t -68.17 -31.56 71.19 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.06 1.3 . . . . 0.0 111.652 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 34.6 mm -70.35 -43.22 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.383 1.073 . . . . 0.0 111.49 171.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.83 -37.05 77.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.031 0.532 . . . . 0.0 111.445 173.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -74.87 -38.99 61.79 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.319 1.848 . . . . 0.0 110.729 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 20.3 tp -57.71 -48.4 79.69 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.272 1.029 . . . . 0.0 111.072 166.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 76.4 mt -69.43 -37.21 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 121.839 -0.538 . . . . 0.0 111.284 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.6 t -75.3 -33.41 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-N 119.918 1.235 . . . . 0.0 112.58 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 4.4 p -67.43 -34.2 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 120.615 1.552 . . . . 0.0 110.685 170.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 78.1 t -72.76 -39.52 59.93 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-O 117.936 -1.031 . . . . 0.0 110.115 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.61 -45.47 85.3 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 119.106 0.867 . . . . 0.0 110.41 170.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 30.2 t -62.95 -48.82 77.24 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.549 1.14 . . . . 0.0 111.851 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 75.2 mtm -55.58 -51.43 67.13 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.837 1.255 . . . . 0.0 111.004 168.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 9.5 t -59.09 -47.08 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 118.972 0.806 . . . . 0.0 111.295 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 222' ' ' PHE . 33.5 m -75.71 -41.56 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 119.403 1.001 . . . . 0.0 111.845 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.6 pp -63.31 -23.81 67.58 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.719 1.145 . . . . 0.0 111.601 171.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 19.2 m -77.8 -44.89 26.08 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.83 1.252 . . . . 0.0 112.929 173.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.73 -38.04 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.157 1.783 . . . . 0.0 109.476 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 218' ' ' LYS . . . 142.31 162.33 9.17 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 125.909 1.719 . . . . 0.0 110.029 172.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 60.5 p -70.62 18.23 0.06 Allowed 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 216' ' ' GLY . 5.8 mtmt -173.15 175.67 3.13 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 131.514 3.926 . . . . 0.0 108.937 -172.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 66.81 105.96 0.02 OUTLIER Glycine 0 N--CA 1.436 -1.3 0 N-CA-C 106.176 -2.77 . . . . 0.0 106.176 -115.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -56.4 -5.66 0.22 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.492 1.517 . . . . 0.0 113.276 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 18.1 m -68.79 -38.12 78.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 125.421 1.489 . . . . 0.0 110.507 172.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.457 ' HA ' ' HB ' ' A' ' 212' ' ' VAL . 0.8 OUTLIER -56.53 -49.77 73.79 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.348 166.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.92 -54.76 43.52 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.3 t -69.05 -30.74 69.15 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 34.1 t -74.29 -41.77 60.65 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.627 -1.295 . . . . 0.0 111.076 175.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.85 -62.13 1.91 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.114 0.966 . . . . 0.0 109.083 173.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 38.6 mt -57.26 -83.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.503 1.121 . . . . 0.0 109.79 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -65.32 -50.11 66.89 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-O 116.85 -1.548 . . . . 0.0 109.606 -163.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -54.56 -56.5 21.85 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 120.247 1.385 . . . . 0.0 113.281 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.8 -34.89 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 118.024 0.912 . . . . 0.0 111.639 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -77.8 -26.96 49.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.573 -1.329 . . . . 0.0 113.78 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -60.37 -42.29 95.51 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.782 1.633 . . . . 0.0 107.666 174.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 15.5 tp -62.9 -33.85 76.18 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.413 174.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -75.47 -43.49 49.08 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 120.87 1.668 . . . . 0.0 112.815 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 45.0 pt -66.35 -6.63 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 169.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 48.2 tp -95.9 -35.3 11.51 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.485 1.514 . . . . 0.0 111.137 171.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -63.52 -35.61 81.04 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.966 1.307 . . . . 0.0 110.121 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 61.3 tpp -34.07 -33.97 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 129.342 3.057 . . . . 0.0 116.702 156.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 49.9 mt -111.64 -13.32 13.79 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.859 1.663 . . . . 0.0 111.983 -171.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.3 3.5 54.43 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.83 0.852 . . . . 0.0 113.201 160.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 7.6 p -37.5 102.93 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 C-N-CA 127.161 2.184 . . . . 0.0 111.667 -164.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -76.53 11.78 1.5 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 112.731 -2.032 . . . . 0.0 114.074 -166.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -64.03 -18.72 64.61 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.032 1.733 . . . . 0.0 113.259 151.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . 0.272 22.4 pt20 60.66 30.49 19.75 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 145.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -83.35 -7.27 86.81 Favored Glycine 0 N--CA 1.468 0.774 0 O-C-N 121.237 -0.915 . . . . 0.0 114.754 173.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 117.88 78.16 0.62 Allowed Glycine 0 C--O 1.229 -0.215 0 C-N-CA 125.897 1.713 . . . . 0.0 110.192 -166.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 59.2 p -52.72 101.57 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.526 2.33 . . . . 0.0 112.655 -170.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 97.0 m95 54.99 35.05 23.75 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.587 1.955 . . . . 0.0 114.873 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 5.3 ppt_? . . . . . 0 C--O 1.253 1.275 0 C-N-CA 125.936 1.694 . . . . 0.0 112.866 173.167 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.506 -0.727 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.9 tp -103.8 157.03 17.36 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-O 122.724 1.25 . . . . 0.0 107.892 152.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.402 ' HA ' ' CD2' ' A' ' 105' ' ' HIS . . . 67.49 -18.5 0.14 Allowed 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 127.268 2.227 . . . . 0.0 116.133 173.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.03 -34.51 70.14 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.044 1.338 . . . . 0.0 111.841 176.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.7 t -80.87 -26.19 37.1 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.335 -0.853 . . . . 0.0 113.268 166.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.402 ' CD2' ' HA ' ' A' ' 102' ' ' ALA . 11.8 m-70 -75.13 -27.17 59.69 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 119.568 -1.957 . . . . 0.0 111.885 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 23.3 m -85.31 2.55 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 126.12 1.768 . . . . 0.0 113.435 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -111.66 -45.61 3.34 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 127.575 2.35 . . . . 0.0 108.052 170.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.09 -20.29 8.73 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.509 1.528 . . . . 0.0 115.393 161.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . 0.261 25.0 ptt180 -73.22 -37.32 66.45 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.327 1.564 . . . . 0.0 110.455 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.7 t -58.88 -47.88 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.758 1.223 . . . . 0.0 110.541 168.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -66.91 -54.64 20.15 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.413 1.085 . . . . 0.0 111.447 -174.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -62.3 -25.29 67.79 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.81 -1.181 . . . . 0.0 112.719 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -75.76 -41.76 52.24 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.317 1.417 . . . . 0.0 110.375 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 pp -75.4 -22.51 57.39 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -125.16 -9.72 7.06 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -166.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -109.55 118.63 50.07 Favored Pre-proline 0 N--CA 1.473 0.722 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 161.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -61.47 137.77 71.8 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 121.697 1.598 . . . . 0.0 113.307 -171.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -151.85 143.3 23.46 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.671 1.189 . . . . 0.0 107.973 173.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.21 -28.76 50.75 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.904 -0.387 . . . . 0.0 112.59 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -67.37 -32.92 74.17 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 172.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -61.25 -48.76 79.98 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.559 1.072 . . . . 0.0 108.203 168.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 35.6 m -64.49 -40.41 95.61 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.415 0.686 . . . . 0.0 112.147 -174.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -56.64 -67.52 0.3 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.107 0.963 . . . . 0.0 111.214 173.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.7 p -79.67 -38.26 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 121.009 -1.057 . . . . 0.0 113.627 -168.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -73.12 -42.96 62.34 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.38 -0.825 . . . . 0.0 112.067 -170.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -71.52 -26.73 62.78 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -68.19 -49.4 61.1 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.196 -0.94 . . . . 0.0 111.989 166.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -51.3 -40.15 58.37 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 117.514 -1.231 . . . . 0.0 114.232 173.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . 0.289 2.9 m -62.97 -43.38 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 121.174 1.806 . . . . 0.0 112.634 174.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -67.85 -39.25 83.81 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.737 0.699 . . . . 0.0 112.548 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 73.4 mt -56.39 -54.87 40.52 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 118.624 -0.703 . . . . 0.0 110.366 169.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -53.87 -49.89 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.456 0.703 . . . . 0.0 112.011 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.4 p -66.13 -42.97 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 119.837 1.198 . . . . 0.0 113.09 -171.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 35.6 tp -70.38 -45.4 66.12 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.051 0.94 . . . . 0.0 111.567 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 32.2 m -65.08 -38.51 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 119.86 1.209 . . . . 0.0 111.901 176.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 98.4 m -66.83 -34.15 77.18 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.66 -0.686 . . . . 0.0 112.799 174.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.7 mt -74.42 -37.59 63.3 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.651 1.569 . . . . 0.0 112.516 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 52.2 mt -61.87 -46.6 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.312 0.96 . . . . 0.0 110.72 169.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -62.34 -27.17 68.87 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 117.866 -1.064 . . . . 0.0 112.343 171.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.7 m -65.68 -31.1 71.92 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 121.019 1.736 . . . . 0.0 113.166 173.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.33 -35.84 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.113 0.565 . . . . 0.0 110.699 172.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.0 tp -74.28 -50.69 17.85 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.296 0.953 . . . . 0.0 112.391 169.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.7 p -67.19 -27.13 67.01 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 120.377 -1.452 . . . . 0.0 113.273 -166.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.0 t -68.6 -22.85 64.42 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 176.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 17.9 pt -95.32 -31.41 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.946 1.248 . . . . 0.0 113.187 169.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -59.7 -26.57 65.7 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 121.021 -1.049 . . . . 0.0 111.281 164.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -60.57 -30.21 69.65 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.929 2.092 . . . . 0.0 113.093 167.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -87.9 -26.34 22.78 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.817 -1.177 . . . . 0.0 110.856 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.08 -40.2 94.32 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.149 0.579 . . . . 0.0 111.637 166.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.31 -15.22 23.36 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.632 1.573 . . . . 0.0 114.869 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 64.5 mt -59.15 -31.63 69.15 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.807 -1.183 . . . . 0.0 112.69 167.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.86 -43.83 0.21 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -153.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 82.8 p -134.09 152.83 52.01 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.163 1.385 . . . . 0.0 109.976 -155.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -75.4 128.93 10.12 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 121.289 -0.882 . . . . 0.0 112.582 -170.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.3 t -144.46 148.61 34.78 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -155.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.3 mt -56.4 4.28 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.568 2.347 . . . . 0.0 114.88 166.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -62.12 -13.94 31.93 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 120.975 1.716 . . . . 0.0 112.803 163.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 18.0 p-90 -59.37 -29.8 67.95 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.092 -1.63 . . . . 0.0 112.233 163.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 10.7 tpt -76.83 -25.55 53.34 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.335 0.97 . . . . 0.0 112.804 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -61.0 -48.82 80.06 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.788 -1.195 . . . . 0.0 109.404 162.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.82 -37.62 72.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 122.993 0.517 . . . . 0.0 111.583 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 64.0 t -60.93 -51.92 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 120.948 -1.095 . . . . 0.0 112.293 173.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 11.5 mt -69.98 -30.44 67.79 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.119 -0.988 . . . . 0.0 112.355 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 22.7 t -58.17 -38.17 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.698 1.136 . . . . 0.0 109.958 169.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 64.7 t -75.22 -29.7 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 118.104 -0.951 . . . . 0.0 111.11 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -66.6 -51.03 60.83 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 121.011 1.732 . . . . 0.0 112.933 170.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -60.65 -46.46 90.24 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.198 0.908 . . . . 0.0 111.37 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.96 -40.89 93.94 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.974 0.797 . . . . 0.0 113.15 173.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 55.5 m -66.96 -40.01 87.38 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.738 -0.86 . . . . 0.0 111.453 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -62.4 -41.38 98.63 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.303 0.956 . . . . 0.0 111.738 173.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -55.65 -45.67 77.63 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.646 0.657 . . . . 0.0 111.5 170.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 69.1 t -67.31 -41.89 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.188 -0.945 . . . . 0.0 113.13 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 25.8 t -62.28 -38.16 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.452 1.501 . . . . 0.0 112.337 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -55.91 -45.14 78.78 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.487 0.715 . . . . 0.0 111.811 168.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 21.8 mt -67.0 -40.3 87.32 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 178.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -65.81 -30.8 71.49 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.5 t -69.79 -21.16 63.43 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 173.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.1 -14.58 25.24 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 170.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -158.07 51.25 0.41 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 124.972 1.272 . . . . 0.0 110.505 -161.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 35.1 t -45.2 -31.07 1.34 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.225 1.81 . . . . 0.0 112.643 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.19 -59.45 1.73 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.172 1.789 . . . . 0.0 111.656 159.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 55.1 p -70.98 -16.1 62.62 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.906 1.282 . . . . 0.0 113.776 -156.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 59.8 pttt 47.01 -59.55 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.361 1 C-N-CA 133.464 4.706 . . . . 0.0 115.868 172.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -93.84 -29.21 15.44 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 124.68 1.192 . . . . 0.0 112.011 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.19 -54.32 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 166.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -51.1 -70.46 0.85 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 126.973 2.225 . . . . 0.0 112.362 176.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.4 tt -52.0 -42.07 62.69 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.33 1.452 . . . . 0.0 112.584 -170.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 44.6 t-105 -75.4 -46.36 33.35 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -172.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -64.19 -36.76 93.64 Favored Glycine 0 N--CA 1.48 1.568 0 O-C-N 121.641 -0.662 . . . . 0.0 112.501 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -61.16 -44.61 97.04 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 127.178 2.191 . . . . 0.0 112.167 168.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 25.7 tp -68.31 -32.58 72.82 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.608 0.64 . . . . 0.0 112.451 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -67.1 -18.57 65.38 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.108 -0.995 . . . . 0.0 113.213 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -67.49 -3.71 9.36 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.118 1.367 . . . . 0.0 114.301 167.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.31 83.47 0.55 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.53 1.532 . . . . 0.0 110.43 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 12.7 ttt85 -149.92 -37.67 0.15 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -164.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -68.89 151.25 97.35 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 123.974 0.91 . . . . 0.0 109.906 168.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -51.26 -46.85 28.85 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 CA-C-N 121.534 1.583 . . . . 0.0 115.488 -170.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 17.5 tt -62.99 -36.23 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 119.422 1.01 . . . . 0.0 113.501 176.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 95.5 p -82.93 -25.85 32.0 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.148 1.34 . . . . 0.0 111.231 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 15.1 mm -63.19 -49.1 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.8 0.84 . . . . 0.0 110.026 160.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 21.2 mm -59.36 -41.61 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.539 -0.726 . . . . 0.0 111.376 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -69.71 -35.24 74.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.587 1.555 . . . . 0.0 111.43 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.3 tp -64.21 -49.2 72.9 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.088 0.555 . . . . 0.0 110.696 171.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 59.5 mt -61.5 -40.95 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 121.653 -0.654 . . . . 0.0 110.154 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.434 ' HA ' ' HB3' ' A' ' 208' ' ' ALA . 73.5 t -78.92 -22.65 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 117.605 -1.188 . . . . 0.0 113.779 -176.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.46 -32.21 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 122.316 2.325 . . . . 0.0 110.344 166.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 46.0 t -81.17 -29.69 11.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 O-C-N 120.951 -1.093 . . . . 0.0 109.51 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.434 ' HB3' ' HA ' ' A' ' 205' ' ' VAL . . . -58.38 -42.79 87.84 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.805 -0.559 . . . . 0.0 111.511 161.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.1 m -61.3 -36.99 81.62 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.948 0.899 . . . . 0.0 111.843 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 55.6 mtt -64.46 -54.19 36.44 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.523 1.129 . . . . 0.0 111.0 166.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 30.4 t -56.63 -38.39 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 119.771 1.168 . . . . 0.0 112.237 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 28.4 t -53.53 -52.61 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 126.293 1.837 . . . . 0.0 111.396 171.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.87 -15.46 44.57 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.078 0.951 . . . . 0.0 113.294 -175.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 93.2 m -102.68 -56.25 2.28 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.52 1.528 . . . . 0.0 114.4 -171.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 25.4 t -56.88 -38.75 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-N 119.521 1.055 . . . . 0.0 112.025 -175.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 164.21 -116.55 0.71 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.037 1.303 . . . . 0.0 110.288 168.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 77.3 p -164.17 34.64 0.08 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.436 1.094 . . . . 0.0 113.063 -174.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -169.45 168.75 9.29 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.97 2.108 . . . . 0.0 110.709 -174.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -67.36 -49.78 49.3 Favored Glycine 0 N--CA 1.473 1.139 0 C-N-CA 127.556 2.503 . . . . 0.0 112.461 -10.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -144.62 4.9 1.18 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.364 1.066 . . . . 0.0 113.775 170.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 15.2 t -73.55 -42.88 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 120.155 1.343 . . . . 0.0 111.493 -170.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -47.28 -45.91 24.45 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.933 1.293 . . . . 0.0 112.394 164.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.38 -54.68 9.9 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.833 1.253 . . . . 0.0 111.214 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.11 -35.74 81.28 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 121.113 -0.992 . . . . 0.0 111.885 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 18.0 m -69.17 -45.65 69.48 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.485 1.493 . . . . 0.0 110.884 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -52.87 -52.37 57.63 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.615 -0.678 . . . . 0.0 111.412 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 227' ' ' ILE . 72.6 mt -67.08 -84.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 123.392 1.568 . . . . 0.0 110.269 175.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -76.36 10.04 2.28 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 128.145 2.578 . . . . 0.0 113.338 -167.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -117.84 -63.64 0.31 Allowed Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 166.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 18.2 mt -79.57 -37.44 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 118.482 1.141 . . . . 0.0 111.374 -171.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.72 -41.59 87.67 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.862 1.21 . . . . 0.0 109.771 174.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -63.32 -33.25 75.12 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.057 2.143 . . . . 0.0 113.521 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 23.4 tp -63.87 -33.41 75.62 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.344 1.058 . . . . 0.0 111.654 165.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -69.08 -37.54 78.53 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.715 1.598 . . . . 0.0 114.289 -175.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -19.69 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.255 -0.903 . . . . 0.0 113.094 175.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 37.7 mt -72.99 -23.67 60.67 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.974 0.893 . . . . 0.0 110.539 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -83.12 -18.45 39.46 Favored 'General case' 0 C--O 1.216 -0.708 0 C-N-CA 124.386 1.074 . . . . 0.0 112.816 -167.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -24.76 -40.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 128.587 2.755 . . . . 0.0 114.779 143.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 16.6 mt -99.99 -28.24 13.18 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.258 1.423 . . . . 0.0 110.717 -172.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -75.58 9.78 2.06 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 158.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.303 4.2 t -104.0 46.79 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-O 124.779 2.228 . . . . 0.0 110.409 150.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 47.1 p-10 -59.56 61.7 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 113.283 -1.78 . . . . 0.0 111.273 137.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -45.79 -43.68 13.36 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 126.895 2.078 . . . . 0.0 114.688 -138.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -145.54 27.02 1.25 Allowed 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 127.456 2.302 . . . . 0.0 112.02 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 114.61 15.84 7.89 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.001 1.286 . . . . 0.0 115.556 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 172.5 88.16 0.07 OUTLIER Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.573 1.559 . . . . 0.0 111.655 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 4.3 t -47.01 151.43 0.64 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.389 1.476 . . . . 0.0 113.533 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 69.0 m95 46.19 43.88 11.59 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 126.853 2.061 . . . . 0.0 114.125 164.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 118.535 -0.745 . . . . 0.0 112.147 178.48 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.7 tp -69.79 102.35 1.91 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 123.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 47.18 72.89 0.21 Allowed 'General case' 0 N--CA 1.432 -1.356 0 O-C-N 124.54 1.15 . . . . 0.0 109.864 142.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.569 ' HA ' HG22 ' A' ' 106' ' ' VAL 0.265 0.0 OUTLIER -53.18 -24.4 10.72 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 120.884 -1.135 . . . . 0.0 110.97 168.02 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -58.09 -40.13 80.32 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.352 1.461 . . . . 0.0 114.634 165.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -78.25 -51.38 10.25 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 126.119 1.768 . . . . 0.0 109.743 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.569 HG22 ' HA ' ' A' ' 103' ' ' ARG . 35.0 m -81.04 -21.15 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -157.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -73.69 -29.3 62.2 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.199 0.599 . . . . 0.0 110.802 166.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.12 -32.82 60.02 Favored Glycine 0 CA--C 1.525 0.696 0 O-C-N 121.097 -1.002 . . . . 0.0 111.552 167.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -63.34 -40.19 96.62 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.117 1.367 . . . . 0.0 111.256 175.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.2 t -60.51 -55.36 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.53 1.932 . . . . 0.0 110.98 168.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -62.44 -22.54 66.28 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.407 1.083 . . . . 0.0 113.803 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -84.8 -34.18 22.8 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.824 1.25 . . . . 0.0 111.913 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -74.09 -43.34 58.01 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.136 -0.977 . . . . 0.0 112.814 -176.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.25 -20.98 64.85 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 176.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -101.88 -24.51 14.02 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 125.046 1.338 . . . . 0.0 112.676 -171.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.4 mtm105 -91.74 107.68 24.13 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 124.363 1.065 . . . . 0.0 109.928 165.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -65.29 127.13 17.59 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.904 1.736 . . . . 0.0 109.091 166.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 82.2 p -139.44 178.61 7.08 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.271 1.029 . . . . 0.0 109.091 176.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.82 -30.03 62.47 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 121.912 -0.493 . . . . 0.0 112.597 165.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -78.54 -43.42 26.77 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -60.27 -40.3 89.9 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.342 0.973 . . . . 0.0 109.746 170.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 49.7 t -61.43 -54.36 44.58 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.26 1.024 . . . . 0.0 112.294 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -53.62 -49.64 67.39 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.364 1.066 . . . . 0.0 111.89 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.0 p -85.81 -47.23 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -73.21 -39.27 65.66 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.998 0.817 . . . . 0.0 111.858 -163.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -80.3 -27.99 38.36 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 120.852 -1.155 . . . . 0.0 112.788 -173.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -70.39 -35.59 73.58 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.816 0.734 . . . . 0.0 111.122 164.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.97 -44.68 87.22 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 119.923 1.238 . . . . 0.0 113.218 168.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.43 -35.56 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 121.7 2.046 . . . . 0.0 113.235 176.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -68.02 -47.61 67.96 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.222 1.009 . . . . 0.0 112.077 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 62.9 mt -62.78 -47.84 81.72 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.459 0.704 . . . . 0.0 111.435 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 84.7 mt -61.99 -34.48 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 118.11 -0.948 . . . . 0.0 111.253 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.7 t -74.89 -34.07 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 120.781 1.628 . . . . 0.0 114.273 177.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 28.2 mt -59.44 -48.22 82.49 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.447 1.476 . . . . 0.0 110.535 167.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.5 t -55.89 -53.67 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 118.348 0.522 . . . . 0.0 110.23 172.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 60.8 m -61.62 -46.09 91.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.988 -173.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.9 mt -72.31 -40.91 67.13 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.679 1.127 . . . . 0.0 112.58 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.53 -42.35 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.366 0.666 . . . . 0.0 110.557 174.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -68.5 -33.29 73.88 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.384 -0.823 . . . . 0.0 111.99 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 t -58.08 -40.71 81.79 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.928 0.891 . . . . 0.0 111.716 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.33 -53.01 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.386 1.074 . . . . 0.0 110.299 174.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.9 tp -55.6 -50.44 70.1 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.014 0.526 . . . . 0.0 111.714 171.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 68.7 m -57.42 -23.53 50.08 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 116.172 1.915 . . . . 0.0 116.172 -174.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.4 t -109.44 -5.46 15.78 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.367 0.985 . . . . 0.0 112.845 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.7 tp -85.03 -36.08 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 O-C-N 121.554 -0.716 . . . . 0.0 111.344 149.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -71.95 -4.05 26.17 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 119.967 -1.708 . . . . 0.0 115.304 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -63.28 -34.09 76.93 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 120.72 -1.238 . . . . 0.0 112.58 169.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -74.52 -20.62 59.91 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.348 -0.845 . . . . 0.0 112.844 172.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.93 -45.22 43.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.956 0.903 . . . . 0.0 111.254 166.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -57.49 -28.67 63.63 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.747 1.219 . . . . 0.0 113.151 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.43 -35.45 73.39 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.196 1.398 . . . . 0.0 113.559 173.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -97.56 -47.91 5.47 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.993 2.117 . . . . 0.0 114.124 -168.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 69.7 p -149.52 -169.05 3.27 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.469 2.308 . . . . 0.0 109.006 -159.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -77.62 169.69 54.8 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.323 -0.861 . . . . 0.0 112.828 159.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.452 HG23 ' HB3' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -170.28 152.35 4.1 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.411 1.885 . . . . 0.0 110.887 -176.266 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.0 mt -52.59 -14.82 0.56 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.039 1.736 . . . . 0.0 114.368 172.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.452 ' HB3' HG23 ' A' ' 155' ' ' THR . 58.1 t80 -49.38 -15.9 0.16 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.823 1.649 . . . . 0.0 114.428 168.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 18.5 p-90 -57.22 -27.74 62.27 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.752 -1.217 . . . . 0.0 112.713 166.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 28.4 ttp -70.71 -20.77 62.63 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.197 -1.564 . . . . 0.0 112.067 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -64.65 -26.04 68.22 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.683 -1.26 . . . . 0.0 112.184 169.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 26.9 mt -70.17 -42.36 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.044 0.538 . . . . 0.0 109.575 172.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.41 -44.12 98.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.698 0.799 . . . . 0.0 111.372 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.04 -28.38 57.66 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.127 0.876 . . . . 0.0 113.262 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.6 t -60.11 -41.83 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 120.646 1.566 . . . . 0.0 110.46 165.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.57 -35.25 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 117.759 -1.115 . . . . 0.0 110.347 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -64.42 -53.6 45.83 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.874 1.67 . . . . 0.0 112.546 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -69.1 -24.3 64.11 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.2 1.364 . . . . 0.0 112.916 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -72.05 -47.11 32.63 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.543 1.068 . . . . 0.0 111.348 168.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.9 m -66.51 -36.25 82.26 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -62.56 -49.22 76.14 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 120.537 1.517 . . . . 0.0 110.874 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -51.69 -48.62 63.42 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.151 0.581 . . . . 0.0 111.896 172.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.58 -38.65 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.19 0.996 . . . . 0.0 113.239 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 14.4 t -61.86 -33.54 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.509 1.524 . . . . 0.0 111.56 173.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -63.23 -32.82 74.32 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.219 1.008 . . . . 0.0 112.393 170.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.405 ' HA ' ' HG2' ' A' ' 190' ' ' ARG . 23.4 mt -74.28 -35.46 63.75 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 173.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -70.6 -35.76 73.18 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.097 0.959 . . . . 0.0 113.42 173.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 83.6 p -68.22 -10.4 54.15 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 168.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.98 -15.27 20.93 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 120.05 1.296 . . . . 0.0 114.329 157.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 178.97 80.77 0.06 OUTLIER Glycine 0 C--N 1.343 0.964 0 CA-C-N 120.149 1.34 . . . . 0.0 115.674 -167.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 49.5 t -49.27 -27.3 3.67 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 117.759 0.779 . . . . 0.0 112.753 153.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.86 58.69 1.72 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.599 1.19 . . . . 0.0 111.94 157.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 21.2 p -162.65 50.16 0.18 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.198 159.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.449 ' HE2' ' CD2' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -61.13 -22.12 64.38 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -167.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.449 ' CD2' ' HE2' ' A' ' 183' ' ' LYS . 25.2 m-85 -105.46 -38.91 6.3 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 118.167 -0.921 . . . . 0.0 112.587 161.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -56.36 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 119.686 1.13 . . . . 0.0 111.408 -172.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -70.35 -43.08 63.65 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.56 -38.96 64.39 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.031 1.733 . . . . 0.0 111.947 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -70.79 -44.32 66.89 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.089 0.859 . . . . 0.0 112.296 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -66.74 -35.19 89.38 Favored Glycine 0 N--CA 1.476 1.354 0 O-C-N 121.259 -0.901 . . . . 0.0 112.283 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.405 ' HG2' ' HA ' ' A' ' 175' ' ' LEU . 7.5 tpp180 -65.67 -39.42 91.32 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 127.804 2.442 . . . . 0.0 112.942 172.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.498 HD11 HD13 ' A' ' 203' ' ' LEU . 23.6 tp -68.58 -33.37 73.95 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.864 -0.522 . . . . 0.0 111.827 173.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -73.05 -7.39 51.05 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -74.02 59.47 0.72 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.39 1.45 . . . . 0.0 110.214 163.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -142.66 76.58 1.54 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.86 2.864 . . . . 0.0 106.857 -169.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 44.8 mtp85 -137.89 -43.99 0.53 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.398 1.079 . . . . 0.0 111.472 -169.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -64.97 152.04 91.97 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 123.752 0.821 . . . . 0.0 110.434 167.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -54.1 -46.89 30.24 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.671 2.247 . . . . 0.0 112.827 -172.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.3 tt -58.21 -39.01 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.536 1.134 . . . . 0.0 113.981 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 78.7 p -87.63 -20.11 26.8 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 120.573 1.533 . . . . 0.0 112.633 -174.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 64.0 mt -72.39 -43.38 64.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 118.383 0.538 . . . . 0.0 110.509 159.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 43.5 mt -60.1 -39.58 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.238 1.015 . . . . 0.0 110.971 174.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -70.09 -39.69 75.41 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.782 1.633 . . . . 0.0 110.684 -178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.498 HD13 HD11 ' A' ' 191' ' ' LEU . 38.0 tp -61.51 -46.85 88.23 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.483 1.113 . . . . 0.0 112.707 169.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 54.1 mt -63.68 -41.76 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 O-C-N 120.685 -1.26 . . . . 0.0 110.411 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 31.6 t -66.27 -39.79 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 116.308 -1.806 . . . . 0.0 112.559 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.08 -33.06 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 122.212 2.278 . . . . 0.0 111.485 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.28 -46.12 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 123.373 0.669 . . . . 0.0 109.694 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -53.26 -48.14 68.53 Favored 'General case' 0 C--O 1.223 -0.342 0 C-N-CA 123.732 0.813 . . . . 0.0 110.797 169.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 34.3 t -59.84 -49.69 76.73 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.636 1.175 . . . . 0.0 112.947 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 15.0 tpt -70.85 -34.03 71.25 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 118.786 -0.626 . . . . 0.0 112.027 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.7 t -60.76 -50.99 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 120.38 1.446 . . . . 0.0 111.938 171.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.18 -33.09 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 119.461 1.028 . . . . 0.0 111.117 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 5.1 tp -58.38 -45.01 89.13 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.51 0.724 . . . . 0.0 111.211 165.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 59.4 m -69.69 -25.66 63.98 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.287 1.435 . . . . 0.0 114.706 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 52.1 t -64.02 -16.01 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.008 1.323 . . . . 0.0 110.95 166.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 94.13 114.29 2.52 Favored Glycine 0 C--N 1.332 0.35 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -165.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 66.3 p -62.3 34.8 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 129.092 2.957 . . . . 0.0 116.969 -170.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . 0.261 39.7 mmtm -171.2 -23.46 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.343 2.257 . . . . 0.0 114.162 -155.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -46.04 123.66 6.87 Favored Glycine 0 C--N 1.341 0.809 0 N-CA-C 104.014 -3.635 . . . . 0.0 104.014 138.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -75.65 50.49 0.56 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 126.345 1.858 . . . . 0.0 110.377 -162.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 11.1 m -150.76 -35.72 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.583 1.553 . . . . 0.0 109.491 -162.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -57.07 -38.31 73.1 Favored 'General case' 0 C--O 1.216 -0.667 0 O-C-N 120.743 -1.223 . . . . 0.0 111.269 151.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.53 -42.83 88.69 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.266 0.939 . . . . 0.0 111.283 173.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 23.1 p -79.04 -55.3 5.22 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.039 -173.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 15.9 t -63.47 -34.18 77.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.528 1.513 . . . . 0.0 113.197 175.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.18 -50.19 72.82 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.102 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 65.4 mt -63.52 -70.27 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-O 122.282 1.039 . . . . 0.0 110.044 173.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 72.6 mtt-85 -76.74 1.65 16.58 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.122 1.769 . . . . 0.0 113.381 -163.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -125.48 -69.45 0.19 Allowed Glycine 0 N--CA 1.461 0.354 0 C-N-CA 125.636 1.589 . . . . 0.0 109.75 175.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.26 -27.57 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 117.169 -1.396 . . . . 0.0 112.518 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -96.87 -28.83 14.05 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 120.844 1.657 . . . . 0.0 114.095 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -54.69 -34.19 61.98 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.584 1.154 . . . . 0.0 111.009 167.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 58.0 tp -56.67 -30.3 63.23 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 168.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -82.84 -37.0 25.01 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 119.387 -2.071 . . . . 0.0 115.4 -171.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -16.67 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.427 1.091 . . . . 0.0 112.577 170.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 70.4 mt -75.02 -45.02 44.59 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.65 -0.656 . . . . 0.0 111.723 168.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -68.64 -41.09 79.87 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.752 1.621 . . . . 0.0 111.451 -170.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 32.1 tpp -25.7 -22.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 131.153 3.781 . . . . 0.0 117.797 149.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 17.0 mt -131.3 -4.39 3.84 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.061 1.745 . . . . 0.0 112.701 -174.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -66.6 -53.05 38.54 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.276 141.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 52.5 t 47.06 75.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.115 1.366 . . . . 0.0 109.344 -160.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -75.04 42.22 0.18 Allowed 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.56 -1.337 . . . . 0.0 114.537 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 20.3 ttt85 -121.3 74.92 1.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 128.377 2.671 . . . . 0.0 106.662 174.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -168.88 40.46 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.113 0 O-C-N 118.644 -2.535 . . . . 0.0 111.184 18.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 83.03 84.07 0.87 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -147.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 110.42 71.54 0.66 Allowed Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.145 1.355 . . . . 0.0 113.614 -169.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 19.9 p -58.46 142.79 47.65 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.72 1.208 . . . . 0.0 111.543 174.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 76.7 m95 53.47 38.35 27.82 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 166.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 . . . . . 0 C--O 1.253 1.243 0 CA-C-O 117.078 -1.439 . . . . 0.0 111.838 179.478 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 CA--C 1.515 -0.377 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.2 tp -82.59 172.46 12.95 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 140.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 67.83 -33.54 0.22 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 127.779 2.431 . . . . 0.0 116.828 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 37.6 mmm-85 -58.65 -18.09 27.83 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 121.213 1.824 . . . . 0.0 115.881 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.25 -28.35 4.71 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.17 0.988 . . . . 0.0 110.96 162.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -65.23 -47.71 75.86 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.244 1.384 . . . . 0.0 114.039 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.07 -32.11 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.342 1.457 . . . . 0.0 111.044 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -72.12 -36.32 69.4 Favored 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 123.683 0.793 . . . . 0.0 110.859 174.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -55.12 -34.74 58.78 Favored Glycine 0 CA--C 1.541 1.701 0 O-C-N 121.144 -0.973 . . . . 0.0 111.044 165.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.8 mtm180 -66.76 -43.63 83.54 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 117.944 0.872 . . . . 0.0 111.719 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 42.6 t -56.93 -53.29 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 125.18 1.392 . . . . 0.0 110.469 173.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -62.39 -49.95 73.49 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.644 0.778 . . . . 0.0 111.593 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -62.61 -19.91 64.23 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.092 1.357 . . . . 0.0 113.919 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.433 ' CZ ' ' HA ' ' A' ' 121' ' ' LYS . 26.4 t80 -83.06 -41.44 18.62 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 126.344 1.857 . . . . 0.0 110.719 174.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.7 mt -62.41 -43.07 99.68 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.421 1.009 . . . . 0.0 110.971 169.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -77.37 -37.6 51.8 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.5 -157.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 16.1 mtp-105 -82.72 161.69 57.8 Favored Pre-proline 0 N--CA 1.47 0.544 0 C-N-CA 125.409 1.484 . . . . 0.0 113.022 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -71.18 131.26 18.93 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 121.177 1.251 . . . . 0.0 109.11 149.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.9 t -154.73 149.91 27.02 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 120.352 -1.467 . . . . 0.0 109.8 167.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.0 8.64 0.05 OUTLIER Glycine 0 CA--C 1.537 1.468 0 N-CA-C 117.114 1.606 . . . . 0.0 117.114 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -124.82 -16.11 6.26 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 166.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 113' ' ' PHE . 35.5 ttpt -61.24 -69.56 0.23 Allowed 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 121.114 1.779 . . . . 0.0 111.528 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 60.2 m -65.78 -34.93 79.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 118.881 -0.58 . . . . 0.0 109.926 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -58.61 -52.13 66.96 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.365 0.53 . . . . 0.0 111.705 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.7 t -82.47 -43.2 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 121.25 -0.906 . . . . 0.0 113.018 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -75.72 -33.97 60.32 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.628 -0.67 . . . . 0.0 112.343 -171.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -68.74 -33.56 74.12 Favored 'General case' 0 C--N 1.346 0.435 0 O-C-N 120.897 -1.127 . . . . 0.0 111.128 169.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -64.31 -40.9 96.84 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.253 -0.904 . . . . 0.0 112.977 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.23 -44.83 65.04 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 118.168 -0.92 . . . . 0.0 113.443 167.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.64 -36.76 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 120.95 1.704 . . . . 0.0 113.159 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -54.62 -52.32 62.6 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.019 0.827 . . . . 0.0 111.308 172.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 87.7 mt -68.17 -40.64 82.25 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.908 0.483 . . . . 0.0 112.296 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 58.9 mt -69.62 -43.12 80.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 CA-C-O 117.874 -1.06 . . . . 0.0 112.083 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 80.8 t -60.82 -45.09 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 121.25 1.841 . . . . 0.0 111.674 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.4 tp -53.85 -54.07 43.59 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.513 1.525 . . . . 0.0 111.731 171.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 53.5 t -62.6 -39.97 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.712 0.805 . . . . 0.0 112.241 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.5 m -61.21 -42.98 99.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 119.335 0.971 . . . . 0.0 111.721 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.2 mt -74.61 -38.45 62.57 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.336 0.655 . . . . 0.0 112.23 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 71.7 mt -59.31 -48.42 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.887 0.875 . . . . 0.0 110.639 170.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -69.05 -35.71 76.87 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 118.969 -0.539 . . . . 0.0 111.563 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.3 t -58.42 -44.45 89.09 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.852 1.261 . . . . 0.0 112.874 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.1 m -67.49 -28.19 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.7 mt -71.42 -46.81 59.19 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.679 0.672 . . . . 0.0 111.756 166.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 72.6 m -70.39 -33.02 70.91 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.29 1.836 . . . . 0.0 115.036 -170.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.2 t -66.57 -47.52 72.51 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 120.164 1.347 . . . . 0.0 109.895 -174.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 26.5 mm -56.0 -44.63 78.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 124.466 1.106 . . . . 0.0 111.135 175.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -80.65 -14.37 58.22 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -73.19 -37.71 66.39 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.361 1.437 . . . . 0.0 111.196 166.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -79.9 -2.83 45.44 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.163 -0.961 . . . . 0.0 112.089 170.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.65 -27.93 18.72 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.596 1.158 . . . . 0.0 112.954 157.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.467 ' HB2' HG21 ' A' ' 155' ' ' THR . . . -60.58 -19.38 57.43 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -173.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.432 ' H ' ' HG ' ' A' ' 151' ' ' LEU . 1.6 pp -63.88 -4.49 3.31 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 126.697 1.999 . . . . 0.0 114.557 166.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.23 -35.17 0.32 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.851 2.46 . . . . 0.0 114.24 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 72.5 m -129.22 141.53 51.11 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.7 1.2 . . . . 0.0 110.448 -151.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -72.49 140.91 30.13 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.278 -0.487 . . . . 0.0 112.101 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.467 HG21 ' HB2' ' A' ' 150' ' ' ALA . 2.2 t -147.62 143.44 27.71 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -158.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -60.93 -7.23 2.27 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 170.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -56.31 -8.67 0.54 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.89 2.476 . . . . 0.0 116.367 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -68.8 -24.04 64.35 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.472 -1.392 . . . . 0.0 112.508 171.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 76.5 mtm -74.16 -13.81 60.87 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -68.56 -44.08 75.23 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.723 1.147 . . . . 0.0 110.492 164.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 28.8 mt -58.62 -36.75 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 118.481 -0.771 . . . . 0.0 111.916 169.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.5 t -57.53 -45.58 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 120.409 1.459 . . . . 0.0 111.49 171.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 19.3 mt -62.7 -42.82 99.84 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 173.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.88 -24.17 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.24 0.927 . . . . 0.0 112.34 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 54.6 t -78.87 -38.99 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.233 1.013 . . . . 0.0 110.429 172.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -61.56 -49.75 75.4 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.394 0.997 . . . . 0.0 112.297 170.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -65.71 -46.33 79.35 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.711 0.687 . . . . 0.0 112.47 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -52.26 -40.86 53.48 Favored Glycine 0 CA--C 1.539 1.546 0 O-C-N 121.598 -0.689 . . . . 0.0 112.788 167.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 70.2 m -69.17 -37.83 78.39 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 117.775 0.787 . . . . 0.0 112.482 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -59.71 -50.2 74.75 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.981 1.312 . . . . 0.0 110.888 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -51.66 -47.41 63.8 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.362 1.065 . . . . 0.0 112.247 172.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 37.8 t -66.37 -37.97 80.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.959 0.904 . . . . 0.0 112.363 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 12.2 t -62.85 -33.51 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.146 1.379 . . . . 0.0 112.427 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 24.5 mtt180 -59.99 -44.86 94.24 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.118 -0.989 . . . . 0.0 111.221 170.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.7 mt -68.7 -35.43 77.17 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.173 0.589 . . . . 0.0 112.381 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 53.2 m0 -65.34 -26.58 68.1 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 172.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 47.8 t -70.34 -30.21 67.11 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.604 1.093 . . . . 0.0 113.534 166.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -68.89 -0.46 5.56 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.307 -1.496 . . . . 0.0 112.598 161.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -104.92 7.39 44.75 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 126.58 2.038 . . . . 0.0 116.238 172.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 7.8 t -54.49 -23.12 14.97 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.247 1.524 . . . . 0.0 112.48 173.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -122.47 -60.37 1.55 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.254 1.422 . . . . 0.0 110.988 153.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.9 p -86.35 64.5 8.58 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.473 1.509 . . . . 0.0 111.971 -163.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -44.82 -35.73 2.91 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.732 1.613 . . . . 0.0 115.05 -167.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -112.32 -33.07 6.31 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.739 1.216 . . . . 0.0 113.859 174.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -56.74 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 119.786 1.176 . . . . 0.0 111.606 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -67.63 -35.79 86.69 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 119.022 -0.877 . . . . 0.0 111.179 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 1.2 tt -51.9 -33.21 35.88 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.019 0.928 . . . . 0.0 113.062 169.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 49.8 t-105 -86.13 -36.18 19.72 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -73.88 -38.17 49.55 Favored Glycine 0 N--CA 1.466 0.638 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -64.99 -40.29 94.73 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 124.675 1.19 . . . . 0.0 111.005 169.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 19.3 tp -63.76 -40.87 97.74 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.41 1.005 . . . . 0.0 111.914 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 52.5 mtp180 -64.43 -23.81 67.41 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 171.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -74.73 0.47 15.16 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.919 1.288 . . . . 0.0 113.977 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.03 27.71 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 116.839 2.163 . . . . 0.0 116.839 -173.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -92.75 -7.16 47.4 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 117.198 2.295 . . . . 0.0 117.198 -159.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -61.03 147.23 86.48 Favored Pre-proline 0 N--CA 1.482 1.138 0 CA-C-N 120.976 1.716 . . . . 0.0 109.975 167.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -45.33 -50.18 9.39 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.93 3.087 . . . . 0.0 115.669 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 96.5 mt -71.98 -29.96 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.409 1.083 . . . . 0.0 111.784 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 50.6 m -72.79 -30.72 64.31 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.093 0.957 . . . . 0.0 112.279 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 46.8 mt -68.16 -42.77 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.586 0.754 . . . . 0.0 109.808 168.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 49.4 mt -61.87 -43.52 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 121.656 -0.653 . . . . 0.0 110.933 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.13 -38.78 92.29 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.501 1.52 . . . . 0.0 112.099 175.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.5 tt -63.12 -48.76 77.16 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.55 0.614 . . . . 0.0 110.716 170.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.1 -36.93 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.618 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 72.1 t -74.1 -33.93 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 120.24 1.382 . . . . 0.0 113.5 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.3 p -66.39 -36.99 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 121.052 1.751 . . . . 0.0 110.802 169.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 77.4 t -71.45 -39.56 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 120.904 -1.122 . . . . 0.0 110.777 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.5 -57.77 10.83 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.036 0.934 . . . . 0.0 110.628 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 59.8 p -56.14 -42.44 76.93 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.761 0.424 . . . . 0.0 111.261 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -64.0 -54.93 26.55 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.928 0.891 . . . . 0.0 112.526 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.15 -36.43 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 119.65 1.113 . . . . 0.0 111.855 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 27.9 m -75.17 -38.87 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 117.561 -1.209 . . . . 0.0 112.047 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.92 -22.13 65.08 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.031 1.287 . . . . 0.0 111.655 171.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 66.8 m -74.68 -36.87 62.79 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.422 1.089 . . . . 0.0 113.177 171.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 76.6 t -64.04 -31.61 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 118.933 0.788 . . . . 0.0 110.273 164.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 137.76 -107.68 0.59 Allowed Glycine 0 CA--C 1.522 0.506 0 C-N-CA 124.555 1.074 . . . . 0.0 112.908 158.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 87.1 p -139.8 2.21 1.95 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.55 1.14 . . . . 0.0 113.195 -167.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -171.92 -177.8 2.01 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.667 2.387 . . . . 0.0 110.23 -172.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 57.69 108.25 0.01 OUTLIER Glycine 0 CA--C 1.526 0.781 0 N-CA-C 106.966 -2.454 . . . . 0.0 106.966 -107.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -57.92 -6.4 0.56 Allowed 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 120.348 2.074 . . . . 0.0 112.586 172.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.531 ' HA ' HG22 ' A' ' 224' ' ' THR . 22.3 m -72.12 -32.17 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.528 1.531 . . . . 0.0 113.119 169.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.37 -47.68 62.76 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.929 1.241 . . . . 0.0 111.181 159.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.29 -55.31 12.56 Favored 'General case' 0 C--O 1.223 -0.341 0 O-C-N 124.217 0.948 . . . . 0.0 110.768 -168.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.531 HG22 ' HA ' ' A' ' 221' ' ' VAL . 8.1 t -52.97 -39.72 63.21 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.166 -0.959 . . . . 0.0 111.78 176.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 16.1 m -69.2 -58.29 4.25 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.163 -0.961 . . . . 0.0 111.999 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -54.79 -54.69 38.91 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 126.049 1.739 . . . . 0.0 110.914 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.53 -71.79 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.845 1.658 . . . . 0.0 107.835 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -74.52 -43.38 56.15 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.246 -154.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -59.45 -46.33 94.09 Favored Glycine 0 N--CA 1.472 1.056 0 CA-C-O 119.616 -0.547 . . . . 0.0 112.854 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.98 -34.67 39.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 117.979 0.89 . . . . 0.0 111.623 -177.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -40.74 98.54 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.058 -1.026 . . . . 0.0 112.168 166.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -66.56 -36.53 82.9 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.34 0.656 . . . . 0.0 110.634 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 1.5 tp -67.29 -23.85 65.7 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 172.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.48 -48.2 20.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.51 1.124 . . . . 0.0 113.071 176.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 22.9 pt -68.08 -16.6 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 173.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 52.0 tp -70.26 -26.06 63.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.266 1.426 . . . . 0.0 111.608 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.443 ' HG2' ' HD1' ' A' ' 240' ' ' HIS . 10.3 mtp180 -67.44 -19.29 65.35 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.211 1.005 . . . . 0.0 112.221 -176.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.7 -24.08 2.1 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.685 1.994 . . . . 0.0 113.94 160.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.491 ' HA ' HG21 ' A' ' 247' ' ' THR . 4.1 mt -114.36 -19.85 11.07 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.819 1.648 . . . . 0.0 111.334 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . 0.443 ' HD1' ' HG2' ' A' ' 237' ' ' ARG . 39.8 m170 -64.66 -32.22 73.78 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 118.964 -0.541 . . . . 0.0 111.425 162.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.297 11.1 p -79.02 67.37 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-O 125.159 2.409 . . . . 0.0 110.618 158.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.582 ' HA ' HG22 ' A' ' 247' ' ' THR . 24.2 p-10 -51.46 -4.34 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 112.412 -2.176 . . . . 0.0 114.167 152.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 7.0 tpt85 53.11 24.42 3.56 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 127.469 2.308 . . . . 0.0 112.104 -177.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 64.85 34.9 8.88 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 128.044 2.537 . . . . 0.0 114.325 -175.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 171.46 -3.43 0.03 OUTLIER Glycine 0 CA--C 1.537 1.468 0 N-CA-C 117.392 1.717 . . . . 0.0 117.392 169.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 157.33 104.35 0.21 Allowed Glycine 0 CA--C 1.522 0.522 0 C-N-CA 127.156 2.313 . . . . 0.0 108.196 -170.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.582 HG22 ' HA ' ' A' ' 242' ' ' ASP . 5.6 p -46.38 132.14 10.44 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.335 -1.097 . . . . 0.0 110.735 173.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 21.2 m95 55.96 9.71 0.49 Allowed 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 . . . . . 0 C--O 1.247 0.947 0 C-N-CA 124.866 1.266 . . . . 0.0 114.253 -165.748 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.0 m . . . . . 0 C--O 1.235 0.323 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.531 ' HG ' ' HB3' ' A' ' 102' ' ' ALA . 1.7 tp -65.44 94.27 0.17 Allowed 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 134.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.531 ' HB3' ' HG ' ' A' ' 101' ' ' LEU . . . 57.39 59.53 3.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 112.673 -2.058 . . . . 0.0 110.391 139.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.12 -12.55 3.58 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 120.423 -1.423 . . . . 0.0 112.534 169.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.447 HG23 ' H ' ' A' ' 105' ' ' HIS . 2.6 t -62.8 -95.07 0.0 OUTLIER 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 127.382 2.273 . . . . 0.0 113.893 143.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.447 ' H ' HG23 ' A' ' 104' ' ' THR . 49.5 m80 -58.58 -19.85 41.79 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 119.975 3.324 . . . . 0.0 119.975 -168.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.6 p -61.0 -37.62 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 120.456 1.48 . . . . 0.0 111.946 172.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -67.45 -41.5 84.61 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.827 0.851 . . . . 0.0 109.249 173.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -58.86 -26.72 60.94 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.091 -1.394 . . . . 0.0 113.866 167.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -67.18 -45.19 77.7 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 120.36 2.08 . . . . 0.0 111.647 174.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.2 t -57.13 -47.39 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.144 0.978 . . . . 0.0 110.038 171.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -66.32 -56.6 10.38 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 118.848 -0.596 . . . . 0.0 112.453 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -58.89 -20.44 51.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 119.376 0.989 . . . . 0.0 113.463 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -80.39 -42.73 22.27 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.65 1.114 . . . . 0.0 111.773 171.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.63 -25.68 38.2 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -178.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -108.99 -38.71 5.5 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.06 1.344 . . . . 0.0 112.513 -164.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -90.75 151.1 43.37 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 123.279 0.632 . . . . 0.0 111.885 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.65 128.37 18.91 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.991 1.794 . . . . 0.0 112.986 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.2 t -152.4 151.13 30.43 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 156.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.47 -28.86 22.34 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 119.544 1.065 . . . . 0.0 112.654 172.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -70.88 -27.54 63.9 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 175.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.7 tmmt? -56.61 -60.87 2.91 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.34 1.056 . . . . 0.0 109.165 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 25.5 p -71.69 -27.33 62.96 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.682 1.193 . . . . 0.0 112.682 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -61.67 -52.24 65.14 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.715 1.598 . . . . 0.0 110.427 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.5 t -76.54 -48.17 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.051 0.54 . . . . 0.0 111.666 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -63.99 -46.54 84.1 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -75.77 -28.95 58.63 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.571 -0.705 . . . . 0.0 111.285 -174.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -69.99 -39.24 76.04 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.469 1.031 . . . . 0.0 112.375 169.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.51 -43.99 84.66 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.477 1.035 . . . . 0.0 113.362 167.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 76.4 t -62.15 -44.42 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 120.553 1.524 . . . . 0.0 111.727 172.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -56.72 -50.47 72.11 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.05 1.295 . . . . 0.0 111.553 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 94.2 mt -65.19 -45.37 85.11 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 119.019 -0.515 . . . . 0.0 111.469 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 76.1 mt -65.36 -37.23 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.859 0.754 . . . . 0.0 112.085 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.76 -45.46 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 119.956 1.253 . . . . 0.0 110.731 174.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 45.3 tp -63.92 -47.98 78.39 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.074 0.95 . . . . 0.0 111.922 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.4 t -59.9 -47.37 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.631 0.772 . . . . 0.0 110.126 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 41.5 t -58.06 -43.71 87.09 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.713 1.205 . . . . 0.0 112.824 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 61.2 mt -76.75 -36.18 57.26 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.2 mt -61.66 -48.31 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 120.813 -1.179 . . . . 0.0 109.77 167.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -63.48 -25.78 68.42 Favored 'General case' 0 C--O 1.22 -0.485 0 O-C-N 121.431 -0.793 . . . . 0.0 111.921 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.1 t -56.94 -39.59 74.81 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 120.047 1.294 . . . . 0.0 112.068 175.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 52.1 t -66.31 -42.34 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.584 0.754 . . . . 0.0 111.652 173.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.4 mt -70.63 -55.52 8.59 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.652 1.181 . . . . 0.0 112.661 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.3 m -68.17 -29.82 68.79 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.915 2.086 . . . . 0.0 113.538 -171.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.19 -46.29 51.44 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.218 1.372 . . . . 0.0 110.382 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.7 mm -52.84 -44.0 47.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.023 0.929 . . . . 0.0 110.834 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -74.07 -33.41 63.66 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -74.26 -21.69 59.65 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 119.856 -1.778 . . . . 0.0 112.082 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -79.98 -41.88 25.03 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.556 0.616 . . . . 0.0 109.455 171.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -57.91 -28.14 63.97 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.369 1.068 . . . . 0.0 113.424 170.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -57.63 -18.11 18.35 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.8 mp -83.86 -34.88 24.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.047 0.939 . . . . 0.0 111.952 174.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -84.58 -36.7 21.89 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.005 1.722 . . . . 0.0 114.073 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.0 t -158.51 -168.13 2.35 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 126.784 2.034 . . . . 0.0 108.313 -159.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -71.91 -174.99 23.44 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 120.711 -1.243 . . . . 0.0 113.74 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 10.0 t -161.02 148.18 15.25 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 49.3 tp -68.42 -10.38 54.83 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.194 1.798 . . . . 0.0 114.314 165.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -53.52 -17.77 2.31 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 -167.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 30.0 p-90 -58.14 -29.86 65.9 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 119.978 -1.701 . . . . 0.0 112.908 169.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 61.7 ttp -65.09 -32.89 74.83 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.858 1.663 . . . . 0.0 112.108 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -69.16 -38.94 79.01 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.508 -0.745 . . . . 0.0 111.884 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 50.1 mm -56.35 -34.51 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.059 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.4 t -60.5 -46.18 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.147 0.885 . . . . 0.0 111.271 172.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 15.9 mt -72.19 -47.47 50.45 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.746 0.818 . . . . 0.0 112.871 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 69.0 t -62.14 -43.29 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.754 0.822 . . . . 0.0 111.161 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 84.6 t -72.15 -32.41 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.05 174.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -62.12 -49.16 77.0 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 120.807 1.64 . . . . 0.0 112.486 170.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -64.83 -39.71 94.02 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.52 -1.363 . . . . 0.0 111.636 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -62.56 -38.11 95.84 Favored Glycine 0 CA--C 1.538 1.475 0 O-C-N 121.989 -0.444 . . . . 0.0 112.714 169.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 59.8 m -67.53 -36.65 81.43 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 117.731 0.765 . . . . 0.0 111.706 173.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -62.33 -44.18 97.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.521 1.128 . . . . 0.0 110.784 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -58.51 -41.1 84.63 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 77.9 t -71.08 -36.65 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.217 -0.927 . . . . 0.0 113.153 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 46.8 t -67.17 -29.99 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.035 1.334 . . . . 0.0 111.746 175.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -59.43 -40.01 85.35 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.971 -1.081 . . . . 0.0 112.19 165.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 74.5 mt -74.63 -36.93 62.92 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.708 0.803 . . . . 0.0 112.928 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 54.9 m0 -62.57 -41.17 98.76 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.072 1.305 . . . . 0.0 112.708 169.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 42.8 p -71.41 0.82 7.37 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.84 -23.45 60.67 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.556 1.525 . . . . 0.0 113.579 154.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 164.27 112.54 0.27 Allowed Glycine 0 N--CA 1.433 -1.541 0 O-C-N 121.878 -0.514 . . . . 0.0 112.157 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 45.0 t -34.06 -32.51 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.14 1.776 . . . . 0.0 113.514 152.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.46 -44.64 3.85 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 161.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.7 m -74.47 24.97 0.08 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -171.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -5.66 2.89 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 118.067 2.618 . . . . 0.0 118.067 -173.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -119.2 -37.53 3.18 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 120.276 1.398 . . . . 0.0 111.822 166.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.404 HG13 ' H ' ' A' ' 186' ' ' GLY . 10.8 p -73.09 -62.0 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.96 0.904 . . . . 0.0 112.71 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.404 ' H ' HG13 ' A' ' 185' ' ' VAL . . . -61.63 -31.65 78.61 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 118.591 -1.116 . . . . 0.0 112.656 169.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.0 tt -55.79 -49.58 72.8 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.4 1.6 . . . . 0.0 110.048 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -66.99 -42.38 85.17 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 122.211 -0.305 . . . . 0.0 111.092 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -53.36 -43.95 65.62 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.238 1.399 . . . . 0.0 114.105 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . 0.326 9.9 ptp180 -80.51 -31.02 37.26 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 40.0 tp -69.0 -41.02 78.34 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.49 0.586 . . . . 0.0 112.365 171.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -76.18 -17.39 59.57 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -78.97 -13.83 59.56 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.757 1.223 . . . . 0.0 113.831 169.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -78.79 43.89 0.52 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 117.052 2.242 . . . . 0.0 117.052 -165.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -93.86 -5.57 47.72 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -165.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -61.89 141.45 95.4 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 120.199 1.363 . . . . 0.0 109.104 175.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -47.57 -43.37 27.95 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.025 2.483 . . . . 0.0 115.021 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 35.0 mm -68.43 -32.24 54.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.117 0.967 . . . . 0.0 112.419 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 14.3 m -71.61 -36.6 70.86 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.973 1.309 . . . . 0.0 111.46 175.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 63.6 mt -68.94 -39.32 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.707 1.203 . . . . 0.0 110.733 173.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 33.9 mt -62.85 -41.48 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 121.286 -0.884 . . . . 0.0 111.129 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -65.23 -36.45 84.19 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.26 1.424 . . . . 0.0 111.647 176.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 28.6 tp -60.95 -52.96 62.83 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.529 0.732 . . . . 0.0 111.48 166.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 49.5 mt -61.59 -36.32 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.496 -0.752 . . . . 0.0 111.077 -175.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.0 t -65.9 -45.84 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.962 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.02 -31.39 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 CA-C-N 120.818 1.645 . . . . 0.0 112.018 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 97.5 t -74.25 -39.38 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 120.557 1.526 . . . . 0.0 110.893 176.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.15 81.96 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.34 0.973 . . . . 0.0 110.369 170.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 47.6 m -58.62 -43.94 89.79 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.77 0.828 . . . . 0.0 112.197 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 28.3 ttm -59.66 -55.45 34.31 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.295 1.438 . . . . 0.0 111.875 171.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 23.8 t -56.01 -47.47 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.099 1.36 . . . . 0.0 112.053 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 33.4 m -75.95 -25.79 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 118.043 -0.979 . . . . 0.0 113.28 -171.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 86.3 mt -68.85 -48.32 63.75 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.829 1.195 . . . . 0.0 110.968 159.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 43.8 t -63.04 -46.79 85.85 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.169 0.987 . . . . 0.0 113.003 -165.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 8.4 p -71.13 -11.72 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.896 -1.128 . . . . 0.0 113.214 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.41 125.58 5.66 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 125.357 1.456 . . . . 0.0 112.301 -168.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.5 m -72.75 61.23 0.53 Allowed 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 128.37 2.668 . . . . 0.0 113.427 -168.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -166.73 164.72 16.64 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 127.735 2.414 . . . . 0.0 112.064 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -85.24 -106.14 0.67 Allowed Glycine 0 C--N 1.337 0.603 0 C-N-CA 126.462 1.982 . . . . 0.0 111.923 -1.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -66.32 -23.64 66.4 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.095 -1.053 . . . . 0.0 112.302 171.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.68 -44.79 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 O-C-N 121.259 -0.901 . . . . 0.0 110.486 -166.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.65 -51.58 54.69 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.482 0.713 . . . . 0.0 111.906 163.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.66 -52.36 65.46 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.58 0.752 . . . . 0.0 109.559 -171.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.49 -37.73 88.57 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-O 117.915 -1.04 . . . . 0.0 112.715 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 46.1 m -67.92 -48.26 66.48 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 121.397 1.908 . . . . 0.0 111.298 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -56.42 -46.77 80.07 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 125.072 1.349 . . . . 0.0 110.976 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 227' ' ' ILE . 72.5 mt -59.29 -71.1 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-O 122.478 1.133 . . . . 0.0 110.184 167.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -78.38 -17.92 55.79 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.153 -150.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.43 -53.73 2.24 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.532 1.063 . . . . 0.0 114.058 162.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -30.66 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 119.512 1.656 . . . . 0.0 113.637 -170.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 4.0 mmt85 -73.49 -32.46 64.31 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.779 -1.2 . . . . 0.0 110.923 170.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -67.19 -36.5 81.89 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.479 1.111 . . . . 0.0 112.42 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 65.3 tp -58.34 -36.23 73.1 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 118.316 0.507 . . . . 0.0 112.198 165.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.21 -34.71 61.52 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 119.95 -1.719 . . . . 0.0 113.552 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 3.7 pt -73.35 -22.75 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 120.779 -1.2 . . . . 0.0 113.832 164.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.5 tp -58.7 -42.47 88.68 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.606 1.163 . . . . 0.0 110.789 164.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -56.98 -30.6 64.26 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.309 1.044 . . . . 0.0 112.893 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 18.5 mmt -49.08 -31.93 8.79 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 168.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 40.5 mt -112.65 -7.67 13.84 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.182 1.393 . . . . 0.0 109.982 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -68.12 -12.93 61.77 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.661 0.664 . . . . 0.0 112.084 153.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.75 75.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-O 124.272 1.987 . . . . 0.0 108.765 138.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 52.9 p30 -105.84 29.08 6.94 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 112.379 -2.192 . . . . 0.0 111.497 144.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -55.8 -65.27 0.62 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 128.211 2.604 . . . . 0.0 112.501 -171.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -158.97 148.68 19.04 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 69.99 13.43 69.59 Favored Glycine 0 N--CA 1.466 0.649 0 CA-C-N 114.216 -1.356 . . . . 0.0 116.221 142.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 124.26 44.83 0.28 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 119.018 1.409 . . . . 0.0 113.073 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 82.1 p -59.89 116.88 4.43 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.095 -1.238 . . . . 0.0 110.33 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 78.3 m95 56.61 21.21 5.56 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.83 2.052 . . . . 0.0 115.33 -173.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 . . . . . 0 C--O 1.244 0.765 0 C-N-CA 126.594 1.958 . . . . 0.0 112.047 179.629 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.465 0.314 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.79 115.78 3.31 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 103.692 -2.707 . . . . 0.0 103.692 118.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 27.24 82.18 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 125.204 1.402 . . . . 0.0 110.744 139.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.588 ' HA ' HG12 ' A' ' 106' ' ' VAL . 18.7 ttp180 -49.91 -34.0 19.08 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 113.892 -1.504 . . . . 0.0 112.057 -170.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 t -43.71 -57.27 3.29 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.932 2.493 . . . . 0.0 114.027 165.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -92.22 -25.33 18.69 Favored 'General case' 0 C--N 1.335 -0.06 0 O-C-N 120.196 -1.565 . . . . 0.0 114.349 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.588 HG12 ' HA ' ' A' ' 103' ' ' ARG . 1.4 p -69.56 -38.93 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 119.446 1.021 . . . . 0.0 111.144 171.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -73.54 -32.35 64.16 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.137 -0.977 . . . . 0.0 111.159 171.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.02 -32.31 42.0 Favored Glycine 0 CA--C 1.536 1.348 0 O-C-N 121.755 -0.591 . . . . 0.0 112.579 163.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -37.05 84.13 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.263 1.425 . . . . 0.0 111.546 -177.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.07 -54.1 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 122.292 1.044 . . . . 0.0 109.485 170.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . 0.25 77.0 m-85 -74.78 -33.75 62.33 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.101 -168.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -62.31 -22.86 66.38 Favored 'General case' 0 CA--C 1.552 1.051 0 O-C-N 120.179 -1.576 . . . . 0.0 114.469 165.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -75.38 -28.41 59.47 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.289 1.035 . . . . 0.0 111.811 171.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.2 mt -58.92 -43.65 91.16 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.56 1.073 . . . . 0.0 109.836 165.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -74.65 -40.82 61.23 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.306 -161.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.9 ptt85 -87.43 123.0 70.41 Favored Pre-proline 0 N--CA 1.47 0.554 0 C-N-CA 124.24 1.016 . . . . 0.0 110.46 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -65.89 126.61 16.21 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.869 1.712 . . . . 0.0 110.886 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.1 p -133.32 166.84 21.56 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 167.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.01 -37.59 71.78 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-N 118.634 0.652 . . . . 0.0 112.579 171.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -73.0 -34.99 66.74 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 175.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.43 -55.99 27.73 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.785 1.175 . . . . 0.0 108.864 164.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 34.0 t -58.52 -48.5 80.62 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.488 1.115 . . . . 0.0 111.994 -171.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -59.72 -52.96 63.26 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.824 0.45 . . . . 0.0 111.428 -175.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.6 t -84.27 -42.87 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -64.77 -48.98 72.52 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.705 0.402 . . . . 0.0 112.05 -172.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -68.8 -33.96 74.74 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.9 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -68.55 -36.08 78.31 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.275 0.943 . . . . 0.0 113.047 173.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.79 -46.13 81.74 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.352 0.978 . . . . 0.0 113.628 169.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . 0.268 0.7 OUTLIER -64.69 -39.05 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 CA-C-N 120.39 1.45 . . . . 0.0 111.16 178.743 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -60.45 -48.74 80.46 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.868 -1.145 . . . . 0.0 113.173 172.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.7 mt -61.82 -38.89 89.84 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.854 -1.154 . . . . 0.0 111.895 177.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 77.2 mt -63.26 -43.49 98.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 118.716 -0.659 . . . . 0.0 111.779 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -38.11 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 119.556 1.071 . . . . 0.0 111.662 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.6 mt -59.31 -47.74 84.27 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.761 0.425 . . . . 0.0 111.859 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.4 m -70.63 -41.11 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.608 1.095 . . . . 0.0 110.944 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 95.9 m -64.51 -39.91 94.67 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 119.105 0.866 . . . . 0.0 112.834 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 78.1 mt -71.2 -41.23 70.55 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 120.091 1.314 . . . . 0.0 112.599 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 29.3 mm -64.31 -48.09 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 121.232 -0.917 . . . . 0.0 110.02 172.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -61.5 -35.63 78.24 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-O 116.915 -1.516 . . . . 0.0 110.663 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.4 m -49.73 -48.38 50.12 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 121.006 1.73 . . . . 0.0 113.084 173.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.43 -30.67 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 122.999 0.52 . . . . 0.0 112.212 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 16.3 mt -89.84 -30.92 17.6 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.49 1.516 . . . . 0.0 114.907 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.7 p -90.17 -26.11 20.31 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.014 -1.053 . . . . 0.0 113.25 -158.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.3 t -68.97 -32.51 72.14 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.307 -0.871 . . . . 0.0 112.439 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 11.8 pt -72.28 -9.13 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -62.91 -23.38 67.33 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.661 0.784 . . . . 0.0 112.099 170.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -62.85 -38.74 92.03 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.845 1.258 . . . . 0.0 111.457 168.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -74.84 -37.37 62.28 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.892 0.769 . . . . 0.0 111.36 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.75 -42.29 95.28 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.124 0.969 . . . . 0.0 113.501 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -58.23 -25.08 61.24 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -170.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -69.77 -48.14 60.36 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.488 1.115 . . . . 0.0 111.859 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.96 -51.91 11.4 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.671 1.188 . . . . 0.0 113.273 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.5 t -159.4 -179.0 7.56 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.611 -139.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -62.71 152.73 45.19 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 122.006 0.781 . . . . 0.0 112.936 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.8 t -152.9 148.28 26.96 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.843 0.83 . . . . 0.0 112.101 -166.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 11.3 tp -81.66 14.97 2.32 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.924 2.09 . . . . 0.0 112.796 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -50.24 -29.14 8.88 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.116 2.566 . . . . 0.0 114.618 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -70.99 -31.14 67.59 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.134 -0.979 . . . . 0.0 112.408 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 9.0 tpt -73.91 -35.41 64.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.433 1.015 . . . . 0.0 110.767 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -55.82 -56.35 21.56 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.516 0.726 . . . . 0.0 110.775 166.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 75.0 mt -58.45 -40.13 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.6 0.76 . . . . 0.0 112.282 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.7 t -61.95 -44.82 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 120.279 -1.513 . . . . 0.0 112.567 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.2 mt -71.2 -34.37 70.82 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.219 1.372 . . . . 0.0 112.037 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 54.9 t -59.8 -36.77 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.54 1.063 . . . . 0.0 110.881 170.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 78.8 t -76.26 -28.2 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 118.503 -0.761 . . . . 0.0 112.055 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -60.85 -48.99 79.29 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.197 1.362 . . . . 0.0 110.669 169.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -71.93 -35.79 69.75 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.53 -43.54 94.11 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 123.368 0.508 . . . . 0.0 112.361 167.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 88.9 m -68.88 -36.95 78.7 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.837 0.819 . . . . 0.0 110.739 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.4 tm-20 -60.14 -35.11 74.57 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 118.751 0.705 . . . . 0.0 112.541 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -60.69 -46.25 91.08 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.263 -0.898 . . . . 0.0 112.044 169.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 30.4 t -69.99 -30.82 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.494 0.717 . . . . 0.0 111.988 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.1 t -60.65 -39.51 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.305 1.442 . . . . 0.0 112.47 171.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -69.79 -20.1 63.48 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 170.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 31.8 mt -77.73 -37.7 48.73 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.311 0.959 . . . . 0.0 112.222 166.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 34.8 m0 -64.92 -45.63 85.03 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.008 -1.058 . . . . 0.0 113.355 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 95.1 p -56.02 -38.49 70.61 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.024 1.283 . . . . 0.0 113.845 169.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.09 -8.85 33.74 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 173.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -106.63 5.2 37.34 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.142 1.83 . . . . 0.0 113.815 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 20.7 p -57.35 -15.28 6.01 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -173.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.28 -33.17 2.17 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.011 1.725 . . . . 0.0 112.658 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 21.7 t -159.26 115.2 2.56 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.093 1.757 . . . . 0.0 107.347 177.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -57.7 -34.74 69.76 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -155.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -100.24 -29.32 12.53 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -169.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 99.4 t -54.42 -59.63 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 118.834 0.743 . . . . 0.0 110.695 -173.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.35 -26.76 68.33 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-O 116.101 -2.499 . . . . 0.0 114.507 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 66.4 mt -57.3 -39.47 75.83 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 121.519 2.66 . . . . 0.0 111.237 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 6.7 t-105 -70.25 -42.46 72.15 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.472 -0.768 . . . . 0.0 111.748 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -62.79 -27.1 69.5 Favored Glycine 0 CA--C 1.533 1.173 0 O-C-N 121.608 -0.682 . . . . 0.0 113.38 175.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -82.69 -31.37 28.61 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 129.901 3.28 . . . . 0.0 113.104 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 52.8 mt -81.19 -30.26 34.37 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.58 1.152 . . . . 0.0 111.906 171.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -58.94 -45.01 91.46 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 126.327 1.851 . . . . 0.0 112.291 159.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -63.13 -31.27 72.37 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.694 -0.628 . . . . 0.0 112.193 169.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.28 17.23 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 173.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 -108.01 -20.97 13.0 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.287 1.835 . . . . 0.0 112.89 172.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -70.03 153.7 95.18 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 126.025 1.73 . . . . 0.0 110.031 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.69 -57.28 1.06 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 CA-C-N 122.236 1.834 . . . . 0.0 116.019 -157.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 81.7 mt -68.34 -18.54 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 120.017 1.28 . . . . 0.0 111.834 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 37.2 m -89.44 -29.28 19.13 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 16.5 tt -79.75 -33.1 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 119.823 1.192 . . . . 0.0 110.701 168.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.09 -36.69 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 118.852 0.751 . . . . 0.0 110.213 165.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -72.02 -35.67 69.47 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.701 1.137 . . . . 0.0 111.789 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 24.1 tp -62.15 -49.31 76.34 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.729 0.412 . . . . 0.0 111.417 169.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 60.6 mt -60.78 -45.24 98.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.786 1.234 . . . . 0.0 111.084 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.2 t -68.27 -40.02 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.048 0.939 . . . . 0.0 112.002 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.1 p -69.73 -31.6 49.13 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 CA-C-N 121.331 1.878 . . . . 0.0 111.707 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 73.2 t -71.71 -45.03 68.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -54.86 -48.58 72.75 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 118.186 0.448 . . . . 0.0 111.297 171.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.0 m -57.12 -50.28 73.29 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.341 1.057 . . . . 0.0 112.847 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 21.6 ptp -69.14 -38.65 78.94 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 118.906 -0.569 . . . . 0.0 111.86 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 14.9 t -58.66 -42.12 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.336 1.054 . . . . 0.0 111.687 174.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 30.2 m -84.38 -30.84 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.32 -33.07 65.25 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.082 0.855 . . . . 0.0 111.813 160.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 48.9 t -84.56 -44.34 13.64 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.845 0.858 . . . . 0.0 112.958 -170.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 5.0 p -67.14 -21.51 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -169.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 122.61 108.22 1.94 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -159.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . 0.412 ' HA ' ' CG ' ' A' ' 222' ' ' PHE . 97.4 p -73.37 41.21 0.11 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.84 2.056 . . . . 0.0 114.133 -173.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -157.21 166.7 32.46 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 128.621 2.769 . . . . 0.0 109.829 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -87.11 -90.61 1.0 Allowed Glycine 0 N--CA 1.468 0.775 0 C-N-CA 127.258 2.361 . . . . 0.0 107.357 -13.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -60.86 -37.15 81.13 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.648 -1.276 . . . . 0.0 112.442 169.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 24.6 t -85.89 -40.91 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 117.883 -1.527 . . . . 0.0 111.488 -148.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.412 ' CG ' ' HA ' ' A' ' 217' ' ' SER . 0.1 OUTLIER -53.1 -46.51 68.73 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.223 162.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.92 -56.06 11.9 Favored 'General case' 0 C--O 1.214 -0.765 0 O-C-N 123.815 0.697 . . . . 0.0 111.307 -171.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.1 t -54.2 -36.71 63.75 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.739 -1.226 . . . . 0.0 112.228 176.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 15.6 m -68.93 -56.71 7.0 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.243 -0.91 . . . . 0.0 112.506 174.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.33 -57.45 12.27 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 125.864 1.666 . . . . 0.0 111.953 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.425 HD13 HG21 ' A' ' 227' ' ' ILE . 59.5 mt -54.71 -79.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-O 123.413 1.578 . . . . 0.0 108.902 169.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -74.83 -34.96 62.42 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 113.946 -1.479 . . . . 0.0 108.358 -150.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -72.72 -52.87 8.94 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.025 1.298 . . . . 0.0 115.17 172.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.41 -36.94 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-N 120.747 2.273 . . . . 0.0 111.487 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -81.33 -20.94 39.64 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.4 -46.6 89.42 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.51 0.724 . . . . 0.0 109.734 164.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.79 -24.93 67.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.57 -0.728 . . . . 0.0 110.987 171.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -70.46 -46.43 63.85 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 122.015 2.189 . . . . 0.0 113.62 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 8.3 pt -72.47 -2.25 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 120.509 -1.37 . . . . 0.0 114.206 173.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 44.1 tp -87.23 -21.58 25.76 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.677 1.191 . . . . 0.0 113.213 164.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -80.53 -12.38 59.54 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.949 1.7 . . . . 0.0 111.959 175.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 16.4 tpp -35.84 -30.8 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 128.981 2.913 . . . . 0.0 114.031 147.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 10.1 mt -102.9 -9.74 19.62 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.617 1.567 . . . . 0.0 110.767 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 52.3 m170 -83.88 -15.05 49.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.179 1.392 . . . . 0.0 112.147 161.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.359 3.4 t -88.78 46.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 125.648 2.642 . . . . 0.0 111.019 146.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 244' ' ' GLN . 38.3 t0 -46.4 90.44 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 112.306 -2.224 . . . . 0.0 109.92 104.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -68.2 37.0 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 128.73 2.812 . . . . 0.0 111.947 171.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.509 ' H ' ' C ' ' A' ' 242' ' ' ASP . 6.9 mt-30 69.31 41.03 1.4 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 129.466 3.106 . . . . 0.0 114.424 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -170.86 19.88 0.07 OUTLIER Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.069 -1.406 . . . . 0.0 116.523 172.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 95.25 107.16 2.15 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 119.565 1.682 . . . . 0.0 109.989 -171.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 15.0 t -44.44 130.41 6.6 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.974 1.31 . . . . 0.0 113.684 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 69.1 m95 58.55 18.91 6.13 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.1 2.16 . . . . 0.0 116.643 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.235 1.414 . . . . 0.0 113.575 176.361 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.485 HG12 ' H ' ' A' ' 103' ' ' ARG . 12.0 m . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 119.543 -0.265 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.494 ' HG ' ' HB2' ' A' ' 102' ' ' ALA . 3.7 tp -45.9 127.49 8.22 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 130.587 3.555 . . . . 0.0 111.935 -12.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.494 ' HB2' ' HG ' ' A' ' 101' ' ' LEU . . . -156.76 125.7 5.93 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 118.837 -2.414 . . . . 0.0 109.605 -11.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.547 ' HA ' HG12 ' A' ' 106' ' ' VAL . 2.5 ptt180 -59.26 -28.06 66.37 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.833 -1.53 . . . . 0.0 111.487 155.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -73.4 -31.51 63.92 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.227 -0.92 . . . . 0.0 110.903 172.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.466 ' H ' ' CB ' ' A' ' 102' ' ' ALA . 83.6 t60 -69.0 -48.46 63.03 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.928 -1.107 . . . . 0.0 111.964 172.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 103' ' ' ARG . 5.2 p -68.47 -34.97 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 118.273 0.488 . . . . 0.0 111.832 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -67.28 -35.16 78.93 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.193 -0.942 . . . . 0.0 110.429 172.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -57.57 -31.26 63.24 Favored Glycine 0 CA--C 1.545 1.958 0 C-N-CA 124.989 1.281 . . . . 0.0 113.841 163.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -72.26 -40.88 67.34 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.355 -1.086 . . . . 0.0 112.538 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.99 -43.53 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.705 1.202 . . . . 0.0 110.707 162.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.434 ' HB3' ' HA ' ' A' ' 177' ' ' SER . 19.6 m-30 -62.52 -45.63 92.11 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 117.433 -1.27 . . . . 0.0 112.552 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -53.39 -36.86 61.9 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.983 1.265 . . . . 0.0 113.045 170.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -73.62 -31.28 63.45 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.295 -0.878 . . . . 0.0 111.777 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.4 mt -68.35 -46.7 69.43 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.133 0.879 . . . . 0.0 110.572 168.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -70.71 -42.05 71.12 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.413 -165.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 25.9 ptt85 -75.81 156.52 84.52 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 123.858 0.863 . . . . 0.0 112.338 177.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -82.07 142.13 12.13 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.907 2.405 . . . . 0.0 111.498 167.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 75.3 p -147.74 156.92 43.25 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.561 1.544 . . . . 0.0 109.624 167.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.87 -36.04 78.24 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.016 166.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -64.66 -43.66 92.91 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -63.26 -46.2 87.97 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.292 0.951 . . . . 0.0 111.122 174.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 46.5 t -65.56 -33.76 76.67 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -62.08 -56.46 18.73 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.989 -1.07 . . . . 0.0 111.349 171.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.6 p -73.49 -41.08 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 120.721 -1.237 . . . . 0.0 113.207 -173.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -67.99 -50.9 52.82 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.665 0.786 . . . . 0.0 112.491 -173.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -68.14 -27.62 66.59 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.7 0.682 . . . . 0.0 111.991 -172.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -89.4 -30.4 18.38 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.4 -38.54 74.45 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 120.183 1.356 . . . . 0.0 112.529 158.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 19.4 t -58.28 -47.98 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 120.414 1.461 . . . . 0.0 111.884 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -59.66 -50.45 73.83 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.755 0.822 . . . . 0.0 113.193 172.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.57 -42.95 99.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -176.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.3 mt -63.38 -50.81 77.16 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.035 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.56 -36.46 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 119.926 1.239 . . . . 0.0 112.544 -173.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.1 tt -62.13 -47.71 83.35 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.277 1.031 . . . . 0.0 111.616 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 32.6 m -75.9 -40.89 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.747 0.703 . . . . 0.0 111.053 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 12.5 t -49.66 -58.27 5.6 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.351 1.86 . . . . 0.0 112.834 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 69.5 mt -77.28 -32.42 55.53 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.273 -0.892 . . . . 0.0 112.987 -173.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.9 mt -68.96 -46.14 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 120.038 1.29 . . . . 0.0 110.406 171.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -61.59 -30.33 70.61 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.806 175.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.8 m -60.08 -38.42 82.84 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.445 1.475 . . . . 0.0 113.212 172.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 50.7 t -67.27 -24.04 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 123.924 0.89 . . . . 0.0 111.807 174.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 46.2 mt -87.75 -48.33 7.94 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.292 1.037 . . . . 0.0 113.208 173.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 59.4 p -71.12 -12.41 61.48 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 127.497 2.319 . . . . 0.0 113.531 -171.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.7 t -70.63 -32.67 70.07 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.663 1.185 . . . . 0.0 111.444 170.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 48.4 mm -72.6 -33.35 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.712 0.805 . . . . 0.0 110.64 168.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -66.31 -33.29 75.39 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.271 0.628 . . . . 0.0 112.187 169.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -65.2 -40.86 94.76 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.843 1.257 . . . . 0.0 111.595 170.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -69.27 -34.4 74.69 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.338 0.655 . . . . 0.0 112.379 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.03 98.14 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.852 0.861 . . . . 0.0 111.722 167.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.13 -10.27 9.89 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 76.3 mt -70.78 -12.31 61.47 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.117 1.367 . . . . 0.0 113.738 166.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -152.56 -45.73 0.1 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -163.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.6 t -156.26 175.65 13.71 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.746 0.819 . . . . 0.0 110.833 -143.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.1 139.62 48.27 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 114.628 0.611 . . . . 0.0 114.628 -166.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.1 t -156.26 143.84 19.33 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -162.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 16.7 tp -87.18 7.89 26.27 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.882 1.273 . . . . 0.0 112.624 171.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -65.59 -10.98 40.27 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 119.546 -1.972 . . . . 0.0 114.093 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 53.7 p-90 -65.3 -26.46 68.08 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.057 -1.652 . . . . 0.0 112.492 166.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 51.0 tpp -75.36 -28.75 59.66 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.652 1.581 . . . . 0.0 112.261 174.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -61.24 -43.8 98.29 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.133 -0.979 . . . . 0.0 110.453 165.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.12 -35.26 73.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 118.096 -0.954 . . . . 0.0 111.3 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.43 -53.0 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 120.66 1.573 . . . . 0.0 111.745 170.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.8 mt -68.18 -36.8 80.16 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.239 0.927 . . . . 0.0 112.411 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 38.0 t -59.29 -41.47 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 120.666 1.576 . . . . 0.0 111.092 172.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.17 -31.13 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.502 -0.761 . . . . 0.0 111.05 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -59.66 -51.94 67.65 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.601 1.092 . . . . 0.0 111.752 165.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -62.47 -36.77 83.53 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 121.226 1.83 . . . . 0.0 112.055 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -62.31 -43.87 98.47 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 172.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 56.0 m -67.27 -32.81 74.06 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.401 -1.058 . . . . 0.0 110.895 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -65.42 -41.96 93.0 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 120.738 -1.226 . . . . 0.0 112.344 173.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -58.35 -45.71 87.66 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.529 0.604 . . . . 0.0 111.832 170.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.4 t -66.04 -38.18 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.816 0.846 . . . . 0.0 111.515 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 23.1 t -65.23 -38.83 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.004 1.322 . . . . 0.0 110.967 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -62.47 -34.26 76.49 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.585 1.084 . . . . 0.0 113.335 171.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 9.7 mt -67.96 -47.34 68.87 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.915 0.779 . . . . 0.0 111.875 169.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -61.91 -43.51 98.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 118.013 -0.994 . . . . 0.0 112.858 -178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.434 ' HA ' ' HB3' ' A' ' 111' ' ' TYR 0.265 43.0 p -65.49 -26.98 68.16 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 176.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.448 ' HB1' ' C ' ' A' ' 186' ' ' GLY . . . -57.23 -25.14 58.62 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.801 1.182 . . . . 0.0 113.247 168.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.412 ' CA ' ' HA ' ' A' ' 183' ' ' LYS . . . -70.49 -9.65 65.17 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 126.098 1.808 . . . . 0.0 114.643 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 44.1 t -53.82 -40.34 66.3 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.263 1.025 . . . . 0.0 112.382 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 3.1 ptp85 -68.51 -57.83 5.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.577 0.751 . . . . 0.0 111.803 171.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 41.7 t -162.96 137.67 6.46 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.498 1.919 . . . . 0.0 108.009 169.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.412 ' HA ' ' CA ' ' A' ' 179' ' ' GLY . 18.0 ptmt -60.28 -34.02 73.15 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -153.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -103.03 -27.19 12.74 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.209 1.004 . . . . 0.0 112.765 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 61.3 t -62.21 -68.08 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.068 1.347 . . . . 0.0 111.325 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.448 ' C ' ' HB1' ' A' ' 178' ' ' ALA . . . -61.0 -31.04 75.06 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 119.128 -0.818 . . . . 0.0 112.195 -178.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 7.9 tt -66.94 -39.93 87.45 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.61 1.564 . . . . 0.0 112.449 176.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 4.7 t-105 -60.26 -40.47 90.48 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 120.804 -1.185 . . . . 0.0 110.844 166.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -64.89 -30.31 77.65 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 122.226 0.903 . . . . 0.0 113.385 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 -76.3 -32.49 58.79 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.866 2.466 . . . . 0.0 112.312 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 75.1 mt -76.0 -35.35 59.59 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.943 1.297 . . . . 0.0 112.662 167.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 65.0 mtt-85 -59.67 -36.49 76.54 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.819 -1.176 . . . . 0.0 111.456 166.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -69.49 28.5 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 126.298 1.839 . . . . 0.0 113.994 170.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.66 27.95 1.21 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.598 2.359 . . . . 0.0 112.991 164.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -105.99 -37.08 6.76 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -149.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -77.86 146.81 72.92 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 117.265 -1.35 . . . . 0.0 109.868 172.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -45.22 -44.21 15.96 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.694 3.596 . . . . 0.0 116.901 -171.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -70.27 -30.38 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 119.353 0.979 . . . . 0.0 110.93 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.446 ' HA ' ' HB3' ' A' ' 202' ' ' ASP . 66.7 m -81.68 -26.83 34.38 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.509 1.523 . . . . 0.0 112.997 176.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.96 -48.14 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 163.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 65.5 mt -65.01 -30.08 49.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-O 118.689 -0.672 . . . . 0.0 111.566 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.446 ' HB3' ' HA ' ' A' ' 199' ' ' SER . 29.1 t70 -71.53 -44.52 64.46 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.496 1.498 . . . . 0.0 110.542 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 43.4 tp -61.6 -44.29 97.28 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.635 0.774 . . . . 0.0 111.403 171.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 72.2 mt -63.26 -49.1 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 121.393 -0.817 . . . . 0.0 110.804 176.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.0 t -70.39 -33.96 56.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 117.098 -1.429 . . . . 0.0 112.427 -173.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.5 p -65.38 -34.76 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 121.568 1.986 . . . . 0.0 111.394 172.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 86.9 t -75.17 -38.47 41.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 O-C-N 121.372 -0.83 . . . . 0.0 110.063 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -55.75 -47.26 77.27 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.697 0.68 . . . . 0.0 110.82 168.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 20.0 m -56.16 -43.48 78.39 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.148 0.979 . . . . 0.0 111.783 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 58.6 ttm -75.55 -50.3 16.02 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.276 0.631 . . . . 0.0 111.752 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 56.0 t -56.06 -46.74 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.066 0.946 . . . . 0.0 111.837 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 222' ' ' PHE . 13.9 m -77.01 -39.71 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 118.974 0.806 . . . . 0.0 113.035 -173.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -56.91 -32.87 66.37 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.919 0.887 . . . . 0.0 110.746 170.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 55.2 m -75.48 -52.15 11.36 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.376 1.471 . . . . 0.0 112.97 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.7 t -58.17 -40.25 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 125.265 1.426 . . . . 0.0 112.369 -171.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 139.35 154.66 6.41 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 123.595 0.617 . . . . 0.0 112.374 173.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 55.1 p -73.56 23.21 0.07 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -160.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm -156.41 165.39 36.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.477 1.911 . . . . 0.0 111.933 -160.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -78.01 -80.31 0.7 Allowed Glycine 0 N--CA 1.478 1.434 0 C-N-CA 127.462 2.458 . . . . 0.0 109.386 -9.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -84.77 -27.17 27.06 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.927 1.291 . . . . 0.0 110.827 161.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 73.5 t -76.7 -40.91 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 121.179 -0.951 . . . . 0.0 112.42 -145.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.428 ' HA ' ' HB ' ' A' ' 212' ' ' VAL . 0.0 OUTLIER -60.01 -39.81 87.07 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 169.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -74.17 -49.8 22.02 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.764 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 8.8 t -53.77 -38.4 64.42 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 121.123 1.783 . . . . 0.0 112.219 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 19.3 m -66.05 -56.85 9.48 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.505 -0.747 . . . . 0.0 112.357 173.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.54 -48.37 77.8 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.931 1.293 . . . . 0.0 112.496 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 67.2 mt -62.72 -84.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.79 0 O-C-N 119.255 -2.153 . . . . 0.0 109.133 169.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -71.87 -38.28 70.05 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.778 -152.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -71.05 -44.21 55.19 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 125.991 1.758 . . . . 0.0 114.32 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.5 mp -78.26 -30.18 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 118.773 1.286 . . . . 0.0 109.74 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -39.91 82.34 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 120.841 -1.162 . . . . 0.0 111.57 164.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -68.01 -41.48 82.14 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 117.385 -1.293 . . . . 0.0 110.73 -174.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 31.9 tp -57.43 -45.16 84.97 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.154 0.888 . . . . 0.0 110.856 167.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -59.09 -45.94 89.57 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -170.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 15.4 pt -66.93 -20.8 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 35.4 mt -66.88 -22.87 65.96 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.285 -0.884 . . . . 0.0 110.756 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -74.65 -11.35 60.16 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.263 -0.898 . . . . 0.0 111.731 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 81.2 mtp -45.79 -33.72 3.26 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 126.025 1.73 . . . . 0.0 113.1 153.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.3 mt -98.56 -14.02 20.14 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.346 1.459 . . . . 0.0 111.304 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 50.0 m170 -75.31 -27.49 59.31 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.681 -0.637 . . . . 0.0 111.495 157.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . 0.251 15.5 t -79.01 60.62 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 125.557 2.599 . . . . 0.0 110.027 157.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' A' ' 244' ' ' GLN . 40.9 t0 -61.18 100.01 0.11 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 112.397 -2.183 . . . . 0.0 108.422 107.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.606 ' HB3' HG21 ' A' ' 247' ' ' THR . 5.4 ttt180 -64.51 30.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 130.127 3.371 . . . . 0.0 113.526 171.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.475 ' H ' ' C ' ' A' ' 242' ' ' ASP . 49.6 mt-30 74.66 38.5 0.48 Allowed 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 128.812 2.845 . . . . 0.0 113.837 170.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -166.46 12.22 0.07 OUTLIER Glycine 0 CA--C 1.537 1.433 0 CA-C-O 118.113 -1.382 . . . . 0.0 116.309 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 78.89 67.49 1.59 Allowed Glycine 0 N--CA 1.468 0.801 0 CA-C-N 120.083 1.942 . . . . 0.0 112.638 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.606 HG21 ' HB3' ' A' ' 243' ' ' ARG . 15.6 p -106.38 -177.68 3.43 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -156.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 9.3 m95 60.81 32.02 20.1 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 126.318 1.847 . . . . 0.0 112.826 -140.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 . . . . . 0 N--CA 1.479 0.98 0 O-C-N 119.338 -2.101 . . . . 0.0 111.996 -173.187 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.402 ' HB ' ' H ' ' A' ' 102' ' ' ALA . 17.5 m . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' A' ' 102' ' ' ALA . 5.1 tp -89.44 92.16 9.01 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 116.658 -2.017 . . . . 0.0 105.56 124.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.496 ' HB1' ' CB ' ' A' ' 105' ' ' HIS 0.278 . . 61.79 57.85 2.1 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 110.785 -2.916 . . . . 0.0 115.738 142.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -49.47 -29.38 6.54 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.178 142.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.2 t -63.42 -33.28 75.21 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 168.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.496 ' CB ' ' HB1' ' A' ' 102' ' ' ALA . 86.5 t60 -79.85 -30.39 40.31 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.439 -1.413 . . . . 0.0 110.763 -174.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.3 m -84.1 -34.25 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-O 121.845 0.831 . . . . 0.0 112.334 -174.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -52.74 -47.83 67.12 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.321 -1.308 . . . . 0.0 110.348 156.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -56.12 -36.83 69.37 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 118.928 -0.929 . . . . 0.0 113.613 169.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -70.11 -36.07 74.59 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.942 1.371 . . . . 0.0 112.089 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 t -57.0 -57.02 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.49 0.716 . . . . 0.0 109.87 162.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.419 ' HB3' ' HA ' ' A' ' 177' ' ' SER . 20.5 m-85 -58.76 -45.79 88.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.483 0.313 . . . . 0.0 111.623 -172.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -67.68 -21.54 65.33 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -77.0 -36.45 56.4 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.349 0.977 . . . . 0.0 111.294 172.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.8 mt -62.0 -40.79 96.85 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.799 -0.563 . . . . 0.0 109.735 164.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -71.75 -44.0 64.83 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.973 -167.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -98.87 101.72 13.0 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 126.632 1.973 . . . . 0.0 110.683 -174.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -65.17 156.95 60.14 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.49 2.126 . . . . 0.0 114.97 -164.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 40.4 p -145.31 168.14 21.17 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 127.107 2.163 . . . . 0.0 107.692 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.1 -35.14 32.94 Favored Glycine 0 CA--C 1.536 1.389 0 O-C-N 121.627 -0.671 . . . . 0.0 112.282 164.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 33.9 m95 -69.13 -34.45 75.04 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -60.87 -51.18 70.38 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.66 1.118 . . . . 0.0 110.51 169.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 42.8 t -63.09 -37.19 86.23 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.265 0.626 . . . . 0.0 111.573 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -58.96 -59.26 5.75 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.023 0.44 . . . . 0.0 109.844 173.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.86 -49.37 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.012 0.525 . . . . 0.0 111.993 -168.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -68.39 -46.2 70.65 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -170.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -77.89 -27.92 49.76 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.566 -0.709 . . . . 0.0 112.113 -172.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -68.78 -44.86 72.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.997 165.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -51.78 -48.91 63.59 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 117.314 -1.327 . . . . 0.0 113.96 168.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . 0.265 0.9 OUTLIER -63.82 -41.5 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 121.76 2.073 . . . . 0.0 112.293 -179.126 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -67.27 -43.17 82.47 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.742 0.701 . . . . 0.0 111.849 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 85.4 mt -66.1 -41.85 90.05 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.612 0.365 . . . . 0.0 111.766 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 69.4 mt -64.26 -47.74 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 118.011 -0.995 . . . . 0.0 111.194 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -40.32 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 120.495 1.498 . . . . 0.0 111.378 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 33.8 tp -59.43 -43.69 93.04 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.624 1.17 . . . . 0.0 111.658 175.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.8 t -64.3 -45.79 95.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 118.694 -0.669 . . . . 0.0 111.356 171.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 90.5 m -63.7 -39.98 95.64 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.172 0.896 . . . . 0.0 112.385 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 87.5 mt -79.49 -37.27 37.17 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.419 -0.801 . . . . 0.0 112.686 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.3 mt -59.25 -48.32 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.301 0.572 . . . . 0.0 109.94 167.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -60.96 -36.3 79.03 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-O 117.726 -1.131 . . . . 0.0 110.845 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.9 m -55.41 -44.49 76.24 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 121.538 1.972 . . . . 0.0 112.444 -176.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.3 m -79.28 -16.04 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 78.4 mt -81.98 -28.41 32.66 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 120.074 1.306 . . . . 0.0 113.554 161.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 37.8 t -78.5 -38.67 40.2 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.808 1.643 . . . . 0.0 113.579 -160.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . 0.336 3.4 t -74.28 -17.19 60.89 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 120.295 1.407 . . . . 0.0 113.312 -175.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.1 mp -58.89 -43.13 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 O-C-N 120.587 -1.32 . . . . 0.0 110.959 159.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -69.52 -41.04 76.54 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.479 1.111 . . . . 0.0 110.669 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -59.04 -41.6 88.21 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.779 1.232 . . . . 0.0 111.647 171.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -67.99 -40.83 83.0 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.782 -1.199 . . . . 0.0 110.922 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.94 -33.47 73.23 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.615 0.766 . . . . 0.0 111.481 172.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.28 -8.66 8.98 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 72.3 mt -70.71 -11.93 61.25 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 120.249 -1.532 . . . . 0.0 113.482 166.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.49 -45.54 0.17 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -170.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.1 t -157.52 -178.66 7.5 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.806 0.813 . . . . 0.0 112.402 -138.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.13 134.99 52.11 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 124.609 1.099 . . . . 0.0 114.445 -170.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.5 t -155.07 137.52 15.01 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.227 1.011 . . . . 0.0 112.735 -160.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.6 tp -81.09 6.13 14.58 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.988 1.315 . . . . 0.0 113.342 166.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -64.93 -9.01 17.98 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 119.664 -1.897 . . . . 0.0 114.484 -173.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -68.73 -28.33 66.73 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.22 1.008 . . . . 0.0 112.129 167.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 50.6 tpp -66.24 -25.4 66.88 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.985 1.266 . . . . 0.0 111.862 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -63.99 -45.28 89.7 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.21 -0.931 . . . . 0.0 111.276 170.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 33.5 mt -57.48 -43.23 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.41 1.084 . . . . 0.0 111.087 172.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.3 t -61.35 -42.85 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 121.391 -0.818 . . . . 0.0 112.271 176.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 10.7 mt -71.84 -36.17 70.09 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.618 1.099 . . . . 0.0 113.233 173.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 45.2 t -59.54 -34.05 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 O-C-N 120.809 -1.182 . . . . 0.0 110.937 169.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 81.6 t -82.15 -26.75 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.315 1.046 . . . . 0.0 111.236 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -61.41 -56.72 17.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.29 1.404 . . . . 0.0 110.225 166.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -64.84 -39.09 93.01 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.221 0.919 . . . . 0.0 112.071 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -61.8 -42.85 99.8 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.638 1.113 . . . . 0.0 113.255 175.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.8 m -78.6 -30.31 46.55 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.997 1.398 . . . . 0.0 111.701 175.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.75 -41.11 97.23 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.898 -1.126 . . . . 0.0 111.851 170.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -53.09 -45.98 68.44 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.72 0.691 . . . . 0.0 110.571 169.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 92.5 t -68.22 -37.66 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.407 0.683 . . . . 0.0 112.006 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 39.3 t -63.21 -36.05 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 121.215 -0.928 . . . . 0.0 112.342 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -58.45 -38.8 78.27 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.279 0.945 . . . . 0.0 111.954 169.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 33.3 mt -72.97 -34.28 66.37 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 176.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -70.78 -39.84 72.96 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 173.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.419 ' HA ' ' HB3' ' A' ' 111' ' ' TYR . 17.6 p -62.35 -20.96 64.92 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 120.439 -1.413 . . . . 0.0 114.724 165.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -70.77 -6.63 39.1 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 120.203 1.365 . . . . 0.0 113.862 163.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -154.97 44.69 0.55 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.553 1.549 . . . . 0.0 112.986 -160.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' CYS . . . . . . . . . . . . . 25.8 p -51.94 -24.53 6.55 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.028 0.931 . . . . 0.0 113.248 169.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.92 -53.41 2.28 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.76 2.024 . . . . 0.0 110.175 161.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.8 m -76.04 48.14 0.48 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 128.42 2.688 . . . . 0.0 112.563 -172.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -55.52 -19.24 9.18 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.939 2.496 . . . . 0.0 115.447 -169.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -114.18 -29.19 7.04 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 169.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 2.0 t -65.15 -61.68 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 119.907 1.231 . . . . 0.0 111.197 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -73.44 -28.45 65.73 Favored Glycine 0 C--O 1.222 -0.647 0 O-C-N 121.929 -0.482 . . . . 0.0 112.525 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 3.0 tt -53.34 -41.03 65.34 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.509 0.724 . . . . 0.0 110.773 166.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -85.93 -18.21 33.32 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.02 -37.08 16.62 Favored Glycine 0 N--CA 1.467 0.727 0 O-C-N 119.728 -1.858 . . . . 0.0 110.418 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -67.13 -25.49 66.21 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.942 1.697 . . . . 0.0 112.704 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 21.7 mt -76.0 -1.32 25.15 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 165.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 37.6 mtm105 -122.98 -8.11 8.34 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.321 1.848 . . . . 0.0 113.432 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -72.81 66.68 0.77 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.936 1.694 . . . . 0.0 108.409 149.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -148.36 82.26 1.48 Allowed 'General case' 0 C--O 1.239 0.501 0 C-N-CA 127.625 2.37 . . . . 0.0 107.432 -156.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 48.8 ttt85 -147.42 -73.69 0.2 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -154.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -72.83 154.94 91.04 Favored Pre-proline 0 N--CA 1.474 0.764 0 CA-C-N 119.28 0.945 . . . . 0.0 112.865 175.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.92 -45.61 24.23 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.893 3.062 . . . . 0.0 116.704 -168.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 69.4 mt -64.15 -35.4 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 121.525 1.966 . . . . 0.0 111.554 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 54.6 p -70.51 -31.1 68.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.8 1.182 . . . . 0.0 112.937 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 48.4 mm -75.39 -40.52 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.443 1.097 . . . . 0.0 111.13 172.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 56.4 mt -61.91 -41.78 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.146 0.978 . . . . 0.0 110.429 171.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.73 -43.21 97.16 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.834 1.654 . . . . 0.0 111.794 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 68.4 tp -60.98 -49.25 78.22 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.925 0.89 . . . . 0.0 112.687 170.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 61.9 mt -62.28 -44.55 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.167 -0.958 . . . . 0.0 110.53 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.0 t -69.11 -34.53 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 116.823 -1.561 . . . . 0.0 113.073 -174.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.1 p -68.22 -33.08 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 121.677 2.035 . . . . 0.0 111.6 173.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 82.4 t -77.37 -40.37 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 O-C-N 121.456 -0.777 . . . . 0.0 109.988 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.467 ' O ' HG22 ' A' ' 212' ' ' VAL . . . -54.76 -52.03 63.84 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.118 0.967 . . . . 0.0 110.758 167.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.4 m -56.06 -47.42 77.96 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.807 0.843 . . . . 0.0 112.344 -178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 72.5 mtm -59.73 -48.72 80.57 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 174.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.57 -44.04 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 118.547 0.612 . . . . 0.0 112.323 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 208' ' ' ALA . 27.2 m -84.67 -24.81 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 117.525 -1.226 . . . . 0.0 112.368 -167.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 38.9 mt -63.1 -30.69 71.79 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.561 1.528 . . . . 0.0 112.043 156.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 43.3 t -83.67 -45.73 13.1 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.841 0.856 . . . . 0.0 113.166 -164.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 9.5 t -50.94 -30.16 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 125.975 1.71 . . . . 0.0 114.474 -173.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 131.52 157.41 8.76 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 126.603 2.049 . . . . 0.0 109.771 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 90.3 p -81.76 34.44 0.39 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.89 -1.359 . . . . 0.0 113.663 -168.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -171.05 177.94 3.53 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 130.289 3.436 . . . . 0.0 109.092 176.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 63.36 112.48 0.01 OUTLIER Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 115.765 -3.112 . . . . 0.0 107.626 -111.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.43 -8.41 0.13 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.845 0.831 . . . . 0.0 111.89 160.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.452 ' HA ' HG22 ' A' ' 224' ' ' THR . 0.5 OUTLIER -67.66 -44.45 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 127.35 2.26 . . . . 0.0 112.138 174.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -50.12 -52.13 37.55 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.345 1.458 . . . . 0.0 110.652 169.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.33 -59.89 3.28 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.494 1.118 . . . . 0.0 110.418 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 221' ' ' VAL . 13.8 t -59.8 -42.12 92.73 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.458 ' HB2' HG21 ' A' ' 212' ' ' VAL . 21.6 m -69.13 -45.06 71.07 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.14 -0.975 . . . . 0.0 110.893 -173.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -53.36 -62.98 1.3 Allowed 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 126.073 1.749 . . . . 0.0 110.975 170.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 53.4 mt -56.4 -72.71 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 123.52 1.629 . . . . 0.0 111.141 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -73.7 -44.72 55.75 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 112.715 -2.039 . . . . 0.0 106.959 -152.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -65.87 -52.88 34.28 Favored Glycine 0 N--CA 1.466 0.667 0 C-N-CA 125.021 1.296 . . . . 0.0 114.41 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.72 -38.72 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.489 1.645 . . . . 0.0 111.275 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -82.82 -28.86 29.92 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -175.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -55.38 -43.4 75.12 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.051 1.341 . . . . 0.0 109.27 168.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 57.0 tp -65.07 -38.21 90.05 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 117.723 -1.132 . . . . 0.0 111.816 173.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -66.09 -37.94 87.02 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 121.899 2.136 . . . . 0.0 112.547 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 35.6 pt -69.52 -10.83 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 114.981 1.475 . . . . 0.0 114.981 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 11.1 mt -78.96 -20.6 48.79 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 120.918 -1.114 . . . . 0.0 110.944 167.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . 0.268 53.9 mtp180 -73.08 -19.28 61.2 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.668 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 89.2 mtp -48.63 -16.26 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 129.7 3.2 . . . . 0.0 117.059 156.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.6 pp -143.81 -19.98 0.59 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.679 1.127 . . . . 0.0 112.913 -174.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -75.63 -8.41 56.72 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.645 1.178 . . . . 0.0 111.853 157.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 3.2 p -56.31 125.12 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.152 0 CA-C-O 124.188 1.947 . . . . 0.0 107.858 171.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 244' ' ' GLN . 27.5 t0 -119.84 97.23 5.52 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 110.592 -3.004 . . . . 0.0 109.653 150.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 27.1 ttt-85 -64.56 18.33 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.176 1.39 . . . . 0.0 113.113 157.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.494 ' H ' ' C ' ' A' ' 242' ' ' ASP 0.415 8.2 pt20 74.82 51.77 0.08 Allowed 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 131.634 3.974 . . . . 0.0 114.096 159.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -157.78 3.96 0.14 Allowed Glycine 0 CA--C 1.541 1.686 0 CA-C-N 114.211 -1.359 . . . . 0.0 114.23 164.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 87.46 75.58 1.27 Allowed Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.061 1.43 . . . . 0.0 110.911 -163.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 4.5 m -59.01 155.51 13.41 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.081 1.752 . . . . 0.0 112.466 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' TRP . . . . . . . . . . . . . 99.0 m95 55.1 38.74 30.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.61 1.964 . . . . 0.0 115.302 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 45.1 ttm-85 . . . . . 0 C--O 1.25 1.129 0 C-N-CA 124.958 1.303 . . . . 0.0 112.81 179.465 . . . . . . . . 0 0 . 1 stop_ save_